<SEC-DOCUMENT>0001899287-23-000076.txt : 20230511
<SEC-HEADER>0001899287-23-000076.hdr.sgml : 20230511
<ACCEPTANCE-DATETIME>20230511160348
ACCESSION NUMBER:		0001899287-23-000076
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		61
CONFORMED PERIOD OF REPORT:	20230331
FILED AS OF DATE:		20230511
DATE AS OF CHANGE:		20230511

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Amprius Technologies, Inc.
		CENTRAL INDEX KEY:			0001899287
		STANDARD INDUSTRIAL CLASSIFICATION:	MISCELLANEOUS ELECTRICAL MACHINERY, EQUIPMENT & SUPPLIES [3690]
		IRS NUMBER:				981591811
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-41314
		FILM NUMBER:		23910855

	BUSINESS ADDRESS:	
		STREET 1:		1180 PAGE AVENUE
		CITY:			FREMONT
		STATE:			CA
		ZIP:			94538
		BUSINESS PHONE:		(800) 425-8803

	MAIL ADDRESS:	
		STREET 1:		1180 PAGE AVENUE
		CITY:			FREMONT
		STATE:			CA
		ZIP:			94538

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Kensington Capital Acquisition Corp. IV
		DATE OF NAME CHANGE:	20211214
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>ampx-20230331.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:fb8494f8-cb68-4af0-9ed5-216002fa868d,g:3b95c37f-4a77-4ae7-bad0-5ccbe8b7d32c,d:066fdabb1d0848d5b0391931f87c3c0e--><html xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ampx="http://www.amprius.com/20230331" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:us-gaap="http://fasb.org/us-gaap/2022" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:srt="http://fasb.org/srt/2022" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>ampx-20230331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV83L2ZyYWc6ZmY4OTM4M2JjZTA2NDU5ZjhhMGU3NDAyMDk2MmRiZDkvdGFibGU6Mzc1MWExYWUxYTQxNDM0YThkOWM4NTc3NzlhNmRiYzQvdGFibGVyYW5nZTozNzUxYTFhZTFhNDE0MzRhOGQ5Yzg1Nzc3OWE2ZGJjNF8yLTEtMS0xLTYxOTkw_486805dc-d176-4a1a-96af-d95c98b3e6bc">0001899287</ix:nonNumeric><ix:nonNumeric contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" name="dei:CurrentFiscalYearEndDate" format="ixt:date-month-day" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV83L2ZyYWc6ZmY4OTM4M2JjZTA2NDU5ZjhhMGU3NDAyMDk2MmRiZDkvdGFibGU6Mzc1MWExYWUxYTQxNDM0YThkOWM4NTc3NzlhNmRiYzQvdGFibGVyYW5nZTozNzUxYTFhZTFhNDE0MzRhOGQ5Yzg1Nzc3OWE2ZGJjNF8zLTEtMS0xLTYxOTkw_211e80f0-cceb-4d7e-978c-2ff864d74df6">12-31</ix:nonNumeric><ix:nonNumeric contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV83L2ZyYWc6ZmY4OTM4M2JjZTA2NDU5ZjhhMGU3NDAyMDk2MmRiZDkvdGFibGU6Mzc1MWExYWUxYTQxNDM0YThkOWM4NTc3NzlhNmRiYzQvdGFibGVyYW5nZTozNzUxYTFhZTFhNDE0MzRhOGQ5Yzg1Nzc3OWE2ZGJjNF80LTEtMS0xLTYxOTkw_85abab34-4068-4a88-9918-8eb21c20729d">2023</ix:nonNumeric><ix:nonNumeric contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV83L2ZyYWc6ZmY4OTM4M2JjZTA2NDU5ZjhhMGU3NDAyMDk2MmRiZDkvdGFibGU6Mzc1MWExYWUxYTQxNDM0YThkOWM4NTc3NzlhNmRiYzQvdGFibGVyYW5nZTozNzUxYTFhZTFhNDE0MzRhOGQ5Yzg1Nzc3OWE2ZGJjNF81LTEtMS0xLTYxOTkw_6708a397-9312-477e-9018-5b190cf769d3">Q1</ix:nonNumeric><ix:nonNumeric contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV83L2ZyYWc6ZmY4OTM4M2JjZTA2NDU5ZjhhMGU3NDAyMDk2MmRiZDkvdGFibGU6Mzc1MWExYWUxYTQxNDM0YThkOWM4NTc3NzlhNmRiYzQvdGFibGVyYW5nZTozNzUxYTFhZTFhNDE0MzRhOGQ5Yzg1Nzc3OWE2ZGJjNF82LTEtMS0xLTYxOTkw_14782df6-a0a3-42bd-86e6-9082a9d96538">false</ix:nonNumeric><ix:nonNumeric contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331" name="us-gaap:AccountingStandardsUpdateExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOjFjNDZmODgyMWIzNjRjYmM4NTllMzRhMjE5M2I3ZjAzL3RhYmxlcmFuZ2U6MWM0NmY4ODIxYjM2NGNiYzg1OWUzNGEyMTkzYjdmMDNfNy0wLTEtMS02MTk5MA_553a4f00-e978-4e3b-ac10-ef28c58a3c8b">http://fasb.org/us-gaap/2022#AccountingStandardsUpdate201602Member</ix:nonNumeric><ix:nonNumeric contextRef="i9f2425ecaf1e4131b7a7a5b98fa6ec56_I20230331" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80OS9mcmFnOmU5ZjM4NDljODljMTQ5YmFhYTA5MmM5OWJkYWMyYzQ0L3RleHRyZWdpb246ZTlmMzg0OWM4OWMxNDliYWFhMDkyYzk5YmRhYzJjNDRfMTky_a7f1b717-5185-4cf6-a180-906ce440400f">four years</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="ampx-20230331.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f69aaee1e4f40698eb541763e1fdba8_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f2107c9841f453a82a0c7c211510fd3_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ampx:RedeemableWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib58f786ebe7b4b848751f6ae32c45cf4_I20230504"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-05-04</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i6023c648ad62464a83503c70b103bde2_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i988b24a7822c4dd0a13444855095dca6_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8f5097542ed94e019e553cb2481ed488_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2afb5bfd349b44c8b991e6359c2ea6ac_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6db38870876b40778cbddcf2716d2e8c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id53f479a40704e0db1e45d90b74f3ab2_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee3994aee9fd4eec960461ddc9dede6e_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf9077943bf2498e945a5b5cffea4ede_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icbda858436fb409e928a18346f855b84_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i38d004c355644a42b820f2b35e0874a5_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i55afdc11794d46c3844a5877adc375f6_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife934d56970b49fdbc5f246e8c61d0f5_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i720988f66ee2413488964d010217db49_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0266250627e24a9d98564b0fca01e7dc_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i11415fde3f7d40df98aa03c58126edec_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idd6d5ba96ae14bb0b84986d93719cf0c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6449e443d30c455184fed3bff4010086_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a1b0acc07434411a2695d9dbe33e259_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1a1fa4a0e8fb49cc8d3c759e2e0c17e7_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0cad88c1b2cb4985ad2e0e7a12c33ca0_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifce6518367b34d3ab4c10e9de84e7829_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4378b9360776445ba70d80981bf38d62_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7f7477a44afb4479b9c1eee284f3005c_I20211231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f1b454495df444b9b332af549b60b6a_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50f6cb59fed6438795bb51a3698b7cef_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i269ea436a3b44ee9800781cda13e9ced_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7025e13610834dba9e2d509086735e0f_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id94df322b86f4f07b19482d29fdb864b_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i74bb0e27b0d34b379dd2c30509852fed_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4b2c45cb6722425d93cf25d37d538c75_I20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i10455920b55e4d9b921af5961e20e70c_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ampx:PurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5204fd658af644a69b260e135d17b875_I20221019"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-10-19</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1e90ee49c2a54d3a851c9f496677d786_I20220914"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-09-14</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:unit id="executiveemployee"><xbrli:measure>ampx:executiveEmployee</xbrli:measure></xbrli:unit><xbrli:context id="i249e71b6552c4c1eb0877da134e2de5a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i57089d02123243da8af388b3d544181d_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5371cedb4ff54ccd8164da48c07a4e65_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ampx:CustomerOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2491a8cf26ae441db19f29da6405e4f3_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ampx:CustomerTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia0ca1db60f404e5e8963bf33fc47c360_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ampx:CustomerThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i97a5618b45474da28680c8670a3e72f1_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ampx:CustomerOneMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id9df38d6aecc41ac937ddb4c6110b735_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ampx:CustomerTwoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iade7297fa7ee4e99b67dd741d1ffe066_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ampx:CustomerThreeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i851c46bd9c414d139116e6b9fb6058fa_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ampx:ThreeCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifa2cb13888a54b6c8e0df0d3d5d53aee_D20220101-20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ampx:FiveCustomersMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i43cd424ce72a4a40ac5fe4088c873948_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ampx:SaleOfBatteryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iee19788a62c34779b7e8c93581517ccc_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ampx:SaleOfBatteryMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic144432f29d243b0b1d00f76340bc40e_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ampx:CustomizedDesignServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i42b2afc255654cec93289ac97a7463f7_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ampx:CustomizedDesignServicesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3ef781aff42644a5b81b5015320dace1_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ampx:TotalRevenueFromCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6cf8fcfb69a74fd9aa89d6dc6e5f7b7f_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ampx:TotalRevenueFromCustomersMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0e692c0e7a0a484c82160d4323ca8b64_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ampx:OtherRevenueGovernmentGrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8593a7e0ef1947cc8d2ea977da1fe0b0_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ampx:OtherRevenueGovernmentGrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0ae713297f034937abe6ba4c9366e66b_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i076e74831991483a8e8261e35d5fdc5d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35c52756179342cb89a7e4fbbc177710_I20220101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i904eec3b78d5419aa0f9501d2ea7f78e_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-04-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f2425ecaf1e4131b7a7a5b98fa6ec56_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"><us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2024-04-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i903b361bf85148a5aa5dbeb03ba0ea1d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ampx:ProductionEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5977eefa4b7f4aa09e7fdb5aea5dd806_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ampx:ProductionEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia6d7ea55505e405b8d49c84e5c00e216_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ampx:LaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0cdadfcb55ef4456992d4eac608c568c_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ampx:LaboratoryEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6305afd21797431abefaa882fdec1d44_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie7d6fdab3f1b47a985e1326bf5737eca_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib5ac7197a264438baf93759ed1193030_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3e9ea2df75d5435493c2296c08d770cc_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i255153329caf42fbad158d721b25384a_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i670d9fe2f1524ac7bd4b7736aac57795_I20221231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic33e1539b78a40bda4ef216dea1bd960_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ampx:TwentyTwentyTwoEquityIncentivePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if8307ba91dca43aa98a87dbc1eace892_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ampx:EquityIncentivePlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i998fc01b463d4ba5a09b1286fdb9c50a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ampx:EquityIncentivePlansMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i50e98b1619b14d3aad7cc2e81158f8fd_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibe21b3a289994d4a97c4c69f932acff6_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3aff53d2317b441595d7b67e66f87d6d_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i296bde8d08c2448f98f54612571ba0c2_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ampx:TwentyTwentyTwoEmployeeStockPurchasePlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i88342beb5da647d28102477fd33b6c49_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ampx:ExecutiveIncentiveCompensationPlanMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1083d46db3cb4333bd42aa18cd72741b_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ampx:PublicWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i89b26f35c8c743ec898b2e7cbd65d2da_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ampx:PrivateWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia369e97ca86a4015bacdfaf2d5b614d2_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ampx:PIPEWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i65f6ecb200ca4a2ea079f7914b85be3e_I20220301"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2022-03-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i8b54249c302d4bbd84bcc1b8b3beb2fc_D20220914-20220914"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ampx:PublicWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-14</xbrli:startDate><xbrli:endDate>2022-09-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="day"><xbrli:measure>ampx:day</xbrli:measure></xbrli:unit><xbrli:context id="i31467a3e9fbe4b59983ccf8194ea8070_D20220914-20220914"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ampx:PIPEWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-14</xbrli:startDate><xbrli:endDate>2022-09-14</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i421fa02da0234be3b23eab9845b639a4_D20220927-20220927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ampx:PurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ampx:BRPCIIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-09-27</xbrli:startDate><xbrli:endDate>2022-09-27</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6f0bf828381846a8b705dd517c0690c7_I20220927"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ampx:PurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ampx:BRPCIIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2022-09-27</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i09c21ae7eb0c4550b4f44db99a8f9cfa_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ampx:PurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ampx:BRPCIIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6240ae66e6554cf88516b271e123fbbe_I20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ampx:PurchaseAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ampx:BRPCIIMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7b9b12b7e31d4c76a8d6a376c2b7d713_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ide8e49695f9d47238f505b8412513868_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1d86f0bf8ca54c31a23e7d6b7920910e_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i755fa2560d3b49c389b0764776734331_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i118c22344d0e445ab1d3ec905d1a450d_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95e94b4180df453fa35e812c22acf32d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="lease"><xbrli:measure>ampx:lease</xbrli:measure></xbrli:unit><xbrli:context id="ie8eddb8a90d3462cb31d18d8295be70a_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:LegalEntityAxis">ampx:AmpriusHoldingsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5f45d6b4a1b249b19e2aff7a526d83be_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i571e7f29efd349649731d4a3cf40f70d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0650b7f12c5745f1b9f3e5dd848c75eb_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie7e13065ea5344339868b25a9ccb583d_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib6658dea46b142f48028a62a75c5d390_D20230101-20230331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia19169091dae45ab9040ca0a01a98e92_D20220101-20220331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie3036f0dcbac452caf4e05d02eb07b89_D20230415-20230415"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ampx:NameOfFacilityAxis">ampx:BrightonColoradoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-15</xbrli:startDate><xbrli:endDate>2023-04-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="term"><xbrli:measure>ampx:term</xbrli:measure></xbrli:unit><xbrli:context id="i054651541ac248b38a3b2a7e6475566b_I20230415"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001899287</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ampx:NameOfFacilityAxis">ampx:BrightonColoradoMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2023-04-15</xbrli:instant></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i066fdabb1d0848d5b0391931f87c3c0e_4"></div><div style="min-height:45pt;width:100%"><div style="margin-top:3pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_10">Table of Contents</a></span></div></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">_______________________</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80L2ZyYWc6ZjY1ZWY5YzkzN2U2NGMyZWIwN2RlZTk1ZWEzOTIxMzYvdGV4dHJlZ2lvbjpmNjVlZjljOTM3ZTY0YzJlYjA3ZGVlOTVlYTM5MjEzNl8yMTQz_30b4697e-8689-420f-bbd2-d255fb5f072c">10-Q</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">_______________________</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Mark One)</span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:1.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.870%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" name="dei:DocumentQuarterlyReport" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80L2ZyYWc6ZjY1ZWY5YzkzN2U2NGMyZWIwN2RlZTk1ZWEzOTIxMzYvdGFibGU6Yjk0NzdkOTY3MGQ4NDYzZDliZmQwZTdmY2YwM2I4NzMvdGFibGVyYW5nZTpiOTQ3N2Q5NjcwZDg0NjNkOWJmZDBlN2ZjZjAzYjg3M18wLTAtMS0xLTYxOTkw_ccb0a9a4-1279-4913-895c-7a5034a5723f">&#9746;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div></td></tr></table></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80L2ZyYWc6ZjY1ZWY5YzkzN2U2NGMyZWIwN2RlZTk1ZWEzOTIxMzYvdGV4dHJlZ2lvbjpmNjVlZjljOTM3ZTY0YzJlYjA3ZGVlOTVlYTM5MjEzNl8xODE_1a032017-1c15-4620-b32c-7bb1ab6eaef4">March 31, 2023</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">OR</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:1.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:95.870%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1.5pt;margin-top:2.65pt"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" name="dei:DocumentTransitionReport" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80L2ZyYWc6ZjY1ZWY5YzkzN2U2NGMyZWIwN2RlZTk1ZWEzOTIxMzYvdGFibGU6Y2UyZjZjMThhZmYwNDEyMWI1YjI1NGFjY2FjNWVmYTEvdGFibGVyYW5nZTpjZTJmNmMxOGFmZjA0MTIxYjViMjU0YWNjYWM1ZWZhMV8wLTAtMS0xLTYxOTkw_71174b77-f30b-485c-b766-c55366249b52">&#9744;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">For the transition period from&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;to&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Commission file number <ix:nonNumeric contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80L2ZyYWc6ZjY1ZWY5YzkzN2U2NGMyZWIwN2RlZTk1ZWEzOTIxMzYvdGV4dHJlZ2lvbjpmNjVlZjljOTM3ZTY0YzJlYjA3ZGVlOTVlYTM5MjEzNl8yMTQ0_e23a3468-6878-4b8b-a168-1e71f60dd56f">001-04321</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">_______________________</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80L2ZyYWc6ZjY1ZWY5YzkzN2U2NGMyZWIwN2RlZTk1ZWEzOTIxMzYvdGV4dHJlZ2lvbjpmNjVlZjljOTM3ZTY0YzJlYjA3ZGVlOTVlYTM5MjEzNl8yMTQ3_e89004e0-776c-470c-bc7b-a030b4fc87b9">AMPRIUS TECHNOLOGIES, INC.</ix:nonNumeric></span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">_______________________</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.878%"><tr><td style="width:1.0%"></td><td style="width:49.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:1.995%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.722%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80L2ZyYWc6ZjY1ZWY5YzkzN2U2NGMyZWIwN2RlZTk1ZWEzOTIxMzYvdGFibGU6NmJkZWU2MGY5ZDc5NDBlNGFiNDM2ZTkzNGUzYjQ2YmYvdGFibGVyYW5nZTo2YmRlZTYwZjlkNzk0MGU0YWI0MzZlOTM0ZTNiNDZiZl8wLTAtMS0xLTYxOTkw_94d7d184-ac42-4075-8c5e-a21be096c40e">Delaware</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" name="dei:EntityTaxIdentificationNumber" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80L2ZyYWc6ZjY1ZWY5YzkzN2U2NGMyZWIwN2RlZTk1ZWEzOTIxMzYvdGFibGU6NmJkZWU2MGY5ZDc5NDBlNGFiNDM2ZTkzNGUzYjQ2YmYvdGFibGVyYW5nZTo2YmRlZTYwZjlkNzk0MGU0YWI0MzZlOTM0ZTNiNDZiZl8wLTItMS0xLTYxOTkw_1b3c53dd-5a74-43e7-9aa5-c45601e4d0fe">98-1591811</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(State or other jurisdiction of  incorporation or organization)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></div></td></tr><tr style="height:6pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80L2ZyYWc6ZjY1ZWY5YzkzN2U2NGMyZWIwN2RlZTk1ZWEzOTIxMzYvdGFibGU6NmJkZWU2MGY5ZDc5NDBlNGFiNDM2ZTkzNGUzYjQ2YmYvdGFibGVyYW5nZTo2YmRlZTYwZjlkNzk0MGU0YWI0MzZlOTM0ZTNiNDZiZl8zLTAtMS0xLTYxOTkwL3RleHRyZWdpb246ZjUxMmU0MWVkMGYwNDM4MTk0NjJlNzNhYTFhY2EzZDlfNQ_572a632c-fcc2-4fd4-89a7-f7c22aeb8134">1180 Page Avenue</ix:nonNumeric>, <ix:nonNumeric contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80L2ZyYWc6ZjY1ZWY5YzkzN2U2NGMyZWIwN2RlZTk1ZWEzOTIxMzYvdGFibGU6NmJkZWU2MGY5ZDc5NDBlNGFiNDM2ZTkzNGUzYjQ2YmYvdGFibGVyYW5nZTo2YmRlZTYwZjlkNzk0MGU0YWI0MzZlOTM0ZTNiNDZiZl8zLTAtMS0xLTYxOTkwL3RleHRyZWdpb246ZjUxMmU0MWVkMGYwNDM4MTk0NjJlNzNhYTFhY2EzZDlfOQ_ff7c175b-2263-491b-bc61-30ce8ceca7c5">Fremont</ix:nonNumeric>, <ix:nonNumeric contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80L2ZyYWc6ZjY1ZWY5YzkzN2U2NGMyZWIwN2RlZTk1ZWEzOTIxMzYvdGFibGU6NmJkZWU2MGY5ZDc5NDBlNGFiNDM2ZTkzNGUzYjQ2YmYvdGFibGVyYW5nZTo2YmRlZTYwZjlkNzk0MGU0YWI0MzZlOTM0ZTNiNDZiZl8zLTAtMS0xLTYxOTkwL3RleHRyZWdpb246ZjUxMmU0MWVkMGYwNDM4MTk0NjJlNzNhYTFhY2EzZDlfMTM_8f1c0165-428b-4623-9a27-8124f2f283ec">California</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" name="dei:EntityAddressPostalZipCode" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80L2ZyYWc6ZjY1ZWY5YzkzN2U2NGMyZWIwN2RlZTk1ZWEzOTIxMzYvdGFibGU6NmJkZWU2MGY5ZDc5NDBlNGFiNDM2ZTkzNGUzYjQ2YmYvdGFibGVyYW5nZTo2YmRlZTYwZjlkNzk0MGU0YWI0MzZlOTM0ZTNiNDZiZl8zLTItMS0xLTYxOTkw_b5eced0c-c017-4a17-a3b4-5a55585792ae">94538</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Address of Principal Executive Offices)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Zip Code)</span></div></td></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(<ix:nonNumeric contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80L2ZyYWc6ZjY1ZWY5YzkzN2U2NGMyZWIwN2RlZTk1ZWEzOTIxMzYvdGV4dHJlZ2lvbjpmNjVlZjljOTM3ZTY0YzJlYjA3ZGVlOTVlYTM5MjEzNl80MDg_6ee99f14-3f3b-4bfb-b63a-41941bb89c70">800</ix:nonNumeric>)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80L2ZyYWc6ZjY1ZWY5YzkzN2U2NGMyZWIwN2RlZTk1ZWEzOTIxMzYvdGV4dHJlZ2lvbjpmNjVlZjljOTM3ZTY0YzJlYjA3ZGVlOTVlYTM5MjEzNl8yMTQ4_4f4a2590-4b28-4a74-bb40-5292445c085a">425-8803</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Registrant's telephone number, including area code</span></div><div style="margin-top:6pt;text-align:center"><span><br/></span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Former name, former address and former fiscal year, if changed since last report)</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act: </span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:43.142%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:15.718%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.840%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Trading <br/>Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5f69aaee1e4f40698eb541763e1fdba8_D20230101-20230331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80L2ZyYWc6ZjY1ZWY5YzkzN2U2NGMyZWIwN2RlZTk1ZWEzOTIxMzYvdGFibGU6NjQ3MzI0NWMzMzU4NDdjMTlhMzE0NDZjMmE5ZTczYmQvdGFibGVyYW5nZTo2NDczMjQ1YzMzNTg0N2MxOWEzMTQ0NmMyYTllNzNiZF8xLTAtMS0xLTYxOTkw_8733d363-1208-443d-ac87-ec05e9cf8b01">Common stock, $0.0001 par value</ix:nonNumeric></span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5f69aaee1e4f40698eb541763e1fdba8_D20230101-20230331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80L2ZyYWc6ZjY1ZWY5YzkzN2U2NGMyZWIwN2RlZTk1ZWEzOTIxMzYvdGFibGU6NjQ3MzI0NWMzMzU4NDdjMTlhMzE0NDZjMmE5ZTczYmQvdGFibGVyYW5nZTo2NDczMjQ1YzMzNTg0N2MxOWEzMTQ0NmMyYTllNzNiZF8xLTEtMS0xLTYxOTkw_f787153f-882f-44d8-ac11-63761fe3a9b3">AMPX</ix:nonNumeric></span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i5f69aaee1e4f40698eb541763e1fdba8_D20230101-20230331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80L2ZyYWc6ZjY1ZWY5YzkzN2U2NGMyZWIwN2RlZTk1ZWEzOTIxMzYvdGFibGU6NjQ3MzI0NWMzMzU4NDdjMTlhMzE0NDZjMmE5ZTczYmQvdGFibGVyYW5nZTo2NDczMjQ1YzMzNTg0N2MxOWEzMTQ0NmMyYTllNzNiZF8xLTItMS0xLTYxOTkw_0f8f252c-ae25-4b25-a8e8-f809671dbef2">The New York Stock Exchange</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0f2107c9841f453a82a0c7c211510fd3_D20230101-20230331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80L2ZyYWc6ZjY1ZWY5YzkzN2U2NGMyZWIwN2RlZTk1ZWEzOTIxMzYvdGFibGU6NjQ3MzI0NWMzMzU4NDdjMTlhMzE0NDZjMmE5ZTczYmQvdGFibGVyYW5nZTo2NDczMjQ1YzMzNTg0N2MxOWEzMTQ0NmMyYTllNzNiZF8yLTAtMS0xLTYxOTkw_9c30b8ec-0ef8-45e1-b202-98dda0bc5c78">Redeemable warrants, each exercisable for one share of common stock at an exercise price of $11.50</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0f2107c9841f453a82a0c7c211510fd3_D20230101-20230331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80L2ZyYWc6ZjY1ZWY5YzkzN2U2NGMyZWIwN2RlZTk1ZWEzOTIxMzYvdGFibGU6NjQ3MzI0NWMzMzU4NDdjMTlhMzE0NDZjMmE5ZTczYmQvdGFibGVyYW5nZTo2NDczMjQ1YzMzNTg0N2MxOWEzMTQ0NmMyYTllNzNiZF8yLTEtMS0xLTYxOTkw_e1ac103d-997f-44ac-bdec-60e0109fdd8e">AMPX.W</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i0f2107c9841f453a82a0c7c211510fd3_D20230101-20230331" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80L2ZyYWc6ZjY1ZWY5YzkzN2U2NGMyZWIwN2RlZTk1ZWEzOTIxMzYvdGFibGU6NjQ3MzI0NWMzMzU4NDdjMTlhMzE0NDZjMmE5ZTczYmQvdGFibGVyYW5nZTo2NDczMjQ1YzMzNTg0N2MxOWEzMTQ0NmMyYTllNzNiZF8yLTItMS0xLTYxOTkw_18583187-a3ae-4e16-940a-cce43a7ce519">The New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports); and (2) has been subject to such filing requirements for the past 90 days.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80L2ZyYWc6ZjY1ZWY5YzkzN2U2NGMyZWIwN2RlZTk1ZWEzOTIxMzYvdGV4dHJlZ2lvbjpmNjVlZjljOTM3ZTY0YzJlYjA3ZGVlOTVlYTM5MjEzNl8yMTQ1_8fbb8c04-5227-4a97-b799-de91064461d9">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically and posted on its corporate website, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (&#167;232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80L2ZyYWc6ZjY1ZWY5YzkzN2U2NGMyZWIwN2RlZTk1ZWEzOTIxMzYvdGV4dHJlZ2lvbjpmNjVlZjljOTM3ZTY0YzJlYjA3ZGVlOTVlYTM5MjEzNl8yMTQ2_0b95bf9f-455d-4636-be3d-407f3bd8f8f9">Yes</ix:nonNumeric>&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;No&#160;&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer&#8221; and &#8220;smaller reporting company&#8221; in Rule 12b-2 of the Exchange Act. (Check one):</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.848%"><tr><td style="width:1.0%"></td><td style="width:41.085%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.997%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.335%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:41.085%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:2.998%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Large accelerated filer</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated filer</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" name="dei:EntityFilerCategory" format="ixt-sec:entityfilercategoryen" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80L2ZyYWc6ZjY1ZWY5YzkzN2U2NGMyZWIwN2RlZTk1ZWEzOTIxMzYvdGFibGU6YjJjMjAyZjFjMDM2NDY1YWI2NjAxZmEzN2JjMzBlMTYvdGFibGVyYW5nZTpiMmMyMDJmMWMwMzY0NjVhYjY2MDFmYTM3YmMzMGUxNl8xLTAtMS0xLTYxOTkw_4e574cf6-f8da-4685-af01-59af2fc409fb">Non-accelerated filer</ix:nonNumeric></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Smaller reporting company</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" name="dei:EntitySmallBusiness" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80L2ZyYWc6ZjY1ZWY5YzkzN2U2NGMyZWIwN2RlZTk1ZWEzOTIxMzYvdGFibGU6YjJjMjAyZjFjMDM2NDY1YWI2NjAxZmEzN2JjMzBlMTYvdGFibGVyYW5nZTpiMmMyMDJmMWMwMzY0NjVhYjY2MDFmYTM3YmMzMGUxNl8xLTQtMS0xLTYxOTkw_2f7c5b31-97a7-48b8-9f00-b701461efb11">&#9746;</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-right:2.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Emerging growth company</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1.5pt;margin-top:2.65pt;padding-left:1.12pt;padding-right:1.12pt;text-align:center"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-true" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80L2ZyYWc6ZjY1ZWY5YzkzN2U2NGMyZWIwN2RlZTk1ZWEzOTIxMzYvdGFibGU6YjJjMjAyZjFjMDM2NDY1YWI2NjAxZmEzN2JjMzBlMTYvdGFibGVyYW5nZTpiMmMyMDJmMWMwMzY0NjVhYjY2MDFmYTM3YmMzMGUxNl8yLTQtMS0xLTYxOTkw_6997d08c-35d0-4081-b476-7bdd3d541e39">&#9746;</ix:nonNumeric></span></div></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" name="dei:EntityExTransitionPeriod" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80L2ZyYWc6ZjY1ZWY5YzkzN2U2NGMyZWIwN2RlZTk1ZWEzOTIxMzYvdGV4dHJlZ2lvbjpmNjVlZjljOTM3ZTY0YzJlYjA3ZGVlOTVlYTM5MjEzNl8yMTQx_1d6499dc-7110-4ff8-92f9-1bbc16ec3cd1">o</ix:nonNumeric></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" name="dei:EntityShellCompany" format="ixt:fixed-false" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80L2ZyYWc6ZjY1ZWY5YzkzN2U2NGMyZWIwN2RlZTk1ZWEzOTIxMzYvdGV4dHJlZ2lvbjpmNjVlZjljOTM3ZTY0YzJlYjA3ZGVlOTVlYTM5MjEzNl8xMDk5NTExNjI5OTI5_d5eee307-787d-4551-bcea-be952d216189">&#9744;</ix:nonNumeric> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9746;</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of May&#160;4, 2023, the registrant had <ix:nonFraction unitRef="shares" contextRef="ib58f786ebe7b4b848751f6ae32c45cf4_I20230504" decimals="INF" name="dei:EntityCommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80L2ZyYWc6ZjY1ZWY5YzkzN2U2NGMyZWIwN2RlZTk1ZWEzOTIxMzYvdGV4dHJlZ2lvbjpmNjVlZjljOTM3ZTY0YzJlYjA3ZGVlOTVlYTM5MjEzNl8yMDgy_4ce6c04b-6c53-403f-951d-05d52ded61df">84,971,565</ix:nonFraction> shares of common stock, par value $0.0001, outstanding.</span></div><div style="margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="i066fdabb1d0848d5b0391931f87c3c0e_10"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:3pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_10">Table of Contents</a></span></div></div><div style="margin-top:18pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Table of Contents</span></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:91.778%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.022%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Page</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_853">Cautionary Note Regarding Forward-Looking Statements</a></span></div></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i066fdabb1d0848d5b0391931f87c3c0e_853">1</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_16">Part I - Financial Information</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i066fdabb1d0848d5b0391931f87c3c0e_16">2</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:31.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_19">Item 1. Financial Statements (Unaudited)</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i066fdabb1d0848d5b0391931f87c3c0e_19">2</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:63pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_22">Condensed Consolidated Balance Sheets</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i066fdabb1d0848d5b0391931f87c3c0e_22">2</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:63pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_25">Condensed Consolidated Statements of Operations</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i066fdabb1d0848d5b0391931f87c3c0e_25">3</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:63pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_28">Condensed Consolidated Statements of Stockholders&#8217; Equity</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i066fdabb1d0848d5b0391931f87c3c0e_28">4</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:63pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_31">Condensed Consolidated Statements of Cash Flows</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i066fdabb1d0848d5b0391931f87c3c0e_31">5</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:63pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_34">Notes to Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i066fdabb1d0848d5b0391931f87c3c0e_34">6</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:31.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_82">Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i066fdabb1d0848d5b0391931f87c3c0e_82">16</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:31.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_127">Item 3. Quantitative and Qualitative Disclosures About Market Risk </a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i066fdabb1d0848d5b0391931f87c3c0e_127">25</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:31.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_130">Item 4. Controls and Procedures</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i066fdabb1d0848d5b0391931f87c3c0e_130">25</a></span></div></td></tr><tr style="height:9pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_133">Part II </a></span><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_133">- </a></span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_133">Other Information</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i066fdabb1d0848d5b0391931f87c3c0e_133">27</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:31.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_136">Item 1. Legal Proceedings </a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i066fdabb1d0848d5b0391931f87c3c0e_136">27</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:31.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_686">Item 1A. Risk Factors</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i066fdabb1d0848d5b0391931f87c3c0e_686">27</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:31.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_160">Item 2. Unregistered Sales of Equity Securities and Use of Proceeds </a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i066fdabb1d0848d5b0391931f87c3c0e_160">56</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:31.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_163">Item 3. Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i066fdabb1d0848d5b0391931f87c3c0e_163">56</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:31.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_166">Item 4. Mine Safety Disclosures</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i066fdabb1d0848d5b0391931f87c3c0e_166">56</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:31.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_169">Item 5. Other Information</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i066fdabb1d0848d5b0391931f87c3c0e_169">56</a></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:31.5pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_172">Item 6. Exhibits</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i066fdabb1d0848d5b0391931f87c3c0e_172">57</a></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_175">Signatures</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><a style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:none" href="#i066fdabb1d0848d5b0391931f87c3c0e_175">58</a></span></div></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="i066fdabb1d0848d5b0391931f87c3c0e_853"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:3pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_10">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-align:center;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cautionary Note Regarding Forward-Looking Statements</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain statements in this Quarterly Report on Form 10-Q of Amprius Technologies, Inc. (formerly known as Kensington Capital Acquisition Corp. IV, &#8220;Amprius,&#8221; the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; or &#8220;our&#8221;) and in documents incorporated herein by reference may constitute &#8220;forward-looking statements&#8221; for purposes of the federal securities laws. Such forward-looking statements include, but are not limited to, statements regarding our expectations, hopes, beliefs, intentions or strategies regarding the future. In addition, any statements that refer to forecasts or other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words &#8220;anticipate,&#8221; &#8220;believe,&#8221; &#8220;continue,&#8221; &#8220;could,&#8221; &#8220;estimate,&#8221; &#8220;expect,&#8221; &#8220;intends,&#8221; &#8220;may,&#8221; &#8220;might,&#8221; &#8220;plan,&#8221; &#8220;possible,&#8221; &#8220;potential,&#8221; &#8220;predict,&#8221; &#8220;project,&#8221; &#8220;should,&#8221; &#8220;will,&#8221; &#8220;would&#8221; and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements in this Quarterly Report on Form 10-Q may include, for example, statements about:</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our financial and business performance, including financial and business metrics;</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in our strategy, future operations, financial position, estimated revenues and losses, projected costs, prospects and plans;</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to develop a high-volume manufacturing line and otherwise scale in a cost-effective manner;</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to add manufacturing capacity and the costs and timing to add such capacity;</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the expected addressable market for our products;</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">developments relating to our competitors and industry;</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations regarding our ability to obtain and maintain intellectual property protection and not infringe on the rights of others;</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our future capital requirements and sources and uses of cash;</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to obtain funding for our operations;</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our business, expansion plans and opportunities; and</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the outcome of any known and unknown litigation and regulatory proceedings.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These forward-looking statements are based on information available as of the date of this Quarterly Report on Form 10-Q, and current expectations, forecasts and assumptions, and involve a number of judgments, risks and uncertainties. Accordingly, forward-looking statements should not be relied upon as representing our views as of any subsequent date, and we do not undertake any obligation to update forward-looking statements to reflect events or circumstances after the date they were made, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of a number of known and unknown risks and uncertainties, our actual results or performance may be materially different from those expressed or implied by these forward-looking statements. Some factors that could cause actual results to differ include:</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to execute our business model, including scaling production and increasing the addressable market for our products and services;</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to raise capital;</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the outcome of any legal proceedings that may be instituted against us;</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the ability to maintain the listing of our securities on the New York Stock Exchange;</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the possibility that we may be adversely affected by other economic, business or competitive factors, including supply chain interruptions, and may not be able to manage other risks and uncertainties;</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in applicable laws or regulations;</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the effect of the COVID-19 pandemic and/or the military conflict between Russia and Ukraine, or other macroeconomic factors, on our business;</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the possibility that we may be adversely affected by other economic, business, and/or competitive factors; and</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">other risks and uncertainties described in this Quarterly Report on Form 10-Q, including risk factors discussed in Part II, Item 1A under the Heading, "</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Factors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">".</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="i066fdabb1d0848d5b0391931f87c3c0e_16"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:3pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_10">Table of Contents</a></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Part I - Financial Information</span></div><div id="i066fdabb1d0848d5b0391931f87c3c0e_19"></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Financial Statements </span></div><div id="i066fdabb1d0848d5b0391931f87c3c0e_22"></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">AMPRIUS TECHNOLOGIES, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED BALANCE SHEETS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.112%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.990%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.992%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In thousands, except share and par value data)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ASSETS</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="INF" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMy0xLTEtMS02MTk5MA_18ff5f3e-9353-4494-8b8b-a4b7247b6bbb">64,187</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231" decimals="INF" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMy0zLTEtMS02MTk5MA_9aae5909-f526-448f-a53c-7d5ffa446e76">69,696</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="INF" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfNC0xLTEtMS02MTk5MA_e1a46df5-89c1-43ea-9f85-5b93997acd3b">555</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231" decimals="INF" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfNC0zLTEtMS02MTk5MA_9d9e1fc2-9958-4c3b-a5e0-5451ef58cc93">686</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="INF" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfNS0xLTEtMS02MTk5MA_9aef43dd-7d8c-4417-990b-810d4cd3f680">845</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231" decimals="INF" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfNS0zLTEtMS02MTk5MA_0df53bf8-3a08-4658-b27e-8bcd8e94b0d4">500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="INF" name="us-gaap:DeferredCostsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfNi0xLTEtMS02MTk5MA_1920aa51-afb4-493a-aee5-a6ca2e9a6028">2,475</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231" decimals="INF" name="us-gaap:DeferredCostsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfNi0zLTEtMS02MTk5MA_1c9dde1c-5a86-43af-a250-b5c9cb416b01">1,897</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="INF" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfNy0xLTEtMS02MTk5MA_4c2eb257-984d-41f4-b16a-dae7458b8572">1,841</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231" decimals="INF" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfNy0zLTEtMS02MTk5MA_a7455079-5183-4a47-b9a8-2852730be303">2,394</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfOC0xLTEtMS02MTk5MA_8fbdb7f7-9da2-4b2f-87da-d8fdf0d43e92">69,903</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231" decimals="-3" name="us-gaap:AssetsCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfOC0zLTEtMS02MTk5MA_95be1c49-d104-489e-adc7-d67fdb244e28">75,173</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current assets:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="INF" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMTAtMS0xLTEtNjE5OTA_75efc4e6-da2d-4e86-ae00-906c2bdf26f8">4,948</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231" decimals="INF" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMTAtMy0xLTEtNjE5OTA_1452bfd9-69ca-40ea-adb8-c7b1ecde844c">4,236</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="INF" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMTEtMS0xLTEtNjE5OTA_ca02f758-084a-4f87-b127-56884b63d119">7,894</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231" decimals="INF" name="us-gaap:OperatingLeaseRightOfUseAsset" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMTEtMy0xLTEtNjE5OTA_99ad7eda-3c07-4661-a052-923d65a78229">2,751</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="INF" name="us-gaap:DeferredCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMTItMS0xLTEtNjE5OTA_0f5040b4-a17b-45b8-b26d-2688e9fed372">519</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231" decimals="INF" name="us-gaap:DeferredCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMTItMy0xLTEtNjE5OTA_ae68c2e4-33e5-4eb5-bfa4-afd68324cd70">367</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="INF" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMTMtMS0xLTEtNjE5OTA_e5ff9cb5-9a61-4077-b387-0deda1499246">684</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231" decimals="INF" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMTMtMy0xLTEtNjE5OTA_31f441c7-920f-49b7-a3a4-96e9efa603a9">644</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMTQtMS0xLTEtNjE5OTA_3f6d01a2-7ffc-4bd8-848a-a73121221e9c">83,948</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231" decimals="-3" name="us-gaap:Assets" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMTQtMy0xLTEtNjE5OTA_2ecb732e-3c51-4022-ba7d-4de8ae0afcc3">83,171</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="INF" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMTctMS0xLTEtNjE5OTA_a1408131-ab8b-4ddc-b4b5-c029f240f924">1,023</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231" decimals="INF" name="us-gaap:AccountsPayableCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMTctMy0xLTEtNjE5OTA_10e6a791-3ff3-4776-88c5-cdf7ec04678d">1,028</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued and other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="INF" name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMTgtMS0xLTEtNjE5OTA_f58a62c7-e50a-4170-b8d9-c61b90942fbe">3,665</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231" decimals="INF" name="us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMTgtMy0xLTEtNjE5OTA_c3091626-bfec-4d97-a65b-fb83f57918e5">2,708</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="INF" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMTktMS0xLTEtNjE5OTA_b362a79a-b109-4e39-b4d4-a77a0ef5c81d">3,135</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231" decimals="INF" name="us-gaap:ContractWithCustomerLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMTktMy0xLTEtNjE5OTA_88eb04b5-7f3f-46e2-94a2-09b132b329e8">2,660</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="INF" name="us-gaap:OperatingLeaseLiabilityCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMjAtMS0xLTEtNjE5OTA_1e0fde44-b31c-42ad-b087-6dc38bcd0aaa">1,061</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231" decimals="INF" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMjAtMy0xLTEtNjE5OTA_e2b679e0-c842-4bc7-8914-7676cb99fe3e">521</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMjEtMS0xLTEtNjE5OTA_e9e6ce83-8f24-49bb-ab3e-2289d1ee8b33">8,884</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231" decimals="-3" name="us-gaap:LiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMjEtMy0xLTEtNjE5OTA_35b5cdc5-1af3-4485-a24f-1cf2932b0e62">6,917</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="INF" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMjMtMS0xLTEtNjE5OTA_9f28a020-5e26-49e2-909d-132512fa0cbd">902</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231" decimals="INF" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMjMtMy0xLTEtNjE5OTA_1f090afd-bf63-4945-ad29-93231cda8e66">720</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="INF" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMjQtMS0xLTEtNjE5OTA_d61231e1-15e5-429d-8edf-2f7bcddae942">7,127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231" decimals="INF" name="us-gaap:OperatingLeaseLiabilityNoncurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMjQtMy0xLTEtNjE5OTA_73fc146a-ac87-46a9-acd7-2bc28209979c">2,501</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMjUtMS0xLTEtNjE5OTA_42e2350c-4caa-475e-bf4b-13ed7bdecad1">16,913</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231" decimals="-3" name="us-gaap:Liabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMjUtMy0xLTEtNjE5OTA_1c8b5ce1-8782-4b4c-8bfc-c6fb01d16a45">10,138</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commitments and contingencies (Note 10)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMjYtMS0xLTEtNjE5OTA_736390aa-4368-4331-a43a-00d77efdfdac"></ix:nonFraction></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMjYtMy0xLTEtNjE5OTA_28b8a596-b267-4ca1-b70c-29891739217a"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stockholders&#8217; equity:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preferred stock; $<ix:nonFraction unitRef="usdPerShare" contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMjktMC0xLTEtNjI4MjMvdGV4dHJlZ2lvbjo3NTBkYjljNDkwNGQ0MmU2OWY5ZTU4NzFhNmYwYTgwYV81NDk3NTU4MTM5OTg_8f5f3e34-dc68-4e6e-a12a-206b05c520ae"><ix:nonFraction unitRef="usdPerShare" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMjktMC0xLTEtNjI4MjMvdGV4dHJlZ2lvbjo3NTBkYjljNDkwNGQ0MmU2OWY5ZTU4NzFhNmYwYTgwYV81NDk3NTU4MTM5OTg_f25fa216-fc5c-495d-8535-4ed406a0c676">0.0001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMjktMC0xLTEtNjI4MjMvdGV4dHJlZ2lvbjo3NTBkYjljNDkwNGQ0MmU2OWY5ZTU4NzFhNmYwYTgwYV81NDk3NTU4MTQwMTE_6771fe5b-71a6-4c83-879d-8cdd2d8d06e9"><ix:nonFraction unitRef="shares" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMjktMC0xLTEtNjI4MjMvdGV4dHJlZ2lvbjo3NTBkYjljNDkwNGQ0MmU2OWY5ZTU4NzFhNmYwYTgwYV81NDk3NTU4MTQwMTE_fd14377b-783d-4aa2-a966-05c81da37c5d">50,000,000</ix:nonFraction></ix:nonFraction> shares authorized; </span></div><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;<ix:nonFraction unitRef="shares" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMjktMC0xLTEtNjI4MjMvdGV4dHJlZ2lvbjo3NTBkYjljNDkwNGQ0MmU2OWY5ZTU4NzFhNmYwYTgwYV81NDk3NTU4MTQwMTY_1bedffce-4f18-436c-8544-06cd162fea0e"><ix:nonFraction unitRef="shares" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMjktMC0xLTEtNjI4MjMvdGV4dHJlZ2lvbjo3NTBkYjljNDkwNGQ0MmU2OWY5ZTU4NzFhNmYwYTgwYV81NDk3NTU4MTQwMTY_31556111-7a58-4fcb-a547-680dc802974a"><ix:nonFraction unitRef="shares" contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231" decimals="INF" name="us-gaap:PreferredStockSharesIssued" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMjktMC0xLTEtNjI4MjMvdGV4dHJlZ2lvbjo3NTBkYjljNDkwNGQ0MmU2OWY5ZTU4NzFhNmYwYTgwYV81NDk3NTU4MTQwMTY_da8903a6-2fec-431e-9a1f-d3e9dd7224d9"><ix:nonFraction unitRef="shares" contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231" decimals="INF" name="us-gaap:PreferredStockSharesOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMjktMC0xLTEtNjI4MjMvdGV4dHJlZ2lvbjo3NTBkYjljNDkwNGQ0MmU2OWY5ZTU4NzFhNmYwYTgwYV81NDk3NTU4MTQwMTY_ebb1ba9b-cc60-44cb-a7eb-67dd2bda0d90">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> shares issued and outstanding.</span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="INF" name="us-gaap:PreferredStockValueOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMjktMS0xLTEtNjI3ODk_91f9ea54-54cd-40d6-8442-ff5a806d010b">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231" decimals="INF" name="us-gaap:PreferredStockValueOutstanding" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMjktMy0xLTEtNjI3ODk_a50537e0-c732-4bf5-88bf-ac889dbceec6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common stock; $<ix:nonFraction unitRef="usdPerShare" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMjgtMC0xLTEtNjE5OTAvdGV4dHJlZ2lvbjo5ZTI4NmY4ZmU1MzI0NDg2ODdjYjBkNzY3ZDY0NzIyZl81NDk3NTU4MTQwNjI_9c7801c2-3051-465a-baaa-57160c737954"><ix:nonFraction unitRef="usdPerShare" contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMjgtMC0xLTEtNjE5OTAvdGV4dHJlZ2lvbjo5ZTI4NmY4ZmU1MzI0NDg2ODdjYjBkNzY3ZDY0NzIyZl81NDk3NTU4MTQwNjI_c6d6a3f2-6090-4e25-9940-d00b7ef1c08c">0.0001</ix:nonFraction></ix:nonFraction> par value; <ix:nonFraction unitRef="shares" contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMjgtMC0xLTEtNjE5OTAvdGV4dHJlZ2lvbjo5ZTI4NmY4ZmU1MzI0NDg2ODdjYjBkNzY3ZDY0NzIyZl81NDk3NTU4MTQwNzY_4f94db58-83a3-4410-a687-a6f99d84f44e"><ix:nonFraction unitRef="shares" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMjgtMC0xLTEtNjE5OTAvdGV4dHJlZ2lvbjo5ZTI4NmY4ZmU1MzI0NDg2ODdjYjBkNzY3ZDY0NzIyZl81NDk3NTU4MTQwNzY_d44737fc-445e-4bcc-b194-8bb8e50579da">950,000,000</ix:nonFraction></ix:nonFraction> shares authorized; <ix:nonFraction unitRef="shares" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMjgtMC0xLTEtNjE5OTAvdGV4dHJlZ2lvbjo5ZTI4NmY4ZmU1MzI0NDg2ODdjYjBkNzY3ZDY0NzIyZl81NDk3NTU4MTQxMjY_98a79a0f-4ecd-402e-b0cd-b3870805986a"><ix:nonFraction unitRef="shares" contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231" decimals="INF" name="us-gaap:CommonStockSharesIssued" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMjgtMC0xLTEtNjE5OTAvdGV4dHJlZ2lvbjo5ZTI4NmY4ZmU1MzI0NDg2ODdjYjBkNzY3ZDY0NzIyZl81NDk3NTU4MTQxMjY_f8a798a1-588c-4f34-af33-510064aba6f5">84,971,465</ix:nonFraction></ix:nonFraction> </span></div><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;and <ix:nonFraction unitRef="shares" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMjgtMC0xLTEtNjE5OTAvdGV4dHJlZ2lvbjo5ZTI4NmY4ZmU1MzI0NDg2ODdjYjBkNzY3ZDY0NzIyZl81NDk3NTU4MTQxMzk_b153b0d8-05b9-42c8-80db-b14c8ed44e5f"><ix:nonFraction unitRef="shares" contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231" decimals="INF" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMjgtMC0xLTEtNjE5OTAvdGV4dHJlZ2lvbjo5ZTI4NmY4ZmU1MzI0NDg2ODdjYjBkNzY3ZDY0NzIyZl81NDk3NTU4MTQxMzk_e5576488-af73-451c-a99d-5778d5f9bf02">84,610,114</ix:nonFraction></ix:nonFraction> shares issued and outstanding at March&#160;31, 2023 and</span></div><div style="padding-left:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;December&#160;31, 2022, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="INF" name="us-gaap:CommonStockValueOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMjgtMS0xLTEtNjE5OTA_486b5ed7-5c24-44b8-a337-340ab7ad6673">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231" decimals="INF" name="us-gaap:CommonStockValueOutstanding" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMjgtMy0xLTEtNjE5OTA_33ae3147-466a-421c-a75e-99d5dbb067fb">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Additional paid-in&#160;capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="INF" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMjktMS0xLTEtNjE5OTA_16d3a821-cc01-4895-9eae-f8ec0a463d4e">169,016</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231" decimals="INF" name="us-gaap:AdditionalPaidInCapital" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMjktMy0xLTEtNjE5OTA_98e9b103-3c02-4d1d-8d15-302df82fec60">165,912</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="INF" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMzAtMS0xLTEtNjE5OTA_4a637076-4f2f-42bf-bd19-f89ec2cac497">101,989</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231" decimals="INF" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMzAtMy0xLTEtNjE5OTA_7b29d12c-b033-4c83-aeea-f6deac3d4ce8">92,887</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stockholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMzEtMS0xLTEtNjE5OTA_82201bbb-68c4-4be1-b219-fc8d4be7c5c1">67,035</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMzEtMy0xLTEtNjE5OTA_2df1967f-6593-4192-809b-b39ac566a85e">73,033</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total liabilities and stockholders&#8217; equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMzItMS0xLTEtNjE5OTA_10ce8265-d623-4d06-ac97-49ba7741d624">83,948</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231" decimals="-3" name="us-gaap:LiabilitiesAndStockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMzItMy0xLTEtNjE5OTA_ec39a10d-49a3-4c89-8485-ce8cfc271244">83,171</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i066fdabb1d0848d5b0391931f87c3c0e_25"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:3pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_10">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">MPRIUS </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">T</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ECHNOLOGIES, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">I</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">NC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">O</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">PERATIONS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In thousands, except share and per share data)</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" decimals="-3" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yNS9mcmFnOjhkMjg1MGRkOWMxYjQ4YTU4YjEwNWVkZGQ2M2RkYTFlL3RhYmxlOjA2NzIxOWFjMzI0ODQ3Zjg5NDA2YmUxYjE2NjMzMDMyL3RhYmxlcmFuZ2U6MDY3MjE5YWMzMjQ4NDdmODk0MDZiZTFiMTY2MzMwMzJfMi0xLTEtMS02MTk5MA_c25ba343-8bdf-40d5-b693-fccf7f18561d">679</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yNS9mcmFnOjhkMjg1MGRkOWMxYjQ4YTU4YjEwNWVkZGQ2M2RkYTFlL3RhYmxlOjA2NzIxOWFjMzI0ODQ3Zjg5NDA2YmUxYjE2NjMzMDMyL3RhYmxlcmFuZ2U6MDY3MjE5YWMzMjQ4NDdmODk0MDZiZTFiMTY2MzMwMzJfMi0zLTEtMS02MTk5MA_7360c104-dc3d-4f2b-a61d-83b36ad2f49e">2,110</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yNS9mcmFnOjhkMjg1MGRkOWMxYjQ4YTU4YjEwNWVkZGQ2M2RkYTFlL3RhYmxlOjA2NzIxOWFjMzI0ODQ3Zjg5NDA2YmUxYjE2NjMzMDMyL3RhYmxlcmFuZ2U6MDY3MjE5YWMzMjQ4NDdmODk0MDZiZTFiMTY2MzMwMzJfMy0xLTEtMS02MTk5MA_a7a0160d-3bb2-4f4f-97b9-f12be9005d71">4,104</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331" decimals="-3" name="us-gaap:CostOfRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yNS9mcmFnOjhkMjg1MGRkOWMxYjQ4YTU4YjEwNWVkZGQ2M2RkYTFlL3RhYmxlOjA2NzIxOWFjMzI0ODQ3Zjg5NDA2YmUxYjE2NjMzMDMyL3RhYmxlcmFuZ2U6MDY3MjE5YWMzMjQ4NDdmODk0MDZiZTFiMTY2MzMwMzJfMy0zLTEtMS02MTk5MA_a32bb4fc-c7cb-432c-8763-00be713a14fb">3,149</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yNS9mcmFnOjhkMjg1MGRkOWMxYjQ4YTU4YjEwNWVkZGQ2M2RkYTFlL3RhYmxlOjA2NzIxOWFjMzI0ODQ3Zjg5NDA2YmUxYjE2NjMzMDMyL3RhYmxlcmFuZ2U6MDY3MjE5YWMzMjQ4NDdmODk0MDZiZTFiMTY2MzMwMzJfNC0xLTEtMS02MTk5MA_00b22de6-c887-4504-86a1-010effd8673e">3,425</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:GrossProfit" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yNS9mcmFnOjhkMjg1MGRkOWMxYjQ4YTU4YjEwNWVkZGQ2M2RkYTFlL3RhYmxlOjA2NzIxOWFjMzI0ODQ3Zjg5NDA2YmUxYjE2NjMzMDMyL3RhYmxlcmFuZ2U6MDY3MjE5YWMzMjQ4NDdmODk0MDZiZTFiMTY2MzMwMzJfNC0zLTEtMS02MTk5MA_c97ed165-572d-428f-87f1-1c7a718a1d44">1,039</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yNS9mcmFnOjhkMjg1MGRkOWMxYjQ4YTU4YjEwNWVkZGQ2M2RkYTFlL3RhYmxlOjA2NzIxOWFjMzI0ODQ3Zjg5NDA2YmUxYjE2NjMzMDMyL3RhYmxlcmFuZ2U6MDY3MjE5YWMzMjQ4NDdmODk0MDZiZTFiMTY2MzMwMzJfNi0xLTEtMS02MTk5MA_6484cd85-d1cb-42fe-b78a-5198d8fa1860">800</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331" decimals="-3" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yNS9mcmFnOjhkMjg1MGRkOWMxYjQ4YTU4YjEwNWVkZGQ2M2RkYTFlL3RhYmxlOjA2NzIxOWFjMzI0ODQ3Zjg5NDA2YmUxYjE2NjMzMDMyL3RhYmxlcmFuZ2U6MDY3MjE5YWMzMjQ4NDdmODk0MDZiZTFiMTY2MzMwMzJfNi0zLTEtMS02MTk5MA_62d76aca-02a7-4772-a6ff-8efdbd8b6d7c">369</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yNS9mcmFnOjhkMjg1MGRkOWMxYjQ4YTU4YjEwNWVkZGQ2M2RkYTFlL3RhYmxlOjA2NzIxOWFjMzI0ODQ3Zjg5NDA2YmUxYjE2NjMzMDMyL3RhYmxlcmFuZ2U6MDY3MjE5YWMzMjQ4NDdmODk0MDZiZTFiMTY2MzMwMzJfNy0xLTEtMS02MTk5MA_45489fa0-7e2b-4b39-b47a-360989582e4b">5,526</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331" decimals="-3" name="us-gaap:SellingGeneralAndAdministrativeExpense" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yNS9mcmFnOjhkMjg1MGRkOWMxYjQ4YTU4YjEwNWVkZGQ2M2RkYTFlL3RhYmxlOjA2NzIxOWFjMzI0ODQ3Zjg5NDA2YmUxYjE2NjMzMDMyL3RhYmxlcmFuZ2U6MDY3MjE5YWMzMjQ4NDdmODk0MDZiZTFiMTY2MzMwMzJfNy0zLTEtMS02MTk5MA_23b38f51-e0b5-493c-9fd5-a47e00341a79">1,502</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yNS9mcmFnOjhkMjg1MGRkOWMxYjQ4YTU4YjEwNWVkZGQ2M2RkYTFlL3RhYmxlOjA2NzIxOWFjMzI0ODQ3Zjg5NDA2YmUxYjE2NjMzMDMyL3RhYmxlcmFuZ2U6MDY3MjE5YWMzMjQ4NDdmODk0MDZiZTFiMTY2MzMwMzJfOC0xLTEtMS02MTk5MA_eea2a142-6c28-495f-aeeb-e0f8a66551e0">6,326</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331" decimals="-3" name="us-gaap:OperatingExpenses" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yNS9mcmFnOjhkMjg1MGRkOWMxYjQ4YTU4YjEwNWVkZGQ2M2RkYTFlL3RhYmxlOjA2NzIxOWFjMzI0ODQ3Zjg5NDA2YmUxYjE2NjMzMDMyL3RhYmxlcmFuZ2U6MDY3MjE5YWMzMjQ4NDdmODk0MDZiZTFiMTY2MzMwMzJfOC0zLTEtMS02MTk5MA_0c3b432f-02af-43da-9139-95b1af36627e">1,871</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yNS9mcmFnOjhkMjg1MGRkOWMxYjQ4YTU4YjEwNWVkZGQ2M2RkYTFlL3RhYmxlOjA2NzIxOWFjMzI0ODQ3Zjg5NDA2YmUxYjE2NjMzMDMyL3RhYmxlcmFuZ2U6MDY3MjE5YWMzMjQ4NDdmODk0MDZiZTFiMTY2MzMwMzJfOS0xLTEtMS02MTk5MA_ea913c90-c884-4f66-b13b-b36109084d55">9,751</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:OperatingIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yNS9mcmFnOjhkMjg1MGRkOWMxYjQ4YTU4YjEwNWVkZGQ2M2RkYTFlL3RhYmxlOjA2NzIxOWFjMzI0ODQ3Zjg5NDA2YmUxYjE2NjMzMDMyL3RhYmxlcmFuZ2U6MDY3MjE5YWMzMjQ4NDdmODk0MDZiZTFiMTY2MzMwMzJfOS0zLTEtMS02MTk5MA_096b7875-5087-4381-8c6e-4e747461a9ec">2,910</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yNS9mcmFnOjhkMjg1MGRkOWMxYjQ4YTU4YjEwNWVkZGQ2M2RkYTFlL3RhYmxlOjA2NzIxOWFjMzI0ODQ3Zjg5NDA2YmUxYjE2NjMzMDMyL3RhYmxlcmFuZ2U6MDY3MjE5YWMzMjQ4NDdmODk0MDZiZTFiMTY2MzMwMzJfMTMtMS0xLTEtNjE5OTA_e5bb5b88-fc3a-4f5a-9da2-723989d010a2">649</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331" decimals="-3" name="us-gaap:NonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yNS9mcmFnOjhkMjg1MGRkOWMxYjQ4YTU4YjEwNWVkZGQ2M2RkYTFlL3RhYmxlOjA2NzIxOWFjMzI0ODQ3Zjg5NDA2YmUxYjE2NjMzMDMyL3RhYmxlcmFuZ2U6MDY3MjE5YWMzMjQ4NDdmODk0MDZiZTFiMTY2MzMwMzJfMTMtMy0xLTEtNjE5OTA_0dcf12ef-7fa2-42ad-b8f2-61b146725b35">32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yNS9mcmFnOjhkMjg1MGRkOWMxYjQ4YTU4YjEwNWVkZGQ2M2RkYTFlL3RhYmxlOjA2NzIxOWFjMzI0ODQ3Zjg5NDA2YmUxYjE2NjMzMDMyL3RhYmxlcmFuZ2U6MDY3MjE5YWMzMjQ4NDdmODk0MDZiZTFiMTY2MzMwMzJfMTQtMS0xLTEtNjE5OTA_d77ed056-a9de-44c1-a32b-47e9c74ed7b2">9,102</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yNS9mcmFnOjhkMjg1MGRkOWMxYjQ4YTU4YjEwNWVkZGQ2M2RkYTFlL3RhYmxlOjA2NzIxOWFjMzI0ODQ3Zjg5NDA2YmUxYjE2NjMzMDMyL3RhYmxlcmFuZ2U6MDY3MjE5YWMzMjQ4NDdmODk0MDZiZTFiMTY2MzMwMzJfMTQtMy0xLTEtNjE5OTA_fea9bee6-a962-48c6-ac3d-c9430c46955e">2,878</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average common shares outstanding:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yNS9mcmFnOjhkMjg1MGRkOWMxYjQ4YTU4YjEwNWVkZGQ2M2RkYTFlL3RhYmxlOjA2NzIxOWFjMzI0ODQ3Zjg5NDA2YmUxYjE2NjMzMDMyL3RhYmxlcmFuZ2U6MDY3MjE5YWMzMjQ4NDdmODk0MDZiZTFiMTY2MzMwMzJfMTctMS0xLTEtNjE5OTA_33debc42-506e-4185-9240-1ba771f2f8ff"><ix:nonFraction unitRef="shares" contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yNS9mcmFnOjhkMjg1MGRkOWMxYjQ4YTU4YjEwNWVkZGQ2M2RkYTFlL3RhYmxlOjA2NzIxOWFjMzI0ODQ3Zjg5NDA2YmUxYjE2NjMzMDMyL3RhYmxlcmFuZ2U6MDY3MjE5YWMzMjQ4NDdmODk0MDZiZTFiMTY2MzMwMzJfMTctMS0xLTEtNjE5OTA_abae1b03-8d4b-4a20-9d0b-c14abeaafd1a">84,645,097</ix:nonFraction></ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yNS9mcmFnOjhkMjg1MGRkOWMxYjQ4YTU4YjEwNWVkZGQ2M2RkYTFlL3RhYmxlOjA2NzIxOWFjMzI0ODQ3Zjg5NDA2YmUxYjE2NjMzMDMyL3RhYmxlcmFuZ2U6MDY3MjE5YWMzMjQ4NDdmODk0MDZiZTFiMTY2MzMwMzJfMTctMy0xLTEtNjE5OTA_9e573f62-de79-4a12-bff0-e965588ce71c"><ix:nonFraction unitRef="shares" contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yNS9mcmFnOjhkMjg1MGRkOWMxYjQ4YTU4YjEwNWVkZGQ2M2RkYTFlL3RhYmxlOjA2NzIxOWFjMzI0ODQ3Zjg5NDA2YmUxYjE2NjMzMDMyL3RhYmxlcmFuZ2U6MDY3MjE5YWMzMjQ4NDdmODk0MDZiZTFiMTY2MzMwMzJfMTctMy0xLTEtNjE5OTA_f019863a-5d61-4975-a186-98eafedcfb4e">65,774,528</ix:nonFraction></ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss per share of common stock:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yNS9mcmFnOjhkMjg1MGRkOWMxYjQ4YTU4YjEwNWVkZGQ2M2RkYTFlL3RhYmxlOjA2NzIxOWFjMzI0ODQ3Zjg5NDA2YmUxYjE2NjMzMDMyL3RhYmxlcmFuZ2U6MDY3MjE5YWMzMjQ4NDdmODk0MDZiZTFiMTY2MzMwMzJfMTktMS0xLTEtNjE5OTA_620a2cdc-adfb-4468-8630-c4fa7d86cb89"><ix:nonFraction unitRef="usdPerShare" contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yNS9mcmFnOjhkMjg1MGRkOWMxYjQ4YTU4YjEwNWVkZGQ2M2RkYTFlL3RhYmxlOjA2NzIxOWFjMzI0ODQ3Zjg5NDA2YmUxYjE2NjMzMDMyL3RhYmxlcmFuZ2U6MDY3MjE5YWMzMjQ4NDdmODk0MDZiZTFiMTY2MzMwMzJfMTktMS0xLTEtNjE5OTA_e5387956-33f3-4196-ab58-8765e99859e1">0.11</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yNS9mcmFnOjhkMjg1MGRkOWMxYjQ4YTU4YjEwNWVkZGQ2M2RkYTFlL3RhYmxlOjA2NzIxOWFjMzI0ODQ3Zjg5NDA2YmUxYjE2NjMzMDMyL3RhYmxlcmFuZ2U6MDY3MjE5YWMzMjQ4NDdmODk0MDZiZTFiMTY2MzMwMzJfMTktMy0xLTEtNjE5OTA_0c2371d4-782b-410d-af82-76910b0da6d4"><ix:nonFraction unitRef="usdPerShare" contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yNS9mcmFnOjhkMjg1MGRkOWMxYjQ4YTU4YjEwNWVkZGQ2M2RkYTFlL3RhYmxlOjA2NzIxOWFjMzI0ODQ3Zjg5NDA2YmUxYjE2NjMzMDMyL3RhYmxlcmFuZ2U6MDY3MjE5YWMzMjQ4NDdmODk0MDZiZTFiMTY2MzMwMzJfMTktMy0xLTEtNjE5OTA_ba5ad63c-84ac-480f-be5a-ba166d8053b1">0.04</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i066fdabb1d0848d5b0391931f87c3c0e_28"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:3pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_10">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">AMPRIUS </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">T</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ECHNOLOGIES, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">I</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">NC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">S</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">TOCKHOLDERS&#8217; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">E</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">QUITY</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">(Unaudited)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"> </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.939%"><tr><td style="width:1.0%"></td><td style="width:41.472%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.151%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.412%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.088%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.412%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.079%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.412%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.079%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.412%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31, 2023</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Stockholders&#8217;<br/>Equity</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In thousands, except share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2022</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i8f5097542ed94e019e553cb2481ed488_I20221231" decimals="0" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOmZjYzFjYWI4YmE4MjRiZWViYjY0MWQ5NjAwZDk2ZWIxL3RhYmxlcmFuZ2U6ZmNjMWNhYjhiYTgyNGJlZWJiNjQxZDk2MDBkOTZlYjFfMy0xLTEtMS02MTk5MA_c492165a-b7e7-4839-92b7-9efdcf75c9e3">84,610,114</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8f5097542ed94e019e553cb2481ed488_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOmZjYzFjYWI4YmE4MjRiZWViYjY0MWQ5NjAwZDk2ZWIxL3RhYmxlcmFuZ2U6ZmNjMWNhYjhiYTgyNGJlZWJiNjQxZDk2MDBkOTZlYjFfMy0zLTEtMS02MTk5MA_ddd7630f-417b-432f-b380-430773b67517">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2afb5bfd349b44c8b991e6359c2ea6ac_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOmZjYzFjYWI4YmE4MjRiZWViYjY0MWQ5NjAwZDk2ZWIxL3RhYmxlcmFuZ2U6ZmNjMWNhYjhiYTgyNGJlZWJiNjQxZDk2MDBkOTZlYjFfMy01LTEtMS02MTk5MA_269a533a-4b55-4e39-a126-56999cd0d6ee">165,912</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6db38870876b40778cbddcf2716d2e8c_I20221231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOmZjYzFjYWI4YmE4MjRiZWViYjY0MWQ5NjAwZDk2ZWIxL3RhYmxlcmFuZ2U6ZmNjMWNhYjhiYTgyNGJlZWJiNjQxZDk2MDBkOTZlYjFfMy03LTEtMS02MTk5MA_42a011b7-5ded-4f77-9869-40cb14228006">92,887</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOmZjYzFjYWI4YmE4MjRiZWViYjY0MWQ5NjAwZDk2ZWIxL3RhYmxlcmFuZ2U6ZmNjMWNhYjhiYTgyNGJlZWJiNjQxZDk2MDBkOTZlYjFfMy05LTEtMS02MTk5MA_4b5b2cdd-b547-447b-8d38-3eea80d2877b">73,033</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock in connection with a <br/>&#160;&#160;&#160;stock purchase agreement, net of issuance cost</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id53f479a40704e0db1e45d90b74f3ab2_D20230101-20230331" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOmZjYzFjYWI4YmE4MjRiZWViYjY0MWQ5NjAwZDk2ZWIxL3RhYmxlcmFuZ2U6ZmNjMWNhYjhiYTgyNGJlZWJiNjQxZDk2MDBkOTZlYjFfNC0xLTEtMS03MDAwMA_40af28e1-6a0c-4dcf-80b7-55d81a8df382">331,351</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee3994aee9fd4eec960461ddc9dede6e_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOmZjYzFjYWI4YmE4MjRiZWViYjY0MWQ5NjAwZDk2ZWIxL3RhYmxlcmFuZ2U6ZmNjMWNhYjhiYTgyNGJlZWJiNjQxZDk2MDBkOTZlYjFfNC01LTEtMS03MDAwMA_1ac82d83-f148-4dd4-87ea-9760574e5902">2,376</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOmZjYzFjYWI4YmE4MjRiZWViYjY0MWQ5NjAwZDk2ZWIxL3RhYmxlcmFuZ2U6ZmNjMWNhYjhiYTgyNGJlZWJiNjQxZDk2MDBkOTZlYjFfNC05LTEtMS03MDAwMA_be70d0c7-47ec-4829-9d7d-0a7c6becb44a">2,376</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id53f479a40704e0db1e45d90b74f3ab2_D20230101-20230331" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOmZjYzFjYWI4YmE4MjRiZWViYjY0MWQ5NjAwZDk2ZWIxL3RhYmxlcmFuZ2U6ZmNjMWNhYjhiYTgyNGJlZWJiNjQxZDk2MDBkOTZlYjFfNi0xLTEtMS02MTk5MA_48b21d64-9743-4549-8e97-03b156d57dd0">30,000</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee3994aee9fd4eec960461ddc9dede6e_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOmZjYzFjYWI4YmE4MjRiZWViYjY0MWQ5NjAwZDk2ZWIxL3RhYmxlcmFuZ2U6ZmNjMWNhYjhiYTgyNGJlZWJiNjQxZDk2MDBkOTZlYjFfNi01LTEtMS02MTk5MA_85e83500-25bd-4015-af37-e57c827ae8dc">2</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOmZjYzFjYWI4YmE4MjRiZWViYjY0MWQ5NjAwZDk2ZWIxL3RhYmxlcmFuZ2U6ZmNjMWNhYjhiYTgyNGJlZWJiNjQxZDk2MDBkOTZlYjFfNi05LTEtMS02MTk5MA_79bb1d42-c04a-45a4-b85e-10081b9dc911">2</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee3994aee9fd4eec960461ddc9dede6e_D20230101-20230331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOmZjYzFjYWI4YmE4MjRiZWViYjY0MWQ5NjAwZDk2ZWIxL3RhYmxlcmFuZ2U6ZmNjMWNhYjhiYTgyNGJlZWJiNjQxZDk2MDBkOTZlYjFfOC01LTEtMS02MTk5MA_14b28642-7fc3-41d5-a74b-f1c494f54e41">723</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOmZjYzFjYWI4YmE4MjRiZWViYjY0MWQ5NjAwZDk2ZWIxL3RhYmxlcmFuZ2U6ZmNjMWNhYjhiYTgyNGJlZWJiNjQxZDk2MDBkOTZlYjFfOC05LTEtMS02MTk5MA_e537f685-58ac-46a7-860e-8f3c4f625b0b">723</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contribution from Amprius Holdings<br/>&#160;&#160;&#160;related to stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee3994aee9fd4eec960461ddc9dede6e_D20230101-20230331" decimals="-3" name="ampx:AdjustmentsToAdditionalPaidInCapitalContributionFromParentRelatedToStockBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOmZjYzFjYWI4YmE4MjRiZWViYjY0MWQ5NjAwZDk2ZWIxL3RhYmxlcmFuZ2U6ZmNjMWNhYjhiYTgyNGJlZWJiNjQxZDk2MDBkOTZlYjFfOS01LTEtMS02MTk5MA_d3334ab8-239d-4dc6-ae19-efaa7e6dcbde">3</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" decimals="-3" name="ampx:AdjustmentsToAdditionalPaidInCapitalContributionFromParentRelatedToStockBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOmZjYzFjYWI4YmE4MjRiZWViYjY0MWQ5NjAwZDk2ZWIxL3RhYmxlcmFuZ2U6ZmNjMWNhYjhiYTgyNGJlZWJiNjQxZDk2MDBkOTZlYjFfOS05LTEtMS02MTk5MA_0b86baff-346b-481f-8c92-1f642ebfe62e">3</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf9077943bf2498e945a5b5cffea4ede_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOmZjYzFjYWI4YmE4MjRiZWViYjY0MWQ5NjAwZDk2ZWIxL3RhYmxlcmFuZ2U6ZmNjMWNhYjhiYTgyNGJlZWJiNjQxZDk2MDBkOTZlYjFfMTAtNy0xLTEtNjE5OTA_123581fe-3fbe-4394-913d-129a9079129f">9,102</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOmZjYzFjYWI4YmE4MjRiZWViYjY0MWQ5NjAwZDk2ZWIxL3RhYmxlcmFuZ2U6ZmNjMWNhYjhiYTgyNGJlZWJiNjQxZDk2MDBkOTZlYjFfMTAtOS0xLTEtNjE5OTA_b8769b76-73d4-4984-899d-bb1ff6fb2c80">9,102</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2023</span></td><td colspan="3" style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icbda858436fb409e928a18346f855b84_I20230331" decimals="0" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOmZjYzFjYWI4YmE4MjRiZWViYjY0MWQ5NjAwZDk2ZWIxL3RhYmxlcmFuZ2U6ZmNjMWNhYjhiYTgyNGJlZWJiNjQxZDk2MDBkOTZlYjFfMTEtMS0xLTEtNjE5OTA_9ed27d18-a70b-4033-9a13-9c150c8dfab0">84,971,465</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="icbda858436fb409e928a18346f855b84_I20230331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOmZjYzFjYWI4YmE4MjRiZWViYjY0MWQ5NjAwZDk2ZWIxL3RhYmxlcmFuZ2U6ZmNjMWNhYjhiYTgyNGJlZWJiNjQxZDk2MDBkOTZlYjFfMTEtMy0xLTEtNjE5OTA_2cc72b90-14ff-4ded-b01b-dfb9e0b1e624">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i38d004c355644a42b820f2b35e0874a5_I20230331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOmZjYzFjYWI4YmE4MjRiZWViYjY0MWQ5NjAwZDk2ZWIxL3RhYmxlcmFuZ2U6ZmNjMWNhYjhiYTgyNGJlZWJiNjQxZDk2MDBkOTZlYjFfMTEtNS0xLTEtNjE5OTA_3596915b-2ee5-4aa0-b45f-60c50f5ec134">169,016</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i55afdc11794d46c3844a5877adc375f6_I20230331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOmZjYzFjYWI4YmE4MjRiZWViYjY0MWQ5NjAwZDk2ZWIxL3RhYmxlcmFuZ2U6ZmNjMWNhYjhiYTgyNGJlZWJiNjQxZDk2MDBkOTZlYjFfMTEtNy0xLTEtNjE5OTA_83f07ae1-f154-4f2a-b6ff-072ae1afb42f">101,989</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOmZjYzFjYWI4YmE4MjRiZWViYjY0MWQ5NjAwZDk2ZWIxL3RhYmxlcmFuZ2U6ZmNjMWNhYjhiYTgyNGJlZWJiNjQxZDk2MDBkOTZlYjFfMTEtOS0xLTEtNjE5OTA_c5e7b749-6349-4ffd-ab2d-0e5c5414141f">67,035</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.090%"><tr><td style="width:1.0%"></td><td style="width:41.713%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.979%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.411%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.074%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.411%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.062%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.411%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.062%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.411%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.066%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="27" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31, 2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Common Stock</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additional<br/>Paid-in<br/>Capital</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" rowspan="2" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>Stockholders&#8217;<br/>Equity</span></td></tr><tr style="height:12pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In thousands, except share data)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ife934d56970b49fdbc5f246e8c61d0f5_I20211231" decimals="0" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOjFjNDZmODgyMWIzNjRjYmM4NTllMzRhMjE5M2I3ZjAzL3RhYmxlcmFuZ2U6MWM0NmY4ODIxYjM2NGNiYzg1OWUzNGEyMTkzYjdmMDNfNS0xLTEtMS02MTk5MA_e767619a-5700-4993-aa41-ad88fdc4bc95">45,176,145</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife934d56970b49fdbc5f246e8c61d0f5_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOjFjNDZmODgyMWIzNjRjYmM4NTllMzRhMjE5M2I3ZjAzL3RhYmxlcmFuZ2U6MWM0NmY4ODIxYjM2NGNiYzg1OWUzNGEyMTkzYjdmMDNfNS0zLTEtMS02MTk5MA_4f28e086-d0e0-4d01-b091-925370e14331">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i720988f66ee2413488964d010217db49_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOjFjNDZmODgyMWIzNjRjYmM4NTllMzRhMjE5M2I3ZjAzL3RhYmxlcmFuZ2U6MWM0NmY4ODIxYjM2NGNiYzg1OWUzNGEyMTkzYjdmMDNfNS01LTEtMS02MTk5MA_b3394c72-e101-4220-b2af-bfa6045072ba">89,258</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0266250627e24a9d98564b0fca01e7dc_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOjFjNDZmODgyMWIzNjRjYmM4NTllMzRhMjE5M2I3ZjAzL3RhYmxlcmFuZ2U6MWM0NmY4ODIxYjM2NGNiYzg1OWUzNGEyMTkzYjdmMDNfNS03LTEtMS02MTk5MA_7bd0cf78-a6d4-48ed-9501-ddfe22f2da11">75,401</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i11415fde3f7d40df98aa03c58126edec_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOjFjNDZmODgyMWIzNjRjYmM4NTllMzRhMjE5M2I3ZjAzL3RhYmxlcmFuZ2U6MWM0NmY4ODIxYjM2NGNiYzg1OWUzNGEyMTkzYjdmMDNfNS05LTEtMS02MTk5MA_f109c80b-eb4e-4110-bca9-05f12428c2f8">13,858</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Retroactive conversion of common <br/>&#160;&#160;&#160;stock due to Business Combination</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="idd6d5ba96ae14bb0b84986d93719cf0c_I20211231" decimals="0" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOjFjNDZmODgyMWIzNjRjYmM4NTllMzRhMjE5M2I3ZjAzL3RhYmxlcmFuZ2U6MWM0NmY4ODIxYjM2NGNiYzg1OWUzNGEyMTkzYjdmMDNfNC0xLTEtMS02MzMyOA_6671168d-b1a3-41d4-903c-3210508258bf">20,595,856</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idd6d5ba96ae14bb0b84986d93719cf0c_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOjFjNDZmODgyMWIzNjRjYmM4NTllMzRhMjE5M2I3ZjAzL3RhYmxlcmFuZ2U6MWM0NmY4ODIxYjM2NGNiYzg1OWUzNGEyMTkzYjdmMDNfNC0zLTEtMS02MzMyOA_b910d4c6-363e-47cb-a45d-db89b8dcc22e">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6449e443d30c455184fed3bff4010086_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOjFjNDZmODgyMWIzNjRjYmM4NTllMzRhMjE5M2I3ZjAzL3RhYmxlcmFuZ2U6MWM0NmY4ODIxYjM2NGNiYzg1OWUzNGEyMTkzYjdmMDNfNC01LTEtMS02MzMyOA_81020192-b1e1-480e-abef-7a4729c02832">6</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of December 31, 2021, as adjusted</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i3a1b0acc07434411a2695d9dbe33e259_I20211231" decimals="0" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOjFjNDZmODgyMWIzNjRjYmM4NTllMzRhMjE5M2I3ZjAzL3RhYmxlcmFuZ2U6MWM0NmY4ODIxYjM2NGNiYzg1OWUzNGEyMTkzYjdmMDNfNi0xLTEtMS02MTk5MA_9745897d-6c60-4d60-9d56-6f5b7bbff4bb">65,772,001</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a1b0acc07434411a2695d9dbe33e259_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOjFjNDZmODgyMWIzNjRjYmM4NTllMzRhMjE5M2I3ZjAzL3RhYmxlcmFuZ2U6MWM0NmY4ODIxYjM2NGNiYzg1OWUzNGEyMTkzYjdmMDNfNi0zLTEtMS02MTk5MA_608cf046-25b7-4a8d-8e08-ff48c477a117">7</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1a1fa4a0e8fb49cc8d3c759e2e0c17e7_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOjFjNDZmODgyMWIzNjRjYmM4NTllMzRhMjE5M2I3ZjAzL3RhYmxlcmFuZ2U6MWM0NmY4ODIxYjM2NGNiYzg1OWUzNGEyMTkzYjdmMDNfNi01LTEtMS02MTk5MA_afcf0236-f3ae-4a47-b2c5-0d9d2285f868">89,252</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0cad88c1b2cb4985ad2e0e7a12c33ca0_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOjFjNDZmODgyMWIzNjRjYmM4NTllMzRhMjE5M2I3ZjAzL3RhYmxlcmFuZ2U6MWM0NmY4ODIxYjM2NGNiYzg1OWUzNGEyMTkzYjdmMDNfNi03LTEtMS02MTk5MA_3b9f0fa0-cc93-4e7a-a18c-454794bfe918">75,401</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifce6518367b34d3ab4c10e9de84e7829_I20211231" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOjFjNDZmODgyMWIzNjRjYmM4NTllMzRhMjE5M2I3ZjAzL3RhYmxlcmFuZ2U6MWM0NmY4ODIxYjM2NGNiYzg1OWUzNGEyMTkzYjdmMDNfNi05LTEtMS02MTk5MA_c62b1e13-f4ee-4d4f-b1a2-e518bc967f13">13,858</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOjFjNDZmODgyMWIzNjRjYmM4NTllMzRhMjE5M2I3ZjAzL3RhYmxlcmFuZ2U6MWM0NmY4ODIxYjM2NGNiYzg1OWUzNGEyMTkzYjdmMDNfNy0wLTEtMS02MTk5MA_553a4f00-e978-4e3b-ac10-ef28c58a3c8b">Cumulative effect adjustment from <br/>&#160;&#160;&#160;the adoption of ASC 842</span></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i4378b9360776445ba70d80981bf38d62_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOjFjNDZmODgyMWIzNjRjYmM4NTllMzRhMjE5M2I3ZjAzL3RhYmxlcmFuZ2U6MWM0NmY4ODIxYjM2NGNiYzg1OWUzNGEyMTkzYjdmMDNfNy03LTEtMS02MTk5MA_3eb70384-d4f6-402b-8ecd-1a18fc6ec25c">154</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i7f7477a44afb4479b9c1eee284f3005c_I20211231" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOjFjNDZmODgyMWIzNjRjYmM4NTllMzRhMjE5M2I3ZjAzL3RhYmxlcmFuZ2U6MWM0NmY4ODIxYjM2NGNiYzg1OWUzNGEyMTkzYjdmMDNfNy05LTEtMS02MTk5MA_0d3c7130-db61-460c-95a0-f3ca9a0d8496">154</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercise of stock options</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0f1b454495df444b9b332af549b60b6a_D20220101-20220331" decimals="0" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOjFjNDZmODgyMWIzNjRjYmM4NTllMzRhMjE5M2I3ZjAzL3RhYmxlcmFuZ2U6MWM0NmY4ODIxYjM2NGNiYzg1OWUzNGEyMTkzYjdmMDNfOC0xLTEtMS02MTk5MA_f9faf29d-caf4-4e58-a9bc-ed9692ad05d7">4,549</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50f6cb59fed6438795bb51a3698b7cef_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOjFjNDZmODgyMWIzNjRjYmM4NTllMzRhMjE5M2I3ZjAzL3RhYmxlcmFuZ2U6MWM0NmY4ODIxYjM2NGNiYzg1OWUzNGEyMTkzYjdmMDNfOC01LTEtMS02MTk5MA_e8a6cbfb-d2aa-4914-96e5-36936eeb6bf2">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOjFjNDZmODgyMWIzNjRjYmM4NTllMzRhMjE5M2I3ZjAzL3RhYmxlcmFuZ2U6MWM0NmY4ODIxYjM2NGNiYzg1OWUzNGEyMTkzYjdmMDNfOC05LTEtMS02MTk5MA_8af7409f-5cc6-4dab-bc09-d62cb0f63b17">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital contributions from Amprius Holdings</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50f6cb59fed6438795bb51a3698b7cef_D20220101-20220331" decimals="-3" name="ampx:AdjustmentsToAdditionalPaidInCapitalCapitalContributionsFromParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOjFjNDZmODgyMWIzNjRjYmM4NTllMzRhMjE5M2I3ZjAzL3RhYmxlcmFuZ2U6MWM0NmY4ODIxYjM2NGNiYzg1OWUzNGEyMTkzYjdmMDNfOS01LTEtMS02MTk5MA_fc187c30-77c3-402b-a8f1-0fe446681076">247</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331" decimals="-3" name="ampx:AdjustmentsToAdditionalPaidInCapitalCapitalContributionsFromParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOjFjNDZmODgyMWIzNjRjYmM4NTllMzRhMjE5M2I3ZjAzL3RhYmxlcmFuZ2U6MWM0NmY4ODIxYjM2NGNiYzg1OWUzNGEyMTkzYjdmMDNfOS05LTEtMS02MTk5MA_74f0b651-50a2-4821-b143-929c402b5b6c">247</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50f6cb59fed6438795bb51a3698b7cef_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOjFjNDZmODgyMWIzNjRjYmM4NTllMzRhMjE5M2I3ZjAzL3RhYmxlcmFuZ2U6MWM0NmY4ODIxYjM2NGNiYzg1OWUzNGEyMTkzYjdmMDNfMTAtNS0xLTEtNjE5OTA_8fe4902e-7cb8-44c2-ab5a-1b2ed9fde9a6">350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331" decimals="-3" name="us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOjFjNDZmODgyMWIzNjRjYmM4NTllMzRhMjE5M2I3ZjAzL3RhYmxlcmFuZ2U6MWM0NmY4ODIxYjM2NGNiYzg1OWUzNGEyMTkzYjdmMDNfMTAtOS0xLTEtNjE5OTA_9b4b2548-31d0-434d-b500-3bdf122cf917">350</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Contribution from Amprius Holdings<br/>&#160;&#160;&#160;related to stock-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i50f6cb59fed6438795bb51a3698b7cef_D20220101-20220331" decimals="-3" name="ampx:AdjustmentsToAdditionalPaidInCapitalContributionFromParentRelatedToStockBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOjFjNDZmODgyMWIzNjRjYmM4NTllMzRhMjE5M2I3ZjAzL3RhYmxlcmFuZ2U6MWM0NmY4ODIxYjM2NGNiYzg1OWUzNGEyMTkzYjdmMDNfMTAtNS0xLTEtNjQ1Mzc_edef3695-91e1-406a-8384-3646e1ff7539">106</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331" decimals="-3" name="ampx:AdjustmentsToAdditionalPaidInCapitalContributionFromParentRelatedToStockBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOjFjNDZmODgyMWIzNjRjYmM4NTllMzRhMjE5M2I3ZjAzL3RhYmxlcmFuZ2U6MWM0NmY4ODIxYjM2NGNiYzg1OWUzNGEyMTkzYjdmMDNfMTAtOS0xLTEtNjQ1Mzc_83bf65ae-1d34-4572-b1ce-3fe6382e857c">106</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i269ea436a3b44ee9800781cda13e9ced_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOjFjNDZmODgyMWIzNjRjYmM4NTllMzRhMjE5M2I3ZjAzL3RhYmxlcmFuZ2U6MWM0NmY4ODIxYjM2NGNiYzg1OWUzNGEyMTkzYjdmMDNfMTEtNy0xLTEtNjg3MTY_1b8892df-4070-4e7b-b1da-16c4788bdbdc">2,878</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOjFjNDZmODgyMWIzNjRjYmM4NTllMzRhMjE5M2I3ZjAzL3RhYmxlcmFuZ2U6MWM0NmY4ODIxYjM2NGNiYzg1OWUzNGEyMTkzYjdmMDNfMTEtOS0xLTEtNjg3MTY_45c89ca1-3491-4aff-a986-1dbbbc0421f2">2,878</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance as of March 31, 2022</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i7025e13610834dba9e2d509086735e0f_I20220331" decimals="0" name="us-gaap:CommonStockSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOjFjNDZmODgyMWIzNjRjYmM4NTllMzRhMjE5M2I3ZjAzL3RhYmxlcmFuZ2U6MWM0NmY4ODIxYjM2NGNiYzg1OWUzNGEyMTkzYjdmMDNfMTItMS0xLTEtNjg3MTY_a8e2b284-ed9a-4b48-a635-f6fc8c2f9823">65,776,550</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7025e13610834dba9e2d509086735e0f_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOjFjNDZmODgyMWIzNjRjYmM4NTllMzRhMjE5M2I3ZjAzL3RhYmxlcmFuZ2U6MWM0NmY4ODIxYjM2NGNiYzg1OWUzNGEyMTkzYjdmMDNfMTItMy0xLTEtNjg3MTY_006ee9d7-aeb2-42d6-a9d7-ff4f27a325ec">7</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id94df322b86f4f07b19482d29fdb864b_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOjFjNDZmODgyMWIzNjRjYmM4NTllMzRhMjE5M2I3ZjAzL3RhYmxlcmFuZ2U6MWM0NmY4ODIxYjM2NGNiYzg1OWUzNGEyMTkzYjdmMDNfMTItNS0xLTEtNjg3MTY_56888e5c-2836-4bf9-9597-38216d9bdc4d">89,963</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i74bb0e27b0d34b379dd2c30509852fed_I20220331" decimals="-3" sign="-" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOjFjNDZmODgyMWIzNjRjYmM4NTllMzRhMjE5M2I3ZjAzL3RhYmxlcmFuZ2U6MWM0NmY4ODIxYjM2NGNiYzg1OWUzNGEyMTkzYjdmMDNfMTItNy0xLTEtNjg3MTY_4ed21718-a31e-4a76-bbd2-f0fa0bfd7bdc">78,433</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b2c45cb6722425d93cf25d37d538c75_I20220331" decimals="-3" name="us-gaap:StockholdersEquity" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOjFjNDZmODgyMWIzNjRjYmM4NTllMzRhMjE5M2I3ZjAzL3RhYmxlcmFuZ2U6MWM0NmY4ODIxYjM2NGNiYzg1OWUzNGEyMTkzYjdmMDNfMTItOS0xLTEtNjg3MTY_1564d74f-bd68-4d6d-8153-70e8e86d9836">11,537</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i066fdabb1d0848d5b0391931f87c3c0e_31"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:3pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_10">Table of Contents</a></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">MPRIUS </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">T</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ECHNOLOGIES, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">I</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">NC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">CONDENSED CONSOLIDATED STATEMENTS OF </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">C</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ASH </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">F</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">LOWS</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">(Unaudited)</span></div><div style="text-align:center"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.930%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.081%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.083%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-style:italic;font-weight:700;line-height:100%">(In thousands)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMy0xLTEtMS02MTk5MA_76404d8f-5276-44d1-9370-a6c05e82dba0">9,102</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMy0zLTEtMS02MTk5MA_e199291a-e30c-44ca-b06f-95aeb5dc2adf">2,878</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock-based compensation</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" decimals="-3" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfNS0xLTEtMS02MTk5MA_11f6af1c-2248-41c4-a0d3-d53b581b6c1e">726</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331" decimals="-3" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfNS0zLTEtMS02MTk5MA_2f140fa6-45a6-42af-abca-f2af91b25335">456</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfNi0xLTEtMS02MTk5MA_a7a3acd5-021a-4fe0-af1b-6ff76ae9ef3c">416</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331" decimals="-3" name="us-gaap:DepreciationDepletionAndAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfNi0zLTEtMS02MTk5MA_20751b76-276c-4ab6-805c-034709733153">358</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization of deferred costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" decimals="-3" name="us-gaap:OtherAmortizationOfDeferredCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfNy0xLTEtMS02MTk5MA_2bd73ece-6a0b-43e9-837a-e30b64301228">134</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331" decimals="-3" name="us-gaap:OtherAmortizationOfDeferredCharges" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfNy0zLTEtMS02MTk5MA_fbdd0dc1-db3b-486a-84c3-8447bac2798a">1,252</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Non-cash operating lease expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfOC0xLTEtMS02MTk5MA_c0ce9400-bff4-4fdd-bc8b-c9942a19a043">202</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfOC0zLTEtMS02MTk5MA_e51cfc0e-7822-48a9-b294-db97208a739f">140</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMTAtMS0xLTEtNjE5OTA_3c74648e-0340-4849-979e-27730af7e6b7">131</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMTAtMy0xLTEtNjE5OTA_9a03c5b9-c3dd-474a-bbb0-cfa96e529d1c">209</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMTEtMS0xLTEtNjE5OTA_62e51a1e-b3ff-4ae9-b599-a978fd68a63d">345</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMTEtMy0xLTEtNjE5OTA_daaba134-6e86-4ac4-8f26-e139702fe6c0">161</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" decimals="-3" name="us-gaap:IncreaseDecreaseInDeferredCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMTItMS0xLTEtNjE5OTA_6a235f07-ae1e-4686-86f4-7b9f783fb96f">864</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331" decimals="-3" name="us-gaap:IncreaseDecreaseInDeferredCharges" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMTItMy0xLTEtNjE5OTA_6c1c7e3b-3674-4e74-af85-ddf2c5a0a3f2">595</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMTMtMS0xLTEtNjE5OTA_bbdac6db-8318-4eed-b06f-5d40c7c83075">553</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMTMtMy0xLTEtNjE5OTA_14fb87d1-67f2-480f-9b5a-239cdfb50b5e">41</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMTQtMS0xLTEtNjE5OTA_3aa44316-a519-408f-9b8b-b244d867e56f">59</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMTQtMy0xLTEtNjE5OTA_799b3abc-093a-47c6-991c-72cab0b8e113">51</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued and other current liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMTUtMS0xLTEtNjE5OTA_55ab6cf5-baea-4d6d-99fa-08447774ae47">1,120</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMTUtMy0xLTEtNjE5OTA_9c19bab9-c270-4abc-809a-95c78c6a8cb3">332</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" decimals="-3" name="us-gaap:IncreaseDecreaseInDeferredRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMTYtMS0xLTEtNjE5OTA_d7dae4ac-37cb-4ce6-bdf2-fa0d7b17ffb2">657</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInDeferredRevenue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMTYtMy0xLTEtNjE5OTA_9d1b13d9-42fb-4028-88ec-5f9293732dbe">1,300</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 31pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMTctMS0xLTEtNjE5OTA_60892ea1-88d8-4302-8989-68014de218a0">179</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMTctMy0xLTEtNjE5OTA_8f22669f-83d4-4241-9efe-fed1f3900e04">86</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 49pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in operating activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMTgtMS0xLTEtNjE5OTA_99126a1a-096f-4402-94bc-bd6f2fc62979">6,492</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMTgtMy0xLTEtNjE5OTA_d570a0af-0d7f-4bdd-a29e-1009bb77bd6a">3,043</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Purchase of property, plant and equipment</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMjAtMS0xLTEtNjE5OTA_a702eb8d-e3b4-400f-9d2f-38aead18927e">1,140</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMjAtMy0xLTEtNjE5OTA_40054632-0e82-4aac-8e6d-f6a9c01a9445">34</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 49pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMjEtMS0xLTEtNjE5OTA_6e593857-04b4-484d-a358-e81b9669d4f8">1,140</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMjEtMy0xLTEtNjE5OTA_2df2f45a-ff32-44ff-81de-406d0e67bb38">34</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Issuance of common stock in connection with a stock purchase agreement</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMjQtMS0xLTEtNjg3OTM_65c6d103-f1d0-4e3f-9e9c-b37e70c48cb4">2,389</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMjQtMy0xLTEtNjg3OTM_7c78ad8d-a0d1-4b47-86e3-114b6a24fc8e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment of financing costs in connection with a stock purchase agreement</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMjQtMS0xLTEtNzA4MTc_2957c3a8-01c9-4735-8c4e-cb88635c8d43">268</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331" decimals="-3" name="us-gaap:PaymentsOfStockIssuanceCosts" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMjUtMy0xLTEtNzAwMzc_37b2aeaf-cc4d-4ae9-9428-6897b5b4634a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Proceeds from exercise of stock options</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMjMtMS0xLTEtNjE5OTA_ba627d24-3285-45ca-be8d-980c0aff6560">2</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMjMtMy0xLTEtNjE5OTA_b3bfdb14-05d8-4e11-b5fe-a5cd2df1df3a">8</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capital contributions from Amprius Holdings</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" decimals="-3" name="us-gaap:ProceedsFromContributionsFromParent" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMjUtMS0xLTEtNjE5OTA_e581bb96-d817-4826-8748-9d051578a10e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331" decimals="-3" name="us-gaap:ProceedsFromContributionsFromParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMjUtMy0xLTEtNjE5OTA_52a87992-b64d-4017-a1ef-3db4788f66d3">247</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment of transaction and issuance costs in connection with Business<br/>&#160;&#160;&#160;Combination and PIPE investment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" decimals="-3" name="ampx:PaymentOfTransactionAndIssuanceCostsInConnectionWithBusinessCombinationAndPIPEInvestment" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMjYtMS0xLTEtNjE5OTA_1065a008-bc47-4c9d-a92e-2013e542525f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331" decimals="-3" name="ampx:PaymentOfTransactionAndIssuanceCostsInConnectionWithBusinessCombinationAndPIPEInvestment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMjYtMy0xLTEtNjE5OTA_2c137553-26f1-4372-9d69-19637c45de01">51</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 49pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by financing activities</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMjctMS0xLTEtNjE5OTA_23d62f52-e1bd-4809-ba39-b596ac676f0f">2,123</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331" decimals="-3" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMjctMy0xLTEtNjE5OTA_b58d4b7b-f659-499a-b840-ad8c191ede58">204</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Net decrease in cash, cash equivalents and restricted cash</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMjgtMS0xLTEtNjE5OTA_07c59dfd-1e76-4862-bfd1-31e905eb3fab">5,509</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMjgtMy0xLTEtNjE5OTA_f7577f8e-8962-4e71-b0f9-efeecc83f90b">2,873</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash, cash equivalents and restricted cash, beginning of period</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMjktMS0xLTEtNjE5OTA_6ab98a79-7b3e-423c-9999-f0771c243cca">69,752</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifce6518367b34d3ab4c10e9de84e7829_I20211231" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMjktMy0xLTEtNjE5OTA_38e88a8a-4654-4600-bb23-f1b95de36f97">11,489</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Cash, cash equivalents and restricted cash, end of period</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMzAtMS0xLTEtNjE5OTA_ce4c3192-c0b7-4871-85f0-a46df1ed9cf8">64,243</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b2c45cb6722425d93cf25d37d538c75_I20220331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMzAtMy0xLTEtNjE5OTA_f29bba33-905c-4adb-a4ac-aad4754c28ed">8,616</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Reconciliation of cash, cash equivalents and restricted cash shown on the <br/>&#160;&#160;&#160;condensed consolidated balance sheets:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash and cash equivalents</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMzMtMS0xLTEtNjE5OTA_699e05f0-af43-42ba-a89c-3ee1bff4fb7b">64,187</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b2c45cb6722425d93cf25d37d538c75_I20220331" decimals="-3" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMzMtMy0xLTEtNjE5OTA_f97f8f83-bf07-45bf-aba0-4900254681a6">8,616</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Restricted cash included in other assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="-3" name="us-gaap:RestrictedCash" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMzQtMS0xLTEtNjE5OTA_d3cce74c-25e4-44a1-877e-25b789f37936">56</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b2c45cb6722425d93cf25d37d538c75_I20220331" decimals="-3" name="us-gaap:RestrictedCash" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMzQtMy0xLTEtNjE5OTA_2cb4f468-5650-4cac-81a2-64d3c6e4e11f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total cash, cash equivalents and restricted cash</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMzUtMS0xLTEtNjE5OTA_7da061f7-93f9-4fc0-9f7f-6814342f8fb8">64,243</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4b2c45cb6722425d93cf25d37d538c75_I20220331" decimals="-3" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMzUtMy0xLTEtNjE5OTA_62f49148-e93f-46c1-bd92-90a880222e1f">8,616</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i066fdabb1d0848d5b0391931f87c3c0e_34"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_10">Table of Contents</a></span></div><div style="text-align:center"><span><br/></span></div></div><div style="margin-top:10pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">A</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">MPRIUS </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">T</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">ECHNOLOGIES, </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">I</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">NC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">N</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">OTES </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">T</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:115%">O CONDENSED CONSOLIDATED FINANCIAL STATEMENTS  </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:115%">(Unaudited)</span></div><div id="i066fdabb1d0848d5b0391931f87c3c0e_37"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 1.  <ix:nonNumeric contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zNy9mcmFnOmVjNzk0OThkMjM3YTRlOWFhN2FiMGIyYWRkOTc0ODkyL3RleHRyZWdpb246ZWM3OTQ5OGQyMzdhNGU5YWE3YWIwYjJhZGQ5NzQ4OTJfODg2OQ_b1dcf0e8-01fd-4e2b-9e53-4452cf9e1b8d" continuedAt="ia4d466b212cd49f5a14998c718982f19" escape="true">Nature of Operations and Organization </ix:nonNumeric></span></div><ix:continuation id="ia4d466b212cd49f5a14998c718982f19" continuedAt="ia6121519c0984544a6d611d33529d097"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nature of Operations</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amprius Technologies, Inc. (hereafter referred to as the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; or &#8220;our&#8221;) has developed, and since 2018, been in commercial production of lithium-ion batteries for mobility applications leveraging a disruptive silicon anode. Our silicon anode technology is intended to enable batteries with higher energy density, higher power density and fast charging capabilities over a wide range of operating temperatures. Our headquarters is located in Fremont, California.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Combination</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal year 2022, on September 14, 2022 (the &#8220;Closing Date&#8221;), we completed a business combination pursuant to the Business Combination Agreement, dated May 11, 2022 (the &#8220;Business Combination Agreement&#8221;), by and among the Company, Amprius Technologies Operating, Inc. (formerly known as Amprius Technologies, Inc. or "Legacy Amprius"), Kensington Capital Acquisition Corp. IV, and Kensington Capital Merger Sub Corp. (&#8220;Merger Sub&#8221;). Pursuant to the terms of the Business Combination Agreement, Kensington Capital Acquisition Corp. IV changed its jurisdiction of incorporation by domesticating as a corporation incorporated under the laws of the State of Delaware (the &#8220;Domestication&#8221;), upon which it changed its name to &#8220;Amprius Technologies, Inc.,&#8221; and a business combination between  Kensington Capital Acquisition Corp. IV and Legacy Amprius was effected through the merger of Merger Sub with and into Legacy Amprius, with Legacy Amprius surviving as a wholly owned subsidiary of the Company (together with the Domestication and the other transactions contemplated by the Business Combination Agreement, the &#8220;Business Combination&#8221;).</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless the context otherwise provides, the &#8220;Company&#8221; refers (i) prior to the Closing Date, to Legacy Amprius and (ii) on and after the Closing Date, to Amprius Technologies, Inc. and its subsidiaries, including Legacy Amprius. Prior to the Business Combination, Kensington Capital Acquisition Corp. IV is referred to herein as &#8220;Kensington.&#8221; </span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Business Combination was treated as a reverse recapitalization. Legacy Amprius was determined as the accounting acquirer and Kensington as the accounting acquiree for financial reporting purposes.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since our inception, we have incurred recurring losses and negative cash flows from operations. During the three months ended March&#160;31, 2023, our net loss was $<ix:nonFraction unitRef="usd" contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" decimals="-5" sign="-" name="us-gaap:NetIncomeLoss" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zNy9mcmFnOmVjNzk0OThkMjM3YTRlOWFhN2FiMGIyYWRkOTc0ODkyL3RleHRyZWdpb246ZWM3OTQ5OGQyMzdhNGU5YWE3YWIwYjJhZGQ5NzQ4OTJfNTQ5NzU1ODQ5MzE3_d53a187c-2bb6-45e4-a12c-ece46e6f9a1e">9.1</ix:nonFraction> million and at March&#160;31, 2023, our accumulated deficit was $<ix:nonFraction unitRef="usd" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="-5" sign="-" name="us-gaap:RetainedEarningsAccumulatedDeficit" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zNy9mcmFnOmVjNzk0OThkMjM3YTRlOWFhN2FiMGIyYWRkOTc0ODkyL3RleHRyZWdpb246ZWM3OTQ5OGQyMzdhNGU5YWE3YWIwYjJhZGQ5NzQ4OTJfNTQ5NzU1ODQ5MzUz_009c0355-42a9-4503-9095-1cccf4232af0">102.0</ix:nonFraction> million. We expect to incur additional losses in the future as we scale our business and increase our operating expenditures, such as increasing our research and development spend and headcount. Additionally, we expect to increase our capital expenditures as we plan to build a </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GWh-scale manufacturing facility </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the future. We may need to raise funds in order to meet our future operating and capital expenditure requirements. We may be unable to raise additional funds or enter into such other agreements when needed on favorable terms or at all. If sufficient funding is not raised, we may need to reduce our spending activities, which may negatively affect our ability to achieve our operating goals. To the extent that we raise additional funds by issuing equity securities, our stockholders may experience additional dilution.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had cash and cash equivalents of $<ix:nonFraction unitRef="usd" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="-5" name="us-gaap:CashAndCashEquivalentsAtCarryingValue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zNy9mcmFnOmVjNzk0OThkMjM3YTRlOWFhN2FiMGIyYWRkOTc0ODkyL3RleHRyZWdpb246ZWM3OTQ5OGQyMzdhNGU5YWE3YWIwYjJhZGQ5NzQ4OTJfNTQ5NzU1ODQ5NTE5_ac3cb2f1-9414-4881-a2b5-696c1a0806cb">64.2</ix:nonFraction> million as of March&#160;31, 2023. We believe that our cash and cash equivalents will be sufficient to fund our operating and capital expenditure requirements over twelve months from the date these financial statements are issued. </span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September&#160;27, 2022, we entered into a Common Stock Purchase Agreement (&#8220;Purchase Agreement&#8221;) with B. Riley Principal Capital II, LLC (&#8220;BRPC II&#8221;), pursuant to which BRPC II committed to purchase up to $<ix:nonFraction unitRef="usd" contextRef="i10455920b55e4d9b921af5961e20e70c_D20230101-20230331" decimals="-5" name="us-gaap:SaleOfStockConsiderationReceivedOnTransaction" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zNy9mcmFnOmVjNzk0OThkMjM3YTRlOWFhN2FiMGIyYWRkOTc0ODkyL3RleHRyZWdpb246ZWM3OTQ5OGQyMzdhNGU5YWE3YWIwYjJhZGQ5NzQ4OTJfNTQ5NzU1ODQ5NDI4_71e1e8fa-3af8-48c0-b6aa-a3ea71f27eab">200.0</ix:nonFraction> million of our common stock until January 1, 2025, subject to certain contractual terms (the &#8220;Committed Equity Financing&#8221;). As of March&#160;31, 2023, $<ix:nonFraction unitRef="usd" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="-5" name="ampx:CommittedEquityFinancing" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zNy9mcmFnOmVjNzk0OThkMjM3YTRlOWFhN2FiMGIyYWRkOTc0ODkyL3RleHRyZWdpb246ZWM3OTQ5OGQyMzdhNGU5YWE3YWIwYjJhZGQ5NzQ4OTJfNTQ5NzU1ODUzNjI5_c969bc11-7480-439d-912c-1f2a0e26a977">197.6</ix:nonFraction> million remained available under the Committed Equity Financing. There can be no assurance that we will be able to raise such amount over the remaining period as the Committed Equity Financing contains certain limitations and conditions. </span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October&#160;19, 2022, the U.S. Department of Energy (&#8220;DOE&#8221;) under the Bipartisan Infrastructure Law awarded us a cost-sharing grant of $<ix:nonFraction unitRef="usd" contextRef="i5204fd658af644a69b260e135d17b875_I20221019" decimals="-5" name="ampx:GovernmentAssistanceGrantNotYetReceived" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zNy9mcmFnOmVjNzk0OThkMjM3YTRlOWFhN2FiMGIyYWRkOTc0ODkyL3RleHRyZWdpb246ZWM3OTQ5OGQyMzdhNGU5YWE3YWIwYjJhZGQ5NzQ4OTJfNTQ5NzU1ODQ5NDgz_8101b2f8-84a0-48c4-9a50-4cb0592b8b35">50.0</ix:nonFraction> million. The grant is dependent upon the successful negotiation of a final contract. There can be no assurance that such negotiation will be successful.   </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_10">Table of Contents</a></span></div></div><ix:continuation id="ia6121519c0984544a6d611d33529d097" continuedAt="id28d3ce7ee904dbd97b8be009dd4f07e"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Risk and Uncertainties</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We face risks related to the COVID-19&#160;pandemic, which has created significant volatility in the global economy, led to business disruptions, reduced economic activities, and imposition of travel restrictions. Although the COVID-19 pandemic did not have an adverse impact to us to-date, its future development is highly uncertain and cannot be predicted. Even after the COVID-19 pandemic has subsided, our company and our customers may continue to experience its negative effect, which may adversely affect our future financial condition, results of operations and cash flows.</span></div></ix:continuation><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="id28d3ce7ee904dbd97b8be009dd4f07e">We also face risks related to the war between Russia and Ukraine, which has also led to significant volatility in the global economy resulting in higher inflation, volatility in the credit and capital markets, and interruption in the supply chain. Although this war did not have an adverse impact to us to-date, its future outcome is highly unpredictable and uncertain, which may also adversely affect our future financial condition, results of operations and cash flows.</ix:continuation> </span></div><div id="i066fdabb1d0848d5b0391931f87c3c0e_40"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 2.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80MC9mcmFnOjdhMTk2Y2ZkMGIwYjRjY2M5YjM1NjU5M2M4MWIzMzIxL3RleHRyZWdpb246N2ExOTZjZmQwYjBiNGNjYzliMzU2NTkzYzgxYjMzMjFfMjk5MDA_95899616-eedd-4a60-b76f-f194807c412a" continuedAt="ie7e1d1e6243646399a5693c2ae24fe56" escape="true">Summary of Significant Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="ie7e1d1e6243646399a5693c2ae24fe56" continuedAt="if57e9f4f8a6543709990ec69db884274"><ix:nonNumeric contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80MC9mcmFnOjdhMTk2Y2ZkMGIwYjRjY2M5YjM1NjU5M2M4MWIzMzIxL3RleHRyZWdpb246N2ExOTZjZmQwYjBiNGNjYzliMzU2NTkzYzgxYjMzMjFfMjk5MDg_cf03e9e2-8397-4683-b632-d47941fdee53" continuedAt="i694b172050ba4d0cb7350c1e5e6d73e8" escape="true"><ix:nonNumeric contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80MC9mcmFnOjdhMTk2Y2ZkMGIwYjRjY2M5YjM1NjU5M2M4MWIzMzIxL3RleHRyZWdpb246N2ExOTZjZmQwYjBiNGNjYzliMzU2NTkzYzgxYjMzMjFfMjk5MDg_f7d2f93a-6d93-4c4c-8603-575b5db187c2" continuedAt="i463048ecb8de41089a80cd53c906af9f" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">and Principles of Consolidation</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;). </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All intercompany accounts and transactions have been eliminated.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The significant accounting policies described below, together with other notes that follow, are an integral part of the condensed consolidated financial statements. </span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the closing of the Business Combination, whereby Legacy Amprius was determined as the accounting acquirer for accounting and reporting purposes, the historical financial statements of Legacy Amprius became the historical financial statements of the combined company and no goodwill or other intangible assets were recorded. As a result, the accompanying condensed consolidated financial statements reflect (i) the assets and liabilities of Legacy Amprius at their historical cost; (ii) the historical operating results of Legacy Amprius prior to the Business Combination; and (iii) Legacy Amprius&#8217; equity structure, which has been retroactively restated in the comparative period to reflect the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">number of shares of the Compa</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ny&#8217;s common stock issued to Legacy Amprius stockholders. As such, the shares, corresponding capital amounts, and net loss per share related to Legacy Amprius common stock have been retroactively restated to reflect the effect of the exchange ratio of <ix:nonFraction unitRef="number" contextRef="i1e90ee49c2a54d3a851c9f496677d786_I20220914" decimals="5" name="ampx:RecapitalizationExchangeRatio" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80MC9mcmFnOjdhMTk2Y2ZkMGIwYjRjY2M5YjM1NjU5M2M4MWIzMzIxL3RleHRyZWdpb246N2ExOTZjZmQwYjBiNGNjYzliMzU2NTkzYzgxYjMzMjFfNTQ5NzU1ODc0OTE1_4dc80335-45ab-429a-b112-ee5ba937a262">1.45590</ix:nonFraction> (the &#8220;Exchange Ratio&#8221;) established in the Business Combination.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Business Combination, our financial statements were presented on a carve-out basis using our historical results of operations and historical basis of assets and liabilities derived from the accounting records of our majority stockholder, Amprius, Inc. (&#8220;Amprius Holdings&#8221;), adjusted as necessary to conform with U.S. GAAP.  The underlying assumptions in our presentation of our financial statements prior to the Business Combination include:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Balance sheet includes all of our owned assets, assets assigned or contributed by Amprius Holdings, and liabilities incurred by Amprius Holdings on our behalf. </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Statement of operations reflects all activities directly attributable to us, which include an allocation of certain general and administrative expenses of Amprius Holdings. </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Certain general and administrative expenses of Amprius Holdings, such as the payroll-related expenses for <ix:nonFraction unitRef="executiveemployee" contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" decimals="0" name="ampx:NumberOfExecutiveEmployeesOfParentSharingFacilitiesCosts" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80MC9mcmFnOjdhMTk2Y2ZkMGIwYjRjY2M5YjM1NjU5M2M4MWIzMzIxL3RleHRyZWdpb246N2ExOTZjZmQwYjBiNGNjYzliMzU2NTkzYzgxYjMzMjFfNTQ5NzU1ODc1MDAw_8cd753c2-6e79-4dfb-9d22-c10ab87fe679">two</ix:nonFraction> executive employees, legal, tax, insurance and accounting fees, were shared between us, Amprius Holdings and its other subsidiaries. Since those <ix:nonFraction unitRef="executiveemployee" contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" decimals="0" name="ampx:NumberOfExecutiveEmployeesOfParentSharingFacilitiesCosts" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80MC9mcmFnOjdhMTk2Y2ZkMGIwYjRjY2M5YjM1NjU5M2M4MWIzMzIxL3RleHRyZWdpb246N2ExOTZjZmQwYjBiNGNjYzliMzU2NTkzYzgxYjMzMjFfNTQ5NzU1ODc1MDA3_8cd753c2-6e79-4dfb-9d22-c10ab87fe679">two</ix:nonFraction> executive employees provided us and Amprius Holdings' other subsidiaries with governance and management oversight, those shared expenses were allocated between us and Amprius Holdings' other subsidiaries. The level of effort spent by Amprius Holdings' executives was not correlated with the level of our business activity, revenue or other financial operating metrics and of Amprius Holdings' other subsidiaries. As a result, those shared expenses were allocated equally between us and Amprius Holdings' other subsidiaries. </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Prior to the distribution of Amprius Holdings' other subsidiaries in January 2022 and February 2022, the shared expenses of Amprius Holdings were allocated equally between us and Amprius Holdings' other subsidiaries. After February 2022, those expenses were fully allocated to us.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management believes that the assumptions described above, including the allocation of certain shared expenses, are reasonable and consistently applied for all periods presented prior to the Business Combination. However, the financial statements of that were presented prior to the Business Combination may not be indicative of our future performance and </span></div></ix:nonNumeric></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_10">Table of Contents</a></span></div></div><ix:continuation id="if57e9f4f8a6543709990ec69db884274" continuedAt="ie765189c1c254ea896cd091774ce3cba"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i694b172050ba4d0cb7350c1e5e6d73e8"><ix:continuation id="i463048ecb8de41089a80cd53c906af9f">do not necessarily reflect what the financial position, results of operations and cash flows would have been had we operated as a separate and standalone entity.</ix:continuation></ix:continuation></span></div><ix:nonNumeric contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" name="ampx:UnauditedInterimCondensedFinancialStatementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80MC9mcmFnOjdhMTk2Y2ZkMGIwYjRjY2M5YjM1NjU5M2M4MWIzMzIxL3RleHRyZWdpb246N2ExOTZjZmQwYjBiNGNjYzliMzU2NTkzYzgxYjMzMjFfMjk5MDQ_8374ea3d-7b73-47a8-bc77-bcc232ab532d" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unaudited Interim Condensed Consolidated Financial Statements</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated balance sheet as of December&#160;31, 2022, which has been derived from our audited financial statements as filed in our Annual Report on Form 10-K with the Securities and Exchange Commission (&#8220;SEC&#8221;) on March 30, 2023, and the unaudited interim condensed consolidated financial statements have been prepared in accordance with U.S. GAAP and applicable rules and regulations of the SEC regarding interim financial reporting. Any reference in these notes to applicable accounting guidance is meant to refer to the authoritative U.S. GAAP included in the Accounting Standards Codification (&#8220;ASC&#8221;), and Accounting Standards Updates (&#8220;ASU&#8221;) issued by the Financial Accounting Standards Board (&#8220;FASB&#8221;). The condensed consolidated financial statements have been prepared on a basis consistent with the audited financial statements. In management&#8217;s opinion, all adjustments made were normal or recurring in nature and necessary for the fair statement of our financial position as of March&#160;31, 2023 and our results of operations and cash flows during the three months ended March&#160;31, 2023 and 2022. The financial data and other financial information disclosed in the notes to these condensed consolidated financial statements are also unaudited. The results of operations during the three months ended March&#160;31, 2023 are not necessarily indicative of the results to be expected for the full fiscal year or any other period.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain information and note disclosures normally included in annual financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to those rules and regulations, although we believe that the disclosures made are adequate to make the information not misleading.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" name="ampx:EmergingGrowthCompanyPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80MC9mcmFnOjdhMTk2Y2ZkMGIwYjRjY2M5YjM1NjU5M2M4MWIzMzIxL3RleHRyZWdpb246N2ExOTZjZmQwYjBiNGNjYzliMzU2NTkzYzgxYjMzMjFfMjk5MDE_b8d0611e-b09a-49d4-87fb-921eba57bf1c" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Emerging Growth Company</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are an emerging growth company as defined in Section&#160;2(a) of the Securities Act of 1933 (as amended) (&#8220;Securities Act&#8221;), and we may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies. Further, Section&#160;102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised accounting standards until private companies are required to comply with such standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. We have elected to not opt out of such extended transition period. This means that when a standard is issued or revised and it has different application dates for public or private companies, we, as an&#160;emerging growth company, can adopt the new or revised standard at the time private companies adopt such new or revised standard unless we are no longer deemed an emerging growth company. As a result, the accompanying condensed consolidated financial statements may not be comparable to companies that comply with the new or revised accounting pronouncements as of public company effective dates.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80MC9mcmFnOjdhMTk2Y2ZkMGIwYjRjY2M5YjM1NjU5M2M4MWIzMzIxL3RleHRyZWdpb246N2ExOTZjZmQwYjBiNGNjYzliMzU2NTkzYzgxYjMzMjFfMjk5MDU_ee0a0109-a13e-4058-8ced-c3211b980f78" continuedAt="i6d0bcc0405ea4fd3a042a7de5e0fdbee" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. These estimates are based on current facts, historical experience and various other factors believed to be reasonable under the circumstances; the results of which form the basis for making judgements that are not readily apparent from other sources. Actual results could materially differ from management estimates using different assumptions or under different conditions. </span></div></ix:nonNumeric><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i6d0bcc0405ea4fd3a042a7de5e0fdbee">Our significant accounting estimates include useful lives of property, plant and equipment; valuation of deferred taxes; lower of cost or net realizable adjustment of inventory; carve-out of financial statements including the allocation of assets, liabilities and expenses prior to the Business Combination; incremental borrowing rate used in calculating lease obligations and right-of-use assets; and fair value of common stock prior to the Business Combination and other inputs used to value stock-based compensation awards.</ix:continuation>  </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had a money market fund amounting to $<ix:nonFraction unitRef="usd" contextRef="i249e71b6552c4c1eb0877da134e2de5a_I20230331" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80MC9mcmFnOjdhMTk2Y2ZkMGIwYjRjY2M5YjM1NjU5M2M4MWIzMzIxL3RleHRyZWdpb246N2ExOTZjZmQwYjBiNGNjYzliMzU2NTkzYzgxYjMzMjFfNTQ5NzU1ODg1MTMy_f046d17c-34b4-4b03-9d45-1dccbb452d3a">41.1</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i57089d02123243da8af388b3d544181d_I20221231" decimals="-5" name="us-gaap:CashAndCashEquivalentsFairValueDisclosure" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80MC9mcmFnOjdhMTk2Y2ZkMGIwYjRjY2M5YjM1NjU5M2M4MWIzMzIxL3RleHRyZWdpb246N2ExOTZjZmQwYjBiNGNjYzliMzU2NTkzYzgxYjMzMjFfNTQ5NzU1ODg1MTM5_7792ef90-c5ca-48a3-9c31-749b620094d5">69.4</ix:nonFraction>&#160;million as of March&#160;31, 2023 and December&#160;31, 2022, respectively, which was measured at Level 1 fair value based on the active market price of such instrument. </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_10">Table of Contents</a></span></div></div><ix:continuation id="ie765189c1c254ea896cd091774ce3cba"><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did not have assets or liabilities measured at fair value on a recurring basis using Level 2 or Level 3 inputs as of March&#160;31, 2023 and December&#160;31, 2022. </span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no transfers of financial instruments between Level 1, Level 2 and Level 3 during the three months ended March&#160;31, 2023 and 2022.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" name="us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80MC9mcmFnOjdhMTk2Y2ZkMGIwYjRjY2M5YjM1NjU5M2M4MWIzMzIxL3RleHRyZWdpb246N2ExOTZjZmQwYjBiNGNjYzliMzU2NTkzYzgxYjMzMjFfMTY0OTI2NzU0NDY1OQ_4c06d999-55ec-4079-9534-f29a93f090ff" continuedAt="ie8ced202b4214371afe5bee873857dcf" escape="true">Restricted Cash</ix:nonNumeric></span></div><div style="margin-top:10pt;text-align:justify;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"><ix:continuation id="ie8ced202b4214371afe5bee873857dcf">Restricted cash pertains to cash collateral required by our lessor to satisfy a letter of credit requirement under our lease agreement.</ix:continuation> Restricted cash, which is included in other assets in the accompanying condensed consolidated balance sheets, was $<ix:nonFraction unitRef="usd" contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231" decimals="-3" name="us-gaap:RestrictedCash" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80MC9mcmFnOjdhMTk2Y2ZkMGIwYjRjY2M5YjM1NjU5M2M4MWIzMzIxL3RleHRyZWdpb246N2ExOTZjZmQwYjBiNGNjYzliMzU2NTkzYzgxYjMzMjFfNTQ5NzU1OTE0NTY2_1e21df38-e38b-4412-a7c3-460cb0fe3525"><ix:nonFraction unitRef="usd" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="-3" name="us-gaap:RestrictedCash" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80MC9mcmFnOjdhMTk2Y2ZkMGIwYjRjY2M5YjM1NjU5M2M4MWIzMzIxL3RleHRyZWdpb246N2ExOTZjZmQwYjBiNGNjYzliMzU2NTkzYzgxYjMzMjFfNTQ5NzU1OTE0NTY2_d133ec9e-4c00-4e3e-8bd5-522eda95a158">56</ix:nonFraction></ix:nonFraction> thousand as of March&#160;31, 2023 and December&#160;31, 2022. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" name="us-gaap:ConcentrationRiskCreditRisk" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80MC9mcmFnOjdhMTk2Y2ZkMGIwYjRjY2M5YjM1NjU5M2M4MWIzMzIxL3RleHRyZWdpb246N2ExOTZjZmQwYjBiNGNjYzliMzU2NTkzYzgxYjMzMjFfMjk5MTM_7fbd9a2f-9996-4293-a468-19324966e452" continuedAt="i9716aa09afa84c5a8f5c1d178c4f5f9d" escape="true">Concentration of Credit Risk</ix:nonNumeric></span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i9716aa09afa84c5a8f5c1d178c4f5f9d">Accounts receivable mainly consist of amounts due from U.S. government agencies or sponsored entities and large public entities which limits our credit risk. Through March&#160;31, 2023, we have not experienced any credit losses.</ix:continuation> </span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2023, three customers represented <ix:nonFraction unitRef="number" contextRef="i5371cedb4ff54ccd8164da48c07a4e65_D20230101-20230331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80MC9mcmFnOjdhMTk2Y2ZkMGIwYjRjY2M5YjM1NjU5M2M4MWIzMzIxL3RleHRyZWdpb246N2ExOTZjZmQwYjBiNGNjYzliMzU2NTkzYzgxYjMzMjFfNTQ5NzU1ODg3MzU1_c83ebc4e-0631-4ec4-9bcb-feeb59051be6">34</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="i2491a8cf26ae441db19f29da6405e4f3_D20230101-20230331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80MC9mcmFnOjdhMTk2Y2ZkMGIwYjRjY2M5YjM1NjU5M2M4MWIzMzIxL3RleHRyZWdpb246N2ExOTZjZmQwYjBiNGNjYzliMzU2NTkzYzgxYjMzMjFfNTQ5NzU1ODg3MzYw_fc964c20-38b9-43af-9950-1de6305f9190">23</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="ia0ca1db60f404e5e8963bf33fc47c360_D20230101-20230331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80MC9mcmFnOjdhMTk2Y2ZkMGIwYjRjY2M5YjM1NjU5M2M4MWIzMzIxL3RleHRyZWdpb246N2ExOTZjZmQwYjBiNGNjYzliMzU2NTkzYzgxYjMzMjFfNTQ5NzU1ODg3MzY1_3488febe-f2a9-4ef6-bdaa-99728527badb">19</ix:nonFraction>% of our revenue. During the three months ended March&#160;31, 2022, three customers represented <ix:nonFraction unitRef="number" contextRef="i97a5618b45474da28680c8670a3e72f1_D20220101-20220331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80MC9mcmFnOjdhMTk2Y2ZkMGIwYjRjY2M5YjM1NjU5M2M4MWIzMzIxL3RleHRyZWdpb246N2ExOTZjZmQwYjBiNGNjYzliMzU2NTkzYzgxYjMzMjFfNTQ5NzU1ODg3NDMw_510690b8-4fce-4e22-8abf-0704a241fa0e">40</ix:nonFraction>%, <ix:nonFraction unitRef="number" contextRef="id9df38d6aecc41ac937ddb4c6110b735_D20220101-20220331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80MC9mcmFnOjdhMTk2Y2ZkMGIwYjRjY2M5YjM1NjU5M2M4MWIzMzIxL3RleHRyZWdpb246N2ExOTZjZmQwYjBiNGNjYzliMzU2NTkzYzgxYjMzMjFfNTQ5NzU1ODg3NDM0_7cbf4ecd-9c7b-48c6-85df-820f9f0dbd4d">31</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="iade7297fa7ee4e99b67dd741d1ffe066_D20220101-20220331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80MC9mcmFnOjdhMTk2Y2ZkMGIwYjRjY2M5YjM1NjU5M2M4MWIzMzIxL3RleHRyZWdpb246N2ExOTZjZmQwYjBiNGNjYzliMzU2NTkzYzgxYjMzMjFfNTQ5NzU1OTE3NTM3_7362794f-570b-4e3a-ae22-6faabfa8692d">19</ix:nonFraction>% of our revenue. </span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023 and December&#160;31, 2022, two and three customers represented <ix:nonFraction unitRef="number" contextRef="i851c46bd9c414d139116e6b9fb6058fa_D20230101-20230331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80MC9mcmFnOjdhMTk2Y2ZkMGIwYjRjY2M5YjM1NjU5M2M4MWIzMzIxL3RleHRyZWdpb246N2ExOTZjZmQwYjBiNGNjYzliMzU2NTkzYzgxYjMzMjFfNTQ5NzU1ODg3NDYx_293e8f50-4bc6-4d2f-bfbe-238755c6349c">65</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="ifa2cb13888a54b6c8e0df0d3d5d53aee_D20220101-20221231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80MC9mcmFnOjdhMTk2Y2ZkMGIwYjRjY2M5YjM1NjU5M2M4MWIzMzIxL3RleHRyZWdpb246N2ExOTZjZmQwYjBiNGNjYzliMzU2NTkzYzgxYjMzMjFfNTQ5NzU1ODg3NDY1_dc0770eb-6516-46e6-bb1d-fb2babe5dd39">88</ix:nonFraction>%, respectively, of our total accounts receivable.</span></div><ix:nonNumeric contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80MC9mcmFnOjdhMTk2Y2ZkMGIwYjRjY2M5YjM1NjU5M2M4MWIzMzIxL3RleHRyZWdpb246N2ExOTZjZmQwYjBiNGNjYzliMzU2NTkzYzgxYjMzMjFfMjk5MTE_cc43e17f-e288-42ae-ba6a-04d490c27a82" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment Reporting</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have determined that the Chief Executive Officer is our Chief Operating Decision Maker (&#8220;CODM&#8221;). The CODM reviews financial information presented on an aggregate basis for the purposes of assessing our performance and making decisions on how to allocate resources. Accordingly, we have determined that we operate in a single operating and reportable segment. All of our revenues are geographically earned in the United States and our property, plant and equipment are located in the United States.</span></div></ix:nonNumeric><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Significant Accounting Policies</span></div><div><span><br/></span></div><div style="text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no changes to our significant accounting policies described in the Annual Report on Form 10-K for the year ended December 31, 2022, other than the new accounting policy that was implemented as a result of the adoption of a new accounting standard as described below.</span></div><ix:nonNumeric contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80MC9mcmFnOjdhMTk2Y2ZkMGIwYjRjY2M5YjM1NjU5M2M4MWIzMzIxL3RleHRyZWdpb246N2ExOTZjZmQwYjBiNGNjYzliMzU2NTkzYzgxYjMzMjFfMjk5MDc_9cbdff93-0db4-43e0-836d-c527a43d08bc" escape="true"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Adopted Accounting Standard</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2023, we adopted FASB ASU 2016-13,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Financial Instruments&#8212;Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and related amendment under ASU 2019-10, which requires that credit losses on financial assets, such as trade and other receivables, be recognized as allowance for losses. Credit losses on trade and other receivables will reflect the current estimate of the expected credit losses that generally will result in the earlier recognition of allowances for losses. The adoption of this ASU did not have a material impact on our condensed consolidated financial statements.</span></div></ix:nonNumeric></ix:continuation><div id="i066fdabb1d0848d5b0391931f87c3c0e_46"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 3.  <ix:nonNumeric contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" name="us-gaap:RevenueFromContractWithCustomerTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80Ni9mcmFnOjNhZjQxMTFjMjA4ZjQwZmNhMzlkYjY5YWViMmYzYzIwL3RleHRyZWdpb246M2FmNDExMWMyMDhmNDBmY2EzOWRiNjlhZWIyZjNjMjBfMzEyOA_0ddeda06-9d91-4034-a58c-06c097df7d0c" continuedAt="i525838ea3b1546bb837dfc787cbda6f2" escape="true">Revenue</ix:nonNumeric></span></div><ix:continuation id="i525838ea3b1546bb837dfc787cbda6f2" continuedAt="i7a2f92dc05b140179b1e3477fe56d9b9"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disaggregation of Revenue</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from customers consists mainly of customized design services arrangements and sale of battery products. Revenue from customized design services arrangements, which may include a requirement to achieve certain agreed upon milestones, is recognized when the battery design is completed and the final prototype batteries are delivered. Revenue from sale of battery products is recognized upon shipment. We disaggregate our revenue from customers by the type of arrangement, either as customization design services or as sale of battery products, as this depicts how the nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factors. <ix:nonNumeric contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" name="us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80Ni9mcmFnOjNhZjQxMTFjMjA4ZjQwZmNhMzlkYjY5YWViMmYzYzIwL3RleHRyZWdpb246M2FmNDExMWMyMDhmNDBmY2EzOWRiNjlhZWIyZjNjMjBfMTY0OTI2NzQ0ODEzNw_8e6f6e64-a65c-4d28-b3c5-db21924e64c3" continuedAt="i31bcd972cc124c42957e04eddb10f386" escape="true">The table below shows the composition of revenue from customers, as disaggregated by type of arrangement in accordance with Topic 606, and other revenue from a government grant accounted for using the analogy from IAS 20 (in thousands). </ix:nonNumeric></span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_10">Table of Contents</a></span></div></div><ix:continuation id="i7a2f92dc05b140179b1e3477fe56d9b9"><div style="margin-top:10pt;text-indent:25.2pt"><ix:continuation id="i31bcd972cc124c42957e04eddb10f386"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.939%"><tr><td style="width:1.0%"></td><td style="width:71.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.803%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:12.933%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue from customers:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sale of battery products</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43cd424ce72a4a40ac5fe4088c873948_D20230101-20230331" decimals="-3" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80Ni9mcmFnOjNhZjQxMTFjMjA4ZjQwZmNhMzlkYjY5YWViMmYzYzIwL3RhYmxlOmQ0MmU4MzU2ZjFmZDQ2YzFiOTgwMDBiMzhhNWU1OTZhL3RhYmxlcmFuZ2U6ZDQyZTgzNTZmMWZkNDZjMWI5ODAwMGIzOGE1ZTU5NmFfMy0xLTEtMS02NjUxMg_2d8d9532-c6b4-4fdb-9d0c-226d4081df51">470</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iee19788a62c34779b7e8c93581517ccc_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80Ni9mcmFnOjNhZjQxMTFjMjA4ZjQwZmNhMzlkYjY5YWViMmYzYzIwL3RhYmxlOmQ0MmU4MzU2ZjFmZDQ2YzFiOTgwMDBiMzhhNWU1OTZhL3RhYmxlcmFuZ2U6ZDQyZTgzNTZmMWZkNDZjMWI5ODAwMGIzOGE1ZTU5NmFfMy0zLTEtMS02NjUxMg_58e7393b-2d9f-4145-bd04-2611af542c97">605</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customized design services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic144432f29d243b0b1d00f76340bc40e_D20230101-20230331" decimals="-3" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80Ni9mcmFnOjNhZjQxMTFjMjA4ZjQwZmNhMzlkYjY5YWViMmYzYzIwL3RhYmxlOmQ0MmU4MzU2ZjFmZDQ2YzFiOTgwMDBiMzhhNWU1OTZhL3RhYmxlcmFuZ2U6ZDQyZTgzNTZmMWZkNDZjMWI5ODAwMGIzOGE1ZTU5NmFfNC0xLTEtMS02NjUxMg_17d3645f-f56b-42cf-a31c-65f120b95f0a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i42b2afc255654cec93289ac97a7463f7_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80Ni9mcmFnOjNhZjQxMTFjMjA4ZjQwZmNhMzlkYjY5YWViMmYzYzIwL3RhYmxlOmQ0MmU4MzU2ZjFmZDQ2YzFiOTgwMDBiMzhhNWU1OTZhL3RhYmxlcmFuZ2U6ZDQyZTgzNTZmMWZkNDZjMWI5ODAwMGIzOGE1ZTU5NmFfNC0zLTEtMS02NjUxMg_0642f417-ca83-446d-9176-d460c9d99a5e">1,505</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue from customers</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3ef781aff42644a5b81b5015320dace1_D20230101-20230331" decimals="-3" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80Ni9mcmFnOjNhZjQxMTFjMjA4ZjQwZmNhMzlkYjY5YWViMmYzYzIwL3RhYmxlOmQ0MmU4MzU2ZjFmZDQ2YzFiOTgwMDBiMzhhNWU1OTZhL3RhYmxlcmFuZ2U6ZDQyZTgzNTZmMWZkNDZjMWI5ODAwMGIzOGE1ZTU5NmFfNS0xLTEtMS02NjUxMg_03fca890-dcf4-48c8-9975-254311fb944f">470</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6cf8fcfb69a74fd9aa89d6dc6e5f7b7f_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80Ni9mcmFnOjNhZjQxMTFjMjA4ZjQwZmNhMzlkYjY5YWViMmYzYzIwL3RhYmxlOmQ0MmU4MzU2ZjFmZDQ2YzFiOTgwMDBiMzhhNWU1OTZhL3RhYmxlcmFuZ2U6ZDQyZTgzNTZmMWZkNDZjMWI5ODAwMGIzOGE1ZTU5NmFfNS0zLTEtMS02NjUxMg_b1538df0-c7a8-427e-be4e-176976fbceb9">2,110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenue &#8211; government grant</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0e692c0e7a0a484c82160d4323ca8b64_D20230101-20230331" decimals="-3" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80Ni9mcmFnOjNhZjQxMTFjMjA4ZjQwZmNhMzlkYjY5YWViMmYzYzIwL3RhYmxlOmQ0MmU4MzU2ZjFmZDQ2YzFiOTgwMDBiMzhhNWU1OTZhL3RhYmxlcmFuZ2U6ZDQyZTgzNTZmMWZkNDZjMWI5ODAwMGIzOGE1ZTU5NmFfNi0xLTEtMS02NjUxMg_d7dbe2e1-8eff-499a-99d0-256b206c9344">209</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8593a7e0ef1947cc8d2ea977da1fe0b0_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80Ni9mcmFnOjNhZjQxMTFjMjA4ZjQwZmNhMzlkYjY5YWViMmYzYzIwL3RhYmxlOmQ0MmU4MzU2ZjFmZDQ2YzFiOTgwMDBiMzhhNWU1OTZhL3RhYmxlcmFuZ2U6ZDQyZTgzNTZmMWZkNDZjMWI5ODAwMGIzOGE1ZTU5NmFfNi0zLTEtMS02NjUxMg_02c0a112-0a80-4f4c-8bd1-58404e296498">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" decimals="-3" name="us-gaap:Revenues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80Ni9mcmFnOjNhZjQxMTFjMjA4ZjQwZmNhMzlkYjY5YWViMmYzYzIwL3RhYmxlOmQ0MmU4MzU2ZjFmZDQ2YzFiOTgwMDBiMzhhNWU1OTZhL3RhYmxlcmFuZ2U6ZDQyZTgzNTZmMWZkNDZjMWI5ODAwMGIzOGE1ZTU5NmFfNy0xLTEtMS02NjUxMg_7590fb26-cac8-48bd-9f0c-20bdb68bfc42">679</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80Ni9mcmFnOjNhZjQxMTFjMjA4ZjQwZmNhMzlkYjY5YWViMmYzYzIwL3RhYmxlOmQ0MmU4MzU2ZjFmZDQ2YzFiOTgwMDBiMzhhNWU1OTZhL3RhYmxlcmFuZ2U6ZDQyZTgzNTZmMWZkNDZjMWI5ODAwMGIzOGE1ZTU5NmFfNy0zLTEtMS02NjUxMg_226806ce-f132-45e2-83f0-722dc2b515cb">2,110</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></ix:continuation></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from sale of batteries includes bill-and-hold arrangements, of which there was <ix:nonFraction unitRef="usd" contextRef="i0ae713297f034937abe6ba4c9366e66b_D20230101-20230331" decimals="0" name="us-gaap:Revenues" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80Ni9mcmFnOjNhZjQxMTFjMjA4ZjQwZmNhMzlkYjY5YWViMmYzYzIwL3RleHRyZWdpb246M2FmNDExMWMyMDhmNDBmY2EzOWRiNjlhZWIyZjNjMjBfNTQ5NzU1ODM1Mjkz_6daa8bb3-e2ae-4523-ae23-8ae28dcc1f4a">none</ix:nonFraction> during the three months ended March&#160;31, 2023 and $<ix:nonFraction unitRef="usd" contextRef="i076e74831991483a8e8261e35d5fdc5d_D20220101-20220331" decimals="-3" name="us-gaap:Revenues" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80Ni9mcmFnOjNhZjQxMTFjMjA4ZjQwZmNhMzlkYjY5YWViMmYzYzIwL3RleHRyZWdpb246M2FmNDExMWMyMDhmNDBmY2EzOWRiNjlhZWIyZjNjMjBfNTQ5NzU1ODI1MTk0_8a0756a3-096c-4adf-b36d-79c221bd8e00">67</ix:nonFraction> thousand during the three months ended March&#160;31, 2022.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract Balances</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The timing of revenue recognition, billings and cash collections can result in accounts receivable, contract assets recorded as unbilled receivables, and contract liabilities recorded as deferred revenue.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable represents our right to consideration that is unconditional. A right to consideration is unconditional if only the passage of time is required before payment of that consideration is due. Accounts receivable was $<ix:nonFraction unitRef="usd" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80Ni9mcmFnOjNhZjQxMTFjMjA4ZjQwZmNhMzlkYjY5YWViMmYzYzIwL3RleHRyZWdpb246M2FmNDExMWMyMDhmNDBmY2EzOWRiNjlhZWIyZjNjMjBfNjU5NzA2OTc4ODg5Nw_abe1c848-7ba8-4e2d-bdac-74b320102955">0.6</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80Ni9mcmFnOjNhZjQxMTFjMjA4ZjQwZmNhMzlkYjY5YWViMmYzYzIwL3RleHRyZWdpb246M2FmNDExMWMyMDhmNDBmY2EzOWRiNjlhZWIyZjNjMjBfNjU5NzA2OTc4ODkwMQ_4c6f5741-bf99-4c03-a821-15ff8640945d">0.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i35c52756179342cb89a7e4fbbc177710_I20220101" decimals="-5" name="us-gaap:AccountsReceivableNetCurrent" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80Ni9mcmFnOjNhZjQxMTFjMjA4ZjQwZmNhMzlkYjY5YWViMmYzYzIwL3RleHRyZWdpb246M2FmNDExMWMyMDhmNDBmY2EzOWRiNjlhZWIyZjNjMjBfNjU5NzA2OTc4ODkwNQ_6d5138dd-40ce-4b3f-8edd-ef5271140809">0.3</ix:nonFraction> million as of March&#160;31, 2023, December&#160;31, 2022 and January 1, 2022, respectively. </span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract assets primarily relate to the rights to consideration for progress on contractual requirements performed but not billed at the reporting date. The contract assets are transferred to accounts receivable when the rights become unconditional. As of March&#160;31, 2023 and December&#160;31, 2022, we had <ix:nonFraction unitRef="usd" contextRef="i4b2c45cb6722425d93cf25d37d538c75_I20220331" decimals="0" name="us-gaap:ContractWithCustomerAssetNet" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80Ni9mcmFnOjNhZjQxMTFjMjA4ZjQwZmNhMzlkYjY5YWViMmYzYzIwL3RleHRyZWdpb246M2FmNDExMWMyMDhmNDBmY2EzOWRiNjlhZWIyZjNjMjBfODc5NjA5MzAzOTU1OQ_62789a6a-a372-40e2-87a4-a17906b50d0f"><ix:nonFraction unitRef="usd" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="0" name="us-gaap:ContractWithCustomerAssetNet" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80Ni9mcmFnOjNhZjQxMTFjMjA4ZjQwZmNhMzlkYjY5YWViMmYzYzIwL3RleHRyZWdpb246M2FmNDExMWMyMDhmNDBmY2EzOWRiNjlhZWIyZjNjMjBfODc5NjA5MzAzOTU1OQ_dd8f5283-c3f2-4b74-bde0-d0f0733926dd">no</ix:nonFraction></ix:nonFraction> contract assets.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities consist primarily of deferred revenue, w</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">hich is the amount of progress payments received or billed in advance of revenue recognition. Deferred revenue is subsequently recognized as revenue when the performance obligation is satisfied. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred revenue was $<ix:nonFraction unitRef="usd" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="-5" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80Ni9mcmFnOjNhZjQxMTFjMjA4ZjQwZmNhMzlkYjY5YWViMmYzYzIwL3RleHRyZWdpb246M2FmNDExMWMyMDhmNDBmY2EzOWRiNjlhZWIyZjNjMjBfNjU5NzA2OTc4OTE4NQ_44e12c74-6ebf-4bd5-ae7d-9195ae93db4b">4.0</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231" decimals="-5" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80Ni9mcmFnOjNhZjQxMTFjMjA4ZjQwZmNhMzlkYjY5YWViMmYzYzIwL3RleHRyZWdpb246M2FmNDExMWMyMDhmNDBmY2EzOWRiNjlhZWIyZjNjMjBfNjU5NzA2OTc4OTE4OQ_abb2f42b-bbbe-4d98-92a0-02598210ac0c">3.4</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i35c52756179342cb89a7e4fbbc177710_I20220101" decimals="-5" name="us-gaap:ContractWithCustomerLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80Ni9mcmFnOjNhZjQxMTFjMjA4ZjQwZmNhMzlkYjY5YWViMmYzYzIwL3RleHRyZWdpb246M2FmNDExMWMyMDhmNDBmY2EzOWRiNjlhZWIyZjNjMjBfNjU5NzA2OTc4OTE5Mw_7e7dd88e-f2b3-4b16-b75f-912994f74f88">2.9</ix:nonFraction> million as of March&#160;31, 2023, December&#160;31, 2022 and January 1, 2022, respectively. Deferred revenue as of March&#160;31, 2023 and December&#160;31, 2022 increased compared to the deferred revenue as of December&#160;31, 2022 and January 1, 2022, respectively, primarily due to progress payments for certain customer contracts that have not been recognized as revenue as of the end of those periods.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> During the three months ended March&#160;31, 2023 and 2022, revenue recognized from the prior year deferred revenue balance was $<ix:nonFraction unitRef="usd" contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" decimals="-3" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80Ni9mcmFnOjNhZjQxMTFjMjA4ZjQwZmNhMzlkYjY5YWViMmYzYzIwL3RleHRyZWdpb246M2FmNDExMWMyMDhmNDBmY2EzOWRiNjlhZWIyZjNjMjBfODc5NjA5MzAzNzcxNA_dc81254b-dac2-4f0d-b81d-9acc19d5d5b2">120</ix:nonFraction> thousand and $<ix:nonFraction unitRef="usd" contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331" decimals="-5" name="us-gaap:ContractWithCustomerLiabilityRevenueRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80Ni9mcmFnOjNhZjQxMTFjMjA4ZjQwZmNhMzlkYjY5YWViMmYzYzIwL3RleHRyZWdpb246M2FmNDExMWMyMDhmNDBmY2EzOWRiNjlhZWIyZjNjMjBfODc5NjA5MzAzNzcxOA_454325b6-1728-4576-bb52-0f6d7b1cf75d">1.4</ix:nonFraction> million, respectively.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Remaining Performance Obligations</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have performance obligations associated with commitments in customer contracts for future services that have not yet been recognized as revenue. As of March&#160;31, 2023, the aggregate amount of the transaction price allocated to the remaining performance obligations related to customer contracts that were unsatisfied or partially unsatisfied, including deferred revenue, was approximately $<ix:nonFraction unitRef="usd" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="-5" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80Ni9mcmFnOjNhZjQxMTFjMjA4ZjQwZmNhMzlkYjY5YWViMmYzYzIwL3RleHRyZWdpb246M2FmNDExMWMyMDhmNDBmY2EzOWRiNjlhZWIyZjNjMjBfNTQ5NzU1ODIxMzYy_55d1c73b-c556-49db-9c37-795d4860f5cc">11.0</ix:nonFraction> million. Given the applicable contract terms, approximately $<ix:nonFraction unitRef="usd" contextRef="i904eec3b78d5419aa0f9501d2ea7f78e_I20230331" decimals="-5" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80Ni9mcmFnOjNhZjQxMTFjMjA4ZjQwZmNhMzlkYjY5YWViMmYzYzIwL3RleHRyZWdpb246M2FmNDExMWMyMDhmNDBmY2EzOWRiNjlhZWIyZjNjMjBfNTQ5NzU1ODIxMzY2_2dcdbc4b-5205-4a56-8bbc-956402272971">7.1</ix:nonFraction> million is expected to be recognized as revenue within <ix:nonNumeric contextRef="i904eec3b78d5419aa0f9501d2ea7f78e_I20230331" name="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80Ni9mcmFnOjNhZjQxMTFjMjA4ZjQwZmNhMzlkYjY5YWViMmYzYzIwL3RleHRyZWdpb246M2FmNDExMWMyMDhmNDBmY2EzOWRiNjlhZWIyZjNjMjBfNTQ5NzU1ODIxMzUx_11d5156f-8b13-46c4-8e80-eea6069b02e4">one year</ix:nonNumeric> and approximately $<ix:nonFraction unitRef="usd" contextRef="i9f2425ecaf1e4131b7a7a5b98fa6ec56_I20230331" decimals="-5" name="us-gaap:RevenueRemainingPerformanceObligation" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80Ni9mcmFnOjNhZjQxMTFjMjA4ZjQwZmNhMzlkYjY5YWViMmYzYzIwL3RleHRyZWdpb246M2FmNDExMWMyMDhmNDBmY2EzOWRiNjlhZWIyZjNjMjBfNTQ5NzU1ODIxMzcw_6de19d28-2754-4c5f-aeb5-f698b2f1ad09">3.9</ix:nonFraction> million is expected to be recognized between two to five years. This amount does not include contracts to which the customer is not committed. The estimated timing of the recognition of remaining unsatisfied performance obligations is subject to change and is affected by changes to scope, changes in timing of delivery of products and services, or contract modifications.</span></div></ix:continuation><div id="i066fdabb1d0848d5b0391931f87c3c0e_52"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 4.  <ix:nonNumeric contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" name="us-gaap:InventoryDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81Mi9mcmFnOjUzOTA4ZjM5MTdmMzQwNDFhMDE2YzYwNmI1ODY5YzY4L3RleHRyZWdpb246NTM5MDhmMzkxN2YzNDA0MWEwMTZjNjA2YjU4NjljNjhfNjM_cee3eb62-ccef-452a-b4ee-7d287f7476b5" continuedAt="if1001de98f0e489494ba26fe395f6e08" escape="true">Inventory</ix:nonNumeric></span></div><ix:continuation id="if1001de98f0e489494ba26fe395f6e08"><ix:nonNumeric contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81Mi9mcmFnOjUzOTA4ZjM5MTdmMzQwNDFhMDE2YzYwNmI1ODY5YzY4L3RleHRyZWdpb246NTM5MDhmMzkxN2YzNDA0MWEwMTZjNjA2YjU4NjljNjhfMTY0OTI2NzQ0MTc2OA_fcf00d88-b3f9-4ffa-a2b0-bdb8b924ea92" escape="true"><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory consisted of the following (in thousands):</span></div><div style="text-indent:25.2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.636%"><tr><td style="width:1.0%"></td><td style="width:70.097%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.977%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.447%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.979%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="-3" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81Mi9mcmFnOjUzOTA4ZjM5MTdmMzQwNDFhMDE2YzYwNmI1ODY5YzY4L3RhYmxlOmI3ZTgxNWY5OGQ5MTQ5MTI5N2JjNjllN2U5MjFhYWM3L3RhYmxlcmFuZ2U6YjdlODE1Zjk4ZDkxNDkxMjk3YmM2OWU3ZTkyMWFhYzdfMi0xLTEtMS02MTk5MA_ba276059-bac5-47eb-a73f-9198b53841ef">164</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231" decimals="-3" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81Mi9mcmFnOjUzOTA4ZjM5MTdmMzQwNDFhMDE2YzYwNmI1ODY5YzY4L3RhYmxlOmI3ZTgxNWY5OGQ5MTQ5MTI5N2JjNjllN2U5MjFhYWM3L3RhYmxlcmFuZ2U6YjdlODE1Zjk4ZDkxNDkxMjk3YmM2OWU3ZTkyMWFhYzdfMi0zLTEtMS02MTk5MA_475175ff-07ab-4fd9-95a3-0f160468631f">180</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="-3" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81Mi9mcmFnOjUzOTA4ZjM5MTdmMzQwNDFhMDE2YzYwNmI1ODY5YzY4L3RhYmxlOmI3ZTgxNWY5OGQ5MTQ5MTI5N2JjNjllN2U5MjFhYWM3L3RhYmxlcmFuZ2U6YjdlODE1Zjk4ZDkxNDkxMjk3YmM2OWU3ZTkyMWFhYzdfMy0xLTEtMS02MTk5MA_d415358a-94ea-4fa9-b56e-5aa6373e9aca">395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231" decimals="-3" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81Mi9mcmFnOjUzOTA4ZjM5MTdmMzQwNDFhMDE2YzYwNmI1ODY5YzY4L3RhYmxlOmI3ZTgxNWY5OGQ5MTQ5MTI5N2JjNjllN2U5MjFhYWM3L3RhYmxlcmFuZ2U6YjdlODE1Zjk4ZDkxNDkxMjk3YmM2OWU3ZTkyMWFhYzdfMy0zLTEtMS02MTk5MA_db6e0932-be0a-48be-97f3-f7e66b56a815">218</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="-3" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81Mi9mcmFnOjUzOTA4ZjM5MTdmMzQwNDFhMDE2YzYwNmI1ODY5YzY4L3RhYmxlOmI3ZTgxNWY5OGQ5MTQ5MTI5N2JjNjllN2U5MjFhYWM3L3RhYmxlcmFuZ2U6YjdlODE1Zjk4ZDkxNDkxMjk3YmM2OWU3ZTkyMWFhYzdfNC0xLTEtMS02MTk5MA_ec73ad35-1dea-4360-b2c4-916257e133e0">286</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231" decimals="-3" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81Mi9mcmFnOjUzOTA4ZjM5MTdmMzQwNDFhMDE2YzYwNmI1ODY5YzY4L3RhYmxlOmI3ZTgxNWY5OGQ5MTQ5MTI5N2JjNjllN2U5MjFhYWM3L3RhYmxlcmFuZ2U6YjdlODE1Zjk4ZDkxNDkxMjk3YmM2OWU3ZTkyMWFhYzdfNC0zLTEtMS02MTk5MA_dbefdd84-f962-4f64-9ab4-578a628cdce9">102</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td style="background-color:#ffffff;border-bottom:2.5pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2.5pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="-3" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81Mi9mcmFnOjUzOTA4ZjM5MTdmMzQwNDFhMDE2YzYwNmI1ODY5YzY4L3RhYmxlOmI3ZTgxNWY5OGQ5MTQ5MTI5N2JjNjllN2U5MjFhYWM3L3RhYmxlcmFuZ2U6YjdlODE1Zjk4ZDkxNDkxMjk3YmM2OWU3ZTkyMWFhYzdfNS0xLTEtMS02MTk5MA_ebba04b5-9d19-4f6b-8b1e-4f81713858c3">845</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2.5pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:2.5pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2.5pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231" decimals="-3" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81Mi9mcmFnOjUzOTA4ZjM5MTdmMzQwNDFhMDE2YzYwNmI1ODY5YzY4L3RhYmxlOmI3ZTgxNWY5OGQ5MTQ5MTI5N2JjNjllN2U5MjFhYWM3L3RhYmxlcmFuZ2U6YjdlODE1Zjk4ZDkxNDkxMjk3YmM2OWU3ZTkyMWFhYzdfNS0zLTEtMS02MTk5MA_70040b63-8a54-482d-897a-0f362fab1d0e">500</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:2.5pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><div id="i066fdabb1d0848d5b0391931f87c3c0e_55"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_10">Table of Contents</a></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 5.  <ix:nonNumeric contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" name="us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81NS9mcmFnOjdiOTViYWNhNzdlNDRjMTRiMDdhYjQyOWU2ZjkzZDdiL3RleHRyZWdpb246N2I5NWJhY2E3N2U0NGMxNGIwN2FiNDI5ZTZmOTNkN2JfMzY4_eea1d147-544f-4530-868c-cf746d90d5df" continuedAt="i88f4c8580c0044d59f3e946b4e69ed39" escape="true">Property, Plant and Equipment, Net</ix:nonNumeric></span></div><ix:continuation id="i88f4c8580c0044d59f3e946b4e69ed39" continuedAt="ibb16e23911ca4909adce35ae0bd654f1"><ix:nonNumeric contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81NS9mcmFnOjdiOTViYWNhNzdlNDRjMTRiMDdhYjQyOWU2ZjkzZDdiL3RleHRyZWdpb246N2I5NWJhY2E3N2U0NGMxNGIwN2FiNDI5ZTZmOTNkN2JfMzY5_1bff2d5d-3c1d-4494-8bec-85ecf9b98abc" escape="true"><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment, net consisted of the following (in thousands):</span></div><div style="text-indent:25.2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.636%"><tr><td style="width:1.0%"></td><td style="width:70.097%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.977%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.447%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.979%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Production equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i903b361bf85148a5aa5dbeb03ba0ea1d_I20230331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81NS9mcmFnOjdiOTViYWNhNzdlNDRjMTRiMDdhYjQyOWU2ZjkzZDdiL3RhYmxlOjM5MThmMzgxMTA3ZjQzY2I4NDI2ZDI2NGZlZjgxNzM4L3RhYmxlcmFuZ2U6MzkxOGYzODExMDdmNDNjYjg0MjZkMjY0ZmVmODE3MzhfMi0xLTEtMS02MTk5MA_82cf7cad-3db6-499f-9f13-163ee6b772cf">5,114</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5977eefa4b7f4aa09e7fdb5aea5dd806_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81NS9mcmFnOjdiOTViYWNhNzdlNDRjMTRiMDdhYjQyOWU2ZjkzZDdiL3RhYmxlOjM5MThmMzgxMTA3ZjQzY2I4NDI2ZDI2NGZlZjgxNzM4L3RhYmxlcmFuZ2U6MzkxOGYzODExMDdmNDNjYjg0MjZkMjY0ZmVmODE3MzhfMi0zLTEtMS02MTk5MA_d46ca015-9c5f-4fa0-a146-3ad9aceb8229">4,488</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lab equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia6d7ea55505e405b8d49c84e5c00e216_I20230331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81NS9mcmFnOjdiOTViYWNhNzdlNDRjMTRiMDdhYjQyOWU2ZjkzZDdiL3RhYmxlOjM5MThmMzgxMTA3ZjQzY2I4NDI2ZDI2NGZlZjgxNzM4L3RhYmxlcmFuZ2U6MzkxOGYzODExMDdmNDNjYjg0MjZkMjY0ZmVmODE3MzhfMy0xLTEtMS02MTk5MA_e43cefc7-2bb2-48b8-80d6-7418519a045e">2,452</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0cdadfcb55ef4456992d4eac608c568c_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81NS9mcmFnOjdiOTViYWNhNzdlNDRjMTRiMDdhYjQyOWU2ZjkzZDdiL3RhYmxlOjM5MThmMzgxMTA3ZjQzY2I4NDI2ZDI2NGZlZjgxNzM4L3RhYmxlcmFuZ2U6MzkxOGYzODExMDdmNDNjYjg0MjZkMjY0ZmVmODE3MzhfMy0zLTEtMS02MTk5MA_90a4e7eb-94af-4c3e-867a-46ee6df9d563">2,304</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6305afd21797431abefaa882fdec1d44_I20230331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81NS9mcmFnOjdiOTViYWNhNzdlNDRjMTRiMDdhYjQyOWU2ZjkzZDdiL3RhYmxlOjM5MThmMzgxMTA3ZjQzY2I4NDI2ZDI2NGZlZjgxNzM4L3RhYmxlcmFuZ2U6MzkxOGYzODExMDdmNDNjYjg0MjZkMjY0ZmVmODE3MzhfNC0xLTEtMS02MTk5MA_6c8d8496-1a8d-4783-94b5-a47c26c9b8ff">4,080</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie7d6fdab3f1b47a985e1326bf5737eca_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81NS9mcmFnOjdiOTViYWNhNzdlNDRjMTRiMDdhYjQyOWU2ZjkzZDdiL3RhYmxlOjM5MThmMzgxMTA3ZjQzY2I4NDI2ZDI2NGZlZjgxNzM4L3RhYmxlcmFuZ2U6MzkxOGYzODExMDdmNDNjYjg0MjZkMjY0ZmVmODE3MzhfNC0zLTEtMS02MTk5MA_162fb22d-8605-4306-a61c-53b2dbbda456">3,525</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture, fixtures and other equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib5ac7197a264438baf93759ed1193030_I20230331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81NS9mcmFnOjdiOTViYWNhNzdlNDRjMTRiMDdhYjQyOWU2ZjkzZDdiL3RhYmxlOjM5MThmMzgxMTA3ZjQzY2I4NDI2ZDI2NGZlZjgxNzM4L3RhYmxlcmFuZ2U6MzkxOGYzODExMDdmNDNjYjg0MjZkMjY0ZmVmODE3MzhfNS0xLTEtMS02MTk5MA_ee2c0d0e-d85b-4aaf-8757-10c78a1af690">360</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3e9ea2df75d5435493c2296c08d770cc_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81NS9mcmFnOjdiOTViYWNhNzdlNDRjMTRiMDdhYjQyOWU2ZjkzZDdiL3RhYmxlOjM5MThmMzgxMTA3ZjQzY2I4NDI2ZDI2NGZlZjgxNzM4L3RhYmxlcmFuZ2U6MzkxOGYzODExMDdmNDNjYjg0MjZkMjY0ZmVmODE3MzhfNS0zLTEtMS02MTk5MA_e4a047fa-9691-4b78-b219-1338c9644655">206</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i255153329caf42fbad158d721b25384a_I20230331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81NS9mcmFnOjdiOTViYWNhNzdlNDRjMTRiMDdhYjQyOWU2ZjkzZDdiL3RhYmxlOjM5MThmMzgxMTA3ZjQzY2I4NDI2ZDI2NGZlZjgxNzM4L3RhYmxlcmFuZ2U6MzkxOGYzODExMDdmNDNjYjg0MjZkMjY0ZmVmODE3MzhfNi0xLTEtMS02OTc2MQ_c4b6ad1f-1486-4ecf-b58c-6550a63f6acb">602</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i670d9fe2f1524ac7bd4b7736aac57795_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81NS9mcmFnOjdiOTViYWNhNzdlNDRjMTRiMDdhYjQyOWU2ZjkzZDdiL3RhYmxlOjM5MThmMzgxMTA3ZjQzY2I4NDI2ZDI2NGZlZjgxNzM4L3RhYmxlcmFuZ2U6MzkxOGYzODExMDdmNDNjYjg0MjZkMjY0ZmVmODE3MzhfNi0zLTEtMS02OTc2MQ_00b667f3-ff4d-44f2-afac-2018293bfdfa">957</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, at cost</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81NS9mcmFnOjdiOTViYWNhNzdlNDRjMTRiMDdhYjQyOWU2ZjkzZDdiL3RhYmxlOjM5MThmMzgxMTA3ZjQzY2I4NDI2ZDI2NGZlZjgxNzM4L3RhYmxlcmFuZ2U6MzkxOGYzODExMDdmNDNjYjg0MjZkMjY0ZmVmODE3MzhfNi0xLTEtMS02MTk5MA_19bdac53-c81d-4f9e-9865-1a24a0b8c7a1">12,608</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81NS9mcmFnOjdiOTViYWNhNzdlNDRjMTRiMDdhYjQyOWU2ZjkzZDdiL3RhYmxlOjM5MThmMzgxMTA3ZjQzY2I4NDI2ZDI2NGZlZjgxNzM4L3RhYmxlcmFuZ2U6MzkxOGYzODExMDdmNDNjYjg0MjZkMjY0ZmVmODE3MzhfNi0zLTEtMS02MTk5MA_d5928502-7342-424c-902b-b29f21e95dca">11,480</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81NS9mcmFnOjdiOTViYWNhNzdlNDRjMTRiMDdhYjQyOWU2ZjkzZDdiL3RhYmxlOjM5MThmMzgxMTA3ZjQzY2I4NDI2ZDI2NGZlZjgxNzM4L3RhYmxlcmFuZ2U6MzkxOGYzODExMDdmNDNjYjg0MjZkMjY0ZmVmODE3MzhfNy0xLTEtMS02MTk5MA_63c479f6-bf1e-4333-80b5-89387dba276e">7,660</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231" decimals="-3" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81NS9mcmFnOjdiOTViYWNhNzdlNDRjMTRiMDdhYjQyOWU2ZjkzZDdiL3RhYmxlOjM5MThmMzgxMTA3ZjQzY2I4NDI2ZDI2NGZlZjgxNzM4L3RhYmxlcmFuZ2U6MzkxOGYzODExMDdmNDNjYjg0MjZkMjY0ZmVmODE3MzhfNy0zLTEtMS02MTk5MA_4ffb61cb-9005-4f21-adb9-0385853cde1b">7,244</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81NS9mcmFnOjdiOTViYWNhNzdlNDRjMTRiMDdhYjQyOWU2ZjkzZDdiL3RhYmxlOjM5MThmMzgxMTA3ZjQzY2I4NDI2ZDI2NGZlZjgxNzM4L3RhYmxlcmFuZ2U6MzkxOGYzODExMDdmNDNjYjg0MjZkMjY0ZmVmODE3MzhfOC0xLTEtMS02MTk5MA_b3a94cc8-b6b3-4495-b85a-062a43536d88">4,948</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentNet" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81NS9mcmFnOjdiOTViYWNhNzdlNDRjMTRiMDdhYjQyOWU2ZjkzZDdiL3RhYmxlOjM5MThmMzgxMTA3ZjQzY2I4NDI2ZDI2NGZlZjgxNzM4L3RhYmxlcmFuZ2U6MzkxOGYzODExMDdmNDNjYjg0MjZkMjY0ZmVmODE3MzhfOC0zLTEtMS02MTk5MA_b923d933-27cd-49b8-ad10-8562f56048c7">4,236</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ibb16e23911ca4909adce35ae0bd654f1">Depreciation and amortization expense was $<ix:nonFraction unitRef="usd" contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81NS9mcmFnOjdiOTViYWNhNzdlNDRjMTRiMDdhYjQyOWU2ZjkzZDdiL3RleHRyZWdpb246N2I5NWJhY2E3N2U0NGMxNGIwN2FiNDI5ZTZmOTNkN2JfNTQ5NzU1ODE0NDQ5_50de8e06-e7d9-4dec-ba5e-751f8fbcdb30"><ix:nonFraction unitRef="usd" contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" decimals="-5" name="us-gaap:DepreciationDepletionAndAmortization" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81NS9mcmFnOjdiOTViYWNhNzdlNDRjMTRiMDdhYjQyOWU2ZjkzZDdiL3RleHRyZWdpb246N2I5NWJhY2E3N2U0NGMxNGIwN2FiNDI5ZTZmOTNkN2JfNTQ5NzU1ODE0NDQ5_87dc6087-c8b4-45ad-80d5-01b98f9ef3c1">0.4</ix:nonFraction></ix:nonFraction> million during each of the three months ended March&#160;31, 2023 and 2022.</ix:continuation> </span></div><div id="i066fdabb1d0848d5b0391931f87c3c0e_58"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 6.  <ix:nonNumeric contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" name="us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81OC9mcmFnOjg2OWFiOTY5ZDMwNDQ3NmRhNzBlYzM3MjlmYzIwMGI0L3RleHRyZWdpb246ODY5YWI5NjlkMzA0NDc2ZGE3MGVjMzcyOWZjMjAwYjRfMTE4_23d3cf35-f2db-414d-bb18-c3bb9a343d43" continuedAt="ifcf8a18076044ab2a7beb10476e9e66c" escape="true">Accrued and Other Current Liabilities </ix:nonNumeric></span></div><ix:continuation id="ifcf8a18076044ab2a7beb10476e9e66c"><ix:nonNumeric contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" name="us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81OC9mcmFnOjg2OWFiOTY5ZDMwNDQ3NmRhNzBlYzM3MjlmYzIwMGI0L3RleHRyZWdpb246ODY5YWI5NjlkMzA0NDc2ZGE3MGVjMzcyOWZjMjAwYjRfMTE5_e672ad84-7cd0-434a-b1b6-61addd60eed0" escape="true"><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued and other current liabilities consisted of the following (in thousands):</span></div><div style="margin-top:10pt;text-indent:25.2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.333%"><tr><td style="width:1.0%"></td><td style="width:70.653%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.023%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.024%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional fees</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81OC9mcmFnOjg2OWFiOTY5ZDMwNDQ3NmRhNzBlYzM3MjlmYzIwMGI0L3RhYmxlOmNjYjMyYTYyZDNiNTQ2ZTE5ZDk1NjNiZjY1Y2M4MzIzL3RhYmxlcmFuZ2U6Y2NiMzJhNjJkM2I1NDZlMTlkOTU2M2JmNjVjYzgzMjNfMi0xLTEtMS02MTk5MA_70225752-5a3d-45bb-aefa-de879e48f50e">2,406</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81OC9mcmFnOjg2OWFiOTY5ZDMwNDQ3NmRhNzBlYzM3MjlmYzIwMGI0L3RhYmxlOmNjYjMyYTYyZDNiNTQ2ZTE5ZDk1NjNiZjY1Y2M4MzIzL3RhYmxlcmFuZ2U6Y2NiMzJhNjJkM2I1NDZlMTlkOTU2M2JmNjVjYzgzMjNfMi0zLTEtMS02MTk5MA_dd70ac2c-3bc8-4201-9526-246040b6f226">481</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation and benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81OC9mcmFnOjg2OWFiOTY5ZDMwNDQ3NmRhNzBlYzM3MjlmYzIwMGI0L3RhYmxlOmNjYjMyYTYyZDNiNTQ2ZTE5ZDk1NjNiZjY1Y2M4MzIzL3RhYmxlcmFuZ2U6Y2NiMzJhNjJkM2I1NDZlMTlkOTU2M2JmNjVjYzgzMjNfMy0xLTEtMS02MTk5MA_5c5cdafe-4184-4346-ac51-6255e4b73fe1">1,105</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231" decimals="-3" name="us-gaap:EmployeeRelatedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81OC9mcmFnOjg2OWFiOTY5ZDMwNDQ3NmRhNzBlYzM3MjlmYzIwMGI0L3RhYmxlOmNjYjMyYTYyZDNiNTQ2ZTE5ZDk1NjNiZjY1Y2M4MzIzL3RhYmxlcmFuZ2U6Y2NiMzJhNjJkM2I1NDZlMTlkOTU2M2JmNjVjYzgzMjNfMy0zLTEtMS02MTk5MA_93860509-572d-4a8a-a79c-6905a717b857">1,840</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued financing costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="-3" name="ampx:AccruedOfferingCostsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81OC9mcmFnOjg2OWFiOTY5ZDMwNDQ3NmRhNzBlYzM3MjlmYzIwMGI0L3RhYmxlOmNjYjMyYTYyZDNiNTQ2ZTE5ZDk1NjNiZjY1Y2M4MzIzL3RhYmxlcmFuZ2U6Y2NiMzJhNjJkM2I1NDZlMTlkOTU2M2JmNjVjYzgzMjNfNC0xLTEtMS02MTk5MA_e82e908f-25f7-4946-80aa-fe02a21c1c1a">31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231" decimals="-3" name="ampx:AccruedOfferingCostsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81OC9mcmFnOjg2OWFiOTY5ZDMwNDQ3NmRhNzBlYzM3MjlmYzIwMGI0L3RhYmxlOmNjYjMyYTYyZDNiNTQ2ZTE5ZDk1NjNiZjY1Y2M4MzIzL3RhYmxlcmFuZ2U6Y2NiMzJhNjJkM2I1NDZlMTlkOTU2M2JmNjVjYzgzMjNfNC0zLTEtMS02MTk5MA_913b342c-c676-40d2-b6fd-0b0ab99f4598">194</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81OC9mcmFnOjg2OWFiOTY5ZDMwNDQ3NmRhNzBlYzM3MjlmYzIwMGI0L3RhYmxlOmNjYjMyYTYyZDNiNTQ2ZTE5ZDk1NjNiZjY1Y2M4MzIzL3RhYmxlcmFuZ2U6Y2NiMzJhNjJkM2I1NDZlMTlkOTU2M2JmNjVjYzgzMjNfOC0xLTEtMS02MTk5MA_c98b86ce-0004-4ed6-af9b-9763e761e5e5">123</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81OC9mcmFnOjg2OWFiOTY5ZDMwNDQ3NmRhNzBlYzM3MjlmYzIwMGI0L3RhYmxlOmNjYjMyYTYyZDNiNTQ2ZTE5ZDk1NjNiZjY1Y2M4MzIzL3RhYmxlcmFuZ2U6Y2NiMzJhNjJkM2I1NDZlMTlkOTU2M2JmNjVjYzgzMjNfOC0zLTEtMS02MTk5MA_f9de69fd-674e-4488-a742-fed415bac221">193</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued and other current liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81OC9mcmFnOjg2OWFiOTY5ZDMwNDQ3NmRhNzBlYzM3MjlmYzIwMGI0L3RhYmxlOmNjYjMyYTYyZDNiNTQ2ZTE5ZDk1NjNiZjY1Y2M4MzIzL3RhYmxlcmFuZ2U6Y2NiMzJhNjJkM2I1NDZlMTlkOTU2M2JmNjVjYzgzMjNfNy0xLTEtMS03NDIyOA_528a1904-e42e-4724-a406-605fb9c72e09">3,665</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231" decimals="-3" name="us-gaap:AccruedLiabilitiesCurrent" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81OC9mcmFnOjg2OWFiOTY5ZDMwNDQ3NmRhNzBlYzM3MjlmYzIwMGI0L3RhYmxlOmNjYjMyYTYyZDNiNTQ2ZTE5ZDk1NjNiZjY1Y2M4MzIzL3RhYmxlcmFuZ2U6Y2NiMzJhNjJkM2I1NDZlMTlkOTU2M2JmNjVjYzgzMjNfNy0zLTEtMS03NDIyOA_804d6130-ccce-4c3d-bc12-c4927f874d77">2,708</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i066fdabb1d0848d5b0391931f87c3c0e_61"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 7.  <ix:nonNumeric contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RleHRyZWdpb246ZWQ1NzgzMjFhMWEzNDExM2I5NGU3Mzc4YmRjN2E2MTdfOTE5NA_efbc7573-5740-49e2-8476-e1a0b9c4970e" continuedAt="i0f1bd83da11a4df88225efffd421f7fd" escape="true">Stockholders&#8217; Equity</ix:nonNumeric></span></div><ix:continuation id="i0f1bd83da11a4df88225efffd421f7fd" continuedAt="ib96bf1a12cb44eaa822fb770cb7314f7"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Common and Preferred Stock</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, we had a total of <ix:nonFraction unitRef="shares" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="INF" name="ampx:SharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RleHRyZWdpb246ZWQ1NzgzMjFhMWEzNDExM2I5NGU3Mzc4YmRjN2E2MTdfNDk0NzgwMjM1Njc5NQ_7515e431-a911-49cc-a560-8dfe042a708b">1,000,000,000</ix:nonFraction> shares of stock authorized to be issued, of which <ix:nonFraction unitRef="shares" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="INF" name="us-gaap:CommonStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RleHRyZWdpb246ZWQ1NzgzMjFhMWEzNDExM2I5NGU3Mzc4YmRjN2E2MTdfNDk0NzgwMjM1Njc5OQ_57ff5758-82d0-4df5-b770-bf3dbf858e32">950,000,000</ix:nonFraction> shares are designated as common stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="INF" name="us-gaap:CommonStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RleHRyZWdpb246ZWQ1NzgzMjFhMWEzNDExM2I5NGU3Mzc4YmRjN2E2MTdfNDk0NzgwMjM1NjgwMw_c9f620b9-9df9-47ac-9b24-45eaf98b9bbe">0.0001</ix:nonFraction> par value per share, and <ix:nonFraction unitRef="shares" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="INF" name="us-gaap:PreferredStockSharesAuthorized" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RleHRyZWdpb246ZWQ1NzgzMjFhMWEzNDExM2I5NGU3Mzc4YmRjN2E2MTdfNDk0NzgwMjM1NjgwNw_9e33a615-81df-4c72-8021-271dd2b1f9e9">50,000,000</ix:nonFraction> shares are designated as preferred stock, $<ix:nonFraction unitRef="usdPerShare" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="INF" name="us-gaap:PreferredStockParOrStatedValuePerShare" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RleHRyZWdpb246ZWQ1NzgzMjFhMWEzNDExM2I5NGU3Mzc4YmRjN2E2MTdfNDk0NzgwMjM1NjgxMQ_1434549f-48fc-468c-8b7e-3cd318a7329a">0.0001</ix:nonFraction> par value per share. Holders of common stock are entitled to one vote for each share held and entitled to receive dividends when and if declared by the board of directors. Through and as of March&#160;31, 2023, we have not declared any dividends.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Equity Incentive Plans</span></div><div style="margin-top:10pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">We adopted the 2022 Equity Incentive Plan (&#8220;2022 Plan&#8221;) effective September 14, 2022. The 2022 Plan authorizes awards in the form of stock options, stock appreciation rights, restricted stock, restricted stock units, or performance awards and may be granted to directors, employees or consultants. </span></div><div style="margin-top:10pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">As of March&#160;31, 2023, the total number of shares reserved for issuance under the 2022 Plan was <ix:nonFraction unitRef="shares" contextRef="ic33e1539b78a40bda4ef216dea1bd960_I20230331" decimals="0" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RleHRyZWdpb246ZWQ1NzgzMjFhMWEzNDExM2I5NGU3Mzc4YmRjN2E2MTdfNTQ5NzU1ODU0Njg1_bdbb5ba2-10cf-4143-8c2e-8f74524faea7">13,915,807</ix:nonFraction>, which includes the increase in shares reserved pursuant to the evergreen provisions contained in the 2022 Plan and the assumed awards that were cancelled, expired or otherwise terminated without having been exercised in full, were tendered to or withheld for payment of an exercise price or for tax withholding obligations, or were forfeited to or repurchased due to failure to vest. The number of shares available for issuance under the 2022 Plan may be increased annually at the beginning of the fiscal year, subject to certain limitations.</span></div><div style="margin-top:10pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Amprius Technologies, Inc. 2016 Equity Incentive Plan (&#8220;2016 Plan&#8221;), which we maintained prior to the Business Combination, was terminated concurrently with the adoption of the 2022 Plan. However, the 2016 Plan continues to govern the terms and conditions of the outstanding awards previously granted under the 2016 Plan.</span></div><div style="margin-top:10pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The 2022 Plan and 2016 Plan are collectively referred to as the &#8220;Equity Incentive Plans.&#8221;</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_10">Table of Contents</a></span></div></div><ix:continuation id="ib96bf1a12cb44eaa822fb770cb7314f7" continuedAt="i8438000a90a543b59ecea973dd167b9a"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%">Stock Options</span></div><div style="margin-top:10pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options granted under the Equity Incentive Plans provided an exercise price not less than <ix:nonFraction unitRef="number" contextRef="if8307ba91dca43aa98a87dbc1eace892_D20230101-20230331" decimals="2" name="ampx:ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfFairValue" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RleHRyZWdpb246ZWQ1NzgzMjFhMWEzNDExM2I5NGU3Mzc4YmRjN2E2MTdfMzg0NA_490acde8-85b2-41b1-bdcb-b74a649c0e50">100</ix:nonFraction>% of the fair value at the grant date, unless the optionee is a <ix:nonFraction unitRef="number" contextRef="if8307ba91dca43aa98a87dbc1eace892_D20230101-20230331" decimals="2" name="ampx:StockholderPercentageOfOptioneeForOptionPrice" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RleHRyZWdpb246ZWQ1NzgzMjFhMWEzNDExM2I5NGU3Mzc4YmRjN2E2MTdfMzkwOQ_4b4b05f8-8617-4f56-8daf-09710f73fc02">10</ix:nonFraction>% stockholder, in which case the option price will not be less than <ix:nonFraction unitRef="number" contextRef="if8307ba91dca43aa98a87dbc1eace892_D20230101-20230331" decimals="2" name="ampx:ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfFairValueSignificantStockholder" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RleHRyZWdpb246ZWQ1NzgzMjFhMWEzNDExM2I5NGU3Mzc4YmRjN2E2MTdfMzk3OA_6f14d2d7-32c7-475d-925f-1be650c8836e">110</ix:nonFraction>% of such fair market value. Options granted generally have a maximum term of <ix:nonNumeric contextRef="if8307ba91dca43aa98a87dbc1eace892_D20230101-20230331" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RleHRyZWdpb246ZWQ1NzgzMjFhMWEzNDExM2I5NGU3Mzc4YmRjN2E2MTdfNDA1Nw_1c477f31-fcb9-4c9a-9a98-a81f73f88e4e">10</ix:nonNumeric> years from grant date or 90 days from the termination of the optionee, are exercisable upon vesting unless otherwise designated for early exercise by the Board of Directors at the time of grant, and generally vest over a period of <ix:nonNumeric contextRef="i998fc01b463d4ba5a09b1286fdb9c50a_D20230101-20230331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RleHRyZWdpb246ZWQ1NzgzMjFhMWEzNDExM2I5NGU3Mzc4YmRjN2E2MTdfNTQ5NzU1ODcwMzE1_98d1f1a1-7694-4cfc-8752-9b227eaa0bd5">four years</ix:nonNumeric>. </span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of March&#160;31, 2023, the total unrecognized stock-based compensation expense related to the unvested stock options was approximately $<ix:nonFraction unitRef="usd" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RleHRyZWdpb246ZWQ1NzgzMjFhMWEzNDExM2I5NGU3Mzc4YmRjN2E2MTdfNDk0NzgwMjM1MDM0MA_ca997b5b-fd8d-4e0c-a2ed-7959fbdbf588">7.7</ix:nonFraction> million, which we expect to recognize over a weighted-average period of <ix:nonNumeric contextRef="i50e98b1619b14d3aad7cc2e81158f8fd_D20230101-20230331" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RleHRyZWdpb246ZWQ1NzgzMjFhMWEzNDExM2I5NGU3Mzc4YmRjN2E2MTdfNjU5NzA2OTgyMzc5MA_53d2a581-1a18-4d85-8186-dc445d01a66b">2.9</ix:nonNumeric> years.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Restricted Stock Units (&#8220;RSU&#8221;)</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of RSUs is determined based upon the market closing price of our common stock on the date of grant. RSUs generally vest over a period of approximately <ix:nonNumeric contextRef="ibe21b3a289994d4a97c4c69f932acff6_D20230101-20230331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RleHRyZWdpb246ZWQ1NzgzMjFhMWEzNDExM2I5NGU3Mzc4YmRjN2E2MTdfNTQ5NzU1ODcwMzIw_5e8e7c91-b900-4835-a760-4cf98d2e342e">four years</ix:nonNumeric> from the date of grant, subject to the continued employment or services of the grantee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, the total unrecognized stock-based compensation expense related to the unvested RSUs was approximately $<ix:nonFraction unitRef="usd" contextRef="i3aff53d2317b441595d7b67e66f87d6d_I20230331" decimals="-5" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RleHRyZWdpb246ZWQ1NzgzMjFhMWEzNDExM2I5NGU3Mzc4YmRjN2E2MTdfNDk0NzgwMjM0MTUzMg_b4a57369-1b51-4b55-b894-929cbebd2f81">2.4</ix:nonFraction>&#160;million, which we expect to recognize over a weighted-average period of <ix:nonNumeric contextRef="ibe21b3a289994d4a97c4c69f932acff6_D20230101-20230331" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RleHRyZWdpb246ZWQ1NzgzMjFhMWEzNDExM2I5NGU3Mzc4YmRjN2E2MTdfNjU5NzA2OTgyMzc5OA_37fb704e-8b58-414f-8e76-882d5631731d">3.8</ix:nonNumeric> years.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Amprius Holdings 2008 Stock Plan</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The stock-based compensation costs associated with grants to certain individuals who provided services to our company under the Amprius Holdings 2008 Stock Plan were included in the accompanying condensed consolidated statements of operations, with a corresponding increase in additional paid-in capital. The remaining unrecognized compensation cost as of March&#160;31, 2023 was not material.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:107%">Employee Stock Purchase Plan (&#8220;ESPP&#8221;)</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">We adopted the 2022 Employee Stock Purchase Plan (&#8220;ESPP&#8221;) effective September&#160;14, 2022. As of March&#160;31, 2023, the total number of shares reserved for issuance was <ix:nonFraction unitRef="shares" contextRef="i296bde8d08c2448f98f54612571ba0c2_I20230331" decimals="0" name="ampx:ShareBasedCompensationArrangementByShareBasedPaymentAwardReservedForIssuance" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RleHRyZWdpb246ZWQ1NzgzMjFhMWEzNDExM2I5NGU3Mzc4YmRjN2E2MTdfNTQ5NzU1ODU0MTUz_b54034e5-d81f-49e8-99e4-eca7790f27ac">1,836,101</ix:nonFraction>, which may be increased annually at the beginning of the fiscal year subject to certain limitations. The ESPP is intended to qualify under Section 423 of the Internal Revenue Code of 1986 (as amended) and will provide eligible employees an opportunity to purchase our common stock at a discount through payroll deductions. We have not established an offering under the ESPP as of March&#160;31, 2023.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">  </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:107%">Executive Incentive Compensation Plan</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">On September&#160;14, 2022, our board of directors approved our Executive Incentive Compensation Plan, which will allow us to grant incentive awards to certain executive employees, generally payable in cash, based upon achieving specified goals. We have the right to settle the award by granting an equity award, which may be subject to vesting conditions. All awards under the Executive Incentive Compensation Plan will be subject to reduction, cancellation, forfeiture, or recoupment in accordance with any clawback policy that we are required to adopt pursuant to applicable laws. As of March&#160;31, 2023, there were <ix:nonFraction unitRef="shares" contextRef="i88342beb5da647d28102477fd33b6c49_D20230101-20230331" decimals="0" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RleHRyZWdpb246ZWQ1NzgzMjFhMWEzNDExM2I5NGU3Mzc4YmRjN2E2MTdfNTQ5NzU1ODcwMzI5_50fad636-50c7-4a41-8dd3-377f8a13f03e">no</ix:nonFraction> awards granted under the Executive Incentive Compensation Plan. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Common Stock Warrants</span></div><ix:nonNumeric contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" name="us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RleHRyZWdpb246ZWQ1NzgzMjFhMWEzNDExM2I5NGU3Mzc4YmRjN2E2MTdfMTY0OTI2NzQ3NTMwOQ_9200fd7b-3a7d-4443-95a4-6094e4d5fbb4" escape="true"><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding stock warrants consisted of the following as of March&#160;31, 2023:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.787%"><tr><td style="width:1.0%"></td><td style="width:45.588%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.185%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:11.824%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:22.003%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of <br/>Warrants</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exercise Price <br/>Per Share</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Expiration Date</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Public warrants</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1083d46db3cb4333bd42aa18cd72741b_I20230331" decimals="0" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RhYmxlOmI3OWJiN2M2ZTNjMDQwMTM4MDlmYzJmN2Q1Zjk3YzBmL3RhYmxlcmFuZ2U6Yjc5YmI3YzZlM2MwNDAxMzgwOWZjMmY3ZDVmOTdjMGZfMS0xLTEtMS02NDk5Nw_90fede9a-0aed-4640-90a2-4c5a6856f5a0">29,268,336</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i1083d46db3cb4333bd42aa18cd72741b_I20230331" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RhYmxlOmI3OWJiN2M2ZTNjMDQwMTM4MDlmYzJmN2Q1Zjk3YzBmL3RhYmxlcmFuZ2U6Yjc5YmI3YzZlM2MwNDAxMzgwOWZjMmY3ZDVmOTdjMGZfMS0zLTEtMS02NDk5Nw_727b7ca3-c868-45d2-9112-8c4878e70be3">11.50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 14, 2027</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i89b26f35c8c743ec898b2e7cbd65d2da_I20230331" decimals="0" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RhYmxlOmI3OWJiN2M2ZTNjMDQwMTM4MDlmYzJmN2Q1Zjk3YzBmL3RhYmxlcmFuZ2U6Yjc5YmI3YzZlM2MwNDAxMzgwOWZjMmY3ZDVmOTdjMGZfMi0xLTEtMS02NDk5Nw_d6f602f8-4c48-46cf-b644-52711e22ad1d">16,400,000</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i89b26f35c8c743ec898b2e7cbd65d2da_I20230331" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RhYmxlOmI3OWJiN2M2ZTNjMDQwMTM4MDlmYzJmN2Q1Zjk3YzBmL3RhYmxlcmFuZ2U6Yjc5YmI3YzZlM2MwNDAxMzgwOWZjMmY3ZDVmOTdjMGZfMi0zLTEtMS02NDk5Nw_b468b348-3c45-45af-96d7-9e403b11fed8">11.50</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 14, 2027</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PIPE warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia369e97ca86a4015bacdfaf2d5b614d2_I20230331" decimals="0" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RhYmxlOmI3OWJiN2M2ZTNjMDQwMTM4MDlmYzJmN2Q1Zjk3YzBmL3RhYmxlcmFuZ2U6Yjc5YmI3YzZlM2MwNDAxMzgwOWZjMmY3ZDVmOTdjMGZfMy0xLTEtMS02NDk5Nw_02a0b328-8013-4073-824a-c199ced73f92">2,052,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ia369e97ca86a4015bacdfaf2d5b614d2_I20230331" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RhYmxlOmI3OWJiN2M2ZTNjMDQwMTM4MDlmYzJmN2Q1Zjk3YzBmL3RhYmxlcmFuZ2U6Yjc5YmI3YzZlM2MwNDAxMzgwOWZjMmY3ZDVmOTdjMGZfMy0zLTEtMS02NDk5Nw_d7ffbc1f-2105-4b28-8be8-25883f0b4e24">12.50</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 14, 2027</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total warrants</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="0" name="us-gaap:ClassOfWarrantOrRightOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RhYmxlOmI3OWJiN2M2ZTNjMDQwMTM4MDlmYzJmN2Q1Zjk3YzBmL3RhYmxlcmFuZ2U6Yjc5YmI3YzZlM2MwNDAxMzgwOWZjMmY3ZDVmOTdjMGZfNC0xLTEtMS02NDk5Nw_c7436c5d-c3e4-4c05-a0aa-275c5ee48948">47,720,836</ix:nonFraction></span></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div></ix:nonNumeric><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the public warrants and private warrants are entitled to purchase one share our common stock at a price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i65f6ecb200ca4a2ea079f7914b85be3e_I20220301" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RleHRyZWdpb246ZWQ1NzgzMjFhMWEzNDExM2I5NGU3Mzc4YmRjN2E2MTdfNTQ5NzU1ODcwMzM1_54148bab-abe2-44e8-a9c7-1fbfbf3b612a">11.50</ix:nonFraction> per share subject to adjustment pursuant to the Warrant Agreement, dated as of March 1, 2022. The public warrants are listed on the NYSE and are redeemable by us when the price per share of our common stock equals or </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">exceeds $<ix:nonFraction unitRef="usdPerShare" contextRef="i8b54249c302d4bbd84bcc1b8b3beb2fc_D20220914-20220914" decimals="2" name="ampx:SaleOfStockAveragePricePerShareRedemption" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RleHRyZWdpb246ZWQ1NzgzMjFhMWEzNDExM2I5NGU3Mzc4YmRjN2E2MTdfNTQ5NzU1ODcwMzM5_e183117c-fa23-4a00-a1b9-b76ffefcb41c">18.00</ix:nonFraction> </span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_10">Table of Contents</a></span></div></div><ix:continuation id="i8438000a90a543b59ecea973dd167b9a"><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">per share for at least <ix:nonFraction unitRef="day" contextRef="i8b54249c302d4bbd84bcc1b8b3beb2fc_D20220914-20220914" decimals="INF" name="ampx:WarrantsRedemptionThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RleHRyZWdpb246ZWQ1NzgzMjFhMWEzNDExM2I5NGU3Mzc4YmRjN2E2MTdfNTQ5NzU1ODcwMzQ3_d13ee84a-49cf-4afb-8632-d30b08e58615">20</ix:nonFraction> trading days during a period of <ix:nonFraction unitRef="day" contextRef="i8b54249c302d4bbd84bcc1b8b3beb2fc_D20220914-20220914" decimals="INF" name="ampx:WarrantsRedemptionThresholdConsecutiveTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RleHRyZWdpb246ZWQ1NzgzMjFhMWEzNDExM2I5NGU3Mzc4YmRjN2E2MTdfNTQ5NzU1ODcwMzUx_20e561f8-d83e-421c-8a83-cd998c3f4fe3">30</ix:nonFraction> consecutive trading days prior to the redemption date. The private warrants are not listed on any securities exchange and not redeemable.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The warrants issued as part of units in a private placement in connection with the Business Combination (the &#8220;PIPE warrants&#8221;) are substantially identical to the public warrants, except that the exercise price of each PIPE warrant is $<ix:nonFraction unitRef="usdPerShare" contextRef="ia369e97ca86a4015bacdfaf2d5b614d2_I20230331" decimals="2" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RleHRyZWdpb246ZWQ1NzgzMjFhMWEzNDExM2I5NGU3Mzc4YmRjN2E2MTdfNDk0NzgwMjM1MzI4MA_8fecc9bd-eda0-43fd-b6a7-69c891f6cbac">12.50</ix:nonFraction> per share. In addition, we may only be able to redeem the PIPE warrants if the price per share of our common stock equals or exceeds $<ix:nonFraction unitRef="usdPerShare" contextRef="i31467a3e9fbe4b59983ccf8194ea8070_D20220914-20220914" decimals="2" name="ampx:SaleOfStockAveragePricePerShareRedemption" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RleHRyZWdpb246ZWQ1NzgzMjFhMWEzNDExM2I5NGU3Mzc4YmRjN2E2MTdfNDk0NzgwMjM1MzQzNg_ea0c7392-b203-485f-8e86-ed87ed1190f7">20.00</ix:nonFraction> per share for at least <ix:nonFraction unitRef="day" contextRef="i31467a3e9fbe4b59983ccf8194ea8070_D20220914-20220914" decimals="INF" name="ampx:WarrantsRedemptionThresholdTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RleHRyZWdpb246ZWQ1NzgzMjFhMWEzNDExM2I5NGU3Mzc4YmRjN2E2MTdfNTQ5NzU1ODcwMzU1_435c0d39-ca4c-4b21-86b6-9ca1369c85ef">20</ix:nonFraction> trading days during a period of <ix:nonFraction unitRef="day" contextRef="i31467a3e9fbe4b59983ccf8194ea8070_D20220914-20220914" decimals="INF" name="ampx:WarrantsRedemptionThresholdConsecutiveTradingDays" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RleHRyZWdpb246ZWQ1NzgzMjFhMWEzNDExM2I5NGU3Mzc4YmRjN2E2MTdfNTQ5NzU1ODcwMzU5_c6622ec9-a7f4-4f1a-b441-82fb27135905">30</ix:nonFraction> consecutive trading days prior to the redemption date. The PIPE warrants are also not listed on any securities exchange.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The warrants described above are classified as equity in accordance with the guidance under ASC 815-40, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging&#8211;Contracts in Entity&#8217;s Own Equity</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Equity-classified contracts, such as stock warrants, are initially measured at fair value or allocated value. Any subsequent changes in fair value are not recognized as long as the contracts continue to be classified in equity. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Purchase Agreement</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September&#160;27, 2022, we entered into the Purchase Agreement with BRPC II, pursuant to which we, at our option, have the right to sell to BRPC II up to $<ix:nonFraction unitRef="usd" contextRef="i421fa02da0234be3b23eab9845b639a4_D20220927-20220927" decimals="INF" name="ampx:SaleOfStockPotentialMaximumConsiderationReceivedOnTransaction" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RleHRyZWdpb246ZWQ1NzgzMjFhMWEzNDExM2I5NGU3Mzc4YmRjN2E2MTdfNzg4Mw_107eeb18-2879-4d1f-930a-ab0446e1ea9c">200.0</ix:nonFraction> million of our common stock until January 1, 2025, subject to certain contractual terms. The purchase price will be determined by reference to the volume weighted average price of our common stock (as defined in the Purchase Agreement), less a discount of <ix:nonFraction unitRef="number" contextRef="i6f0bf828381846a8b705dd517c0690c7_I20220927" decimals="2" name="ampx:SaleOfStockDiscount" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RleHRyZWdpb246ZWQ1NzgzMjFhMWEzNDExM2I5NGU3Mzc4YmRjN2E2MTdfODI1Mg_20b8dd82-04f6-4ff5-ade7-77b928b0c8ad">3</ix:nonFraction>%. We cannot issue to BRPC II more than <ix:nonFraction unitRef="number" contextRef="i421fa02da0234be3b23eab9845b639a4_D20220927-20220927" decimals="4" name="ampx:SaleOfStockMaximumSharesAvailableForSalePercentageOfSharesIssuedAndOutstandingPriorToTransaction" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RleHRyZWdpb246ZWQ1NzgzMjFhMWEzNDExM2I5NGU3Mzc4YmRjN2E2MTdfODMwMg_66c45f49-fc49-4c0e-b35a-7a690c13bfc4">19.99</ix:nonFraction>% of the aggregate number of shares of the common stock issued and outstanding immediately prior to the execution of the Purchase Agreement, except in limited circumstances. Proceeds from the sale of our common stock to BRPC II will depend upon the frequency and the market price of our common stock on the date of sale.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2023, we issued a total of <ix:nonFraction unitRef="shares" contextRef="i09c21ae7eb0c4550b4f44db99a8f9cfa_D20230101-20230331" decimals="0" name="us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RleHRyZWdpb246ZWQ1NzgzMjFhMWEzNDExM2I5NGU3Mzc4YmRjN2E2MTdfNTQ5NzU1ODU2NTQ3_ad46a244-c673-44a0-a21c-da8662785658">331,351</ix:nonFraction> shares of common stock to BRPC II with proceeds totaling $<ix:nonFraction unitRef="usd" contextRef="i09c21ae7eb0c4550b4f44db99a8f9cfa_D20230101-20230331" decimals="-5" name="us-gaap:ProceedsFromIssuanceOfCommonStock" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RleHRyZWdpb246ZWQ1NzgzMjFhMWEzNDExM2I5NGU3Mzc4YmRjN2E2MTdfNTQ5NzU1ODU2NjEw_48d52cce-2a71-4696-8fe7-c6327566ea9a">2.4</ix:nonFraction>&#160;million. The deferred stock issuance cost, which is included in other assets in the accompanying condensed consolidated balance sheets and will be charged proportionally against the proceeds from future issuance of shares to BRPC II under the Purchase Agreement, was $<ix:nonFraction unitRef="usd" contextRef="i6240ae66e6554cf88516b271e123fbbe_I20230331" decimals="-5" name="ampx:DeferredStockIssuanceCosts" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RleHRyZWdpb246ZWQ1NzgzMjFhMWEzNDExM2I5NGU3Mzc4YmRjN2E2MTdfNDk0NzgwMjM2MDA3OA_c5aad065-e9f9-4479-bb19-27b4c8aa7c2d">0.6</ix:nonFraction>&#160;million as of March&#160;31, 2023.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:107%">Stock-Based Compensation </span></div><ix:nonNumeric contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" name="us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RleHRyZWdpb246ZWQ1NzgzMjFhMWEzNDExM2I5NGU3Mzc4YmRjN2E2MTdfMTY0OTI2NzQ3NTMwOA_3b118cc0-0604-4b64-9e11-1f3dc016dc29" escape="true"><div style="margin-top:10pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation from stock options and RSUs under the Equity Incentive Plans and from stock options under the Amprius Holdings 2008 Stock Plan that we recorded were included in the following lines in the accompanying condensed consolidated statements of operations during the periods presented (in thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div><span><br/></span></div><div style="text-indent:25.2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.636%"><tr><td style="width:1.0%"></td><td style="width:70.097%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.977%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.447%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.979%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#ccecff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td style="background-color:#ccecff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ccecff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7b9b12b7e31d4c76a8d6a376c2b7d713_D20230101-20230331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RhYmxlOjI4NTBlODJlZmNhNDRmZTI4MzViZWQxM2VlNjY4NmExL3RhYmxlcmFuZ2U6Mjg1MGU4MmVmY2E0NGZlMjgzNWJlZDEzZWU2Njg2YTFfMi0xLTEtMS02NDE2Mw_771ddc37-3680-4163-a5c5-e0e3e1042e5c">169</ix:nonFraction>&#160;</span></td><td style="background-color:#ccecff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccecff;padding:0 1pt"></td><td style="background-color:#ccecff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ccecff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ide8e49695f9d47238f505b8412513868_D20220101-20220331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RhYmxlOjI4NTBlODJlZmNhNDRmZTI4MzViZWQxM2VlNjY4NmExL3RhYmxlcmFuZ2U6Mjg1MGU4MmVmY2E0NGZlMjgzNWJlZDEzZWU2Njg2YTFfMi0zLTEtMS02NDE2Mw_3997473c-542a-4e55-ab79-5e5d6464c1d9">113</ix:nonFraction>&#160;</span></td><td style="background-color:#ccecff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1d86f0bf8ca54c31a23e7d6b7920910e_D20230101-20230331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RhYmxlOjI4NTBlODJlZmNhNDRmZTI4MzViZWQxM2VlNjY4NmExL3RhYmxlcmFuZ2U6Mjg1MGU4MmVmY2E0NGZlMjgzNWJlZDEzZWU2Njg2YTFfMy0xLTEtMS02NDE2Mw_a796f687-0e82-4edf-8d47-88b45486b63f">20</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i755fa2560d3b49c389b0764776734331_D20220101-20220331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RhYmxlOjI4NTBlODJlZmNhNDRmZTI4MzViZWQxM2VlNjY4NmExL3RhYmxlcmFuZ2U6Mjg1MGU4MmVmY2E0NGZlMjgzNWJlZDEzZWU2Njg2YTFfMy0zLTEtMS02NDE2Mw_80520dab-5f6d-4421-b2ca-197de5cdf5d5">6</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ccecff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#ccecff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i118c22344d0e445ab1d3ec905d1a450d_D20230101-20230331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RhYmxlOjI4NTBlODJlZmNhNDRmZTI4MzViZWQxM2VlNjY4NmExL3RhYmxlcmFuZ2U6Mjg1MGU4MmVmY2E0NGZlMjgzNWJlZDEzZWU2Njg2YTFfNC0xLTEtMS02NDE2Mw_77a5c09b-842d-4804-a629-b751c4ad14ba">537</ix:nonFraction>&#160;</span></td><td style="background-color:#ccecff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ccecff;padding:0 1pt"></td><td colspan="2" style="background-color:#ccecff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95e94b4180df453fa35e812c22acf32d_D20220101-20220331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RhYmxlOjI4NTBlODJlZmNhNDRmZTI4MzViZWQxM2VlNjY4NmExL3RhYmxlcmFuZ2U6Mjg1MGU4MmVmY2E0NGZlMjgzNWJlZDEzZWU2Njg2YTFfNC0zLTEtMS02NDE2Mw_ea8801cb-0851-4c28-ac41-106867cc1cec">337</ix:nonFraction>&#160;</span></td><td style="background-color:#ccecff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RhYmxlOjI4NTBlODJlZmNhNDRmZTI4MzViZWQxM2VlNjY4NmExL3RhYmxlcmFuZ2U6Mjg1MGU4MmVmY2E0NGZlMjgzNWJlZDEzZWU2Njg2YTFfNS0xLTEtMS02NDE2Mw_01048bb9-3245-41ac-a6e9-a7fba29b2df2">726</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RhYmxlOjI4NTBlODJlZmNhNDRmZTI4MzViZWQxM2VlNjY4NmExL3RhYmxlcmFuZ2U6Mjg1MGU4MmVmY2E0NGZlMjgzNWJlZDEzZWU2Njg2YTFfNS0zLTEtMS02NDE2Mw_f698b35d-1897-4436-87a9-4901c2e42b0d">456</ix:nonFraction>&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i066fdabb1d0848d5b0391931f87c3c0e_64"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 8.  <ix:nonNumeric contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" name="us-gaap:IncomeTaxDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82NC9mcmFnOjg2NDA2ZTdhMjhmODQzNWVhMjQ2YTA2MTdlMTY4YjVjL3RleHRyZWdpb246ODY0MDZlN2EyOGY4NDM1ZWEyNDZhMDYxN2UxNjhiNWNfMjg2_ac6dbc04-f2b1-4a2e-85e3-e336db9332a8" continuedAt="idd5c4f86c711434986562d9fdd2de1d1" escape="true">Income Taxes</ix:nonNumeric></span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="idd5c4f86c711434986562d9fdd2de1d1">We have <ix:nonFraction unitRef="usd" contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" decimals="0" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82NC9mcmFnOjg2NDA2ZTdhMjhmODQzNWVhMjQ2YTA2MTdlMTY4YjVjL3RleHRyZWdpb246ODY0MDZlN2EyOGY4NDM1ZWEyNDZhMDYxN2UxNjhiNWNfNDM_626000ec-9d7e-4fc2-9344-d4422a6b9542"><ix:nonFraction unitRef="usd" contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" decimals="0" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82NC9mcmFnOjg2NDA2ZTdhMjhmODQzNWVhMjQ2YTA2MTdlMTY4YjVjL3RleHRyZWdpb246ODY0MDZlN2EyOGY4NDM1ZWEyNDZhMDYxN2UxNjhiNWNfNDM_93ea5984-6394-4d7b-8b49-add2df90d921"><ix:nonFraction unitRef="usd" contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" decimals="0" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82NC9mcmFnOjg2NDA2ZTdhMjhmODQzNWVhMjQ2YTA2MTdlMTY4YjVjL3RleHRyZWdpb246ODY0MDZlN2EyOGY4NDM1ZWEyNDZhMDYxN2UxNjhiNWNfNDM_9bdd9251-3659-43b4-9a73-3e5b33a8ccfb"><ix:nonFraction unitRef="usd" contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" decimals="0" name="us-gaap:IncomeTaxExpenseBenefit" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82NC9mcmFnOjg2NDA2ZTdhMjhmODQzNWVhMjQ2YTA2MTdlMTY4YjVjL3RleHRyZWdpb246ODY0MDZlN2EyOGY4NDM1ZWEyNDZhMDYxN2UxNjhiNWNfNDM_a1fac311-4641-48fa-9397-24a4330fb3ff">no</ix:nonFraction></ix:nonFraction></ix:nonFraction></ix:nonFraction> income tax expense as a result of the continued generation of net operating losses (&#8220;NOLs&#8221;)&#160;offset by a full valuation allowance recorded on such NOLs, as we determined it is not more-likely-than-not&#160;that our NOLs will be utilized.</ix:continuation> </span></div><div id="i066fdabb1d0848d5b0391931f87c3c0e_70"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 9.  <ix:nonNumeric contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV83MC9mcmFnOjdhZDljNTRlMGNhODQ4ZGViNjk0MmZmZjhkNWExNjQ2L3RleHRyZWdpb246N2FkOWM1NGUwY2E4NDhkZWI2OTQyZmZmOGQ1YTE2NDZfMTI5Ng_1abcc2da-8fae-423e-af14-6c5c6a6128e6" continuedAt="ic98dc48b144a4139b5c8a0ff064dc686" escape="true">Leases</ix:nonNumeric></span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="ic98dc48b144a4139b5c8a0ff064dc686" continuedAt="i5cf16b5091e4477999c8d8ffab8f3958">We have a non-cancelable operating lease for our corporate headquarters and facilities in Fremont, California. On January&#160;4, 2023, we entered into an amendment of such lease, which includes the lease of additional space in the same building and extending the lease term to end on June&#160;30, 2027, with an option to extend for an additional&#160;<ix:nonNumeric contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" name="us-gaap:LesseeOperatingLeaseRenewalTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV83MC9mcmFnOjdhZDljNTRlMGNhODQ4ZGViNjk0MmZmZjhkNWExNjQ2L3RleHRyZWdpb246N2FkOWM1NGUwY2E4NDhkZWI2OTQyZmZmOGQ1YTE2NDZfMTA5OTUxMTY0NjkxMw_42a4532e-a83f-48a8-ac7b-0133407dac93">five-year</ix:nonNumeric> term.  Our operating lease does not contain any material residual value guarantees. We had <ix:nonFraction unitRef="lease" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="0" name="ampx:LesseeFinanceLeaseNumberOfLeases" format="ixt:fixed-zero" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV83MC9mcmFnOjdhZDljNTRlMGNhODQ4ZGViNjk0MmZmZjhkNWExNjQ2L3RleHRyZWdpb246N2FkOWM1NGUwY2E4NDhkZWI2OTQyZmZmOGQ1YTE2NDZfNTQ5NzU1ODI2MjMx_e6a27ae9-05b7-40fe-ac49-d42cde6af41b">no</ix:nonFraction> leases that were classified as a financing lease as of March&#160;31, 2023.  </ix:continuation></span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="background-color:#ffffff"><div style="min-height:45pt;width:100%"><div style="margin-top:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_10">Table of Contents</a></span></div></div><ix:continuation id="i5cf16b5091e4477999c8d8ffab8f3958"><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, the weighted-average remaining term of the operating lease was <ix:nonNumeric contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" format="ixt-sec:duryear" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV83MC9mcmFnOjdhZDljNTRlMGNhODQ4ZGViNjk0MmZmZjhkNWExNjQ2L3RleHRyZWdpb246N2FkOWM1NGUwY2E4NDhkZWI2OTQyZmZmOGQ1YTE2NDZfNTQ5NzU1ODE2MjAz_79f2d899-b2e8-433a-a76b-aca6915e4a42">9.3</ix:nonNumeric> years and the weighted-average discount rate used to estimate the net present value of the operating lease liabilities was <ix:nonFraction unitRef="number" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV83MC9mcmFnOjdhZDljNTRlMGNhODQ4ZGViNjk0MmZmZjhkNWExNjQ2L3RleHRyZWdpb246N2FkOWM1NGUwY2E4NDhkZWI2OTQyZmZmOGQ1YTE2NDZfNTQ5NzU1ODE2MjEw_9864b5f9-a64e-41e8-868a-57c45c08c45e">7.9</ix:nonFraction>%.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2023, the total amount of right-of-use assets obtained in exchange for new operating lease liabilities was $<ix:nonFraction unitRef="usd" contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" decimals="-5" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV83MC9mcmFnOjdhZDljNTRlMGNhODQ4ZGViNjk0MmZmZjhkNWExNjQ2L3RleHRyZWdpb246N2FkOWM1NGUwY2E4NDhkZWI2OTQyZmZmOGQ1YTE2NDZfODc5NjA5MzAzNTc2MQ_281785e1-f821-412f-a488-a265b53355fc">5.2</ix:nonFraction> million. The total amount paid for amounts included in the measurement of operating lease liabilities was $<ix:nonFraction unitRef="usd" contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV83MC9mcmFnOjdhZDljNTRlMGNhODQ4ZGViNjk0MmZmZjhkNWExNjQ2L3RleHRyZWdpb246N2FkOWM1NGUwY2E4NDhkZWI2OTQyZmZmOGQ1YTE2NDZfNTQ5NzU1ODIwMjg2_aff76456-569f-4b96-a9d9-c17f75a3aa35">179</ix:nonFraction> thousand and $<ix:nonFraction unitRef="usd" contextRef="ie8eddb8a90d3462cb31d18d8295be70a_D20230101-20230331" decimals="-3" name="us-gaap:OperatingLeasePayments" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV83MC9mcmFnOjdhZDljNTRlMGNhODQ4ZGViNjk0MmZmZjhkNWExNjQ2L3RleHRyZWdpb246N2FkOWM1NGUwY2E4NDhkZWI2OTQyZmZmOGQ1YTE2NDZfNjU5NzA2OTc4MzgxMQ_9b9f79d1-9cba-4302-86f0-06d746277e01">86</ix:nonFraction> thousand during the three months ended March&#160;31, 2023 and 2022, respectively.  </span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease expense was $<ix:nonFraction unitRef="usd" contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV83MC9mcmFnOjdhZDljNTRlMGNhODQ4ZGViNjk0MmZmZjhkNWExNjQ2L3RleHRyZWdpb246N2FkOWM1NGUwY2E4NDhkZWI2OTQyZmZmOGQ1YTE2NDZfNTQ5NzU1ODIwMzM3_83e35fc3-f8ca-492d-abb4-0f50c08cf7b7">202</ix:nonFraction> thousand and $<ix:nonFraction unitRef="usd" contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331" decimals="-3" name="us-gaap:OperatingLeaseCost" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV83MC9mcmFnOjdhZDljNTRlMGNhODQ4ZGViNjk0MmZmZjhkNWExNjQ2L3RleHRyZWdpb246N2FkOWM1NGUwY2E4NDhkZWI2OTQyZmZmOGQ1YTE2NDZfNjU5NzA2OTc4Mzc4MQ_42e9765e-ede8-4b67-b71d-24745fd1f038">140</ix:nonFraction> thousand during the three months ended March&#160;31, 2023 and 2022, respectively. Variable lease expense was not material.</span></div><ix:nonNumeric contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV83MC9mcmFnOjdhZDljNTRlMGNhODQ4ZGViNjk0MmZmZjhkNWExNjQ2L3RleHRyZWdpb246N2FkOWM1NGUwY2E4NDhkZWI2OTQyZmZmOGQ1YTE2NDZfMTI5Nw_f5a7ca60-188a-4fdf-9475-493ff6a3b952" escape="true"><div style="margin-top:9pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future operating lease payments as of March&#160;31, 2023 were as follows (in thousands): </span></div><div style="margin-top:10pt;text-indent:25.2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.272%"><tr><td style="width:1.0%"></td><td style="width:84.614%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.186%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ending December 31:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV83MC9mcmFnOjdhZDljNTRlMGNhODQ4ZGViNjk0MmZmZjhkNWExNjQ2L3RhYmxlOjJlYjNjNjYxMjkxMDRmYjY4MjMzMTcwMGRkYWQyNTRmL3RhYmxlcmFuZ2U6MmViM2M2NjEyOTEwNGZiNjgyMzMxNzAwZGRhZDI1NGZfMS0xLTEtMS02MTk5MA_b19321fc-ad8c-4a4c-9fb9-f1cabd5dd3f8">822</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV83MC9mcmFnOjdhZDljNTRlMGNhODQ4ZGViNjk0MmZmZjhkNWExNjQ2L3RhYmxlOjJlYjNjNjYxMjkxMDRmYjY4MjMzMTcwMGRkYWQyNTRmL3RhYmxlcmFuZ2U6MmViM2M2NjEyOTEwNGZiNjgyMzMxNzAwZGRhZDI1NGZfMi0xLTEtMS02MTk5MA_c02b7476-57d7-4514-b1a1-2b62a29ad4a7">1,126</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV83MC9mcmFnOjdhZDljNTRlMGNhODQ4ZGViNjk0MmZmZjhkNWExNjQ2L3RhYmxlOjJlYjNjNjYxMjkxMDRmYjY4MjMzMTcwMGRkYWQyNTRmL3RhYmxlcmFuZ2U6MmViM2M2NjEyOTEwNGZiNjgyMzMxNzAwZGRhZDI1NGZfMy0xLTEtMS02MTk5MA_7391f8ff-5bed-42e6-bd46-c000baef1f85">1,158</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV83MC9mcmFnOjdhZDljNTRlMGNhODQ4ZGViNjk0MmZmZjhkNWExNjQ2L3RhYmxlOjJlYjNjNjYxMjkxMDRmYjY4MjMzMTcwMGRkYWQyNTRmL3RhYmxlcmFuZ2U6MmViM2M2NjEyOTEwNGZiNjgyMzMxNzAwZGRhZDI1NGZfNC0xLTEtMS02MTk5MA_7a317108-0d9d-488f-bd0b-7a9240a13954">1,193</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV83MC9mcmFnOjdhZDljNTRlMGNhODQ4ZGViNjk0MmZmZjhkNWExNjQ2L3RhYmxlOjJlYjNjNjYxMjkxMDRmYjY4MjMzMTcwMGRkYWQyNTRmL3RhYmxlcmFuZ2U6MmViM2M2NjEyOTEwNGZiNjgyMzMxNzAwZGRhZDI1NGZfNS0xLTEtMS02MTk5MA_65d1c3b3-aedc-46b4-bc48-ee182bfe0856">1,241</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV83MC9mcmFnOjdhZDljNTRlMGNhODQ4ZGViNjk0MmZmZjhkNWExNjQ2L3RhYmxlOjJlYjNjNjYxMjkxMDRmYjY4MjMzMTcwMGRkYWQyNTRmL3RhYmxlcmFuZ2U6MmViM2M2NjEyOTEwNGZiNjgyMzMxNzAwZGRhZDI1NGZfNi0xLTEtMS02MTk5MA_32eea2bf-1f4c-464f-b5b8-e9cc8329e6c7">1,278</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV83MC9mcmFnOjdhZDljNTRlMGNhODQ4ZGViNjk0MmZmZjhkNWExNjQ2L3RhYmxlOjJlYjNjNjYxMjkxMDRmYjY4MjMzMTcwMGRkYWQyNTRmL3RhYmxlcmFuZ2U6MmViM2M2NjEyOTEwNGZiNjgyMzMxNzAwZGRhZDI1NGZfNy0xLTEtMS02MTk5MA_750ef889-79fd-4f1f-9ab7-379e225c371c">4,729</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross lease payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV83MC9mcmFnOjdhZDljNTRlMGNhODQ4ZGViNjk0MmZmZjhkNWExNjQ2L3RhYmxlOjJlYjNjNjYxMjkxMDRmYjY4MjMzMTcwMGRkYWQyNTRmL3RhYmxlcmFuZ2U6MmViM2M2NjEyOTEwNGZiNjgyMzMxNzAwZGRhZDI1NGZfOC0xLTEtMS02MTk5MA_87c7b6da-297f-4739-a068-deab6a6484f6">11,547</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less - present value adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV83MC9mcmFnOjdhZDljNTRlMGNhODQ4ZGViNjk0MmZmZjhkNWExNjQ2L3RhYmxlOjJlYjNjNjYxMjkxMDRmYjY4MjMzMTcwMGRkYWQyNTRmL3RhYmxlcmFuZ2U6MmViM2M2NjEyOTEwNGZiNjgyMzMxNzAwZGRhZDI1NGZfOS0xLTEtMS02MTk5MA_bdea0c04-0d25-4570-a336-7baa2c24570d">3,359</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6023c648ad62464a83503c70b103bde2_I20230331" decimals="-3" name="us-gaap:OperatingLeaseLiability" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV83MC9mcmFnOjdhZDljNTRlMGNhODQ4ZGViNjk0MmZmZjhkNWExNjQ2L3RhYmxlOjJlYjNjNjYxMjkxMDRmYjY4MjMzMTcwMGRkYWQyNTRmL3RhYmxlcmFuZ2U6MmViM2M2NjEyOTEwNGZiNjgyMzMxNzAwZGRhZDI1NGZfMTAtMS0xLTEtNjE5OTA_a52560fe-045c-4113-9468-8f769c5e02d6">8,188</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i066fdabb1d0848d5b0391931f87c3c0e_73"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 10.  <ix:nonNumeric contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV83My9mcmFnOmRmNWY2OTJlYjIxYzQ5MDdiMDBhMjIwYjQyNWJjMDVjL3RleHRyZWdpb246ZGY1ZjY5MmViMjFjNDkwN2IwMGEyMjBiNDI1YmMwNWNfNTMy_ca3895f0-0674-48be-9668-b97b5be01cfa" continuedAt="i64a8ed0f0fb142be8c0cf29c22effc45" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i64a8ed0f0fb142be8c0cf29c22effc45">From time to time, we may be involved in lawsuits, claims or legal proceedings that arise in the ordinary course of business. We accrue a contingent liability when it is probable that a liability has been incurred and the amount of loss can be reasonably estimated. Management believes that there are no claims against us for which the outcome is expected to have a material effect on our financial position, results of operations or cash flows .</ix:continuation></span></div><div id="i066fdabb1d0848d5b0391931f87c3c0e_67"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 11.  <ix:nonNumeric contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82Ny9mcmFnOjYwMjFhMjYxYjc1YTQ3MzJhMjgyY2UxM2VmMWEwMzE4L3RleHRyZWdpb246NjAyMWEyNjFiNzVhNDczMmEyODJjZTEzZWYxYTAzMThfNDM3_edcdd541-5c5f-4272-99b0-721a76a1c1eb" continuedAt="i7a2d7b24e61d4286b13f2af504aad1b0" escape="true">Net Loss Per Share</ix:nonNumeric></span></div><ix:continuation id="i7a2d7b24e61d4286b13f2af504aad1b0"><ix:nonNumeric contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82Ny9mcmFnOjYwMjFhMjYxYjc1YTQ3MzJhMjgyY2UxM2VmMWEwMzE4L3RleHRyZWdpb246NjAyMWEyNjFiNzVhNDczMmEyODJjZTEzZWYxYTAzMThfNDM1_34794ad8-55d9-47eb-8cba-995eac521392" escape="true"><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the calculation of basic and diluted net loss per share attributable to common stockholders </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in thousands, except share and per share amounts)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div><span><br/></span></div><div style="text-indent:25.2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.636%"><tr><td style="width:1.0%"></td><td style="width:70.097%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.977%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.447%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.979%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82Ny9mcmFnOjYwMjFhMjYxYjc1YTQ3MzJhMjgyY2UxM2VmMWEwMzE4L3RhYmxlOmQ2ZDMyYTEyZWIyZjRhZTc5NzA2NmI3MjMxMDNjNDNhL3RhYmxlcmFuZ2U6ZDZkMzJhMTJlYjJmNGFlNzk3MDY2YjcyMzEwM2M0M2FfMy0xLTEtMS02MTk5MA_7f910901-649a-41fc-8ec7-46616b16039f"><ix:nonFraction unitRef="usd" contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82Ny9mcmFnOjYwMjFhMjYxYjc1YTQ3MzJhMjgyY2UxM2VmMWEwMzE4L3RhYmxlOmQ2ZDMyYTEyZWIyZjRhZTc5NzA2NmI3MjMxMDNjNDNhL3RhYmxlcmFuZ2U6ZDZkMzJhMTJlYjJmNGFlNzk3MDY2YjcyMzEwM2M0M2FfMy0xLTEtMS02MTk5MA_84cb233d-46d3-49b2-9e81-fcd116556274">9,102</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82Ny9mcmFnOjYwMjFhMjYxYjc1YTQ3MzJhMjgyY2UxM2VmMWEwMzE4L3RhYmxlOmQ2ZDMyYTEyZWIyZjRhZTc5NzA2NmI3MjMxMDNjNDNhL3RhYmxlcmFuZ2U6ZDZkMzJhMTJlYjJmNGFlNzk3MDY2YjcyMzEwM2M0M2FfMy0zLTEtMS02MTk5MA_0e448888-1499-481b-a5fc-75c65a02e22e"><ix:nonFraction unitRef="usd" contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331" decimals="-3" sign="-" name="us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted" format="ixt:num-dot-decimal" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82Ny9mcmFnOjYwMjFhMjYxYjc1YTQ3MzJhMjgyY2UxM2VmMWEwMzE4L3RhYmxlOmQ2ZDMyYTEyZWIyZjRhZTc5NzA2NmI3MjMxMDNjNDNhL3RhYmxlcmFuZ2U6ZDZkMzJhMTJlYjJmNGFlNzk3MDY2YjcyMzEwM2M0M2FfMy0zLTEtMS02MTk5MA_f83d9925-d0a0-419f-b897-2bb2af1737e9">2,878</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average number of common shares outstanding</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82Ny9mcmFnOjYwMjFhMjYxYjc1YTQ3MzJhMjgyY2UxM2VmMWEwMzE4L3RhYmxlOmQ2ZDMyYTEyZWIyZjRhZTc5NzA2NmI3MjMxMDNjNDNhL3RhYmxlcmFuZ2U6ZDZkMzJhMTJlYjJmNGFlNzk3MDY2YjcyMzEwM2M0M2FfNS0xLTEtMS02MTk5MA_6c314a32-41fe-42c6-ba9f-7d417a373acc"><ix:nonFraction unitRef="shares" contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82Ny9mcmFnOjYwMjFhMjYxYjc1YTQ3MzJhMjgyY2UxM2VmMWEwMzE4L3RhYmxlOmQ2ZDMyYTEyZWIyZjRhZTc5NzA2NmI3MjMxMDNjNDNhL3RhYmxlcmFuZ2U6ZDZkMzJhMTJlYjJmNGFlNzk3MDY2YjcyMzEwM2M0M2FfNS0xLTEtMS02MTk5MA_7aba954a-74a9-40de-aacc-429761ba9a78">84,645,097</ix:nonFraction></ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331" decimals="0" name="us-gaap:WeightedAverageNumberOfSharesOutstandingBasic" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82Ny9mcmFnOjYwMjFhMjYxYjc1YTQ3MzJhMjgyY2UxM2VmMWEwMzE4L3RhYmxlOmQ2ZDMyYTEyZWIyZjRhZTc5NzA2NmI3MjMxMDNjNDNhL3RhYmxlcmFuZ2U6ZDZkMzJhMTJlYjJmNGFlNzk3MDY2YjcyMzEwM2M0M2FfNS0zLTEtMS02MTk5MA_8846c8e7-7e0c-4e95-94be-c5b880509093"><ix:nonFraction unitRef="shares" contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331" decimals="0" name="us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82Ny9mcmFnOjYwMjFhMjYxYjc1YTQ3MzJhMjgyY2UxM2VmMWEwMzE4L3RhYmxlOmQ2ZDMyYTEyZWIyZjRhZTc5NzA2NmI3MjMxMDNjNDNhL3RhYmxlcmFuZ2U6ZDZkMzJhMTJlYjJmNGFlNzk3MDY2YjcyMzEwM2M0M2FfNS0zLTEtMS02MTk5MA_e71de950-5b2d-476f-86e8-451da6592c19">65,774,528</ix:nonFraction></ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net loss per common share</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82Ny9mcmFnOjYwMjFhMjYxYjc1YTQ3MzJhMjgyY2UxM2VmMWEwMzE4L3RhYmxlOmQ2ZDMyYTEyZWIyZjRhZTc5NzA2NmI3MjMxMDNjNDNhL3RhYmxlcmFuZ2U6ZDZkMzJhMTJlYjJmNGFlNzk3MDY2YjcyMzEwM2M0M2FfNi0xLTEtMS02MTk5MA_41ee40d8-7811-4166-a40b-606fb19e976c"><ix:nonFraction unitRef="usdPerShare" contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82Ny9mcmFnOjYwMjFhMjYxYjc1YTQ3MzJhMjgyY2UxM2VmMWEwMzE4L3RhYmxlOmQ2ZDMyYTEyZWIyZjRhZTc5NzA2NmI3MjMxMDNjNDNhL3RhYmxlcmFuZ2U6ZDZkMzJhMTJlYjJmNGFlNzk3MDY2YjcyMzEwM2M0M2FfNi0xLTEtMS02MTk5MA_938eed96-66f8-4037-98fd-2b4d15baaa7f">0.11</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasic" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82Ny9mcmFnOjYwMjFhMjYxYjc1YTQ3MzJhMjgyY2UxM2VmMWEwMzE4L3RhYmxlOmQ2ZDMyYTEyZWIyZjRhZTc5NzA2NmI3MjMxMDNjNDNhL3RhYmxlcmFuZ2U6ZDZkMzJhMTJlYjJmNGFlNzk3MDY2YjcyMzEwM2M0M2FfNi0zLTEtMS02MTk5MA_4e65d75b-934a-4f4d-b995-924bfb3970ea"><ix:nonFraction unitRef="usdPerShare" contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331" decimals="2" sign="-" name="us-gaap:EarningsPerShareDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82Ny9mcmFnOjYwMjFhMjYxYjc1YTQ3MzJhMjgyY2UxM2VmMWEwMzE4L3RhYmxlOmQ2ZDMyYTEyZWIyZjRhZTc5NzA2NmI3MjMxMDNjNDNhL3RhYmxlcmFuZ2U6ZDZkMzJhMTJlYjJmNGFlNzk3MDY2YjcyMzEwM2M0M2FfNi0zLTEtMS02MTk5MA_813e573c-4a66-49c9-93f4-f02e9178e488">0.04</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82Ny9mcmFnOjYwMjFhMjYxYjc1YTQ3MzJhMjgyY2UxM2VmMWEwMzE4L3RleHRyZWdpb246NjAyMWEyNjFiNzVhNDczMmEyODJjZTEzZWYxYTAzMThfNDM2_5af9d156-24fa-430d-a7d1-1284417c0d29" escape="true"><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the outstanding shares of potentially dilutive securities that were excluded from the calculation of diluted earnings per share because their inclusion would have been anti-dilutive:</span></div><div><span><br/></span></div><div style="text-indent:25.2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.939%"><tr><td style="width:1.0%"></td><td style="width:41.964%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.803%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.445%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.932%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.445%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.932%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.445%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.934%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5f45d6b4a1b249b19e2aff7a526d83be_D20230101-20230331" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82Ny9mcmFnOjYwMjFhMjYxYjc1YTQ3MzJhMjgyY2UxM2VmMWEwMzE4L3RhYmxlOmJhYzZmMGNiMjZjMTRiZDJiZTFiYWZlNGNkYzExM2QwL3RhYmxlcmFuZ2U6YmFjNmYwY2IyNmMxNGJkMmJlMWJhZmU0Y2RjMTEzZDBfMi01LTEtMS02MTk5MA_ca0155d4-27c3-4f17-b020-abd1d6cdf3f6">47,720,836</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i571e7f29efd349649731d4a3cf40f70d_D20220101-20220331" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82Ny9mcmFnOjYwMjFhMjYxYjc1YTQ3MzJhMjgyY2UxM2VmMWEwMzE4L3RhYmxlOmJhYzZmMGNiMjZjMTRiZDJiZTFiYWZlNGNkYzExM2QwL3RhYmxlcmFuZ2U6YmFjNmYwY2IyNmMxNGJkMmJlMWJhZmU0Y2RjMTEzZDBfMi03LTEtMS02MTk5MA_fe87e239-7232-4918-a56f-e18f834b1c5f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0650b7f12c5745f1b9f3e5dd848c75eb_D20230101-20230331" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82Ny9mcmFnOjYwMjFhMjYxYjc1YTQ3MzJhMjgyY2UxM2VmMWEwMzE4L3RhYmxlOmJhYzZmMGNiMjZjMTRiZDJiZTFiYWZlNGNkYzExM2QwL3RhYmxlcmFuZ2U6YmFjNmYwY2IyNmMxNGJkMmJlMWJhZmU0Y2RjMTEzZDBfMy01LTEtMS02MTk5MA_a3399826-f5e8-48fc-933f-3be2f7b8aea8">13,971,079</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie7e13065ea5344339868b25a9ccb583d_D20220101-20220331" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82Ny9mcmFnOjYwMjFhMjYxYjc1YTQ3MzJhMjgyY2UxM2VmMWEwMzE4L3RhYmxlOmJhYzZmMGNiMjZjMTRiZDJiZTFiYWZlNGNkYzExM2QwL3RhYmxlcmFuZ2U6YmFjNmYwY2IyNmMxNGJkMmJlMWJhZmU0Y2RjMTEzZDBfMy03LTEtMS02MTk5MA_1d5cc634-3c4e-423e-80a7-26b586dc1790">10,351,020</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib6658dea46b142f48028a62a75c5d390_D20230101-20230331" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82Ny9mcmFnOjYwMjFhMjYxYjc1YTQ3MzJhMjgyY2UxM2VmMWEwMzE4L3RhYmxlOmJhYzZmMGNiMjZjMTRiZDJiZTFiYWZlNGNkYzExM2QwL3RhYmxlcmFuZ2U6YmFjNmYwY2IyNmMxNGJkMmJlMWJhZmU0Y2RjMTEzZDBfNC01LTEtMS02MTk5MA_574d764e-be2c-460f-8ac6-5cfe17474bd2">295,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia19169091dae45ab9040ca0a01a98e92_D20220101-20220331" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:fixed-zero" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82Ny9mcmFnOjYwMjFhMjYxYjc1YTQ3MzJhMjgyY2UxM2VmMWEwMzE4L3RhYmxlOmJhYzZmMGNiMjZjMTRiZDJiZTFiYWZlNGNkYzExM2QwL3RhYmxlcmFuZ2U6YmFjNmYwY2IyNmMxNGJkMmJlMWJhZmU0Y2RjMTEzZDBfNC03LTEtMS02MTk5MA_a9fa4c5c-79f5-41d2-8322-5968d46cb7bb">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82Ny9mcmFnOjYwMjFhMjYxYjc1YTQ3MzJhMjgyY2UxM2VmMWEwMzE4L3RhYmxlOmJhYzZmMGNiMjZjMTRiZDJiZTFiYWZlNGNkYzExM2QwL3RhYmxlcmFuZ2U6YmFjNmYwY2IyNmMxNGJkMmJlMWJhZmU0Y2RjMTEzZDBfNS01LTEtMS02NDgxOQ_8972e6bb-1471-4e0f-ab4b-fca4d24470bb">61,986,915</ix:nonFraction></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331" decimals="0" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" format="ixt:num-dot-decimal" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82Ny9mcmFnOjYwMjFhMjYxYjc1YTQ3MzJhMjgyY2UxM2VmMWEwMzE4L3RhYmxlOmJhYzZmMGNiMjZjMTRiZDJiZTFiYWZlNGNkYzExM2QwL3RhYmxlcmFuZ2U6YmFjNmYwY2IyNmMxNGJkMmJlMWJhZmU0Y2RjMTEzZDBfNS03LTEtMS02NDgxOQ_451be7c7-5b2a-452c-9a45-06a42389235b">10,351,020</ix:nonFraction></span></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div></div><div id="i066fdabb1d0848d5b0391931f87c3c0e_79"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="margin-top:18pt"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_10">Table of Contents</a></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Note 12.  <ix:nonNumeric contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331" name="us-gaap:SubsequentEventsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV83OS9mcmFnOmI5NWQ5OTJiNDNkMTQwNjk4ZThiY2MxODE2N2MwNTNkL3RleHRyZWdpb246Yjk1ZDk5MmI0M2QxNDA2OThlOGJjYzE4MTY3YzA1M2RfMTI1NA_825d7b85-1921-48ba-a7ac-63a73ba47992" continuedAt="i455e435faff54d6a8a73ae3c4a60b4dc" escape="true">Subsequent Events</ix:nonNumeric></span></div><ix:continuation id="i455e435faff54d6a8a73ae3c4a60b4dc"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Brighton, Colorado Lease</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April&#160;15, 2023, we entered into a lease agreement to lease a space for our GWh-scale manufacturing facility in Brighton, Colorado. The lease expires in May 2039, with an option to extend for <ix:nonFraction unitRef="term" contextRef="ie3036f0dcbac452caf4e05d02eb07b89_D20230415-20230415" decimals="0" name="ampx:LesseeOperatingLeaseOptionToExtendNumber" format="ixt-sec:numwordsen" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV83OS9mcmFnOmI5NWQ5OTJiNDNkMTQwNjk4ZThiY2MxODE2N2MwNTNkL3RleHRyZWdpb246Yjk1ZDk5MmI0M2QxNDA2OThlOGJjYzE4MTY3YzA1M2RfNTQ5NzU1ODE4Njg0_71d2e84c-95eb-4d0e-be31-15d7246609e7">two</ix:nonFraction> additional <ix:nonNumeric contextRef="i054651541ac248b38a3b2a7e6475566b_I20230415" name="us-gaap:LesseeOperatingLeaseRenewalTerm" format="ixt-sec:durwordsen" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV83OS9mcmFnOmI5NWQ5OTJiNDNkMTQwNjk4ZThiY2MxODE2N2MwNTNkL3RleHRyZWdpb246Yjk1ZDk5MmI0M2QxNDA2OThlOGJjYzE4MTY3YzA1M2RfMTA5OTUxMTY1NTA1Ng_f0d0aab7-3fde-4aad-9503-8211ee8437a5">five-year</ix:nonNumeric> terms. Future lease payments, which commence in December 2024 after the rent abatement period, total approximately $<ix:nonFraction unitRef="usd" contextRef="i054651541ac248b38a3b2a7e6475566b_I20230415" decimals="-5" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" format="ixt:num-dot-decimal" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV83OS9mcmFnOmI5NWQ5OTJiNDNkMTQwNjk4ZThiY2MxODE2N2MwNTNkL3RleHRyZWdpb246Yjk1ZDk5MmI0M2QxNDA2OThlOGJjYzE4MTY3YzA1M2RfNTQ5NzU1ODE4Njc3_7e30c7ee-6152-4fb6-8496-04eea9da5fa8">62.9</ix:nonFraction> million. The current zoning for this site does not allow for manufacturing our batteries. As such, the property owner is in the process of applying to re-zone the site for our planned development and use. Until the re-zoning is complete, we will not be able to apply for permits required to repurpose the facility for manufacturing. If the re-zoning application is not approved, the lease agreement will automatically terminate.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Merger with Amprius Holdings</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 9, 2023, we entered into an Agreement and Plan of Merger and Reorganization (the &#8220;Merger Agreement&#8221;) with, among others, Amprius Holdings. Under the Merger Agreement, through a series of transactions that are intended to qualify as a tax-free reorganization for U.S. income tax purposes, Amprius Holdings will become our wholly owned subsidiary and then be merged into another wholly owned subsidiary, with such other subsidiary surviving. Subject to the terms and conditions in the Merger Agreement, the shares of our common stock currently owned by Amprius Holdings will be cancelled, and we will issue to the stockholders of Amprius Holdings new shares of our common stock or shares of our non-voting common stock based on a negotiated and discounted exchange ratio. Furthermore, the options in Amprius Holdings, whether vested or unvested, to purchase Amprius Holdings stock shall be converted into options to purchase shares of our common stock and the warrants to purchase Amprius Holdings stock shall automatically be replaced with warrants representing the right to receive shares of our common stock on a net-exercise basis. The transactions contemplated by the Merger Agreement are conditioned on, among other items, the approval of a majority of shares held by our stockholders that are not affiliated with either Amprius Holdings or held by any of our directors or officers.</span></div></ix:continuation><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><div id="i066fdabb1d0848d5b0391931f87c3c0e_82"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_10">Table of Contents</a></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">You should read the following discussion and analysis of our financial condition and results of operations together with our unaudited condensed consolidated financial statements and the related notes included elsewhere in this Quarterly Report on Form 10-Q. Some of the information contained in this discussion and analysis or set forth elsewhere in this Form 10-Q, including information with respect to our plans and strategy for our business and related financing, includes forward-looking statements that involve risks and uncertainties. As a result of many factors, including those factors set forth in the sections titled &#8220;Risk Factors&#8221; and &#8220;Cautionary Note Regarding Forward-Looking Statements&#8221; in this Form 10-Q, our actual results could differ materially from the results described in or implied by the forward-looking statements contained in the following discussion and analysis. Unless otherwise indicated or the context otherwise requires, references in this section to the &#8220;Company,&#8221; &#8220;Amprius,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; &#8220;our&#8221; and other similar terms refer (i) prior to the Closing Date (as defined below), to Amprius Technologies Operating, Inc. (formerly known as Amprius Technologies, Inc. or &#8220;Legacy Amprius&#8221;) and (ii) after the Closing Date, to Amprius Technologies, Inc.</span></div><div id="i066fdabb1d0848d5b0391931f87c3c0e_796"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amprius Technologies, Inc. has developed and, since 2018, been in commercial production of ultra-high energy density lithium-ion batteries for mobility applications leveraging a disruptive silicon anode. Our silicon anode technology enables batteries with higher energy density, higher power density, and extreme fast charging capabilities over a wide range of operating temperatures, which results in our batteries providing superior performance compared to conventional graphite lithium-ion batteries. Our silicon anode is a direct drop-in replacement of the graphite anode in traditional lithium-ion batteries, and our manufacturing process leverages the manufacturing process for conventional lithium-ion batteries and the related supply chain.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Currently, our batteries are primarily used for existing and emerging aviation applications, including unmanned aerial systems, such as drones and high-altitude pseudo satellites. We believe our proprietary technology has the potential for broad application in electric transportation. Our batteries and their performance specifications have been tested and validated for application by over 40 customers, including Airbus, AeroVironment, BAE Systems, the U.S. Army and Teledyne FLIR, and from inception, we have shipped over 10,000 batteries as of March&#160;31, 2023, which have enabled mission critical applications. Our proprietary silicon anode structures, battery designs and manufacturing processes are defended by our portfolio of patents, trade secrets and know-how developed over 10 years of research and development.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently manufacture batteries on a kWh-scale manufacturing line at our headquarters in Fremont, California, where we believe demand for our batteries exceeds our manufacturing capacity. We are working to meet the expected demand in several rapidly growing addressable markets, including by expanding our production capacity in Fremont and by designing and building a large-scale manufacturing facility, at our newly leased facility in Brighton, Colorado to manufacture at a GWh+ scale through an automated, high-volume manufacturing line for our silicon anode. As discussed below, the current zoning for the newly leased facility in Brighton, Colorado does not allow for manufacturing our batteries.</span></div><div id="i066fdabb1d0848d5b0391931f87c3c0e_803"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Combination</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September&#160;14, 2022 (the Closing Date&#8221;), we completed a business combination (the &#8220;Business Combination&#8221;) pursuant to the Business Combination Agreement, dated May 11, 2022 (the &#8220;Business Combination Agreement&#8221;), by and among the Company, Legacy Amprius, Kensington Capital Acquisition Corp. IV (&#8220;Kensington&#8221;), and Kensington Capital Merger Sub Corp. (&#8220;Merger Sub&#8221;). We accounted for the Business Combination as a reverse recapitalization, with Legacy Amprius deemed to be the acquirer and Kensington deemed to be the acquiree for financial statement reporting purposes. As a result, the assets, liabilities and results of operations of Legacy Amprius became the historical financial statements after the Business Combination. Our assets and liabilities continued to be stated at historical cost and there were no goodwill or other intangible assets recorded.</span></div><div id="i066fdabb1d0848d5b0391931f87c3c0e_807"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Committed Equity Financing</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As further described in Note 1 to our condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q, we entered into a Common Stock Purchase Agreement (the &#8220;Purchase Agreement&#8221;) with </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">B. Riley Principal Capital II, LLC (&#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BRPC II&#8221;) on September 27, 2022, whereby we have the right, but not the obligation, to sell to BRPC II up to $200.0 million of newly issued shares of common stock, subject to certain conditions and limitations, from time to time until January 1, 2025 (the &#8220;Committed Equity Financing&#8221;)</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Under the Purchase Agreement, we may</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> direct BRPC II to purchase a specified maximum number of shares of common stock, not to exceed certain limitations.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_10">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As consideration for BRPC II&#8217;s commitment to purchase shares of common stock, we issued 84,793 shares of common stock to BRPC II upon execution of the Purchase Agreement and we will issue 84,793 additional shares of common stock to BRPC II upon receipt of total aggregate gross cash proceeds equal to $100.0 million. Any shares of common stock issued under the Committed Equity Financing to BRPC II other than the Commitment Shares will be purchased by BRPC II at current market prices less a 3.0% fixed discount.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the Purchase Agreement provides that we may sell up to an additional  $197.6 million of our common stock to BRPC II, only 16,409,222 shares of our common stock were registered for resale under a registration statement on Form S-1 filed with the Securities and Exchange Commission (&#8220;SEC&#8221;). If it becomes necessary for us to issue and sell more than 16,825,366 shares to BRPC II in order to receive aggregate gross proceeds equal to $200.0 million, we must first file with the SEC one or more additional registration statements to register the resale by BRPC II of any such additional shares of our common stock. As of March 31, 2023, we had sold an aggregate of 331,351 shares of our common stock for gross proceeds of $2.4 million under the Purchase Agreement, all of which were sold in the first quarter of 2023.</span></div><div id="i066fdabb1d0848d5b0391931f87c3c0e_811"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">U.S. Department of Energy (&#8220;DOE&#8221;) Cost Sharing Grant</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In October 2022, we were awarded a $50.0 million cost sharing grant from the U.S. DOE under the Bipartisan Infrastructure Law. This cost sharing grant is dependent on the successful negotiation of a final contract, and among the terms to be finalized are the portion of relevant costs that will be covered by the grant. </span></div><div id="i066fdabb1d0848d5b0391931f87c3c0e_895"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Merger with Amprius Holdings</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We entered into the Merger Agreement on May 9, 2023 with our 77% stockholder, Amprius Holdings. Amprius Holdings is a holding company that is owned by our legacy stockholders. The proposed merger transaction, if approved, will eliminate our controlling stockholder and result in these legacy stockholders holding our shares directly. Currently, the shares of stock held by Amprius Holdings are subject to a lock-up that expires on the one year anniversary of the Closing Date (subject to certain exceptions as set forth in our Bylaws). The shares of the Company to be issued to the stockholders of Amprius Holdings in this proposed merger will be subject to the same lock-up restrictions set forth in our Bylaws, which will expire no later than September 14, 2023 and will be subject to the same exceptions. </span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The proposed merger was approved by our board of directors based on the recommendation of a special, independent board committee. Under the Merger Agreement, the stockholders of Amprius Holdings will receive new shares of our common stock based on a discounted exchange ratio relative to Amprius Holdings&#8217; current holdings. We will also assume all options and warrants outstanding at Amprius Holdings. The merger is conditioned on, among other items, the approval of a majority of shares held by stockholders of the Company that are not affiliated with either Amprius Holdings or held by any of our directors or officers. We expect that the special meeting to approve the merger will occur in the third fiscal quarter of 2023.</span></div><div id="i066fdabb1d0848d5b0391931f87c3c0e_815"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Known Trends, Demands, Commitments, Events, or Uncertainties Impacting Our Business</span></div><div style="margin-top:10pt;text-align:justify;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that our performance and future success depends on several factors that present significant opportunities for us but also pose risks and challenges, including those discussed below and in the section titled &#8220;Risk Factors.&#8221;</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Establishing Manufacturing Capacity</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">While we have manufactured on a kWh-scale capacity to date, we have started our phased build out of capacity with parallel paths. </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In January 2023, we entered into an amendment to the lease agreement of our Fremont facility, pursuant to which we leased approximately 25,000 square feet of additional space located in the same building as our current headquarters. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have received the first large-scale anode production machine from centrotherm at our facility in Fremont and have started using it for production purposes. We expect this machine to increase our capacity for silicon anode production to approximately 2 MWh by the end of 2023. This is expected to accelerate our development of technological processes for building batteries at a GWh-scale as we prepare, in parallel, for the design and build of our high volume manufacturing facility.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April&#160;15, 2023, we entered into a lease agreement for premises consisting of approximately 774,000 square feet of space located in Brighton, Colorado. In order to meet increased demand for our products, we plan to build and design our GWh-scale manufacturing facility on these premises. The current zoning for this site does not allow for manufacturing our batteries. As such, the property owner is in the process of applying to re-zone the site for our planned development and use. While we expect the re-zoning to be completed by September 2023, the re-zoning application may not be approved and we may not be able to obtain the necessary licenses or permits for the manufacturing facility, which will delay the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_10">Table of Contents</a></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">expected timing for our GWh-scale manufacturing facility. Until the re-zoning is complete, we will not be able to apply for permits required to repurpose the facility for manufacturing. If the re-zoning application is not approved, the lease agreement will automatically terminate. We plan to procure manufacturing equipment that allows for anode and cathode fabrication, battery assembly, and battery testing. To achieve capacity at commercial scale, we need to establish supply relationships for necessary materials, components and equipment to mass produce our silicon technology for our prospective markets, which will allow us to develop an automated, high-volume manufacturing line to increase production volume. The capacity and timing of our future manufacturing requirements, and related capital expenditures, remain uncertain and will depend on a variety of factors, including: our ability to design and construct new manufacturing sites and develop an automated, high-volume manufacturing line for our silicon anode, to mitigate supply chain constraints and manage a new labor force, to utilize planned capacity in our existing facilities, to obtain the required regulatory and zoning permits and approvals, to realize the benefits of any government incentives, and to operate in new geographic areas apart from our current headquarters. Our potential suppliers and other equipment vendors may also encounter delays, including to our expected initial production capacity of 500 MWh, which is expected to be operational in 2025, along with additional costs, and other obstacles in building our manufacturing line, which are currently unknown. To the extent we are unable to develop an automated, high-volume manufacturing line for our silicon anode, our ability to grow will be adversely affected. Additionally, although we have tested and validated the performance of our products on one supplier&#8217;s platform, there is uncertainty as to whether our planned manufacturing line will be successful. We expect our operating requirements and capital expenditures to increase as we ramp up our manufacturing capacity and expand operations.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Achieving capacity at commercial scale of high energy density lithium-ion batteries will require us to make significant and increasing capital expenditures to scale our manufacturing capacity and improve our supply chain processes. Based on our current expectations, we estimate that our capital equipment expenditures will range between $120.0 million and $150.0 million to achieve 1.0 GWh per year of manufacturing capacity. Because our silicon anode process requires different equipment than traditional anode manufacturing, our capital equipment costs are likely to be higher than equipment used for production of graphite anodes. </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability in the future to generate revenue sufficient to achieve profitability will depend largely on our ability to scale production to meet the expected market demand for our products. Accordingly, the drivers of our future financial results, as well as the components of such results, may not be comparable to our historical results of operations.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reducing Costs of Manufacturing</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe focusing on reducing the manufacturing costs of our batteries on a $/kWh basis is an important factor to accelerate the demand for our batteries and the expansion of our customer base. As a result, we will continue to work to develop further and validate our manufacturing processes to enable high volume manufacturing and reduce manufacturing costs. As the production of our silicon anode requires different equipment than traditional graphite anode manufacturing, our capital equipment costs are likely to be initially higher than equipment used for the production of graphite anodes. As we scale, we believe we will benefit from reduced per-unit fixed costs, such as overhead, labor and capital expenditures, tool utilization improvements and volume pricing for equipment and materials. We will also seek to reduce costs by optimizing material utilization, throughput and yield. This is complemented by our plans to continue to invest in research and development to improve both battery performance and manufacturing processes. However, until we are able to successfully design and implement an automated, high-volume manufacturing line for our silicon anode and manufacture our batteries at scale, we cannot accurately forecast our manufacturing costs, which may adversely affect our ability to achieve reduced costs in our manufacturing processes.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Highly Competitive Market</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our competition includes both established manufacturers and new entrants that are developing new battery technologies and chemistries to address the growing market for electrified transportation solutions. We believe the manufacturers of these batteries will continue to invest funds, time and effort to improve the capabilities of their batteries with the recent developments of silicon anode batteries as a potential alternative to conventional graphite batteries. Currently, we are the only known manufacturer using a 100% silicon anode that is free of any inactive additives. We believe we are the leading company in the market that has a high-performance battery that can meet the requirements of aviation applications. We are not currently producing batteries for electric vehicles (&#8220;EVs&#8221;). The EV battery industry has a limited number of commercially available batteries that meet the minimum performance specifications. This creates a fast-growing and highly competitive industry for many battery manufacturers to claim market share for commercially acceptable batteries. We believe that there is significant room for improvement in the EV industry in driving range and fast charging capabilities that our silicon technology may address. To compete in the EV industry, we expect that we will need to significantly reduce our manufacturing costs, improve cycle life, increase form factors and increase production quantity. One or more of our competitors and potential future entrants may be better capitalized to expand production capacities, </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_10">Table of Contents</a></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">have greater resources to commercialize and have greater access to customers in either or both the aviation and EV markets. As such, we may be at a competitive disadvantage and be unable to retain or grow our market share.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Product Development</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to continue investing in the development of battery technology with the goal of enabling commercial production after the completion of our new GWh-scale manufacturing facility. We continue to develop customized battery solutions and deliver standardized samples (i.e., prototypes) of batteries to industry leading manufacturers as well as the federal government. We plan to focus our research and development on the following key areas:</span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:7.3pt">Improving battery life:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> To continue to meet the specific needs of our customers and drive adoption of our batteries in new areas of electrified transportation, including the EV space. We are working with chemical compounds as potential additives to the silane gas we use to produce our silicon anodes, which have demonstrated the potential to improve cycle life without negatively impacting other performance characteristics such as energy density.</span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:7.3pt">Further improvements to energy density:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We are engaged in ongoing development activities to explore different cathode materials, including a conversion cathode, to further improve the energy density of our batteries.</span></div><div style="margin-top:10pt;padding-left:36pt;text-indent:-10.8pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:7.3pt">Larger cell form factors: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The batteries we have developed and are developing for our customers are typically approximately 2-15Ah for small-sized aircraft. As we expand our customer base, we expect to develop larger form factor batteries for broader electrified transportation applications.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of these efforts, our goal is to fully realize the benefits of our silicon anode technology and develop the highest performing products in the market.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Regulatory Landscape</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We operate in an industry that is subject to many established environmental regulations, which have generally become more stringent over time. As we process, store, dispose of, transport, and use large amounts of hazardous materials, we are subject to laws and regulations surrounding battery safety and transportation, as well as health and production safety laws and regulations governing hazardous materials. We expect that environmental regulations under the Biden administration could, if adopted, facilitate market demand and revenue growth, while other potential regulations, if adopted, could result in additional operating costs. If we fail to comply with existing and future laws and regulations, our business and results of operations could be adversely affected, such as the imposition of fines, litigation, criminal charges, sanctions by regulators, or other liabilities. As future regulatory changes are uncertain, we are unable to measure the impact of such changes on our business and our results of operations.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Global Risks</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic has been unpredictable and unprecedented and may continue to result in significant national and global economic disruption, which may adversely affect our business. The extent to which the COVID-19 pandemic continues to impact our business, financial condition, prospects and results of operations will depend on future developments, which are highly uncertain and cannot be predicted. Even after the COVID-19 pandemic has subsided, we may continue to experience an adverse impact to our business as a result of its global economic impact, including any economic recession that has occurred or may occur in the future.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the military conflict between Russia and Ukraine, which began in February 2022, has had an adverse impact on the global economy and financial markets. Although our business has not been directly impacted by this ongoing military conflict, as we have no assets or operations, and we have not purchased materials from, Russia, Belarus or Ukraine, it is impossible to predict the extent to which our operations, or those of our customers, suppliers and manufacturers, will be impacted in the short and long term, or the ways in which the conflict may impact our business. The extent and duration of the military action, sanctions and resulting market disruptions and inflationary pressures, and the impact of such changes on our business and our results of operations are impossible to predict, but could be material.</span></div><div id="i066fdabb1d0848d5b0391931f87c3c0e_822"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Comparability of Financial Information</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our future results of operations and financial position may not be comparable to historical results as a result of the Business Combination. Since the Business Combination close, we have incurred, and expect to continue to incur, higher capital expenditures related to both the design and build out of our new GWh-scale manufacturing facility and the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_10">Table of Contents</a></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">development of an automated, high-volume manufacturing line for our silicon anode, as well as higher costs for continued research and development efforts, compliance with regulatory matters and other general and administrative expenses, including those related to being a public company.</span></div><div id="i066fdabb1d0848d5b0391931f87c3c0e_827"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q were prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;). We carry on our business through one operating segment. Given that Amprius, Inc. (&#8220;Amprius Holdings&#8221;), which held approximately 99.6% of the Legacy Amprius common stock prior to the Business Combination, has not historically prepared financial statements for Legacy Amprius, the historical results for Legacy Amprius have been prepared from the financial records of Amprius Holdings on a carve-out basis derived from the accounting records of Amprius Holdings using the historical results of operations and the historical basis of assets and liabilities of our business, adjusted as necessary to conform to U.S. GAAP.</span></div><div id="i066fdabb1d0848d5b0391931f87c3c0e_832"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Components of Our Results of Operations</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have historically generated revenue from providing both design services for the development of customized silicon-anode lithium-ion battery technology and selling our batteries to our customers. Our contracts typically contain a single performance obligation. Revenue is recognized at the point in time either when a final milestone is met, generally when a final working prototype is delivered that meets required specifications, or when the customer obtains control of the product, which is generally upon shipment. We also generate revenue from U.S. federal government expense reimbursement grants that is recognized in the period in which the qualifying costs have been incurred.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Revenue</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of revenue, which includes the cost of finished goods sold and the cost of customization development services, consist mainly of the costs of raw materials, labor costs, and the allocation of overhead costs incurred in producing batteries or performing the customization work. Labor costs consist of personnel-related expenses such as salaries, employee benefits and stock-based compensation expense. Overhead and other costs consist primarily of outside services, utilities, rent, depreciation expense and other facilities-related costs. Costs related to batteries and design services are recognized in the same period as the associated revenue. In addition, we expect that our cost of revenue will increase as we ramp up manufacturing in our existing facility and by building a GWh-scale manufacturing facility.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development (&#8220;R&amp;D&#8221;) Expense</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">R&amp;D expense consist mainly of personnel-related expenses such as salaries, employee benefits and stock-based compensation expense of our R&amp;D personnel, outside contractors, materials, R&amp;D equipment, and allocation of overhead costs, which include utilities, rent, depreciation expense and other facilities-related costs. R&amp;D activities relate to the conceptual formulation and design of preproduction experimental prototypes and models, including the cost of equipment and material for which there is no alternative future use. R&amp;D expenses are expensed as incurred. We expect that our R&amp;D expenses will increase for the foreseeable future as we continue to invest in activities to develop and enhance product capabilities, as well as build and test battery prototypes to meet the expected market demand.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Selling, General and Administrative Expense</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expense consists mainly of personnel-related expenses such as salaries, employee benefits and stock-based compensation expense of our executive and administrative employees, as well as fees for professional and advisory services such as legal, accounting and audit. Selling, general and administrative expense also includes corporate insurance expense including directors and officers insurance costs, and allocation of overhead costs, which include utilities, rent, depreciation expense and other facilities-related costs. We expect that our selling, general and administrative expenses will increase due to the additional costs for compliance-related requirements resulting from being a public company and investment in additional general and administrative personnel to support the growth of our business.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Income, Net</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income, net consists mainly of interest income.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_10">Table of Contents</a></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Provision for Income Taxes</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our provision for income tax consists of an estimate for U.S. federal and state income taxes based on enacted rates, as adjusted for allowable credits, deductions, uncertain tax positions, changes in deferred tax assets and liabilities, and changes in tax law. We maintain a valuation allowance against the full value of our U.S. federal and state net deferred tax assets because it is not more likely that our deferred tax assets will be recoverable. </span></div><div id="i066fdabb1d0848d5b0391931f87c3c0e_109"></div><div style="margin-top:10pt"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Results of Operations</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comparison of the Three Months Ended March&#160;31, 2023 and 2022</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our results of operations during the three months ended March&#160;31, 2023 and 2022 (in thousands, except percentage data):</span></div><div style="margin-top:10pt;text-indent:25.2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.696%"><tr><td style="width:1.0%"></td><td style="width:48.980%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.700%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.440%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.700%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.440%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.700%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.440%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.500%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,110&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,431)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(68)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,104&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,149&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">955&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Gross loss</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,425)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,039)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,386)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Gross margin</span></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(504)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(49)</span></td><td style="border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">800&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">369&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">431&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">117&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,526&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,502&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,024&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">268&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,326&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,871&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,455&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">238&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,751)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,910)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,841)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">235&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other income, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">649&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">32&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">617&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1928&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net Loss</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,102)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,878)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,224)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">216&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost and operating expenses reported above include stock-based compensation as follows:</span></div><div style="margin-top:10pt;text-indent:25.2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.696%"><tr><td style="width:1.0%"></td><td style="width:48.980%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.700%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.440%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.700%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.440%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.700%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.440%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.500%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development expense</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">233&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative expense</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">537&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">200&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">726&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">456&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">270&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">59&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revenue</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue decreased by $1.4 million, or 68%, to $0.7 million during the three months ended March&#160;31, 2023 from $2.1 million during the same period last year. The decrease was primarily due to $1.5 million of non-recurring customized design service revenue that was recognized during the three months ended March 31, 2022 and a $0.1 million decrease in product revenue, partially offset by an increase of $0.2 million in government grant revenue. Revenue in the current period included $0.3 million of silicon anode batteries produced under a toll manufacturing partnership with Berzelius (Nanjing) Co. Ltd., (a formerly affiliated company) as part of an ongoing market exploration. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Cost of Revenue</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of revenue increased by $1.0 million, or 30%, to $4.1 million during the three months ended March&#160;31, 2023 from $3.1 million during the same period last year. The increase was primarily due to a $1.8&#160;million increase in outside services and consulting fees, which include a nonrecurring fee incurred in connection with our selection of a GWh manufacturing site in Brighton, Colorado, and a $0.2 million increase in overhead and other costs, partially offset by a $1.1 million decrease in costs related to non-recurring customized design services that were incurred during the three months ended March 31, 2022.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_10">Table of Contents</a></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development Expense</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Research and development expense increased by $0.4 million, or 117%, to $0.8 million during the three months ended March&#160;31, 2023 from $0.4 million during the same period last year. The increase was primarily due to the increase in development costs, mainly personnel-related costs, associated with ongoing research projects.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Selling, General and Administrative Expense</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Selling, general and administrative expense increased by $4.0 million, or 268%, to $5.5 million during the three months ended March&#160;31, 2023 from $1.5 million during the same period last year, primarily due to our transition to operating as a public company. Drivers of this increase were a $2.0 million increase in professional and consulting fees as we obtained additional outside service assistance after we became a public company, a $0.9 million increase in personnel-related costs, including stock-based compensation expense, due to the hiring of additional administrative personnel, a $0.5 million increase in corporate insurance costs, including director and officer insurance costs, a $0.4 million increase in recruiting expense, and a $0.2 million increase in other general and administrative spend.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Other Income, Net</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other income, net increased by $0.6 million during the three months ended March&#160;31, 2023 due primarily to a $0.6 million increase in interest income attributed to a higher amount of funds held during the three months ended March&#160;31, 2023 compared to the same period last year. </span></div><div id="i066fdabb1d0848d5b0391931f87c3c0e_112"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sources and Uses of Liquidity</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Liquidity describes the ability of a company to generate sufficient cash flows to meet the cash requirements of its business operations, including working capital needs, debt service, acquisitions, contractual obligations and other commitments. We assess liquidity in terms of our cash flows from operations and their sufficiency to fund our operating and investing activities. To meet our contractual obligations, we must continually have sufficient liquid assets.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Business Combination, we financed our operations primarily through capital contributions from Amprius Holdings and revenue generated from operations. </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to rely on our cash and cash equivalents, which was $64.2 million as of </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;31, 2023</span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and cash flows from operations to meet our working capital and capital expenditure requirements for a period of at least twelve months from the date our financial statements included in this Quarterly Report on Form 10-Q are issued.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> In addition, we may receive additional funds from the following sources: (i) all or a portion of the remaining $197.6 million balance of the Committed Equity Financing with BRPC II if we decide to issue shares of common stock to BRPC II under the Purchase Agreement, (ii) $50.0 million grant from the U.S. DOE if we successfully finalize a contract and perform under such contract, and (iii) exercise of outstanding stock warrants. </span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Actual sales, if any, of shares of common stock under the Committed Equity Financing will depend on a variety of factors to be determined by us from time to time, including, among other things, market conditions, the trading price of our common stock and determinations by us as to appropriate sources of funding for our business and operations. We cannot guarantee the extent to which we may utilize the Committed Equity Financing. </span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The $50.0 million cost sharing grant from the U.S. DOE is dependent on the successful negotiation of a final contract, and among the terms to be finalized are the portion of relevant costs that will be covered by the grant. The contract is not yet finalized. There can be no assurance that such negotiation will be successful and, if successful, that we will be able to perform under such contract.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may receive up to approximately $550.8&#160;million from the exercise in full of all outstanding warrants. The exercise price of our public warrants and private warrants is $11.50 per share, and the exercise price of the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">warrants issued as part of units in a private placement connection with the Business Combination (the &#8220;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">PIPE warrants&#8221;) is $12.50 per share. As of March&#160;31, 2023, we had an aggregate of 45,668,336 public warrants and private warrants and 2,052,500 PIPE warrants outstanding. The likelihood that warrant holders will exercise the warrants and any cash proceeds that we would receive is dependent upon the market price of our common stock. If the market price for our common stock is less than $11.50 per share, in the case of the public warrants or private warrants, or $12.50 per share, in the case of the PIPE warrants, we believe warrant holders will be unlikely to exercise their warrants.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_10">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to become profitable is dependent upon future events, including obtaining adequate financing to fund our business plan, completing the design and build out of our GWh-scale manufacturing facility, obtaining adequate supplier relationships, building our customer base, successfully executing our business and marketing strategy and hiring appropriate personnel.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect our capital expenditures and working capital requirements to increase materially in the near future. At our headquarters in Fremont, California, we currently operate a kWh-scale manufacturing line that we are expanding in order to achieve production on a MWh-scale. To meet the demand for our batteries, we are in the process of designing and then building a new GWh-scale manufacturing facility. Based on our current expectations, we estimate that our capital equipment expenditures will range between $120.0 million and $150.0 million to achieve 1.0 GWh per year of manufacturing capacity, with the build-out to be completed over phases. The initial phase of 500 MWh is expected to be operational in 2025. </span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have incurred net losses to date. During the three months ended March&#160;31, 2023, we incurred a net loss of $9.1 million. We expect to incur additional losses and increased expenses in future periods, including those associated with the design and build out of our GWh-scale manufacturing facility, continued research and development efforts and increased employee headcount.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, our contractual obligations consisted primarily of our noncancellable operating lease agreement for our corporate headquarters and facilities in Fremont, California. The total future lease payments under this operating lease were approximately $11.5 million as of March&#160;31, 2023, of which a total of $1.1 million is payable over the next twelve months. Subsequent to our first quarter, on April&#160;15, 2023, we entered into a lease agreement to lease a space for our GWh-scale manufacturing facility in Brighton, Colorado. Future lease payments, which commence in December 2024 after the rent abatement period, total approximately $62.9 million. The current zoning for this site does not allow for manufacturing our batteries. As such, the property owner is in the process of applying to re-zone the site. Until the re-zoning is complete, we will not be able to apply for permits required to repurpose the facility for manufacturing. If the re-zoning application is not approved, the lease agreement will automatically terminate. For additional discussion about our leases, refer to Note 9 to our condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q.  </span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent that our resources are insufficient to satisfy our cash requirements, we may need to seek additional equity or debt financing. If financing is not available, or if the terms of financing are less desirable than we expect, we may be forced to take actions to reduce our capital or operating expenditures, including by reducing or delaying our production facility expansion, which may adversely affect our business, operating results, financial condition and prospects. For example, because we expect to expand through a Copy Exact methodology, to the extent we have less cash than expected and additional financing is unavailable on acceptable terms, we expect that we would reduce the initial production capacity of our large-scale facility and thereafter add capacity as appropriate. Any such reduction or delay may have an adverse impact on our business plan and our results of operations.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes our cash flows from operating, investing and financing activities for the periods presented (in thousands):</span></div><div style="margin-top:10pt;text-indent:25.2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.787%"><tr><td style="width:1.0%"></td><td style="width:58.835%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.824%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.446%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.824%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.446%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.825%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Change</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">$</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in operating activities</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,492)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,043)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,449)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,140)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(34)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,106)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by financing activities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,123&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">204&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,919&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Cash Used in Operating Activities</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our primary source of cash provided by operations is revenue from customized design services and sale of batteries. Our uses of cash in our operating activities primarily include payments for personnel-related costs, procurement of materials used to produce batteries and to conduct research, professional fees and other general corporate expenses.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in operating activities increased to $6.5 million during the three months ended March&#160;31, 2023 from $3.0 million during the same period last year primarily due to an increase in personnel-related costs as we hired additional </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_10">Table of Contents</a></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">employees, an increase in professional and consulting fees as we utilized additional outside services after we became a public company, and an increase in corporate insurance costs, including directors' and officers' insurance costs.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Cash Used in Investing Activities</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our primary use of cash in investing activities is for purchases of property, plant and equipment.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in investing activities increased to $1.1 million during the three months ended March&#160;31, 2023 from $34 thousand during the same period last year primarily due to a purchase of production equipment and improvements made to our manufacturing facility as we continued to expand our business operations.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Cash Provided by Financing Activities</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our primary source of cash provided by financing activities consists primarily of proceeds from issuance of common stock in the current year period and capital contributions from Amprius Holdings in the prior year period. Our cash usage for financing activities consists primarily of payments related to the issuance of common stock.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by financing activities increased to $2.1 million during the three months ended March&#160;31, 2023 from $0.2 million during the same period last year primarily due to the proceeds from the issuance of common stock in connection with the Purchase Agreement. Our cash provided by financing activities during the three months ended March&#160;31, 2022 consisted primarily of capital contributions from Amprius Holdings.</span></div><div id="i066fdabb1d0848d5b0391931f87c3c0e_115"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Related Party Transactions</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had a service agreement with Amprius Holdings, which was terminated upon the closing of the Business Combination. Prior to its termination, the service agreement required Amprius Holdings to provide us certain services such as administration, management service, information technology and engineering services to support our operations. During the three months ended March 31, 2022, the administrative costs incurred by Amprius Holdings up to the termination of the service agreement were allocated to us and were treated as capital contributions. </span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, we purchased raw materials, development materials and finished batteries from two previous related parties that were owned and controlled by Amprius Holdings, including silicon anode batteries produced under a toll manufacturing partnership with Berzelius (Nanjing) Co. Ltd. as part of an ongoing market exploration. We do not have purchase commitments with these previous related parties.</span></div><div id="i066fdabb1d0848d5b0391931f87c3c0e_118"></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Emerging Growth Company and Smaller Reporting Company Status</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are an emerging growth company as defined in the Jumpstart Our Business Startups Act of 2012 (&#8220;JOBS Act&#8221;) and may take advantage of reduced reporting requirements that are otherwise applicable to public companies. Section 107 of the JOBS Act exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies are required to comply with those standards. This means that when a standard is issued or revised and it has different application dates for public and nonpublic companies, we have the option to adopt the new or revised standard at the time nonpublic companies adopt the new or revised standard and can do so until such time that we either (i) irrevocably elect to &#8220;opt out&#8221; of such extended transition period or (ii) no longer qualify as an emerging growth company. We have elected to use the extended transition period for complying with new or revised accounting standards unless we otherwise early adopt select standards.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also a &#8220;smaller reporting company&#8221; as defined in Item 10(f)(1) of Regulation S-K. Smaller reporting companies may take advantage of certain reduced disclosure obligations, including, among other things, providing only two years of audited financial statements. We will remain a smaller reporting company until the last day of the fiscal year in which (i) the market value of our common stock held by non-affiliates exceeds $250.0 million as of the prior June 30 or (ii) our annual revenue exceeds $100.0 million during such completed fiscal year and the market value of our common stock held by non-affiliates exceeds $700.0 million as of the prior June 30.</span></div><div id="i066fdabb1d0848d5b0391931f87c3c0e_121"></div><div style="margin-top:10pt"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Estimates</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management&#8217;s discussion and analysis of our financial condition and results of operations is based on our unaudited condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q, which have been prepared in accordance with U.S. GAAP. The preparation of our financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported loss generated and expenses incurred during the </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_10">Table of Contents</a></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reporting periods. Our estimates are based on our historical experience and on various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions and any such differences may be material. </span></div><div style="margin-top:10pt;text-align:justify;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes to our critical accounting estimates as compared to the critical accounting estimates described in &#8220;Management's Discussion and Analysis of Financial Condition and Results of Operations&#8221; set forth in our Annual Report on Form 10-K for the year ended December 31, 2022.</span></div><div id="i066fdabb1d0848d5b0391931f87c3c0e_124"></div><div style="margin-top:10pt"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">See Note 2 to the condensed consolidated financial statements included elsewhere in this Quarterly Report on Form 10-Q for further information about recent accounting pronouncements, the timing of their adoption, and our assessment, to the extent we have made one, of their potential impact on our financial condition and results of operations.</span></div><div id="i066fdabb1d0848d5b0391931f87c3c0e_127"></div><div style="margin-top:10pt"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. Quantitative and Qualitative Disclosures about Market Risk</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to a variety of market-related risks, which broadly includes interest rate risk, credit risk, and inflation risk. These risks may affect our results of operations and cash flows.  </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest Rate Risk</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to interest-rate risk related to our interest-bearing bank deposits. Adverse changes in interest rates may affect our results of operations. Cash and cash equivalents as of March&#160;31, 2023 was $64.2 million. Hypothetically, if our cash and cash equivalents remain the same and if the interest rate changes by 100 basis points, our interest income may change by approximately $0.6 million on a per annum basis.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have no interest-bearing borrowings as of March&#160;31, 2023.  </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Credit Risk</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are exposed to credit risk from our customers. Our customers may default on their obligations to us due to bankruptcy, lack of liquidity or other reasons. Although we regularly review our credit exposure to our customers, default risk may arise from events or circumstances that are difficult to foresee. We rely primarily on the creditworthiness of our customers and have limited recourse for collection. Our inability to assess creditworthiness of our customers could adversely affect our operating results and cash flows.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inflation Risk </span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">High inflation may affect our operating results and cash flows. However, we do not believe that inflation had a material impact on our operating results and cash flows during the three months ended March&#160;31, 2023. If our costs become subjected to significant inflationary pressures, we may not be able to fully offset such higher costs through increase in prices of products we sell.</span></div><div id="i066fdabb1d0848d5b0391931f87c3c0e_130"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4. Controls and Procedures</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Evaluation of Disclosure Controls and Procedures</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management, with the participation and supervision of our Chief Executive Officer and our Chief Financial Officer, have evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act as of the end of the period covered by this Quarterly Report on Form 10-Q. Our disclosure controls and procedures are designed to ensure that information we are required to disclose in reports that we file or submit under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in SEC rules and forms, and that such information is accumulated and communicated to our management, including our Chief Executive Officer and our Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure. Based on such evaluation, our Chief Executive Officer and our Chief Financial Officer have concluded that our disclosure controls and procedures were not effective because of the material weaknesses in internal controls over financial reporting identified during the years ended December 31, 2022 and 2021 that have not been remediated as of March 31, 2023. Based on additional procedures and post-closing review, management concluded that the condensed consolidated financial statements included in this Quarterly Report on Form 10-Q present fairly, in all material respects, our financial position, </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_10">Table of Contents</a></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">results of operations, and cash flows for the periods presented, in conformity with accounting principles generally accepted in the United States.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Remediation Plan for Material Weaknesses</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management identified material weaknesses in our internal controls over financial reporting during the years ended December 31, 2022 and 2021. Those material weaknesses pertained to (i) inadequate design and maintenance of effective internal controls over our financial reporting and close process, which specifically relate to the inadequate controls on our review, analysis and approval of journal entries, and review of monthly financial statements; and (ii) lack of segregation of duties. </span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management performed the following remediation efforts, which are in progress as of March&#160;31, 2023:</span></div><div style="margin-top:6pt;padding-left:45pt;text-indent:-18.72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.22pt">increased the size of our accounting team by hiring permanent employees for key roles to allow for improved segregation of duties;</span></div><div style="margin-top:6pt;padding-left:45pt;text-indent:-18.72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.22pt">enhanced and improved our monthly close process, including establishing a close schedule and close checklists, as well as implementing review and reconciliation processes including performing detailed review and validation of journal entries, and implementing software to assist with financial reporting; and </span></div><div style="margin-top:6pt;padding-left:45pt;text-indent:-18.72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:15.22pt">engaged an external specialist to assist in performing a risk assessment to identify key areas for improvement in accounting and financial reporting.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management believes that the remediation efforts described above will enable us to address the material weaknesses that were identified in a timely manner, maintain a properly designed and effective system of internal controls over financial reporting, and provide appropriate segregation of duties. Our remediation efforts are in progress as of March&#160;31, 2023. We will not be able to demonstrate that the material weaknesses have been fully remediated, or that our controls are operating effectively, until we complete our remediation efforts. We will continue to evaluate the effectiveness of our internal control over financial reporting and will continue to make changes that we believe will strengthen our internal control over financial reporting to ensure that our financial statements continue to be fairly stated in all material respects.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in internal control over financial reporting</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Except for the activities taken related to the remediation of the material weaknesses described above, there were no changes in our internal control over financial reporting identified in connection with the evaluation required by Rules 13a-15(d) and 15d-15(d) of the Exchange Act that occurred during the quarter ended March&#160;31, 2023 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><div id="i066fdabb1d0848d5b0391931f87c3c0e_133"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_10">Table of Contents</a></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Part II - Other Information</span></div><div id="i066fdabb1d0848d5b0391931f87c3c0e_136"></div><div style="margin-top:10pt"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1. Legal Proceedings</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we may become involved in litigation or other legal proceedings. We are not currently a party to any litigation or legal proceedings that are likely to have a material adverse effect on our business. Regardless of outcome, litigation can have an adverse impact on us because of defense and settlement costs, diversion of management resources and other factors.</span></div><div id="i066fdabb1d0848d5b0391931f87c3c0e_686"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1A. Risk Factors </span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investing in our securities involves a high degree of risk. Before making an investment decision, you should carefully consider the risks and uncertainties described below, together with all of the other information in this Quarterly Report on Form 10-Q, including the section titled &#8220;Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations&#8221; and our condensed consolidated financial statements and related notes thereto included elsewhere in this Quarterly Report on Form 10-Q. Our business, financial condition, results of operations or prospects could also be harmed by risks and uncertainties not currently known to us or that we currently do not believe are material. If any of the risks actually occur, our business, financial condition, results of operations and prospects could be adversely affected. In that event, the market price of our securities could decline, and you could lose part or all of your investment.</span></div><div id="i066fdabb1d0848d5b0391931f87c3c0e_693"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Summary of Risk Factors</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of the material risks that we face include: </span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If our batteries fail to perform as expected, our ability to develop, market and sell our batteries would be adversely affected.</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may not succeed in developing a new high-volume manufacturing line that meets our requirements for cell quality, yield, throughput and other performance metrics. </span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may not meet our manufacturing cost targets, which would limit the size of our market opportunities. </span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our establishment of a volume manufacturing facility is subject to many risks, including, among others, risks relating to executing a definitive lease agreement, re-zoning, construction, permitting, delays, cost overruns, supply chain constraints, and operating in a new geographic area away from our current headquarters.</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may not succeed in retaining and attracting key employees, particularly technical talent, needed to operate and build our business successfully. </span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may encounter delays and technical obstacles in developing new battery products such as different cell formats to meet varied market requirements.</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Certain components of our batteries are hazardous and pose safety risks that may cause accidents in our manufacturing facility. </span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may be subject to financial and reputational risks due to product recalls and product liability claims, and we could face substantial liabilities that exceed our resources.</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may not be able to accurately estimate the future supply and demand for our batteries, which could result in a variety of inefficiencies in our business and hinder our ability to generate revenue. If we fail to accurately predict our manufacturing requirements, we could incur additional costs or experience delays.</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The battery market is intensely competitive. Competitors include new entrants and established companies, many of which have significantly greater resources than us. </span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our future sales opportunities depend in part on the growth of markets for battery-powered aviation applications. These applications may develop slower or at a size that is less than expected, to the extent they develop at all.</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Developments in alternative technology or other fossil fuel alternatives may adversely affect the demand for our battery products. </span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We have pursued and may continue to pursue development agreements and other strategic alliances, which could have an adverse impact on our business if they are unsuccessful.</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may require additional capital to support business growth, and this capital might not be available on commercially reasonable terms or at all.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_10">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are an early stage company with a history of financial losses and expect to incur significant expenses and continuing losses for the foreseeable future.</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may not be able to complete the merger transaction with Amprius Holdings, thereby not allowing us to realize the potential benefits associated with the transaction, and we could continue to incur significant costs, expenses and fees for professional services and other transaction costs in connection with the merger for which we will have received little or no benefit if the merger is not completed.</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We have previously identified material weaknesses in our internal control over financial reporting. If we are unable to develop and maintain an effective system of internal controls and procedures required by Section 404(a) of the Sarbanes-Oxley Act, we may not be able to accurately report our financial results in a timely manner, which may adversely affect investor confidence in us and materially and adversely affect our stock price, business and operating results. </span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">A significant portion of our business depends on sales to the public sector, and our failure to receive and maintain government contracts or changes in the contracting or fiscal policies of the public sector could have a material adverse effect on our business.</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We rely heavily on our intellectual property portfolio. If we are unable to protect our intellectual property rights, our business and competitive position would be harmed.</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We may need to defend ourselves against intellectual property infringement claims, which may be time-consuming and could cause us to incur substantial costs.</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our operations expose us to litigation, environmental and other legal compliance risks. Compliance with laws and regulations can be expensive, and our failure to comply with these laws and regulations may result in monetary damages and fines, adverse publicity and a material adverse effect on our business.</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We are or will be subject to anti-corruption and anti-bribery and anti-money laundering and similar laws, and non-compliance with such laws can subject us to administrative, civil and criminal fines and penalties, collateral consequences, remedial measures and legal expenses, all of which could adversely affect our business, results of operations, financial condition and reputation.</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Sales of substantial amounts of our common stock in the public markets, or the perception that such sales could occur, could cause the market price of our common stock to drop significantly, even if our business is doing well.</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">There is no guarantee that our warrants will be in the money at the time they become exercisable, and they may expire worthless.</span></div><div id="i066fdabb1d0848d5b0391931f87c3c0e_700"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Technology, Products and Manufacturing</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If our batteries fail to perform as expected, our ability to develop, market and sell our batteries would be adversely affected.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our batteries may contain defects in design and manufacture that may cause them to not perform as expected or that may require repairs, recalls and design changes. Our batteries are inherently complex and incorporate technology and components that have not been used for certain applications and that may contain defects and errors, particularly when first introduced to such applications. Although our batteries undergo quality control testing prior to release for shipment, there can be no assurance that we will be able to detect and fix all defects prior to shipment, and nonconformances, defects or errors could occur or be present in batteries that we release for shipment to customers. If our batteries fail to perform as expected, our customers may delay deliveries, our customer may terminate orders or we may initiate product recalls, each of which could adversely affect our sales and brand and could adversely affect our business, financial condition, prospects and results of operations.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our battery architecture is different from our peers&#8217; and may behave differently in customer use applications, certain applications of which we have not yet evaluated. This could limit our ability to deliver to certain applications. In addition, our historical data on the performance and reliability of our batteries is limited, and therefore our batteries could fail unexpectedly in the field resulting in significant warranty costs or brand damage in the market. Further, the silicon anode structure of our battery is different from traditional lithium-ion batteries and therefore our batteries could be susceptible to different and unknown failure modes leading our batteries to fail and cause a safety event in the field. Such an event could result in the failure of our end customers&#8217; product as well as the loss of life or property, resulting in severe financial penalties for us, including the loss of revenue, cancellation of supply contracts and the inability to win new business due to </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_10">Table of Contents</a></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">reputational damage in the market. In addition, some of our supply agreements require us to bear certain costs relating to recalls and replacements of end products when such recalls and replacements are due to defects of our battery products that are incorporated in such end products.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not succeed in developing a new high-volume manufacturing line that meets our requirements for cell quality, yield, throughput and other performance metrics. Additionally, assuming we are able to develop a high-volume manufacturing line, it may be unreliable, require regular and significant maintenance and could be capital and resource intensive to operate.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To date, we have manufactured on a kWh-scale capacity. Our ability to manufacture our batteries at scale depends on the successful development of an automated, high-volume manufacturing line for our silicon anode that meets our requirements for cell quality, throughput, yield, and other performance metrics. Currently, we do not have a manufacturing line capable of producing our silicon anode batteries at scale. As part of our manufacturing expansion plans, in addition to designing and building a GWh-scale manufacturing facility, we are in the process of developing an automated, high-volume manufacturing line.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we have received our first large-scale anode production machine, we are customizing the machine for our production processes and must then complete tuning and testing before the machine goes online for production purposes. There is no guarantee that the customization, development and implementation of this manufacturing line will be successful. In addition, there is no guarantee that we will be able to correspondingly expand our manufacturing capacity for other battery components following the installation and implementation of such large-scale anode production machine. We and our potential suppliers and other equipment vendors may encounter significant engineering challenges, performance issues, delays, unforeseen development costs and other obstacles in building the high-volume manufacturing line, and if we are not successful, or if we encounter significant delays, our business, financial condition, prospects and results of operations would be adversely affected.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, in order for us to produce our batteries at scale and at a cost advantage, we must achieve levels of quality, throughput, and yield demonstrated for mature battery production. As we have not produced our batteries at scale, our ability to achieve such rates is untested and subject to significant constraints and uncertainties. Operational performance and costs can be difficult to predict and are often influenced by factors outside of our control, such as, but not limited to, failures by suppliers to deliver necessary components of our batteries in a timely manner and at prices and volumes acceptable to us, environmental hazards and remediation costs, costs associated with commissioning of machines, difficulty or delays in obtaining governmental permits, damages or defects in electronic systems, industrial accidents, fires, seismic activity and natural disasters, and problems with equipment vendors. Should operational risks materialize, they may result in lower yield, which would negatively affect our revenue growth and profitability.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the development of the manufacturing line will require us to make intensive capital expenditures before we are able to benefit from such development. The manufacturing line may also suffer unexpected malfunctions from time to time and will depend on repairs and spare parts to resume operations, which may not be available when needed. Further, unexpected equipment malfunctions may significantly affect the intended operational efficiency, thus materially and adversely affecting our business, financial condition, prospects and results of operations.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not meet our manufacturing cost targets, which would limit the size of our market opportunities.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We will require significant capital to develop and grow our business and expect to incur significant expenses, including those relating to the expansion of our manufacturing capacity, development of our high-volume manufacturing line, raw material procurement, leases, sales and distribution as we build our brand and market our batteries, and general and administrative costs. Our profitability will not only depend on our ability to successfully market our batteries, but also our ability to control our costs. Some of the processes in the manufacturing of our silicon anodes require chemical vapor deposition, or CVD, for which equipment is more costly than those involved in standard anode production techniques. If we are unable to cost efficiently design, manufacture, market, sell and distribute our batteries, our margins, profitability and prospects would be materially and adversely affected. We have not yet commenced high-volume production of our batteries, and any cost advantage for the production of our batteries at scale, compared to conventional lithium-ion batteries, will require us to manufacture at rates of cell quality, throughput, and yield demonstrated for mature batteries and battery material that we have not yet achieved. If we are unable to achieve these targeted rates, our business will be adversely impacted.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_10">Table of Contents</a></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We rely on, and will continue to rely on, complex equipment for our operations, and production involves a significant degree of risk and uncertainty in terms of operational performance and costs.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely heavily on, and will continue to rely heavily on, complex equipment for our operations and the production of our batteries, which involves a significant degree of uncertainty and risk in terms of operational performance and costs. Our manufacturing equipment consists of many components, which may suffer unexpected malfunctions from time to time and may depend on repairs and spare parts to resume operations, which may not be available when needed. Problems with our manufacturing processes could result in the loss of manufacturing equipment, damage to manufacturing facilities, monetary losses, delays, unanticipated fluctuations in production and personal injury to or death of workers. Should these precautions be inadequate or an event be larger than expected, we could have significant equipment or facility damage that would impact our ability to deliver our battery products and require additional cash to recover. In addition, in some cases, operational problems may result in environmental damage, administrative fines, increased insurance costs and potential legal liabilities. Any of these operational problems, or a combination of them could have a material adverse effect on our cash flows, business, financial condition, prospects or results of operations.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, manufacturing technology may evolve rapidly, and we may decide to update our manufacturing processes more quickly than expected. Moreover, as we scale the commercial production of our batteries, our experience may cause us to discontinue the use of already installed equipment in favor of different or additional equipment. The useful life of any equipment that would be retired early as a result would be shortened, causing the depreciation on such equipment to be accelerated, and our results of operations could be negatively impacted.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our establishment of a volume manufacturing facility is subject to many risks, including, among others, risks relating to executing a definitive lease agreement, re-zoning, construction, permitting, delays, cost overruns, supply chain constraints, and operating in a new geographic area away from our current headquarters.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently operate only at a kWh-scale manufacturing capacity. As part of our manufacturing expansion plans, we are in the process of designing a GWh-scale manufacturing facility for our batteries, concurrently with the development of our high-volume manufacturing line for our silicon anode. We may not be successful in establishing our GWh-scale manufacturing facility. On April&#160;15, 2023, we entered into a lease agreement for premises consisting of approximately 774,000 square feet of space located in Brighton, Colorado, and we are in the process of designing and building our GWh-scale manufacturing facility on these premises. The current zoning for this site does not allow for manufacturing our batteries. As such, the landlord is in the process of applying to re-zone the site for our planned development and use. While we expect the re-zoning to be completed by September 2023, the re-zoning application may not be approved and we may not be able to obtain the necessary licenses or permits for the manufacturing facility, which will delay the expected timing for our GWh-scale manufacturing facility. Until the re-zoning is complete, we will not be able to apply for permits required to repurpose the facility for manufacturing. Furthermore, if the re-zoning process is unsuccessful, we expect that we would terminate the lease in accordance with its terms and recommence our search for an alternate location for our expansion efforts, which will delay our operational timeline.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we will need to operate the manufacturing facility in a new geographic area away from our current headquarters. Our potential suppliers and other equipment vendors may also encounter delays, additional costs, and other obstacles in building our manufacturing line, which are currently unknown. Additionally, although we have tested and validated the performance of our products on one supplier&#8217;s platform, there is uncertainty as to whether our planned manufacturing line will be successful. If we fail to complete the construction in an efficient manner, or fail to recruit the required personnel and generally manage our growth effectively, large-scale production of our batteries could be curtailed or delayed. </span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Achieving capacity at commercial scale of high energy density lithium-ion batteries will require us to make significant and increasing capital expenditures to scale our production capacity and improve our supply chain processes. Further, because our silicon anode process requires different equipment than traditional anode manufacturing, our capital equipment costs are likely to be higher than equipment used for production of graphite anodes. Based on our current expectations, we estimate that our capital equipment expenditures will range between $120.0 million and $150.0 million to achieve 1.0 GWh per year of manufacturing capacity. The actual costs and time to complete our silicon anode process may materially exceed such estimates, if we are able to at all. Even if we are successful in the establishment of the new facility, our manufacturing capabilities could be affected by cost-overruns, unexpected delays, equipment failures, supply chain constraints, natural disasters, including earthquakes, fire, floods and typhoons, power failures, telecommunications failures, break-ins, war, riots, terrorist attacks and numerous other factors that could prevent us from realizing the intended benefits of our manufacturing strategy, or cause the loss or corruption of data or malfunctions of software or hardware, and have a material adverse effect on our business.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_10">Table of Contents</a></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not succeed in retaining and attracting key employees, particularly technical talent, needed to operate and build our business successfully.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success depends on our ability to attract and retain our executive officers, key employees and other qualified personnel, particularly technical talent, and as a relatively small company with key talent residing in a limited number of employees, our operations may be severely disrupted if we lost their services. In particular, we are highly dependent on the services of Dr. Kang Sun, our Chief Executive Officer, and other senior technical and management personnel, including our executive officers, who would be difficult to replace.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If Dr. Sun or any other key personnel were to depart, we may not be able to successfully attract and retain senior leadership necessary to grow our business. As we build our brand and become better known, there is increased risk that competitors or other companies will seek to hire our personnel. The failure to attract, integrate, train, motivate and retain these personnel could seriously harm our business and prospects.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, designing, building and operating our new manufacturing facility and large-scale production tools will require us to hire highly skilled personnel, including battery factory design and operations experts. There are currently a limited number of people with this experience in the United States. Recruiting and training skilled engineers, workers and other laborers will take significant cost and time, and an inability to do so timely or at all would inhibit the successful design, build-out and operation of the new manufacturing facility, thus negatively affecting our business and our results of operations.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Certain of our officers and Board of Directors provide services to Amprius Holdings and other entities formerly affiliated with Amprius Holdings.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our officers and Board of Directors provide services to Amprius Holdings. Also, Dr. Kang Sun, our Chief Executive Officer, serves on the boards of certain entities that were formerly affiliated with Amprius Holdings. As a result, there could be competition for the time and effort of these individuals and potential conflicts of interests in our transactions with such entities. If such officers and directors do not devote sufficient attention to the management and operation of our business or if such conflicts of interest are not resolved, our business and financial results may suffer.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may encounter delays and technical obstacles in developing new battery products such as different cell formats to meet varied market requirements.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our customers often require unique battery configurations or custom designs for their products. Once we enter into contracts with customers to produce batteries for their products, we expect to tailor the design of our batteries specifically to the products that these customers manufacture. This development process requires not only substantial lead time between the commencement of design efforts for customized batteries and the commencement of volume shipments of the battery cells to the customer, but also the cooperation and assistance of the customer in order to determine the requirements for each specific application. Technical problems may arise that affect the acceptance of our battery products by the customers. Our ability to tailor our batteries to meet the needs of our customers is affected by whether we can, amongst other things: </span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">receive and maintain necessary intellectual property protections;</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">obtain governmental approvals and registrations;</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">comply with governmental regulations;</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">further develop and refine our technology; and</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">anticipate customer needs and preferences successfully.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we are unable to design and develop new battery products that meet our customers&#8217; requirements, we may lose opportunities to obtain purchase orders, and our reputation and prospects may be damaged.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Certain components of our batteries are hazardous and pose safety risks that may cause accidents in our manufacturing facility. We may be subject to financial and reputational risks due to product recalls and product liability claims, and we could face substantial liabilities that exceed our resources.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the high energy density inherent in lithium-ion batteries, our batteries can pose certain safety risks, including the risk of fire. Accidents causing death or personal injury or property damage, can occur, and no high energy density battery will ever be 100% safe. For example, under certain abuse conditions, lithium-ion batteries can go into thermal </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_10">Table of Contents</a></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">runaway, which can result in fire. Although we incorporate safety procedures in the research, development, manufacture and transportation of batteries that are designed to minimize safety risks, the manufacture or use of our battery products may still cause accidents. Any accident, whether occurring at our manufacturing facilities or from the use of our battery products, may result in significant production interruption, delays or claims for substantial damages caused by personal injuries or property damage.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, due to the harsh environments in which batteries are used&#8212;extremely low temperature and pressure, and combat for military applications&#8212;our batteries go through rigorous testing to ensure safe behavior under abuse-case conditions. Although such tests have been successful to date, we cannot assure you such tests will be successful in the future. If we have to make design changes to address any safety issues, we may have to delay or suspend our planned production, which could materially damage our brand, business, financial condition, prospects and results of operations.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Product liability claims, even those without merit or those that do not involve our battery products, could harm our business, financial condition, prospects and results of operations.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A successful product liability claim against us, resulting from safety issues or otherwise, could require us to pay a substantial monetary award. We may not be able to cover any substantial monetary judgment against us. Moreover, a product liability claim against us or our competitors could generate substantial negative publicity about our battery products and could have a material adverse effect on our brand, business, financial condition, prospects and results of operations.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be able to accurately estimate the future supply and demand for our batteries, which could result in a variety of inefficiencies in our business and hinder our ability to generate revenue. If we fail to accurately predict our manufacturing requirements, we could incur additional costs or experience delays.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We anticipate being required to provide forecasts of our demand to our current and future suppliers prior to the scheduled delivery of products to potential customers. Currently, there is limited historical basis for making judgments on the demand for our batteries and our ability to develop, manufacture, and deliver our battery products. Our customers&#8217; final purchase orders may not be consistent with our estimates. If we overestimate our requirements, our suppliers may deliver excess inventory, which indirectly would increase our costs and result in unprofitable sales or write-offs. Given that our batteries are often customized to meet our customers&#8217; specifications, they are susceptible to obsolescence due to their limited shelf life. Because we have no history of large-scale production, we may also be unable to forecast accurately the pace of manufacturing or the take-up of our battery products by our customers.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we underestimate our requirements, our suppliers may have inadequate inventory, which could interrupt manufacturing of our battery products and result in delays in shipments and revenues. In addition, lead times for materials and components that our suppliers order may vary significantly and depend on factors such as the specific supplier, contract terms and demand for each component at a given time. If we fail to order sufficient quantities of battery components in a timely manner, the delivery of our batteries to our potential customers could be delayed, which would harm our business, financial condition and results of operations. Producing additional battery products to make up for any shortages within a short time frame may be difficult, making us unable to fulfill the purchase orders, especially due to the customized nature of our batteries. In either case, our business, financial condition, prospects and results of operations may be adversely affected.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be able to establish supply relationships for necessary materials, components or equipment or may be required to pay more than anticipated for components or equipment, which could negatively impact our business.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on third-party suppliers for components necessary to develop and manufacture our batteries, including key supplies such as our silane gas, substrate foil, electrolytes, separators, and cathode materials. We face risks relating to the availability of these materials and components, including that we will be subject to demand shortages and supply chain challenges and generally may not have sufficient purchasing power to eliminate the risk of price increases for the raw materials and lines we need. For example, we expect to procure the silane gas needed for our manufacturing from one vendor, a global supplier of silane and silicon materials; however, we expect that they may not be able to supply the volume required for highly scaled production. We are also in the process of collaborating with other key suppliers but have not yet entered into agreements for the supply of scaled production quantities of these materials. To the extent that we are unable to enter into commercial agreements with these suppliers on beneficial terms, or these suppliers experience difficulties ramping up their supply of materials to meet our requirements, high-volume production of our batteries will be delayed and we will not be able to meet our production timelines.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_10">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Separately, we may be subject to various supply chain requirements regarding, among other things, conflict minerals and labor practices. We may be required to incur substantial costs to comply with these requirements, which may include locating new suppliers to replace existing ones. We may not be able to find any new suppliers for certain raw materials or components required for our operations, or such suppliers may be unwilling or unable to provide us with products.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to incur significant costs related to procuring materials required to manufacture and assemble our batteries. We expect to use various materials in our batteries that will require us to negotiate purchase agreements and delivery lead-times on advantageous terms. We may not be able to control fluctuation in the prices for these materials or negotiate agreements with suppliers on terms that are beneficial to us. Substantial increases in the prices for our raw materials, or our inability to reduce our raw material costs as we scale, would negatively impact our prospects.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any disruption in the supply of components or materials could temporarily disrupt research and development activities or production of our batteries until an alternative supplier is able to supply the required material. Changes in business conditions, unforeseen circumstances, governmental changes, and other factors beyond our control or which we do not presently anticipate, could also affect our suppliers&#8217; ability to deliver components to us on a timely basis. Any of the foregoing could materially and adversely affect our business, financial condition, prospects and results of operations.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are actively monitoring the impacts of Russia&#8217;s invasion of Ukraine and continuing to assess its potential to adversely affect our business. Our business has not been directly impacted by this ongoing military conflict, as we have no assets or operations, and we have not purchased materials from, Russia, Belarus or Ukraine. To date, we have not experienced any material disruption in our business. Accordingly, we have not yet taken measures to mitigate potential adverse effects of such conflict. However, the length and outcome of Russia&#8217;s invasion of Ukraine is highly unpredictable. The conflict may continue to cause significant market and other disruptions, including significant volatility in commodity prices, supply of components and supply chain interruptions, which could adversely and adversely affect our business, financial condition, prospects and results of operations.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Currency fluctuations, geopolitics, trade barriers, embargoes, tariffs or shortages and other general economic or political conditions may limit our ability to obtain key components for our batteries or significantly increase freight charges, raw material costs and other expenses associated with our business, which could materially and adversely affect our business, financial condition, prospects and results of operations.</span></div><div id="i066fdabb1d0848d5b0391931f87c3c0e_707"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Business and Industry</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The battery market is intensely competitive. Competitors include new entrants and established companies, many of which have significantly greater resources than us. Our battery products must compete with advances in new battery chemistries and manufacturing methods as well as continued improvements in conventional batteries and battery anodes.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The battery market in which we compete continues to evolve rapidly and is highly competitive. To date, we have focused our efforts on our silicon anode technology, which is designed to outperform conventional lithium-ion battery technology and other battery technologies. However, lithium-ion battery technology has been widely adopted and our current competitors have, and future competitors may have, greater resources than us and may also be able to devote greater resources to the development of their current and future technologies. These competitors also may have greater access to customers and may be able to establish cooperative or strategic relationships amongst themselves or with third parties that may further enhance their resources and competitive positioning. In addition, lithium-ion battery manufacturers may make improvements in energy density faster than they have historically, continue to reduce cost and expand supply of conventional batteries and therefore reduce our energy density advantage and price premium, which would negatively impact the prospects for our business or negatively impact our ability to sell our battery products at a market-competitive price and with sufficient margins.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are a number of companies seeking to develop alternative approaches to lithium-ion battery technology. We expect competition in battery technology to intensify. Developments in alternative technologies or improvements in batteries technology made by competitors may materially adversely affect the sales, pricing and gross margins of our batteries. If a competing technology is developed that has superior operational or price performance, our business will be harmed. If we fail to accurately predict and ensure that our battery technology can address customers&#8217; changing needs or emerging technological trends, or if our customers fail to achieve the benefits expected from our silicon anode technology, our business will be harmed.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to commit significant resources to scale our battery manufacturing capacity and maintain a competitive position, and these commitments may be made without knowing whether such investments will result in products potential </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_10">Table of Contents</a></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">customers will accept. There is no assurance we will successfully identify new customer requirements, develop and bring our batteries to market on a timely basis, or that products and technologies developed by others will not render our batteries obsolete or noncompetitive, any of which would adversely affect our business, financial condition and results of operations.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Customers will be less likely to purchase our batteries if they are not convinced that our business will succeed in the long term. Similarly, suppliers and other third parties will be less likely to invest time and resources in developing business relationships with us if they are not convinced that our business will succeed in the long term. Accordingly, in order to build and maintain our business, we must maintain confidence among current and future partners, customers, suppliers, analysts, ratings agencies and other parties in our long-term financial viability and business prospects. Maintaining such confidence may be particularly complicated by certain factors including those that are largely outside of our control, such as our limited operating history, market unfamiliarity with our battery products, any delays in scaling manufacturing, delivery and service operations to meet demand, competition and uncertainty regarding our production and sales performance compared with market expectations.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our future sales opportunities depend in part on the growth of markets for battery-powered aviation applications. These applications may develop slower or at a size that is less than expected, to the extent they develop at all.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our growth and future demand for our battery products is dependent in part upon the adoption by consumers of alternative fuel vehicles in general and battery-powered aviation applications in particular. The market for new energy vehicles is still evolving, characterized by changing technologies, competitive pricing and competitive factors, evolving government regulation and industry standards, and changing consumer demands and behaviors.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Market estimates and growth forecasts are also subject to significant uncertainty and are based on assumptions and estimates that may prove to be inaccurate. For example, if the assumptions that we base our market forecasts on, including the continued development and availability of high performance batteries at a competitive price point, OEM investment in aircraft and software, consumer preference and, with respect to electric air transportation, regulatory approval and the requisite infrastructure, are incorrect, this expected growth may occur slower than expected, if it occurs at all. If the market for battery-powered applications in general does not develop as expected, or develops more slowly than expected, our business, financial condition, prospects and results of operations could be harmed.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Developments in alternative technology or other fossil fuel alternatives may adversely affect the demand for our battery products.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant developments in alternative technologies, such as fuel cell technology, advanced diesel, ethanol or natural gas, or breathing batteries, may materially and adversely affect our business, financial condition, prospects and results of operations in ways that we may not currently anticipate. Existing and other battery technologies, fuels or sources of energy may emerge as customers&#8217; preferred alternatives to our battery products. Any failure by us to develop new or enhanced technologies or processes, or to react to changes in existing technologies, could materially delay our development and introduction of new and enhanced alternative products, which could result in decreased revenue and adversely affect our prospects.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our research and development efforts may not be sufficient to adapt to changes in alternative fuels or aviation and EV technology. As technologies evolve, we plan to develop more efficient manufacturing processes, and advanced battery chemistry, which may also negatively impact the adoption of our other battery products. However, we may not compete effectively with alternative systems if we are not able to develop, source and integrate the latest technology into our battery products.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have pursued and may continue to pursue development agreements and other strategic alliances, which could have an adverse impact on our business if they are unsuccessful.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into development agreements and master supply agreements with certain of our customers, and may in the future enter into similar arrangements and development agreements with our customers, including with Airbus and the U.S. Army. While offering potential benefits, these strategic alliances with OEMs and others could subject us to a number of risks, including risks associated with sharing proprietary information, non-performance by our partners and costs of establishing and maintaining new strategic alliances, any of which may materially and adversely affect our business. We may have limited ability to monitor or control the actions of our partners and, to the extent any of them suffers negative publicity or harm to their reputation from events relating to their business, we may also suffer negative publicity or harm to our reputation by virtue of our association with them. For example, if we rely on our partners&#8217; manufacturing facilities, those operations would be outside of our control. We could experience delays if our partners do </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_10">Table of Contents</a></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">not meet agreed-upon timelines or experience capacity constraints, and in turn, we could lose customers and face reputational harm.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our ability to grow will depend, in part, on our ability to contract with aviation and EV OEMs to incorporate our batteries in their products, which will require significant time and expense, and may not come to fruition.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success, and our ability to increase revenue and operate profitably, depends in part on our ability to contract with aviation and EV OEMs. This process will require significant time and resources, especially for incorporation into EVs. For example, EV manufacturers frequently require several years of evaluation prior to incorporating new products, like our batteries, into their EVs. This evaluation process includes, among other things, extensive safety and abuse tests, performance tests and cost modeling. We have not begun this process with any EV manufacturers. Thus, our efforts to expand our manufacturing and sales to OEMs may not be successful, and may never result in products that achieve market acceptance, create additional revenue or become profitable, thus harming our business, financial condition, prospects and results of operations.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our research and development efforts strive to create products that are on the cutting edge of technology and meeting the evolving requirements of our customers, but competition in our industry is high. To secure acceptance of our battery products, we must also constantly develop and introduce cost-effective, increasingly more scalable silicon anode batteries with enhanced functionality and performance to meet evolving industry standards. If we are unable to retain and grow our existing customer relationships, or convert early trial deployments into meaningful orders, our business, financial condition, prospects and results of operations could be materially adversely affected.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If existing customers do not make subsequent purchases from us or renew their contracts with us, our revenue could decline, and our results of operations would be adversely impacted.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We derive a significant portion of our revenue from existing customers that expand their relationships with us. Increasing the size and number of the deployments of our existing customers is an important part of our growth strategy. We may not be effective in executing this or any other aspect of our growth strategy.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For our customers who individually represent 10% or more of our revenue, three customers together accounted for 76% of our revenue during the three months ended March&#160;31, 2023 and three customers together accounted for 90% of our revenue during the three months ended March&#160;31, 2022. Certain of our customers, including customers that represent a significant portion of our business, have in the past reduced their spend with us or terminated their agreements with us, which has reduced our anticipated future cash receipts or revenue from these customers. It is not possible for us to predict the future level of demand from our larger customers for our battery products, and there can be no assurance that our existing customers will continue to purchase from us.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Achieving renewal or expansion of deployments may require us to increasingly engage in sophisticated and costly sales efforts that may not result in additional sales. In addition, our customers&#8217; decisions to expand the use of our battery products depends on a number of factors, including general economic conditions, the functioning of our batteries, and our customers&#8217; satisfaction with our battery products. If our efforts to expand within our existing customer base are not successful, our business may suffer.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may require additional capital to support business growth, and this capital might not be available on commercially reasonable terms or at all.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may need additional capital before we commence production at scale, and it may not be available on acceptable terms, if at all. For example, our capital budget assumes, among other things, that our development timeline progresses as planned and our corresponding expenditures are consistent with current expectations, both of which are subject to various risks and uncertainties, including those described herein, and, as needed, that we are able to utilize the Committed Equity Financing.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">More specifically, we expect our capital expenditures and working capital requirements to increase materially in the near future, as we design our automated, high-volume manufacturing line and scale up production. Through this process, we expect our operating expenses will increase substantially on account of increased headcount and other general and administrative expenses necessary to support a rapidly growing company.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_10">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result, we may need to access the debt and equity capital markets, including through the Committed Equity Financing, to obtain additional financing in the future. However, these sources of financing may not be available on acceptable terms, or at all. Our ability to obtain additional financing will be subject to a number of factors, including:</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">market conditions;</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the level of success with our current manufacturing capabilities;</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our operating performance;</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">investor sentiment; and</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to incur additional debt in compliance with any agreements governing our then-outstanding debt.</span></div><div style="padding-left:7.2pt"><span><br/></span></div><div style="text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, the sale of a substantial number of securities under our Registration Statement on Form S-1 filed with the SEC on September 30, 2022 or to </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">B. Riley Principal Capital II, LLC ("</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">BRPC II") in the Committed Equity Financing, or the anticipation of such sales, could make it more difficult for us to sell equity or equity-related securities in the future at a time and at a price that we might otherwise wish to effect sales. </span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, the military conflict between Russia and Ukraine, which began in February 2022, has had an adverse impact on the global economy and financial markets. Although our business has not been directly impacted by this ongoing military conflict, as we have no assets or operations, and we have not purchased materials from, Russia, Belarus or Ukraine, it is impossible to predict the extent to which our operations, or those of our customers, suppliers and manufacturers, will be impacted in the short and long term, or the ways in which the conflict may impact our business. The extent and duration of the military action, sanctions and resulting market disruptions are impossible to predict, but could be material.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, actual events involving limited liquidity, defaults, non-performance or other adverse developments that affect financial institutions or the financial services industry generally, or concerns or rumors about any events of these kinds or other similar risks, have in the past and may in the future lead to market-wide liquidity problems. These factors may make the timing, amount, terms or conditions of additional financings unattractive to us. If we raise additional funds by issuing equity, equity-linked or debt securities, those securities may have rights, references or privileges senior to the rights of our currently issued and outstanding equity or debt, and our existing stockholders may experience dilution. If we are unable to generate sufficient funds from operations, raise additional capital or access our existing funds, we may be forced to take actions to reduce our capital or operating expenditures, including by eliminating redundancies, or reducing or delaying our production facility expansions, which may adversely affect our business, financial condition, prospects and results of operations.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">It is not possible to predict the actual number of shares we will sell under the Purchase Agreement to BRPC II, or the actual gross proceeds resulting from those sales.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September&#160;27, 2022, we entered into a Common Stock Purchase Agreement with BRPC II ("Purchase Agreement"), pursuant to which BRPC II committed to purchase up to $200.0 million of shares of our common stock, subject to certain limitations and conditions set forth in the Purchase Agreement (the &#8220;Committed Equity Financing&#8221;). The shares of our common stock that may be issued under the Purchase Agreement may be sold by us to BRPC II at our discretion from time to time until January&#160;1, 2025.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We generally have the right to control the timing and amount of any sales of our shares of common stock to BRPC II under the Purchase Agreement. Sales of our common stock, if any, to BRPC II under the Purchase Agreement will depend upon market conditions and other factors to be determined by us. We may ultimately decide to sell to BRPC II all, some or none of the shares of our common stock that may be available for us to sell to BRPC II pursuant to the Purchase Agreement.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As consideration for BRPC II&#8217;s commitment to purchase shares of common stock at our direction upon the terms and subject to the conditions set forth in the Purchase Agreement, upon execution of the Purchase Agreement, we issued 84,793 shares of common stock (the &#8220;Initial Commitment Shares&#8221;) to BRPC II. Upon our receipt of total aggregate gross cash proceeds equal to $100.0 million from BRPC II under the Purchase Agreement, we will issue 84,793 additional shares of common stock (collectively with the Initial Commitment Shares, the &#8220;Commitment Shares&#8221;) to BRPC II.  Any shares of common stock issued in the Committed Equity Financing to BRPC II other than the Commitment Shares will be purchased by BRPC II at current market prices less a 3.0% fixed discount. Because the purchase price per share to be paid by BRPC II for the shares of common stock that we may elect to sell to BRPC II under the Purchase Agreement, if any, will fluctuate based on the market prices of our common stock at the time we elect to sell shares to BRPC II pursuant to the Purchase </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_10">Table of Contents</a></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Agreement, if any, it is not possible for us to predict, prior to any such sales, the number of shares of common stock that we will sell to BRPC II under the Purchase Agreement, the purchase price per share that BRPC II will pay for shares purchased from us under the Purchase Agreement, or the aggregate gross proceeds that we will receive from those purchases by BRPC II under the Purchase Agreement.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although the Purchase Agreement provides that we may sell up to an additional $197.6 million of our common stock to BRPC II, only 16,409,222 shares of our common stock were registered for resale under a registration statement on Form S-1 (the &#8220;Committed Equity Registration Statement&#8221;) filed with the SEC on September 30, 2022 and declared effective by the SEC on December 27, 2022, as amended by Post-Effective Amendment No. 1. If it becomes necessary for us to issue and sell to BRPC II under the Purchase Agreement more than the 16,825,366 shares being registered for resale under the Committed Equity Registration Statement in order to receive aggregate gross proceeds equal to $200.0 million under the Purchase Agreement, we must first file with the SEC one or more additional registration statements to register under the Securities Act the resale by BRPC II of any such additional shares of our common stock we wish to sell from time to time under the Purchase Agreement, which the SEC must declare effective before we may elect to sell any additional shares of our common stock to BRPC II under the Purchase Agreement.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the applicable rules of the New York Stock Exchange (the "NYSE"), in no event may we issue to BRPC II under the Purchase Agreement more than the Exchange Cap, unless we obtain stockholder approval to issue shares of common stock in excess of the Exchange Cap in accordance with the applicable NYSE rules. The Exchange Cap is not applicable to issuances and sales of common stock pursuant to VWAP Purchases and Intraday VWAP Purchases that we may effect pursuant to the Purchase Agreement, to the extent such shares of common stock are sold in such VWAP Purchases and Intraday VWAP Purchases (as applicable) at a price equal to or in excess of the applicable &#8220;minimum price&#8221; (as defined in the applicable listing rules of the NYSE) of the common stock, calculated at the time such VWAP Purchases and Intraday VWAP Purchases (as applicable) are effected by us under the Purchase Agreement, if any, as adjusted to take into account our issuance of the Commitment Shares to BRPC II and our reimbursement of a certain amount of BRPC II&#8217;s legal fees and expenses. Moreover, we may not issue or sell any shares of common stock to BRPC II under the Purchase Agreement which, when aggregated with all other shares of common stock then beneficially owned by BRPC II and its affiliates (as calculated pursuant to Section 13(d) of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), and Rule 13d-3 thereunder), would result in BRPC II beneficially owning more than 4.99% of the outstanding shares of common stock.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any issuance and sale by us under the Purchase Agreement of a substantial number of shares of common stock in addition to the 16,409,222 shares of common stock that were registered for resale by BRPC II under the Committed Equity Registration Statement could cause additional substantial dilution to our stockholders. The number of shares of our common stock ultimately offered for sale by BRPC II is dependent upon the number of shares of common stock, if any, we ultimately elect to sell to BRPC II under the Purchase Agreement.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our future growth and success depend in part on our ability to grow our customer base and effectively sell to a wide variety of customers.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our potential customers are manufacturers of products that tend to be large enterprises or governmental agencies. Therefore, our future success will depend on our ability to grow our customer base and effectively sell to a wide variety of customers. Sales to these end-customers involve risks that may not be present (or that are present to a lesser extent) with sales to smaller customers. These risks include, but are not limited to, (i) increased purchasing power and leverage held by large customers in negotiating contractual arrangements with us and (ii) longer sales cycles and the associated risk that substantial time and resources may be spent on a potential end-customer that elects not to purchase our solutions.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Large organizations often undertake a significant evaluation process that results in a lengthy sales cycle. In addition, product purchases by large organizations are frequently subject to budget constraints, multiple approvals and unanticipated administrative, processing and other delays. Finally, large organizations typically have longer implementation cycles, require greater product functionality and scalability, require a broader range of services, demand that vendors take on a larger share of risks, require acceptance provisions that can lead to a delay in revenue recognition and expect greater payment flexibility. All of these factors can add further risk to business conducted with these potential customers.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, if we were unable to maintain or increase our customer retention rates or generate new customers in a cost-effective manner, our business, financial condition and results of operations would likely be adversely affected. We cannot assure you that we will be able to maintain or grow our customer base in a cost-effective way. If we are unable to develop high quality products at scale, or introduce new products, we may fail to attract new customers or lose our existing customers, which could adversely affect our growth and profitability.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_10">Table of Contents</a></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business model has yet to be tested and any failure to realize our strategic plans would have an adverse effect on our operating results and business, harm our reputation and could result in substantial liabilities that exceed our resources.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is additional risk associated with new enterprises like Amprius, that are encountering new challenges and issues for the first time, many of which are beyond our control, including substantial risks and expenses in the course of establishing or entering new markets, organizing operations and undertaking marketing activities. The likelihood of our success must be considered in light of these risks, expenses, complications, delays and the competitive environment in which we operate. There is, therefore, nothing at this time upon which to base an assumption that our business plan will prove successful, and we may not be able to generate significant revenue, raise additional capital or operate profitably. We will continue to encounter risks and difficulties frequently experienced by early commercial stage companies, including scaling up our infrastructure and headcount, and may encounter unforeseen expenses, difficulties or delays in connection with our growth. In addition, as a result of the capital requirements of our business, we can be expected to continue to sustain substantial operating expenses without generating sufficient revenue to cover expenditures. Any investment in our company is therefore highly speculative and could result in the loss of your entire investment.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is difficult to predict our future revenues and appropriately budget for our expenses, and we have limited insight into trends that may emerge and affect our business. In the event that actual results differ from our estimates or we adjust our estimates in future periods, our business, financial condition, prospects and results of operations could be materially affected.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are an early stage company with a history of financial losses and expect to incur significant expenses and continuing losses for the foreseeable future.</span></div><div style="text-indent:25.2pt"><span><br/></span></div><div style="text-indent:25.2pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have incurred significant operating losses since our inception, including in the comparable periods presented in this Quarterly Report on Form 10-Q. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that we will continue to incur operating and net losses each quarter until at least the time we begin scaled production of our batteries.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect the rate at which we will incur losses to be significantly higher in future periods as we, among other things: continue to incur significant expenses in connection with building out our high-volume manufacturing facility and manufacturing line; endeavor to hire the experienced scientific, quality-control, and manufacturing personnel needed to operate our scaled manufacturing processes; build up inventories of components for our batteries; increase our sales and marketing activities; develop our distribution infrastructure; and increase our general and administrative functions to support our growing operations. We may find that these efforts are more expensive than we currently anticipate or that these efforts may not result in revenues, which would further increase our losses.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we fail to effectively manage our future personnel growth, we may not be able to market and sell our batteries successfully.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our future success depends upon our ability to grow, and if we are unable to manage our personnel growth effectively, we may incur unexpected expenses and be unable to meet our eventual customers&#8217; requirements, all of which could materially adversely affect our business, financial condition, prospects and results of operations. To manage our current and anticipated future growth effectively, we must continue to maintain and enhance our infrastructure, financial and accounting systems, and controls. We must also attract, train and retain a significant number of scientists, engineers, sales and marketing personnel, technical and manufacturing personnel, and management personnel, and the availability of such personnel may be constrained. For more information, see &#8220;&#8212;We may not succeed in retaining and attracting key employees, particularly technical talent, needed to operate and build our business successfully.&#8221;</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As we continue to grow, including from the integration of employees and businesses acquired in connection with future acquisitions, we may find it difficult to maintain important aspects of our corporate culture, which could negatively affect our profitability and our ability to retain and recruit qualified personnel who are essential for our future success. If we do not effectively manage our growth, we may not be able to execute on our growth plan, respond to competitive pressures, take advantage of market opportunities, satisfy customer requirements or manufacture high-quality battery products. Additionally, we may not be able to expand and upgrade our infrastructure to accommodate future growth.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Failure to effectively manage our growth could also lead us to over-invest or under-invest in development and operations; result in weaknesses in our infrastructure, systems or controls; give rise to operational mistakes, financial losses, loss of productivity or business opportunities; and result in loss of employees and reduced productivity of remaining employees. Our growth is expected to require significant capital expenditures, which may lower our earnings, and may divert financial resources from other projects such as the development of new products and services. If we are unable to </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_10">Table of Contents</a></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">manage our growth effectively, our expenses may increase more than expected, our revenue may not increase or may grow more slowly than expected and we may be unable to implement our business strategy.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be able to complete the merger transaction with Amprius Holdings, thereby not allowing us to realize the potential benefits associated with the transaction,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">and we could continue to incur significant costs, expenses and fees for professional services and other transaction costs in connection with the merger for which we will have received little or no benefit if the merger is not completed.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 10, 2023, we announced the signing of a definitive agreement to effect a merger with Amprius Holdings. There can be no assurance that the merger will occur. The merger is conditioned upon, among other things, the effectiveness of a registration statement and obtaining the approval of a majority of shares held by our stockholders that are not affiliated with either Amprius Holdings or held by any of our directors or officers, and there can be no assurance that these conditions or any other conditions will be satisfied in a timely manner or at all. Failure to satisfy any such condition may result in a material delay in, or the abandonment of, the merger. Any delay in completing the merger may materially adversely affect the timing and benefits that are expected to be achieved from the merger. Further, we will continue to incur significant costs, expenses and fees for professional services and other transaction costs in connection with the merger for which we will have received little or no benefit if the merger is not completed. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have been, and may in the future be, adversely affected by the global COVID-19 pandemic and/or any other pandemic.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We face various risks related to epidemics, pandemics and other outbreaks, including the recent COVID-19 pandemic. The impact of COVID-19, including changes in consumer and business behavior, pandemic fears and market downturns, and restrictions on business and individual activities, has created significant volatility in the global economy and led to reduced economic activity. If a significant portion of our workforce is unable to work due to COVID-19 illness, quarantine or other government restrictions in connection with COVID-19, our operations may be negatively impacted. The spread of COVID-19 has also impacted our potential customers and suppliers by disrupting the manufacturing, delivery and overall supply chain of battery and device manufacturers. As a result, the effects of the COVID-19 pandemic could impact the availability of materials and resources necessary for our operations.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The pandemic has resulted in government authorities implementing numerous measures to try to contain the virus, such as travel bans and restrictions, quarantines, stay-at-home or shelter-in-place orders, and business shutdowns. For example, some employees at our headquarters located in Fremont, California were subject to a stay-at-home order from the state government for a period of time. These measures have and may continue to adversely impact our employees and operations and the operations of our suppliers, vendors and business partners, and may negatively impact our sales and marketing activities. In addition, various aspects of our business cannot be conducted remotely. These measures by government authorities may remain in place for a significant period of time and could adversely affect our future manufacturing plans, sales and marketing activities, business and results of operations. We may take further actions as may be required by government authorities or that we determine are in the best interests of our employees, suppliers, vendors and business partners.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The extent to which the COVID-19 pandemic continues to impact our business, financial condition, prospects and results of operations will depend on future developments, which are highly uncertain and cannot be predicted, including the duration and spread of the pandemic, its severity, the actions to contain the virus or treat its impact, and how quickly and to what extent normal economic and operating activities can resume. Even after the COVID-19 pandemic has subsided, we may continue to experience an adverse impact to our business as a result of its global economic impact, including any economic recession that has occurred or may occur in the future.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no comparable recent events that may provide guidance as to the effect of the spread of COVID-19 and a pandemic, and, as a result, the ultimate impact of the COVID-19 pandemic or a similar health epidemic is highly uncertain.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Certain members of our management do not have experience in operating a public company.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our executive officers do not have experience in the management of a publicly traded company. Our management team may not successfully or effectively manage our recent transition to being a public company due to significant regulatory oversight and reporting obligations under federal securities laws and the continuous scrutiny of securities analysts and investors. We may not have adequate personnel with the appropriate level of knowledge, experience and training in the policies, practices or internal controls over financial reporting required of public companies in the United States. As a result, we may be required to pay higher outside legal, accounting or consulting costs than our competitors, and our management team members may have to devote a higher proportion of their time to issues relating to </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_10">Table of Contents</a></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">compliance with the laws applicable to public companies, both of which might put us at a disadvantage relative to competitors.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our insurance coverage may not be adequate to protect us from all business risks.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may be subject, in the ordinary course of business, to losses resulting from product liability, accidents, acts of God, and other claims against us, for which we may have no insurance coverage. As a general matter, the policies that we do have may include significant deductibles or self-insured retentions, and we cannot be certain that our insurance coverage will be sufficient to cover all future losses or claims against us. A loss that is uninsured or which exceeds policy limits may require us to pay substantial amounts, which could adversely affect our business, financial condition and results of operations.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our cash and cash equivalents could be adversely affected if the financial institutions in which we hold our cash and cash equivalents fail.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We regularly maintain cash balances at third-party financial institutions, including Silicon Valley Bank, in excess of the Federal Deposit Insurance Corporation insurance limit. Silicon Valley Bank&#8217;s temporary failure to return certain of our deposits briefly impacted access to our invested cash or cash equivalents, and a similar failure of a depository institution to return these deposits, or if a depository institution is subject to other adverse conditions in the financial or credit markets, could further impact access to our invested cash or cash equivalents and could adversely impact our operating liquidity and financial performance.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have previously identified material weaknesses in our internal controls over financial reporting. If we are unable to develop and maintain an effective system of internal controls and procedures required by Section 404(a) of the Sarbanes-Oxley Act, we may not be able to accurately report our financial results in a timely manner, which may adversely affect investor confidence in us and materially and adversely affect our stock price, business and operating results.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Effective internal control over financial reporting is necessary for us to provide reliable financial reports in a timely manner. In connection with the audit of our financial statements for the years ended December 31, 2022 and 2021, we identified two material weaknesses in our internal control over financial reporting that have not been remediated as of March 31, 2023. A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The first material weakness was related to not designing or maintaining an effective control environment specific to the areas of our financial reporting and close process, including ineffective review, analysis and approval of journal entries and ineffective review of monthly financial statements. The second material weakness was related to inadequate segregation of incompatible duties due to the small size of our accounting and finance team.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In order to address these identified material weaknesses, we are in the process of increasing re</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">s</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ources within our finance department, including the expansion of our accounting, control and compliance functions to develop and implement continued improvements and enhancements to address the overall deficiencies that led to the material weaknesses. Our management believes that these actions will enable us to address the material weaknesses that were identified in a timely manner and maintain a properly designed and effective system of internal control over financial reporting and provide appropriate segregation of duties. However, these remediation measures may be time consuming and costly and there is no assurance that these initiatives will ultimately have the intended effects.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We plan to continue to assess our internal controls and procedures and intend to take further action as necessary or appropriate to address any other matters we identify. We cannot assure you that the measures we have taken to date and may take in the future, will be sufficient to remediate the control deficiencies that led to our material weaknesses in internal control over financial reporting or that it will prevent or avoid potential future material weaknesses. The effectiveness of our internal control over financial reporting is subject to various inherent limitations, including cost limitations, judgments used in decision making, assumptions about the likelihood of future events, the possibility of human error and the risk of fraud. If we are unable to remediate our current material weaknesses or any material weaknesses in the future, our ability to record, process and report financial information accurately, and to prepare financial statements within the time periods specified by the forms of the SEC, could be adversely affected which, in turn, may adversely affect our reputation and business and the market price of our common stock. In addition, any such failures could result in litigation or regulatory actions by the SEC or other regulatory authorities, loss of investor confidence, delisting of our securities and harm to our reputation and financial condition, or diversion of financial and management resources from the operation of our business.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_10">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, it is possible that control deficiencies could be identified by our management, by our independent registered public accounting firm in the future or may occur without being identified. Such a failure could result in regulatory scrutiny and cause investors to lose confidence in our reported financial condition, lead to a default under future indebtedness and otherwise have a material adverse effect on our business, financial condition, cash flow or results of operations.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a public company, we are required, pursuant to Section 404 of the Sarbanes-Oxley Act, to furnish a report by management on, among other things, the effectiveness of its internal control over financial reporting for annual reports on Form 10-K that we file with the SEC beginning with Annual Report on Form 10-K for the year ending December 31, 2023.  Future assessments will need to include disclosure of any material weaknesses identified by our management in our internal control over financial reporting. Eventually, it is possible that our independent registered public accounting firm will also be required to audit the effectiveness of our internal control over financial reporting in future annual reports on Form 10-K to be filed with the SEC. We are required to disclose changes made in our internal control over financial reporting on a quarterly basis. Failure to comply with the Sarbanes-Oxley Act could potentially subject us to sanctions or investigations by the SEC, the applicable stock exchange or other regulatory authorities, which would require additional financial and management resources. We have begun the process of compiling the system and processing documentation necessary to perform the evaluation needed to comply with Section 404 in the future, but we may not be able to complete our evaluation, testing and any required remediation in a timely fashion.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our ability to utilize our net operating losses, tax credit carryforwards, and certain other tax attributes to offset future taxable income may be subject to certain limitations.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In general, under Section 382 of the Internal Revenue Code, a corporation that undergoes an &#8220;ownership change&#8221; is subject to limitations on its ability to use its pre-change net operating loss carryforwards, or NOLs, to offset future taxable income. The limitations apply if a corporation undergoes an &#8220;ownership change,&#8221; which is generally defined as a greater than 50 percentage point change (by value) in its equity ownership by certain stockholders over a three-year period. If Legacy Amprius experienced an ownership change at any time since its incorporation, we may already be subject to limitations on our ability to utilize Legacy Amprius&#8217; existing NOLs and other tax attributes to offset taxable income or tax liability. In addition, future changes in our stock ownership, which may be outside of our control, may trigger an ownership change. Similar provisions of state tax law may also apply to limit our use of accumulated state tax attributes. As a result, even if we earn net taxable income in the future, our ability to use our or Legacy Amprius&#8217; pre-change NOL carryforwards and other tax attributes to offset such taxable income or tax liability may be subject to limitations, which could potentially result in increased future income tax liability to us. Further, because Legacy Amprius and Amprius Holdings were members of a consolidated group for U.S. federal income tax purposes up to the Closing Date, NOLs and other tax attributes of Legacy Amprius are available to be utilized by any member of the consolidated group. Accordingly, our existing NOLs and other tax attributes may not be available to offset future income tax liabilities.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There is also a risk that changes in law or regulatory changes made in response to the need for some jurisdictions to raise additional revenue to help counter the fiscal impact from the COVID-19 pandemic or for other unforeseen reasons, including suspensions on the use of net operating losses, tax credits, and other tax attributes, possibly with retroactive effect, may result in our and Legacy Amprius&#8217; existing net operating losses, tax credits, or other tax attributes expiring or otherwise being unavailable to offset future income tax liabilities. Also, starting in fiscal year 2022, the Tax Cuts and Jobs Act requires taxpayers to capitalize research and development expenditures and to amortize domestic expenditures over five years and foreign expenditures over 15 years. If Congress does not modify or repeal this provision, it may result in the acceleration of future taxable income (and associated income tax liabilities) for us, beginning in fiscal year 2022. Any resulting income tax liabilities may reduce our cash flows beginning in fiscal year 2023.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The Internal Revenue Service (&#8220;IRS&#8221;) or other taxing authority could assert income tax liability against us, notwithstanding the provisions of the Tax Sharing Agreement.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Tax Sharing Agreement with Amprius Holdings, Amprius Holdings generally would be required to indemnify us for the U.S. federal income tax liabilities of the U.S. federal consolidated group of which Amprius Holdings and Legacy Amprius were members (and any similar consolidated, combined or unitary tax group for state tax purposes) for taxable periods prior to (and including) the Closing Date (a &#8220;Consolidated Return Year&#8221;). The Tax Sharing Agreement also provides that Amprius Holdings will generally control any tax returns and any tax audits or other proceedings for the taxes addressed by the Tax Sharing Agreement. However, the Tax Sharing Agreement is not binding on the IRS or other state taxing authority, and does not prevent the IRS or other state taxing authority from asserting a tax claim against us or Legacy Amprius for any unpaid income tax liabilities of Legacy Amprius or Amprius Holdings for any Consolidated Return Year. If that were to occur, we would be required to seek indemnification against Amprius Holdings for payment of </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_10">Table of Contents</a></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">any amounts on such claims, and Amprius Holdings&#8217; ability to satisfy such claims may depend on whether Amprius Holdings is able to sell sufficient shares of our common stock to satisfy the tax liability.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The unavailability, reduction or elimination of government and economic incentives could have a material adverse effect on our business, financial condition, prospects and results of operations.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently, and expect to continue to, benefit from certain government subsidies and economic incentives including tax credits, rebates and other incentives that support the development and adoption of clean energy technology. For example, the Inflation Reduction Act of 2022 introduces or extends a number of tax credits to promote clean energy development. We cannot assure you that we will be able to benefit from such programs or that these subsidies and incentive programs will be available to us at the same or comparable levels in the future. </span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Specifically, in October 2022, we were awarded a $50.0 million cost sharing grant from the U.S. DOE. The cost sharing grant is dependent on the successful negotiation of a final contract, and among the terms to be finalized are the portion of relevant costs that will be covered by the grant. Even if we are able to successfully negotiate a final contract, we may not receive any funding if we are not able to satisfy the terms of the grant, including any matching requirements. In addition, such funding may still be insufficient to complete the project.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we have received commitments of state and local incentive packages providing approximately $10.0 million in tax incentives relating to our design and buildout of a GWh-scale facility in Brighton, Colorado. Specifically, the Colorado Economic Development Commission approved up to an approximately $5.5 million in Job Growth Incentive Tax Credits for us, over an eight-year period, which are contingent upon us meeting net new job creation and salary requirements. The City of Brighton also approved incentives with a total estimated value of $0.9 million, including a five-year property tax rebate of 100% and a 50% rebate on the city&#8217;s use tax collected on construction materials. In addition, the Adams County Regional Economic Partnership approved incentives in the form of tax abatement with performance-based contingencies. If we are not able to enter into a lease agreement on reasonably acceptable terms, our development timeline is delayed or we are not able to achieve the performance-based goals set for the incentives, we may not receive any funding or benefits from the state and local governments of Colorado.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any reduction, elimination or discriminatory application of government subsidies and economic incentives because of policy changes, or the reduced need for such subsidies and incentives due to the perceived success of clean and renewable energy products or other reasons, may require us to seek additional financing, which may not be obtainable on commercially attractive terms or at all, and may result in the diminished competitiveness of the battery cell industry generally or our silicon anode battery cells in particular. Any change in the level of subsidies and incentives from which we benefit could materially and adversely affect our business, financial condition, prospects and results of operations.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">A significant portion of our business depends on sales to the public sector, and our failure to receive and maintain government contracts or changes in the contracting or fiscal policies of the public sector could have a material adverse effect on our business.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently rely on U.S. government contracts (as a prime contractor or subcontractor) for a material portion of our revenue and to partially fund our research and development activities, and we believe that the success and growth of our business will continue to depend on our successful procurement of government contracts.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales to government agencies are subject to a number of challenges and risks. Selling to government agencies can be highly competitive, expensive, and time-consuming, often requiring significant upfront time and expense without any assurance that these efforts will generate a sale. We also must comply with laws and regulations relating to the formation, administration, and performance of contracts, which provide public sector customers rights, many of which are not typically found in commercial contracts.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accordingly, our business, financial condition, prospects and results of operations may be adversely affected by certain events or activities, including, but not limited to:</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in fiscal or contracting policies or decreases in available government funding;</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in government programs or applicable requirements;</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in the political environment, including before or after a change to the leadership within the government administration, and any resulting uncertainty or changes in policy or priorities and resultant funding;</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">appeals, disputes, or litigation relating to government procurement, including but not limited to bid protests by unsuccessful bidders on potential or actual awards of contracts to us or our partners by the government;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_10">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the adoption of new laws or regulations or changes to existing laws or regulations;</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">influence by, or competition from, third parties with respect to pending, new, or existing contracts with government customers; and</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increased or unexpected costs or unanticipated delays caused by other factors outside of our control, such as performance failures of our subcontractors.</span></div><div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any such event or activity, among others, could cause governments and governmental agencies to delay or refrain from purchasing our battery products in the future, reduce the size or payment amounts of purchases from existing or new government customers, or otherwise have an adverse effect on our business, financial condition, prospects and results of operations.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Government contracts often also contain provisions and are subject to laws and regulations that provide government customers with additional rights and remedies not typically found in commercial contracts. These rights and remedies allow government customers, among other things, to:</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">terminate existing contracts for convenience;</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reduce orders under or otherwise modify contracts;</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">for contracts subject to the Truth in Negotiations Act, reduce the contract price or cost where it was increased because a contractor or subcontractor furnished cost or pricing data during negotiations that was not complete, accurate, and current;</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">for some contracts, (i) demand a refund, make a forward price adjustment, or terminate a contract for default if a contractor provided inaccurate or incomplete data during the contract negotiation process and (ii) reduce the contract price under triggering circumstances, including the revision of price lists or other documents upon which the contract award was predicated;</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">decline to exercise an option to renew a multi-year contract;</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">claim rights in solutions, systems, or technology produced by us, appropriate such work-product for their continued use without continuing to contract for our services, and disclose such work-product to third parties, including other government agencies and our competitors, which could harm our competitive position;</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">prohibit future procurement awards with a particular agency due to a finding of organizational conflicts of interest;</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">suspend or debar us from doing business with the applicable government; and</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">control or prohibit the export of our battery products and technology.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Government contracts are also generally subject to greater scrutiny by the government, which can initiate reviews, audits and investigations regarding our compliance with government contract requirements. Current and new regulations or procurement requirements (including, for example regulations regarding counterfeit and corrupt parts, supply chain diligence, mandatory socioeconomic compliance requirements and cybersecurity) or changes to current requirements could increase our costs and risk of non-compliance. Failure to comply with government contracting laws, regulations and contract requirements, or adverse findings from a government audit or investigation can lead to criminal, civil or administrative proceedings (including pursuant to the False Claims Act), termination of contracts, forfeiture of profits, suspension of payments, adverse media coverage, fines and suspension or debarment from doing business with U.S. government agencies, all of which may have an adverse effect on our reputation, business, financial condition, prospects and results of operations.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our technology and our website, systems, and data we maintain may be subject to intentional disruption, security breaches and other security incidents, or alleged violations of laws, regulations, or other obligations relating to data handling that could result in liability and adversely impact our reputation and future sales. We may be required to expend significant resources to continue to modify or enhance our protective measures to detect, investigate and remediate vulnerabilities to security breaches and incidents. Any actual or alleged failure to comply with applicable cybersecurity or data privacy legislation or regulation could have a material adverse effect on our business, reputation, results of operations or financial condition.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect to face significant challenges with respect to information security and maintaining the security and integrity of our systems and other systems used in our business, as well as with respect to the data stored on or processed by these systems. We also anticipate receiving and storing confidential business information of our partners and customers. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_10">Table of Contents</a></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Advances in technology, an increased level of sophistication and expertise of hackers, and new discoveries in the field of cryptography can result in a compromise or breach of the systems used in our business or of security measures used in our business to protect confidential information, personal information, and other data. We may be a target for attacks designed to disrupt our operations or to attempt to gain access to our systems or to data that we possess, including proprietary information that we obtain from our partners pursuant to our agreements with them. We also are at risk for interruptions, outages and breaches of our and our outsourced service providers&#8217; operational systems and security systems, our integrated software and technology, and data that we or our third-party service providers process or possess. These may be caused by, among other causes, physical theft, viruses, or other malicious code, denial or degradation of service attacks, ransomware, social engineering schemes, and insider theft or misuse. We have suffered security incidents in the past. In December 2021, we experienced a ransomware incident and notified certain employees of such incident. The security risks we and our outsourced service providers face could also be elevated in connection with the Russian invasion of Ukraine, as we and our outsourced service providers are vulnerable to a heightened risk of cyberattacks from or affiliated with nation-state actors, including retaliatory attacks from Chinese or Russian actors against U.S.-based companies.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The availability and effectiveness of our silicon anode technology and our ability to conduct our business and operations depend on the continued operation of information technology and communications systems, some of which we have yet to develop or otherwise obtain the ability to use. Systems we currently use or may use in the future in conducting our business, including data centers and other information technology systems, will be vulnerable to damage or interruption. Such systems could also be subject to break-ins, sabotage and intentional acts of vandalism, as well as disruptions and security breaches and security incidents as a result of non-technical issues, including intentional or inadvertent acts or omissions by employees, service providers, or others. We currently use, and may use in the future, outsourced service providers to help provide certain services, and any such outsourced service providers face similar security and system disruption risks as us. Our ability to monitor our outsourced service providers&#8217; security measures is limited, and, in any event, third parties may be able to circumvent those security measures, resulting in the unauthorized access to, misuse, acquisition, disclosure, loss, alteration, or destruction of personal, confidential, or other data, including data relating to individuals. Some of the systems used in our business will not be fully redundant, and our disaster recovery planning cannot account for all eventualities. Any data security incidents or other disruptions to any data centers or other systems used in our business could result in lengthy interruptions in our service and may adversely affect our reputation, business, financial condition, prospects and results of operations.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant capital and other resources may be required in efforts to protect against information security breaches, security incidents, and system disruptions, or to alleviate problems caused by actual or suspected information security breaches and other data security incidents and system disruptions. The resources required may increase over time as the methods used by hackers and others engaged in online criminal activities and otherwise seeking to obtain unauthorized access to systems or data, and to disrupt systems, are increasingly sophisticated and constantly evolving. In particular, ransomware attacks have become more prevalent in the industrial sector, which could materially and adversely affect our ability to operate and may result in significant expense.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we may face increased compliance burdens regarding such requirements with regulators and customers regarding our battery products and also incur additional costs for oversight and monitoring of our supply chain. These additional compliance and logistical burdens are attenuated through our international partnerships. We also cannot be certain that these systems, networks, and other infrastructure or technology upon which we rely, including those of our third-party suppliers or service providers, will be effectively implemented, maintained or expanded as planned, or will be free from bugs, defects, errors, vulnerabilities, viruses, ransomware, or other malicious code. We may be required to expend significant resources to make corrections or to remediate issues that are identified or to find alternative sources.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any failure or perceived failure by us or our service providers to prevent information security breaches or other security incidents or system disruptions, or any compromise of security that results in or is perceived or reported to result in unauthorized access to, or loss, theft, alteration, release or transfer of, our information, or any personal information, confidential information, or other data could result in loss or theft of proprietary or sensitive data and intellectual property, could harm our reputation and competitive position and could expose us to legal claims, regulatory investigations and proceedings, and fines, penalties, and other liability. Any such actual or perceived security breach, security incident or disruption could also divert the efforts of our technical and management personnel and could require us to incur significant costs and operational consequences in connection with investigating, remediating, eliminating and putting in place additional tools, devices, policies, and other measures designed to prevent actual or perceived security breaches and other incidents and system disruptions. Moreover, we could be required or otherwise find it appropriate to expend significant capital and other resources to respond to, notify third parties of, and otherwise address the incident or breach and its root cause, and most jurisdictions have enacted laws requiring companies to notify individuals, regulatory authorities and others of security breaches involving certain types of data.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_10">Table of Contents</a></span></div></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, we cannot assure that any limitations of liability provisions in our current or future contracts that may be applicable would be enforceable or adequate or would otherwise protect us from any liabilities or damages with respect to any particular claim relating to a security breach or other security-related matter. We also cannot be sure that our existing insurance coverage will continue to be available on acceptable terms or will be available in sufficient amounts to cover claims related to a security breach or incident, or that the insurer will not deny coverage as to any future claim. The successful assertion of claims against us that exceed available insurance coverage, or the occurrence of changes in our insurance policies, including premium increases or the imposition of large deductible or co-insurance requirements, could have a material adverse effect on our business, including our reputation, financial condition, and results of operations.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, laws, regulations, and other actual and potential obligations relating to privacy, data hosting and other processing of data, data protection, and data security are evolving rapidly, and we expect to potentially be subject to new laws and regulations, or new interpretations of laws and regulations, in the future in various jurisdictions. These laws, regulations, and other obligations, and changes in their interpretation, could require us to modify our operations and practices, restrict our activities, and increase our costs. Further, these laws, regulations, and other obligations are complex and evolving rapidly, and we cannot provide assurance that we will not be subject to claims, allegations, or other proceedings related to actual or alleged obligations relating to privacy, data protection, or data security. It is possible that these laws, regulations, and other obligations may be inconsistent with one another or be interpreted or asserted to be inconsistent with our business or practices. We anticipate needing to dedicate substantial resources to comply with laws, regulations, and other obligations relating to privacy and data security in order to comply. Any failure or alleged or perceived failure to comply with any applicable laws, regulations, or other obligations relating to privacy, data protection, or data security could also result in regulatory investigations and proceedings, and misuse of or failure to secure data relating to individuals could also result in claims and proceedings against us by governmental entities or others, penalties and other liability, and damage to our reputation and credibility, and could have a negative impact on our business, financial condition, prospects and results of operations.</span></div><div id="i066fdabb1d0848d5b0391931f87c3c0e_714"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Intellectual Property</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We rely heavily on our intellectual property portfolio. If we are unable to protect our intellectual property rights, our business and competitive position would be harmed.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may not be able to prevent unauthorized use of our intellectual property, which could harm our business and competitive position. We rely upon a combination of various intellectual property protections afforded by patent, copyright, trademark and trade secret laws in the United States and other jurisdictions, as well as contractual protections afforded by license agreements and other agreements, to establish, maintain and enforce rights in our proprietary technologies. In addition, we seek to protect our intellectual property rights through nondisclosure and invention assignment agreements with our employees and consultants, and through non-disclosure agreements with business partners and other third parties. Despite our efforts to protect our proprietary rights, third parties may, without proper authorization, attempt to copy or otherwise obtain and use our intellectual property or be able to design around our intellectual property. Monitoring unauthorized use of our intellectual property is difficult and costly, and the steps we have taken or will take to prevent misappropriation may not be adequate, sufficient, or effective. Any enforcement efforts we undertake, including litigation, could be time-consuming and expensive and could divert management&#8217;s attention, which could harm our business, results of operations and financial condition. Moreover, certain proprietary technology that is stored on computer systems could be penetrated by intruders and potentially misappropriated. There is no guarantee that our efforts to protect our computer systems will be effective. In addition, existing intellectual property laws and contractual remedies may afford less protection than needed to safeguard our intellectual property portfolio.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patent, copyright, trademark and trade secret laws vary significantly throughout the world. A number of foreign countries do not protect intellectual property rights to the same extent as do the laws of the United States. Therefore, our intellectual property rights may not be as strong or as easily enforced outside of the United States and efforts to protect against the unauthorized use of our intellectual property rights, technology and other proprietary rights may be more expensive and difficult outside of the United States. Further, we have not established our intellectual property rights in all countries in the world, and competitors may copy our designs and technology and operate in countries in which it has not prosecuted our intellectual property. Failure to adequately protect our intellectual property rights could result in our competitors using our intellectual property to offer products, and competitors&#8217; ability to design around our intellectual property would enable competitors to offer similar or better batteries, in each case potentially resulting in the loss of some of our competitive advantage and a decrease in our revenue which, would adversely affect our business, financial condition, prospects and results of operations.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_10">Table of Contents</a></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may need to defend ourselves against intellectual property infringement claims, which may be time-consuming and could cause us to incur substantial costs.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Companies, organizations or individuals, including our current and future competitors, may hold or obtain patents, trademarks or other proprietary rights that would prevent, limit or interfere with our ability to make, use, develop, distribute, or sell our battery products, which could make it more difficult for us to operate our business. From time to time, we may receive inquiries from holders of patents or trademarks inquiring whether we are infringing their proprietary rights and/or seek court declarations that they do not infringe upon our intellectual property rights. Companies holding patents or other intellectual property rights relating to batteries, electric motors or electronic power management systems may bring suits alleging infringement by our battery products of such rights or otherwise asserting their rights and seeking licenses. In addition, if we are determined to have infringed upon a third party&#8217;s intellectual property rights, we may be required to do one or more of the following:</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">cease selling, incorporating or using products that incorporate the challenged intellectual property;</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">pay substantial damages;</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">obtain a license from the holder of the infringed intellectual property right, which license may not be available on reasonable terms or at all; or</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">redesign our batteries.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have in the past experienced infringement claims from non-practicing organizations (sometimes referred to as &#8220;patent trolls&#8221;) filing lawsuits for patent infringement. For example, in December 2020, we settled a patent infringement case against us and agreed to make licensing payments in connection with such settlement. We may be subject to additional infringement claims in the future, and even if we believe such claims are without merit, such claims are time-consuming, expensive to litigate or settle and can divert management&#8217;s resources and attention. An adverse determination could require that we pay damages, which could be substantial, or stop using technologies found to be in violation of a third-party&#8217;s rights and could prevent us from selling our batteries. In order to avoid these restrictions, we may have to seek a license for the technology. Any such license may not be available on reasonable terms or at all, could require us to pay significant royalties and may significantly increase our operating expenses or otherwise seriously harm our business or operating results.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event of a successful claim of infringement against us and our failure or inability to obtain a license to the infringed technology, our business, financial condition, prospects and results of operations could be materially adversely affected. In addition, any litigation or claims, whether or not valid, could result in substantial costs and diversion of resources and management&#8217;s attention.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also license patents and other intellectual property from third parties, and we may face claims that our use of this intellectual property infringes the rights of others. In such cases, we may seek indemnification from our licensors under our license contracts with them. However, our rights to indemnification may be unavailable or insufficient to cover our costs and losses, depending on our use of the technology, whether we choose to retain control over conduct of the litigation, and other factors.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our patent applications may not result in issued patents or our patent rights may be contested, circumvented, invalidated or limited in scope, any of which could have a material adverse effect on our ability to prevent others from interfering with our commercialization of our batteries.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our patent applications may not result in issued patents, which may have a material adverse effect on our ability to prevent others from commercially exploiting products similar to ours. The status of patents involves complex legal and factual questions and the breadth of claims allowed is uncertain. As a result, we cannot be certain that the patent applications that we file will result in patents being issued, or that our patents and any patents that may be issued to us will afford protection against competitors with similar technology. Numerous patents and pending patent applications owned by others exist in the fields in which we have developed and is and will be developing our technology. In addition to those who may claim priority, any of our existing or pending patents may also be challenged by others on the basis that they are otherwise invalid or unenforceable. Furthermore, patent applications filed in foreign countries are subject to laws, rules and procedures that differ from those of the United States, and thus we cannot be certain that foreign patent applications related to issued U.S. patents will be issued.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if our patent applications succeed and we are issued patents in accordance with them, it is still uncertain whether these patents will be contested, circumvented, invalidated or limited in scope in the future. The rights granted </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_10">Table of Contents</a></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">under any issued patents may not provide us with meaningful protection or competitive advantages, and some foreign countries provide significantly less effective patent enforcement than what the United States provides. In addition, the claims under any patents that issued to us may not be broad enough to prevent others from developing technologies that are similar or that achieve results similar to ours. The intellectual property rights of others could also bar or limit us from licensing, exploiting, or enforcing any patents issued to us. In addition, patents issued to us may be infringed upon or designed around by others and others may obtain patents that it needs to license or design around, either of which would increase costs and may adversely affect our business, financial condition, prospects and results of operations.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may obtain licenses on technology that has not been commercialized or has been commercialized only to a limited extent, and the success of our business may be adversely affected if such technology does not perform as expected.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we may license from third parties, technologies that have not been commercialized or which have been commercialized only to a limited extent. These technologies may not perform as expected within our silicon anode battery cells and related products. If the cost, performance characteristics, manufacturing process or other specifications of these licensed technologies fall short of our targets, our expected sales, costs, time to market, competitive advantage, future product pricing and potential operating margins may be adversely affected.</span></div><div id="i066fdabb1d0848d5b0391931f87c3c0e_775"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Litigation and Regulatory Compliance</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our operations expose us to litigation, environmental and other legal compliance risks. Compliance with laws and regulations can be expensive, and our failure to comply with these laws and regulations may result in monetary damages and fines, adverse publicity and a material adverse effect on our business.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to a variety of litigation, environmental, health and safety, investment screening and national security laws, and other legal compliance risks. These risks include, among other things, possible liability relating to product liability matters, personal injuries, intellectual property rights, contract-related claims, health and safety liabilities, employment-related liabilities, environmental matters, investment screening and national security laws, and compliance with U.S. and foreign laws, competition laws and laws governing improper business practices.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations in the United States are subject to numerous environmental laws and regulations, including federal, state and local laws and regulations relating to, among other things: water; natural resources; discharges; emissions; chemicals; solid and hazardous waste storage, treatment and disposal; remediation of releases of hazardous materials; and contamination. Compliance with these laws can be difficult and costly. For example, battery life cycle management regulations and regulations governing the transport of batteries may impose substantial requirements on our operations in the United States. Our operations may be required to obtain and comply with environmental permits, many of which may be difficult and expensive to obtain and must be renewed on a periodic basis. A failure to comply with these laws, regulations or permits could result in substantial liabilities, including fines, penalties, the suspension or loss of permits, and possibly orders to cease the non-compliant operations. Our manufacturing process will have hazards such as, but not limited to, hazardous materials, machines with moving parts, and high voltage and/or high current electrical systems typical of large manufacturing equipment and related safety incidents. There may be safety incidents that damage machinery or manufacturing components, slow or stop production, or harm employees. Consequences may include litigation, regulation, fines, increased insurance premiums, mandates to temporarily halt production, workers&#8217; compensation claims, or other actions that impact our brand, finances or ability to operate.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a business with international reach, we are subject to complex laws and regulations, including investment screening laws, in jurisdictions in which we operate. Those laws and regulations may be interpreted in different ways. They may also change from time to time, as may related interpretations and other guidance. Changes in laws or regulations could result in higher expenses and payments, and uncertainty relating to laws or regulations may also affect how we conduct our operations and structure our investments and could limit our ability to enforce our rights.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in environmental and climate laws or regulations, including laws relating to greenhouse gas emissions, could lead to new or additional investment in manufacturing designs, subject us to additional costs and restrictions, including increased energy and raw materials costs, and could increase environmental compliance expenditures. We are subject to various environmental laws and regulations on air emission, waste water discharge, solid waste, noise and the disposal of hazardous materials. Cobalt and lithium are toxic materials that are important raw materials in our batteries. We also use, generate and discharge other toxic, volatile and hazardous chemicals and wastes in our research, development and manufacturing activities. Under U.S. environmental regulations, we are required to maintain the pollutant emission levels at the facility within the levels prescribed by the relevant governmental authorities and obtain a pollution discharge permit for water and air emissions. Future changes to environmental laws or permit requirements could require us to install new control equipment or otherwise change operations in order to comply with any such change in laws or permit requirements. </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_10">Table of Contents</a></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, certain laws and regulations require enterprises like us that generate hazardous wastes to engage companies which are licensed and qualified to process the hazardous wastes, and to collect, store, dispose of and transfer the hazardous waste.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we fail to comply with national and local environmental protection laws and regulations, the relevant governmental authorities may impose fines or deadlines to cure instances of noncompliance, and may even order us to cease operations if we fail to comply with their requirements. In particular, any breach by us in connection with requirements relating to the handling of hazardous wastes may subject us to monetary damages and fines. In addition, if any third party suffers any loss as a result of our pollutant emission practices, our improper handling of hazardous wastes or our noncompliance with environmental regulations, such third parties may seek damages from us.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot assure you that we will be able to comply with all environmental laws and regulations at all times as the environmental legal regime is evolving and becoming more stringent, especially in the United States. Therefore, if these or other governments where we do business impose more stringent regulations in the future, we will have to incur additional substantial costs and expenses in order to comply with new regulations, which may negatively affect our results of operations. If we fail to comply with any of the present or future environmental regulations in any material aspect or cause any loss to any third parties due to our pollutant emission practices, improper handling of hazardous wastes or other environmental noncompliance, we may suffer from negative publicity and may be required to pay substantial fines, pay damages to such third parties, or suspend or even cease operations, all of which may materially and adversely affect our business, financial condition, prospects and results of operations. Environmental laws and regulations may become more stringent in the future, which could increase costs of compliance or require us to manufacture with alternative technologies and materials.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may be subject to review and enforcement actions under domestic and foreign laws that screen investments and to other national-security-related laws and regulations. In certain jurisdictions, these legal and regulatory requirements may be more stringent than in the United States and may impact battery companies more specifically. As a result of these laws and regulations, investments by particular investors may need to be filed with local regulators, which in turn may impose added costs on our business, impact our operations, and/or limit our ability to engage in strategic transactions that might otherwise be beneficial to us and our investors.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to a variety of laws and regulations related to the safety and transportation of our batteries. Our failure to comply with these laws and regulations may have a material adverse effect on our business and results of operations.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many federal, state and local authorities require certification by Underwriters Laboratory, Inc., an independent, not-for-profit corporation engaged in the testing of products for compliance with certain public safety standards, or other safety regulation certification prior to marketing battery cells. Foreign jurisdictions also have regulatory authorities overseeing the safety of consumer products. Our batteries may not meet the specifications required by these authorities. A determination that any of our battery products are not in compliance with these rules and regulations could result in the imposition of fines or an award of damages to private litigants.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, lithium batteries have been identified as a Class 9 dangerous good during transport. To be safely transported (by air, sea, rail or roadways), they must meet various international, national, state and local regulations, including, for example, the provisions laid out in United Nations standard UN 38.3. This standard applies to batteries transported either on their own or installed in a device. UN 38.3 has been adopted by regulators and competent authorities around the world, thus making it a requirement for global market access. Our failure to manage the transportation of our batteries could subject us to increased costs or future liabilities.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Failure to comply with certain health and production safety laws and regulations governing hazardous materials could materially adversely affect our business and results of operations.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the sourcing of our battery products throughout the world, we process, store, dispose of and otherwise use large amounts of hazardous materials. As a result, we are subject to extensive and evolving health and production safety laws and regulations governing, among other things: the health of our employees and safety production requirements regarding the generation, handling, storage, use and transportation of hazardous materials. Compliance with these laws and regulations results in ongoing costs. Failure to comply with these laws or regulations, or to obtain or comply with the relevant permits, could result in fines, criminal charges or other sanctions by regulators. Furthermore, we may be ordered to rectify a noncompliance within a stipulated deadline; and if we fail to do so, we may be ordered to cease operations. Our ongoing compliance with health and safety laws, regulations and permits could require us to incur significant expenses, limit our ability to modify or expand our facilities or continue manufacturing and make other capital improvements. In </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_10">Table of Contents</a></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">addition, private parties, including current or former employees, could bring personal injury or other claims against us due to the presence of, or exposure to, hazardous substances used, stored or disposed of by us or contained in our batteries.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are or will be subject to anti-corruption and anti-bribery and anti-money laundering and similar laws, and non-compliance with such laws can subject us to administrative, civil and criminal fines and penalties, collateral consequences, remedial measures and legal expenses, all of which could adversely affect our business, results of operations, financial condition and reputation.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to the FCPA, the U.S. domestic bribery statute contained in 18 U.S.C. &#167; 201, the U.S. Travel Act, and possibly other anti-bribery and anti-corruption laws and anti-money laundering laws in various jurisdictions in which we conduct, or in the future may conduct, activities. Anti-corruption and anti-bribery laws have been enforced aggressively in recent years and are interpreted broadly to generally prohibit us and our officers, directors, employees, business partners agents, representatives and third-party intermediaries from corruptly offering, promising, authorizing or providing, directly or indirectly anything of value to recipients in the public or private sector.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may leverage third parties to sell our battery products and conduct our business abroad. We, our officers, directors, employees, business partners agents, representatives and third-party intermediaries may have direct or indirect interactions with officials and employees of government agencies or state-owned or affiliated entities and we may be held liable for the corrupt or other illegal activities of these employees, agents, representatives, business partners or third-party intermediaries even if we do not explicitly authorize such activities. We cannot assure you that all of our officers, directors, employees, business partners agents, representatives and third-party intermediaries will not take actions in violation of applicable law, for which we may be ultimately held responsible. As our international activities and sales expand, our risks under these laws may increase.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These laws also require companies to make and keep books, records and accounts that accurately reflect transactions and dispositions of assets and to maintain a system of adequate internal accounting controls and compliance procedures designed to prevent any such actions. While we have certain policies and procedures to address compliance with such laws, we cannot assure you that none of our officers, directors, employees, business partners agents, representatives and third-party intermediaries will take actions in violation of our policies and applicable law, for which we may be ultimately held responsible.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any allegations or violation of the FCPA or other applicable anti-bribery and anti-corruption laws and anti-money laundering laws could subject us to whistleblower complaints, adverse media coverage, investigations, settlements, prosecutions, enforcement actions, fines, damages, loss of export privileges, and severe administrative, civil and criminal sanctions, suspension or debarment from government contracts, collateral consequences, remedial measures and legal expenses, all of which could materially and adversely affect our reputation, business, financial condition, prospects and results of operations. Responding to any investigation or action will likely result in a materially significant diversion of management&#8217;s attention and resources and significant defense costs and other professional fees.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are subject to governmental export and import controls that could impair our ability to compete in international markets or subject us to liability if we violate these controls.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our battery products may be subject to U.S. export control laws and regulations including the Export Administration Regulations (&#8220;EAR&#8221;), the International Traffic in Arms Regulations (&#8220;ITAR&#8221;), and trade and economic sanctions maintained by the Office of Foreign Assets Control (&#8220;OFAC&#8221;). As such, an export license may be required to export, reexport, or transfer our battery products to certain countries, end-users, and end-uses. If we were to fail to comply with such U.S. export controls laws and regulations, U.S. economic sanctions, or other similar laws, we could be subject to both civil and criminal penalties, including substantial fines, possible incarceration for employees and managers for willful violations, and the possible loss of our export or import privileges. Obtaining the necessary export license for a particular sale or offering may not be possible and may be time-consuming and may result in the delay or loss of sales opportunities. Furthermore, U.S. export control laws and economic sanctions prohibit the export of products to certain U.S. embargoed or sanctioned countries, governments, and persons, as well as for prohibited end-uses. Even though we take precautions to ensure that we and our partners comply with all relevant export control laws and regulations, any failure by us or our partners to comply with such laws and regulations could have negative consequences for us, including reputational harm, government investigations and penalties.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Changes in our battery products or changes in export and import regulations in such countries may create delays in the introduction of our products into international markets, prevent our end-customers with international operations from deploying our battery products globally or, in some cases, prevent or delay the export or import of our battery products to certain countries, governments or persons altogether. Any change in export or import laws or regulations, economic </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_10">Table of Contents</a></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">sanctions or related legislation, shift in the enforcement or scope of existing export, import or sanctions laws or regulations, or change in the countries, governments, persons, or technologies targeted by such export, import or sanctions laws or regulations, could result in decreased use of our battery products by, or in our decreased ability to export or sell our battery products to, existing or potential end-customers with international operations. Any decreased use of our battery products or limitation on our ability to export to or sell our battery products in international markets could adversely affect our business, financial condition, and results of operations.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be subject to U.S. foreign investment regulations which may impose conditions on or limit certain investors&#8217; ability to purchase our stock, potentially making the stock less attractive to investors. Our future investments in U.S. companies may also be subject to U.S. foreign investment regulations.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain investments that involve the acquisition of, or investment in, a U.S. business by a non-U.S. investor may be subject to review and approval by the Committee on Foreign Investment in the United States (&#8220;CFIUS&#8221;). Whether CFIUS has jurisdiction to review an acquisition or investment transaction depends on, among other factors, the nature and structure of the transaction, including the level of beneficial ownership interest and the nature of any information or governance rights involved. For example, investments that result in &#8220;control&#8221; of a U.S. business by a foreign person always are subject to CFIUS jurisdiction. Significant CFIUS reform legislation, which was fully implemented through regulations that became effective on February 13, 2020, expanded the scope of CFIUS&#8217;s jurisdiction to investments that do not result in control of a U.S. business by a foreign person but afford certain foreign investors certain information or governance rights in a U.S. business that has a nexus to &#8220;critical technologies,&#8221; &#8220;critical infrastructure&#8221; and/or &#8220;sensitive personal data.&#8221; Based on its export control classification, our battery technology is considered a &#8220;critical technology.&#8221;</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">CFIUS could choose to review past or proposed transactions involving new or existing foreign investors in us or in Amprius Holdings even if a filing with CFIUS is or was not required at the time of the transaction. Any review and approval of an investment or transaction by CFIUS may have outsized impacts on transaction certainty, timing, feasibility, and cost, among other things. CFIUS policies and practices are rapidly evolving, and in the event that CFIUS reviews one or more proposed or existing investment by investors, there can be no assurances that such investors will be able to maintain, or proceed with, such investments on terms acceptable to such investors. CFIUS could seek to impose limitations or restrictions on, or prohibit, investments by such investors (including, but not limited to, limits on purchasing our stock, limits on information sharing with such investors, requiring a voting trust, governance modifications, or forced divestiture, among other things).</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent and potential tariffs imposed by the U.S. government or a global trade war could increase the cost of our products, which could have a material adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. government has and continues to make significant changes in U.S. trade policy and has taken certain actions that could negatively impact U.S. trade, including imposing tariffs on certain goods imported into the United States. In retaliation, China has implemented, and continues to evaluate imposing additional tariffs on a wide range of American products. There is also a concern that the imposition of additional tariffs by the United States could result in the adoption of tariffs by other countries as well, leading to a global trade war. More specifically, the U.S. government has from time to time imposed significant tariffs on certain product categories imported from China. Such tariffs, if expanded to other categories, could have a significant impact on our business, particularly the importation of parts of our batteries and certain production equipment that are manufactured in China. If we attempt to renegotiate prices with suppliers or diversify our supply chain in response to tariffs, such efforts may not yield immediate results or may be ineffective. We might also consider increasing prices to the end consumer; however, this could reduce the competitiveness of our products and adversely affect net sales. If we fail to manage these dynamics successfully, gross margins and profitability could be adversely affected. As of the date of this report, tariffs have not had a material impact on our business, but increased tariffs or trade restrictions implemented by the United States or other countries in connection with a global trade war could have a material adverse effect on our business, financial condition and results of operations. We cannot predict what actions may ultimately be taken with respect to tariffs or trade relations between the United States and China or other countries, what products may be subject to such actions, or what actions may be taken by the other countries in retaliation. Any further deterioration in the relations between the United States and China could exacerbate these actions and other governmental intervention. For example, a future event that created additional U.S.-China tensions could potentially increase the risks associated with the business and operations of U.S.-based technology companies in China.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2022, the import restrictions contained in the Uyghur Forced Labor Prevention Act ("UFLPA") became effective. The UFLPA creates a rebuttable presumption that any goods mined, produced or manufactured, wholly or in part in the Xinjiang Uyghur Autonomous Region (&#8220;XUAR&#8221;) of China, or produced by a listed entity, were made with forced labor and are not entitled to entry into the United States. If a shipment is detained, importers are required to present clear </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_10">Table of Contents</a></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and convincing evidence that such goods are not made with forced labor. While we do not source goods from the XUAR or from listed parties, because we import from China, there is risk that our ability to import components and products may be adversely affected by the UFLPA.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The U.S. or foreign governments may take additional administrative, legislative, or regulatory action that could materially interfere with our ability to source from or sell products in certain countries. Sustained uncertainty about, or worsening of, current global economic conditions and further escalation of trade tensions between the United States and its trading partners, especially China, could result in a global economic slowdown and long-term changes to global trade, including retaliatory trade restrictions that restrict our ability to operate in China. Any alterations to our business strategy or operations made in order to adapt to or comply with any such changes would be time-consuming and expensive, and certain of our competitors may be better suited to withstand or react to these changes.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">From time to time, we may be involved in legal proceedings and commercial or contractual disputes, which could have an adverse impact on our profitability and financial position.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may be involved in legal proceedings and commercial or contractual disputes that, from time to time, are significant. These are typically claims that arise in the normal course of business including, without limitation, commercial or contractual disputes, including warranty claims and other disputes with potential customers and suppliers, intellectual property matters, personal injury claims, environmental issues, tax matters and employment matters.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, our predecessor, Kensington Capital Acquisition Corp. IV, was a special purpose acquisition company (&#8220;SPAC&#8221;). SPACs have been subject to increased regulatory oversight and scrutiny, including from the SEC. Any governmental or regulatory investigation or inquiry related to the Business Combination or otherwise could have a material adverse effect on our business and negatively affect our reputation.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is difficult to predict the outcome or ultimate financial exposure, if any, represented by these matters, and there can be no assurance that any such exposure will not be material. Such claims may also negatively affect our reputation.</span></div><div id="i066fdabb1d0848d5b0391931f87c3c0e_721"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Ownership of Our Common Stock</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">There can be no assurance that we will be able to comply with the continued listing standards of the NYSE.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common stock and public warrants are listed on the NYSE under the symbols &#8220;AMPX&#8221; and &#8220;AMPX.W,&#8221; respectively. If the NYSE delists our securities from trading on its exchange for failure to meet the listing standards and we are not able to list such securities on another national securities exchange, we expect such securities could be quoted on an over-the-counter market. If this were to occur, we and our stockholders could face significant material adverse consequences including:</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a limited availability of market quotations for our securities;</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reduced liquidity for our securities;</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a determination that our common stock is a &#8220;penny stock,&#8221; which will require brokers trading our common stock to adhere to more stringent rules, possibly resulting in a reduced level of trading activity in the secondary trading market for shares of our common stock;</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a limited amount of analyst coverage; and</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a decreased ability to issue additional securities or obtain additional financing in the future.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Anti-takeover provisions in our certificate of incorporation, Bylaws and Delaware law could make an acquisition of us more difficult, limit attempts by stockholders to replace or remove our management and limit the market price of our common stock.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our certificate of incorporation (the &#8220;Certificate of Incorporation&#8221;), Bylaws and Delaware law contain provisions that could have the effect of rendering more difficult, delaying or preventing an acquisition deemed undesirable by our Board. These provisions include:</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">authorizing &#8220;blank check&#8221; preferred stock, which could be issued by our Board without stockholder approval and may contain voting, liquidation, dividend and other rights superior to our common stock;</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">limiting the liability of, and providing indemnification to, our directors and officers;</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">prohibiting cumulative voting in the election of directors;</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_10">Table of Contents</a></span></div></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">providing that vacancies on our Board may be filled only by majority of directors then in office of the Board, even though less than a quorum;</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">prohibiting the ability of our stockholders to call special meetings;</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">establishing an advance notice procedure for stockholder proposals to be brought before an annual meeting, including proposed nominations of persons for election to the Board;</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">dividing directorships of our Board into three classes, each to be elected for a term of three years, so that only one class of directorships is up for election at each annual meeting of the stockholders; and</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">specifying that special meetings of our stockholders can be called only by a majority of the Board, the chair of the Board, or our Chief Executive Officer.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These provisions may frustrate or prevent any attempts by stockholders to replace or remove our current management by making it more difficult for stockholders to replace members of our Board, which is responsible for appointing the members of our management. In addition, because we are incorporated in Delaware, it is governed by the provisions of Section 203 of the DGCL, which generally prohibits a Delaware corporation from engaging in any of a broad range of business combinations with any &#8220;interested&#8221; stockholder for a period of three years following the date on which the stockholder became an &#8220;interested&#8221; stockholder.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our Bylaws provide, subject to limited exceptions, that the Court of Chancery of the State of Delaware and the federal district courts of the United States will be the sole and exclusive forum for certain stockholder litigation matters, which could limit our stockholders&#8217; ability to obtain a chosen judicial forum for disputes with us or our directors, officers, employees or stockholders.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Bylaws provide that, unless otherwise consented to by us in writing, the Court of Chancery of the State of Delaware (or, if the Court of Chancery does not have jurisdiction, another State court in Delaware or the federal district court for the District of Delaware) shall, to the fullest extent permitted by law, be the sole and exclusive forum for the following types of actions or proceedings: (i) any derivative action or proceeding brought on behalf of us; (ii) any action asserting a claim of breach of a fiduciary duty owed by, or otherwise wrongdoing by, any of our directors, officers, or other employees to us or our stockholders; (iii) any action arising pursuant to any provision of the DGCL or our Certificate of Incorporation or our Bylaws; (iv) any action to interpret, apply, enforce or determine the validity of our Certificate of Incorporation or our Bylaws; or (v) any other action asserting a claim that is governed by the internal affairs doctrine, in all cases subject to the court having jurisdiction over indispensable parties named as defendants. This provision would not apply to suits brought to enforce a duty or liability created by the Exchange Act or any other claim for which the U.S. federal courts have exclusive jurisdiction. The Bylaws further provide that, unless otherwise consented to by us in writing, the federal district courts of the United States will be the sole and exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any person or entity purchasing or otherwise acquiring any interest in our securities shall be deemed to have notice of and consented to this provision. This choice of forum provision may limit a stockholder&#8217;s ability to bring a claim in a judicial forum of its choosing for disputes with us or any of our directors, officers, other employees or stockholders, which may discourage lawsuits with respect to such claims. There is uncertainty as to whether a court would enforce such provisions, and the enforceability of similar choice of forum provisions in other companies&#8217; charter documents has been challenged in legal proceedings. It is possible that a court could find these types of provisions to be inapplicable or unenforceable, and if a court were to find the choice of forum provision contained in the Bylaws to be inapplicable or unenforceable in an action, we may incur additional costs associated with resolving such action in other jurisdictions, which could harm our business, operating results and financial condition.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of ownership among our executive officers, directors and affiliates may prevent new investors from influencing significant corporate decisions.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, our executive officers and directors as a group beneficially own approximately 14.9% of the common stock outstanding. Additionally, certain of our executive officers and directors own interests in Amprius Holdings, which owns approximately 77.1% of our common stock outstanding, and certain of our directors are members of Amprius Holdings&#8217; board of directors. As a result, these stockholders are able to exercise a significant level of control over all matters requiring stockholder approval, including the election of directors, any amendment of the Certificate of Incorporation and approval of significant corporate transactions. This control could have the effect of delaying or preventing a change of control or changes in our management and will make the approval of certain transactions difficult or impossible without the support of these stockholders and of their votes.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_10">Table of Contents</a></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We will incur significant increased expenses and administrative burdens as a public company, which could have an adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a public company, we face increased legal, accounting, insurance, administrative and other costs and expenses that Legacy Amprius did not face as a private company. The Sarbanes-Oxley Act of 2002 (the &#8220;Sarbanes-Oxley Act&#8221;), including the requirements of Section 404, as well as rules and regulations subsequently implemented by the SEC, the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010 and the rules and regulations promulgated and to be promulgated thereunder, the PCAOB and the securities exchanges, impose additional reporting and other obligations on public companies. The development and implementation of the standards and controls necessary for us to achieve the level of accounting standards required of a public company in the United States may require costs greater than expected. It is likely that we will expand our employee base and hire additional employees to support our operations as a public company, which will increase our operating costs in future periods.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compliance with public company requirements has increased costs and made certain activities more time-consuming. A number of these requirements require us to carry out activities Legacy Amprius had not done previously. For example, our Board has committees that did not exist on the Legacy Amprius board of directors, and we have adopted new internal controls and disclosure controls and procedures. In addition, we are incurring expenses associated with SEC reporting requirements. Furthermore, if any issues in complying with those requirements are identified (for example, if the auditors identify a material weakness or significant deficiency in the internal control over financial reporting), we could incur additional costs rectifying those issues, and the existence of those issues could adversely affect our reputation or investor perceptions of us. As a public company, it is also more expensive to obtain director and officer liability insurance. The additional reporting and other obligations imposed by these rules and regulations have and will continue to increase legal and financial compliance costs and the costs of related legal, accounting and administrative activities. These increased costs will require us to spend money that could otherwise be used on our research and development programs and to achieve strategic objectives. Advocacy efforts by stockholders and third parties may also prompt additional changes in governance and reporting requirements, which could further increase costs.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We do not expect to declare any dividends in the foreseeable future.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not anticipate declaring any cash dividends to holders of our common stock in the foreseeable future. Consequently, investors may need to rely on sales of their shares after price appreciation, which may never occur, as the only way to realize any future gains on their investment.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If securities or industry analysts do not publish or cease publishing research or reports about us, our business, or our market, or if they change their recommendations regarding our securities adversely, the price and trading volume of our securities could decline.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The trading market for our securities will be influenced by the research and reports that industry or securities analysts may publish about us, our business, market or competitors. If any of the analysts who may cover us change their recommendation regarding our common stock adversely, or provide more favorable relative recommendations about our competitors, the price of our common stock and warrants would likely decline. If any analyst who may cover us were to cease coverage of us or fail to regularly publish reports on us, we could lose visibility in the financial markets, which in turn could cause our stock price or trading volume to decline.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We qualify as an &#8220;emerging growth company&#8221; and a &#8220;smaller reporting company&#8221; within the meaning of the Securities Act, and if we take advantage of certain exemptions from disclosure requirements available to emerging growth companies or smaller reporting companies, this could make our securities less attractive to investors and may make it more difficult to compare our performance with other public companies.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We qualify as an &#8220;emerging growth company&#8221; as defined in Section 2(a)(19) of the Securities Act, as modified by the JOBS Act. As such, we are eligible for and intend to take advantage of certain exemptions from various reporting requirements applicable to other public companies that are not emerging growth companies for as long as we continue to be an emerging growth company, including (i) the exemption from the auditor attestation requirements with respect to internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act, (ii) the exemptions from say-on-pay, say-on-frequency and say-on-golden parachute voting requirements and (iii) reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements. As a result, our stockholders may not have access to certain information they may deem important. We will remain an emerging growth company until the earliest of (i) the last day of the fiscal year in which the market value of our common stock that are held by non-affiliates exceeds $700 million as of June 30 of that fiscal year, (ii) the last day of the fiscal year in which we have total annual gross revenue of $1.235 billion or more during such fiscal year (as indexed for inflation), (iii) the date on which we have issued more than $1 billion in </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_10">Table of Contents</a></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">non-convertible debt in the prior three-year period or (iv) December 31, 2027. In addition, Section 107 of the JOBS Act also provides that an emerging growth company can take advantage of the exemption from complying with new or revised accounting standards provided in Section 7(a)(2)(B) of the Securities Act as long as we are an emerging growth company. An emerging growth company can therefore delay the adoption of certain accounting standards until those standards would otherwise apply to private companies. We have elected not to opt out of such extended transition period and, therefore, we may not be subject to the same new or revised accounting standards as other public companies that are not emerging growth companies. Investors may find our common stock less attractive because we rely on these exemptions, which may result in a less active trading market for our common stock and its price may be more volatile.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, we qualify as a &#8220;smaller reporting company&#8221; as defined in Item 10(f)(1) of Regulation S-K. Smaller reporting companies may take advantage of certain reduced disclosure obligations, including, among other things, providing only two years of audited financial statements. We expect to remain a smaller reporting company until the last day of the fiscal year in which (i) the market value of our common stock held by non-affiliates exceeds $250,000,000 as of the prior June 30, or (ii) our annual revenues exceeded $100,000,000 during such completed fiscal year and the market value of our common stock held by non-affiliates exceeds $700,000,000 as of the prior June 30. To the extent we take advantage of such reduced disclosure obligations, comparison of our financial statements with other public companies may be difficult or impossible.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sales of substantial amounts of our common stock in the public markets, or the perception that such sales could occur, could cause the market price of our common stock to drop significantly, even if our business is doing well.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales of a substantial number of shares of our securities in the public market could occur at any time. For example, we have certain registration right obligations with respect to 104,820,694 shares of our common stock constituting approximately 95.3% of our issued and outstanding common stock as of March&#160;31, 2023 (assuming the exercise in full of all of the warrants registered thereunder), as well as the shares underlying the remainder of our public warrants.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These sales, any future sales of a substantial number of shares of our securities in the public market or the perception in the market that the holders of a large number of shares intend to sell shares, could reduce the market price of our securities. Despite such a decline in the public trading price, certain securityholders may still experience a positive rate of return on the securities they purchased due to the lower price that they purchased their shares compared to other public investors and be incentivized to sell securities when others are not. </span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additionally, we have filed a registration statement to register shares reserved for future issuance under our equity compensation plans and the shares issuable upon exercise of the options outstanding under the Amprius Technologies, Inc. 2016 Equity Incentive Plan, which were an aggregate of 13,971,079 shares of common stock as of March&#160;31, 2023. Subject to applicable securities laws, the satisfaction of any vesting restrictions and the expiration or waiver of the lock-up restrictions contained in our Bylaws, the shares issued thereunder will be available for immediate resale in the public market.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, we have filed a resale registration statement covering the resale by BRPC II of shares of our common stock that we may issue to BRPC II from time to time during the term of the Purchase Agreement. The purchase price for the shares that we may sell to BRPC II in the Committed Equity Financing will fluctuate based on the price of our common stock. Depending on market liquidity at the time, sales of such shares may cause the trading price of our common stock to fall. If and when we do sell shares to BRPC II, after BRPC II has acquired the shares, BRPC II may resell all, some, or none of those shares at any time or from time to time in its discretion. Therefore, sales to BRPC II by us could result in substantial dilution to the interests of other holders of our common stock. Additionally, the sale of a substantial number of shares of our common stock to BRPC II, or the anticipation of such sales, could make it more difficult for us to sell equity or equity-related securities in the future at a time and at a price that we might otherwise wish to effect sales.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, approximately 88.7% of our outstanding shares of common stock are subject to lock-up restrictions, which expire on or before September 13, 2023. Sales of our common stock following the expiration of these lock-up restrictions or pursuant to the exercise of registration rights may make it more difficult for us to sell equity securities in the future at a time and at a price that we deem appropriate. These sales could also cause the market price of our common stock to decline if such equity holders sell or are perceived by the market as intending to sell any such securities, and make it more difficult for you to sell your shares of common stock at a time and price that you deem appropriate.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_10">Table of Contents</a></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may issue additional shares of common stock under an employee incentive plan (including the 2022 Equity Incentive Plan and the Employee Stock Purchase Plan), or may issue preferred stock. Any such issuances would dilute the interest of our stockholders and likely present other risks.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may issue a substantial number of additional shares of common stock under our employee incentive plan (including the 2022 Equity Incentive Plan (the "2022 Plan") and the Employee Stock Purchase Plan (the "ESPP")) or we may issue preferred stock. The issuance of additional securities:</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">may significantly dilute the equity interests of our investors;</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">may subordinate the rights of our stockholders if preferred stock is issued with rights senior to those afforded our common stock;</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">could cause a change in control if a substantial number of securities are issued, which may affect, among other things, our ability to use our net operating loss carry forwards, if any, and could result in the resignation or removal of our present officers and directors; and</span></div><div style="margin-top:6pt;padding-left:43.2pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">may adversely affect prevailing market prices for our common stock and/or warrants.</span></div><div id="i066fdabb1d0848d5b0391931f87c3c0e_728"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risks Related to Our Warrants</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">There is no guarantee that our warrants will be in the money at the time they become exercisable, and they may expire worthless.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The likelihood that warrant holders will exercise the warrants and any cash proceeds that we would receive is dependent upon the market price of our common stock. If the market price for our common stock is less than $11.50 per share, in the case of our private warrants and public warrants, or $12.50 per share, in the case of our PIPE warrants, we believe warrant holders will be unlikely to exercise their warrants. There is no guarantee that the warrants will be in the money following the time they become exercisable and prior to their expiration, and as such, the warrants may expire worthless.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may redeem unexpired public warrants prior to their exercise at a time that is disadvantageous to the warrant holders, thereby making the public warrants worthless.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have the ability to redeem outstanding public warrants or PIPE warrants at any time after they become exercisable and prior to their expiration, at a price of $0.01 per warrant, provided that the last reported sales price of our common stock equals or exceeds $18.00 per share (as may be adjusted), in the case of the public warrants, or $20.00 per share (as may be adjusted), in the case of the PIPE warrants, for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which we send the notice of redemption to public warrant or PIPE warrant holders and provided certain other conditions are met. If and when the public warrants or PIPE warrants become redeemable by us, we may exercise our redemption right even if we are unable to register or qualify the underlying securities for sale under all applicable state securities laws. As a result, we may redeem the public warrants or PIPE warrants as set forth above even if the holders are otherwise unable to exercise the public warrants or PIPE warrants. Redemption of the outstanding public warrants or PIPE warrants could force holders (i) to exercise public warrants or PIPE warrants and pay the exercise price therefor at a time when it may be disadvantageous, (ii) to sell public warrants or PIPE warrants at the then-current market price when holders might otherwise wish to hold public warrants or PIPE warrants or (iii) to accept the nominal redemption price that, at the time the outstanding public warrants or PIPE warrants are called for redemption, may be substantially less than the market value of the public warrants or PIPE warrants.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may amend the terms of the warrants in a manner that may be adverse to holders of warrants with the approval by the holders of at least 50% of the then outstanding warrants. As a result, the exercise price of warrants could be increased, the exercise period could be shortened and the number of shares of common stock purchasable upon exercise of a warrant could be decreased, all without warrant holder approval.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The public warrants and private warrants were issued in registered form under the respective warrant agreements. The Warrant Agreement, dated as of March 1, 2022 (the &#8220;Warrant Agreement&#8221;), by and among us and Continental Stock Transfer &amp; Trust Company, provides that the terms of the public warrants and private warrants may be amended without the consent of any holder to cure any ambiguity or correct any defective provision but requires the approval by the holders of at least 50% of the then outstanding public warrants to make any change that adversely affects the interests of the registered holders of public warrants and, solely with respect to any amendment to the terms of the private warrants or any provision of the Warrant Agreement with respect to the private warrants, 50% of the number of the then outstanding private warrants. The Warrant Agreement, dated as of September 14, 2022 (the &#8220;PIPE Warrant Agreement&#8221;), by and </span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_10">Table of Contents</a></span></div></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">among us and Continental Stock Transfer &amp; Trust Company, provides that the terms of the PIPE warrants may be amended without the consent of any holder to cure any ambiguity or correct any defective provision but requires the approval by the holders of at least 50% of the then outstanding PIPE warrants to make any change that adversely affects the interests of the registered holders of PIPE warrants. Accordingly, we may amend the terms of the warrants in a manner adverse to a holder if holders of at least 50% of such then-outstanding warrants approve of such amendment. Although our ability to amend the terms of the warrants with the consent of at least 50% of such then-outstanding warrants is unlimited, examples of such amendments could be amendments to, among other things, increase the exercise price of the warrants, convert the warrants into cash or shares, shorten the exercise period or decrease the number of shares of common stock issuable upon exercise of a warrant.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The warrants are exercisable for common stock, which would increase the number of shares eligible for future resale in the public market and result in dilution to our stockholders.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, outstanding warrants to purchase an aggregate of 47,720,836 shares of common stock are exercisable in accordance with the terms of the warrant agreement governing those securities. The exercise price of the private warrants and public warrants is $11.50 per share, and the exercise price of the PIPE warrants is $12.50 per share. To the extent the warrants are exercised, additional shares of common stock will be issued, which will result in dilution to the holders of common stock and increase the number of shares eligible for resale in the public market. Shares of common stock issuable pursuant to the warrants are not subject to lock-up restrictions. As such, once the warrants are exercised, the holder of such shares issuable upon the exercise of the warrants will be able to resell the shares to the market, subject to other applicable laws. Sales of substantial numbers of such shares in the public market or the fact that such warrants may be exercised could adversely affect the market price of our common stock. Further, there is no guarantee that the warrants will ever be in the money prior to their expiration, and as such, such warrants may expire worthless.</span></div><div id="i066fdabb1d0848d5b0391931f87c3c0e_160"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2. Unregistered Sales of Equity Securities and Use of Proceeds</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i066fdabb1d0848d5b0391931f87c3c0e_163"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 3. Defaults Upon Senior Securities</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i066fdabb1d0848d5b0391931f87c3c0e_166"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 4. Mine Safety Disclosures</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div id="i066fdabb1d0848d5b0391931f87c3c0e_169"></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5. Other Information</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Not applicable.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><div id="i066fdabb1d0848d5b0391931f87c3c0e_172"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div style="-sec-extract:summary"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_10">Table of Contents</a></span></div></div><div style="-sec-extract:summary;margin-top:18pt"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 6. Exhibits</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.930%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:38.445%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:8.596%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.354%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.778%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.475%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.406%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.086%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Incorporated by Reference</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit Number</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Form</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">File No.</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit Number</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Filing <br/>Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Filed Herewith</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.1&#8224;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1899287/000189928723000072/exhibit21projectcombine-me.htm">Agreement and Plan of Merger and Reorganization, dated May 9, 2023, by and among Amprius Technologies, Inc., Amprius, Inc., Combine Merger Sub, Inc. and Combine Merger Sub, LLC </a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Form 8-K</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">File No. 001-41314</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">May 10, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1899287/000119312522246477/d401031dex31.htm">Certificate of Incorporation of Amprius Technologies, Inc.</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Form 8-K</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">File No. 001-41314</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">September 16, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1899287/000189928723000021/ampx-20230323xexhibit31.htm">Amended and Restated Bylaws of Amprius Technologies, Inc.</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Form 8-K</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">File No. 001-41314</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">March 23, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1899287/000119312522246477/d401031dex41.htm">Specimen Common Stock Certificate</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Form 8-K</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">File No. 001-41314</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">September 16, 2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/1899287/000189928723000037/leaseagreementdatedapril15.htm">Lease Agreement dated April 15, 2023</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Form 8-K</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">File No. 001-41314</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10.1</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">April 19, 2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="ampx-20230331xexhibit311.htm">Certification of Principal Executive Officer pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="ampx-20230331xexhibit312.htm">Certification of Principal Financial Officer pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;32.1*</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="ampx-20230331xexhibit321.htm">Certification of Principal Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32.2*</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%;text-decoration:underline" href="ampx-20230331xexhibit322.htm">Certification of Principal Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because XBRL tags are embedded within the Inline XBRL document.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition Linkbase Document</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase Document</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">X</span></td></tr></table></div><div style="padding-left:18pt;text-indent:-10.08pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-10.08pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#8224;   Certain schedules have been omitted pursuant to Item 601(a)(5) of Regulation S-K. A copy of any omitted schedule will be finished to the SEC upon request.</span></div><div style="margin-top:10pt;padding-left:18pt;text-indent:-10.08pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%">*   These certifications furnished in Exhibit 32.1 and 32.2 hereto are deemed to accompany this Quarterly Report on Form 10-Q and are not deemed &#8220;filed&#8221; for purposes of Section 18 of the Exchange Act, or otherwise subject to the liability of that section, nor shall they be deemed incorporated by reference into any filing under the Securities Act or the Exchange Act.</span></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><div id="i066fdabb1d0848d5b0391931f87c3c0e_175"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i066fdabb1d0848d5b0391931f87c3c0e_10">Table of Contents</a></span></div></div><div style="margin-top:18pt;text-align:center"><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.636%"><tr><td style="width:1.0%"></td><td style="width:37.763%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:5.812%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.962%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:44.063%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amprius Technologies, Inc.:</span></td></tr><tr style="height:23pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 11, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Dr. Kang Sun</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Date)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dr. Kang Sun</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 11, 2023</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Sandra Wallach</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Date)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sandra Wallach</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial and Accounting Officer)</span></td></tr></table></div><div style="height:45pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">58</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>ampx-20230331xexhibit311.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i46acd339454746bebd784971bcb36a69_1"></div><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RULE 13a-14(a) OR 15d-14(a) OF THE SECURITIES EXCHANGE ACT OF 1934,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Dr. Kang Sun, certify that&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. &#160;&#160;&#160;&#160;I have reviewed this Quarterly Report on Form 10-Q of Amprius Technologies, Inc. (the &#8220;registrant&#8221;)&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. &#160;&#160;&#160;&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. &#160;&#160;&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. &#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59; </font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59; </font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and </font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. &#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting, which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="padding-left:36pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:45.972%"><tr><td style="width:1.0%"></td><td style="width:45.727%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.942%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.031%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 11, 2023</font></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amprius Technologies, Inc.&#58;</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Dr. Kang Sun</font></td></tr><tr><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dr. Kang Sun</font></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</font></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td></tr></table></div><div style="height:18pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>ampx-20230331xexhibit312.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i23417dc883ef4960bb45b0df5c1e74f9_1"></div><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit 31.2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RULE 13a-14(a) OR 15d-14(a) OF THE SECURITIES EXCHANGE ACT OF 1934,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">I, Sandra Wallach, certify that&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1. &#160;&#160;&#160;&#160;I have reviewed this Quarterly Report on Form 10-Q of Amprius Technologies, Inc. (the &#8220;registrant&#8221;)&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2. &#160;&#160;&#160;&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3. &#160;&#160;&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4. &#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59; </font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59; </font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">c.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and </font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">d.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5. &#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">a.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:11.07pt">all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting, which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div style="padding-left:36pt"><font><br></font></div><div style="padding-left:72pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">b.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div style="padding-left:36pt"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:45.972%"><tr><td style="width:1.0%"></td><td style="width:45.727%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:4.942%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.031%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 11, 2023</font></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amprius Technologies, Inc.&#58;</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Sandra Wallach</font></td></tr><tr><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sandra Wallach</font></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Financial and Accounting Officer)</font></td></tr></table></div><div style="height:18pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>ampx-20230331xexhibit321.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="iea1471e39bca4790b9c0ae6e05b5520e_1"></div><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">Exhibit 32.1</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">I, Dr. Kang Sun, Chief Executive Officer of Amprius Technologies, Inc. (the &#8220;Company&#8221;), do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.5pt">The Quarterly Report on Form 10-Q of the Company for the fiscal quarter ended March&#160;31, 2023, as filed with the Securities and Exchange Commission, (the &#8220;Report&#8221;) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">The information contained in the Report fairly presents, in all material respects, the financial condition, and results of operations of the Company.</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:36.111%"><tr><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="9" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 11, 2023</font></td></tr><tr style="height:11pt"><td colspan="12" style="padding:0 1pt"></td></tr><tr><td colspan="12" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amprius Technologies, Inc.&#58;</font></td></tr><tr style="height:15pt"><td colspan="12" style="padding:0 1pt"></td></tr><tr><td colspan="12" style="border-bottom:1pt solid #000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Dr. Kang Sun</font></td></tr><tr><td colspan="12" style="border-top:1pt solid #000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dr. Kang Sun</font></td></tr><tr><td colspan="12" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer</font></td></tr><tr><td colspan="12" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td></tr></table></div><div><font><br></font></div><div style="height:18pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.2
<SEQUENCE>5
<FILENAME>ampx-20230331xexhibit322.htm
<DESCRIPTION>EX-32.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i64b6d5285b3a4580b3f2ecfd0c457956_1"></div><div style="min-height:28.8pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:161%">Exhibit 32.2</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:139%">SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">I, Sandra Wallach, Chief Financial Officer of Amprius Technologies, Inc. (the &#8220;Company&#8221;), do hereby certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to my knowledge&#58;</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%">1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:130%;padding-left:10.5pt">The Quarterly Report on Form 10-Q of the Company for the fiscal quarter ended March&#160;31, 2023, as filed with the Securities and Exchange Commission, (the &#8220;Report&#8221;) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended&#59; and</font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%;padding-left:10.5pt">The information contained in the Report fairly presents, in all material respects, the financial condition, and results of operations of the Company.</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:37.222%"><tr><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:23.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 11, 2023</font></td></tr><tr style="height:11pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="12" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Amprius Technologies, Inc.&#58;</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="12" style="border-bottom:1pt solid #000000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#47;s&#47; Sandra Wallach</font></td></tr><tr><td colspan="12" style="border-top:1pt solid #000000;padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sandra Wallach</font></td></tr><tr><td colspan="12" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr><tr><td colspan="12" style="padding:2px 1pt 2px 1.02pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">(Principal Financial and Accounting Officer)</font></td></tr></table></div><div><font><br></font></div><div style="height:18pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>ampx-20230331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:fb8494f8-cb68-4af0-9ed5-216002fa868d,g:3b95c37f-4a77-4ae7-bad0-5ccbe8b7d32c-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ampx="http://www.amprius.com/20230331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.amprius.com/20230331">
  <xs:import namespace="http://fasb.org/srt/2022" schemaLocation="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2022" schemaLocation="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ampx-20230331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ampx-20230331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ampx-20230331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ampx-20230331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.amprius.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETS" roleURI="http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS">
        <link:definition>0000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" roleURI="http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical">
        <link:definition>0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" roleURI="http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS">
        <link:definition>0000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" roleURI="http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
        <link:definition>0000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" roleURI="http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS">
        <link:definition>0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NatureofOperationsandOrganization" roleURI="http://www.amprius.com/role/NatureofOperationsandOrganization">
        <link:definition>0000007 - Disclosure - Nature of Operations and Organization</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://www.amprius.com/role/SummaryofSignificantAccountingPolicies">
        <link:definition>0000008 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Revenue" roleURI="http://www.amprius.com/role/Revenue">
        <link:definition>0000009 - Disclosure - Revenue</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Inventory" roleURI="http://www.amprius.com/role/Inventory">
        <link:definition>0000010 - Disclosure - Inventory</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipmentNet" roleURI="http://www.amprius.com/role/PropertyPlantandEquipmentNet">
        <link:definition>0000011 - Disclosure - Property, Plant and Equipment, Net</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedandOtherCurrentLiabilities" roleURI="http://www.amprius.com/role/AccruedandOtherCurrentLiabilities">
        <link:definition>0000012 - Disclosure - Accrued and Other Current Liabilities</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquity" roleURI="http://www.amprius.com/role/StockholdersEquity">
        <link:definition>0000013 - Disclosure - Stockholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxes" roleURI="http://www.amprius.com/role/IncomeTaxes">
        <link:definition>0000014 - Disclosure - Income Taxes</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://www.amprius.com/role/Leases">
        <link:definition>0000015 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentandContingencies" roleURI="http://www.amprius.com/role/CommitmentandContingencies">
        <link:definition>0000016 - Disclosure - Commitment and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShare" roleURI="http://www.amprius.com/role/NetLossPerShare">
        <link:definition>0000017 - Disclosure - Net Loss Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEvents" roleURI="http://www.amprius.com/role/SubsequentEvents">
        <link:definition>0000018 - Disclosure - Subsequent Events</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://www.amprius.com/role/SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>0000019 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueTables" roleURI="http://www.amprius.com/role/RevenueTables">
        <link:definition>0000020 - Disclosure - Revenue (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoryTables" roleURI="http://www.amprius.com/role/InventoryTables">
        <link:definition>0000021 - Disclosure - Inventory (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipmentNetTables" roleURI="http://www.amprius.com/role/PropertyPlantandEquipmentNetTables">
        <link:definition>0000022 - Disclosure - Property, Plant and Equipment, Net (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedandOtherCurrentLiabilitiesTables" roleURI="http://www.amprius.com/role/AccruedandOtherCurrentLiabilitiesTables">
        <link:definition>0000023 - Disclosure - Accrued and Other Current Liabilities (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityTables" roleURI="http://www.amprius.com/role/StockholdersEquityTables">
        <link:definition>0000024 - Disclosure - Stockholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://www.amprius.com/role/LeasesTables">
        <link:definition>0000025 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareTables" roleURI="http://www.amprius.com/role/NetLossPerShareTables">
        <link:definition>0000026 - Disclosure - Net Loss Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NatureofOperationsandOrganizationNarrativeDetails" roleURI="http://www.amprius.com/role/NatureofOperationsandOrganizationNarrativeDetails">
        <link:definition>0000027 - Disclosure - Nature of Operations and Organization - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesNarrativeDetails" roleURI="http://www.amprius.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails">
        <link:definition>0000028 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueScheduleofCompositionofRevenueDetails" roleURI="http://www.amprius.com/role/RevenueScheduleofCompositionofRevenueDetails">
        <link:definition>0000029 - Disclosure - Revenue - Schedule of Composition of Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenueNarrativeDetails" roleURI="http://www.amprius.com/role/RevenueNarrativeDetails">
        <link:definition>0000030 - Disclosure - Revenue - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuePerformanceObligationDetails" roleURI="http://www.amprius.com/role/RevenuePerformanceObligationDetails">
        <link:definition>0000031 - Disclosure - Revenue - Performance Obligation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RevenuePerformanceObligationDetails_1" roleURI="http://www.amprius.com/role/RevenuePerformanceObligationDetails_1">
        <link:definition>0000031 - Disclosure - Revenue - Performance Obligation (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="InventoryScheduleofInventoryDetails" roleURI="http://www.amprius.com/role/InventoryScheduleofInventoryDetails">
        <link:definition>0000032 - Disclosure - Inventory - Schedule of Inventory (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipmentNetScheduleofPropertyandEquipmentDetails" roleURI="http://www.amprius.com/role/PropertyPlantandEquipmentNetScheduleofPropertyandEquipmentDetails">
        <link:definition>0000033 - Disclosure - Property, Plant and Equipment, Net - Schedule of Property and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="PropertyPlantandEquipmentNetNarrativeDetails" roleURI="http://www.amprius.com/role/PropertyPlantandEquipmentNetNarrativeDetails">
        <link:definition>0000034 - Disclosure - Property, Plant and Equipment, Net - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="AccruedandOtherCurrentLiabilitiesDetails" roleURI="http://www.amprius.com/role/AccruedandOtherCurrentLiabilitiesDetails">
        <link:definition>0000035 - Disclosure - Accrued and Other Current Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityNarrativeDetails" roleURI="http://www.amprius.com/role/StockholdersEquityNarrativeDetails">
        <link:definition>0000036 - Disclosure - Stockholders' Equity - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityStockWarrantDetails" roleURI="http://www.amprius.com/role/StockholdersEquityStockWarrantDetails">
        <link:definition>0000037 - Disclosure - Stockholders' Equity - Stock Warrant (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="StockholdersEquityStockBasedCompensationExpenseDetails" roleURI="http://www.amprius.com/role/StockholdersEquityStockBasedCompensationExpenseDetails">
        <link:definition>0000038 - Disclosure - Stockholders' Equity - Stock-Based Compensation Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="IncomeTaxesDetails" roleURI="http://www.amprius.com/role/IncomeTaxesDetails">
        <link:definition>0000039 - Disclosure - Income Taxes (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesNarrativeDetails" roleURI="http://www.amprius.com/role/LeasesNarrativeDetails">
        <link:definition>0000040 - Disclosure - Leases - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleofFutureMaturingOperatingLeasePaymentsDetails" roleURI="http://www.amprius.com/role/LeasesScheduleofFutureMaturingOperatingLeasePaymentsDetails">
        <link:definition>0000041 - Disclosure - Leases - Schedule of Future Maturing Operating Lease Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesScheduleofFutureMaturingOperatingLeasePaymentsDetails_1" roleURI="http://www.amprius.com/role/LeasesScheduleofFutureMaturingOperatingLeasePaymentsDetails_1">
        <link:definition>0000041 - Disclosure - Leases - Schedule of Future Maturing Operating Lease Payments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareScheduleofCalculationofBasicandDilutedNetLossPerShareDetails" roleURI="http://www.amprius.com/role/NetLossPerShareScheduleofCalculationofBasicandDilutedNetLossPerShareDetails">
        <link:definition>0000042 - Disclosure - Net Loss Per Share - Schedule of Calculation of Basic and Diluted Net Loss Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerSharePotentiallyDilutiveSecuritiesDetails" roleURI="http://www.amprius.com/role/NetLossPerSharePotentiallyDilutiveSecuritiesDetails">
        <link:definition>0000043 - Disclosure - Net Loss Per Share - Potentially Dilutive Securities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SubsequentEventsNarrativeDetails" roleURI="http://www.amprius.com/role/SubsequentEventsNarrativeDetails">
        <link:definition>0000044 - Disclosure - Subsequent Events - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="ampx_SaleOfStockAveragePricePerShareRedemption" abstract="false" name="SaleOfStockAveragePricePerShareRedemption" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:perShareItemType"/>
  <xs:element id="ampx_NameOfFacilityAxis" abstract="true" name="NameOfFacilityAxis" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:dimensionItem" type="xbrli:stringItemType"/>
  <xs:element id="ampx_PublicWarrantsMember" abstract="true" name="PublicWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ampx_PIPEWarrantsMember" abstract="true" name="PIPEWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ampx_SaleOfStockPotentialMaximumConsiderationReceivedOnTransaction" abstract="false" name="SaleOfStockPotentialMaximumConsiderationReceivedOnTransaction" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ampx_UnauditedInterimCondensedFinancialStatementsPolicyPolicyTextBlock" abstract="false" name="UnauditedInterimCondensedFinancialStatementsPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="ampx_PurchaseAgreementMember" abstract="true" name="PurchaseAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ampx_ThreeCustomersMember" abstract="true" name="ThreeCustomersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ampx_GovernmentAssistanceGrantNotYetReceived" abstract="false" name="GovernmentAssistanceGrantNotYetReceived" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ampx_AdjustmentsToAdditionalPaidInCapitalContributionFromParentRelatedToStockBasedCompensation" abstract="false" name="AdjustmentsToAdditionalPaidInCapitalContributionFromParentRelatedToStockBasedCompensation" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ampx_LesseeOperatingLeaseOptionToExtendNumber" abstract="false" name="LesseeOperatingLeaseOptionToExtendNumber" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ampx_TwentyTwentyTwoEquityIncentivePlanMember" abstract="true" name="TwentyTwentyTwoEquityIncentivePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ampx_WarrantsRedemptionThresholdTradingDays" abstract="false" name="WarrantsRedemptionThresholdTradingDays" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ampx_StockholderPercentageOfOptioneeForOptionPrice" abstract="false" name="StockholderPercentageOfOptioneeForOptionPrice" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="ampx_TwentyTwentyTwoEmployeeStockPurchasePlanMember" abstract="true" name="TwentyTwentyTwoEmployeeStockPurchasePlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ampx_WarrantsRedemptionThresholdConsecutiveTradingDays" abstract="false" name="WarrantsRedemptionThresholdConsecutiveTradingDays" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ampx_OtherRevenueGovernmentGrantMember" abstract="true" name="OtherRevenueGovernmentGrantMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ampx_DeferredStockIssuanceCosts" abstract="false" name="DeferredStockIssuanceCosts" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ampx_SaleOfBatteryMember" abstract="true" name="SaleOfBatteryMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ampx_BRPCIIMember" abstract="true" name="BRPCIIMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ampx_ProductionEquipmentMember" abstract="true" name="ProductionEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ampx_AccruedOfferingCostsCurrent" abstract="false" name="AccruedOfferingCostsCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ampx_AdjustmentsToAdditionalPaidInCapitalCapitalContributionsFromParent" abstract="false" name="AdjustmentsToAdditionalPaidInCapitalCapitalContributionsFromParent" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ampx_AmpriusHoldingsMember" abstract="true" name="AmpriusHoldingsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ampx_SaleOfStockDiscount" abstract="false" name="SaleOfStockDiscount" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="ampx_LaboratoryEquipmentMember" abstract="true" name="LaboratoryEquipmentMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ampx_LesseeFinanceLeaseNumberOfLeases" abstract="false" name="LesseeFinanceLeaseNumberOfLeases" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ampx_EmergingGrowthCompanyPolicyPolicyTextBlock" abstract="false" name="EmergingGrowthCompanyPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:textBlockItemType"/>
  <xs:element id="ampx_PrivateWarrantsMember" abstract="true" name="PrivateWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ampx_SaleOfStockMaximumSharesAvailableForSalePercentageOfSharesIssuedAndOutstandingPriorToTransaction" abstract="false" name="SaleOfStockMaximumSharesAvailableForSalePercentageOfSharesIssuedAndOutstandingPriorToTransaction" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="ampx_CommittedEquityFinancing" abstract="false" name="CommittedEquityFinancing" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ampx_RedeemableWarrantsMember" abstract="true" name="RedeemableWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ampx_FiveCustomersMember" abstract="true" name="FiveCustomersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ampx_CustomerOneMember" abstract="true" name="CustomerOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ampx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfFairValueSignificantStockholder" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfFairValueSignificantStockholder" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="ampx_CustomerTwoMember" abstract="true" name="CustomerTwoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ampx_BrightonColoradoMember" abstract="true" name="BrightonColoradoMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ampx_CustomerThreeMember" abstract="true" name="CustomerThreeMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ampx_EquityIncentivePlansMember" abstract="true" name="EquityIncentivePlansMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ampx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfFairValue" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfFairValue" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:percentItemType"/>
  <xs:element id="ampx_TotalRevenueFromCustomersMember" abstract="true" name="TotalRevenueFromCustomersMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ampx_RecapitalizationExchangeRatio" abstract="false" name="RecapitalizationExchangeRatio" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:pureItemType"/>
  <xs:element id="ampx_SharesAuthorized" abstract="false" name="SharesAuthorized" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="ampx_PaymentOfTransactionAndIssuanceCostsInConnectionWithBusinessCombinationAndPIPEInvestment" abstract="false" name="PaymentOfTransactionAndIssuanceCostsInConnectionWithBusinessCombinationAndPIPEInvestment" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="ampx_NumberOfExecutiveEmployeesOfParentSharingFacilitiesCosts" abstract="false" name="NumberOfExecutiveEmployeesOfParentSharingFacilitiesCosts" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="ampx_ShareBasedCompensationArrangementByShareBasedPaymentAwardReservedForIssuance" abstract="false" name="ShareBasedCompensationArrangementByShareBasedPaymentAwardReservedForIssuance" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="ampx_CustomizedDesignServicesMember" abstract="true" name="CustomizedDesignServicesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ampx_NameOfFacilityDomain" abstract="true" name="NameOfFacilityDomain" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
  <xs:element id="ampx_ExecutiveIncentiveCompensationPlanMember" abstract="true" name="ExecutiveIncentiveCompensationPlanMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>7
<FILENAME>ampx-20230331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:fb8494f8-cb68-4af0-9ed5-216002fa868d,g:3b95c37f-4a77-4ae7-bad0-5ccbe8b7d32c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="ampx-20230331.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:calculationLink xlink:role="http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_4291dc8e-a878-4037-9dc4-fb167cfeb6f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_6fa6e930-954f-487c-9613-c06a0700dae3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_4291dc8e-a878-4037-9dc4-fb167cfeb6f6" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_6fa6e930-954f-487c-9613-c06a0700dae3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCurrent_03c97c51-cc0c-4f6f-9658-5f244561b05f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCostsCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_4291dc8e-a878-4037-9dc4-fb167cfeb6f6" xlink:to="loc_us-gaap_DeferredCostsCurrent_03c97c51-cc0c-4f6f-9658-5f244561b05f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_29b8ad6b-9c40-4e99-ba7d-4889211f2d64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_4291dc8e-a878-4037-9dc4-fb167cfeb6f6" xlink:to="loc_us-gaap_InventoryNet_29b8ad6b-9c40-4e99-ba7d-4889211f2d64" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_dbf14424-5647-45a1-aa85-82ab4e962fe8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_4291dc8e-a878-4037-9dc4-fb167cfeb6f6" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_dbf14424-5647-45a1-aa85-82ab4e962fe8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_308581a5-fdee-4096-b929-0a4bd0d65b6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_4291dc8e-a878-4037-9dc4-fb167cfeb6f6" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_308581a5-fdee-4096-b929-0a4bd0d65b6e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_94e2b362-b723-4c02-9955-239ed3df0b82" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCosts_960b8971-7162-406b-bec0-13c5ae03e491" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCosts"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_94e2b362-b723-4c02-9955-239ed3df0b82" xlink:to="loc_us-gaap_DeferredCosts_960b8971-7162-406b-bec0-13c5ae03e491" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_e17e9ab2-116d-47e5-8fa8-2c69ffc611e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_94e2b362-b723-4c02-9955-239ed3df0b82" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_e17e9ab2-116d-47e5-8fa8-2c69ffc611e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_5f63a6bd-7332-4cc8-90c4-bdf6aa008dac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_94e2b362-b723-4c02-9955-239ed3df0b82" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_5f63a6bd-7332-4cc8-90c4-bdf6aa008dac" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_cf320010-b932-4b34-95c2-a4110869ea83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_94e2b362-b723-4c02-9955-239ed3df0b82" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_cf320010-b932-4b34-95c2-a4110869ea83" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_e940c68a-bc97-495c-8775-204ecba2382a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_94e2b362-b723-4c02-9955-239ed3df0b82" xlink:to="loc_us-gaap_AssetsCurrent_e940c68a-bc97-495c-8775-204ecba2382a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_0bf97366-828d-4df2-90d6-f4940e699850" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_73b92436-6204-456b-9bfe-5e8008bba01e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_0bf97366-828d-4df2-90d6-f4940e699850" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_73b92436-6204-456b-9bfe-5e8008bba01e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_a0f2a313-790c-4a3e-bcfb-b2b3c53f4535" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_0bf97366-828d-4df2-90d6-f4940e699850" xlink:to="loc_us-gaap_AdditionalPaidInCapital_a0f2a313-790c-4a3e-bcfb-b2b3c53f4535" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValueOutstanding_e1fe2400-de19-4fc4-8d10-d03e4c2ce6e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValueOutstanding"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_0bf97366-828d-4df2-90d6-f4940e699850" xlink:to="loc_us-gaap_CommonStockValueOutstanding_e1fe2400-de19-4fc4-8d10-d03e4c2ce6e4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValueOutstanding_64dfa405-675f-4677-9d54-bdd4f7171cd4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValueOutstanding"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_0bf97366-828d-4df2-90d6-f4940e699850" xlink:to="loc_us-gaap_PreferredStockValueOutstanding_64dfa405-675f-4677-9d54-bdd4f7171cd4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_39012e49-bd6b-4959-baa7-366d7c7dac54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_0b9cbcf1-2983-41bf-a222-c8e5bfe4914e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_39012e49-bd6b-4959-baa7-366d7c7dac54" xlink:to="loc_us-gaap_AccountsPayableCurrent_0b9cbcf1-2983-41bf-a222-c8e5bfe4914e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_7909b75c-a344-4507-84ba-771fee5f4696" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_39012e49-bd6b-4959-baa7-366d7c7dac54" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_7909b75c-a344-4507-84ba-771fee5f4696" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_7123eb7b-a1f8-404e-af58-584c216054cb" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_39012e49-bd6b-4959-baa7-366d7c7dac54" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_7123eb7b-a1f8-404e-af58-584c216054cb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_06611f6c-a559-4e61-b9fa-e181f6e685e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_39012e49-bd6b-4959-baa7-366d7c7dac54" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_06611f6c-a559-4e61-b9fa-e181f6e685e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_ee662d7e-a233-48d8-ba93-99b293467c43" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_2c48fcf4-c74d-4fa4-9aa2-bd4914ece6ef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_ee662d7e-a233-48d8-ba93-99b293467c43" xlink:to="loc_us-gaap_CommitmentsAndContingencies_2c48fcf4-c74d-4fa4-9aa2-bd4914ece6ef" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_0919b8cb-8487-44cd-96a5-3414da884cc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_ee662d7e-a233-48d8-ba93-99b293467c43" xlink:to="loc_us-gaap_StockholdersEquity_0919b8cb-8487-44cd-96a5-3414da884cc4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_92753e5b-591e-4145-b61e-4586fe5dfce4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_ee662d7e-a233-48d8-ba93-99b293467c43" xlink:to="loc_us-gaap_Liabilities_92753e5b-591e-4145-b61e-4586fe5dfce4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_697a0a40-9029-4416-9146-861fadece0ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_8d13eea3-b93e-499b-a522-6c9d2817158c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_697a0a40-9029-4416-9146-861fadece0ee" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_8d13eea3-b93e-499b-a522-6c9d2817158c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_73e1a80f-5d61-4da6-9603-32b07fcaa17d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_697a0a40-9029-4416-9146-861fadece0ee" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_73e1a80f-5d61-4da6-9603-32b07fcaa17d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_5d62b626-3866-4259-b072-e902aac3ea04" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_697a0a40-9029-4416-9146-861fadece0ee" xlink:to="loc_us-gaap_LiabilitiesCurrent_5d62b626-3866-4259-b072-e902aac3ea04" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="ampx-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:calculationLink xlink:role="http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_327610d5-d65e-4458-aa7e-86b0f9c3a337" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_cf2a178c-ba58-464b-be44-4c4687a43636" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_327610d5-d65e-4458-aa7e-86b0f9c3a337" xlink:to="loc_us-gaap_Revenues_cf2a178c-ba58-464b-be44-4c4687a43636" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_6b6acdd8-da68-482b-8909-31f2656c72f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_327610d5-d65e-4458-aa7e-86b0f9c3a337" xlink:to="loc_us-gaap_CostOfRevenue_6b6acdd8-da68-482b-8909-31f2656c72f9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_6f35432b-0d8e-4d70-a93b-96116530892c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_e3c8f71e-93bd-4cd2-b515-b818c6477e8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_6f35432b-0d8e-4d70-a93b-96116530892c" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_e3c8f71e-93bd-4cd2-b515-b818c6477e8d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_7ac6dd67-10c0-4f5d-b28e-15c2c8d25399" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_6f35432b-0d8e-4d70-a93b-96116530892c" xlink:to="loc_us-gaap_OperatingIncomeLoss_7ac6dd67-10c0-4f5d-b28e-15c2c8d25399" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_f10be88a-2528-4664-a0ba-cde899e410ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_53fd6898-f1e8-4c40-b606-081a26813cdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_f10be88a-2528-4664-a0ba-cde899e410ac" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_53fd6898-f1e8-4c40-b606-081a26813cdc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_98185f4b-01c2-4fc5-817a-adee1d85975f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_f10be88a-2528-4664-a0ba-cde899e410ac" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_98185f4b-01c2-4fc5-817a-adee1d85975f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_86c271c6-b1e7-4122-a499-7c0685e6ec9c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_9ed2c4ff-8c7a-4b25-987e-2c307b84282a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_86c271c6-b1e7-4122-a499-7c0685e6ec9c" xlink:to="loc_us-gaap_GrossProfit_9ed2c4ff-8c7a-4b25-987e-2c307b84282a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_c1de570c-e4e2-427f-84f7-8c9109ae9080" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_86c271c6-b1e7-4122-a499-7c0685e6ec9c" xlink:to="loc_us-gaap_OperatingExpenses_c1de570c-e4e2-427f-84f7-8c9109ae9080" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="ampx-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:calculationLink xlink:role="http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_695f12b2-da55-485a-843e-a9a42afe1e90" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromContributionsFromParent_8edb64a4-bfe6-4a44-8cc1-72334be144db" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromContributionsFromParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_695f12b2-da55-485a-843e-a9a42afe1e90" xlink:to="loc_us-gaap_ProceedsFromContributionsFromParent_8edb64a4-bfe6-4a44-8cc1-72334be144db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_f328d9a0-0d06-4277-ad59-d80736387660" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_695f12b2-da55-485a-843e-a9a42afe1e90" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_f328d9a0-0d06-4277-ad59-d80736387660" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_PaymentOfTransactionAndIssuanceCostsInConnectionWithBusinessCombinationAndPIPEInvestment_2fa4be62-abc3-45ee-ba0d-fec35887d9fc" xlink:href="ampx-20230331.xsd#ampx_PaymentOfTransactionAndIssuanceCostsInConnectionWithBusinessCombinationAndPIPEInvestment"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_695f12b2-da55-485a-843e-a9a42afe1e90" xlink:to="loc_ampx_PaymentOfTransactionAndIssuanceCostsInConnectionWithBusinessCombinationAndPIPEInvestment_2fa4be62-abc3-45ee-ba0d-fec35887d9fc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_3a3a331e-e919-46c8-aba3-a0396e7c5c51" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_695f12b2-da55-485a-843e-a9a42afe1e90" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_3a3a331e-e919-46c8-aba3-a0396e7c5c51" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_222c17cc-f07f-47bd-9475-925d20dcf94f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_695f12b2-da55-485a-843e-a9a42afe1e90" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_222c17cc-f07f-47bd-9475-925d20dcf94f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_188532b7-4a88-4f80-8799-78066484bad6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_c47b84a8-2a3e-4b4b-ae33-96d5d0254a9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_188532b7-4a88-4f80-8799-78066484bad6" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_c47b84a8-2a3e-4b4b-ae33-96d5d0254a9d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_6aadcc7c-a9ee-40c4-b830-e6d1eadb6a68" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_188532b7-4a88-4f80-8799-78066484bad6" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_6aadcc7c-a9ee-40c4-b830-e6d1eadb6a68" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_4ce975b1-f842-4961-bd79-f202409928d0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_188532b7-4a88-4f80-8799-78066484bad6" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_4ce975b1-f842-4961-bd79-f202409928d0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_dd53e23e-e36f-4847-b18a-9c7c0e4047d7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_188532b7-4a88-4f80-8799-78066484bad6" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_dd53e23e-e36f-4847-b18a-9c7c0e4047d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredCharges_1431083f-b18d-43ff-b3c9-240e35764284" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredCharges"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_188532b7-4a88-4f80-8799-78066484bad6" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredCharges_1431083f-b18d-43ff-b3c9-240e35764284" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_e2f9ece0-9931-4fe0-a86d-2077f2b179c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_188532b7-4a88-4f80-8799-78066484bad6" xlink:to="loc_us-gaap_ShareBasedCompensation_e2f9ece0-9931-4fe0-a86d-2077f2b179c1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_3515d211-9298-49d6-960f-5e4e376532fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_188532b7-4a88-4f80-8799-78066484bad6" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_3515d211-9298-49d6-960f-5e4e376532fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_388befc5-8a27-411a-a1ac-184d388c3ac5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_188532b7-4a88-4f80-8799-78066484bad6" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_388befc5-8a27-411a-a1ac-184d388c3ac5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_3c0b53a4-b1a3-4ad9-9a78-c5f0911a6d0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_188532b7-4a88-4f80-8799-78066484bad6" xlink:to="loc_us-gaap_NetIncomeLoss_3c0b53a4-b1a3-4ad9-9a78-c5f0911a6d0c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_3c14f959-af5d-4fa9-aae6-b8625c506d72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_188532b7-4a88-4f80-8799-78066484bad6" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_3c14f959-af5d-4fa9-aae6-b8625c506d72" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_ca21c0bf-35d4-4c8b-9d69-ce2ed6fdde0c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="11" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_188532b7-4a88-4f80-8799-78066484bad6" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_ca21c0bf-35d4-4c8b-9d69-ce2ed6fdde0c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAmortizationOfDeferredCharges_30cbcc96-6ab2-46e5-bd8a-614613764a26" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAmortizationOfDeferredCharges"/>
    <link:calculationArc order="12" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_188532b7-4a88-4f80-8799-78066484bad6" xlink:to="loc_us-gaap_OtherAmortizationOfDeferredCharges_30cbcc96-6ab2-46e5-bd8a-614613764a26" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_1be88ff7-acab-47f0-9142-21d1c59b6349" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_188532b7-4a88-4f80-8799-78066484bad6" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_1be88ff7-acab-47f0-9142-21d1c59b6349" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_57e411ab-a2a5-4ee5-9ffe-88b8366eee8f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_7e8677ea-0d59-49e0-b7ff-09b0b3c35426" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_57e411ab-a2a5-4ee5-9ffe-88b8366eee8f" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_7e8677ea-0d59-49e0-b7ff-09b0b3c35426" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_28e257a1-aba7-41cf-a50b-bcdb2cfa1d97" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_26d176ce-ab98-4988-80e0-4751f944faf9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_28e257a1-aba7-41cf-a50b-bcdb2cfa1d97" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_26d176ce-ab98-4988-80e0-4751f944faf9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9257e036-f28e-44ac-8135-335546207b15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_28e257a1-aba7-41cf-a50b-bcdb2cfa1d97" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_9257e036-f28e-44ac-8135-335546207b15" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b4d5edd3-8a45-4e23-baef-10963d64c9d2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_28e257a1-aba7-41cf-a50b-bcdb2cfa1d97" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_b4d5edd3-8a45-4e23-baef-10963d64c9d2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_24507aec-4abe-4c4c-8bf2-27bc4dfe7a10" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_3ea46253-a247-40de-bece-3e217926fb6e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCash"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_24507aec-4abe-4c4c-8bf2-27bc4dfe7a10" xlink:to="loc_us-gaap_RestrictedCash_3ea46253-a247-40de-bece-3e217926fb6e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_878270d6-54c2-421f-b059-87a5391d023e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_24507aec-4abe-4c4c-8bf2-27bc4dfe7a10" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_878270d6-54c2-421f-b059-87a5391d023e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.amprius.com/role/InventoryScheduleofInventoryDetails" xlink:type="simple" xlink:href="ampx-20230331.xsd#InventoryScheduleofInventoryDetails"/>
  <link:calculationLink xlink:role="http://www.amprius.com/role/InventoryScheduleofInventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_28b2cd1f-0c0d-40a8-99f3-97c8faae5a3b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_8773eab0-cd30-4841-86f6-c59efef70635" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_28b2cd1f-0c0d-40a8-99f3-97c8faae5a3b" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_8773eab0-cd30-4841-86f6-c59efef70635" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_cb815519-94ff-4bce-8e0b-47145f1d3ab9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_28b2cd1f-0c0d-40a8-99f3-97c8faae5a3b" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_cb815519-94ff-4bce-8e0b-47145f1d3ab9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_42cf3a8f-6500-4264-ac1d-4de04588edfe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_28b2cd1f-0c0d-40a8-99f3-97c8faae5a3b" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_42cf3a8f-6500-4264-ac1d-4de04588edfe" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.amprius.com/role/PropertyPlantandEquipmentNetScheduleofPropertyandEquipmentDetails" xlink:type="simple" xlink:href="ampx-20230331.xsd#PropertyPlantandEquipmentNetScheduleofPropertyandEquipmentDetails"/>
  <link:calculationLink xlink:role="http://www.amprius.com/role/PropertyPlantandEquipmentNetScheduleofPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_8ccdd53f-328f-4279-813c-8ed4b83cdbf7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_adc044e3-a095-4138-af94-6f89f24560f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_8ccdd53f-328f-4279-813c-8ed4b83cdbf7" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_adc044e3-a095-4138-af94-6f89f24560f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_eec10b14-a5b3-4924-a48f-23ee86a532c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_8ccdd53f-328f-4279-813c-8ed4b83cdbf7" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_eec10b14-a5b3-4924-a48f-23ee86a532c6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.amprius.com/role/AccruedandOtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="ampx-20230331.xsd#AccruedandOtherCurrentLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://www.amprius.com/role/AccruedandOtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_d57e1f20-39d3-4a07-84a1-1dfd695c43ac" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_5528ccb9-6311-4085-9d9e-c6ff96a00dde" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_d57e1f20-39d3-4a07-84a1-1dfd695c43ac" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_5528ccb9-6311-4085-9d9e-c6ff96a00dde" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_aba070cb-e2c9-47b7-b0ef-d10c53fed566" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_d57e1f20-39d3-4a07-84a1-1dfd695c43ac" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_aba070cb-e2c9-47b7-b0ef-d10c53fed566" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_9b8dfcda-d9e6-4371-aaad-6e2a66540c98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_d57e1f20-39d3-4a07-84a1-1dfd695c43ac" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_9b8dfcda-d9e6-4371-aaad-6e2a66540c98" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_AccruedOfferingCostsCurrent_d9576f8f-f399-4d2f-9850-87c2841db951" xlink:href="ampx-20230331.xsd#ampx_AccruedOfferingCostsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_d57e1f20-39d3-4a07-84a1-1dfd695c43ac" xlink:to="loc_ampx_AccruedOfferingCostsCurrent_d9576f8f-f399-4d2f-9850-87c2841db951" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.amprius.com/role/LeasesScheduleofFutureMaturingOperatingLeasePaymentsDetails" xlink:type="simple" xlink:href="ampx-20230331.xsd#LeasesScheduleofFutureMaturingOperatingLeasePaymentsDetails"/>
  <link:calculationLink xlink:role="http://www.amprius.com/role/LeasesScheduleofFutureMaturingOperatingLeasePaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_7b6c0b1e-5658-46fe-ae92-d44dba7da25c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_be18c40f-9663-41e4-9b1b-adb8c82624c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_7b6c0b1e-5658-46fe-ae92-d44dba7da25c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_be18c40f-9663-41e4-9b1b-adb8c82624c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_578be7a0-7a72-4fcd-b2da-92f576606a8c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_7b6c0b1e-5658-46fe-ae92-d44dba7da25c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_578be7a0-7a72-4fcd-b2da-92f576606a8c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_70f4fb1f-978e-429f-97a7-423a3bd096a5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_7b6c0b1e-5658-46fe-ae92-d44dba7da25c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_70f4fb1f-978e-429f-97a7-423a3bd096a5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_4efcb82d-7feb-4e73-a96f-7c533ea62656" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_7b6c0b1e-5658-46fe-ae92-d44dba7da25c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_4efcb82d-7feb-4e73-a96f-7c533ea62656" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_cf59897b-111f-4b63-81c5-09f93dd89a49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_7b6c0b1e-5658-46fe-ae92-d44dba7da25c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_cf59897b-111f-4b63-81c5-09f93dd89a49" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_6fd3cd3c-01a7-414a-9041-a6547fd24ad4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_7b6c0b1e-5658-46fe-ae92-d44dba7da25c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_6fd3cd3c-01a7-414a-9041-a6547fd24ad4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_c30ff91d-8414-4eb5-a32c-b94b0ace3a87" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_7b6c0b1e-5658-46fe-ae92-d44dba7da25c" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_c30ff91d-8414-4eb5-a32c-b94b0ace3a87" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://www.amprius.com/role/LeasesScheduleofFutureMaturingOperatingLeasePaymentsDetails_1" xlink:type="simple" xlink:href="ampx-20230331.xsd#LeasesScheduleofFutureMaturingOperatingLeasePaymentsDetails_1"/>
  <link:calculationLink xlink:role="http://www.amprius.com/role/LeasesScheduleofFutureMaturingOperatingLeasePaymentsDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1242e4b9-93e4-4b0b-94f2-ea089c7d5cf0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_497d24dc-deb2-43e1-9a5a-879b329ccbd1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1242e4b9-93e4-4b0b-94f2-ea089c7d5cf0" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_497d24dc-deb2-43e1-9a5a-879b329ccbd1" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_f63730f6-c42a-4972-9098-5e2cbfb8bbcd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_1242e4b9-93e4-4b0b-94f2-ea089c7d5cf0" xlink:to="loc_us-gaap_OperatingLeaseLiability_f63730f6-c42a-4972-9098-5e2cbfb8bbcd" xlink:type="arc"/>
  </link:calculationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>8
<FILENAME>ampx-20230331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:fb8494f8-cb68-4af0-9ed5-216002fa868d,g:3b95c37f-4a77-4ae7-bad0-5ccbe8b7d32c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://www.amprius.com/role/Cover" xlink:type="simple" xlink:href="ampx-20230331.xsd#Cover"/>
  <link:definitionLink xlink:role="http://www.amprius.com/role/Cover" xlink:type="extended" id="i2dcd0cd94edb404f9839a1c9ead58db2_Cover">
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_a9c8672f-4ab2-4fa1-b3a7-550e6410801f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_d9bf18a3-df0b-4fa6-89e4-86c2058ec652" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a9c8672f-4ab2-4fa1-b3a7-550e6410801f" xlink:to="loc_dei_DocumentType_d9bf18a3-df0b-4fa6-89e4-86c2058ec652" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_91cd43c4-ce3c-43ce-838f-1ccc7afcd944" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a9c8672f-4ab2-4fa1-b3a7-550e6410801f" xlink:to="loc_dei_DocumentQuarterlyReport_91cd43c4-ce3c-43ce-838f-1ccc7afcd944" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_5f54619b-fe0a-42b4-b8e1-0032bf7c20cd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a9c8672f-4ab2-4fa1-b3a7-550e6410801f" xlink:to="loc_dei_DocumentPeriodEndDate_5f54619b-fe0a-42b4-b8e1-0032bf7c20cd" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_74c7a7d7-2313-4a3a-9b93-3b8ad59bd02a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a9c8672f-4ab2-4fa1-b3a7-550e6410801f" xlink:to="loc_dei_DocumentTransitionReport_74c7a7d7-2313-4a3a-9b93-3b8ad59bd02a" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_f8e9c408-acf0-470f-869a-124ff81f1b57" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a9c8672f-4ab2-4fa1-b3a7-550e6410801f" xlink:to="loc_dei_EntityFileNumber_f8e9c408-acf0-470f-869a-124ff81f1b57" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_5c070a11-8423-46f2-a64b-e1cc1874d169" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a9c8672f-4ab2-4fa1-b3a7-550e6410801f" xlink:to="loc_dei_EntityRegistrantName_5c070a11-8423-46f2-a64b-e1cc1874d169" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_f850720a-ec7a-4c45-afc4-96e3598bc2f6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a9c8672f-4ab2-4fa1-b3a7-550e6410801f" xlink:to="loc_dei_EntityIncorporationStateCountryCode_f850720a-ec7a-4c45-afc4-96e3598bc2f6" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_33c9ba40-21ae-49ba-99df-6e11eadc850d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a9c8672f-4ab2-4fa1-b3a7-550e6410801f" xlink:to="loc_dei_EntityTaxIdentificationNumber_33c9ba40-21ae-49ba-99df-6e11eadc850d" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_404b9069-aadd-49ca-a368-5c8b95b444b7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a9c8672f-4ab2-4fa1-b3a7-550e6410801f" xlink:to="loc_dei_EntityAddressAddressLine1_404b9069-aadd-49ca-a368-5c8b95b444b7" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_fa3d278f-c5e8-4283-96ca-49739e6dd745" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a9c8672f-4ab2-4fa1-b3a7-550e6410801f" xlink:to="loc_dei_EntityAddressCityOrTown_fa3d278f-c5e8-4283-96ca-49739e6dd745" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_c2161710-4c3e-4a74-9bf0-7ba21e5b3e2e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a9c8672f-4ab2-4fa1-b3a7-550e6410801f" xlink:to="loc_dei_EntityAddressStateOrProvince_c2161710-4c3e-4a74-9bf0-7ba21e5b3e2e" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_d4fc7c45-222d-4128-a111-38249e153ae3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a9c8672f-4ab2-4fa1-b3a7-550e6410801f" xlink:to="loc_dei_EntityAddressPostalZipCode_d4fc7c45-222d-4128-a111-38249e153ae3" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_a96451ce-4256-4172-9bb8-de5b34bb8f7a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a9c8672f-4ab2-4fa1-b3a7-550e6410801f" xlink:to="loc_dei_CityAreaCode_a96451ce-4256-4172-9bb8-de5b34bb8f7a" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_a5c95344-8d3a-47e4-9bc0-76f8a5984571" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a9c8672f-4ab2-4fa1-b3a7-550e6410801f" xlink:to="loc_dei_LocalPhoneNumber_a5c95344-8d3a-47e4-9bc0-76f8a5984571" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_a7f62ea0-6fee-4671-84ae-97822220f9a4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a9c8672f-4ab2-4fa1-b3a7-550e6410801f" xlink:to="loc_dei_Security12bTitle_a7f62ea0-6fee-4671-84ae-97822220f9a4" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_89111250-9ada-4f62-b86f-fc89a6f08ad6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a9c8672f-4ab2-4fa1-b3a7-550e6410801f" xlink:to="loc_dei_TradingSymbol_89111250-9ada-4f62-b86f-fc89a6f08ad6" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_d4cd4dca-b8f0-4c97-9d29-fb8c3d6a795a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a9c8672f-4ab2-4fa1-b3a7-550e6410801f" xlink:to="loc_dei_SecurityExchangeName_d4cd4dca-b8f0-4c97-9d29-fb8c3d6a795a" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_393f9ff6-cf2d-470c-b276-b59f0aae334a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a9c8672f-4ab2-4fa1-b3a7-550e6410801f" xlink:to="loc_dei_EntityCurrentReportingStatus_393f9ff6-cf2d-470c-b276-b59f0aae334a" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_b7c3cead-1f65-4028-b68a-9cd74c9034c1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a9c8672f-4ab2-4fa1-b3a7-550e6410801f" xlink:to="loc_dei_EntityInteractiveDataCurrent_b7c3cead-1f65-4028-b68a-9cd74c9034c1" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_62358de8-e6bd-45af-a384-2e960f3eaa54" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a9c8672f-4ab2-4fa1-b3a7-550e6410801f" xlink:to="loc_dei_EntityFilerCategory_62358de8-e6bd-45af-a384-2e960f3eaa54" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_12043118-0a4f-4e9b-8e19-74017feca6bf" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a9c8672f-4ab2-4fa1-b3a7-550e6410801f" xlink:to="loc_dei_EntitySmallBusiness_12043118-0a4f-4e9b-8e19-74017feca6bf" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_b94541b0-d018-49c9-8c1e-40ea45864a00" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a9c8672f-4ab2-4fa1-b3a7-550e6410801f" xlink:to="loc_dei_EntityEmergingGrowthCompany_b94541b0-d018-49c9-8c1e-40ea45864a00" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod_ab4de1c8-d365-4eb4-8801-86ef09b85bc7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a9c8672f-4ab2-4fa1-b3a7-550e6410801f" xlink:to="loc_dei_EntityExTransitionPeriod_ab4de1c8-d365-4eb4-8801-86ef09b85bc7" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_4f047a4a-7be3-485d-b739-90ea0d3a6048" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a9c8672f-4ab2-4fa1-b3a7-550e6410801f" xlink:to="loc_dei_EntityShellCompany_4f047a4a-7be3-485d-b739-90ea0d3a6048" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_054659a3-301a-4e8c-bee6-2295d6d0232b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a9c8672f-4ab2-4fa1-b3a7-550e6410801f" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_054659a3-301a-4e8c-bee6-2295d6d0232b" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_63ce1785-6f24-4595-a867-6496f0376931" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a9c8672f-4ab2-4fa1-b3a7-550e6410801f" xlink:to="loc_dei_EntityCentralIndexKey_63ce1785-6f24-4595-a867-6496f0376931" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_3d4a94cc-450b-4ab4-bcb4-4839688acf76" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a9c8672f-4ab2-4fa1-b3a7-550e6410801f" xlink:to="loc_dei_CurrentFiscalYearEndDate_3d4a94cc-450b-4ab4-bcb4-4839688acf76" xlink:type="arc" order="26"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_21882861-7c1e-4e86-ad69-02cd8214c1ba" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a9c8672f-4ab2-4fa1-b3a7-550e6410801f" xlink:to="loc_dei_DocumentFiscalYearFocus_21882861-7c1e-4e86-ad69-02cd8214c1ba" xlink:type="arc" order="27"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_8dff1fd4-3c14-4326-8669-6c8fc549af93" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a9c8672f-4ab2-4fa1-b3a7-550e6410801f" xlink:to="loc_dei_DocumentFiscalPeriodFocus_8dff1fd4-3c14-4326-8669-6c8fc549af93" xlink:type="arc" order="28"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_84470001-2683-46c7-b647-944c290877ae" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_DocumentInformationLineItems_a9c8672f-4ab2-4fa1-b3a7-550e6410801f" xlink:to="loc_dei_AmendmentFlag_84470001-2683-46c7-b647-944c290877ae" xlink:type="arc" order="29"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_367116a1-61de-4b69-893b-bff2c0bb5827" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_dei_DocumentInformationLineItems_a9c8672f-4ab2-4fa1-b3a7-550e6410801f" xlink:to="loc_dei_DocumentInformationTable_367116a1-61de-4b69-893b-bff2c0bb5827" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_20bc173d-68c1-4f3a-98d6-e9a633c04719" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_dei_DocumentInformationTable_367116a1-61de-4b69-893b-bff2c0bb5827" xlink:to="loc_us-gaap_StatementClassOfStockAxis_20bc173d-68c1-4f3a-98d6-e9a633c04719" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_20bc173d-68c1-4f3a-98d6-e9a633c04719_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_20bc173d-68c1-4f3a-98d6-e9a633c04719" xlink:to="loc_us-gaap_ClassOfStockDomain_20bc173d-68c1-4f3a-98d6-e9a633c04719_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_d780c50f-1651-47ea-82f8-e0f0ceaf7340" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_20bc173d-68c1-4f3a-98d6-e9a633c04719" xlink:to="loc_us-gaap_ClassOfStockDomain_d780c50f-1651-47ea-82f8-e0f0ceaf7340" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_903c9f48-5b30-4ccd-888d-f7c953c7b075" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_d780c50f-1651-47ea-82f8-e0f0ceaf7340" xlink:to="loc_us-gaap_CommonStockMember_903c9f48-5b30-4ccd-888d-f7c953c7b075" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_RedeemableWarrantsMember_2e27309f-68ab-40db-b737-0428013010a9" xlink:href="ampx-20230331.xsd#ampx_RedeemableWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_d780c50f-1651-47ea-82f8-e0f0ceaf7340" xlink:to="loc_ampx_RedeemableWarrantsMember_2e27309f-68ab-40db-b737-0428013010a9" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="ampx-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:definitionLink xlink:role="http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended" id="ib01c2b0d1fd942aab01e6403aa23062b_CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_1b4a65eb-68fa-485d-a4a9-4ad6c346e483" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bc522f7f-ff50-4067-9a59-d677f26ee33c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1b4a65eb-68fa-485d-a4a9-4ad6c346e483" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bc522f7f-ff50-4067-9a59-d677f26ee33c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_e97e878f-d3bc-4654-ad7f-5167f165f767" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bc522f7f-ff50-4067-9a59-d677f26ee33c" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_e97e878f-d3bc-4654-ad7f-5167f165f767" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_41c1d83d-dc06-4d61-8689-a2f52b02b9ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bc522f7f-ff50-4067-9a59-d677f26ee33c" xlink:to="loc_us-gaap_StockholdersEquity_41c1d83d-dc06-4d61-8689-a2f52b02b9ed" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_0ce70ed7-5fdc-454c-b9d5-54deca5a4d32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bc522f7f-ff50-4067-9a59-d677f26ee33c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_0ce70ed7-5fdc-454c-b9d5-54deca5a4d32" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_d6df9441-1f8e-4298-a212-c8b4e5cc0624" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bc522f7f-ff50-4067-9a59-d677f26ee33c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_d6df9441-1f8e-4298-a212-c8b4e5cc0624" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_752563e9-287e-41ca-a1c6-f61c999b2b83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bc522f7f-ff50-4067-9a59-d677f26ee33c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_752563e9-287e-41ca-a1c6-f61c999b2b83" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_cbcb2fa2-bc01-40bf-875f-336f2c2c6c58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bc522f7f-ff50-4067-9a59-d677f26ee33c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_cbcb2fa2-bc01-40bf-875f-336f2c2c6c58" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_AdjustmentsToAdditionalPaidInCapitalCapitalContributionsFromParent_0dc92453-61e2-405a-8ce9-3c2c2ee18d89" xlink:href="ampx-20230331.xsd#ampx_AdjustmentsToAdditionalPaidInCapitalCapitalContributionsFromParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bc522f7f-ff50-4067-9a59-d677f26ee33c" xlink:to="loc_ampx_AdjustmentsToAdditionalPaidInCapitalCapitalContributionsFromParent_0dc92453-61e2-405a-8ce9-3c2c2ee18d89" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1b9907a1-3e9a-41cd-80fe-5e18e79eea54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bc522f7f-ff50-4067-9a59-d677f26ee33c" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1b9907a1-3e9a-41cd-80fe-5e18e79eea54" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_AdjustmentsToAdditionalPaidInCapitalContributionFromParentRelatedToStockBasedCompensation_223e8acb-e571-446b-94a4-f4bfb74efa2d" xlink:href="ampx-20230331.xsd#ampx_AdjustmentsToAdditionalPaidInCapitalContributionFromParentRelatedToStockBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bc522f7f-ff50-4067-9a59-d677f26ee33c" xlink:to="loc_ampx_AdjustmentsToAdditionalPaidInCapitalContributionFromParentRelatedToStockBasedCompensation_223e8acb-e571-446b-94a4-f4bfb74efa2d" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_17565fd1-76d0-4c64-882c-b2ff180e29ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bc522f7f-ff50-4067-9a59-d677f26ee33c" xlink:to="loc_us-gaap_NetIncomeLoss_17565fd1-76d0-4c64-882c-b2ff180e29ca" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_ba3ea0bd-e5b3-4d19-9857-a3b2348b9673" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_6d752a6f-8551-44c1-8c0c-dd5e9cbb79a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_16c95365-9c14-4fc8-aecc-0cb937f04759" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_1b4a65eb-68fa-485d-a4a9-4ad6c346e483" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_16c95365-9c14-4fc8-aecc-0cb937f04759" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_7c5ec251-c7d9-409c-84d8-ccd270e39af3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_1b4a65eb-68fa-485d-a4a9-4ad6c346e483" xlink:to="loc_us-gaap_StatementTable_7c5ec251-c7d9-409c-84d8-ccd270e39af3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_56dea8a1-9a05-4433-b9b5-e5a84c2c68c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_7c5ec251-c7d9-409c-84d8-ccd270e39af3" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_56dea8a1-9a05-4433-b9b5-e5a84c2c68c5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_56dea8a1-9a05-4433-b9b5-e5a84c2c68c5_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_56dea8a1-9a05-4433-b9b5-e5a84c2c68c5" xlink:to="loc_us-gaap_EquityComponentDomain_56dea8a1-9a05-4433-b9b5-e5a84c2c68c5_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_154e6ae5-e1d9-4822-8eb2-e25bfc8f045a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_56dea8a1-9a05-4433-b9b5-e5a84c2c68c5" xlink:to="loc_us-gaap_EquityComponentDomain_154e6ae5-e1d9-4822-8eb2-e25bfc8f045a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_5cd630a1-0641-4a72-8f11-601c30c83ab8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_154e6ae5-e1d9-4822-8eb2-e25bfc8f045a" xlink:to="loc_us-gaap_CommonStockMember_5cd630a1-0641-4a72-8f11-601c30c83ab8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_b707d099-3dca-46fc-985a-8bee25c8b0a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_154e6ae5-e1d9-4822-8eb2-e25bfc8f045a" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_b707d099-3dca-46fc-985a-8bee25c8b0a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_36559157-3ee1-4734-90af-14172b5ffa36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_154e6ae5-e1d9-4822-8eb2-e25bfc8f045a" xlink:to="loc_us-gaap_RetainedEarningsMember_36559157-3ee1-4734-90af-14172b5ffa36" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_cbf04aa2-1dc3-4432-9051-d2a251ce60ca" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_7c5ec251-c7d9-409c-84d8-ccd270e39af3" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_cbf04aa2-1dc3-4432-9051-d2a251ce60ca" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_cbf04aa2-1dc3-4432-9051-d2a251ce60ca_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_cbf04aa2-1dc3-4432-9051-d2a251ce60ca" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_cbf04aa2-1dc3-4432-9051-d2a251ce60ca_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_6e7020da-8dd4-452c-b45d-3f52af835826" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_cbf04aa2-1dc3-4432-9051-d2a251ce60ca" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_6e7020da-8dd4-452c-b45d-3f52af835826" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_1cf0acb6-6dfa-4a61-96da-0c45a855a5b6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_6e7020da-8dd4-452c-b45d-3f52af835826" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_1cf0acb6-6dfa-4a61-96da-0c45a855a5b6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_7880c102-235a-4b69-a5e5-a23a8c64fcfa" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_7c5ec251-c7d9-409c-84d8-ccd270e39af3" xlink:to="loc_srt_RestatementAxis_7880c102-235a-4b69-a5e5-a23a8c64fcfa" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_7880c102-235a-4b69-a5e5-a23a8c64fcfa_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RestatementAxis_7880c102-235a-4b69-a5e5-a23a8c64fcfa" xlink:to="loc_srt_RestatementDomain_7880c102-235a-4b69-a5e5-a23a8c64fcfa_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_c82d33b6-0c1e-4966-b84b-ab52a4d88fe0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RestatementAxis_7880c102-235a-4b69-a5e5-a23a8c64fcfa" xlink:to="loc_srt_RestatementDomain_c82d33b6-0c1e-4966-b84b-ab52a4d88fe0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_b3f60b07-2f17-47b0-828f-9cc0ca3c9c81" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_c82d33b6-0c1e-4966-b84b-ab52a4d88fe0" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_b3f60b07-2f17-47b0-828f-9cc0ca3c9c81" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_98d05004-c0a8-4fa8-9575-a687f32180f6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAdjustmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RestatementDomain_c82d33b6-0c1e-4966-b84b-ab52a4d88fe0" xlink:to="loc_srt_RestatementAdjustmentMember_98d05004-c0a8-4fa8-9575-a687f32180f6" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.amprius.com/role/NatureofOperationsandOrganizationNarrativeDetails" xlink:type="simple" xlink:href="ampx-20230331.xsd#NatureofOperationsandOrganizationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.amprius.com/role/NatureofOperationsandOrganizationNarrativeDetails" xlink:type="extended" id="ied8a30506c6f48b2954da5b7d19e2513_NatureofOperationsandOrganizationNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems_e6993e2f-9d4f-4abc-9ee5-13a351ff43f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_900f6c41-3e4c-4494-a85c-d39224ae1453" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems_e6993e2f-9d4f-4abc-9ee5-13a351ff43f4" xlink:to="loc_us-gaap_NetIncomeLoss_900f6c41-3e4c-4494-a85c-d39224ae1453" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_d1bd1591-02df-4af2-9d31-cdd74b6a2499" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems_e6993e2f-9d4f-4abc-9ee5-13a351ff43f4" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_d1bd1591-02df-4af2-9d31-cdd74b6a2499" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6df606c5-4d57-4704-a357-a3c3c4484fff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems_e6993e2f-9d4f-4abc-9ee5-13a351ff43f4" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6df606c5-4d57-4704-a357-a3c3c4484fff" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_dcc709d0-2be4-494d-8a68-936c2d1f5bb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems_e6993e2f-9d4f-4abc-9ee5-13a351ff43f4" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_dcc709d0-2be4-494d-8a68-936c2d1f5bb9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_CommittedEquityFinancing_1d9896df-e30f-401a-bd46-8e4a97da8d55" xlink:href="ampx-20230331.xsd#ampx_CommittedEquityFinancing"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems_e6993e2f-9d4f-4abc-9ee5-13a351ff43f4" xlink:to="loc_ampx_CommittedEquityFinancing_1d9896df-e30f-401a-bd46-8e4a97da8d55" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_GovernmentAssistanceGrantNotYetReceived_7cb521c4-d1cb-4cf9-9f8e-1940dfbb7323" xlink:href="ampx-20230331.xsd#ampx_GovernmentAssistanceGrantNotYetReceived"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems_e6993e2f-9d4f-4abc-9ee5-13a351ff43f4" xlink:to="loc_ampx_GovernmentAssistanceGrantNotYetReceived_7cb521c4-d1cb-4cf9-9f8e-1940dfbb7323" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTable_d5c005b9-28e3-4970-92ed-34a8d0b61aed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems_e6993e2f-9d4f-4abc-9ee5-13a351ff43f4" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTable_d5c005b9-28e3-4970-92ed-34a8d0b61aed" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_b382a1f2-7e09-4728-a706-7a18d42ae40c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTable_d5c005b9-28e3-4970-92ed-34a8d0b61aed" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_b382a1f2-7e09-4728-a706-7a18d42ae40c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b382a1f2-7e09-4728-a706-7a18d42ae40c_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_b382a1f2-7e09-4728-a706-7a18d42ae40c" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b382a1f2-7e09-4728-a706-7a18d42ae40c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_c6b3c23b-57fc-4c1e-878a-2daaa3d30439" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_b382a1f2-7e09-4728-a706-7a18d42ae40c" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_c6b3c23b-57fc-4c1e-878a-2daaa3d30439" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_PurchaseAgreementMember_9ba45d70-e33d-4c86-9c26-f10999a9329c" xlink:href="ampx-20230331.xsd#ampx_PurchaseAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_c6b3c23b-57fc-4c1e-878a-2daaa3d30439" xlink:to="loc_ampx_PurchaseAgreementMember_9ba45d70-e33d-4c86-9c26-f10999a9329c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a2bc1ef6-31a8-433e-9d3d-73eb51326a4b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTable_d5c005b9-28e3-4970-92ed-34a8d0b61aed" xlink:to="loc_srt_RangeAxis_a2bc1ef6-31a8-433e-9d3d-73eb51326a4b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_a2bc1ef6-31a8-433e-9d3d-73eb51326a4b_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_a2bc1ef6-31a8-433e-9d3d-73eb51326a4b" xlink:to="loc_srt_RangeMember_a2bc1ef6-31a8-433e-9d3d-73eb51326a4b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3e2db964-e08b-4f9c-b0e8-9c17ed2f7953" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_a2bc1ef6-31a8-433e-9d3d-73eb51326a4b" xlink:to="loc_srt_RangeMember_3e2db964-e08b-4f9c-b0e8-9c17ed2f7953" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_de529e30-cdcc-444a-bbe7-e6deea66bdcd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_3e2db964-e08b-4f9c-b0e8-9c17ed2f7953" xlink:to="loc_srt_MaximumMember_de529e30-cdcc-444a-bbe7-e6deea66bdcd" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.amprius.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="ampx-20230331.xsd#SummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.amprius.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended" id="ief4b012ea3754d9eb3c630113c40d08b_SummaryofSignificantAccountingPoliciesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_9fd796b8-cc73-4874-aa63-21182fe89b91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_RecapitalizationExchangeRatio_ec9e4c06-1501-449d-a209-bd75f2334985" xlink:href="ampx-20230331.xsd#ampx_RecapitalizationExchangeRatio"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_9fd796b8-cc73-4874-aa63-21182fe89b91" xlink:to="loc_ampx_RecapitalizationExchangeRatio_ec9e4c06-1501-449d-a209-bd75f2334985" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_NumberOfExecutiveEmployeesOfParentSharingFacilitiesCosts_d52da8fa-de71-43b0-8edd-875a3556f512" xlink:href="ampx-20230331.xsd#ampx_NumberOfExecutiveEmployeesOfParentSharingFacilitiesCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_9fd796b8-cc73-4874-aa63-21182fe89b91" xlink:to="loc_ampx_NumberOfExecutiveEmployeesOfParentSharingFacilitiesCosts_d52da8fa-de71-43b0-8edd-875a3556f512" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_7a1703db-21b7-4f07-86cb-dfcb6180798b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCash"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_9fd796b8-cc73-4874-aa63-21182fe89b91" xlink:to="loc_us-gaap_RestrictedCash_7a1703db-21b7-4f07-86cb-dfcb6180798b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_b60c2a11-a000-40a2-a565-e79124b59d1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_9fd796b8-cc73-4874-aa63-21182fe89b91" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_b60c2a11-a000-40a2-a565-e79124b59d1e" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_8ad3f829-8c26-4edb-83c1-8d07b9960a07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_9fd796b8-cc73-4874-aa63-21182fe89b91" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_8ad3f829-8c26-4edb-83c1-8d07b9960a07" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_27f050f0-67d1-4edd-a913-23a95ba83db6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_9fd796b8-cc73-4874-aa63-21182fe89b91" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_27f050f0-67d1-4edd-a913-23a95ba83db6" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_3d3dd613-a705-428b-b7ef-6052beaf7d91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_27f050f0-67d1-4edd-a913-23a95ba83db6" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_3d3dd613-a705-428b-b7ef-6052beaf7d91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_3d3dd613-a705-428b-b7ef-6052beaf7d91_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_3d3dd613-a705-428b-b7ef-6052beaf7d91" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_3d3dd613-a705-428b-b7ef-6052beaf7d91_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_f374b967-55c8-4d01-b636-02b5e1ace822" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_3d3dd613-a705-428b-b7ef-6052beaf7d91" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_f374b967-55c8-4d01-b636-02b5e1ace822" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_d1d28236-cb26-4c0a-92fa-995b0ab95a06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_f374b967-55c8-4d01-b636-02b5e1ace822" xlink:to="loc_us-gaap_SalesRevenueNetMember_d1d28236-cb26-4c0a-92fa-995b0ab95a06" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_83e2bf1d-f08c-4ad8-aca7-8fa6b24dcfe5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_f374b967-55c8-4d01-b636-02b5e1ace822" xlink:to="loc_us-gaap_AccountsReceivableMember_83e2bf1d-f08c-4ad8-aca7-8fa6b24dcfe5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_7d25b776-80af-4359-bc4d-5a04edb572c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_27f050f0-67d1-4edd-a913-23a95ba83db6" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_7d25b776-80af-4359-bc4d-5a04edb572c7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_7d25b776-80af-4359-bc4d-5a04edb572c7_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_7d25b776-80af-4359-bc4d-5a04edb572c7" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_7d25b776-80af-4359-bc4d-5a04edb572c7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_36e65e2c-fffc-488b-9c11-b7fb29dabd6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_7d25b776-80af-4359-bc4d-5a04edb572c7" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_36e65e2c-fffc-488b-9c11-b7fb29dabd6d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_742babbf-f88a-4a9f-bcea-b61dcfe2710a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_36e65e2c-fffc-488b-9c11-b7fb29dabd6d" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_742babbf-f88a-4a9f-bcea-b61dcfe2710a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_cc6b079d-0b98-4f8a-9fc7-b502a6d1f030" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_27f050f0-67d1-4edd-a913-23a95ba83db6" xlink:to="loc_srt_MajorCustomersAxis_cc6b079d-0b98-4f8a-9fc7-b502a6d1f030" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_cc6b079d-0b98-4f8a-9fc7-b502a6d1f030_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_cc6b079d-0b98-4f8a-9fc7-b502a6d1f030" xlink:to="loc_srt_NameOfMajorCustomerDomain_cc6b079d-0b98-4f8a-9fc7-b502a6d1f030_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_e90d9f0c-52d0-429a-ace7-9932661c9c2b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_cc6b079d-0b98-4f8a-9fc7-b502a6d1f030" xlink:to="loc_srt_NameOfMajorCustomerDomain_e90d9f0c-52d0-429a-ace7-9932661c9c2b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_CustomerOneMember_05043ecf-cc98-48fd-abc2-4ed964ec34d6" xlink:href="ampx-20230331.xsd#ampx_CustomerOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_e90d9f0c-52d0-429a-ace7-9932661c9c2b" xlink:to="loc_ampx_CustomerOneMember_05043ecf-cc98-48fd-abc2-4ed964ec34d6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_CustomerTwoMember_59901f75-ec48-4ce7-80aa-ddce8a88c7e0" xlink:href="ampx-20230331.xsd#ampx_CustomerTwoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_e90d9f0c-52d0-429a-ace7-9932661c9c2b" xlink:to="loc_ampx_CustomerTwoMember_59901f75-ec48-4ce7-80aa-ddce8a88c7e0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_CustomerThreeMember_60f031ee-db92-4d55-a1ba-6fea93ef698e" xlink:href="ampx-20230331.xsd#ampx_CustomerThreeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_e90d9f0c-52d0-429a-ace7-9932661c9c2b" xlink:to="loc_ampx_CustomerThreeMember_60f031ee-db92-4d55-a1ba-6fea93ef698e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_ThreeCustomersMember_78da5c6d-8055-45ab-8231-257ac40d62b5" xlink:href="ampx-20230331.xsd#ampx_ThreeCustomersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_e90d9f0c-52d0-429a-ace7-9932661c9c2b" xlink:to="loc_ampx_ThreeCustomersMember_78da5c6d-8055-45ab-8231-257ac40d62b5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_FiveCustomersMember_f86ed767-ce12-4509-a484-e5b08cb6d679" xlink:href="ampx-20230331.xsd#ampx_FiveCustomersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_e90d9f0c-52d0-429a-ace7-9932661c9c2b" xlink:to="loc_ampx_FiveCustomersMember_f86ed767-ce12-4509-a484-e5b08cb6d679" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_79e7f63f-6d17-4b1d-96be-702f8a169a7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_27f050f0-67d1-4edd-a913-23a95ba83db6" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_79e7f63f-6d17-4b1d-96be-702f8a169a7d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_79e7f63f-6d17-4b1d-96be-702f8a169a7d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_79e7f63f-6d17-4b1d-96be-702f8a169a7d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_79e7f63f-6d17-4b1d-96be-702f8a169a7d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6ac2a6ea-5d49-4692-9011-b63efbf9214f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_79e7f63f-6d17-4b1d-96be-702f8a169a7d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6ac2a6ea-5d49-4692-9011-b63efbf9214f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_1845894a-fcfb-4dfd-b8ef-13d41fffd7e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6ac2a6ea-5d49-4692-9011-b63efbf9214f" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_1845894a-fcfb-4dfd-b8ef-13d41fffd7e9" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_d96aad4c-cd17-4dac-bfaa-4e27e0c89ab3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_27f050f0-67d1-4edd-a913-23a95ba83db6" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_d96aad4c-cd17-4dac-bfaa-4e27e0c89ab3" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_d96aad4c-cd17-4dac-bfaa-4e27e0c89ab3_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_d96aad4c-cd17-4dac-bfaa-4e27e0c89ab3" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_d96aad4c-cd17-4dac-bfaa-4e27e0c89ab3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_8717b2b2-87ca-4fc7-8795-6f5eebbcda3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_d96aad4c-cd17-4dac-bfaa-4e27e0c89ab3" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_8717b2b2-87ca-4fc7-8795-6f5eebbcda3c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_100886da-98d6-43be-8944-f4ec640b319b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_8717b2b2-87ca-4fc7-8795-6f5eebbcda3c" xlink:to="loc_us-gaap_MoneyMarketFundsMember_100886da-98d6-43be-8944-f4ec640b319b" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.amprius.com/role/RevenueScheduleofCompositionofRevenueDetails" xlink:type="simple" xlink:href="ampx-20230331.xsd#RevenueScheduleofCompositionofRevenueDetails"/>
  <link:definitionLink xlink:role="http://www.amprius.com/role/RevenueScheduleofCompositionofRevenueDetails" xlink:type="extended" id="i8dcb84c4ecb0494d9baf52fd9f2945d8_RevenueScheduleofCompositionofRevenueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_9f59c8d4-a805-41bf-aefb-3b682c0db13f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_4a66e817-058d-47c5-ba9a-7a923712b0aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_9f59c8d4-a805-41bf-aefb-3b682c0db13f" xlink:to="loc_us-gaap_Revenues_4a66e817-058d-47c5-ba9a-7a923712b0aa" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_db6152e8-2a6e-4603-97b3-2865b82223b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_9f59c8d4-a805-41bf-aefb-3b682c0db13f" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_db6152e8-2a6e-4603-97b3-2865b82223b0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_5bfa5723-944f-42be-910c-ab67b60784b1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_db6152e8-2a6e-4603-97b3-2865b82223b0" xlink:to="loc_srt_ProductOrServiceAxis_5bfa5723-944f-42be-910c-ab67b60784b1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_5bfa5723-944f-42be-910c-ab67b60784b1_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_5bfa5723-944f-42be-910c-ab67b60784b1" xlink:to="loc_srt_ProductsAndServicesDomain_5bfa5723-944f-42be-910c-ab67b60784b1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_72a85fba-ad83-4c78-89b0-e1433e9ba1f3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_5bfa5723-944f-42be-910c-ab67b60784b1" xlink:to="loc_srt_ProductsAndServicesDomain_72a85fba-ad83-4c78-89b0-e1433e9ba1f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_TotalRevenueFromCustomersMember_95322701-53a4-41e6-bc04-b22389a60654" xlink:href="ampx-20230331.xsd#ampx_TotalRevenueFromCustomersMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_72a85fba-ad83-4c78-89b0-e1433e9ba1f3" xlink:to="loc_ampx_TotalRevenueFromCustomersMember_95322701-53a4-41e6-bc04-b22389a60654" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_SaleOfBatteryMember_3c398fae-8cdf-425a-bdb8-44262d5db183" xlink:href="ampx-20230331.xsd#ampx_SaleOfBatteryMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ampx_TotalRevenueFromCustomersMember_95322701-53a4-41e6-bc04-b22389a60654" xlink:to="loc_ampx_SaleOfBatteryMember_3c398fae-8cdf-425a-bdb8-44262d5db183" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_CustomizedDesignServicesMember_da31e93a-0bf8-48dd-8017-0044d651e838" xlink:href="ampx-20230331.xsd#ampx_CustomizedDesignServicesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ampx_TotalRevenueFromCustomersMember_95322701-53a4-41e6-bc04-b22389a60654" xlink:to="loc_ampx_CustomizedDesignServicesMember_da31e93a-0bf8-48dd-8017-0044d651e838" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_OtherRevenueGovernmentGrantMember_c43bd9de-9983-404b-ae9c-3e719cc8c893" xlink:href="ampx-20230331.xsd#ampx_OtherRevenueGovernmentGrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_72a85fba-ad83-4c78-89b0-e1433e9ba1f3" xlink:to="loc_ampx_OtherRevenueGovernmentGrantMember_c43bd9de-9983-404b-ae9c-3e719cc8c893" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.amprius.com/role/RevenueNarrativeDetails" xlink:type="simple" xlink:href="ampx-20230331.xsd#RevenueNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.amprius.com/role/RevenueNarrativeDetails" xlink:type="extended" id="i17a93bd540aa4f969a79610b19cc011f_RevenueNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_52000478-2553-49b1-a6d4-68ac7cd97a5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_0d0fe8f8-6585-468b-ac26-a93db030f31b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_52000478-2553-49b1-a6d4-68ac7cd97a5c" xlink:to="loc_us-gaap_Revenues_0d0fe8f8-6585-468b-ac26-a93db030f31b" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_7db26939-89d8-4d31-8d96-ad13b23cb012" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_52000478-2553-49b1-a6d4-68ac7cd97a5c" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_7db26939-89d8-4d31-8d96-ad13b23cb012" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_c17a1be8-e8de-4ac1-b030-886de78cdd0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_52000478-2553-49b1-a6d4-68ac7cd97a5c" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_c17a1be8-e8de-4ac1-b030-886de78cdd0d" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_1b2795b6-4597-485c-a232-946f24895c91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_52000478-2553-49b1-a6d4-68ac7cd97a5c" xlink:to="loc_us-gaap_ContractWithCustomerLiability_1b2795b6-4597-485c-a232-946f24895c91" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_c588d994-b922-483d-a7f1-e9abbe4afa42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_52000478-2553-49b1-a6d4-68ac7cd97a5c" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_c588d994-b922-483d-a7f1-e9abbe4afa42" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_370ca433-4713-49f7-8954-3ff8261304d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_52000478-2553-49b1-a6d4-68ac7cd97a5c" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_370ca433-4713-49f7-8954-3ff8261304d3" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_a597975d-835e-4b44-abc1-627bcde9e835" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_370ca433-4713-49f7-8954-3ff8261304d3" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_a597975d-835e-4b44-abc1-627bcde9e835" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_a597975d-835e-4b44-abc1-627bcde9e835_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_a597975d-835e-4b44-abc1-627bcde9e835" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_a597975d-835e-4b44-abc1-627bcde9e835_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_c2d67628-d9a6-4b24-815f-13e73389d8f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_a597975d-835e-4b44-abc1-627bcde9e835" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_c2d67628-d9a6-4b24-815f-13e73389d8f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredAtPointInTimeMember_755045c7-4cee-4f12-b40c-eb6e15a36745" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransferredAtPointInTimeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_c2d67628-d9a6-4b24-815f-13e73389d8f2" xlink:to="loc_us-gaap_TransferredAtPointInTimeMember_755045c7-4cee-4f12-b40c-eb6e15a36745" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.amprius.com/role/RevenuePerformanceObligationDetails" xlink:type="simple" xlink:href="ampx-20230331.xsd#RevenuePerformanceObligationDetails"/>
  <link:definitionLink xlink:role="http://www.amprius.com/role/RevenuePerformanceObligationDetails" xlink:type="extended" id="ib08578cc2c8e40f7bf9d2b4bd59de904_RevenuePerformanceObligationDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_89c2f44a-da04-4aa2-b970-e7cdd8ecd328" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_dadfc5da-6934-4bc8-a637-9deb383aa809" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_89c2f44a-da04-4aa2-b970-e7cdd8ecd328" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_dadfc5da-6934-4bc8-a637-9deb383aa809" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_8d5d78c3-3c40-4ef8-898c-b3531b49653c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_89c2f44a-da04-4aa2-b970-e7cdd8ecd328" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_8d5d78c3-3c40-4ef8-898c-b3531b49653c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_4b22bd1a-fd4f-4715-b12f-aa20c136c1a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_89c2f44a-da04-4aa2-b970-e7cdd8ecd328" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_4b22bd1a-fd4f-4715-b12f-aa20c136c1a8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_8e21a9e1-a19b-45f7-899c-fde650ec583c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_4b22bd1a-fd4f-4715-b12f-aa20c136c1a8" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_8e21a9e1-a19b-45f7-899c-fde650ec583c" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.amprius.com/role/RevenuePerformanceObligationDetails_1" xlink:type="simple" xlink:href="ampx-20230331.xsd#RevenuePerformanceObligationDetails_1"/>
  <link:definitionLink xlink:role="http://www.amprius.com/role/RevenuePerformanceObligationDetails_1" xlink:type="extended" id="i32e17cb54ee94c7aa4bf4811a24f823b_RevenuePerformanceObligationDetails_1">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_89c2f44a-da04-4aa2-b970-e7cdd8ecd328" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_dadfc5da-6934-4bc8-a637-9deb383aa809" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_89c2f44a-da04-4aa2-b970-e7cdd8ecd328" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_dadfc5da-6934-4bc8-a637-9deb383aa809" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_8d5d78c3-3c40-4ef8-898c-b3531b49653c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_89c2f44a-da04-4aa2-b970-e7cdd8ecd328" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_8d5d78c3-3c40-4ef8-898c-b3531b49653c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_4b22bd1a-fd4f-4715-b12f-aa20c136c1a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_89c2f44a-da04-4aa2-b970-e7cdd8ecd328" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_4b22bd1a-fd4f-4715-b12f-aa20c136c1a8" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.amprius.com/role/PropertyPlantandEquipmentNetScheduleofPropertyandEquipmentDetails" xlink:type="simple" xlink:href="ampx-20230331.xsd#PropertyPlantandEquipmentNetScheduleofPropertyandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://www.amprius.com/role/PropertyPlantandEquipmentNetScheduleofPropertyandEquipmentDetails" xlink:type="extended" id="ib15f56903c1e463ea64f7a6bece832f5_PropertyPlantandEquipmentNetScheduleofPropertyandEquipmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d4ec3e72-87c6-4af0-a447-dbce04fe950e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_ad2fdb82-72e1-49b3-bab6-fb48024e1090" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d4ec3e72-87c6-4af0-a447-dbce04fe950e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_ad2fdb82-72e1-49b3-bab6-fb48024e1090" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_bfaa2ac1-faae-4582-aed6-e0eb85123b38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d4ec3e72-87c6-4af0-a447-dbce04fe950e" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_bfaa2ac1-faae-4582-aed6-e0eb85123b38" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_d9a125ea-580f-4951-945b-46c739cec3b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d4ec3e72-87c6-4af0-a447-dbce04fe950e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_d9a125ea-580f-4951-945b-46c739cec3b1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_3a9176f1-1851-40f0-a860-971e2781efef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d4ec3e72-87c6-4af0-a447-dbce04fe950e" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_3a9176f1-1851-40f0-a860-971e2781efef" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a824fe42-7ba1-43ba-a713-06cfbdad172d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_3a9176f1-1851-40f0-a860-971e2781efef" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a824fe42-7ba1-43ba-a713-06cfbdad172d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a824fe42-7ba1-43ba-a713-06cfbdad172d_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a824fe42-7ba1-43ba-a713-06cfbdad172d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_a824fe42-7ba1-43ba-a713-06cfbdad172d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e6870684-1d07-48ac-bdf7-eb44133f186a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a824fe42-7ba1-43ba-a713-06cfbdad172d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e6870684-1d07-48ac-bdf7-eb44133f186a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_ProductionEquipmentMember_fdb2a4a4-cfb8-4470-99b6-25a41ebc6c61" xlink:href="ampx-20230331.xsd#ampx_ProductionEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e6870684-1d07-48ac-bdf7-eb44133f186a" xlink:to="loc_ampx_ProductionEquipmentMember_fdb2a4a4-cfb8-4470-99b6-25a41ebc6c61" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_LaboratoryEquipmentMember_aaa700ed-4d07-42d9-9e2f-bab37825287b" xlink:href="ampx-20230331.xsd#ampx_LaboratoryEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e6870684-1d07-48ac-bdf7-eb44133f186a" xlink:to="loc_ampx_LaboratoryEquipmentMember_aaa700ed-4d07-42d9-9e2f-bab37825287b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_47f95a5b-8833-4294-bb06-16d9ac6cce92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e6870684-1d07-48ac-bdf7-eb44133f186a" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_47f95a5b-8833-4294-bb06-16d9ac6cce92" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_f6d3c600-ae10-4721-8d1f-66ccf1a2b28b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e6870684-1d07-48ac-bdf7-eb44133f186a" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_f6d3c600-ae10-4721-8d1f-66ccf1a2b28b" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_e9e050ae-ee32-4258-a4e4-18191c0db775" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e6870684-1d07-48ac-bdf7-eb44133f186a" xlink:to="loc_us-gaap_ConstructionInProgressMember_e9e050ae-ee32-4258-a4e4-18191c0db775" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.amprius.com/role/StockholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="ampx-20230331.xsd#StockholdersEquityNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.amprius.com/role/StockholdersEquityNarrativeDetails" xlink:type="extended" id="i9548e6f55c7f4546a66107d5f0500c51_StockholdersEquityNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_85cd2ac7-7891-4dab-af61-6e06749646ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_SharesAuthorized_d97e9c5d-1854-4236-834a-fde44ab38b9d" xlink:href="ampx-20230331.xsd#ampx_SharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_85cd2ac7-7891-4dab-af61-6e06749646ff" xlink:to="loc_ampx_SharesAuthorized_d97e9c5d-1854-4236-834a-fde44ab38b9d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_cbfe342c-efb0-4d5c-9f4f-88e7ce5fdae0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_85cd2ac7-7891-4dab-af61-6e06749646ff" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_cbfe342c-efb0-4d5c-9f4f-88e7ce5fdae0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_29fc0224-b3a4-4a9b-882c-2c3d9de927d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_85cd2ac7-7891-4dab-af61-6e06749646ff" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_29fc0224-b3a4-4a9b-882c-2c3d9de927d1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_ecfac216-1891-4090-8008-700d644c3ed2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_85cd2ac7-7891-4dab-af61-6e06749646ff" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_ecfac216-1891-4090-8008-700d644c3ed2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_806afa3d-705b-457c-9baf-e365be4bf28d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_85cd2ac7-7891-4dab-af61-6e06749646ff" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_806afa3d-705b-457c-9baf-e365be4bf28d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_5c62be5f-e5e5-40cb-a71d-775882d27c24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_85cd2ac7-7891-4dab-af61-6e06749646ff" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_5c62be5f-e5e5-40cb-a71d-775882d27c24" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfFairValue_7aa8db61-e66e-40b9-8d49-cf9b74f28441" xlink:href="ampx-20230331.xsd#ampx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_85cd2ac7-7891-4dab-af61-6e06749646ff" xlink:to="loc_ampx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfFairValue_7aa8db61-e66e-40b9-8d49-cf9b74f28441" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_StockholderPercentageOfOptioneeForOptionPrice_6512b0c7-f8f9-42a5-b210-123388ae774f" xlink:href="ampx-20230331.xsd#ampx_StockholderPercentageOfOptioneeForOptionPrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_85cd2ac7-7891-4dab-af61-6e06749646ff" xlink:to="loc_ampx_StockholderPercentageOfOptioneeForOptionPrice_6512b0c7-f8f9-42a5-b210-123388ae774f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfFairValueSignificantStockholder_a767af32-cffe-43f1-86b4-ea9454eaadfd" xlink:href="ampx-20230331.xsd#ampx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfFairValueSignificantStockholder"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_85cd2ac7-7891-4dab-af61-6e06749646ff" xlink:to="loc_ampx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfFairValueSignificantStockholder_a767af32-cffe-43f1-86b4-ea9454eaadfd" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_448eb512-77af-4867-bc82-e0fb724f12da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_85cd2ac7-7891-4dab-af61-6e06749646ff" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_448eb512-77af-4867-bc82-e0fb724f12da" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_e4a29c32-cf2e-4221-a290-84bbdf6e583b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_85cd2ac7-7891-4dab-af61-6e06749646ff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_e4a29c32-cf2e-4221-a290-84bbdf6e583b" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_30fbb21d-6e95-4b9b-b94f-dc98ced402df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_85cd2ac7-7891-4dab-af61-6e06749646ff" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_30fbb21d-6e95-4b9b-b94f-dc98ced402df" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_7e6d06fe-e9d2-4853-bf4a-14634ddf458d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_85cd2ac7-7891-4dab-af61-6e06749646ff" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_7e6d06fe-e9d2-4853-bf4a-14634ddf458d" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_dcb7b870-fc41-4b35-b21b-7fd41fb41885" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_85cd2ac7-7891-4dab-af61-6e06749646ff" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_dcb7b870-fc41-4b35-b21b-7fd41fb41885" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_32743c0c-811d-41f1-b5c4-b76e9501f545" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_85cd2ac7-7891-4dab-af61-6e06749646ff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_32743c0c-811d-41f1-b5c4-b76e9501f545" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_ShareBasedCompensationArrangementByShareBasedPaymentAwardReservedForIssuance_09613e08-6ca6-486d-b309-53e4cd2cd8c2" xlink:href="ampx-20230331.xsd#ampx_ShareBasedCompensationArrangementByShareBasedPaymentAwardReservedForIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_85cd2ac7-7891-4dab-af61-6e06749646ff" xlink:to="loc_ampx_ShareBasedCompensationArrangementByShareBasedPaymentAwardReservedForIssuance_09613e08-6ca6-486d-b309-53e4cd2cd8c2" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_bad34ebe-0db5-4a2a-886c-f5ed5eddf161" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_85cd2ac7-7891-4dab-af61-6e06749646ff" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_bad34ebe-0db5-4a2a-886c-f5ed5eddf161" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_SaleOfStockAveragePricePerShareRedemption_1271f00b-452e-4002-9fac-4f84deed79f7" xlink:href="ampx-20230331.xsd#ampx_SaleOfStockAveragePricePerShareRedemption"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_85cd2ac7-7891-4dab-af61-6e06749646ff" xlink:to="loc_ampx_SaleOfStockAveragePricePerShareRedemption_1271f00b-452e-4002-9fac-4f84deed79f7" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_WarrantsRedemptionThresholdTradingDays_8eb56761-036b-4a8f-8974-351e9e267b5e" xlink:href="ampx-20230331.xsd#ampx_WarrantsRedemptionThresholdTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_85cd2ac7-7891-4dab-af61-6e06749646ff" xlink:to="loc_ampx_WarrantsRedemptionThresholdTradingDays_8eb56761-036b-4a8f-8974-351e9e267b5e" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_WarrantsRedemptionThresholdConsecutiveTradingDays_e1969b31-b579-4953-8627-ed4c533866b4" xlink:href="ampx-20230331.xsd#ampx_WarrantsRedemptionThresholdConsecutiveTradingDays"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_85cd2ac7-7891-4dab-af61-6e06749646ff" xlink:to="loc_ampx_WarrantsRedemptionThresholdConsecutiveTradingDays_e1969b31-b579-4953-8627-ed4c533866b4" xlink:type="arc" order="19"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_SaleOfStockPotentialMaximumConsiderationReceivedOnTransaction_208cf888-a6af-45de-a8e6-abc6c351706a" xlink:href="ampx-20230331.xsd#ampx_SaleOfStockPotentialMaximumConsiderationReceivedOnTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_85cd2ac7-7891-4dab-af61-6e06749646ff" xlink:to="loc_ampx_SaleOfStockPotentialMaximumConsiderationReceivedOnTransaction_208cf888-a6af-45de-a8e6-abc6c351706a" xlink:type="arc" order="20"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_SaleOfStockDiscount_3b474f24-2f47-417f-a18a-bc86ee20dfbf" xlink:href="ampx-20230331.xsd#ampx_SaleOfStockDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_85cd2ac7-7891-4dab-af61-6e06749646ff" xlink:to="loc_ampx_SaleOfStockDiscount_3b474f24-2f47-417f-a18a-bc86ee20dfbf" xlink:type="arc" order="21"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_SaleOfStockMaximumSharesAvailableForSalePercentageOfSharesIssuedAndOutstandingPriorToTransaction_42832fbf-91fd-446c-8abe-ae09010d801f" xlink:href="ampx-20230331.xsd#ampx_SaleOfStockMaximumSharesAvailableForSalePercentageOfSharesIssuedAndOutstandingPriorToTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_85cd2ac7-7891-4dab-af61-6e06749646ff" xlink:to="loc_ampx_SaleOfStockMaximumSharesAvailableForSalePercentageOfSharesIssuedAndOutstandingPriorToTransaction_42832fbf-91fd-446c-8abe-ae09010d801f" xlink:type="arc" order="22"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_527404b4-2911-497d-8666-0583546e6f8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_85cd2ac7-7891-4dab-af61-6e06749646ff" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_527404b4-2911-497d-8666-0583546e6f8b" xlink:type="arc" order="23"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_a4c21240-6a6b-42f1-b20d-71249ea42976" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_85cd2ac7-7891-4dab-af61-6e06749646ff" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_a4c21240-6a6b-42f1-b20d-71249ea42976" xlink:type="arc" order="24"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_DeferredStockIssuanceCosts_56ae655c-774d-4e33-af1b-503b167d6727" xlink:href="ampx-20230331.xsd#ampx_DeferredStockIssuanceCosts"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_85cd2ac7-7891-4dab-af61-6e06749646ff" xlink:to="loc_ampx_DeferredStockIssuanceCosts_56ae655c-774d-4e33-af1b-503b167d6727" xlink:type="arc" order="25"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_402f03ed-8f87-454b-825a-0ae61fa738ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_85cd2ac7-7891-4dab-af61-6e06749646ff" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_402f03ed-8f87-454b-825a-0ae61fa738ca" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_48413cc1-4983-4ec4-aedd-27dea4a03d57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_402f03ed-8f87-454b-825a-0ae61fa738ca" xlink:to="loc_us-gaap_PlanNameAxis_48413cc1-4983-4ec4-aedd-27dea4a03d57" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_48413cc1-4983-4ec4-aedd-27dea4a03d57_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_48413cc1-4983-4ec4-aedd-27dea4a03d57" xlink:to="loc_us-gaap_PlanNameDomain_48413cc1-4983-4ec4-aedd-27dea4a03d57_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_7e978458-a045-42aa-a3a0-0daf15db96cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_48413cc1-4983-4ec4-aedd-27dea4a03d57" xlink:to="loc_us-gaap_PlanNameDomain_7e978458-a045-42aa-a3a0-0daf15db96cd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_TwentyTwentyTwoEquityIncentivePlanMember_e651d4b9-f217-4cff-bbfb-9c791efc1fe8" xlink:href="ampx-20230331.xsd#ampx_TwentyTwentyTwoEquityIncentivePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_7e978458-a045-42aa-a3a0-0daf15db96cd" xlink:to="loc_ampx_TwentyTwentyTwoEquityIncentivePlanMember_e651d4b9-f217-4cff-bbfb-9c791efc1fe8" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_EquityIncentivePlansMember_3f4d6010-731b-4f13-8bd8-15d2885697c9" xlink:href="ampx-20230331.xsd#ampx_EquityIncentivePlansMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_7e978458-a045-42aa-a3a0-0daf15db96cd" xlink:to="loc_ampx_EquityIncentivePlansMember_3f4d6010-731b-4f13-8bd8-15d2885697c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_TwentyTwentyTwoEmployeeStockPurchasePlanMember_e582c680-4245-4d77-be35-8ab55e1e99ce" xlink:href="ampx-20230331.xsd#ampx_TwentyTwentyTwoEmployeeStockPurchasePlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_7e978458-a045-42aa-a3a0-0daf15db96cd" xlink:to="loc_ampx_TwentyTwentyTwoEmployeeStockPurchasePlanMember_e582c680-4245-4d77-be35-8ab55e1e99ce" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_ExecutiveIncentiveCompensationPlanMember_f0190717-f34a-4087-af8a-293db2a3bf99" xlink:href="ampx-20230331.xsd#ampx_ExecutiveIncentiveCompensationPlanMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_7e978458-a045-42aa-a3a0-0daf15db96cd" xlink:to="loc_ampx_ExecutiveIncentiveCompensationPlanMember_f0190717-f34a-4087-af8a-293db2a3bf99" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_e1dcb6ea-a454-4e45-b7b8-f84987d679cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_402f03ed-8f87-454b-825a-0ae61fa738ca" xlink:to="loc_us-gaap_AwardTypeAxis_e1dcb6ea-a454-4e45-b7b8-f84987d679cf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e1dcb6ea-a454-4e45-b7b8-f84987d679cf_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_e1dcb6ea-a454-4e45-b7b8-f84987d679cf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_e1dcb6ea-a454-4e45-b7b8-f84987d679cf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d33228e4-21d7-4f65-a493-06fab0ddc5d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_e1dcb6ea-a454-4e45-b7b8-f84987d679cf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d33228e4-21d7-4f65-a493-06fab0ddc5d1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_69238cf1-9e16-4682-b5c8-3e1cd1268b93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d33228e4-21d7-4f65-a493-06fab0ddc5d1" xlink:to="loc_us-gaap_EmployeeStockMember_69238cf1-9e16-4682-b5c8-3e1cd1268b93" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_d2067c19-15a9-47d8-a4c4-218779f836ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d33228e4-21d7-4f65-a493-06fab0ddc5d1" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_d2067c19-15a9-47d8-a4c4-218779f836ce" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_2af423c2-e991-4bb4-9112-ff898aaa157a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d33228e4-21d7-4f65-a493-06fab0ddc5d1" xlink:to="loc_us-gaap_EmployeeStockOptionMember_2af423c2-e991-4bb4-9112-ff898aaa157a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_646b28c9-7954-45b1-911d-04b32e1484dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_402f03ed-8f87-454b-825a-0ae61fa738ca" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_646b28c9-7954-45b1-911d-04b32e1484dc" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_646b28c9-7954-45b1-911d-04b32e1484dc_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_646b28c9-7954-45b1-911d-04b32e1484dc" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_646b28c9-7954-45b1-911d-04b32e1484dc_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_285908ed-b4a0-4b44-a813-c62bc6b37df5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_646b28c9-7954-45b1-911d-04b32e1484dc" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_285908ed-b4a0-4b44-a813-c62bc6b37df5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_PublicWarrantsMember_1d7aee19-def1-4f39-b225-73cdda78b3cf" xlink:href="ampx-20230331.xsd#ampx_PublicWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_285908ed-b4a0-4b44-a813-c62bc6b37df5" xlink:to="loc_ampx_PublicWarrantsMember_1d7aee19-def1-4f39-b225-73cdda78b3cf" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_PrivateWarrantsMember_04fad3c6-66cf-4ed3-872f-224d63eb9395" xlink:href="ampx-20230331.xsd#ampx_PrivateWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_285908ed-b4a0-4b44-a813-c62bc6b37df5" xlink:to="loc_ampx_PrivateWarrantsMember_04fad3c6-66cf-4ed3-872f-224d63eb9395" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_PIPEWarrantsMember_b5ac0e4d-35e5-45e6-ad9c-a4792c65e287" xlink:href="ampx-20230331.xsd#ampx_PIPEWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_285908ed-b4a0-4b44-a813-c62bc6b37df5" xlink:to="loc_ampx_PIPEWarrantsMember_b5ac0e4d-35e5-45e6-ad9c-a4792c65e287" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_c7722e10-6d4a-492b-a945-273eead2c123" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_402f03ed-8f87-454b-825a-0ae61fa738ca" xlink:to="loc_srt_CounterpartyNameAxis_c7722e10-6d4a-492b-a945-273eead2c123" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c7722e10-6d4a-492b-a945-273eead2c123_default" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_CounterpartyNameAxis_c7722e10-6d4a-492b-a945-273eead2c123" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_c7722e10-6d4a-492b-a945-273eead2c123_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_33608975-4ec5-4d83-b76b-55a02164afea" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_CounterpartyNameAxis_c7722e10-6d4a-492b-a945-273eead2c123" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_33608975-4ec5-4d83-b76b-55a02164afea" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_BRPCIIMember_6f5c0e01-3118-4386-aa3b-44df3491286e" xlink:href="ampx-20230331.xsd#ampx_BRPCIIMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_33608975-4ec5-4d83-b76b-55a02164afea" xlink:to="loc_ampx_BRPCIIMember_6f5c0e01-3118-4386-aa3b-44df3491286e" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_b741f5d6-9783-4dc8-abc0-f6f1d1cd0d22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_402f03ed-8f87-454b-825a-0ae61fa738ca" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_b741f5d6-9783-4dc8-abc0-f6f1d1cd0d22" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b741f5d6-9783-4dc8-abc0-f6f1d1cd0d22_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_b741f5d6-9783-4dc8-abc0-f6f1d1cd0d22" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_b741f5d6-9783-4dc8-abc0-f6f1d1cd0d22_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_d8c247e0-9082-4e51-b76a-40a7d70393c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_b741f5d6-9783-4dc8-abc0-f6f1d1cd0d22" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_d8c247e0-9082-4e51-b76a-40a7d70393c2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_PurchaseAgreementMember_f4f09e87-0351-4899-bb10-695fc4a5b023" xlink:href="ampx-20230331.xsd#ampx_PurchaseAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_d8c247e0-9082-4e51-b76a-40a7d70393c2" xlink:to="loc_ampx_PurchaseAgreementMember_f4f09e87-0351-4899-bb10-695fc4a5b023" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.amprius.com/role/StockholdersEquityStockWarrantDetails" xlink:type="simple" xlink:href="ampx-20230331.xsd#StockholdersEquityStockWarrantDetails"/>
  <link:definitionLink xlink:role="http://www.amprius.com/role/StockholdersEquityStockWarrantDetails" xlink:type="extended" id="i34f0935c17f14e8585a4e1c089e98c50_StockholdersEquityStockWarrantDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f2edafc-7d13-49ea-b6a6-c757dbc03cf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_8945d499-e449-421a-9b1f-77f8eebaea69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f2edafc-7d13-49ea-b6a6-c757dbc03cf8" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_8945d499-e449-421a-9b1f-77f8eebaea69" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1bbe6fca-87d7-4e5a-b4c1-df187c1cbc02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f2edafc-7d13-49ea-b6a6-c757dbc03cf8" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1bbe6fca-87d7-4e5a-b4c1-df187c1cbc02" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7e05a696-45b2-47f0-a5bb-49eb84b3e923" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f2edafc-7d13-49ea-b6a6-c757dbc03cf8" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7e05a696-45b2-47f0-a5bb-49eb84b3e923" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_53642c1f-18e2-4ef3-a2e0-30dc2aa639e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7e05a696-45b2-47f0-a5bb-49eb84b3e923" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_53642c1f-18e2-4ef3-a2e0-30dc2aa639e2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_53642c1f-18e2-4ef3-a2e0-30dc2aa639e2_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_53642c1f-18e2-4ef3-a2e0-30dc2aa639e2" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_53642c1f-18e2-4ef3-a2e0-30dc2aa639e2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_32fd26d6-fd92-402f-8fcd-a4dc23fc9b45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_53642c1f-18e2-4ef3-a2e0-30dc2aa639e2" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_32fd26d6-fd92-402f-8fcd-a4dc23fc9b45" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_PublicWarrantsMember_f985222d-ec11-4ac0-95db-9ea4ac52e2e5" xlink:href="ampx-20230331.xsd#ampx_PublicWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_32fd26d6-fd92-402f-8fcd-a4dc23fc9b45" xlink:to="loc_ampx_PublicWarrantsMember_f985222d-ec11-4ac0-95db-9ea4ac52e2e5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_PrivateWarrantsMember_c751fcfb-488f-42e3-8941-3da3890b896b" xlink:href="ampx-20230331.xsd#ampx_PrivateWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_32fd26d6-fd92-402f-8fcd-a4dc23fc9b45" xlink:to="loc_ampx_PrivateWarrantsMember_c751fcfb-488f-42e3-8941-3da3890b896b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_PIPEWarrantsMember_f6c81e8f-8d73-43c1-a007-59f32e5f85a9" xlink:href="ampx-20230331.xsd#ampx_PIPEWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_32fd26d6-fd92-402f-8fcd-a4dc23fc9b45" xlink:to="loc_ampx_PIPEWarrantsMember_f6c81e8f-8d73-43c1-a007-59f32e5f85a9" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.amprius.com/role/StockholdersEquityStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="ampx-20230331.xsd#StockholdersEquityStockBasedCompensationExpenseDetails"/>
  <link:definitionLink xlink:role="http://www.amprius.com/role/StockholdersEquityStockBasedCompensationExpenseDetails" xlink:type="extended" id="i80722eed9f254f52a1e2838f187789db_StockholdersEquityStockBasedCompensationExpenseDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_55a8757d-7054-400f-93fe-e83c9374fd14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_a665851d-eb90-40e8-9725-6269ef26c287" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_55a8757d-7054-400f-93fe-e83c9374fd14" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_a665851d-eb90-40e8-9725-6269ef26c287" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_19e404b4-8190-42fc-a5d1-63de6a371675" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_55a8757d-7054-400f-93fe-e83c9374fd14" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_19e404b4-8190-42fc-a5d1-63de6a371675" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_7017ef5b-3b6b-421b-8317-e8b91b6c112e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_19e404b4-8190-42fc-a5d1-63de6a371675" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_7017ef5b-3b6b-421b-8317-e8b91b6c112e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_7017ef5b-3b6b-421b-8317-e8b91b6c112e_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_7017ef5b-3b6b-421b-8317-e8b91b6c112e" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_7017ef5b-3b6b-421b-8317-e8b91b6c112e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_ee6a6586-9ec1-4faa-82be-de8b6ff1fc6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_7017ef5b-3b6b-421b-8317-e8b91b6c112e" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_ee6a6586-9ec1-4faa-82be-de8b6ff1fc6f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_4eb64062-79ca-43b2-80f0-1935eb523b15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ee6a6586-9ec1-4faa-82be-de8b6ff1fc6f" xlink:to="loc_us-gaap_CostOfSalesMember_4eb64062-79ca-43b2-80f0-1935eb523b15" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_f83ac4cf-7d14-4d1e-89e5-bdecc915fb4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ee6a6586-9ec1-4faa-82be-de8b6ff1fc6f" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_f83ac4cf-7d14-4d1e-89e5-bdecc915fb4e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_1d7f9b97-1e87-4d66-a995-ca170a448179" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ee6a6586-9ec1-4faa-82be-de8b6ff1fc6f" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_1d7f9b97-1e87-4d66-a995-ca170a448179" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.amprius.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="ampx-20230331.xsd#LeasesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.amprius.com/role/LeasesNarrativeDetails" xlink:type="extended" id="i1426eb30418c4929a702e3100be86d77_LeasesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_fadc88ff-8d2f-4c95-b98a-8d3ce414a140" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_221b9b3a-63ad-4297-b2f2-a6c6cbd1f617" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fadc88ff-8d2f-4c95-b98a-8d3ce414a140" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_221b9b3a-63ad-4297-b2f2-a6c6cbd1f617" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_LesseeFinanceLeaseNumberOfLeases_ece05d6f-45d2-47b5-a1ec-2589f9f29a5a" xlink:href="ampx-20230331.xsd#ampx_LesseeFinanceLeaseNumberOfLeases"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fadc88ff-8d2f-4c95-b98a-8d3ce414a140" xlink:to="loc_ampx_LesseeFinanceLeaseNumberOfLeases_ece05d6f-45d2-47b5-a1ec-2589f9f29a5a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_51bd1cf5-2c38-4196-93b4-913f6c3260d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fadc88ff-8d2f-4c95-b98a-8d3ce414a140" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_51bd1cf5-2c38-4196-93b4-913f6c3260d3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_cbc03e62-ad3d-4034-8e3f-fc1a436ec3ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fadc88ff-8d2f-4c95-b98a-8d3ce414a140" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_cbc03e62-ad3d-4034-8e3f-fc1a436ec3ff" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_358e921a-5e51-445f-91d2-d97d2b4c446d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fadc88ff-8d2f-4c95-b98a-8d3ce414a140" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_358e921a-5e51-445f-91d2-d97d2b4c446d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_1c691993-20d1-48a6-b48b-b20e9ab619ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fadc88ff-8d2f-4c95-b98a-8d3ce414a140" xlink:to="loc_us-gaap_OperatingLeasePayments_1c691993-20d1-48a6-b48b-b20e9ab619ee" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_bea142ce-b79a-4eca-9150-dd697f4517f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fadc88ff-8d2f-4c95-b98a-8d3ce414a140" xlink:to="loc_us-gaap_OperatingLeaseCost_bea142ce-b79a-4eca-9150-dd697f4517f1" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_ea3b0c32-4125-4a98-bea0-df0708816bed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fadc88ff-8d2f-4c95-b98a-8d3ce414a140" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_ea3b0c32-4125-4a98-bea0-df0708816bed" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_6173052f-51cc-404d-a286-24d277c9cb60" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_ea3b0c32-4125-4a98-bea0-df0708816bed" xlink:to="loc_dei_LegalEntityAxis_6173052f-51cc-404d-a286-24d277c9cb60" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_6173052f-51cc-404d-a286-24d277c9cb60_default" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_dei_LegalEntityAxis_6173052f-51cc-404d-a286-24d277c9cb60" xlink:to="loc_dei_EntityDomain_6173052f-51cc-404d-a286-24d277c9cb60_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_148ba39c-0b7b-43be-9d52-fcf394452936" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_dei_LegalEntityAxis_6173052f-51cc-404d-a286-24d277c9cb60" xlink:to="loc_dei_EntityDomain_148ba39c-0b7b-43be-9d52-fcf394452936" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_AmpriusHoldingsMember_5185b443-409a-4358-be1a-c2548ab014dd" xlink:href="ampx-20230331.xsd#ampx_AmpriusHoldingsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_dei_EntityDomain_148ba39c-0b7b-43be-9d52-fcf394452936" xlink:to="loc_ampx_AmpriusHoldingsMember_5185b443-409a-4358-be1a-c2548ab014dd" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.amprius.com/role/NetLossPerSharePotentiallyDilutiveSecuritiesDetails" xlink:type="simple" xlink:href="ampx-20230331.xsd#NetLossPerSharePotentiallyDilutiveSecuritiesDetails"/>
  <link:definitionLink xlink:role="http://www.amprius.com/role/NetLossPerSharePotentiallyDilutiveSecuritiesDetails" xlink:type="extended" id="ief3aaeca899b421bbcd381f5f9db4c8a_NetLossPerSharePotentiallyDilutiveSecuritiesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_7706be9f-032d-46db-a93a-46bd49bd40ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_fd9ae54d-f7c0-4cdc-8e22-6d3160fb90fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_7706be9f-032d-46db-a93a-46bd49bd40ff" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_fd9ae54d-f7c0-4cdc-8e22-6d3160fb90fe" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_db224e73-d43c-4827-8c56-8c982f856126" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_7706be9f-032d-46db-a93a-46bd49bd40ff" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_db224e73-d43c-4827-8c56-8c982f856126" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_40b6c47c-c7c7-4e0e-9405-49f07dbb1f27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_db224e73-d43c-4827-8c56-8c982f856126" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_40b6c47c-c7c7-4e0e-9405-49f07dbb1f27" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_40b6c47c-c7c7-4e0e-9405-49f07dbb1f27_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_40b6c47c-c7c7-4e0e-9405-49f07dbb1f27" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_40b6c47c-c7c7-4e0e-9405-49f07dbb1f27_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_e7047edb-3013-40f1-91a5-ff25a6f1d568" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_40b6c47c-c7c7-4e0e-9405-49f07dbb1f27" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_e7047edb-3013-40f1-91a5-ff25a6f1d568" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_7d0f3076-5586-4477-a3f9-295f091d1570" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_e7047edb-3013-40f1-91a5-ff25a6f1d568" xlink:to="loc_us-gaap_WarrantMember_7d0f3076-5586-4477-a3f9-295f091d1570" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_567ad9e8-e5cf-489d-a283-b59c8da50f53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_e7047edb-3013-40f1-91a5-ff25a6f1d568" xlink:to="loc_us-gaap_EmployeeStockOptionMember_567ad9e8-e5cf-489d-a283-b59c8da50f53" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_3b586e61-94c2-479f-af3e-b3f81b455fda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_e7047edb-3013-40f1-91a5-ff25a6f1d568" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_3b586e61-94c2-479f-af3e-b3f81b455fda" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://www.amprius.com/role/SubsequentEventsNarrativeDetails" xlink:type="simple" xlink:href="ampx-20230331.xsd#SubsequentEventsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://www.amprius.com/role/SubsequentEventsNarrativeDetails" xlink:type="extended" id="ib72a718f3a20419a95489cdbea81d39a_SubsequentEventsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_11bef32a-dfd2-45aa-9bc1-713435ac9347" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_LesseeOperatingLeaseOptionToExtendNumber_f89d9981-efab-4adb-8bc1-34bae9dd4b00" xlink:href="ampx-20230331.xsd#ampx_LesseeOperatingLeaseOptionToExtendNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_11bef32a-dfd2-45aa-9bc1-713435ac9347" xlink:to="loc_ampx_LesseeOperatingLeaseOptionToExtendNumber_f89d9981-efab-4adb-8bc1-34bae9dd4b00" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_c4ec33ff-f9b7-4fd5-a975-776d945e40e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_11bef32a-dfd2-45aa-9bc1-713435ac9347" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_c4ec33ff-f9b7-4fd5-a975-776d945e40e6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_8052792e-1ab5-4090-b098-d5173dd87a1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventLineItems_11bef32a-dfd2-45aa-9bc1-713435ac9347" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_8052792e-1ab5-4090-b098-d5173dd87a1e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_c325c6a7-2de6-429c-ac28-129b279e2bd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_SubsequentEventLineItems_11bef32a-dfd2-45aa-9bc1-713435ac9347" xlink:to="loc_us-gaap_SubsequentEventTable_c325c6a7-2de6-429c-ac28-129b279e2bd0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_e9c08d77-cac6-4cb4-8082-3b637ebd2a91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_c325c6a7-2de6-429c-ac28-129b279e2bd0" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_e9c08d77-cac6-4cb4-8082-3b637ebd2a91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_e9c08d77-cac6-4cb4-8082-3b637ebd2a91_default" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_e9c08d77-cac6-4cb4-8082-3b637ebd2a91" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_e9c08d77-cac6-4cb4-8082-3b637ebd2a91_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_15f1e48d-e664-4c4e-8a4d-eadb9f364060" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_e9c08d77-cac6-4cb4-8082-3b637ebd2a91" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_15f1e48d-e664-4c4e-8a4d-eadb9f364060" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_d45e1c35-ba83-4bb5-bdb6-be3cf7dcf0c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_15f1e48d-e664-4c4e-8a4d-eadb9f364060" xlink:to="loc_us-gaap_SubsequentEventMember_d45e1c35-ba83-4bb5-bdb6-be3cf7dcf0c1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_NameOfFacilityAxis_6029cae3-2f63-4ca6-bcc6-5ffc6e021df3" xlink:href="ampx-20230331.xsd#ampx_NameOfFacilityAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_SubsequentEventTable_c325c6a7-2de6-429c-ac28-129b279e2bd0" xlink:to="loc_ampx_NameOfFacilityAxis_6029cae3-2f63-4ca6-bcc6-5ffc6e021df3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_NameOfFacilityDomain_6029cae3-2f63-4ca6-bcc6-5ffc6e021df3_default" xlink:href="ampx-20230331.xsd#ampx_NameOfFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_ampx_NameOfFacilityAxis_6029cae3-2f63-4ca6-bcc6-5ffc6e021df3" xlink:to="loc_ampx_NameOfFacilityDomain_6029cae3-2f63-4ca6-bcc6-5ffc6e021df3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_NameOfFacilityDomain_f04485af-8880-45c4-b598-336e9f41b276" xlink:href="ampx-20230331.xsd#ampx_NameOfFacilityDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_ampx_NameOfFacilityAxis_6029cae3-2f63-4ca6-bcc6-5ffc6e021df3" xlink:to="loc_ampx_NameOfFacilityDomain_f04485af-8880-45c4-b598-336e9f41b276" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_BrightonColoradoMember_643000bc-b036-40b2-8a56-24729044cb69" xlink:href="ampx-20230331.xsd#ampx_BrightonColoradoMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ampx_NameOfFacilityDomain_f04485af-8880-45c4-b598-336e9f41b276" xlink:to="loc_ampx_BrightonColoradoMember_643000bc-b036-40b2-8a56-24729044cb69" xlink:type="arc" order="0"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>ampx-20230331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:fb8494f8-cb68-4af0-9ed5-216002fa868d,g:3b95c37f-4a77-4ae7-bad0-5ccbe8b7d32c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_DeferredCosts_5ab25cfd-39a2-48ce-893b-14e24f4a5ce6_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred costs</link:label>
    <link:label id="lab_us-gaap_DeferredCosts_label_en-US" xlink:label="lab_us-gaap_DeferredCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Costs, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCosts" xlink:to="lab_us-gaap_DeferredCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_6964acb6-94cc-43b7-add0-c8b0b19f6001_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ampx_PaymentOfTransactionAndIssuanceCostsInConnectionWithBusinessCombinationAndPIPEInvestment_a20ef969-4fd0-44dd-b342-3793c3a2f8c8_negatedTerseLabel_en-US" xlink:label="lab_ampx_PaymentOfTransactionAndIssuanceCostsInConnectionWithBusinessCombinationAndPIPEInvestment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of transaction and issuance costs in connection with Business Combination and PIPE investment</link:label>
    <link:label id="lab_ampx_PaymentOfTransactionAndIssuanceCostsInConnectionWithBusinessCombinationAndPIPEInvestment_label_en-US" xlink:label="lab_ampx_PaymentOfTransactionAndIssuanceCostsInConnectionWithBusinessCombinationAndPIPEInvestment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of transaction and issuance costs in connection with Business Combination and PIPE investment</link:label>
    <link:label id="lab_ampx_PaymentOfTransactionAndIssuanceCostsInConnectionWithBusinessCombinationAndPIPEInvestment_documentation_en-US" xlink:label="lab_ampx_PaymentOfTransactionAndIssuanceCostsInConnectionWithBusinessCombinationAndPIPEInvestment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of transaction and issuance costs in connection with Business Combination and PIPE investment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_PaymentOfTransactionAndIssuanceCostsInConnectionWithBusinessCombinationAndPIPEInvestment" xlink:href="ampx-20230331.xsd#ampx_PaymentOfTransactionAndIssuanceCostsInConnectionWithBusinessCombinationAndPIPEInvestment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ampx_PaymentOfTransactionAndIssuanceCostsInConnectionWithBusinessCombinationAndPIPEInvestment" xlink:to="lab_ampx_PaymentOfTransactionAndIssuanceCostsInConnectionWithBusinessCombinationAndPIPEInvestment" xlink:type="arc" order="1"/>
    <link:label id="lab_ampx_BRPCIIMember_1a834696-4270-4d99-b0f8-a1fd8d049ac7_terseLabel_en-US" xlink:label="lab_ampx_BRPCIIMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BRPC II</link:label>
    <link:label id="lab_ampx_BRPCIIMember_label_en-US" xlink:label="lab_ampx_BRPCIIMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BRPC II [Member]</link:label>
    <link:label id="lab_ampx_BRPCIIMember_documentation_en-US" xlink:label="lab_ampx_BRPCIIMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BRPC II</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_BRPCIIMember" xlink:href="ampx-20230331.xsd#ampx_BRPCIIMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ampx_BRPCIIMember" xlink:to="lab_ampx_BRPCIIMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementAxis_cc0471fe-647a-4070-8924-b706372a806b_terseLabel_en-US" xlink:label="lab_srt_RestatementAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Axis]</link:label>
    <link:label id="lab_srt_RestatementAxis_label_en-US" xlink:label="lab_srt_RestatementAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementAxis" xlink:to="lab_srt_RestatementAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ampx_ShareBasedCompensationArrangementByShareBasedPaymentAwardReservedForIssuance_24cc5ddf-4fa6-48cc-b21b-a2185d75a1c1_terseLabel_en-US" xlink:label="lab_ampx_ShareBasedCompensationArrangementByShareBasedPaymentAwardReservedForIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reserved for issuance (Shares)</link:label>
    <link:label id="lab_ampx_ShareBasedCompensationArrangementByShareBasedPaymentAwardReservedForIssuance_label_en-US" xlink:label="lab_ampx_ShareBasedCompensationArrangementByShareBasedPaymentAwardReservedForIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Reserved For Issuance</link:label>
    <link:label id="lab_ampx_ShareBasedCompensationArrangementByShareBasedPaymentAwardReservedForIssuance_documentation_en-US" xlink:label="lab_ampx_ShareBasedCompensationArrangementByShareBasedPaymentAwardReservedForIssuance" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Reserved For Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_ShareBasedCompensationArrangementByShareBasedPaymentAwardReservedForIssuance" xlink:href="ampx-20230331.xsd#ampx_ShareBasedCompensationArrangementByShareBasedPaymentAwardReservedForIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ampx_ShareBasedCompensationArrangementByShareBasedPaymentAwardReservedForIssuance" xlink:to="lab_ampx_ShareBasedCompensationArrangementByShareBasedPaymentAwardReservedForIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_5384c95a-bed4-4df3-a9aa-0f8e8ab28fe4_verboseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a6065158-f585-45aa-b8f9-652aecdf689c_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_a34b8b3a-ba6a-479f-baf7-190f92ad6da1_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_eb616554-11dd-4465-a9e3-1d2f5b796282_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Future lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_ampx_AdjustmentsToAdditionalPaidInCapitalCapitalContributionsFromParent_a85e9251-0c3a-4a0f-b498-ec809ff88bb2_terseLabel_en-US" xlink:label="lab_ampx_AdjustmentsToAdditionalPaidInCapitalCapitalContributionsFromParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital contributions from Amprius Holdings</link:label>
    <link:label id="lab_ampx_AdjustmentsToAdditionalPaidInCapitalCapitalContributionsFromParent_label_en-US" xlink:label="lab_ampx_AdjustmentsToAdditionalPaidInCapitalCapitalContributionsFromParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments To Additional Paid In Capital, Capital Contributions From Parent</link:label>
    <link:label id="lab_ampx_AdjustmentsToAdditionalPaidInCapitalCapitalContributionsFromParent_documentation_en-US" xlink:label="lab_ampx_AdjustmentsToAdditionalPaidInCapitalCapitalContributionsFromParent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments To Additional Paid In Capital, Capital Contributions From Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_AdjustmentsToAdditionalPaidInCapitalCapitalContributionsFromParent" xlink:href="ampx-20230331.xsd#ampx_AdjustmentsToAdditionalPaidInCapitalCapitalContributionsFromParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ampx_AdjustmentsToAdditionalPaidInCapitalCapitalContributionsFromParent" xlink:to="lab_ampx_AdjustmentsToAdditionalPaidInCapitalCapitalContributionsFromParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_58323c2b-74e1-4312-8d87-cfede1d595ff_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income tax expense</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_ampx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfFairValueSignificantStockholder_6d218049-7d38-40d5-a574-7143212a27a0_terseLabel_en-US" xlink:label="lab_ampx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfFairValueSignificantStockholder" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise price as a percentage of fair value, ten percent stockholders</link:label>
    <link:label id="lab_ampx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfFairValueSignificantStockholder_label_en-US" xlink:label="lab_ampx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfFairValueSignificantStockholder" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award, Exercise Price As A Percentage Of Fair Value, Significant Stockholder</link:label>
    <link:label id="lab_ampx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfFairValueSignificantStockholder_documentation_en-US" xlink:label="lab_ampx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfFairValueSignificantStockholder" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award, Exercise Price As A Percentage Of Fair Value, Significant Stockholder</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfFairValueSignificantStockholder" xlink:href="ampx-20230331.xsd#ampx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfFairValueSignificantStockholder"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ampx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfFairValueSignificantStockholder" xlink:to="lab_ampx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfFairValueSignificantStockholder" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_808b9c60-67b1-4316-ad95-c1bb22f9bcc6_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_PreferredStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_PreferredStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_d237aab6-cc38-4876-9442-f461b183e3d2_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2027</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_363f4c84-0b19-4369-9ad4-205ea21855c6_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_50ca654c-ee50-465c-bf58-6debc3eb6287_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_0563a270-3686-45e3-a164-934cedf04b92_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_ampx_TotalRevenueFromCustomersMember_ed2e06e5-a5e7-49b8-bb44-90e8cd2d9fbd_terseLabel_en-US" xlink:label="lab_ampx_TotalRevenueFromCustomersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total revenue from customers</link:label>
    <link:label id="lab_ampx_TotalRevenueFromCustomersMember_label_en-US" xlink:label="lab_ampx_TotalRevenueFromCustomersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Revenue From Customers [Member]</link:label>
    <link:label id="lab_ampx_TotalRevenueFromCustomersMember_documentation_en-US" xlink:label="lab_ampx_TotalRevenueFromCustomersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total Revenue From Customers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_TotalRevenueFromCustomersMember" xlink:href="ampx-20230331.xsd#ampx_TotalRevenueFromCustomersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ampx_TotalRevenueFromCustomersMember" xlink:to="lab_ampx_TotalRevenueFromCustomersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentAbstract_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_46ff4b9a-bf64-4403-85d1-7b70db48d233_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average common shares outstanding, diluted (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:to="lab_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_83fdbdab-6a19-4d92-a3e1-2910d4fa1395_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesOutstanding" xlink:to="lab_us-gaap_PreferredStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_303b8377-5dc3-4c24-a10e-a58878757220_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_e30c7336-f148-4eaa-9cfa-f6524aa62d3e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_5fa098e8-cce9-45b8-a8c4-6588aace3ad5_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, at cost</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_ampx_LesseeFinanceLeaseNumberOfLeases_7ddbf6ef-36dd-46b9-8b75-38860d3594f4_terseLabel_en-US" xlink:label="lab_ampx_LesseeFinanceLeaseNumberOfLeases" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of finance leases (in leases)</link:label>
    <link:label id="lab_ampx_LesseeFinanceLeaseNumberOfLeases_label_en-US" xlink:label="lab_ampx_LesseeFinanceLeaseNumberOfLeases" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Lease, Number Of Leases</link:label>
    <link:label id="lab_ampx_LesseeFinanceLeaseNumberOfLeases_documentation_en-US" xlink:label="lab_ampx_LesseeFinanceLeaseNumberOfLeases" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Lease, Number Of Leases</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_LesseeFinanceLeaseNumberOfLeases" xlink:href="ampx-20230331.xsd#ampx_LesseeFinanceLeaseNumberOfLeases"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ampx_LesseeFinanceLeaseNumberOfLeases" xlink:to="lab_ampx_LesseeFinanceLeaseNumberOfLeases" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract" xlink:to="lab_us-gaap_IncomeTaxDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableMember_6f8acfe6-ea86-4333-b695-91b80239f9ac_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableMember_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableMember" xlink:to="lab_us-gaap_AccountsReceivableMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ampx_AdjustmentsToAdditionalPaidInCapitalContributionFromParentRelatedToStockBasedCompensation_08da4699-96e0-4a66-9cab-f31a5e1f9087_terseLabel_en-US" xlink:label="lab_ampx_AdjustmentsToAdditionalPaidInCapitalContributionFromParentRelatedToStockBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contribution from Amprius Holdings related to stock-based compensation</link:label>
    <link:label id="lab_ampx_AdjustmentsToAdditionalPaidInCapitalContributionFromParentRelatedToStockBasedCompensation_label_en-US" xlink:label="lab_ampx_AdjustmentsToAdditionalPaidInCapitalContributionFromParentRelatedToStockBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments To Additional Paid In Capital, Contribution From Parent Related To Stock-Based Compensation</link:label>
    <link:label id="lab_ampx_AdjustmentsToAdditionalPaidInCapitalContributionFromParentRelatedToStockBasedCompensation_documentation_en-US" xlink:label="lab_ampx_AdjustmentsToAdditionalPaidInCapitalContributionFromParentRelatedToStockBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments To Additional Paid In Capital, Contribution From Parent Related To Stock-Based Compensation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_AdjustmentsToAdditionalPaidInCapitalContributionFromParentRelatedToStockBasedCompensation" xlink:href="ampx-20230331.xsd#ampx_AdjustmentsToAdditionalPaidInCapitalContributionFromParentRelatedToStockBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ampx_AdjustmentsToAdditionalPaidInCapitalContributionFromParentRelatedToStockBasedCompensation" xlink:to="lab_ampx_AdjustmentsToAdditionalPaidInCapitalContributionFromParentRelatedToStockBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_ampx_CustomerTwoMember_8029a8f5-95d8-49e8-b844-88d98bfb6d6e_terseLabel_en-US" xlink:label="lab_ampx_CustomerTwoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Two</link:label>
    <link:label id="lab_ampx_CustomerTwoMember_label_en-US" xlink:label="lab_ampx_CustomerTwoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Two [Member]</link:label>
    <link:label id="lab_ampx_CustomerTwoMember_documentation_en-US" xlink:label="lab_ampx_CustomerTwoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_CustomerTwoMember" xlink:href="ampx-20230331.xsd#ampx_CustomerTwoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ampx_CustomerTwoMember" xlink:to="lab_ampx_CustomerTwoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_4fab0821-276b-4cea-9185-7fa2dbc9f3e4_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in&#160;capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_ampx_SaleOfStockAveragePricePerShareRedemption_45a1485c-b410-4738-9ec9-58eb3dcf54fb_terseLabel_en-US" xlink:label="lab_ampx_SaleOfStockAveragePricePerShareRedemption" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Average price per share of redeemable warrants (in dollars per share)</link:label>
    <link:label id="lab_ampx_SaleOfStockAveragePricePerShareRedemption_label_en-US" xlink:label="lab_ampx_SaleOfStockAveragePricePerShareRedemption" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Average Price Per Share, Redemption</link:label>
    <link:label id="lab_ampx_SaleOfStockAveragePricePerShareRedemption_documentation_en-US" xlink:label="lab_ampx_SaleOfStockAveragePricePerShareRedemption" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Average Price Per Share, Redemption</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_SaleOfStockAveragePricePerShareRedemption" xlink:href="ampx-20230331.xsd#ampx_SaleOfStockAveragePricePerShareRedemption"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ampx_SaleOfStockAveragePricePerShareRedemption" xlink:to="lab_ampx_SaleOfStockAveragePricePerShareRedemption" xlink:type="arc" order="1"/>
    <link:label id="lab_ampx_PurchaseAgreementMember_31764341-2627-4ae5-af20-19b482dc6417_terseLabel_en-US" xlink:label="lab_ampx_PurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock Purchase Agreement</link:label>
    <link:label id="lab_ampx_PurchaseAgreementMember_label_en-US" xlink:label="lab_ampx_PurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Agreement [Member]</link:label>
    <link:label id="lab_ampx_PurchaseAgreementMember_documentation_en-US" xlink:label="lab_ampx_PurchaseAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_PurchaseAgreementMember" xlink:href="ampx-20230331.xsd#ampx_PurchaseAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ampx_PurchaseAgreementMember" xlink:to="lab_ampx_PurchaseAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_84734e12-cca2-48fa-b36e-2086db9f0ed8_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_92c59b8c-4ceb-413f-9182-299bae0e4c78_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Potentially Dilutive Securities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_2e45fad9-58e6-46a7-b552-38d114daf2d5_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_ampx_StockholderPercentageOfOptioneeForOptionPrice_1c8637ad-3633-4909-9776-1001d6c3c01b_terseLabel_en-US" xlink:label="lab_ampx_StockholderPercentageOfOptioneeForOptionPrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholder Percentage Of Optionee For Option Price</link:label>
    <link:label id="lab_ampx_StockholderPercentageOfOptioneeForOptionPrice_label_en-US" xlink:label="lab_ampx_StockholderPercentageOfOptioneeForOptionPrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholder Percentage Of Optionee For Option Price</link:label>
    <link:label id="lab_ampx_StockholderPercentageOfOptioneeForOptionPrice_documentation_en-US" xlink:label="lab_ampx_StockholderPercentageOfOptioneeForOptionPrice" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholder Percentage Of Optionee For Option Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_StockholderPercentageOfOptioneeForOptionPrice" xlink:href="ampx-20230331.xsd#ampx_StockholderPercentageOfOptioneeForOptionPrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ampx_StockholderPercentageOfOptioneeForOptionPrice" xlink:to="lab_ampx_StockholderPercentageOfOptioneeForOptionPrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_582a9801-8e96-4039-8200-3739e37f220e_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net present value of operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_b46c5431-3b6a-4927-b11f-8446f3e621d0_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesAuthorized" xlink:to="lab_us-gaap_PreferredStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a9e23179-d90e-48a5-b254-e56e55789bb5_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash, beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_16d0fa78-b2b3-4073-80d2-db2bb4dc9ead_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, cash equivalents and restricted cash, end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_2ecb59b0-01eb-48ad-9631-7bdf2bb61441_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_ampx_ExecutiveIncentiveCompensationPlanMember_2081516c-c861-4139-93b9-5c4411f502ce_terseLabel_en-US" xlink:label="lab_ampx_ExecutiveIncentiveCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Executive Incentive Compensation Plan</link:label>
    <link:label id="lab_ampx_ExecutiveIncentiveCompensationPlanMember_label_en-US" xlink:label="lab_ampx_ExecutiveIncentiveCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Executive Incentive Compensation Plan [Member]</link:label>
    <link:label id="lab_ampx_ExecutiveIncentiveCompensationPlanMember_documentation_en-US" xlink:label="lab_ampx_ExecutiveIncentiveCompensationPlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Executive Incentive Compensation Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_ExecutiveIncentiveCompensationPlanMember" xlink:href="ampx-20230331.xsd#ampx_ExecutiveIncentiveCompensationPlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ampx_ExecutiveIncentiveCompensationPlanMember" xlink:to="lab_ampx_ExecutiveIncentiveCompensationPlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_119d9a4a-9eeb-456f-bf2f-43b344ce2b7f_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_20cdba58-89fa-4535-b4f7-de050c96a4bc_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_7e2f4293-f263-4ae1-aa68-ac0536d7eb1d_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_8b467413-0327-436a-80de-5c34bd9e274d_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_c995fe35-25a9-4d27-8ceb-7210bb5e80f7_verboseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from exercise of stock options</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_7f5d3340-300b-48a0-8233-7e512e2f9f92_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_9e503715-0355-48e4-be2d-b362e689070d_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_79d38d05-1911-4c4e-a489-2fecf4592e41_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_e9edd6e3-3b34-4ad6-8fa3-afa4339ae08b_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_6baba9a3-525c-4ef0-b3a9-efd893af4b62_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_ad4f2490-a2bb-488b-867c-a0c8058d721d_negatedLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_53e61060-70e4-4ca3-b419-69e3977bf1aa_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_aaedd63b-5d71-457c-b473-a4d74d127fa0_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_00000b13-c76e-46be-a125-aedcc4843a24_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_bcf5bc58-fc20-401f-a988-a61782f95301_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Potentially dilutive securities excluded from the computation of net loss per share (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_a2a05751-1296-45eb-9d74-1515e17c3f29_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAxis_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationLineItems_0ad3f923-a656-45db-a6f1-c6650e8eaeaf_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:label id="lab_dei_DocumentInformationLineItems_label_en-US" xlink:label="lab_dei_DocumentInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationLineItems" xlink:to="lab_dei_DocumentInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_cb8934bb-7f1a-4af1-ae75-d3378814c6f7_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeAxis_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeAxis" xlink:to="lab_us-gaap_SubsequentEventTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_61a9863c-8766-451f-8271-1708286a73ef_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_340ab3ef-812c-4710-8fb9-947f22525ce9_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_7eeac3b2-4d3e-4e8f-a76f-59b4279a7d9a_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_ab0f57b0-1275-4faf-a81b-714a6b977fea_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_ab50e491-65bf-4f1b-990a-80ae9b747bb4_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_50576b5e-fa1c-4dd0-97fc-903fe4d8ad89_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTypeDomain_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTypeDomain" xlink:to="lab_us-gaap_SubsequentEventTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_a1be6346-3d13-43f6-86a3-1ae39499d93f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareReconciliationAbstract_bff9bcef-7405-4760-9a36-98db5e662bae_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareReconciliationAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareReconciliationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share Reconciliation [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareReconciliationAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareReconciliationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract" xlink:to="lab_us-gaap_EarningsPerShareReconciliationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_da3a72ff-4008-455c-b52c-e916ff58ce58_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_10535972-815f-468a-b043-0bead4f83499_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_102b5393-0f36-4c45-8953-d7868b8ebef9_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_224495ca-8923-4b8a-92af-06aa8e752f36_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in progress</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressMember" xlink:to="lab_us-gaap_ConstructionInProgressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_3efe0d34-be49-4b9a-81f9-f8bcbfa3b1c0_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_0bad9f8b-99d5-4967-a819-fb6ac4ea5990_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract asset</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetNet_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, after Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetNet" xlink:to="lab_us-gaap_ContractWithCustomerAssetNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_9dbd16ad-318d-477b-a71d-147fc3d232d2_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_f02e1771-61b7-4459-946f-7e85baab564c_terseLabel_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_DepreciationDepletionAndAmortization_label_en-US" xlink:label="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation, Depletion and Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DepreciationDepletionAndAmortization" xlink:to="lab_us-gaap_DepreciationDepletionAndAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_2c7b0a5b-65fd-4ad0-a434-cc4731669921_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ampx_RecapitalizationExchangeRatio_ecf8391d-1388-46ad-8c55-df4fb7121a06_terseLabel_en-US" xlink:label="lab_ampx_RecapitalizationExchangeRatio" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recapitalization exchange ratio</link:label>
    <link:label id="lab_ampx_RecapitalizationExchangeRatio_label_en-US" xlink:label="lab_ampx_RecapitalizationExchangeRatio" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recapitalization Exchange Ratio</link:label>
    <link:label id="lab_ampx_RecapitalizationExchangeRatio_documentation_en-US" xlink:label="lab_ampx_RecapitalizationExchangeRatio" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recapitalization Exchange Ratio</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_RecapitalizationExchangeRatio" xlink:href="ampx-20230331.xsd#ampx_RecapitalizationExchangeRatio"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ampx_RecapitalizationExchangeRatio" xlink:to="lab_ampx_RecapitalizationExchangeRatio" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_5a298848-bf18-4ab3-9f1b-14ef4192bcf0_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation cost</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_ac85fc1a-9ed5-4be6-8801-d14949ed7f98_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_e4f8f2b8-ad7d-48c7-bf81-d772d8aef07d_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Remainder of 2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_ampx_EquityIncentivePlansMember_3e6426b9-2a9e-419d-a56d-52513fe29a39_terseLabel_en-US" xlink:label="lab_ampx_EquityIncentivePlansMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Incentive Plans</link:label>
    <link:label id="lab_ampx_EquityIncentivePlansMember_label_en-US" xlink:label="lab_ampx_EquityIncentivePlansMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Incentive Plans [Member]</link:label>
    <link:label id="lab_ampx_EquityIncentivePlansMember_documentation_en-US" xlink:label="lab_ampx_EquityIncentivePlansMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Incentive Plans</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_EquityIncentivePlansMember" xlink:href="ampx-20230331.xsd#ampx_EquityIncentivePlansMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ampx_EquityIncentivePlansMember" xlink:to="lab_ampx_EquityIncentivePlansMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingCostsAndExpensesAbstract_0be73226-907a-4a98-bad2-d99d6d0bf944_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingCostsAndExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingCostsAndExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Costs and Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpensesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract" xlink:to="lab_us-gaap_OperatingCostsAndExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValueOutstanding_9013e268-28db-4570-b692-953f6c08ca7d_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValueOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock; $0.0001 par value; 950,000,000 shares authorized; 84,971,465 and 84,610,114 shares issued and outstanding at March&#160;31, 2023 and December&#160;31, 2022, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValueOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockValueOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValueOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValueOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValueOutstanding" xlink:to="lab_us-gaap_CommonStockValueOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_6d1271d7-1058-4f3a-a1f7-23a71f752e00_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_9107450b-56fa-4876-a3fb-d5f3b84f7a64_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level 1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CounterpartyNameAxis_3ca83651-c0d0-4437-8345-90f9ad83f720_terseLabel_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:label id="lab_srt_CounterpartyNameAxis_label_en-US" xlink:label="lab_srt_CounterpartyNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CounterpartyNameAxis" xlink:to="lab_srt_CounterpartyNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockMember_0fdea019-099e-436e-b053-6c87198bf427_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee stock</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockMember" xlink:to="lab_us-gaap_EmployeeStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ampx_ThreeCustomersMember_e1c0b148-e24a-4530-b47b-428574c1ee43_terseLabel_en-US" xlink:label="lab_ampx_ThreeCustomersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three customers</link:label>
    <link:label id="lab_ampx_ThreeCustomersMember_label_en-US" xlink:label="lab_ampx_ThreeCustomersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Customers [Member]</link:label>
    <link:label id="lab_ampx_ThreeCustomersMember_documentation_en-US" xlink:label="lab_ampx_ThreeCustomersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Three Customers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_ThreeCustomersMember" xlink:href="ampx-20230331.xsd#ampx_ThreeCustomersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ampx_ThreeCustomersMember" xlink:to="lab_ampx_ThreeCustomersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_b682085f-a68d-4efb-a5d8-c7664c039cc0_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAxis_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis" xlink:to="lab_us-gaap_CashAndCashEquivalentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ampx_CustomizedDesignServicesMember_a50af274-d8d3-4e3b-a2cb-618406057139_terseLabel_en-US" xlink:label="lab_ampx_CustomizedDesignServicesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customized design services</link:label>
    <link:label id="lab_ampx_CustomizedDesignServicesMember_label_en-US" xlink:label="lab_ampx_CustomizedDesignServicesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customized Design Services [Member]</link:label>
    <link:label id="lab_ampx_CustomizedDesignServicesMember_documentation_en-US" xlink:label="lab_ampx_CustomizedDesignServicesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customized Design Services</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_CustomizedDesignServicesMember" xlink:href="ampx-20230331.xsd#ampx_CustomizedDesignServicesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ampx_CustomizedDesignServicesMember" xlink:to="lab_ampx_CustomizedDesignServicesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_5f3ea622-d0d6-4eb6-8344-0fc31a35ad25_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_ebb6f082-d940-4a28-823e-0c054ca22619_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements or Change in Accounting Principle [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_6a455b84-a40a-4d03-892d-7f691e1974da_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_4d2daf27-da4d-430f-aa55-21e497dbcd3d_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_ampx_LaboratoryEquipmentMember_c12e0e59-44b4-4fbb-bc3f-2347e0f17a62_terseLabel_en-US" xlink:label="lab_ampx_LaboratoryEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lab equipment</link:label>
    <link:label id="lab_ampx_LaboratoryEquipmentMember_label_en-US" xlink:label="lab_ampx_LaboratoryEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Laboratory Equipment [Member]</link:label>
    <link:label id="lab_ampx_LaboratoryEquipmentMember_documentation_en-US" xlink:label="lab_ampx_LaboratoryEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Laboratory Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_LaboratoryEquipmentMember" xlink:href="ampx-20230331.xsd#ampx_LaboratoryEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ampx_LaboratoryEquipmentMember" xlink:to="lab_ampx_LaboratoryEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_1c8e1842-b537-4ff3-b085-0fc4e0ecdc2b_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_919b1884-c8fd-44d2-a20d-9dc34893c936_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_a70b9e86-4d05-47e1-b28a-9d8cadf7de53_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_809aa06f-c837-49bc-9ce1-9a0d4ba67408_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_ampx_BrightonColoradoMember_278e9be1-ca72-48d7-b515-418268dd6a18_terseLabel_en-US" xlink:label="lab_ampx_BrightonColoradoMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Brighton, Colorado</link:label>
    <link:label id="lab_ampx_BrightonColoradoMember_label_en-US" xlink:label="lab_ampx_BrightonColoradoMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Brighton, Colorado [Member]</link:label>
    <link:label id="lab_ampx_BrightonColoradoMember_documentation_en-US" xlink:label="lab_ampx_BrightonColoradoMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Brighton, Colorado</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_BrightonColoradoMember" xlink:href="ampx-20230331.xsd#ampx_BrightonColoradoMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ampx_BrightonColoradoMember" xlink:to="lab_ampx_BrightonColoradoMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_6088ce9f-cff8-4d1c-ae2a-1c5831af23d3_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_366c5eed-569f-40d7-a446-d0fedba5bb41_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease payments</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_02869b13-a111-4673-bf89-44373f9add9e_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_9b68abad-3902-451b-9b8a-77b9b05301e1_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock options</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ampx_NumberOfExecutiveEmployeesOfParentSharingFacilitiesCosts_3f593b4f-1abc-4abc-a9f3-1bc54866045e_terseLabel_en-US" xlink:label="lab_ampx_NumberOfExecutiveEmployeesOfParentSharingFacilitiesCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of executive employees of parent sharing facilities costs (in executive employees)</link:label>
    <link:label id="lab_ampx_NumberOfExecutiveEmployeesOfParentSharingFacilitiesCosts_label_en-US" xlink:label="lab_ampx_NumberOfExecutiveEmployeesOfParentSharingFacilitiesCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Executive Employees Of Parent Sharing Facilities Costs</link:label>
    <link:label id="lab_ampx_NumberOfExecutiveEmployeesOfParentSharingFacilitiesCosts_documentation_en-US" xlink:label="lab_ampx_NumberOfExecutiveEmployeesOfParentSharingFacilitiesCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Executive Employees Of Parent Sharing Facilities Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_NumberOfExecutiveEmployeesOfParentSharingFacilitiesCosts" xlink:href="ampx-20230331.xsd#ampx_NumberOfExecutiveEmployeesOfParentSharingFacilitiesCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ampx_NumberOfExecutiveEmployeesOfParentSharingFacilitiesCosts" xlink:to="lab_ampx_NumberOfExecutiveEmployeesOfParentSharingFacilitiesCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_1033adc7-3db6-49f8-a325-dc50d9f8c30b_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise of stock options</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LegalEntityAxis_9722661d-c277-4924-9fc7-bc66992b6bf5_terseLabel_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:label id="lab_dei_LegalEntityAxis_label_en-US" xlink:label="lab_dei_LegalEntityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal Entity [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LegalEntityAxis" xlink:to="lab_dei_LegalEntityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_72271b16-bbef-41eb-9a92-3ee23642d734_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, authorized (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_bd76bf71-5d01-403d-8f21-ca67173273f5_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_193fc1a8-032e-4b19-b65d-e99a9439f01a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average remaining term (in years)</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsNoncurrentAbstract_d3cbac98-d3b1-4b3b-ae65-542adf4e86fe_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract" xlink:to="lab_us-gaap_AssetsNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a9ebcc31-ce39-4f91-8536-755884bef9fe_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightAxis_2ca1c793-4c96-451e-bb8f-8424768cf8c3_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightAxis_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis" xlink:to="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_ba5a5119-a411-4727-9f13-0cda2021f918_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_4a9c2080-e993-4a42-9d67-6fa0290317f9_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_985bdbdf-c529-497c-97ac-0085142cdc11_verboseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_b647119d-eb5d-4fbb-a2c9-8d42b0932b4c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Composition of Revenue</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from External Customers by Products and Services [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:to="lab_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_85e284af-f671-4a55-b9ea-2f06f32fe7ab_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock in connection with a stock purchase agreement, net of issuance cost</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_b29fccba-4ee1-41a9-b9e4-554613223103_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued and other current liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_bb9db0f9-7b40-4b67-915a-1ab4cd198bfd_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6e079e4d-dd94-4203-81aa-c7515a0dab4e_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_b6d29545-e123-428c-9fac-2cde328f52ce_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:to="lab_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_64bb5403-0419-4e23-a771-fba49160ee3c_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashAndCashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_2730d406-d4ca-42b6-a499-ae4a2a01ca8a_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_c49dc53e-a91d-4df3-bff7-d99dc0c90a9f_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Property and Equipment, Net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_5a641c67-08fe-4078-a435-665f5f36800b_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_PreferredStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_PreferredStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Shares Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockSharesIssued" xlink:to="lab_us-gaap_PreferredStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_1a06b2a9-399f-4a8f-acc1-e399fbb7e06e_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_cefb3cd6-ebf7-4275-97bf-849d4859d100_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue recognized</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Revenue Recognized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityRevenueRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransferredAtPointInTimeMember_b255f1ec-4166-4426-836c-c55b1733d099_terseLabel_en-US" xlink:label="lab_us-gaap_TransferredAtPointInTimeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bill-and-hold</link:label>
    <link:label id="lab_us-gaap_TransferredAtPointInTimeMember_label_en-US" xlink:label="lab_us-gaap_TransferredAtPointInTimeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Transferred at Point in Time [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredAtPointInTimeMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransferredAtPointInTimeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransferredAtPointInTimeMember" xlink:to="lab_us-gaap_TransferredAtPointInTimeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_79c95e1c-6b03-4e99-b953-1689d3040e24_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_5ca03caf-92ea-4ec8-850a-912a44f5eea8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Outstanding Stock Warrants</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_7da5d501-1ab8-47fd-98d9-f5d0e619a630_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_c6734734-165a-467f-9eb3-5ddfa3ca0655_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_7e65963d-39b3-4f48-8898-d12112d6622f_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-cash operating lease expense</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Amortization Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ampx_TwentyTwentyTwoEquityIncentivePlanMember_3bddc651-ec19-432e-a0ac-8faac670bd02_terseLabel_en-US" xlink:label="lab_ampx_TwentyTwentyTwoEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022 Plan</link:label>
    <link:label id="lab_ampx_TwentyTwentyTwoEquityIncentivePlanMember_label_en-US" xlink:label="lab_ampx_TwentyTwentyTwoEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Twenty Twenty Two Equity Incentive Plan [Member]</link:label>
    <link:label id="lab_ampx_TwentyTwentyTwoEquityIncentivePlanMember_documentation_en-US" xlink:label="lab_ampx_TwentyTwentyTwoEquityIncentivePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Twenty Twenty Two Equity Incentive Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_TwentyTwentyTwoEquityIncentivePlanMember" xlink:href="ampx-20230331.xsd#ampx_TwentyTwentyTwoEquityIncentivePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ampx_TwentyTwentyTwoEquityIncentivePlanMember" xlink:to="lab_ampx_TwentyTwentyTwoEquityIncentivePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCash_ba1af21d-6954-4c74-a091-625e1a3bce86_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted cash included in other assets</link:label>
    <link:label id="lab_us-gaap_RestrictedCash_label_en-US" xlink:label="lab_us-gaap_RestrictedCash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCash" xlink:to="lab_us-gaap_RestrictedCash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_dc03d2c9-feee-4fac-b6b0-dff5cce63e74_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, remaining performance obligation, period</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_4c981f6c-455a-4f85-af3c-7b3a93aec8a5_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_049631e4-7c90-4a86-a555-3dcf0caae126_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_2fe22207-5e6e-4e93-b1af-7f408363cc47_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation expense</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_23ef206c-dde4-4efe-ad40-e65bbdc4e66e_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_ampx_CustomerThreeMember_6b0f854b-f47e-457a-b5d8-a2e4ec47281d_terseLabel_en-US" xlink:label="lab_ampx_CustomerThreeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Three</link:label>
    <link:label id="lab_ampx_CustomerThreeMember_label_en-US" xlink:label="lab_ampx_CustomerThreeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Three [Member]</link:label>
    <link:label id="lab_ampx_CustomerThreeMember_documentation_en-US" xlink:label="lab_ampx_CustomerThreeMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_CustomerThreeMember" xlink:href="ampx-20230331.xsd#ampx_CustomerThreeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ampx_CustomerThreeMember" xlink:to="lab_ampx_CustomerThreeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_21fb007b-a78f-4591-94d7-297df1c99554_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_c48f447b-dbde-4e81-9c86-ed8bbf7d24ca_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredRevenue_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_ampx_ProductionEquipmentMember_606f8b18-47bb-475b-b3f2-f36372b80aca_terseLabel_en-US" xlink:label="lab_ampx_ProductionEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Production equipment</link:label>
    <link:label id="lab_ampx_ProductionEquipmentMember_label_en-US" xlink:label="lab_ampx_ProductionEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Production Equipment [Member]</link:label>
    <link:label id="lab_ampx_ProductionEquipmentMember_documentation_en-US" xlink:label="lab_ampx_ProductionEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Production Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_ProductionEquipmentMember" xlink:href="ampx-20230331.xsd#ampx_ProductionEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ampx_ProductionEquipmentMember" xlink:to="lab_ampx_ProductionEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_841d296a-24a0-4248-bc56-3cdb884d0645_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_739c4cca-5e71-4301-8cad-24dd6a98659a_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_f26c1091-957f-4453-815b-467990dbb70e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_6ed7ee24-9670-4a0b-90c2-697fa5b888cf_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_58adca91-b264-4534-ad0c-637aae8bfd9c_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nature of Operations and Organization</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventMember_504cb4e8-c83b-4d3f-9512-a952cd3229ab_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events</link:label>
    <link:label id="lab_us-gaap_SubsequentEventMember_label_en-US" xlink:label="lab_us-gaap_SubsequentEventMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventMember" xlink:to="lab_us-gaap_SubsequentEventMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_4a580f53-bf29-450e-9327-ab5ea28e4e52_terseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue benchmark</link:label>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_label_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueNetMember" xlink:to="lab_us-gaap_SalesRevenueNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTable_16325d22-e19a-4c58-82c5-e4270ebf5b02_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions by Acquisition, Equity Interest Issued or Issuable [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Business Acquisitions by Acquisition, Equity Interest Issued or Issuable [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTable" xlink:to="lab_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTable" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_b6975635-9ab9-4a8a-a5fb-c6354e63036e_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PayablesAndAccrualsAbstract_label_en-US" xlink:label="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payables and Accruals [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract" xlink:to="lab_us-gaap_PayablesAndAccrualsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_96e1e572-3d99-42e4-89dd-a4768a8479bc_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventLineItems_label_en-US" xlink:label="lab_us-gaap_SubsequentEventLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventLineItems" xlink:to="lab_us-gaap_SubsequentEventLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_ampx_SharesAuthorized_4275c474-175e-4fa8-9596-21a9fab1c5b1_terseLabel_en-US" xlink:label="lab_ampx_SharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares authorized (in shares)</link:label>
    <link:label id="lab_ampx_SharesAuthorized_label_en-US" xlink:label="lab_ampx_SharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Authorized</link:label>
    <link:label id="lab_ampx_SharesAuthorized_documentation_en-US" xlink:label="lab_ampx_SharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_SharesAuthorized" xlink:href="ampx-20230331.xsd#ampx_SharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ampx_SharesAuthorized" xlink:to="lab_ampx_SharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_3d58b718-2cc9-4aa4-b2ec-c42f0919aa2a_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_5ebce836-5d9a-4326-8c49-d4e4d1ced05d_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_ampx_NameOfFacilityDomain_10251f17-3426-47a0-bce7-7c0fb049e3de_terseLabel_en-US" xlink:label="lab_ampx_NameOfFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name of Facility [Domain]</link:label>
    <link:label id="lab_ampx_NameOfFacilityDomain_label_en-US" xlink:label="lab_ampx_NameOfFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name of Facility [Domain]</link:label>
    <link:label id="lab_ampx_NameOfFacilityDomain_documentation_en-US" xlink:label="lab_ampx_NameOfFacilityDomain" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name of Facility [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_NameOfFacilityDomain" xlink:href="ampx-20230331.xsd#ampx_NameOfFacilityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ampx_NameOfFacilityDomain" xlink:to="lab_ampx_NameOfFacilityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_f5baf50a-6c84-499d-84db-a5c9b250ea2b_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_3fe63b14-095c-4cc0-8b1a-cb27b1a3556e_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per share of common stock:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_15154a52-99a3-40ad-92a3-a71755ba1f52_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ScenarioPreviouslyReportedMember_442f2bb0-8197-42ae-a14a-6313a82982f5_terseLabel_en-US" xlink:label="lab_srt_ScenarioPreviouslyReportedMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Previously Reported</link:label>
    <link:label id="lab_srt_ScenarioPreviouslyReportedMember_label_en-US" xlink:label="lab_srt_ScenarioPreviouslyReportedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Previously Reported [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ScenarioPreviouslyReportedMember" xlink:to="lab_srt_ScenarioPreviouslyReportedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_89f7cb06-c91c-4098-a0a4-38b122cac1f8_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_0cfa62c2-8516-4091-9274-ebe6061ab5f3_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">LIABILITIES AND STOCKHOLDERS&#8217; EQUITY</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_eb030c9b-8d5c-4d37-83e6-fc9d20982850_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued and other current liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_0460bc6f-99fe-4c04-bcf1-1d2e58bf3792_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued and Other Current Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_8d35cf96-265e-48fc-94e3-a1f22d4536c2_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2028</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_ampx_DeferredStockIssuanceCosts_2de1b30f-9d24-4eaf-86d5-9a2cb63c70fa_terseLabel_en-US" xlink:label="lab_ampx_DeferredStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred stock issuance costs</link:label>
    <link:label id="lab_ampx_DeferredStockIssuanceCosts_label_en-US" xlink:label="lab_ampx_DeferredStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Stock Issuance Costs</link:label>
    <link:label id="lab_ampx_DeferredStockIssuanceCosts_documentation_en-US" xlink:label="lab_ampx_DeferredStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Stock Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_DeferredStockIssuanceCosts" xlink:href="ampx-20230331.xsd#ampx_DeferredStockIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ampx_DeferredStockIssuanceCosts" xlink:to="lab_ampx_DeferredStockIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_be7787c6-6b02-4762-b775-c2ae5698efbc_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_78773529-79e8-46a6-ae39-af62ba8ccd9b_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average common shares outstanding:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_443d41e3-58ae-406b-ad5d-a4e44901c0fe_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator:</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_639c18fe-6afe-4394-82af-d352f2ce0eda_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration received</link:label>
    <link:label id="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Consideration Received on Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:to="lab_us-gaap_SaleOfStockConsiderationReceivedOnTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_77a87ccc-83a2-4219-b3e9-48ed8f3c0c94_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_InventoryNet_774fed98-3ee0-4e94-8cb3-ebb72789795b_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_9dcf7f67-7808-4efc-9f82-fa47aa391553_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued compensation and benefits</link:label>
    <link:label id="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee-related Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:to="lab_us-gaap_EmployeeRelatedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_b5598dcc-5f21-4a45-bd92-096226e6bd03_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_bdb99a7f-e518-4fc1-a77f-f0571bf12995_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_b6f2482e-41f2-498c-9f1d-4c61f1cb2fb1_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_f893111d-191d-4729-ba4a-294ba96706bd_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionDomain_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_948c32ce-8909-45fe-b1dc-b633acbdee9c_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Loss Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_6163a52e-b2f7-4c87-935c-5ca916929b65_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ampx_CommittedEquityFinancing_0a135db7-ac6d-4abb-9a25-60f7d5da3213_terseLabel_en-US" xlink:label="lab_ampx_CommittedEquityFinancing" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Committed equity financing balance</link:label>
    <link:label id="lab_ampx_CommittedEquityFinancing_label_en-US" xlink:label="lab_ampx_CommittedEquityFinancing" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Committed Equity Financing</link:label>
    <link:label id="lab_ampx_CommittedEquityFinancing_documentation_en-US" xlink:label="lab_ampx_CommittedEquityFinancing" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Committed Equity Financing</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_CommittedEquityFinancing" xlink:href="ampx-20230331.xsd#ampx_CommittedEquityFinancing"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ampx_CommittedEquityFinancing" xlink:to="lab_ampx_CommittedEquityFinancing" xlink:type="arc" order="1"/>
    <link:label id="lab_ampx_SaleOfBatteryMember_faf471c4-d5ab-4a88-a556-4f0526e32f70_terseLabel_en-US" xlink:label="lab_ampx_SaleOfBatteryMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of battery products</link:label>
    <link:label id="lab_ampx_SaleOfBatteryMember_label_en-US" xlink:label="lab_ampx_SaleOfBatteryMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Battery [Member]</link:label>
    <link:label id="lab_ampx_SaleOfBatteryMember_documentation_en-US" xlink:label="lab_ampx_SaleOfBatteryMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Battery</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_SaleOfBatteryMember" xlink:href="ampx-20230331.xsd#ampx_SaleOfBatteryMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ampx_SaleOfBatteryMember" xlink:to="lab_ampx_SaleOfBatteryMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromContributionsFromParent_017834c5-cd20-45ec-b378-8b2faf6187c4_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromContributionsFromParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital contributions from Amprius Holdings</link:label>
    <link:label id="lab_us-gaap_ProceedsFromContributionsFromParent_label_en-US" xlink:label="lab_us-gaap_ProceedsFromContributionsFromParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Contributions from Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromContributionsFromParent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromContributionsFromParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromContributionsFromParent" xlink:to="lab_us-gaap_ProceedsFromContributionsFromParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantMember_43fceb53-2a18-4295-a605-8f3faef1ad2d_verboseLabel_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock warrants</link:label>
    <link:label id="lab_us-gaap_WarrantMember_label_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantMember" xlink:to="lab_us-gaap_WarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_6c95bc39-57be-4753-a14b-021873314b0f_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_6709b126-8049-4057-929d-0f009c3d20a1_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_942003bc-e0c9-4bee-b3e4-4541f0e7334f_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock in connection with a stock purchase agreement</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_814c3e65-326d-482c-b37b-03470561eefc_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average common shares outstanding, basic (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:to="lab_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_cb73d284-0e61-49fb-ad14-7586348431a7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_ffebaa58-262d-4d8e-88c8-037cdfa247ef_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average period to be recognized</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_3fa69557-94d1-4849-8bd8-fb05a381922c_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_9a5d5624-b7a0-49ed-9abc-4988d0a805d0_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross loss</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_c09f4a5f-32ee-4f9a-a35a-49aba63127a9_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies (Note 10)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_22de3d8c-09ee-4f2b-9a87-dbb1c73bbbfc_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_7c7a6ee7-2506-45dd-b9ca-f4357bc9ef6a_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_51d060e7-e2d8-4eb0-afe3-49bb0e87cfb3_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock in connection with a stock purchase agreement, net of issuance cost (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightDomain_c0c413b7-a452-47ad-b4b8-8ba9d142d574_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain" xlink:to="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_6d13fac5-99a1-466d-875c-06c6fce8b61e_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event</link:label>
    <link:label id="lab_us-gaap_SubsequentEventsTextBlock_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsTextBlock" xlink:to="lab_us-gaap_SubsequentEventsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_c50391b5-752d-4e48-a240-0a13473acf3e_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_eca8976a-804e-4d4e-999e-dc43119bc405_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_b6ab1156-e35b-4b17-bbc9-750d9ad5793f_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares available for future issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_34bbf8de-18b9-405d-9617-0b867be2597d_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_d89b7c44-5fab-4c28-beac-752ca0896dfa_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principles of Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_d01a57b3-383d-4cda-ad31-5af776dd1f0e_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work in process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_28e3f43a-fe31-4cbb-8278-c131f59d80e5_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ampx_LesseeOperatingLeaseOptionToExtendNumber_2ca51cc2-5130-4f79-a526-ecd92128c260_terseLabel_en-US" xlink:label="lab_ampx_LesseeOperatingLeaseOptionToExtendNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of extension terms</link:label>
    <link:label id="lab_ampx_LesseeOperatingLeaseOptionToExtendNumber_label_en-US" xlink:label="lab_ampx_LesseeOperatingLeaseOptionToExtendNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Option to Extend, Number</link:label>
    <link:label id="lab_ampx_LesseeOperatingLeaseOptionToExtendNumber_documentation_en-US" xlink:label="lab_ampx_LesseeOperatingLeaseOptionToExtendNumber" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Option to Extend, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_LesseeOperatingLeaseOptionToExtendNumber" xlink:href="ampx-20230331.xsd#ampx_LesseeOperatingLeaseOptionToExtendNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ampx_LesseeOperatingLeaseOptionToExtendNumber" xlink:to="lab_ampx_LesseeOperatingLeaseOptionToExtendNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_acd1c47d-aa1e-416c-8eac-f8a40aeffe76_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_894fdc6d-4133-40ac-92ea-ad0c710558e7_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, par value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_CommonStockParOrStatedValuePerShare_label_en-US" xlink:label="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Par or Stated Value Per Share</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockParOrStatedValuePerShare" xlink:to="lab_us-gaap_CommonStockParOrStatedValuePerShare" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_1b53a590-a2fe-47c4-89b9-740df690c788_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAmortizationOfDeferredCharges_02768c43-d56c-49a4-91c5-983a9052d95c_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAmortizationOfDeferredCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of deferred costs</link:label>
    <link:label id="lab_us-gaap_OtherAmortizationOfDeferredCharges_label_en-US" xlink:label="lab_us-gaap_OtherAmortizationOfDeferredCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Other Deferred Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAmortizationOfDeferredCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAmortizationOfDeferredCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAmortizationOfDeferredCharges" xlink:to="lab_us-gaap_OtherAmortizationOfDeferredCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_888b4380-4d6e-48e5-b045-305756cb5d8c_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_e6a576b8-2e39-4ea2-a98e-0987ea679896_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_47d1204a-6103-4fe0-9e1a-b9ac7c49d974_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain_a4e4ecac-9cd2-4b66-adb5-d63d6a274f6e_terseLabel_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Domain]</link:label>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain_label_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:to="lab_us-gaap_TimingOfTransferOfGoodOrServiceDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_7508f71f-933b-402e-959b-ecf1a140dd43_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_3d8dd5f8-0ffd-4cb8-9cd9-244a0ce506e2_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ampx_TwentyTwentyTwoEmployeeStockPurchasePlanMember_dd08823f-0f34-432b-af66-118800e15981_terseLabel_en-US" xlink:label="lab_ampx_TwentyTwentyTwoEmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Purchase Plan</link:label>
    <link:label id="lab_ampx_TwentyTwentyTwoEmployeeStockPurchasePlanMember_label_en-US" xlink:label="lab_ampx_TwentyTwentyTwoEmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Twenty Twenty Two Employee Stock Purchase Plan [Member]</link:label>
    <link:label id="lab_ampx_TwentyTwentyTwoEmployeeStockPurchasePlanMember_documentation_en-US" xlink:label="lab_ampx_TwentyTwentyTwoEmployeeStockPurchasePlanMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Twenty Twenty Two Employee Stock Purchase Plan</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_TwentyTwentyTwoEmployeeStockPurchasePlanMember" xlink:href="ampx-20230331.xsd#ampx_TwentyTwentyTwoEmployeeStockPurchasePlanMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ampx_TwentyTwentyTwoEmployeeStockPurchasePlanMember" xlink:to="lab_ampx_TwentyTwentyTwoEmployeeStockPurchasePlanMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_cfddc0b1-54e4-4f49-9cf7-390b07f55c53_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_1d7be1a8-118f-486c-976d-62d228095e42_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_f7c3d860-d781-4e90-8918-54b881a6774b_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSUs</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_ec226d68-69d3-4f81-927d-2d8187de872a_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_ampx_EmergingGrowthCompanyPolicyPolicyTextBlock_d5de7729-8376-462b-857d-a2e37f6b9cfa_terseLabel_en-US" xlink:label="lab_ampx_EmergingGrowthCompanyPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Emerging Growth Company</link:label>
    <link:label id="lab_ampx_EmergingGrowthCompanyPolicyPolicyTextBlock_label_en-US" xlink:label="lab_ampx_EmergingGrowthCompanyPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Emerging Growth Company, Policy [Policy Text Block]</link:label>
    <link:label id="lab_ampx_EmergingGrowthCompanyPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_ampx_EmergingGrowthCompanyPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Emerging Growth Company, Policy</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_EmergingGrowthCompanyPolicyPolicyTextBlock" xlink:href="ampx-20230331.xsd#ampx_EmergingGrowthCompanyPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ampx_EmergingGrowthCompanyPolicyPolicyTextBlock" xlink:to="lab_ampx_EmergingGrowthCompanyPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_00775ac6-2a33-4aae-8520-e3484a262b18_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_da603bf0-1a60-47dc-a327-dffaf3f96114_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued and Other Current Liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Accrued Liabilities Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:to="lab_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_7b7ccffc-dd48-4990-9398-f185fced746f_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less - present value adjustments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_e8ca580e-c213-417a-9152-567aa7abf7b3_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_label_en-US" xlink:label="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Available to Common Stockholders, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:to="lab_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_ampx_WarrantsRedemptionThresholdTradingDays_14cf0bb9-c076-40d6-833b-d07c08a6aee0_terseLabel_en-US" xlink:label="lab_ampx_WarrantsRedemptionThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants, redeem, threshold trading days</link:label>
    <link:label id="lab_ampx_WarrantsRedemptionThresholdTradingDays_label_en-US" xlink:label="lab_ampx_WarrantsRedemptionThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants, Redemption, Threshold Trading Days</link:label>
    <link:label id="lab_ampx_WarrantsRedemptionThresholdTradingDays_documentation_en-US" xlink:label="lab_ampx_WarrantsRedemptionThresholdTradingDays" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants, Redemption, Threshold Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_WarrantsRedemptionThresholdTradingDays" xlink:href="ampx-20230331.xsd#ampx_WarrantsRedemptionThresholdTradingDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ampx_WarrantsRedemptionThresholdTradingDays" xlink:to="lab_ampx_WarrantsRedemptionThresholdTradingDays" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_f96f56f3-b7ff-48e4-9c03-dc06217ef9b3_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per share of common stock, diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_ca9c1695-db5e-4acc-b742-f22e19184b5c_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per common shares, diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareDiluted" xlink:to="lab_us-gaap_EarningsPerShareDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_38bb4aa3-83c2-417d-9ec8-aad162c3eeb8_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNameOfTransactionDomain_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:to="lab_us-gaap_SaleOfStockNameOfTransactionDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_da6b406f-b48d-4195-a979-40d7c10738af_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_bd146621-75b1-4494-91ae-337bc3d0d1ec_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Fair Value Disclosure</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:to="lab_us-gaap_CashAndCashEquivalentsFairValueDisclosure" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_f3790976-4f5e-4ef4-8fe2-2ba66f44ba65_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_65898396-5327-4741-963f-68ea3ee49ce7_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment of financing costs in connection with a stock purchase agreement</link:label>
    <link:label id="lab_us-gaap_PaymentsOfStockIssuanceCosts_label_en-US" xlink:label="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments of Stock Issuance Costs</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsOfStockIssuanceCosts" xlink:to="lab_us-gaap_PaymentsOfStockIssuanceCosts" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_bfb0d785-1e6c-4fad-912f-4494c276e353_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_5be314c3-5e8b-4ee4-966f-83ad537b1d29_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">APIC, Share-Based Payment Arrangement, Increase for Cost Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:to="lab_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_872b1e8c-658c-4e16-8bbb-3bf24672107a_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk percentage</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventsAbstract_label_en-US" xlink:label="lab_us-gaap_SubsequentEventsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Events [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventsAbstract" xlink:to="lab_us-gaap_SubsequentEventsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Revenues_e2ac90d3-c570-4838-a70c-5748d9bb0835_terseLabel_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_Revenues_label_en-US" xlink:label="lab_us-gaap_Revenues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Revenues" xlink:to="lab_us-gaap_Revenues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_dbd0c22f-6e3e-4fd6-a2f3-e4582272d99e_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_1439bb2e-2340-4ae0-8979-8322d918247e_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_d3e544fc-8501-471d-a203-6af82d86de2e_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_ampx_AccruedOfferingCostsCurrent_256bd61f-c237-4596-ad56-51fba861363a_terseLabel_en-US" xlink:label="lab_ampx_AccruedOfferingCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued financing costs</link:label>
    <link:label id="lab_ampx_AccruedOfferingCostsCurrent_label_en-US" xlink:label="lab_ampx_AccruedOfferingCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Offering Costs, Current</link:label>
    <link:label id="lab_ampx_AccruedOfferingCostsCurrent_documentation_en-US" xlink:label="lab_ampx_AccruedOfferingCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Offering Costs, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_AccruedOfferingCostsCurrent" xlink:href="ampx-20230331.xsd#ampx_AccruedOfferingCostsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ampx_AccruedOfferingCostsCurrent" xlink:to="lab_ampx_AccruedOfferingCostsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_1f2e7cdf-4167-42b6-bad0-250f96941853_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxDisclosureTextBlock" xlink:to="lab_us-gaap_IncomeTaxDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_98554c10-0688-4202-8242-4bc35f464855_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer concentration risk</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ampx_FiveCustomersMember_f50cf616-d145-47e6-96e4-2624b0f26086_terseLabel_en-US" xlink:label="lab_ampx_FiveCustomersMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Five customers</link:label>
    <link:label id="lab_ampx_FiveCustomersMember_label_en-US" xlink:label="lab_ampx_FiveCustomersMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Five Customers [Member]</link:label>
    <link:label id="lab_ampx_FiveCustomersMember_documentation_en-US" xlink:label="lab_ampx_FiveCustomersMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Five Customers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_FiveCustomersMember" xlink:href="ampx-20230331.xsd#ampx_FiveCustomersMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ampx_FiveCustomersMember" xlink:to="lab_ampx_FiveCustomersMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_66fa9fc7-c9a5-4e5c-9589-452da4dadf9d_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods&#160;</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PreferredStockValueOutstanding_5207e7a7-1081-445c-ba26-2ca1c311bde7_terseLabel_en-US" xlink:label="lab_us-gaap_PreferredStockValueOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred stock; $0.0001 par value; 50,000,000 shares authorized; no shares issued and outstanding.</link:label>
    <link:label id="lab_us-gaap_PreferredStockValueOutstanding_label_en-US" xlink:label="lab_us-gaap_PreferredStockValueOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Preferred Stock, Value, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValueOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValueOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PreferredStockValueOutstanding" xlink:to="lab_us-gaap_PreferredStockValueOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_cc0793e4-2b6e-47d5-8928-7cad628b530b_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityExTransitionPeriod_139b69d0-00a4-4cf4-ad7f-d50aea77f5ec_terseLabel_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:label id="lab_dei_EntityExTransitionPeriod_label_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityExTransitionPeriod" xlink:to="lab_dei_EntityExTransitionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_8fcf5e4e-e9d6-4561-b96d-1e6e2e95dded_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per share of common stock, basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_aa6d5ede-c0fe-4f17-b20a-1775ed1d60ee_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss per common shares, basic (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasic_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasic" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasic" xlink:to="lab_us-gaap_EarningsPerShareBasic" xlink:type="arc" order="1"/>
    <link:label id="lab_ampx_SaleOfStockMaximumSharesAvailableForSalePercentageOfSharesIssuedAndOutstandingPriorToTransaction_340ad077-f2b0-4d1a-976c-8f9e90562ad1_terseLabel_en-US" xlink:label="lab_ampx_SaleOfStockMaximumSharesAvailableForSalePercentageOfSharesIssuedAndOutstandingPriorToTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum shares available for sale as a percentage of aggregate shares issued and outstanding (percentage)</link:label>
    <link:label id="lab_ampx_SaleOfStockMaximumSharesAvailableForSalePercentageOfSharesIssuedAndOutstandingPriorToTransaction_label_en-US" xlink:label="lab_ampx_SaleOfStockMaximumSharesAvailableForSalePercentageOfSharesIssuedAndOutstandingPriorToTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Maximum Shares Available For Sale, Percentage Of Shares Issued And Outstanding Prior To Transaction</link:label>
    <link:label id="lab_ampx_SaleOfStockMaximumSharesAvailableForSalePercentageOfSharesIssuedAndOutstandingPriorToTransaction_documentation_en-US" xlink:label="lab_ampx_SaleOfStockMaximumSharesAvailableForSalePercentageOfSharesIssuedAndOutstandingPriorToTransaction" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Maximum Shares Available For Sale, Percentage Of Shares Issued And Outstanding Prior To Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_SaleOfStockMaximumSharesAvailableForSalePercentageOfSharesIssuedAndOutstandingPriorToTransaction" xlink:href="ampx-20230331.xsd#ampx_SaleOfStockMaximumSharesAvailableForSalePercentageOfSharesIssuedAndOutstandingPriorToTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ampx_SaleOfStockMaximumSharesAvailableForSalePercentageOfSharesIssuedAndOutstandingPriorToTransaction" xlink:to="lab_ampx_SaleOfStockMaximumSharesAvailableForSalePercentageOfSharesIssuedAndOutstandingPriorToTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_3fede639-226a-4e2b-bedc-9c91020e2e3b_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, remaining performance obligation, amount</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligation_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligation" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_be391d7a-1651-4bfa-8c99-43efd8f114c1_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2026</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_d4656b16-4112-490e-bd70-ad910e43defe_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award expiration period</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_f88af959-a10f-433a-8033-5382770cc6a5_terseLabel_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustment</link:label>
    <link:label id="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_label_en-US" xlink:label="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cumulative Effect, Period of Adoption, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:to="lab_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_0d683e9d-06b6-4a1b-9171-a058d76539be_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update and Change in Accounting Principle [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:to="lab_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_ca86e86b-8b49-4bab-bfd0-e9bd71988be0_verboseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Future Maturing Operating Lease Payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_ampx_PublicWarrantsMember_b0602a59-673a-4c94-a933-494712371ed5_terseLabel_en-US" xlink:label="lab_ampx_PublicWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Public warrants</link:label>
    <link:label id="lab_ampx_PublicWarrantsMember_label_en-US" xlink:label="lab_ampx_PublicWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Public Warrants [Member]</link:label>
    <link:label id="lab_ampx_PublicWarrantsMember_documentation_en-US" xlink:label="lab_ampx_PublicWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Public Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_PublicWarrantsMember" xlink:href="ampx-20230331.xsd#ampx_PublicWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ampx_PublicWarrantsMember" xlink:to="lab_ampx_PublicWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_c10fee1c-922e-4913-a5b0-4353fc758bf3_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_f60e5747-4e5f-41e7-a37a-b1216b98923c_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenue_66b2e1a3-c268-4cf3-94aa-9fd3b51aa550_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of revenue</link:label>
    <link:label id="lab_us-gaap_CostOfRevenue_label_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenue" xlink:to="lab_us-gaap_CostOfRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_a3652605-61a1-4fe2-ad1c-bb90802a527c_terseLabel_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:label id="lab_srt_RepurchaseAgreementCounterpartyNameDomain_label_en-US" xlink:label="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Counterparty Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:to="lab_srt_RepurchaseAgreementCounterpartyNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_53775a06-5f7b-4821-9cf9-84b2d88ba729_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract liability</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiability_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiability" xlink:to="lab_us-gaap_ContractWithCustomerLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_ac8bc6ae-c88d-4352-ab05-3b323ed4f816_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total stockholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_8b978a9b-539b-475a-a024-69db14c3fc8f_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_5770cb79-8529-42c4-af4e-df686c911ad2_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_36826bb7-6256-40cd-8de5-9f3050d698f5_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_085ec439-20bf-4ddc-9ce3-f0b79654b739_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ampx_WarrantsRedemptionThresholdConsecutiveTradingDays_559ef9f6-9afa-4b07-9bc3-07119dc0ff5b_terseLabel_en-US" xlink:label="lab_ampx_WarrantsRedemptionThresholdConsecutiveTradingDays" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants, redeem, threshold consecutive trading days</link:label>
    <link:label id="lab_ampx_WarrantsRedemptionThresholdConsecutiveTradingDays_label_en-US" xlink:label="lab_ampx_WarrantsRedemptionThresholdConsecutiveTradingDays" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants, Redemption, Threshold Consecutive Trading Days</link:label>
    <link:label id="lab_ampx_WarrantsRedemptionThresholdConsecutiveTradingDays_documentation_en-US" xlink:label="lab_ampx_WarrantsRedemptionThresholdConsecutiveTradingDays" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants, Redemption, Threshold Consecutive Trading Days</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_WarrantsRedemptionThresholdConsecutiveTradingDays" xlink:href="ampx-20230331.xsd#ampx_WarrantsRedemptionThresholdConsecutiveTradingDays"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ampx_WarrantsRedemptionThresholdConsecutiveTradingDays" xlink:to="lab_ampx_WarrantsRedemptionThresholdConsecutiveTradingDays" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_0ae90d66-691b-44ec-aa06-4d1d3dcd0fa9_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_82fa85b0-be18-49cb-bc7f-cc278158af02_terseLabel_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares issued in transaction (in shares)</link:label>
    <link:label id="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_label_en-US" xlink:label="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock, Number of Shares Issued in Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:to="lab_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_79a59c3c-89d1-47d6-9fff-6446c7c510a8_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_ac5b7b4b-3671-4dd2-9ee1-5483fbb8b17c_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Operating Capital [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_3626a9c8-9c5b-4834-a7ad-14778127859b_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_InventoryDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureTextBlock" xlink:to="lab_us-gaap_InventoryDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_0a5bd949-35db-4358-928a-b7238ae31eeb_terseLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reconciliation of cash, cash equivalents and restricted cash shown on the condensed consolidated balance sheets:</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_e85f9f28-7508-49c8-b379-f511cd09c9f6_terseLabel_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds</link:label>
    <link:label id="lab_us-gaap_MoneyMarketFundsMember_label_en-US" xlink:label="lab_us-gaap_MoneyMarketFundsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Money Market Funds [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MoneyMarketFundsMember" xlink:to="lab_us-gaap_MoneyMarketFundsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_5d66fcb0-ca91-4500-b0f7-bedb9bc8da08_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:label id="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_label_en-US" xlink:label="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:to="lab_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems_857ffb0a-4364-4e29-ad6b-f88e96681ee2_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interests Issued or Issuable [Line Items]</link:label>
    <link:label id="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems_label_en-US" xlink:label="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Acquisition, Equity Interests Issued or Issuable [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems" xlink:to="lab_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_411faf7a-cedd-4cfc-ad7e-6c42155674ec_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsequentEventTable_21846f87-5bb6-4183-86f9-f96b0032e449_terseLabel_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:label id="lab_us-gaap_SubsequentEventTable_label_en-US" xlink:label="lab_us-gaap_SubsequentEventTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Subsequent Event [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsequentEventTable" xlink:to="lab_us-gaap_SubsequentEventTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_InventoryDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryDisclosureAbstract" xlink:to="lab_us-gaap_InventoryDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_be19451e-d247-44a8-91a6-148c06228f17_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_69f48417-c738-4973-9262-b2e3d31c242f_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_79806e99-1611-471c-8480-cc8dded2bbb9_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Stock-Based Compensation Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:to="lab_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredCharges_febc9161-7bcf-4e1e-acff-c9636a90bbcd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredCharges" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred costs</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInDeferredCharges_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInDeferredCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Deferred Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredCharges" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInDeferredCharges" xlink:to="lab_us-gaap_IncreaseDecreaseInDeferredCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_ampx_SaleOfStockDiscount_90191cb0-a970-48b9-9f94-a473f549b092_terseLabel_en-US" xlink:label="lab_ampx_SaleOfStockDiscount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Discount on sale of stock (percentage)</link:label>
    <link:label id="lab_ampx_SaleOfStockDiscount_label_en-US" xlink:label="lab_ampx_SaleOfStockDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Discount</link:label>
    <link:label id="lab_ampx_SaleOfStockDiscount_documentation_en-US" xlink:label="lab_ampx_SaleOfStockDiscount" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_SaleOfStockDiscount" xlink:href="ampx-20230331.xsd#ampx_SaleOfStockDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ampx_SaleOfStockDiscount" xlink:to="lab_ampx_SaleOfStockDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_ddda822e-24a3-44c6-b68f-214585967922_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ampx_PrivateWarrantsMember_03f08ec2-57c2-4451-a21c-d060751d0ec1_terseLabel_en-US" xlink:label="lab_ampx_PrivateWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private warrants</link:label>
    <link:label id="lab_ampx_PrivateWarrantsMember_label_en-US" xlink:label="lab_ampx_PrivateWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private Warrants [Member]</link:label>
    <link:label id="lab_ampx_PrivateWarrantsMember_documentation_en-US" xlink:label="lab_ampx_PrivateWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Private Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_PrivateWarrantsMember" xlink:href="ampx-20230331.xsd#ampx_PrivateWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ampx_PrivateWarrantsMember" xlink:to="lab_ampx_PrivateWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_37507794-2ebf-43e6-9066-4f5a327fa7c6_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_ampx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfFairValue_76d3365d-ecc4-4d4c-8392-41d65cbd39e0_terseLabel_en-US" xlink:label="lab_ampx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise price as a percentage of fair value</link:label>
    <link:label id="lab_ampx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfFairValue_label_en-US" xlink:label="lab_ampx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award, Exercise Price As A Percentage Of Fair Value</link:label>
    <link:label id="lab_ampx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfFairValue_documentation_en-US" xlink:label="lab_ampx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfFairValue" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share Based Compensation Arrangement By Share Based Payment Award, Exercise Price As A Percentage Of Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfFairValue" xlink:href="ampx-20230331.xsd#ampx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ampx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfFairValue" xlink:to="lab_ampx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerAbstract_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_43810623-d928-4b84-ac18-810438208442_verboseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease renewal term (in years)</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_f145a084-82b5-4319-828d-2e4f59fef895_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease renewal term</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseRenewalTerm_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Renewal Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:to="lab_us-gaap_LesseeOperatingLeaseRenewalTerm" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_fce5f6b3-cc58-433b-8ff4-8fb3cf148ada_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_ampx_SaleOfStockPotentialMaximumConsiderationReceivedOnTransaction_86a98f3f-ecce-4224-ac49-01411ee69ea4_terseLabel_en-US" xlink:label="lab_ampx_SaleOfStockPotentialMaximumConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, purchase agreement, potential maximum consideration</link:label>
    <link:label id="lab_ampx_SaleOfStockPotentialMaximumConsiderationReceivedOnTransaction_label_en-US" xlink:label="lab_ampx_SaleOfStockPotentialMaximumConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Potential Maximum Consideration Received On Transaction</link:label>
    <link:label id="lab_ampx_SaleOfStockPotentialMaximumConsiderationReceivedOnTransaction_documentation_en-US" xlink:label="lab_ampx_SaleOfStockPotentialMaximumConsiderationReceivedOnTransaction" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale Of Stock, Potential Maximum Consideration Received On Transaction</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_SaleOfStockPotentialMaximumConsiderationReceivedOnTransaction" xlink:href="ampx-20230331.xsd#ampx_SaleOfStockPotentialMaximumConsiderationReceivedOnTransaction"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ampx_SaleOfStockPotentialMaximumConsiderationReceivedOnTransaction" xlink:to="lab_ampx_SaleOfStockPotentialMaximumConsiderationReceivedOnTransaction" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_d7152da1-c09d-4254-8759-d213c0e5be89_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture, fixtures and other equipment</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_82e61ecb-cf58-4df3-9733-91b392af9640_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_aa06c6f9-c6ed-475c-b891-4ff4486a5704_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_ampx_AmpriusHoldingsMember_85db8830-2199-48f2-be0f-df6deabc2d97_terseLabel_en-US" xlink:label="lab_ampx_AmpriusHoldingsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amprius Holdings</link:label>
    <link:label id="lab_ampx_AmpriusHoldingsMember_label_en-US" xlink:label="lab_ampx_AmpriusHoldingsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amprius Holdings [Member]</link:label>
    <link:label id="lab_ampx_AmpriusHoldingsMember_documentation_en-US" xlink:label="lab_ampx_AmpriusHoldingsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amprius Holdings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_AmpriusHoldingsMember" xlink:href="ampx-20230331.xsd#ampx_AmpriusHoldingsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ampx_AmpriusHoldingsMember" xlink:to="lab_ampx_AmpriusHoldingsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_6822168f-6d0c-4a77-a0a0-2d481e598a98_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_196480c6-b3dc-4d68-8b99-e6685b559ffe_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net decrease in cash, cash equivalents and restricted cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_04097ac4-4298-4fba-8c6f-0507d0556422_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_e10f77ed-a776-4be5-a39a-4f06b1cc3666_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_f5f80ee0-91bd-42d0-b4b1-f991fe69b3fd_negatedLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_9d24be05-d26b-454c-9f82-008615ba7009_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_eddff615-2917-470f-a110-1c50148f77fd_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_587caf4d-60d8-4caf-8c18-3cbd65e4c057_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_3dc73660-baf6-469c-aa02-c9095dd726e1_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_28228503-ceaf-4e4d-ad8a-82e07a326fcc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis_0e697dcd-060c-44a1-a195-a66fbfffe2cf_terseLabel_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Axis]</link:label>
    <link:label id="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis_label_en-US" xlink:label="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Timing of Transfer of Good or Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:to="lab_us-gaap_TimingOfTransferOfGoodOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_60a183a9-31d2-40e4-86ed-5df928fc7816_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting</link:label>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_f48cfc46-6770-49d5-bfdd-6512b32df855_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration of Credit Risk</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_cf460913-1874-4c81-87a0-93018e90c112_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementDomain_5a8fc0fc-1e55-448d-a846-3db48047db00_terseLabel_en-US" xlink:label="lab_srt_RestatementDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Domain]</link:label>
    <link:label id="lab_srt_RestatementDomain_label_en-US" xlink:label="lab_srt_RestatementDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementDomain" xlink:to="lab_srt_RestatementDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_9e5fe0c9-4a14-4cf0-b928-d0a3389f6379_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityDomain_1865819e-374c-4640-adf5-265283d023f0_terseLabel_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:label id="lab_dei_EntityDomain_label_en-US" xlink:label="lab_dei_EntityDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityDomain" xlink:to="lab_dei_EntityDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_5265df84-f9a9-47bf-a630-b6b26dd4271f_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_7800d8ff-e6dd-4e25-ad2f-14e3070837c2_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_22d490b8-31a4-4ced-acb0-26d70017e779_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued professional fees</link:label>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Professional Fees, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:to="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_8f51b507-074f-49c9-b7dc-76ca7739e659_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_c8aab004-7c73-41a5-892a-21f6b8306f54_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_ampx_CustomerOneMember_5b0fa774-f6a5-41b3-961a-e72298f895a5_terseLabel_en-US" xlink:label="lab_ampx_CustomerOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer One</link:label>
    <link:label id="lab_ampx_CustomerOneMember_label_en-US" xlink:label="lab_ampx_CustomerOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer One [Member]</link:label>
    <link:label id="lab_ampx_CustomerOneMember_documentation_en-US" xlink:label="lab_ampx_CustomerOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_CustomerOneMember" xlink:href="ampx-20230331.xsd#ampx_CustomerOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ampx_CustomerOneMember" xlink:to="lab_ampx_CustomerOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RestatementAdjustmentMember_8224cb3a-dfbe-44a0-9f67-bc273cb59448_terseLabel_en-US" xlink:label="lab_srt_RestatementAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period, Adjustment</link:label>
    <link:label id="lab_srt_RestatementAdjustmentMember_label_en-US" xlink:label="lab_srt_RestatementAdjustmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revision of Prior Period, Adjustment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAdjustmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RestatementAdjustmentMember" xlink:to="lab_srt_RestatementAdjustmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_fe2a2cfc-82fb-4c9c-9e1c-4adfa1884228_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued and other current liabilities</link:label>
    <link:label id="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable and Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_d5f1c561-3c6a-49ec-990c-072d48a9a8c4_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:label id="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_label_en-US" xlink:label="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:to="lab_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_ampx_GovernmentAssistanceGrantNotYetReceived_c5411298-4d9e-490c-99e5-6e795fa14cad_terseLabel_en-US" xlink:label="lab_ampx_GovernmentAssistanceGrantNotYetReceived" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grant not yet received</link:label>
    <link:label id="lab_ampx_GovernmentAssistanceGrantNotYetReceived_label_en-US" xlink:label="lab_ampx_GovernmentAssistanceGrantNotYetReceived" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Assistance, Grant Not Yet Received</link:label>
    <link:label id="lab_ampx_GovernmentAssistanceGrantNotYetReceived_documentation_en-US" xlink:label="lab_ampx_GovernmentAssistanceGrantNotYetReceived" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Government Assistance, Grant Not Yet Received</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_GovernmentAssistanceGrantNotYetReceived" xlink:href="ampx-20230331.xsd#ampx_GovernmentAssistanceGrantNotYetReceived"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ampx_GovernmentAssistanceGrantNotYetReceived" xlink:to="lab_ampx_GovernmentAssistanceGrantNotYetReceived" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_6522ed2e-fe7b-46ff-95b2-3ae90300bfc3_terseLabel_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other income, net</link:label>
    <link:label id="lab_us-gaap_NonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_NonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonoperatingIncomeExpense" xlink:to="lab_us-gaap_NonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredCostsCurrent_5feb2b0c-ac8c-45eb-b155-d78b6c95fc3b_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred costs</link:label>
    <link:label id="lab_us-gaap_DeferredCostsCurrent_label_en-US" xlink:label="lab_us-gaap_DeferredCostsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred Costs, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCurrent" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCostsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredCostsCurrent" xlink:to="lab_us-gaap_DeferredCostsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_10da869d-2ecc-42cd-bd0e-0a07760a88aa_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_a6891a12-898e-435e-bd2e-631b0256c467_terseLabel_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_SubsidiarySaleOfStockAxis_label_en-US" xlink:label="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sale of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis" xlink:to="lab_us-gaap_SubsidiarySaleOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_5d85e19d-0965-4b6e-8447-ae0c0d6273bf_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_ampx_OtherRevenueGovernmentGrantMember_6eea5795-0db9-4725-b26b-a8c18475def6_terseLabel_en-US" xlink:label="lab_ampx_OtherRevenueGovernmentGrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other revenue &#8211; government grant</link:label>
    <link:label id="lab_ampx_OtherRevenueGovernmentGrantMember_label_en-US" xlink:label="lab_ampx_OtherRevenueGovernmentGrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Revenue - Government Grant [Member]</link:label>
    <link:label id="lab_ampx_OtherRevenueGovernmentGrantMember_documentation_en-US" xlink:label="lab_ampx_OtherRevenueGovernmentGrantMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Revenue - Government Grant</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_OtherRevenueGovernmentGrantMember" xlink:href="ampx-20230331.xsd#ampx_OtherRevenueGovernmentGrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ampx_OtherRevenueGovernmentGrantMember" xlink:to="lab_ampx_OtherRevenueGovernmentGrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_ampx_UnauditedInterimCondensedFinancialStatementsPolicyPolicyTextBlock_144bbf88-850f-43ab-9250-173128d90bcc_terseLabel_en-US" xlink:label="lab_ampx_UnauditedInterimCondensedFinancialStatementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unaudited Interim Condensed Consolidated Financial Statements</link:label>
    <link:label id="lab_ampx_UnauditedInterimCondensedFinancialStatementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_ampx_UnauditedInterimCondensedFinancialStatementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unaudited Interim Condensed Financial Statements, Policy [Policy Text Block]</link:label>
    <link:label id="lab_ampx_UnauditedInterimCondensedFinancialStatementsPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_ampx_UnauditedInterimCondensedFinancialStatementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unaudited Interim Condensed Financial Statements, Policy</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_UnauditedInterimCondensedFinancialStatementsPolicyPolicyTextBlock" xlink:href="ampx-20230331.xsd#ampx_UnauditedInterimCondensedFinancialStatementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ampx_UnauditedInterimCondensedFinancialStatementsPolicyPolicyTextBlock" xlink:to="lab_ampx_UnauditedInterimCondensedFinancialStatementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_fdc84e5c-df03-4f27-8ee0-cd82aa260343_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_2520243f-7d5f-4ffa-93ee-26668e9570c4_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease right-of-use assets, net</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_ampx_NameOfFacilityAxis_153665c6-4ed3-409a-9afb-c3f4a313d414_terseLabel_en-US" xlink:label="lab_ampx_NameOfFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name of Facility [Axis]</link:label>
    <link:label id="lab_ampx_NameOfFacilityAxis_label_en-US" xlink:label="lab_ampx_NameOfFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name of Facility [Axis]</link:label>
    <link:label id="lab_ampx_NameOfFacilityAxis_documentation_en-US" xlink:label="lab_ampx_NameOfFacilityAxis" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Name of Facility</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_NameOfFacilityAxis" xlink:href="ampx-20230331.xsd#ampx_NameOfFacilityAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ampx_NameOfFacilityAxis" xlink:to="lab_ampx_NameOfFacilityAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_126cef20-b56d-4f36-9bfa-a05fa9cc3934_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-Based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightOutstanding_28b620ec-e660-43d1-bc50-e8f36b49415f_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightOutstanding_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_ampx_PIPEWarrantsMember_0bfcd9c2-8b8a-4692-b3fe-9eebe84504ce_terseLabel_en-US" xlink:label="lab_ampx_PIPEWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PIPE warrants</link:label>
    <link:label id="lab_ampx_PIPEWarrantsMember_label_en-US" xlink:label="lab_ampx_PIPEWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PIPE Warrants [Member]</link:label>
    <link:label id="lab_ampx_PIPEWarrantsMember_documentation_en-US" xlink:label="lab_ampx_PIPEWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">PIPE Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_PIPEWarrantsMember" xlink:href="ampx-20230331.xsd#ampx_PIPEWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ampx_PIPEWarrantsMember" xlink:to="lab_ampx_PIPEWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_0dd8d1bb-1ada-42ba-bf7c-fc10df332c4f_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_0da77e74-7d3d-4191-873b-e435df9cc031_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_5141841e-747f-4b37-9bfc-2d2dc83f4d34_negatedLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchase of property, plant and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_928897a1-c8f3-427c-baf1-b306b8410e7d_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_019a44be-39d0-4edb-988a-4ef1f425b97a_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_2fc369c3-a0bb-4978-89bd-af172e445ba0_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_b81cdf86-8b24-4471-9b18-fde67a01aff0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventories</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_660019b9-0cb6-4194-9717-7c1c697c0f39_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recently Adopted Accounting Standard</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_88a82c0b-504f-4572-bb73-caaae07bb663_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Calculation of Basic and Diluted Net Loss Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_191ba4d6-e963-463e-9e3e-d2f722eedd66_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use asset obtained in exchange for operating lease liability</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfSalesMember_eb251701-8151-45ce-8427-b3281dc8d897_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of revenue</link:label>
    <link:label id="lab_us-gaap_CostOfSalesMember_label_en-US" xlink:label="lab_us-gaap_CostOfSalesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Sales [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfSalesMember" xlink:to="lab_us-gaap_CostOfSalesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_c2e8c27b-cf3c-4c37-ab06-a3b243cc5128_negatedLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentInformationTable_7abc5ebc-52b7-4b90-a44f-8a9d21076092_terseLabel_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Table]</link:label>
    <link:label id="lab_dei_DocumentInformationTable_label_en-US" xlink:label="lab_dei_DocumentInformationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Information [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentInformationTable" xlink:to="lab_dei_DocumentInformationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_e9d47893-bf0e-4469-89c4-11717ab34171_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_ff2f5066-2e62-4545-877d-75c8ad54d82f_periodStartLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_a353dabb-1825-4bbc-8ae7-188278614cf1_periodEndLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_ce7472bf-6777-4609-88f1-d49e7d8e9de2_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_ampx_RedeemableWarrantsMember_0c1a2867-cf91-4c2e-92fc-872063e18a7d_terseLabel_en-US" xlink:label="lab_ampx_RedeemableWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable warrants</link:label>
    <link:label id="lab_ampx_RedeemableWarrantsMember_label_en-US" xlink:label="lab_ampx_RedeemableWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Warrants [Member]</link:label>
    <link:label id="lab_ampx_RedeemableWarrantsMember_documentation_en-US" xlink:label="lab_ampx_RedeemableWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Redeemable Warrants</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_RedeemableWarrantsMember" xlink:href="ampx-20230331.xsd#ampx_RedeemableWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_ampx_RedeemableWarrantsMember" xlink:to="lab_ampx_RedeemableWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_0c6d0c49-e23b-4f4d-9caa-f050a95c53d0_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible Enumeration]</link:label>
    <link:label id="lab_us-gaap_AccountingStandardsUpdateExtensibleList_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update [Extensible Enumeration]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:to="lab_us-gaap_AccountingStandardsUpdateExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingStandardsUpdate201602Member_label_en-US" xlink:label="lab_us-gaap_AccountingStandardsUpdate201602Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Standards Update 2016-02 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdate201602Member" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdate201602Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingStandardsUpdate201602Member" xlink:to="lab_us-gaap_AccountingStandardsUpdate201602Member" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>ampx-20230331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:fb8494f8-cb68-4af0-9ed5-216002fa868d,g:3b95c37f-4a77-4ae7-bad0-5ccbe8b7d32c-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.amprius.com/role/Cover" xlink:type="simple" xlink:href="ampx-20230331.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.amprius.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_35a5b1d3-8fb9-4345-ad7a-f856b449492e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationTable_367116a1-61de-4b69-893b-bff2c0bb5827" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_35a5b1d3-8fb9-4345-ad7a-f856b449492e" xlink:to="loc_dei_DocumentInformationTable_367116a1-61de-4b69-893b-bff2c0bb5827" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_20bc173d-68c1-4f3a-98d6-e9a633c04719" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_367116a1-61de-4b69-893b-bff2c0bb5827" xlink:to="loc_us-gaap_StatementClassOfStockAxis_20bc173d-68c1-4f3a-98d6-e9a633c04719" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_d780c50f-1651-47ea-82f8-e0f0ceaf7340" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_20bc173d-68c1-4f3a-98d6-e9a633c04719" xlink:to="loc_us-gaap_ClassOfStockDomain_d780c50f-1651-47ea-82f8-e0f0ceaf7340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_903c9f48-5b30-4ccd-888d-f7c953c7b075" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_d780c50f-1651-47ea-82f8-e0f0ceaf7340" xlink:to="loc_us-gaap_CommonStockMember_903c9f48-5b30-4ccd-888d-f7c953c7b075" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_RedeemableWarrantsMember_2e27309f-68ab-40db-b737-0428013010a9" xlink:href="ampx-20230331.xsd#ampx_RedeemableWarrantsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_d780c50f-1651-47ea-82f8-e0f0ceaf7340" xlink:to="loc_ampx_RedeemableWarrantsMember_2e27309f-68ab-40db-b737-0428013010a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentInformationLineItems_a9c8672f-4ab2-4fa1-b3a7-550e6410801f" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationTable_367116a1-61de-4b69-893b-bff2c0bb5827" xlink:to="loc_dei_DocumentInformationLineItems_a9c8672f-4ab2-4fa1-b3a7-550e6410801f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_d9bf18a3-df0b-4fa6-89e4-86c2058ec652" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a9c8672f-4ab2-4fa1-b3a7-550e6410801f" xlink:to="loc_dei_DocumentType_d9bf18a3-df0b-4fa6-89e4-86c2058ec652" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_91cd43c4-ce3c-43ce-838f-1ccc7afcd944" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a9c8672f-4ab2-4fa1-b3a7-550e6410801f" xlink:to="loc_dei_DocumentQuarterlyReport_91cd43c4-ce3c-43ce-838f-1ccc7afcd944" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_5f54619b-fe0a-42b4-b8e1-0032bf7c20cd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a9c8672f-4ab2-4fa1-b3a7-550e6410801f" xlink:to="loc_dei_DocumentPeriodEndDate_5f54619b-fe0a-42b4-b8e1-0032bf7c20cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_74c7a7d7-2313-4a3a-9b93-3b8ad59bd02a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a9c8672f-4ab2-4fa1-b3a7-550e6410801f" xlink:to="loc_dei_DocumentTransitionReport_74c7a7d7-2313-4a3a-9b93-3b8ad59bd02a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_f8e9c408-acf0-470f-869a-124ff81f1b57" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a9c8672f-4ab2-4fa1-b3a7-550e6410801f" xlink:to="loc_dei_EntityFileNumber_f8e9c408-acf0-470f-869a-124ff81f1b57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_5c070a11-8423-46f2-a64b-e1cc1874d169" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a9c8672f-4ab2-4fa1-b3a7-550e6410801f" xlink:to="loc_dei_EntityRegistrantName_5c070a11-8423-46f2-a64b-e1cc1874d169" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_f850720a-ec7a-4c45-afc4-96e3598bc2f6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a9c8672f-4ab2-4fa1-b3a7-550e6410801f" xlink:to="loc_dei_EntityIncorporationStateCountryCode_f850720a-ec7a-4c45-afc4-96e3598bc2f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_33c9ba40-21ae-49ba-99df-6e11eadc850d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a9c8672f-4ab2-4fa1-b3a7-550e6410801f" xlink:to="loc_dei_EntityTaxIdentificationNumber_33c9ba40-21ae-49ba-99df-6e11eadc850d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_404b9069-aadd-49ca-a368-5c8b95b444b7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a9c8672f-4ab2-4fa1-b3a7-550e6410801f" xlink:to="loc_dei_EntityAddressAddressLine1_404b9069-aadd-49ca-a368-5c8b95b444b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_fa3d278f-c5e8-4283-96ca-49739e6dd745" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a9c8672f-4ab2-4fa1-b3a7-550e6410801f" xlink:to="loc_dei_EntityAddressCityOrTown_fa3d278f-c5e8-4283-96ca-49739e6dd745" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_c2161710-4c3e-4a74-9bf0-7ba21e5b3e2e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a9c8672f-4ab2-4fa1-b3a7-550e6410801f" xlink:to="loc_dei_EntityAddressStateOrProvince_c2161710-4c3e-4a74-9bf0-7ba21e5b3e2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_d4fc7c45-222d-4128-a111-38249e153ae3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a9c8672f-4ab2-4fa1-b3a7-550e6410801f" xlink:to="loc_dei_EntityAddressPostalZipCode_d4fc7c45-222d-4128-a111-38249e153ae3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_a96451ce-4256-4172-9bb8-de5b34bb8f7a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a9c8672f-4ab2-4fa1-b3a7-550e6410801f" xlink:to="loc_dei_CityAreaCode_a96451ce-4256-4172-9bb8-de5b34bb8f7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_a5c95344-8d3a-47e4-9bc0-76f8a5984571" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a9c8672f-4ab2-4fa1-b3a7-550e6410801f" xlink:to="loc_dei_LocalPhoneNumber_a5c95344-8d3a-47e4-9bc0-76f8a5984571" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_a7f62ea0-6fee-4671-84ae-97822220f9a4" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a9c8672f-4ab2-4fa1-b3a7-550e6410801f" xlink:to="loc_dei_Security12bTitle_a7f62ea0-6fee-4671-84ae-97822220f9a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_89111250-9ada-4f62-b86f-fc89a6f08ad6" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a9c8672f-4ab2-4fa1-b3a7-550e6410801f" xlink:to="loc_dei_TradingSymbol_89111250-9ada-4f62-b86f-fc89a6f08ad6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_d4cd4dca-b8f0-4c97-9d29-fb8c3d6a795a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a9c8672f-4ab2-4fa1-b3a7-550e6410801f" xlink:to="loc_dei_SecurityExchangeName_d4cd4dca-b8f0-4c97-9d29-fb8c3d6a795a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_393f9ff6-cf2d-470c-b276-b59f0aae334a" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a9c8672f-4ab2-4fa1-b3a7-550e6410801f" xlink:to="loc_dei_EntityCurrentReportingStatus_393f9ff6-cf2d-470c-b276-b59f0aae334a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_b7c3cead-1f65-4028-b68a-9cd74c9034c1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a9c8672f-4ab2-4fa1-b3a7-550e6410801f" xlink:to="loc_dei_EntityInteractiveDataCurrent_b7c3cead-1f65-4028-b68a-9cd74c9034c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_62358de8-e6bd-45af-a384-2e960f3eaa54" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a9c8672f-4ab2-4fa1-b3a7-550e6410801f" xlink:to="loc_dei_EntityFilerCategory_62358de8-e6bd-45af-a384-2e960f3eaa54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_12043118-0a4f-4e9b-8e19-74017feca6bf" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a9c8672f-4ab2-4fa1-b3a7-550e6410801f" xlink:to="loc_dei_EntitySmallBusiness_12043118-0a4f-4e9b-8e19-74017feca6bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_b94541b0-d018-49c9-8c1e-40ea45864a00" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a9c8672f-4ab2-4fa1-b3a7-550e6410801f" xlink:to="loc_dei_EntityEmergingGrowthCompany_b94541b0-d018-49c9-8c1e-40ea45864a00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod_ab4de1c8-d365-4eb4-8801-86ef09b85bc7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityExTransitionPeriod"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a9c8672f-4ab2-4fa1-b3a7-550e6410801f" xlink:to="loc_dei_EntityExTransitionPeriod_ab4de1c8-d365-4eb4-8801-86ef09b85bc7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_4f047a4a-7be3-485d-b739-90ea0d3a6048" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a9c8672f-4ab2-4fa1-b3a7-550e6410801f" xlink:to="loc_dei_EntityShellCompany_4f047a4a-7be3-485d-b739-90ea0d3a6048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_054659a3-301a-4e8c-bee6-2295d6d0232b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a9c8672f-4ab2-4fa1-b3a7-550e6410801f" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_054659a3-301a-4e8c-bee6-2295d6d0232b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_63ce1785-6f24-4595-a867-6496f0376931" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a9c8672f-4ab2-4fa1-b3a7-550e6410801f" xlink:to="loc_dei_EntityCentralIndexKey_63ce1785-6f24-4595-a867-6496f0376931" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_3d4a94cc-450b-4ab4-bcb4-4839688acf76" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a9c8672f-4ab2-4fa1-b3a7-550e6410801f" xlink:to="loc_dei_CurrentFiscalYearEndDate_3d4a94cc-450b-4ab4-bcb4-4839688acf76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_21882861-7c1e-4e86-ad69-02cd8214c1ba" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a9c8672f-4ab2-4fa1-b3a7-550e6410801f" xlink:to="loc_dei_DocumentFiscalYearFocus_21882861-7c1e-4e86-ad69-02cd8214c1ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_8dff1fd4-3c14-4326-8669-6c8fc549af93" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a9c8672f-4ab2-4fa1-b3a7-550e6410801f" xlink:to="loc_dei_DocumentFiscalPeriodFocus_8dff1fd4-3c14-4326-8669-6c8fc549af93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_84470001-2683-46c7-b647-944c290877ae" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_DocumentInformationLineItems_a9c8672f-4ab2-4fa1-b3a7-550e6410801f" xlink:to="loc_dei_AmendmentFlag_84470001-2683-46c7-b647-944c290877ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="simple" xlink:href="ampx-20230331.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETS"/>
  <link:presentationLink xlink:role="http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_e23a0069-b11b-4160-a319-9d41b7c19917" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_4ecc8ef2-5982-48f8-ae48-5cec15b13d64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e23a0069-b11b-4160-a319-9d41b7c19917" xlink:to="loc_us-gaap_AssetsAbstract_4ecc8ef2-5982-48f8-ae48-5cec15b13d64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_e5022a40-3f33-4423-9f66-653da1a65a13" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4ecc8ef2-5982-48f8-ae48-5cec15b13d64" xlink:to="loc_us-gaap_AssetsCurrentAbstract_e5022a40-3f33-4423-9f66-653da1a65a13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_60dd04fd-5aac-4dce-a3de-822156e82753" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_e5022a40-3f33-4423-9f66-653da1a65a13" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_60dd04fd-5aac-4dce-a3de-822156e82753" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_dd85c03d-d7ac-4dfd-b500-21a699ece553" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_e5022a40-3f33-4423-9f66-653da1a65a13" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_dd85c03d-d7ac-4dfd-b500-21a699ece553" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_246f8758-58d0-4cc0-904e-c18e6ad879c0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_e5022a40-3f33-4423-9f66-653da1a65a13" xlink:to="loc_us-gaap_InventoryNet_246f8758-58d0-4cc0-904e-c18e6ad879c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCostsCurrent_48e3eda1-c689-4107-9f4b-643e41d01607" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCostsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_e5022a40-3f33-4423-9f66-653da1a65a13" xlink:to="loc_us-gaap_DeferredCostsCurrent_48e3eda1-c689-4107-9f4b-643e41d01607" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_a7b7fff6-0224-4ba6-b195-b0b90ab7d020" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_e5022a40-3f33-4423-9f66-653da1a65a13" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_a7b7fff6-0224-4ba6-b195-b0b90ab7d020" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_89f9bbba-d99b-413a-bda1-e67e2cc52f42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_e5022a40-3f33-4423-9f66-653da1a65a13" xlink:to="loc_us-gaap_AssetsCurrent_89f9bbba-d99b-413a-bda1-e67e2cc52f42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrentAbstract_29a509ed-479b-47cb-bd66-edd93c060be0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AssetsNoncurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4ecc8ef2-5982-48f8-ae48-5cec15b13d64" xlink:to="loc_us-gaap_AssetsNoncurrentAbstract_29a509ed-479b-47cb-bd66-edd93c060be0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_7545a81b-adc4-4ec2-91ff-52989cc5f03e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_29a509ed-479b-47cb-bd66-edd93c060be0" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_7545a81b-adc4-4ec2-91ff-52989cc5f03e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_323bcade-8f16-4f0e-8fdb-ba3acc8a0990" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_29a509ed-479b-47cb-bd66-edd93c060be0" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_323bcade-8f16-4f0e-8fdb-ba3acc8a0990" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredCosts_f2846379-a624-4784-9459-8581ca561087" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DeferredCosts"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_29a509ed-479b-47cb-bd66-edd93c060be0" xlink:to="loc_us-gaap_DeferredCosts_f2846379-a624-4784-9459-8581ca561087" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_3fea5b11-75db-4d2b-a1ba-f1a4a51318e5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_29a509ed-479b-47cb-bd66-edd93c060be0" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_3fea5b11-75db-4d2b-a1ba-f1a4a51318e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_1744e68a-6f0e-44b0-8c64-f5c1494fad72" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Assets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_4ecc8ef2-5982-48f8-ae48-5cec15b13d64" xlink:to="loc_us-gaap_Assets_1744e68a-6f0e-44b0-8c64-f5c1494fad72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a2710b60-14ee-46cb-978f-05043641d70f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_e23a0069-b11b-4160-a319-9d41b7c19917" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a2710b60-14ee-46cb-978f-05043641d70f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_1157578f-4f79-4076-a251-71a05e44f40c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a2710b60-14ee-46cb-978f-05043641d70f" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_1157578f-4f79-4076-a251-71a05e44f40c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_a1304059-d520-4d82-a7c9-62be4670d697" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_1157578f-4f79-4076-a251-71a05e44f40c" xlink:to="loc_us-gaap_AccountsPayableCurrent_a1304059-d520-4d82-a7c9-62be4670d697" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_3e16aa07-8cf5-4fbf-a725-9cd17b37599f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_1157578f-4f79-4076-a251-71a05e44f40c" xlink:to="loc_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent_3e16aa07-8cf5-4fbf-a725-9cd17b37599f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_bccd015d-7a50-42e1-adf4-601df70d7610" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_1157578f-4f79-4076-a251-71a05e44f40c" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_bccd015d-7a50-42e1-adf4-601df70d7610" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_ad1b28c0-956c-43f3-b633-f53e30b9e005" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_1157578f-4f79-4076-a251-71a05e44f40c" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_ad1b28c0-956c-43f3-b633-f53e30b9e005" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_09f4c65a-af8b-4d2c-8194-68c347322fa3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_1157578f-4f79-4076-a251-71a05e44f40c" xlink:to="loc_us-gaap_LiabilitiesCurrent_09f4c65a-af8b-4d2c-8194-68c347322fa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract_9efcd9cd-7bf4-4a1e-9f3e-54a2c1c775da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a2710b60-14ee-46cb-978f-05043641d70f" xlink:to="loc_us-gaap_LiabilitiesNoncurrentAbstract_9efcd9cd-7bf4-4a1e-9f3e-54a2c1c775da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_6f84d715-581f-43b7-b2a0-1343f79a4926" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_9efcd9cd-7bf4-4a1e-9f3e-54a2c1c775da" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_6f84d715-581f-43b7-b2a0-1343f79a4926" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_efe0e764-8ca2-47b6-9060-b86008fcd68c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_9efcd9cd-7bf4-4a1e-9f3e-54a2c1c775da" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_efe0e764-8ca2-47b6-9060-b86008fcd68c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_9ec7e5b5-d76a-43e2-ab67-aacb1f3bef06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a2710b60-14ee-46cb-978f-05043641d70f" xlink:to="loc_us-gaap_Liabilities_9ec7e5b5-d76a-43e2-ab67-aacb1f3bef06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_0f9afbb9-683b-4620-a459-8a61bb56718c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a2710b60-14ee-46cb-978f-05043641d70f" xlink:to="loc_us-gaap_CommitmentsAndContingencies_0f9afbb9-683b-4620-a459-8a61bb56718c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_f9d93e6e-64d1-48a0-bbac-5a0daea455ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a2710b60-14ee-46cb-978f-05043641d70f" xlink:to="loc_us-gaap_StockholdersEquityAbstract_f9d93e6e-64d1-48a0-bbac-5a0daea455ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockValueOutstanding_34fdfd32-7b7c-45c9-af24-6196ba9a42b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockValueOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f9d93e6e-64d1-48a0-bbac-5a0daea455ed" xlink:to="loc_us-gaap_PreferredStockValueOutstanding_34fdfd32-7b7c-45c9-af24-6196ba9a42b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValueOutstanding_d9881563-fb73-469a-8f87-7fab73b2d839" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockValueOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f9d93e6e-64d1-48a0-bbac-5a0daea455ed" xlink:to="loc_us-gaap_CommonStockValueOutstanding_d9881563-fb73-469a-8f87-7fab73b2d839" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_ced31a49-6469-46c3-a369-5ad14266836d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f9d93e6e-64d1-48a0-bbac-5a0daea455ed" xlink:to="loc_us-gaap_AdditionalPaidInCapital_ced31a49-6469-46c3-a369-5ad14266836d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_feb7aa2f-fcb5-4e2b-87a3-144d4cdf745d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f9d93e6e-64d1-48a0-bbac-5a0daea455ed" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_feb7aa2f-fcb5-4e2b-87a3-144d4cdf745d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_57beaa3a-1be1-420b-80b2-479c097e200f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_f9d93e6e-64d1-48a0-bbac-5a0daea455ed" xlink:to="loc_us-gaap_StockholdersEquity_57beaa3a-1be1-420b-80b2-479c097e200f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_88659273-f7f9-4f87-a2ac-9cfb01c6396e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_a2710b60-14ee-46cb-978f-05043641d70f" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_88659273-f7f9-4f87-a2ac-9cfb01c6396e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="simple" xlink:href="ampx-20230331.xsd#CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"/>
  <link:presentationLink xlink:role="http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_d2ec2272-ba97-4257-a9fe-a7590781a1e4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_f2bcd3ad-8878-40aa-9533-d0d497eb481c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d2ec2272-ba97-4257-a9fe-a7590781a1e4" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_f2bcd3ad-8878-40aa-9533-d0d497eb481c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_2ce29afc-d69b-46af-87ff-33b7f70df70c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d2ec2272-ba97-4257-a9fe-a7590781a1e4" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_2ce29afc-d69b-46af-87ff-33b7f70df70c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesIssued_ae196f5f-782a-454d-b9eb-9f740065acfd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesIssued"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d2ec2272-ba97-4257-a9fe-a7590781a1e4" xlink:to="loc_us-gaap_PreferredStockSharesIssued_ae196f5f-782a-454d-b9eb-9f740065acfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesOutstanding_5d5021ee-258c-4fa4-b902-3422a1b5e50d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesOutstanding"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d2ec2272-ba97-4257-a9fe-a7590781a1e4" xlink:to="loc_us-gaap_PreferredStockSharesOutstanding_5d5021ee-258c-4fa4-b902-3422a1b5e50d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_58e0372f-e205-40de-b78d-de1b7bf28251" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d2ec2272-ba97-4257-a9fe-a7590781a1e4" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_58e0372f-e205-40de-b78d-de1b7bf28251" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_874ce5bb-8ca0-4dde-9fb7-5a516f44c739" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d2ec2272-ba97-4257-a9fe-a7590781a1e4" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_874ce5bb-8ca0-4dde-9fb7-5a516f44c739" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_12bf7c68-2961-49d6-90db-84ee6b61269e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d2ec2272-ba97-4257-a9fe-a7590781a1e4" xlink:to="loc_us-gaap_CommonStockSharesIssued_12bf7c68-2961-49d6-90db-84ee6b61269e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_864d3f42-117e-49de-ade4-df19ae7b0b70" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d2ec2272-ba97-4257-a9fe-a7590781a1e4" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_864d3f42-117e-49de-ade4-df19ae7b0b70" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="simple" xlink:href="ampx-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"/>
  <link:presentationLink xlink:role="http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_a9be3922-db2e-4455-b98b-fce7627238ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_989febe9-b299-45c6-a691-50d01425a18a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_a9be3922-db2e-4455-b98b-fce7627238ee" xlink:to="loc_us-gaap_Revenues_989febe9-b299-45c6-a691-50d01425a18a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_ade9f7a3-d2c7-40c7-a117-a2dbf6f6b55a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfRevenue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_a9be3922-db2e-4455-b98b-fce7627238ee" xlink:to="loc_us-gaap_CostOfRevenue_ade9f7a3-d2c7-40c7-a117-a2dbf6f6b55a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_20d63610-5579-4cfa-bfe0-17182686e6ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_a9be3922-db2e-4455-b98b-fce7627238ee" xlink:to="loc_us-gaap_GrossProfit_20d63610-5579-4cfa-bfe0-17182686e6ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingCostsAndExpensesAbstract_ea799b6b-121c-4838-944b-7bc69d7a814f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingCostsAndExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_a9be3922-db2e-4455-b98b-fce7627238ee" xlink:to="loc_us-gaap_OperatingCostsAndExpensesAbstract_ea799b6b-121c-4838-944b-7bc69d7a814f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_36c3d2e5-b7ef-4216-bc5b-42b8b246802c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_ea799b6b-121c-4838-944b-7bc69d7a814f" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_36c3d2e5-b7ef-4216-bc5b-42b8b246802c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_4a6e262a-e892-44a3-9e31-e03ce14a0246" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_ea799b6b-121c-4838-944b-7bc69d7a814f" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_4a6e262a-e892-44a3-9e31-e03ce14a0246" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_4bb10bbe-7d62-4b94-8d2b-62675423c564" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingCostsAndExpensesAbstract_ea799b6b-121c-4838-944b-7bc69d7a814f" xlink:to="loc_us-gaap_OperatingExpenses_4bb10bbe-7d62-4b94-8d2b-62675423c564" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_9a547498-db0c-4d24-a09a-823a2ed7eb05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_a9be3922-db2e-4455-b98b-fce7627238ee" xlink:to="loc_us-gaap_OperatingIncomeLoss_9a547498-db0c-4d24-a09a-823a2ed7eb05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonoperatingIncomeExpense_33377eb5-af49-4b4e-992f-aa567aecc44b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NonoperatingIncomeExpense"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_a9be3922-db2e-4455-b98b-fce7627238ee" xlink:to="loc_us-gaap_NonoperatingIncomeExpense_33377eb5-af49-4b4e-992f-aa567aecc44b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_cfc613ad-e8f7-45ef-b6b5-c471370817a9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_a9be3922-db2e-4455-b98b-fce7627238ee" xlink:to="loc_us-gaap_NetIncomeLoss_cfc613ad-e8f7-45ef-b6b5-c471370817a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_376b8536-5867-4357-8f67-0344579171ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_a9be3922-db2e-4455-b98b-fce7627238ee" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_376b8536-5867-4357-8f67-0344579171ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3690e478-635c-40a6-bc54-38f8e29f5ebd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_376b8536-5867-4357-8f67-0344579171ca" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_3690e478-635c-40a6-bc54-38f8e29f5ebd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c5593c3d-76f1-4eea-9dc8-8257e158ff3d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_376b8536-5867-4357-8f67-0344579171ca" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_c5593c3d-76f1-4eea-9dc8-8257e158ff3d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_77903fbb-e2ce-4552-9f0c-187540365c4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_a9be3922-db2e-4455-b98b-fce7627238ee" xlink:to="loc_us-gaap_EarningsPerShareAbstract_77903fbb-e2ce-4552-9f0c-187540365c4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_169baaa1-f277-4c79-b473-9d1fe215adc4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_77903fbb-e2ce-4552-9f0c-187540365c4e" xlink:to="loc_us-gaap_EarningsPerShareBasic_169baaa1-f277-4c79-b473-9d1fe215adc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_caf5c2b8-5073-4ded-8fcb-5e7bb49e943b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_77903fbb-e2ce-4552-9f0c-187540365c4e" xlink:to="loc_us-gaap_EarningsPerShareDiluted_caf5c2b8-5073-4ded-8fcb-5e7bb49e943b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="simple" xlink:href="ampx-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"/>
  <link:presentationLink xlink:role="http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_57b10d46-6320-461c-9b50-9875fcf76863" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_7c5ec251-c7d9-409c-84d8-ccd270e39af3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_57b10d46-6320-461c-9b50-9875fcf76863" xlink:to="loc_us-gaap_StatementTable_7c5ec251-c7d9-409c-84d8-ccd270e39af3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_56dea8a1-9a05-4433-b9b5-e5a84c2c68c5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_7c5ec251-c7d9-409c-84d8-ccd270e39af3" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_56dea8a1-9a05-4433-b9b5-e5a84c2c68c5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_154e6ae5-e1d9-4822-8eb2-e25bfc8f045a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_56dea8a1-9a05-4433-b9b5-e5a84c2c68c5" xlink:to="loc_us-gaap_EquityComponentDomain_154e6ae5-e1d9-4822-8eb2-e25bfc8f045a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_5cd630a1-0641-4a72-8f11-601c30c83ab8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_154e6ae5-e1d9-4822-8eb2-e25bfc8f045a" xlink:to="loc_us-gaap_CommonStockMember_5cd630a1-0641-4a72-8f11-601c30c83ab8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_b707d099-3dca-46fc-985a-8bee25c8b0a1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_154e6ae5-e1d9-4822-8eb2-e25bfc8f045a" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_b707d099-3dca-46fc-985a-8bee25c8b0a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_36559157-3ee1-4734-90af-14172b5ffa36" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_154e6ae5-e1d9-4822-8eb2-e25bfc8f045a" xlink:to="loc_us-gaap_RetainedEarningsMember_36559157-3ee1-4734-90af-14172b5ffa36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_cbf04aa2-1dc3-4432-9051-d2a251ce60ca" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_7c5ec251-c7d9-409c-84d8-ccd270e39af3" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_cbf04aa2-1dc3-4432-9051-d2a251ce60ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_6e7020da-8dd4-452c-b45d-3f52af835826" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionAxis_cbf04aa2-1dc3-4432-9051-d2a251ce60ca" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_6e7020da-8dd4-452c-b45d-3f52af835826" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_1cf0acb6-6dfa-4a61-96da-0c45a855a5b6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CumulativeEffectPeriodOfAdoptionDomain_6e7020da-8dd4-452c-b45d-3f52af835826" xlink:to="loc_srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember_1cf0acb6-6dfa-4a61-96da-0c45a855a5b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAxis_7880c102-235a-4b69-a5e5-a23a8c64fcfa" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_7c5ec251-c7d9-409c-84d8-ccd270e39af3" xlink:to="loc_srt_RestatementAxis_7880c102-235a-4b69-a5e5-a23a8c64fcfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementDomain_c82d33b6-0c1e-4966-b84b-ab52a4d88fe0" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementAxis_7880c102-235a-4b69-a5e5-a23a8c64fcfa" xlink:to="loc_srt_RestatementDomain_c82d33b6-0c1e-4966-b84b-ab52a4d88fe0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ScenarioPreviouslyReportedMember_b3f60b07-2f17-47b0-828f-9cc0ca3c9c81" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ScenarioPreviouslyReportedMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_c82d33b6-0c1e-4966-b84b-ab52a4d88fe0" xlink:to="loc_srt_ScenarioPreviouslyReportedMember_b3f60b07-2f17-47b0-828f-9cc0ca3c9c81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RestatementAdjustmentMember_98d05004-c0a8-4fa8-9575-a687f32180f6" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RestatementAdjustmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RestatementDomain_c82d33b6-0c1e-4966-b84b-ab52a4d88fe0" xlink:to="loc_srt_RestatementAdjustmentMember_98d05004-c0a8-4fa8-9575-a687f32180f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_1b4a65eb-68fa-485d-a4a9-4ad6c346e483" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_7c5ec251-c7d9-409c-84d8-ccd270e39af3" xlink:to="loc_us-gaap_StatementLineItems_1b4a65eb-68fa-485d-a4a9-4ad6c346e483" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bc522f7f-ff50-4067-9a59-d677f26ee33c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1b4a65eb-68fa-485d-a4a9-4ad6c346e483" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bc522f7f-ff50-4067-9a59-d677f26ee33c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_e97e878f-d3bc-4654-ad7f-5167f165f767" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bc522f7f-ff50-4067-9a59-d677f26ee33c" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_e97e878f-d3bc-4654-ad7f-5167f165f767" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_41c1d83d-dc06-4d61-8689-a2f52b02b9ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bc522f7f-ff50-4067-9a59-d677f26ee33c" xlink:to="loc_us-gaap_StockholdersEquity_41c1d83d-dc06-4d61-8689-a2f52b02b9ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_0ce70ed7-5fdc-454c-b9d5-54deca5a4d32" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bc522f7f-ff50-4067-9a59-d677f26ee33c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_0ce70ed7-5fdc-454c-b9d5-54deca5a4d32" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_d6df9441-1f8e-4298-a212-c8b4e5cc0624" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bc522f7f-ff50-4067-9a59-d677f26ee33c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_d6df9441-1f8e-4298-a212-c8b4e5cc0624" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_752563e9-287e-41ca-a1c6-f61c999b2b83" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bc522f7f-ff50-4067-9a59-d677f26ee33c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_752563e9-287e-41ca-a1c6-f61c999b2b83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_cbcb2fa2-bc01-40bf-875f-336f2c2c6c58" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bc522f7f-ff50-4067-9a59-d677f26ee33c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_cbcb2fa2-bc01-40bf-875f-336f2c2c6c58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_AdjustmentsToAdditionalPaidInCapitalCapitalContributionsFromParent_0dc92453-61e2-405a-8ce9-3c2c2ee18d89" xlink:href="ampx-20230331.xsd#ampx_AdjustmentsToAdditionalPaidInCapitalCapitalContributionsFromParent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bc522f7f-ff50-4067-9a59-d677f26ee33c" xlink:to="loc_ampx_AdjustmentsToAdditionalPaidInCapitalCapitalContributionsFromParent_0dc92453-61e2-405a-8ce9-3c2c2ee18d89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1b9907a1-3e9a-41cd-80fe-5e18e79eea54" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bc522f7f-ff50-4067-9a59-d677f26ee33c" xlink:to="loc_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1b9907a1-3e9a-41cd-80fe-5e18e79eea54" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_AdjustmentsToAdditionalPaidInCapitalContributionFromParentRelatedToStockBasedCompensation_223e8acb-e571-446b-94a4-f4bfb74efa2d" xlink:href="ampx-20230331.xsd#ampx_AdjustmentsToAdditionalPaidInCapitalContributionFromParentRelatedToStockBasedCompensation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bc522f7f-ff50-4067-9a59-d677f26ee33c" xlink:to="loc_ampx_AdjustmentsToAdditionalPaidInCapitalContributionFromParentRelatedToStockBasedCompensation_223e8acb-e571-446b-94a4-f4bfb74efa2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_17565fd1-76d0-4c64-882c-b2ff180e29ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bc522f7f-ff50-4067-9a59-d677f26ee33c" xlink:to="loc_us-gaap_NetIncomeLoss_17565fd1-76d0-4c64-882c-b2ff180e29ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_ba3ea0bd-e5b3-4d19-9857-a3b2348b9673" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bc522f7f-ff50-4067-9a59-d677f26ee33c" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_ba3ea0bd-e5b3-4d19-9857-a3b2348b9673" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_6d752a6f-8551-44c1-8c0c-dd5e9cbb79a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_bc522f7f-ff50-4067-9a59-d677f26ee33c" xlink:to="loc_us-gaap_StockholdersEquity_6d752a6f-8551-44c1-8c0c-dd5e9cbb79a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingStandardsUpdateExtensibleList_16c95365-9c14-4fc8-aecc-0cb937f04759" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingStandardsUpdateExtensibleList"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_1b4a65eb-68fa-485d-a4a9-4ad6c346e483" xlink:to="loc_us-gaap_AccountingStandardsUpdateExtensibleList_16c95365-9c14-4fc8-aecc-0cb937f04759" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="simple" xlink:href="ampx-20230331.xsd#CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"/>
  <link:presentationLink xlink:role="http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_5463f048-19d1-4b90-8be8-d07cc5509b8a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_98d0e1f3-d6d9-4f8b-a78e-42bfe2b12710" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5463f048-19d1-4b90-8be8-d07cc5509b8a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_98d0e1f3-d6d9-4f8b-a78e-42bfe2b12710" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_41017ad6-80da-407d-83f2-af609ce5dc5e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_98d0e1f3-d6d9-4f8b-a78e-42bfe2b12710" xlink:to="loc_us-gaap_NetIncomeLoss_41017ad6-80da-407d-83f2-af609ce5dc5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_47fed97c-152c-4042-9f96-8497ed26aa28" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_98d0e1f3-d6d9-4f8b-a78e-42bfe2b12710" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_47fed97c-152c-4042-9f96-8497ed26aa28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_85b6103a-b1d1-4490-ae2f-f7cf59206533" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_47fed97c-152c-4042-9f96-8497ed26aa28" xlink:to="loc_us-gaap_ShareBasedCompensation_85b6103a-b1d1-4490-ae2f-f7cf59206533" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_b401797a-2726-4d1e-a14d-a2235ec5e70e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_47fed97c-152c-4042-9f96-8497ed26aa28" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_b401797a-2726-4d1e-a14d-a2235ec5e70e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAmortizationOfDeferredCharges_5e807521-4b16-41ae-b0e6-a1316f1cbaa5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAmortizationOfDeferredCharges"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_47fed97c-152c-4042-9f96-8497ed26aa28" xlink:to="loc_us-gaap_OtherAmortizationOfDeferredCharges_5e807521-4b16-41ae-b0e6-a1316f1cbaa5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_3310908a-fbbf-4ca8-aca5-64ddd49345c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_47fed97c-152c-4042-9f96-8497ed26aa28" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_3310908a-fbbf-4ca8-aca5-64ddd49345c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6add270c-758e-49b9-96d3-5856f3619670" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingCapitalAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_47fed97c-152c-4042-9f96-8497ed26aa28" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6add270c-758e-49b9-96d3-5856f3619670" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_6ca4f353-7393-4c76-8ed5-c607ace7e821" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6add270c-758e-49b9-96d3-5856f3619670" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_6ca4f353-7393-4c76-8ed5-c607ace7e821" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_dde45613-6c28-4daf-8b95-a5d1ffc6b93f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6add270c-758e-49b9-96d3-5856f3619670" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_dde45613-6c28-4daf-8b95-a5d1ffc6b93f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredCharges_b2faed20-8efb-4a36-930f-cd044d320d8d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredCharges"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6add270c-758e-49b9-96d3-5856f3619670" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredCharges_b2faed20-8efb-4a36-930f-cd044d320d8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_e710bb2c-8ec4-4e8e-b592-cc3558da7887" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6add270c-758e-49b9-96d3-5856f3619670" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_e710bb2c-8ec4-4e8e-b592-cc3558da7887" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_3286c9fc-5b3f-4d9e-8de1-9517c1279ce1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6add270c-758e-49b9-96d3-5856f3619670" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_3286c9fc-5b3f-4d9e-8de1-9517c1279ce1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_7f8ddb92-7988-436c-9af2-a98ee81c2007" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6add270c-758e-49b9-96d3-5856f3619670" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_7f8ddb92-7988-436c-9af2-a98ee81c2007" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_ab630a8b-962c-4da6-bb93-77a5a1ad2aa1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInDeferredRevenue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6add270c-758e-49b9-96d3-5856f3619670" xlink:to="loc_us-gaap_IncreaseDecreaseInDeferredRevenue_ab630a8b-962c-4da6-bb93-77a5a1ad2aa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_39bd0a45-f6b4-4c96-a4a5-bc75fc169942" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncreaseDecreaseInOperatingLeaseLiability"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract_6add270c-758e-49b9-96d3-5856f3619670" xlink:to="loc_us-gaap_IncreaseDecreaseInOperatingLeaseLiability_39bd0a45-f6b4-4c96-a4a5-bc75fc169942" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_da4bef92-f3e7-49bf-a6bf-2df669c0fd20" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_98d0e1f3-d6d9-4f8b-a78e-42bfe2b12710" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_da4bef92-f3e7-49bf-a6bf-2df669c0fd20" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_646de769-927d-4f40-8d74-2b13fe16ac9d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5463f048-19d1-4b90-8be8-d07cc5509b8a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_646de769-927d-4f40-8d74-2b13fe16ac9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_80fec702-9b2d-43b6-8577-f5b41ec71a5d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_646de769-927d-4f40-8d74-2b13fe16ac9d" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_80fec702-9b2d-43b6-8577-f5b41ec71a5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4e391942-ec9e-4020-8460-8917742da6a4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_646de769-927d-4f40-8d74-2b13fe16ac9d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_4e391942-ec9e-4020-8460-8917742da6a4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_09cefc2e-33c3-4456-8eb5-381ef78b8f4d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5463f048-19d1-4b90-8be8-d07cc5509b8a" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_09cefc2e-33c3-4456-8eb5-381ef78b8f4d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_fad9366d-2958-49c0-99a1-fd1ff24103f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_09cefc2e-33c3-4456-8eb5-381ef78b8f4d" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_fad9366d-2958-49c0-99a1-fd1ff24103f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsOfStockIssuanceCosts_3227cd27-f1c5-4880-9c71-afa4999522f9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PaymentsOfStockIssuanceCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_09cefc2e-33c3-4456-8eb5-381ef78b8f4d" xlink:to="loc_us-gaap_PaymentsOfStockIssuanceCosts_3227cd27-f1c5-4880-9c71-afa4999522f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_735d26f1-8b78-4907-89d5-ae24ddfe7144" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_09cefc2e-33c3-4456-8eb5-381ef78b8f4d" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_735d26f1-8b78-4907-89d5-ae24ddfe7144" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromContributionsFromParent_57dd93b6-1b6e-4af6-ab76-7dc0f0eb4753" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromContributionsFromParent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_09cefc2e-33c3-4456-8eb5-381ef78b8f4d" xlink:to="loc_us-gaap_ProceedsFromContributionsFromParent_57dd93b6-1b6e-4af6-ab76-7dc0f0eb4753" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_PaymentOfTransactionAndIssuanceCostsInConnectionWithBusinessCombinationAndPIPEInvestment_9a83f38b-835d-4b50-93f0-4a9dfd6b81e8" xlink:href="ampx-20230331.xsd#ampx_PaymentOfTransactionAndIssuanceCostsInConnectionWithBusinessCombinationAndPIPEInvestment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_09cefc2e-33c3-4456-8eb5-381ef78b8f4d" xlink:to="loc_ampx_PaymentOfTransactionAndIssuanceCostsInConnectionWithBusinessCombinationAndPIPEInvestment_9a83f38b-835d-4b50-93f0-4a9dfd6b81e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0d18f451-da31-4e5f-add6-f38908b31c2e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_09cefc2e-33c3-4456-8eb5-381ef78b8f4d" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_0d18f451-da31-4e5f-add6-f38908b31c2e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c0c2bdb4-fa07-4fb4-8ce0-9fe7f37ad18d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5463f048-19d1-4b90-8be8-d07cc5509b8a" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c0c2bdb4-fa07-4fb4-8ce0-9fe7f37ad18d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1a56c05d-d0d2-4719-afc2-a60d634d1e79" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5463f048-19d1-4b90-8be8-d07cc5509b8a" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1a56c05d-d0d2-4719-afc2-a60d634d1e79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_632f9b38-1092-45e7-b101-b153970f12b5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5463f048-19d1-4b90-8be8-d07cc5509b8a" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_632f9b38-1092-45e7-b101-b153970f12b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_d7b4d15a-271a-47a7-a529-ddc9ee752d1a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_5463f048-19d1-4b90-8be8-d07cc5509b8a" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_d7b4d15a-271a-47a7-a529-ddc9ee752d1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_81cbfde8-22e2-4975-9c5c-cd04af611916" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_d7b4d15a-271a-47a7-a529-ddc9ee752d1a" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_81cbfde8-22e2-4975-9c5c-cd04af611916" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_e2121f39-94f5-4e0a-9c7d-4c22d9a832fd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCash"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_d7b4d15a-271a-47a7-a529-ddc9ee752d1a" xlink:to="loc_us-gaap_RestrictedCash_e2121f39-94f5-4e0a-9c7d-4c22d9a832fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b47d1541-eebd-4187-8eee-2412eb5d13f6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract_d7b4d15a-271a-47a7-a529-ddc9ee752d1a" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_b47d1541-eebd-4187-8eee-2412eb5d13f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amprius.com/role/NatureofOperationsandOrganization" xlink:type="simple" xlink:href="ampx-20230331.xsd#NatureofOperationsandOrganization"/>
  <link:presentationLink xlink:role="http://www.amprius.com/role/NatureofOperationsandOrganization" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d3c21457-760c-4235-b8b3-97784f35e5e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_5dbf2a19-5832-4d0d-89e4-d909b3c9df01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_d3c21457-760c-4235-b8b3-97784f35e5e6" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_5dbf2a19-5832-4d0d-89e4-d909b3c9df01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amprius.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="ampx-20230331.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://www.amprius.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_cdc484a5-d665-4d74-bcd6-aa72d4e5b879" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_507d38b7-e9f8-44da-b3ad-5e3a15c4c21b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cdc484a5-d665-4d74-bcd6-aa72d4e5b879" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_507d38b7-e9f8-44da-b3ad-5e3a15c4c21b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amprius.com/role/Revenue" xlink:type="simple" xlink:href="ampx-20230331.xsd#Revenue"/>
  <link:presentationLink xlink:role="http://www.amprius.com/role/Revenue" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_bbb67862-e886-4a95-b7d8-2353ca9af809" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_7117c4dc-54e3-490c-a5b4-3dd9de11933f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_bbb67862-e886-4a95-b7d8-2353ca9af809" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerTextBlock_7117c4dc-54e3-490c-a5b4-3dd9de11933f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amprius.com/role/Inventory" xlink:type="simple" xlink:href="ampx-20230331.xsd#Inventory"/>
  <link:presentationLink xlink:role="http://www.amprius.com/role/Inventory" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_4a3a2921-7310-492c-9226-d3a3a7af4c56" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureTextBlock_166b888d-c4a6-4adb-88d3-b0e8140e4914" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_4a3a2921-7310-492c-9226-d3a3a7af4c56" xlink:to="loc_us-gaap_InventoryDisclosureTextBlock_166b888d-c4a6-4adb-88d3-b0e8140e4914" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amprius.com/role/PropertyPlantandEquipmentNet" xlink:type="simple" xlink:href="ampx-20230331.xsd#PropertyPlantandEquipmentNet"/>
  <link:presentationLink xlink:role="http://www.amprius.com/role/PropertyPlantandEquipmentNet" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_ad5970c0-7ab6-4bad-a1b3-d793aa3a56f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_cc9ccef1-0987-49eb-9c76-4c62819c9f85" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_ad5970c0-7ab6-4bad-a1b3-d793aa3a56f1" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock_cc9ccef1-0987-49eb-9c76-4c62819c9f85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amprius.com/role/AccruedandOtherCurrentLiabilities" xlink:type="simple" xlink:href="ampx-20230331.xsd#AccruedandOtherCurrentLiabilities"/>
  <link:presentationLink xlink:role="http://www.amprius.com/role/AccruedandOtherCurrentLiabilities" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_976f9729-4f56-4277-9295-c8dd16a0c6c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_a2081f30-33ea-4e99-b070-63cc89b4c825" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_976f9729-4f56-4277-9295-c8dd16a0c6c9" xlink:to="loc_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_a2081f30-33ea-4e99-b070-63cc89b4c825" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amprius.com/role/StockholdersEquity" xlink:type="simple" xlink:href="ampx-20230331.xsd#StockholdersEquity"/>
  <link:presentationLink xlink:role="http://www.amprius.com/role/StockholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_f386754b-052b-4b75-a53d-49662ff940c9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_c388823e-c721-4c06-b195-401f50f1cb49" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_f386754b-052b-4b75-a53d-49662ff940c9" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_c388823e-c721-4c06-b195-401f50f1cb49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amprius.com/role/IncomeTaxes" xlink:type="simple" xlink:href="ampx-20230331.xsd#IncomeTaxes"/>
  <link:presentationLink xlink:role="http://www.amprius.com/role/IncomeTaxes" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_cf2bad78-d998-4f02-a44f-c31a69378b35" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureTextBlock_75334b76-5152-49d6-8bce-afbf592fec5a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_cf2bad78-d998-4f02-a44f-c31a69378b35" xlink:to="loc_us-gaap_IncomeTaxDisclosureTextBlock_75334b76-5152-49d6-8bce-afbf592fec5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amprius.com/role/Leases" xlink:type="simple" xlink:href="ampx-20230331.xsd#Leases"/>
  <link:presentationLink xlink:role="http://www.amprius.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_97b349f2-414d-4581-8fde-edb231875b4f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_d9348e15-60bd-43dd-906a-1c87599c3aa3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_97b349f2-414d-4581-8fde-edb231875b4f" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_d9348e15-60bd-43dd-906a-1c87599c3aa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amprius.com/role/CommitmentandContingencies" xlink:type="simple" xlink:href="ampx-20230331.xsd#CommitmentandContingencies"/>
  <link:presentationLink xlink:role="http://www.amprius.com/role/CommitmentandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_375a6bd4-20e1-4f6f-9d53-aa64efbb5cef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_a3ab6e27-c3c0-4e23-b20e-034c51804592" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_375a6bd4-20e1-4f6f-9d53-aa64efbb5cef" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_a3ab6e27-c3c0-4e23-b20e-034c51804592" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amprius.com/role/NetLossPerShare" xlink:type="simple" xlink:href="ampx-20230331.xsd#NetLossPerShare"/>
  <link:presentationLink xlink:role="http://www.amprius.com/role/NetLossPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_e1b042d5-d8f9-47c8-98b3-8c944e804f7c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_155c9065-b5a4-4ee1-83e1-3e56f7780c05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_e1b042d5-d8f9-47c8-98b3-8c944e804f7c" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_155c9065-b5a4-4ee1-83e1-3e56f7780c05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amprius.com/role/SubsequentEvents" xlink:type="simple" xlink:href="ampx-20230331.xsd#SubsequentEvents"/>
  <link:presentationLink xlink:role="http://www.amprius.com/role/SubsequentEvents" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_f54875b5-66c4-4d15-94b4-41d442a96766" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsTextBlock_0012d160-82bb-40bf-ba33-ce934ad1b4ae" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_f54875b5-66c4-4d15-94b4-41d442a96766" xlink:to="loc_us-gaap_SubsequentEventsTextBlock_0012d160-82bb-40bf-ba33-ce934ad1b4ae" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amprius.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="ampx-20230331.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://www.amprius.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_31072edb-6022-41bc-8b0a-3c19bbb96621" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_b99a9b82-e9f8-437f-a19f-d4f28a8a2b16" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_31072edb-6022-41bc-8b0a-3c19bbb96621" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_b99a9b82-e9f8-437f-a19f-d4f28a8a2b16" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_7243abaf-54dd-4e5e-ac38-7cbdc0ed426f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_31072edb-6022-41bc-8b0a-3c19bbb96621" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_7243abaf-54dd-4e5e-ac38-7cbdc0ed426f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_UnauditedInterimCondensedFinancialStatementsPolicyPolicyTextBlock_c4995772-496a-4d26-8d5e-b94d86ddcf1a" xlink:href="ampx-20230331.xsd#ampx_UnauditedInterimCondensedFinancialStatementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_31072edb-6022-41bc-8b0a-3c19bbb96621" xlink:to="loc_ampx_UnauditedInterimCondensedFinancialStatementsPolicyPolicyTextBlock_c4995772-496a-4d26-8d5e-b94d86ddcf1a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_EmergingGrowthCompanyPolicyPolicyTextBlock_5014c1ea-d34d-46c6-8a49-9f1db13d094c" xlink:href="ampx-20230331.xsd#ampx_EmergingGrowthCompanyPolicyPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_31072edb-6022-41bc-8b0a-3c19bbb96621" xlink:to="loc_ampx_EmergingGrowthCompanyPolicyPolicyTextBlock_5014c1ea-d34d-46c6-8a49-9f1db13d094c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_1bad6e2e-e82d-4fee-9e37-f1d376500bc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_31072edb-6022-41bc-8b0a-3c19bbb96621" xlink:to="loc_us-gaap_UseOfEstimates_1bad6e2e-e82d-4fee-9e37-f1d376500bc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_bd72e6be-4aea-4b70-9c2b-5e6a04de6e64" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_31072edb-6022-41bc-8b0a-3c19bbb96621" xlink:to="loc_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy_bd72e6be-4aea-4b70-9c2b-5e6a04de6e64" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_db8040fe-bb0d-4b9d-938a-47ba68aae2b6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_31072edb-6022-41bc-8b0a-3c19bbb96621" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_db8040fe-bb0d-4b9d-938a-47ba68aae2b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_b89a182a-6e87-4e32-9478-252358a4051c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_31072edb-6022-41bc-8b0a-3c19bbb96621" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_b89a182a-6e87-4e32-9478-252358a4051c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_c159441d-461f-46de-a74b-5201868eabdd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_31072edb-6022-41bc-8b0a-3c19bbb96621" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_c159441d-461f-46de-a74b-5201868eabdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amprius.com/role/RevenueTables" xlink:type="simple" xlink:href="ampx-20230331.xsd#RevenueTables"/>
  <link:presentationLink xlink:role="http://www.amprius.com/role/RevenueTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_07b464c4-3538-4e69-9cca-a23cc6fd2f05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_28d3c6f4-1c05-4268-af7d-deb80c46c37c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_07b464c4-3538-4e69-9cca-a23cc6fd2f05" xlink:to="loc_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock_28d3c6f4-1c05-4268-af7d-deb80c46c37c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amprius.com/role/InventoryTables" xlink:type="simple" xlink:href="ampx-20230331.xsd#InventoryTables"/>
  <link:presentationLink xlink:role="http://www.amprius.com/role/InventoryTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_b28055af-35a6-454c-af68-3675dd371e18" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_b9234c93-9480-4f2c-97c8-2c1e7c3ff449" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_b28055af-35a6-454c-af68-3675dd371e18" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_b9234c93-9480-4f2c-97c8-2c1e7c3ff449" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amprius.com/role/PropertyPlantandEquipmentNetTables" xlink:type="simple" xlink:href="ampx-20230331.xsd#PropertyPlantandEquipmentNetTables"/>
  <link:presentationLink xlink:role="http://www.amprius.com/role/PropertyPlantandEquipmentNetTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_786baa72-a607-4230-8030-c7a9f2292895" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_733aac81-d991-4421-81b8-281c5febffdc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_786baa72-a607-4230-8030-c7a9f2292895" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_733aac81-d991-4421-81b8-281c5febffdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amprius.com/role/AccruedandOtherCurrentLiabilitiesTables" xlink:type="simple" xlink:href="ampx-20230331.xsd#AccruedandOtherCurrentLiabilitiesTables"/>
  <link:presentationLink xlink:role="http://www.amprius.com/role/AccruedandOtherCurrentLiabilitiesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_b6265027-c949-47d6-8841-13f13306b55a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_133ab224-c72f-40fd-b537-4a781b7f018b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_b6265027-c949-47d6-8841-13f13306b55a" xlink:to="loc_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_133ab224-c72f-40fd-b537-4a781b7f018b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amprius.com/role/StockholdersEquityTables" xlink:type="simple" xlink:href="ampx-20230331.xsd#StockholdersEquityTables"/>
  <link:presentationLink xlink:role="http://www.amprius.com/role/StockholdersEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_8aae1c21-3daf-475c-926d-30865480851f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_04fa0bf4-94c2-4532-aec3-4b4da96d7081" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_8aae1c21-3daf-475c-926d-30865480851f" xlink:to="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_04fa0bf4-94c2-4532-aec3-4b4da96d7081" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_cd4e3029-529b-44e6-a42e-659ac2c3c0ed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_8aae1c21-3daf-475c-926d-30865480851f" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock_cd4e3029-529b-44e6-a42e-659ac2c3c0ed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amprius.com/role/LeasesTables" xlink:type="simple" xlink:href="ampx-20230331.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://www.amprius.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_e58c0bd0-0567-4a45-a001-369dcd6e98ea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_96ee2202-a066-443b-a5d1-19377020f279" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e58c0bd0-0567-4a45-a001-369dcd6e98ea" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_96ee2202-a066-443b-a5d1-19377020f279" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amprius.com/role/NetLossPerShareTables" xlink:type="simple" xlink:href="ampx-20230331.xsd#NetLossPerShareTables"/>
  <link:presentationLink xlink:role="http://www.amprius.com/role/NetLossPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_34d78e16-4276-41db-b80e-2c7432892c17" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_a4973937-4b34-4ade-860a-7f0202b3b541" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_34d78e16-4276-41db-b80e-2c7432892c17" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_a4973937-4b34-4ade-860a-7f0202b3b541" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_176cb72e-c230-494f-97c9-b94bf4505df6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_34d78e16-4276-41db-b80e-2c7432892c17" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_176cb72e-c230-494f-97c9-b94bf4505df6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amprius.com/role/NatureofOperationsandOrganizationNarrativeDetails" xlink:type="simple" xlink:href="ampx-20230331.xsd#NatureofOperationsandOrganizationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.amprius.com/role/NatureofOperationsandOrganizationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_81ece6be-54a3-4ccd-a9ee-13130d67f7d8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTable_d5c005b9-28e3-4970-92ed-34a8d0b61aed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_81ece6be-54a3-4ccd-a9ee-13130d67f7d8" xlink:to="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTable_d5c005b9-28e3-4970-92ed-34a8d0b61aed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_b382a1f2-7e09-4728-a706-7a18d42ae40c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTable_d5c005b9-28e3-4970-92ed-34a8d0b61aed" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_b382a1f2-7e09-4728-a706-7a18d42ae40c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_c6b3c23b-57fc-4c1e-878a-2daaa3d30439" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_b382a1f2-7e09-4728-a706-7a18d42ae40c" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_c6b3c23b-57fc-4c1e-878a-2daaa3d30439" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_PurchaseAgreementMember_9ba45d70-e33d-4c86-9c26-f10999a9329c" xlink:href="ampx-20230331.xsd#ampx_PurchaseAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_c6b3c23b-57fc-4c1e-878a-2daaa3d30439" xlink:to="loc_ampx_PurchaseAgreementMember_9ba45d70-e33d-4c86-9c26-f10999a9329c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_a2bc1ef6-31a8-433e-9d3d-73eb51326a4b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTable_d5c005b9-28e3-4970-92ed-34a8d0b61aed" xlink:to="loc_srt_RangeAxis_a2bc1ef6-31a8-433e-9d3d-73eb51326a4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_3e2db964-e08b-4f9c-b0e8-9c17ed2f7953" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_a2bc1ef6-31a8-433e-9d3d-73eb51326a4b" xlink:to="loc_srt_RangeMember_3e2db964-e08b-4f9c-b0e8-9c17ed2f7953" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_de529e30-cdcc-444a-bbe7-e6deea66bdcd" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_3e2db964-e08b-4f9c-b0e8-9c17ed2f7953" xlink:to="loc_srt_MaximumMember_de529e30-cdcc-444a-bbe7-e6deea66bdcd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems_e6993e2f-9d4f-4abc-9ee5-13a351ff43f4" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTable_d5c005b9-28e3-4970-92ed-34a8d0b61aed" xlink:to="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems_e6993e2f-9d4f-4abc-9ee5-13a351ff43f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_900f6c41-3e4c-4494-a85c-d39224ae1453" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems_e6993e2f-9d4f-4abc-9ee5-13a351ff43f4" xlink:to="loc_us-gaap_NetIncomeLoss_900f6c41-3e4c-4494-a85c-d39224ae1453" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_d1bd1591-02df-4af2-9d31-cdd74b6a2499" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems_e6993e2f-9d4f-4abc-9ee5-13a351ff43f4" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_d1bd1591-02df-4af2-9d31-cdd74b6a2499" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6df606c5-4d57-4704-a357-a3c3c4484fff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems_e6993e2f-9d4f-4abc-9ee5-13a351ff43f4" xlink:to="loc_us-gaap_CashAndCashEquivalentsAtCarryingValue_6df606c5-4d57-4704-a357-a3c3c4484fff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_dcc709d0-2be4-494d-8a68-936c2d1f5bb9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems_e6993e2f-9d4f-4abc-9ee5-13a351ff43f4" xlink:to="loc_us-gaap_SaleOfStockConsiderationReceivedOnTransaction_dcc709d0-2be4-494d-8a68-936c2d1f5bb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_CommittedEquityFinancing_1d9896df-e30f-401a-bd46-8e4a97da8d55" xlink:href="ampx-20230331.xsd#ampx_CommittedEquityFinancing"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems_e6993e2f-9d4f-4abc-9ee5-13a351ff43f4" xlink:to="loc_ampx_CommittedEquityFinancing_1d9896df-e30f-401a-bd46-8e4a97da8d55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_GovernmentAssistanceGrantNotYetReceived_7cb521c4-d1cb-4cf9-9f8e-1940dfbb7323" xlink:href="ampx-20230331.xsd#ampx_GovernmentAssistanceGrantNotYetReceived"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems_e6993e2f-9d4f-4abc-9ee5-13a351ff43f4" xlink:to="loc_ampx_GovernmentAssistanceGrantNotYetReceived_7cb521c4-d1cb-4cf9-9f8e-1940dfbb7323" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amprius.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="ampx-20230331.xsd#SummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.amprius.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_d2a1f58c-76b5-4721-87eb-2c9d209cec98" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_27f050f0-67d1-4edd-a913-23a95ba83db6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_d2a1f58c-76b5-4721-87eb-2c9d209cec98" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_27f050f0-67d1-4edd-a913-23a95ba83db6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_3d3dd613-a705-428b-b7ef-6052beaf7d91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_27f050f0-67d1-4edd-a913-23a95ba83db6" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_3d3dd613-a705-428b-b7ef-6052beaf7d91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_f374b967-55c8-4d01-b636-02b5e1ace822" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_3d3dd613-a705-428b-b7ef-6052beaf7d91" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_f374b967-55c8-4d01-b636-02b5e1ace822" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_d1d28236-cb26-4c0a-92fa-995b0ab95a06" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_f374b967-55c8-4d01-b636-02b5e1ace822" xlink:to="loc_us-gaap_SalesRevenueNetMember_d1d28236-cb26-4c0a-92fa-995b0ab95a06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableMember_83e2bf1d-f08c-4ad8-aca7-8fa6b24dcfe5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_f374b967-55c8-4d01-b636-02b5e1ace822" xlink:to="loc_us-gaap_AccountsReceivableMember_83e2bf1d-f08c-4ad8-aca7-8fa6b24dcfe5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_7d25b776-80af-4359-bc4d-5a04edb572c7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_27f050f0-67d1-4edd-a913-23a95ba83db6" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_7d25b776-80af-4359-bc4d-5a04edb572c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_36e65e2c-fffc-488b-9c11-b7fb29dabd6d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_7d25b776-80af-4359-bc4d-5a04edb572c7" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_36e65e2c-fffc-488b-9c11-b7fb29dabd6d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_742babbf-f88a-4a9f-bcea-b61dcfe2710a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_36e65e2c-fffc-488b-9c11-b7fb29dabd6d" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_742babbf-f88a-4a9f-bcea-b61dcfe2710a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_cc6b079d-0b98-4f8a-9fc7-b502a6d1f030" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_27f050f0-67d1-4edd-a913-23a95ba83db6" xlink:to="loc_srt_MajorCustomersAxis_cc6b079d-0b98-4f8a-9fc7-b502a6d1f030" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_e90d9f0c-52d0-429a-ace7-9932661c9c2b" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_cc6b079d-0b98-4f8a-9fc7-b502a6d1f030" xlink:to="loc_srt_NameOfMajorCustomerDomain_e90d9f0c-52d0-429a-ace7-9932661c9c2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_CustomerOneMember_05043ecf-cc98-48fd-abc2-4ed964ec34d6" xlink:href="ampx-20230331.xsd#ampx_CustomerOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_e90d9f0c-52d0-429a-ace7-9932661c9c2b" xlink:to="loc_ampx_CustomerOneMember_05043ecf-cc98-48fd-abc2-4ed964ec34d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_CustomerTwoMember_59901f75-ec48-4ce7-80aa-ddce8a88c7e0" xlink:href="ampx-20230331.xsd#ampx_CustomerTwoMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_e90d9f0c-52d0-429a-ace7-9932661c9c2b" xlink:to="loc_ampx_CustomerTwoMember_59901f75-ec48-4ce7-80aa-ddce8a88c7e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_CustomerThreeMember_60f031ee-db92-4d55-a1ba-6fea93ef698e" xlink:href="ampx-20230331.xsd#ampx_CustomerThreeMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_e90d9f0c-52d0-429a-ace7-9932661c9c2b" xlink:to="loc_ampx_CustomerThreeMember_60f031ee-db92-4d55-a1ba-6fea93ef698e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_ThreeCustomersMember_78da5c6d-8055-45ab-8231-257ac40d62b5" xlink:href="ampx-20230331.xsd#ampx_ThreeCustomersMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_e90d9f0c-52d0-429a-ace7-9932661c9c2b" xlink:to="loc_ampx_ThreeCustomersMember_78da5c6d-8055-45ab-8231-257ac40d62b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_FiveCustomersMember_f86ed767-ce12-4509-a484-e5b08cb6d679" xlink:href="ampx-20230331.xsd#ampx_FiveCustomersMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_e90d9f0c-52d0-429a-ace7-9932661c9c2b" xlink:to="loc_ampx_FiveCustomersMember_f86ed767-ce12-4509-a484-e5b08cb6d679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_79e7f63f-6d17-4b1d-96be-702f8a169a7d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_27f050f0-67d1-4edd-a913-23a95ba83db6" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_79e7f63f-6d17-4b1d-96be-702f8a169a7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6ac2a6ea-5d49-4692-9011-b63efbf9214f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_79e7f63f-6d17-4b1d-96be-702f8a169a7d" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6ac2a6ea-5d49-4692-9011-b63efbf9214f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_1845894a-fcfb-4dfd-b8ef-13d41fffd7e9" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_6ac2a6ea-5d49-4692-9011-b63efbf9214f" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_1845894a-fcfb-4dfd-b8ef-13d41fffd7e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsAxis_d96aad4c-cd17-4dac-bfaa-4e27e0c89ab3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_27f050f0-67d1-4edd-a913-23a95ba83db6" xlink:to="loc_us-gaap_CashAndCashEquivalentsAxis_d96aad4c-cd17-4dac-bfaa-4e27e0c89ab3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_8717b2b2-87ca-4fc7-8795-6f5eebbcda3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashAndCashEquivalentsAxis_d96aad4c-cd17-4dac-bfaa-4e27e0c89ab3" xlink:to="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_8717b2b2-87ca-4fc7-8795-6f5eebbcda3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MoneyMarketFundsMember_100886da-98d6-43be-8944-f4ec640b319b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_MoneyMarketFundsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember_8717b2b2-87ca-4fc7-8795-6f5eebbcda3c" xlink:to="loc_us-gaap_MoneyMarketFundsMember_100886da-98d6-43be-8944-f4ec640b319b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_9fd796b8-cc73-4874-aa63-21182fe89b91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable_27f050f0-67d1-4edd-a913-23a95ba83db6" xlink:to="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_9fd796b8-cc73-4874-aa63-21182fe89b91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_RecapitalizationExchangeRatio_ec9e4c06-1501-449d-a209-bd75f2334985" xlink:href="ampx-20230331.xsd#ampx_RecapitalizationExchangeRatio"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_9fd796b8-cc73-4874-aa63-21182fe89b91" xlink:to="loc_ampx_RecapitalizationExchangeRatio_ec9e4c06-1501-449d-a209-bd75f2334985" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_NumberOfExecutiveEmployeesOfParentSharingFacilitiesCosts_d52da8fa-de71-43b0-8edd-875a3556f512" xlink:href="ampx-20230331.xsd#ampx_NumberOfExecutiveEmployeesOfParentSharingFacilitiesCosts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_9fd796b8-cc73-4874-aa63-21182fe89b91" xlink:to="loc_ampx_NumberOfExecutiveEmployeesOfParentSharingFacilitiesCosts_d52da8fa-de71-43b0-8edd-875a3556f512" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedCash_7a1703db-21b7-4f07-86cb-dfcb6180798b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedCash"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_9fd796b8-cc73-4874-aa63-21182fe89b91" xlink:to="loc_us-gaap_RestrictedCash_7a1703db-21b7-4f07-86cb-dfcb6180798b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_b60c2a11-a000-40a2-a565-e79124b59d1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CashAndCashEquivalentsFairValueDisclosure"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_9fd796b8-cc73-4874-aa63-21182fe89b91" xlink:to="loc_us-gaap_CashAndCashEquivalentsFairValueDisclosure_b60c2a11-a000-40a2-a565-e79124b59d1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_8ad3f829-8c26-4edb-83c1-8d07b9960a07" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems_9fd796b8-cc73-4874-aa63-21182fe89b91" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_8ad3f829-8c26-4edb-83c1-8d07b9960a07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amprius.com/role/RevenueScheduleofCompositionofRevenueDetails" xlink:type="simple" xlink:href="ampx-20230331.xsd#RevenueScheduleofCompositionofRevenueDetails"/>
  <link:presentationLink xlink:role="http://www.amprius.com/role/RevenueScheduleofCompositionofRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_abdcb1d3-e108-44d9-91de-4cadd4f9aa2a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_db6152e8-2a6e-4603-97b3-2865b82223b0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_abdcb1d3-e108-44d9-91de-4cadd4f9aa2a" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_db6152e8-2a6e-4603-97b3-2865b82223b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_5bfa5723-944f-42be-910c-ab67b60784b1" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_db6152e8-2a6e-4603-97b3-2865b82223b0" xlink:to="loc_srt_ProductOrServiceAxis_5bfa5723-944f-42be-910c-ab67b60784b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_72a85fba-ad83-4c78-89b0-e1433e9ba1f3" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_5bfa5723-944f-42be-910c-ab67b60784b1" xlink:to="loc_srt_ProductsAndServicesDomain_72a85fba-ad83-4c78-89b0-e1433e9ba1f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_TotalRevenueFromCustomersMember_95322701-53a4-41e6-bc04-b22389a60654" xlink:href="ampx-20230331.xsd#ampx_TotalRevenueFromCustomersMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_72a85fba-ad83-4c78-89b0-e1433e9ba1f3" xlink:to="loc_ampx_TotalRevenueFromCustomersMember_95322701-53a4-41e6-bc04-b22389a60654" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_SaleOfBatteryMember_3c398fae-8cdf-425a-bdb8-44262d5db183" xlink:href="ampx-20230331.xsd#ampx_SaleOfBatteryMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ampx_TotalRevenueFromCustomersMember_95322701-53a4-41e6-bc04-b22389a60654" xlink:to="loc_ampx_SaleOfBatteryMember_3c398fae-8cdf-425a-bdb8-44262d5db183" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_CustomizedDesignServicesMember_da31e93a-0bf8-48dd-8017-0044d651e838" xlink:href="ampx-20230331.xsd#ampx_CustomizedDesignServicesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ampx_TotalRevenueFromCustomersMember_95322701-53a4-41e6-bc04-b22389a60654" xlink:to="loc_ampx_CustomizedDesignServicesMember_da31e93a-0bf8-48dd-8017-0044d651e838" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_OtherRevenueGovernmentGrantMember_c43bd9de-9983-404b-ae9c-3e719cc8c893" xlink:href="ampx-20230331.xsd#ampx_OtherRevenueGovernmentGrantMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_72a85fba-ad83-4c78-89b0-e1433e9ba1f3" xlink:to="loc_ampx_OtherRevenueGovernmentGrantMember_c43bd9de-9983-404b-ae9c-3e719cc8c893" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_9f59c8d4-a805-41bf-aefb-3b682c0db13f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_db6152e8-2a6e-4603-97b3-2865b82223b0" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_9f59c8d4-a805-41bf-aefb-3b682c0db13f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_4a66e817-058d-47c5-ba9a-7a923712b0aa" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_9f59c8d4-a805-41bf-aefb-3b682c0db13f" xlink:to="loc_us-gaap_Revenues_4a66e817-058d-47c5-ba9a-7a923712b0aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amprius.com/role/RevenueNarrativeDetails" xlink:type="simple" xlink:href="ampx-20230331.xsd#RevenueNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.amprius.com/role/RevenueNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_2159d03a-e0fc-48c0-9a21-aa49d0537eea" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_370ca433-4713-49f7-8954-3ff8261304d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_2159d03a-e0fc-48c0-9a21-aa49d0537eea" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_370ca433-4713-49f7-8954-3ff8261304d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_a597975d-835e-4b44-abc1-627bcde9e835" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_370ca433-4713-49f7-8954-3ff8261304d3" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_a597975d-835e-4b44-abc1-627bcde9e835" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_c2d67628-d9a6-4b24-815f-13e73389d8f2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TimingOfTransferOfGoodOrServiceDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceAxis_a597975d-835e-4b44-abc1-627bcde9e835" xlink:to="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_c2d67628-d9a6-4b24-815f-13e73389d8f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransferredAtPointInTimeMember_755045c7-4cee-4f12-b40c-eb6e15a36745" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_TransferredAtPointInTimeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TimingOfTransferOfGoodOrServiceDomain_c2d67628-d9a6-4b24-815f-13e73389d8f2" xlink:to="loc_us-gaap_TransferredAtPointInTimeMember_755045c7-4cee-4f12-b40c-eb6e15a36745" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_52000478-2553-49b1-a6d4-68ac7cd97a5c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_370ca433-4713-49f7-8954-3ff8261304d3" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_52000478-2553-49b1-a6d4-68ac7cd97a5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Revenues_0d0fe8f8-6585-468b-ac26-a93db030f31b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_Revenues"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_52000478-2553-49b1-a6d4-68ac7cd97a5c" xlink:to="loc_us-gaap_Revenues_0d0fe8f8-6585-468b-ac26-a93db030f31b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_7db26939-89d8-4d31-8d96-ad13b23cb012" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_52000478-2553-49b1-a6d4-68ac7cd97a5c" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_7db26939-89d8-4d31-8d96-ad13b23cb012" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetNet_c17a1be8-e8de-4ac1-b030-886de78cdd0d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerAssetNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_52000478-2553-49b1-a6d4-68ac7cd97a5c" xlink:to="loc_us-gaap_ContractWithCustomerAssetNet_c17a1be8-e8de-4ac1-b030-886de78cdd0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiability_1b2795b6-4597-485c-a232-946f24895c91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_52000478-2553-49b1-a6d4-68ac7cd97a5c" xlink:to="loc_us-gaap_ContractWithCustomerLiability_1b2795b6-4597-485c-a232-946f24895c91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_c588d994-b922-483d-a7f1-e9abbe4afa42" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ContractWithCustomerLiabilityRevenueRecognized"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_52000478-2553-49b1-a6d4-68ac7cd97a5c" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityRevenueRecognized_c588d994-b922-483d-a7f1-e9abbe4afa42" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amprius.com/role/RevenuePerformanceObligationDetails" xlink:type="simple" xlink:href="ampx-20230331.xsd#RevenuePerformanceObligationDetails"/>
  <link:presentationLink xlink:role="http://www.amprius.com/role/RevenuePerformanceObligationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerAbstract_77af8372-6202-469d-be6f-6add7fd241e1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueFromContractWithCustomerAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_4b22bd1a-fd4f-4715-b12f-aa20c136c1a8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerAbstract_77af8372-6202-469d-be6f-6add7fd241e1" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_4b22bd1a-fd4f-4715-b12f-aa20c136c1a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_8e21a9e1-a19b-45f7-899c-fde650ec583c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_4b22bd1a-fd4f-4715-b12f-aa20c136c1a8" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis_8e21a9e1-a19b-45f7-899c-fde650ec583c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_89c2f44a-da04-4aa2-b970-e7cdd8ecd328" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable_4b22bd1a-fd4f-4715-b12f-aa20c136c1a8" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_89c2f44a-da04-4aa2-b970-e7cdd8ecd328" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligation_dadfc5da-6934-4bc8-a637-9deb383aa809" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligation"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_89c2f44a-da04-4aa2-b970-e7cdd8ecd328" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligation_dadfc5da-6934-4bc8-a637-9deb383aa809" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_8d5d78c3-3c40-4ef8-898c-b3531b49653c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems_89c2f44a-da04-4aa2-b970-e7cdd8ecd328" xlink:to="loc_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1_8d5d78c3-3c40-4ef8-898c-b3531b49653c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amprius.com/role/RevenuePerformanceObligationDetails_1" xlink:type="simple" xlink:href="ampx-20230331.xsd#RevenuePerformanceObligationDetails_1"/>
  <link:presentationLink xlink:role="http://www.amprius.com/role/RevenuePerformanceObligationDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.amprius.com/role/InventoryScheduleofInventoryDetails" xlink:type="simple" xlink:href="ampx-20230331.xsd#InventoryScheduleofInventoryDetails"/>
  <link:presentationLink xlink:role="http://www.amprius.com/role/InventoryScheduleofInventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryDisclosureAbstract_379e3ad3-3a2b-41bb-8e1c-1192da0d1476" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_85bf6d0c-4fad-4b33-9854-cf116720b9f7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_379e3ad3-3a2b-41bb-8e1c-1192da0d1476" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_85bf6d0c-4fad-4b33-9854-cf116720b9f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_bc3b529a-eac6-43c1-ba98-b58b6331279b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_379e3ad3-3a2b-41bb-8e1c-1192da0d1476" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_bc3b529a-eac6-43c1-ba98-b58b6331279b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_d5981caf-d16d-4a10-ba52-8b06e1f57dc8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_379e3ad3-3a2b-41bb-8e1c-1192da0d1476" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_d5981caf-d16d-4a10-ba52-8b06e1f57dc8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_d913237c-e27d-422a-b2ac-abc463aaaad0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_InventoryDisclosureAbstract_379e3ad3-3a2b-41bb-8e1c-1192da0d1476" xlink:to="loc_us-gaap_InventoryNet_d913237c-e27d-422a-b2ac-abc463aaaad0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amprius.com/role/PropertyPlantandEquipmentNetScheduleofPropertyandEquipmentDetails" xlink:type="simple" xlink:href="ampx-20230331.xsd#PropertyPlantandEquipmentNetScheduleofPropertyandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://www.amprius.com/role/PropertyPlantandEquipmentNetScheduleofPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_8916c75d-ea47-40f9-bbc2-8c9ab2aada46" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_3a9176f1-1851-40f0-a860-971e2781efef" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_8916c75d-ea47-40f9-bbc2-8c9ab2aada46" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_3a9176f1-1851-40f0-a860-971e2781efef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a824fe42-7ba1-43ba-a713-06cfbdad172d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_3a9176f1-1851-40f0-a860-971e2781efef" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a824fe42-7ba1-43ba-a713-06cfbdad172d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e6870684-1d07-48ac-bdf7-eb44133f186a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_a824fe42-7ba1-43ba-a713-06cfbdad172d" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e6870684-1d07-48ac-bdf7-eb44133f186a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_ProductionEquipmentMember_fdb2a4a4-cfb8-4470-99b6-25a41ebc6c61" xlink:href="ampx-20230331.xsd#ampx_ProductionEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e6870684-1d07-48ac-bdf7-eb44133f186a" xlink:to="loc_ampx_ProductionEquipmentMember_fdb2a4a4-cfb8-4470-99b6-25a41ebc6c61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_LaboratoryEquipmentMember_aaa700ed-4d07-42d9-9e2f-bab37825287b" xlink:href="ampx-20230331.xsd#ampx_LaboratoryEquipmentMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e6870684-1d07-48ac-bdf7-eb44133f186a" xlink:to="loc_ampx_LaboratoryEquipmentMember_aaa700ed-4d07-42d9-9e2f-bab37825287b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_47f95a5b-8833-4294-bb06-16d9ac6cce92" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e6870684-1d07-48ac-bdf7-eb44133f186a" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_47f95a5b-8833-4294-bb06-16d9ac6cce92" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_f6d3c600-ae10-4721-8d1f-66ccf1a2b28b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e6870684-1d07-48ac-bdf7-eb44133f186a" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_f6d3c600-ae10-4721-8d1f-66ccf1a2b28b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_e9e050ae-ee32-4258-a4e4-18191c0db775" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_e6870684-1d07-48ac-bdf7-eb44133f186a" xlink:to="loc_us-gaap_ConstructionInProgressMember_e9e050ae-ee32-4258-a4e4-18191c0db775" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d4ec3e72-87c6-4af0-a447-dbce04fe950e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_3a9176f1-1851-40f0-a860-971e2781efef" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d4ec3e72-87c6-4af0-a447-dbce04fe950e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_ad2fdb82-72e1-49b3-bab6-fb48024e1090" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d4ec3e72-87c6-4af0-a447-dbce04fe950e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_ad2fdb82-72e1-49b3-bab6-fb48024e1090" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_bfaa2ac1-faae-4582-aed6-e0eb85123b38" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d4ec3e72-87c6-4af0-a447-dbce04fe950e" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_bfaa2ac1-faae-4582-aed6-e0eb85123b38" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_d9a125ea-580f-4951-945b-46c739cec3b1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d4ec3e72-87c6-4af0-a447-dbce04fe950e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_d9a125ea-580f-4951-945b-46c739cec3b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amprius.com/role/PropertyPlantandEquipmentNetNarrativeDetails" xlink:type="simple" xlink:href="ampx-20230331.xsd#PropertyPlantandEquipmentNetNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.amprius.com/role/PropertyPlantandEquipmentNetNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentAbstract_150b7d78-5ca2-43e3-b31b-cd983839bd40" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PropertyPlantAndEquipmentAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DepreciationDepletionAndAmortization_53b33686-af6b-4408-a064-77b649c5625a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_DepreciationDepletionAndAmortization"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentAbstract_150b7d78-5ca2-43e3-b31b-cd983839bd40" xlink:to="loc_us-gaap_DepreciationDepletionAndAmortization_53b33686-af6b-4408-a064-77b649c5625a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amprius.com/role/AccruedandOtherCurrentLiabilitiesDetails" xlink:type="simple" xlink:href="ampx-20230331.xsd#AccruedandOtherCurrentLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://www.amprius.com/role/AccruedandOtherCurrentLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PayablesAndAccrualsAbstract_dd62d88d-5b3c-438b-938e-7f23ab376f09" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PayablesAndAccrualsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_41dced39-df38-4d28-acdf-f2bb36565622" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_dd62d88d-5b3c-438b-938e-7f23ab376f09" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_41dced39-df38-4d28-acdf-f2bb36565622" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_51ab5cd0-f728-4e88-ba00-dfe8123cffc2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeRelatedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_dd62d88d-5b3c-438b-938e-7f23ab376f09" xlink:to="loc_us-gaap_EmployeeRelatedLiabilitiesCurrent_51ab5cd0-f728-4e88-ba00-dfe8123cffc2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_AccruedOfferingCostsCurrent_fd7123dd-5ae6-4f22-b551-842ddaa0f28a" xlink:href="ampx-20230331.xsd#ampx_AccruedOfferingCostsCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_dd62d88d-5b3c-438b-938e-7f23ab376f09" xlink:to="loc_ampx_AccruedOfferingCostsCurrent_fd7123dd-5ae6-4f22-b551-842ddaa0f28a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_3fed6893-3c99-48c3-9603-91d2a57f91bc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_dd62d88d-5b3c-438b-938e-7f23ab376f09" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_3fed6893-3c99-48c3-9603-91d2a57f91bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_905aee4a-0b70-48d6-9d74-40860f7950a7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PayablesAndAccrualsAbstract_dd62d88d-5b3c-438b-938e-7f23ab376f09" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_905aee4a-0b70-48d6-9d74-40860f7950a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amprius.com/role/StockholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="ampx-20230331.xsd#StockholdersEquityNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.amprius.com/role/StockholdersEquityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_3bcde412-b64f-4180-a26f-363f56717929" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_402f03ed-8f87-454b-825a-0ae61fa738ca" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_3bcde412-b64f-4180-a26f-363f56717929" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_402f03ed-8f87-454b-825a-0ae61fa738ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_48413cc1-4983-4ec4-aedd-27dea4a03d57" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_402f03ed-8f87-454b-825a-0ae61fa738ca" xlink:to="loc_us-gaap_PlanNameAxis_48413cc1-4983-4ec4-aedd-27dea4a03d57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_7e978458-a045-42aa-a3a0-0daf15db96cd" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_48413cc1-4983-4ec4-aedd-27dea4a03d57" xlink:to="loc_us-gaap_PlanNameDomain_7e978458-a045-42aa-a3a0-0daf15db96cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_TwentyTwentyTwoEquityIncentivePlanMember_e651d4b9-f217-4cff-bbfb-9c791efc1fe8" xlink:href="ampx-20230331.xsd#ampx_TwentyTwentyTwoEquityIncentivePlanMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_7e978458-a045-42aa-a3a0-0daf15db96cd" xlink:to="loc_ampx_TwentyTwentyTwoEquityIncentivePlanMember_e651d4b9-f217-4cff-bbfb-9c791efc1fe8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_EquityIncentivePlansMember_3f4d6010-731b-4f13-8bd8-15d2885697c9" xlink:href="ampx-20230331.xsd#ampx_EquityIncentivePlansMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_7e978458-a045-42aa-a3a0-0daf15db96cd" xlink:to="loc_ampx_EquityIncentivePlansMember_3f4d6010-731b-4f13-8bd8-15d2885697c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_TwentyTwentyTwoEmployeeStockPurchasePlanMember_e582c680-4245-4d77-be35-8ab55e1e99ce" xlink:href="ampx-20230331.xsd#ampx_TwentyTwentyTwoEmployeeStockPurchasePlanMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_7e978458-a045-42aa-a3a0-0daf15db96cd" xlink:to="loc_ampx_TwentyTwentyTwoEmployeeStockPurchasePlanMember_e582c680-4245-4d77-be35-8ab55e1e99ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_ExecutiveIncentiveCompensationPlanMember_f0190717-f34a-4087-af8a-293db2a3bf99" xlink:href="ampx-20230331.xsd#ampx_ExecutiveIncentiveCompensationPlanMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_7e978458-a045-42aa-a3a0-0daf15db96cd" xlink:to="loc_ampx_ExecutiveIncentiveCompensationPlanMember_f0190717-f34a-4087-af8a-293db2a3bf99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_e1dcb6ea-a454-4e45-b7b8-f84987d679cf" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_402f03ed-8f87-454b-825a-0ae61fa738ca" xlink:to="loc_us-gaap_AwardTypeAxis_e1dcb6ea-a454-4e45-b7b8-f84987d679cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d33228e4-21d7-4f65-a493-06fab0ddc5d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_e1dcb6ea-a454-4e45-b7b8-f84987d679cf" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d33228e4-21d7-4f65-a493-06fab0ddc5d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_69238cf1-9e16-4682-b5c8-3e1cd1268b93" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d33228e4-21d7-4f65-a493-06fab0ddc5d1" xlink:to="loc_us-gaap_EmployeeStockMember_69238cf1-9e16-4682-b5c8-3e1cd1268b93" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_d2067c19-15a9-47d8-a4c4-218779f836ce" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d33228e4-21d7-4f65-a493-06fab0ddc5d1" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_d2067c19-15a9-47d8-a4c4-218779f836ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_2af423c2-e991-4bb4-9112-ff898aaa157a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_d33228e4-21d7-4f65-a493-06fab0ddc5d1" xlink:to="loc_us-gaap_EmployeeStockOptionMember_2af423c2-e991-4bb4-9112-ff898aaa157a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_646b28c9-7954-45b1-911d-04b32e1484dc" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_402f03ed-8f87-454b-825a-0ae61fa738ca" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_646b28c9-7954-45b1-911d-04b32e1484dc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_285908ed-b4a0-4b44-a813-c62bc6b37df5" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_646b28c9-7954-45b1-911d-04b32e1484dc" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_285908ed-b4a0-4b44-a813-c62bc6b37df5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_PublicWarrantsMember_1d7aee19-def1-4f39-b225-73cdda78b3cf" xlink:href="ampx-20230331.xsd#ampx_PublicWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_285908ed-b4a0-4b44-a813-c62bc6b37df5" xlink:to="loc_ampx_PublicWarrantsMember_1d7aee19-def1-4f39-b225-73cdda78b3cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_PrivateWarrantsMember_04fad3c6-66cf-4ed3-872f-224d63eb9395" xlink:href="ampx-20230331.xsd#ampx_PrivateWarrantsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_285908ed-b4a0-4b44-a813-c62bc6b37df5" xlink:to="loc_ampx_PrivateWarrantsMember_04fad3c6-66cf-4ed3-872f-224d63eb9395" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_PIPEWarrantsMember_b5ac0e4d-35e5-45e6-ad9c-a4792c65e287" xlink:href="ampx-20230331.xsd#ampx_PIPEWarrantsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_285908ed-b4a0-4b44-a813-c62bc6b37df5" xlink:to="loc_ampx_PIPEWarrantsMember_b5ac0e4d-35e5-45e6-ad9c-a4792c65e287" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_CounterpartyNameAxis_c7722e10-6d4a-492b-a945-273eead2c123" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_CounterpartyNameAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_402f03ed-8f87-454b-825a-0ae61fa738ca" xlink:to="loc_srt_CounterpartyNameAxis_c7722e10-6d4a-492b-a945-273eead2c123" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RepurchaseAgreementCounterpartyNameDomain_33608975-4ec5-4d83-b76b-55a02164afea" xlink:href="https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd#srt_RepurchaseAgreementCounterpartyNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_CounterpartyNameAxis_c7722e10-6d4a-492b-a945-273eead2c123" xlink:to="loc_srt_RepurchaseAgreementCounterpartyNameDomain_33608975-4ec5-4d83-b76b-55a02164afea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_BRPCIIMember_6f5c0e01-3118-4386-aa3b-44df3491286e" xlink:href="ampx-20230331.xsd#ampx_BRPCIIMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RepurchaseAgreementCounterpartyNameDomain_33608975-4ec5-4d83-b76b-55a02164afea" xlink:to="loc_ampx_BRPCIIMember_6f5c0e01-3118-4386-aa3b-44df3491286e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsidiarySaleOfStockAxis_b741f5d6-9783-4dc8-abc0-f6f1d1cd0d22" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsidiarySaleOfStockAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_402f03ed-8f87-454b-825a-0ae61fa738ca" xlink:to="loc_us-gaap_SubsidiarySaleOfStockAxis_b741f5d6-9783-4dc8-abc0-f6f1d1cd0d22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNameOfTransactionDomain_d8c247e0-9082-4e51-b76a-40a7d70393c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNameOfTransactionDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsidiarySaleOfStockAxis_b741f5d6-9783-4dc8-abc0-f6f1d1cd0d22" xlink:to="loc_us-gaap_SaleOfStockNameOfTransactionDomain_d8c247e0-9082-4e51-b76a-40a7d70393c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_PurchaseAgreementMember_f4f09e87-0351-4899-bb10-695fc4a5b023" xlink:href="ampx-20230331.xsd#ampx_PurchaseAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SaleOfStockNameOfTransactionDomain_d8c247e0-9082-4e51-b76a-40a7d70393c2" xlink:to="loc_ampx_PurchaseAgreementMember_f4f09e87-0351-4899-bb10-695fc4a5b023" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_85cd2ac7-7891-4dab-af61-6e06749646ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_402f03ed-8f87-454b-825a-0ae61fa738ca" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_85cd2ac7-7891-4dab-af61-6e06749646ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_SharesAuthorized_d97e9c5d-1854-4236-834a-fde44ab38b9d" xlink:href="ampx-20230331.xsd#ampx_SharesAuthorized"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_85cd2ac7-7891-4dab-af61-6e06749646ff" xlink:to="loc_ampx_SharesAuthorized_d97e9c5d-1854-4236-834a-fde44ab38b9d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_cbfe342c-efb0-4d5c-9f4f-88e7ce5fdae0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_85cd2ac7-7891-4dab-af61-6e06749646ff" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_cbfe342c-efb0-4d5c-9f4f-88e7ce5fdae0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockParOrStatedValuePerShare_29fc0224-b3a4-4a9b-882c-2c3d9de927d1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockParOrStatedValuePerShare"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_85cd2ac7-7891-4dab-af61-6e06749646ff" xlink:to="loc_us-gaap_CommonStockParOrStatedValuePerShare_29fc0224-b3a4-4a9b-882c-2c3d9de927d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockSharesAuthorized_ecfac216-1891-4090-8008-700d644c3ed2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockSharesAuthorized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_85cd2ac7-7891-4dab-af61-6e06749646ff" xlink:to="loc_us-gaap_PreferredStockSharesAuthorized_ecfac216-1891-4090-8008-700d644c3ed2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PreferredStockParOrStatedValuePerShare_806afa3d-705b-457c-9baf-e365be4bf28d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_PreferredStockParOrStatedValuePerShare"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_85cd2ac7-7891-4dab-af61-6e06749646ff" xlink:to="loc_us-gaap_PreferredStockParOrStatedValuePerShare_806afa3d-705b-457c-9baf-e365be4bf28d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_5c62be5f-e5e5-40cb-a71d-775882d27c24" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_85cd2ac7-7891-4dab-af61-6e06749646ff" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_5c62be5f-e5e5-40cb-a71d-775882d27c24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfFairValue_7aa8db61-e66e-40b9-8d49-cf9b74f28441" xlink:href="ampx-20230331.xsd#ampx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfFairValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_85cd2ac7-7891-4dab-af61-6e06749646ff" xlink:to="loc_ampx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfFairValue_7aa8db61-e66e-40b9-8d49-cf9b74f28441" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_StockholderPercentageOfOptioneeForOptionPrice_6512b0c7-f8f9-42a5-b210-123388ae774f" xlink:href="ampx-20230331.xsd#ampx_StockholderPercentageOfOptioneeForOptionPrice"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_85cd2ac7-7891-4dab-af61-6e06749646ff" xlink:to="loc_ampx_StockholderPercentageOfOptioneeForOptionPrice_6512b0c7-f8f9-42a5-b210-123388ae774f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfFairValueSignificantStockholder_a767af32-cffe-43f1-86b4-ea9454eaadfd" xlink:href="ampx-20230331.xsd#ampx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfFairValueSignificantStockholder"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_85cd2ac7-7891-4dab-af61-6e06749646ff" xlink:to="loc_ampx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfFairValueSignificantStockholder_a767af32-cffe-43f1-86b4-ea9454eaadfd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_448eb512-77af-4867-bc82-e0fb724f12da" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_85cd2ac7-7891-4dab-af61-6e06749646ff" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod_448eb512-77af-4867-bc82-e0fb724f12da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_e4a29c32-cf2e-4221-a290-84bbdf6e583b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_85cd2ac7-7891-4dab-af61-6e06749646ff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_e4a29c32-cf2e-4221-a290-84bbdf6e583b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_30fbb21d-6e95-4b9b-b94f-dc98ced402df" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_85cd2ac7-7891-4dab-af61-6e06749646ff" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_30fbb21d-6e95-4b9b-b94f-dc98ced402df" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_7e6d06fe-e9d2-4853-bf4a-14634ddf458d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_85cd2ac7-7891-4dab-af61-6e06749646ff" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized_7e6d06fe-e9d2-4853-bf4a-14634ddf458d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_dcb7b870-fc41-4b35-b21b-7fd41fb41885" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_85cd2ac7-7891-4dab-af61-6e06749646ff" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_dcb7b870-fc41-4b35-b21b-7fd41fb41885" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_32743c0c-811d-41f1-b5c4-b76e9501f545" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_85cd2ac7-7891-4dab-af61-6e06749646ff" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_32743c0c-811d-41f1-b5c4-b76e9501f545" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_ShareBasedCompensationArrangementByShareBasedPaymentAwardReservedForIssuance_09613e08-6ca6-486d-b309-53e4cd2cd8c2" xlink:href="ampx-20230331.xsd#ampx_ShareBasedCompensationArrangementByShareBasedPaymentAwardReservedForIssuance"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_85cd2ac7-7891-4dab-af61-6e06749646ff" xlink:to="loc_ampx_ShareBasedCompensationArrangementByShareBasedPaymentAwardReservedForIssuance_09613e08-6ca6-486d-b309-53e4cd2cd8c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_bad34ebe-0db5-4a2a-886c-f5ed5eddf161" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_85cd2ac7-7891-4dab-af61-6e06749646ff" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_bad34ebe-0db5-4a2a-886c-f5ed5eddf161" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_SaleOfStockAveragePricePerShareRedemption_1271f00b-452e-4002-9fac-4f84deed79f7" xlink:href="ampx-20230331.xsd#ampx_SaleOfStockAveragePricePerShareRedemption"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_85cd2ac7-7891-4dab-af61-6e06749646ff" xlink:to="loc_ampx_SaleOfStockAveragePricePerShareRedemption_1271f00b-452e-4002-9fac-4f84deed79f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_WarrantsRedemptionThresholdTradingDays_8eb56761-036b-4a8f-8974-351e9e267b5e" xlink:href="ampx-20230331.xsd#ampx_WarrantsRedemptionThresholdTradingDays"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_85cd2ac7-7891-4dab-af61-6e06749646ff" xlink:to="loc_ampx_WarrantsRedemptionThresholdTradingDays_8eb56761-036b-4a8f-8974-351e9e267b5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_WarrantsRedemptionThresholdConsecutiveTradingDays_e1969b31-b579-4953-8627-ed4c533866b4" xlink:href="ampx-20230331.xsd#ampx_WarrantsRedemptionThresholdConsecutiveTradingDays"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_85cd2ac7-7891-4dab-af61-6e06749646ff" xlink:to="loc_ampx_WarrantsRedemptionThresholdConsecutiveTradingDays_e1969b31-b579-4953-8627-ed4c533866b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_SaleOfStockPotentialMaximumConsiderationReceivedOnTransaction_208cf888-a6af-45de-a8e6-abc6c351706a" xlink:href="ampx-20230331.xsd#ampx_SaleOfStockPotentialMaximumConsiderationReceivedOnTransaction"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_85cd2ac7-7891-4dab-af61-6e06749646ff" xlink:to="loc_ampx_SaleOfStockPotentialMaximumConsiderationReceivedOnTransaction_208cf888-a6af-45de-a8e6-abc6c351706a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_SaleOfStockDiscount_3b474f24-2f47-417f-a18a-bc86ee20dfbf" xlink:href="ampx-20230331.xsd#ampx_SaleOfStockDiscount"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_85cd2ac7-7891-4dab-af61-6e06749646ff" xlink:to="loc_ampx_SaleOfStockDiscount_3b474f24-2f47-417f-a18a-bc86ee20dfbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_SaleOfStockMaximumSharesAvailableForSalePercentageOfSharesIssuedAndOutstandingPriorToTransaction_42832fbf-91fd-446c-8abe-ae09010d801f" xlink:href="ampx-20230331.xsd#ampx_SaleOfStockMaximumSharesAvailableForSalePercentageOfSharesIssuedAndOutstandingPriorToTransaction"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_85cd2ac7-7891-4dab-af61-6e06749646ff" xlink:to="loc_ampx_SaleOfStockMaximumSharesAvailableForSalePercentageOfSharesIssuedAndOutstandingPriorToTransaction_42832fbf-91fd-446c-8abe-ae09010d801f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_527404b4-2911-497d-8666-0583546e6f8b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_85cd2ac7-7891-4dab-af61-6e06749646ff" xlink:to="loc_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction_527404b4-2911-497d-8666-0583546e6f8b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_a4c21240-6a6b-42f1-b20d-71249ea42976" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_85cd2ac7-7891-4dab-af61-6e06749646ff" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_a4c21240-6a6b-42f1-b20d-71249ea42976" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_DeferredStockIssuanceCosts_56ae655c-774d-4e33-af1b-503b167d6727" xlink:href="ampx-20230331.xsd#ampx_DeferredStockIssuanceCosts"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_85cd2ac7-7891-4dab-af61-6e06749646ff" xlink:to="loc_ampx_DeferredStockIssuanceCosts_56ae655c-774d-4e33-af1b-503b167d6727" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amprius.com/role/StockholdersEquityStockWarrantDetails" xlink:type="simple" xlink:href="ampx-20230331.xsd#StockholdersEquityStockWarrantDetails"/>
  <link:presentationLink xlink:role="http://www.amprius.com/role/StockholdersEquityStockWarrantDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_ea812fea-4a26-47fc-a2e7-e6ab5e3e010c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7e05a696-45b2-47f0-a5bb-49eb84b3e923" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_ea812fea-4a26-47fc-a2e7-e6ab5e3e010c" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7e05a696-45b2-47f0-a5bb-49eb84b3e923" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_53642c1f-18e2-4ef3-a2e0-30dc2aa639e2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7e05a696-45b2-47f0-a5bb-49eb84b3e923" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_53642c1f-18e2-4ef3-a2e0-30dc2aa639e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_32fd26d6-fd92-402f-8fcd-a4dc23fc9b45" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_53642c1f-18e2-4ef3-a2e0-30dc2aa639e2" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_32fd26d6-fd92-402f-8fcd-a4dc23fc9b45" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_PublicWarrantsMember_f985222d-ec11-4ac0-95db-9ea4ac52e2e5" xlink:href="ampx-20230331.xsd#ampx_PublicWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_32fd26d6-fd92-402f-8fcd-a4dc23fc9b45" xlink:to="loc_ampx_PublicWarrantsMember_f985222d-ec11-4ac0-95db-9ea4ac52e2e5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_PrivateWarrantsMember_c751fcfb-488f-42e3-8941-3da3890b896b" xlink:href="ampx-20230331.xsd#ampx_PrivateWarrantsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_32fd26d6-fd92-402f-8fcd-a4dc23fc9b45" xlink:to="loc_ampx_PrivateWarrantsMember_c751fcfb-488f-42e3-8941-3da3890b896b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_PIPEWarrantsMember_f6c81e8f-8d73-43c1-a007-59f32e5f85a9" xlink:href="ampx-20230331.xsd#ampx_PIPEWarrantsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_32fd26d6-fd92-402f-8fcd-a4dc23fc9b45" xlink:to="loc_ampx_PIPEWarrantsMember_f6c81e8f-8d73-43c1-a007-59f32e5f85a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f2edafc-7d13-49ea-b6a6-c757dbc03cf8" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_7e05a696-45b2-47f0-a5bb-49eb84b3e923" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f2edafc-7d13-49ea-b6a6-c757dbc03cf8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_8945d499-e449-421a-9b1f-77f8eebaea69" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f2edafc-7d13-49ea-b6a6-c757dbc03cf8" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_8945d499-e449-421a-9b1f-77f8eebaea69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1bbe6fca-87d7-4e5a-b4c1-df187c1cbc02" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_6f2edafc-7d13-49ea-b6a6-c757dbc03cf8" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_1bbe6fca-87d7-4e5a-b4c1-df187c1cbc02" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amprius.com/role/StockholdersEquityStockBasedCompensationExpenseDetails" xlink:type="simple" xlink:href="ampx-20230331.xsd#StockholdersEquityStockBasedCompensationExpenseDetails"/>
  <link:presentationLink xlink:role="http://www.amprius.com/role/StockholdersEquityStockBasedCompensationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_7a61ca13-2ae2-4294-9c5c-1c8e963d1a9a" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_19e404b4-8190-42fc-a5d1-63de6a371675" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_7a61ca13-2ae2-4294-9c5c-1c8e963d1a9a" xlink:to="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_19e404b4-8190-42fc-a5d1-63de6a371675" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_7017ef5b-3b6b-421b-8317-e8b91b6c112e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_19e404b4-8190-42fc-a5d1-63de6a371675" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_7017ef5b-3b6b-421b-8317-e8b91b6c112e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_ee6a6586-9ec1-4faa-82be-de8b6ff1fc6f" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_7017ef5b-3b6b-421b-8317-e8b91b6c112e" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_ee6a6586-9ec1-4faa-82be-de8b6ff1fc6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfSalesMember_4eb64062-79ca-43b2-80f0-1935eb523b15" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_CostOfSalesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ee6a6586-9ec1-4faa-82be-de8b6ff1fc6f" xlink:to="loc_us-gaap_CostOfSalesMember_4eb64062-79ca-43b2-80f0-1935eb523b15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_f83ac4cf-7d14-4d1e-89e5-bdecc915fb4e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ee6a6586-9ec1-4faa-82be-de8b6ff1fc6f" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_f83ac4cf-7d14-4d1e-89e5-bdecc915fb4e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_1d7f9b97-1e87-4d66-a995-ca170a448179" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_ee6a6586-9ec1-4faa-82be-de8b6ff1fc6f" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_1d7f9b97-1e87-4d66-a995-ca170a448179" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_55a8757d-7054-400f-93fe-e83c9374fd14" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable_19e404b4-8190-42fc-a5d1-63de6a371675" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_55a8757d-7054-400f-93fe-e83c9374fd14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_a665851d-eb90-40e8-9725-6269ef26c287" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems_55a8757d-7054-400f-93fe-e83c9374fd14" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_a665851d-eb90-40e8-9725-6269ef26c287" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amprius.com/role/IncomeTaxesDetails" xlink:type="simple" xlink:href="ampx-20230331.xsd#IncomeTaxesDetails"/>
  <link:presentationLink xlink:role="http://www.amprius.com/role/IncomeTaxesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxDisclosureAbstract_eb4f6393-5bf0-4fd1-839a-0b227f4ee17e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_ee5bf91c-7fa3-4766-a24b-390715462551" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeTaxDisclosureAbstract_eb4f6393-5bf0-4fd1-839a-0b227f4ee17e" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_ee5bf91c-7fa3-4766-a24b-390715462551" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amprius.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="ampx-20230331.xsd#LeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.amprius.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_0d84f3a6-fd33-46fd-a1a2-51b75eeb2fa2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_ea3b0c32-4125-4a98-bea0-df0708816bed" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0d84f3a6-fd33-46fd-a1a2-51b75eeb2fa2" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_ea3b0c32-4125-4a98-bea0-df0708816bed" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LegalEntityAxis_6173052f-51cc-404d-a286-24d277c9cb60" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LegalEntityAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_ea3b0c32-4125-4a98-bea0-df0708816bed" xlink:to="loc_dei_LegalEntityAxis_6173052f-51cc-404d-a286-24d277c9cb60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityDomain_148ba39c-0b7b-43be-9d52-fcf394452936" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_LegalEntityAxis_6173052f-51cc-404d-a286-24d277c9cb60" xlink:to="loc_dei_EntityDomain_148ba39c-0b7b-43be-9d52-fcf394452936" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_AmpriusHoldingsMember_5185b443-409a-4358-be1a-c2548ab014dd" xlink:href="ampx-20230331.xsd#ampx_AmpriusHoldingsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_EntityDomain_148ba39c-0b7b-43be-9d52-fcf394452936" xlink:to="loc_ampx_AmpriusHoldingsMember_5185b443-409a-4358-be1a-c2548ab014dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_fadc88ff-8d2f-4c95-b98a-8d3ce414a140" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_ea3b0c32-4125-4a98-bea0-df0708816bed" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_fadc88ff-8d2f-4c95-b98a-8d3ce414a140" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_221b9b3a-63ad-4297-b2f2-a6c6cbd1f617" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fadc88ff-8d2f-4c95-b98a-8d3ce414a140" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_221b9b3a-63ad-4297-b2f2-a6c6cbd1f617" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_LesseeFinanceLeaseNumberOfLeases_ece05d6f-45d2-47b5-a1ec-2589f9f29a5a" xlink:href="ampx-20230331.xsd#ampx_LesseeFinanceLeaseNumberOfLeases"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fadc88ff-8d2f-4c95-b98a-8d3ce414a140" xlink:to="loc_ampx_LesseeFinanceLeaseNumberOfLeases_ece05d6f-45d2-47b5-a1ec-2589f9f29a5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_51bd1cf5-2c38-4196-93b4-913f6c3260d3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fadc88ff-8d2f-4c95-b98a-8d3ce414a140" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_51bd1cf5-2c38-4196-93b4-913f6c3260d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_cbc03e62-ad3d-4034-8e3f-fc1a436ec3ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fadc88ff-8d2f-4c95-b98a-8d3ce414a140" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_cbc03e62-ad3d-4034-8e3f-fc1a436ec3ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_358e921a-5e51-445f-91d2-d97d2b4c446d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fadc88ff-8d2f-4c95-b98a-8d3ce414a140" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_358e921a-5e51-445f-91d2-d97d2b4c446d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_1c691993-20d1-48a6-b48b-b20e9ab619ee" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fadc88ff-8d2f-4c95-b98a-8d3ce414a140" xlink:to="loc_us-gaap_OperatingLeasePayments_1c691993-20d1-48a6-b48b-b20e9ab619ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_bea142ce-b79a-4eca-9150-dd697f4517f1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_fadc88ff-8d2f-4c95-b98a-8d3ce414a140" xlink:to="loc_us-gaap_OperatingLeaseCost_bea142ce-b79a-4eca-9150-dd697f4517f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amprius.com/role/LeasesScheduleofFutureMaturingOperatingLeasePaymentsDetails" xlink:type="simple" xlink:href="ampx-20230331.xsd#LeasesScheduleofFutureMaturingOperatingLeasePaymentsDetails"/>
  <link:presentationLink xlink:role="http://www.amprius.com/role/LeasesScheduleofFutureMaturingOperatingLeasePaymentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_597275e1-5b54-4b88-9346-b1c187cc4e33" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_08867d36-8562-491e-9850-143095df8fa3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_597275e1-5b54-4b88-9346-b1c187cc4e33" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_08867d36-8562-491e-9850-143095df8fa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_9b2db5bb-7a7c-4c18-b47f-1bf4df2544b7" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_597275e1-5b54-4b88-9346-b1c187cc4e33" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_9b2db5bb-7a7c-4c18-b47f-1bf4df2544b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_124480d3-7758-48aa-b6f5-bdd67628c842" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_597275e1-5b54-4b88-9346-b1c187cc4e33" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_124480d3-7758-48aa-b6f5-bdd67628c842" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_f888ab48-fbba-414f-a8d7-7da04902eeb6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_597275e1-5b54-4b88-9346-b1c187cc4e33" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_f888ab48-fbba-414f-a8d7-7da04902eeb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_50607925-acc2-4bf1-bbcd-a631eeb09d91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_597275e1-5b54-4b88-9346-b1c187cc4e33" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_50607925-acc2-4bf1-bbcd-a631eeb09d91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_74842c64-de26-4e46-90df-c85077798495" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_597275e1-5b54-4b88-9346-b1c187cc4e33" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_74842c64-de26-4e46-90df-c85077798495" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_7389be96-953b-4fd4-ad0e-b5a956eec396" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_597275e1-5b54-4b88-9346-b1c187cc4e33" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_7389be96-953b-4fd4-ad0e-b5a956eec396" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_7bc0ff51-df55-47fa-be19-3411c1af8d01" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_597275e1-5b54-4b88-9346-b1c187cc4e33" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_7bc0ff51-df55-47fa-be19-3411c1af8d01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_b19a5eab-dc40-4595-bfd1-2f92ed0cc60d" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_597275e1-5b54-4b88-9346-b1c187cc4e33" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_b19a5eab-dc40-4595-bfd1-2f92ed0cc60d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_efcafe2b-355a-44db-9c12-d112c43981c6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_597275e1-5b54-4b88-9346-b1c187cc4e33" xlink:to="loc_us-gaap_OperatingLeaseLiability_efcafe2b-355a-44db-9c12-d112c43981c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amprius.com/role/LeasesScheduleofFutureMaturingOperatingLeasePaymentsDetails_1" xlink:type="simple" xlink:href="ampx-20230331.xsd#LeasesScheduleofFutureMaturingOperatingLeasePaymentsDetails_1"/>
  <link:presentationLink xlink:role="http://www.amprius.com/role/LeasesScheduleofFutureMaturingOperatingLeasePaymentsDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://www.amprius.com/role/NetLossPerShareScheduleofCalculationofBasicandDilutedNetLossPerShareDetails" xlink:type="simple" xlink:href="ampx-20230331.xsd#NetLossPerShareScheduleofCalculationofBasicandDilutedNetLossPerShareDetails"/>
  <link:presentationLink xlink:role="http://www.amprius.com/role/NetLossPerShareScheduleofCalculationofBasicandDilutedNetLossPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_927e2be1-9c13-4758-9ac1-5a6c183d6512" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareReconciliationAbstract_7f424ddc-04de-47a5-b36c-4d89b2be8044" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareReconciliationAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_927e2be1-9c13-4758-9ac1-5a6c183d6512" xlink:to="loc_us-gaap_EarningsPerShareReconciliationAbstract_7f424ddc-04de-47a5-b36c-4d89b2be8044" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_dc467df1-b84c-4987-87c5-f93b3a146f05" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_7f424ddc-04de-47a5-b36c-4d89b2be8044" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic_dc467df1-b84c-4987-87c5-f93b3a146f05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_43271775-46d4-42fa-9922-812e598e8aad" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareReconciliationAbstract_7f424ddc-04de-47a5-b36c-4d89b2be8044" xlink:to="loc_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted_43271775-46d4-42fa-9922-812e598e8aad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_92d1d9c2-fbd1-435e-9df3-914fb2100785" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_927e2be1-9c13-4758-9ac1-5a6c183d6512" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_92d1d9c2-fbd1-435e-9df3-914fb2100785" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ff3cec4b-3216-4f96-91b2-8ac0a320beb0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfSharesOutstandingBasic"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_92d1d9c2-fbd1-435e-9df3-914fb2100785" xlink:to="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic_ff3cec4b-3216-4f96-91b2-8ac0a320beb0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_11a24ef3-e1a5-45d6-a94d-e74c7de5729e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract_92d1d9c2-fbd1-435e-9df3-914fb2100785" xlink:to="loc_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding_11a24ef3-e1a5-45d6-a94d-e74c7de5729e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasic_a0517c8a-f11e-424a-bf2c-cfdc58ed76c3" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareBasic"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_927e2be1-9c13-4758-9ac1-5a6c183d6512" xlink:to="loc_us-gaap_EarningsPerShareBasic_a0517c8a-f11e-424a-bf2c-cfdc58ed76c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareDiluted_050321a9-3943-4b6b-8111-b093abc4389b" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareDiluted"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_927e2be1-9c13-4758-9ac1-5a6c183d6512" xlink:to="loc_us-gaap_EarningsPerShareDiluted_050321a9-3943-4b6b-8111-b093abc4389b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amprius.com/role/NetLossPerSharePotentiallyDilutiveSecuritiesDetails" xlink:type="simple" xlink:href="ampx-20230331.xsd#NetLossPerSharePotentiallyDilutiveSecuritiesDetails"/>
  <link:presentationLink xlink:role="http://www.amprius.com/role/NetLossPerSharePotentiallyDilutiveSecuritiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_fd70ebe6-a2b3-4541-ba3c-aabb886674c2" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_db224e73-d43c-4827-8c56-8c982f856126" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_fd70ebe6-a2b3-4541-ba3c-aabb886674c2" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_db224e73-d43c-4827-8c56-8c982f856126" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_40b6c47c-c7c7-4e0e-9405-49f07dbb1f27" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_db224e73-d43c-4827-8c56-8c982f856126" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_40b6c47c-c7c7-4e0e-9405-49f07dbb1f27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_e7047edb-3013-40f1-91a5-ff25a6f1d568" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_40b6c47c-c7c7-4e0e-9405-49f07dbb1f27" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_e7047edb-3013-40f1-91a5-ff25a6f1d568" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_7d0f3076-5586-4477-a3f9-295f091d1570" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_e7047edb-3013-40f1-91a5-ff25a6f1d568" xlink:to="loc_us-gaap_WarrantMember_7d0f3076-5586-4477-a3f9-295f091d1570" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_567ad9e8-e5cf-489d-a283-b59c8da50f53" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_e7047edb-3013-40f1-91a5-ff25a6f1d568" xlink:to="loc_us-gaap_EmployeeStockOptionMember_567ad9e8-e5cf-489d-a283-b59c8da50f53" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_3b586e61-94c2-479f-af3e-b3f81b455fda" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_e7047edb-3013-40f1-91a5-ff25a6f1d568" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_3b586e61-94c2-479f-af3e-b3f81b455fda" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_7706be9f-032d-46db-a93a-46bd49bd40ff" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_db224e73-d43c-4827-8c56-8c982f856126" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_7706be9f-032d-46db-a93a-46bd49bd40ff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_fd9ae54d-f7c0-4cdc-8e22-6d3160fb90fe" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_7706be9f-032d-46db-a93a-46bd49bd40ff" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_fd9ae54d-f7c0-4cdc-8e22-6d3160fb90fe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://www.amprius.com/role/SubsequentEventsNarrativeDetails" xlink:type="simple" xlink:href="ampx-20230331.xsd#SubsequentEventsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://www.amprius.com/role/SubsequentEventsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventsAbstract_08c6be10-6c00-4a81-be5f-e3488e76dc3c" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTable_c325c6a7-2de6-429c-ac28-129b279e2bd0" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventsAbstract_08c6be10-6c00-4a81-be5f-e3488e76dc3c" xlink:to="loc_us-gaap_SubsequentEventTable_c325c6a7-2de6-429c-ac28-129b279e2bd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeAxis_e9c08d77-cac6-4cb4-8082-3b637ebd2a91" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_c325c6a7-2de6-429c-ac28-129b279e2bd0" xlink:to="loc_us-gaap_SubsequentEventTypeAxis_e9c08d77-cac6-4cb4-8082-3b637ebd2a91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventTypeDomain_15f1e48d-e664-4c4e-8a4d-eadb9f364060" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeAxis_e9c08d77-cac6-4cb4-8082-3b637ebd2a91" xlink:to="loc_us-gaap_SubsequentEventTypeDomain_15f1e48d-e664-4c4e-8a4d-eadb9f364060" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventMember_d45e1c35-ba83-4bb5-bdb6-be3cf7dcf0c1" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTypeDomain_15f1e48d-e664-4c4e-8a4d-eadb9f364060" xlink:to="loc_us-gaap_SubsequentEventMember_d45e1c35-ba83-4bb5-bdb6-be3cf7dcf0c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_NameOfFacilityAxis_6029cae3-2f63-4ca6-bcc6-5ffc6e021df3" xlink:href="ampx-20230331.xsd#ampx_NameOfFacilityAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_c325c6a7-2de6-429c-ac28-129b279e2bd0" xlink:to="loc_ampx_NameOfFacilityAxis_6029cae3-2f63-4ca6-bcc6-5ffc6e021df3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_NameOfFacilityDomain_f04485af-8880-45c4-b598-336e9f41b276" xlink:href="ampx-20230331.xsd#ampx_NameOfFacilityDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ampx_NameOfFacilityAxis_6029cae3-2f63-4ca6-bcc6-5ffc6e021df3" xlink:to="loc_ampx_NameOfFacilityDomain_f04485af-8880-45c4-b598-336e9f41b276" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_BrightonColoradoMember_643000bc-b036-40b2-8a56-24729044cb69" xlink:href="ampx-20230331.xsd#ampx_BrightonColoradoMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ampx_NameOfFacilityDomain_f04485af-8880-45c4-b598-336e9f41b276" xlink:to="loc_ampx_BrightonColoradoMember_643000bc-b036-40b2-8a56-24729044cb69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SubsequentEventLineItems_11bef32a-dfd2-45aa-9bc1-713435ac9347" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_SubsequentEventLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventTable_c325c6a7-2de6-429c-ac28-129b279e2bd0" xlink:to="loc_us-gaap_SubsequentEventLineItems_11bef32a-dfd2-45aa-9bc1-713435ac9347" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_ampx_LesseeOperatingLeaseOptionToExtendNumber_f89d9981-efab-4adb-8bc1-34bae9dd4b00" xlink:href="ampx-20230331.xsd#ampx_LesseeOperatingLeaseOptionToExtendNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_11bef32a-dfd2-45aa-9bc1-713435ac9347" xlink:to="loc_ampx_LesseeOperatingLeaseOptionToExtendNumber_f89d9981-efab-4adb-8bc1-34bae9dd4b00" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_c4ec33ff-f9b7-4fd5-a975-776d945e40e6" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseRenewalTerm"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_11bef32a-dfd2-45aa-9bc1-713435ac9347" xlink:to="loc_us-gaap_LesseeOperatingLeaseRenewalTerm_c4ec33ff-f9b7-4fd5-a975-776d945e40e6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_8052792e-1ab5-4090-b098-d5173dd87a1e" xlink:href="https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SubsequentEventLineItems_11bef32a-dfd2-45aa-9bc1-713435ac9347" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_8052792e-1ab5-4090-b098-d5173dd87a1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140066176169584">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>May 04, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-04321<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">AMPRIUS TECHNOLOGIES, INC.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">98-1591811<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">1180 Page Avenue<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Fremont<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">CA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">94538<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">425-8803<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">84,971,565<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001899287<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2023<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember', window );">Common Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, $0.0001 par value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">AMPX<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=ampx_RedeemableWarrantsMember', window );">Redeemable warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Redeemable warrants, each exercisable for one share of common stock at an exercise price of $11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">AMPX.W<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=ampx_RedeemableWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=ampx_RedeemableWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140066180907936">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Assets, Current [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">$ 64,187,000<span></span>
</td>
<td class="nump">$ 69,696,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">555,000<span></span>
</td>
<td class="nump">686,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories</a></td>
<td class="nump">845,000<span></span>
</td>
<td class="nump">500,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCostsCurrent', window );">Deferred costs</a></td>
<td class="nump">2,475,000<span></span>
</td>
<td class="nump">1,897,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">1,841,000<span></span>
</td>
<td class="nump">2,394,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">69,903,000<span></span>
</td>
<td class="nump">75,173,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AssetsNoncurrentAbstract', window );"><strong>Non-current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">4,948,000<span></span>
</td>
<td class="nump">4,236,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Operating lease right-of-use assets, net</a></td>
<td class="nump">7,894,000<span></span>
</td>
<td class="nump">2,751,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DeferredCosts', window );">Deferred costs</a></td>
<td class="nump">519,000<span></span>
</td>
<td class="nump">367,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other assets</a></td>
<td class="nump">684,000<span></span>
</td>
<td class="nump">644,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">83,948,000<span></span>
</td>
<td class="nump">83,171,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">1,023,000<span></span>
</td>
<td class="nump">1,028,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent', window );">Accrued and other current liabilities</a></td>
<td class="nump">3,665,000<span></span>
</td>
<td class="nump">2,708,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">3,135,000<span></span>
</td>
<td class="nump">2,660,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities</a></td>
<td class="nump">1,061,000<span></span>
</td>
<td class="nump">521,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">8,884,000<span></span>
</td>
<td class="nump">6,917,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Non-current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Deferred revenue</a></td>
<td class="nump">902,000<span></span>
</td>
<td class="nump">720,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities</a></td>
<td class="nump">7,127,000<span></span>
</td>
<td class="nump">2,501,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">16,913,000<span></span>
</td>
<td class="nump">10,138,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 10)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Stockholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockValueOutstanding', window );">Preferred stock; $0.0001 par value; 50,000,000 shares authorized; no shares issued and outstanding.</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockValueOutstanding', window );">Common stock; $0.0001 par value; 950,000,000 shares authorized; 84,971,465 and 84,610,114 shares issued and outstanding at March&#160;31, 2023 and December&#160;31, 2022, respectively</a></td>
<td class="nump">8,000<span></span>
</td>
<td class="nump">8,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in&#160;capital</a></td>
<td class="nump">169,016,000<span></span>
</td>
<td class="nump">165,912,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(101,989,000)<span></span>
</td>
<td class="num">(92,887,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total stockholders&#8217; equity</a></td>
<td class="nump">67,035,000<span></span>
</td>
<td class="nump">73,033,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and stockholders&#8217; equity</a></td>
<td class="nump">$ 83,948,000<span></span>
</td>
<td class="nump">$ 83,171,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValueOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of all classes of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares exclude common shares repurchased by the entity and held as treasury shares.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValueOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of deferred cost, excluding capitalized cost related to contract with customer; classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(10))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredCostsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of deferred costs capitalized at the end of the reporting period that are expected to be charged against earnings within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredCostsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 20: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124433192&amp;loc=SL2890621-112765<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI https://asc.fasb.org/extlink&amp;oid=123419778&amp;loc=d3e5710-111685<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6904-107765<br><br>Reference 21: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(17))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockValueOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by shareholders, which is net of related treasury stock. May be all or a portion of the number of preferred shares authorized. These shares represent the ownership interest of the preferred shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockValueOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140066180973616">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares<br></strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares)</a></td>
<td class="nump">50,000,000<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesIssued', window );">Preferred stock, shares issued (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesOutstanding', window );">Preferred stock, shares outstanding (in shares)</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, authorized (in shares)</a></td>
<td class="nump">950,000,000<span></span>
</td>
<td class="nump">950,000,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, issued (in shares)</a></td>
<td class="nump">84,971,465<span></span>
</td>
<td class="nump">84,971,465<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, outstanding (in shares)</a></td>
<td class="nump">84,610,114<span></span>
</td>
<td class="nump">84,610,114<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140066176068656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">$ 679<span></span>
</td>
<td class="nump">$ 2,110<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of revenue</a></td>
<td class="nump">4,104<span></span>
</td>
<td class="nump">3,149<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross loss</a></td>
<td class="num">(3,425)<span></span>
</td>
<td class="num">(1,039)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingCostsAndExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">800<span></span>
</td>
<td class="nump">369<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Selling, general and administrative</a></td>
<td class="nump">5,526<span></span>
</td>
<td class="nump">1,502<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">6,326<span></span>
</td>
<td class="nump">1,871<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(9,751)<span></span>
</td>
<td class="num">(2,910)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NonoperatingIncomeExpense', window );">Other income, net</a></td>
<td class="nump">649<span></span>
</td>
<td class="nump">32<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (9,102)<span></span>
</td>
<td class="num">$ (2,878)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Weighted-average common shares outstanding:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average common shares outstanding, basic (in shares)</a></td>
<td class="nump">84,645,097<span></span>
</td>
<td class="nump">65,774,528<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average common shares outstanding, diluted (in shares)</a></td>
<td class="nump">84,645,097<span></span>
</td>
<td class="nump">65,774,528<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Net loss per share of common stock:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per share of common stock, basic (in dollars per share)</a></td>
<td class="num">$ (0.11)<span></span>
</td>
<td class="num">$ (0.04)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per share of common stock, diluted (in dollars per share)</a></td>
<td class="num">$ (0.11)<span></span>
</td>
<td class="num">$ (0.04)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingCostsAndExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingCostsAndExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 912<br> -SubTopic 730<br> -Section 25<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6472174&amp;loc=d3e58812-109433<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140066175124096">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS&#8217; EQUITY - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Previously Reported</div></th>
<th class="th"><div>Adjustment</div></th>
<th class="th"><div>Common Stock</div></th>
<th class="th">
<div>Common Stock </div>
<div>Previously Reported</div>
</th>
<th class="th">
<div>Common Stock </div>
<div>Revision of Prior Period, Adjustment</div>
</th>
<th class="th"><div>Additional Paid-in Capital</div></th>
<th class="th">
<div>Additional Paid-in Capital </div>
<div>Previously Reported</div>
</th>
<th class="th">
<div>Additional Paid-in Capital </div>
<div>Revision of Prior Period, Adjustment</div>
</th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th">
<div>Accumulated Deficit </div>
<div>Previously Reported</div>
</th>
<th class="th">
<div>Accumulated Deficit </div>
<div>Adjustment</div>
</th>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning Balance (in shares) at Dec. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65,772,001<span></span>
</td>
<td class="nump">45,176,145<span></span>
</td>
<td class="nump">20,595,856<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning Balance at Dec. 31, 2021</a></td>
<td class="nump">$ 13,858<span></span>
</td>
<td class="nump">$ 13,858<span></span>
</td>
<td class="num">$ (154)<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="nump">$ 1<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
<td class="nump">$ 89,252<span></span>
</td>
<td class="nump">$ 89,258<span></span>
</td>
<td class="num">$ (6)<span></span>
</td>
<td class="num">$ (75,401)<span></span>
</td>
<td class="num">$ (75,401)<span></span>
</td>
<td class="num">$ (154)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,549<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ampx_AdjustmentsToAdditionalPaidInCapitalCapitalContributionsFromParent', window );">Capital contributions from Amprius Holdings</a></td>
<td class="nump">247<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">247<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">350<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ampx_AdjustmentsToAdditionalPaidInCapitalContributionFromParentRelatedToStockBasedCompensation', window );">Contribution from Amprius Holdings related to stock-based compensation</a></td>
<td class="nump">106<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">106<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(2,878)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(2,878)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending Balance (in shares) at Mar. 31, 2022</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">65,776,550<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance at Mar. 31, 2022</a></td>
<td class="nump">$ 11,537<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">89,963<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(78,433)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingStandardsUpdateExtensibleList', window );">Accounting Standards Update [Extensible Enumeration]</a></td>
<td class="text">Accounting Standards Update 2016-02 [Member]<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Beginning Balance (in shares) at Dec. 31, 2022</a></td>
<td class="nump">84,610,114<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">84,610,114<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning Balance at Dec. 31, 2022</a></td>
<td class="nump">$ 73,033<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">165,912<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(92,887)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock in connection with a stock purchase agreement, net of issuance cost (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">331,351<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock in connection with a stock purchase agreement, net of issuance cost</a></td>
<td class="nump">2,376<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,376<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercise of stock options (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Exercise of stock options</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue', window );">Stock-based compensation</a></td>
<td class="nump">723<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">723<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ampx_AdjustmentsToAdditionalPaidInCapitalContributionFromParentRelatedToStockBasedCompensation', window );">Contribution from Amprius Holdings related to stock-based compensation</a></td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (9,102)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(9,102)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Ending Balance (in shares) at Mar. 31, 2023</a></td>
<td class="nump">84,610,114<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">84,971,465<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending Balance at Mar. 31, 2023</a></td>
<td class="nump">$ 67,035<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 169,016<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">$ (101,989)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ampx_AdjustmentsToAdditionalPaidInCapitalCapitalContributionsFromParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments To Additional Paid In Capital, Capital Contributions From Parent</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ampx_AdjustmentsToAdditionalPaidInCapitalCapitalContributionsFromParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ampx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ampx_AdjustmentsToAdditionalPaidInCapitalContributionFromParentRelatedToStockBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Adjustments To Additional Paid In Capital, Contribution From Parent Related To Stock-Based Compensation</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ampx_AdjustmentsToAdditionalPaidInCapitalContributionFromParentRelatedToStockBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ampx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingStandardsUpdateExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicates amendment to accounting standards.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL126732908-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092918&amp;loc=SL128093175-196984<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092918&amp;loc=SL128093175-196984<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=128097895&amp;loc=SL121327923-165333<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 832<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128342835&amp;loc=SL128342857-244232<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL122642865-165497<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 20<br> -Section 65<br> -Paragraph 3<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128092918&amp;loc=SL128093175-196984<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL121967933-165497<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL120254526-165497<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iv)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(iii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 32: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 65<br> -Paragraph 8<br> -Subparagraph (d)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983759&amp;loc=SL121830611-158277<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 37: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 38: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 39: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 40: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 41: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL122150809-237846<br><br>Reference 42: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 43: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 44: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 45: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL122642865-165497<br><br>Reference 46: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 47: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 20<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126986314&amp;loc=SL124402458-218513<br><br>Reference 48: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126983955&amp;loc=SL120254526-165497<br><br>Reference 49: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 50: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 51: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 52: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 53: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 54: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 55: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 56: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 105<br> -SubTopic 10<br> -Section 65<br> -Paragraph 6<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126987489&amp;loc=SL124442142-165695<br><br>Reference 57: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 58: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(03)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 59: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 60: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 61: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 848<br> -SubTopic 10<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (a)(3)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=125980421&amp;loc=SL125981372-237846<br><br>Reference 62: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 10<br> -Section 65<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128293352&amp;loc=SL126838806-209984<br><br>Reference 63: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 832<br> -SubTopic 10<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128342835&amp;loc=SL128342857-244232<br><br>Reference 64: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 10<br> -Section 65<br> -Paragraph 4<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=122640432&amp;loc=SL121648383-210437<br><br>Reference 65: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 66: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (f)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 67: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 68: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingStandardsUpdateExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>enum2:enumerationSetItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11149-113907<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 20<br> -Section 55<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126964447&amp;loc=d3e11178-113907<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 35<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126961718&amp;loc=d3e4534-113899<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(02)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI https://asc.fasb.org/extlink&amp;oid=122038336&amp;loc=d3e74512-122707<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140066176197424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (9,102,000)<span></span>
</td>
<td class="num">$ (2,878,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Stock-based compensation</a></td>
<td class="nump">726,000<span></span>
</td>
<td class="nump">456,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">416,000<span></span>
</td>
<td class="nump">358,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAmortizationOfDeferredCharges', window );">Amortization of deferred costs</a></td>
<td class="nump">134,000<span></span>
</td>
<td class="nump">1,252,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Non-cash operating lease expense</a></td>
<td class="nump">202,000<span></span>
</td>
<td class="nump">140,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="nump">131,000<span></span>
</td>
<td class="num">(209,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventories</a></td>
<td class="num">(345,000)<span></span>
</td>
<td class="nump">161,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredCharges', window );">Deferred costs</a></td>
<td class="num">(864,000)<span></span>
</td>
<td class="num">(595,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">553,000<span></span>
</td>
<td class="nump">41,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="nump">59,000<span></span>
</td>
<td class="num">(51,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities', window );">Accrued and other current liabilities</a></td>
<td class="nump">1,120,000<span></span>
</td>
<td class="num">(332,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInDeferredRevenue', window );">Deferred revenue</a></td>
<td class="nump">657,000<span></span>
</td>
<td class="num">(1,300,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="num">(179,000)<span></span>
</td>
<td class="num">(86,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(6,492,000)<span></span>
</td>
<td class="num">(3,043,000)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchase of property, plant and equipment</a></td>
<td class="num">(1,140,000)<span></span>
</td>
<td class="num">(34,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(1,140,000)<span></span>
</td>
<td class="num">(34,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Issuance of common stock in connection with a stock purchase agreement</a></td>
<td class="nump">2,389,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PaymentsOfStockIssuanceCosts', window );">Payment of financing costs in connection with a stock purchase agreement</a></td>
<td class="num">(268,000)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from exercise of stock options</a></td>
<td class="nump">2,000<span></span>
</td>
<td class="nump">8,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromContributionsFromParent', window );">Capital contributions from Amprius Holdings</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">247,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ampx_PaymentOfTransactionAndIssuanceCostsInConnectionWithBusinessCombinationAndPIPEInvestment', window );">Payment of transaction and issuance costs in connection with Business Combination and PIPE investment</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(51,000)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">2,123,000<span></span>
</td>
<td class="nump">204,000<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net decrease in cash, cash equivalents and restricted cash</a></td>
<td class="num">(5,509,000)<span></span>
</td>
<td class="num">(2,873,000)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash, beginning of period</a></td>
<td class="nump">69,752,000<span></span>
</td>
<td class="nump">11,489,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash, cash equivalents and restricted cash, end of period</a></td>
<td class="nump">64,243,000<span></span>
</td>
<td class="nump">8,616,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract', window );"><strong>Reconciliation of cash, cash equivalents and restricted cash shown on the condensed consolidated balance sheets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">64,187,000<span></span>
</td>
<td class="nump">8,616,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted cash included in other assets</a></td>
<td class="nump">56,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Total cash, cash equivalents and restricted cash</a></td>
<td class="nump">$ 64,243,000<span></span>
</td>
<td class="nump">$ 8,616,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ampx_PaymentOfTransactionAndIssuanceCostsInConnectionWithBusinessCombinationAndPIPEInvestment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Payment of transaction and issuance costs in connection with Business Combination and PIPE investment</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ampx_PaymentOfTransactionAndIssuanceCostsInConnectionWithBusinessCombinationAndPIPEInvestment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ampx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=123444420&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in accrued expenses, and obligations classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the value of expenditures made during the current reporting period for benefits that will be received over a period of years. Deferred charges differ from prepaid expenses in that they usually extend over a long period of time and may or may not be regularly recurring costs of operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInDeferredRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInDeferredRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingCapitalAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingCapitalAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in obligation for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAmortizationOfDeferredCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization of other deferred costs recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAmortizationOfDeferredCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsOfStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow for cost incurred directly with the issuance of an equity security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsOfStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromContributionsFromParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from parent as a source of financing that is recorded as additional paid in capital.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromContributionsFromParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140066176803808">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of Operations and Organization<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Nature of Operations and Organization</a></td>
<td class="text">Nature of Operations and Organization <div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Nature of Operations</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Amprius Technologies, Inc. (hereafter referred to as the &#8220;Company,&#8221; &#8220;we,&#8221; &#8220;us,&#8221; or &#8220;our&#8221;) has developed, and since 2018, been in commercial production of lithium-ion batteries for mobility applications leveraging a disruptive silicon anode. Our silicon anode technology is intended to enable batteries with higher energy density, higher power density and fast charging capabilities over a wide range of operating temperatures. Our headquarters is located in Fremont, California.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Business Combination</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During fiscal year 2022, on September 14, 2022 (the &#8220;Closing Date&#8221;), we completed a business combination pursuant to the Business Combination Agreement, dated May 11, 2022 (the &#8220;Business Combination Agreement&#8221;), by and among the Company, Amprius Technologies Operating, Inc. (formerly known as Amprius Technologies, Inc. or "Legacy Amprius"), Kensington Capital Acquisition Corp. IV, and Kensington Capital Merger Sub Corp. (&#8220;Merger Sub&#8221;). Pursuant to the terms of the Business Combination Agreement, Kensington Capital Acquisition Corp. IV changed its jurisdiction of incorporation by domesticating as a corporation incorporated under the laws of the State of Delaware (the &#8220;Domestication&#8221;), upon which it changed its name to &#8220;Amprius Technologies, Inc.,&#8221; and a business combination between  Kensington Capital Acquisition Corp. IV and Legacy Amprius was effected through the merger of Merger Sub with and into Legacy Amprius, with Legacy Amprius surviving as a wholly owned subsidiary of the Company (together with the Domestication and the other transactions contemplated by the Business Combination Agreement, the &#8220;Business Combination&#8221;).</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless the context otherwise provides, the &#8220;Company&#8221; refers (i) prior to the Closing Date, to Legacy Amprius and (ii) on and after the Closing Date, to Amprius Technologies, Inc. and its subsidiaries, including Legacy Amprius. Prior to the Business Combination, Kensington Capital Acquisition Corp. IV is referred to herein as &#8220;Kensington.&#8221; </span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Business Combination was treated as a reverse recapitalization. Legacy Amprius was determined as the accounting acquirer and Kensington as the accounting acquiree for financial reporting purposes.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Since our inception, we have incurred recurring losses and negative cash flows from operations. During the three months ended March&#160;31, 2023, our net loss was $9.1 million and at March&#160;31, 2023, our accumulated deficit was $102.0 million. We expect to incur additional losses in the future as we scale our business and increase our operating expenditures, such as increasing our research and development spend and headcount. Additionally, we expect to increase our capital expenditures as we plan to build a </span><span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">GWh-scale manufacturing facility </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in the future. We may need to raise funds in order to meet our future operating and capital expenditure requirements. We may be unable to raise additional funds or enter into such other agreements when needed on favorable terms or at all. If sufficient funding is not raised, we may need to reduce our spending activities, which may negatively affect our ability to achieve our operating goals. To the extent that we raise additional funds by issuing equity securities, our stockholders may experience additional dilution.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had cash and cash equivalents of $64.2 million as of March&#160;31, 2023. We believe that our cash and cash equivalents will be sufficient to fund our operating and capital expenditure requirements over twelve months from the date these financial statements are issued. </span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September&#160;27, 2022, we entered into a Common Stock Purchase Agreement (&#8220;Purchase Agreement&#8221;) with B. Riley Principal Capital II, LLC (&#8220;BRPC II&#8221;), pursuant to which BRPC II committed to purchase up to $200.0 million of our common stock until January 1, 2025, subject to certain contractual terms (the &#8220;Committed Equity Financing&#8221;). As of March&#160;31, 2023, $197.6 million remained available under the Committed Equity Financing. There can be no assurance that we will be able to raise such amount over the remaining period as the Committed Equity Financing contains certain limitations and conditions. </span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On October&#160;19, 2022, the U.S. Department of Energy (&#8220;DOE&#8221;) under the Bipartisan Infrastructure Law awarded us a cost-sharing grant of $50.0 million. The grant is dependent upon the successful negotiation of a final contract. There can be no assurance that such negotiation will be successful.   </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Risk and Uncertainties</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We face risks related to the COVID-19&#160;pandemic, which has created significant volatility in the global economy, led to business disruptions, reduced economic activities, and imposition of travel restrictions. Although the COVID-19 pandemic did not have an adverse impact to us to-date, its future development is highly uncertain and cannot be predicted. Even after the COVID-19 pandemic has subsided, our company and our customers may continue to experience its negative effect, which may adversely affect our future financial condition, results of operations and cash flows.</span></div>We also face risks related to the war between Russia and Ukraine, which has also led to significant volatility in the global economy resulting in higher inflation, volatility in the credit and capital markets, and interruption in the supply chain. Although this war did not have an adverse impact to us to-date, its future outcome is highly unpredictable and uncertain, which may also adversely affect our future financial condition, results of operations and cash flows.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI https://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI https://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140066175435104">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">Summary of Significant Accounting Policies<div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">and Principles of Consolidation</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;). </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All intercompany accounts and transactions have been eliminated.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The significant accounting policies described below, together with other notes that follow, are an integral part of the condensed consolidated financial statements. </span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the closing of the Business Combination, whereby Legacy Amprius was determined as the accounting acquirer for accounting and reporting purposes, the historical financial statements of Legacy Amprius became the historical financial statements of the combined company and no goodwill or other intangible assets were recorded. As a result, the accompanying condensed consolidated financial statements reflect (i) the assets and liabilities of Legacy Amprius at their historical cost; (ii) the historical operating results of Legacy Amprius prior to the Business Combination; and (iii) Legacy Amprius&#8217; equity structure, which has been retroactively restated in the comparative period to reflect the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">number of shares of the Compa</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ny&#8217;s common stock issued to Legacy Amprius stockholders. As such, the shares, corresponding capital amounts, and net loss per share related to Legacy Amprius common stock have been retroactively restated to reflect the effect of the exchange ratio of 1.45590 (the &#8220;Exchange Ratio&#8221;) established in the Business Combination.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Business Combination, our financial statements were presented on a carve-out basis using our historical results of operations and historical basis of assets and liabilities derived from the accounting records of our majority stockholder, Amprius, Inc. (&#8220;Amprius Holdings&#8221;), adjusted as necessary to conform with U.S. GAAP.  The underlying assumptions in our presentation of our financial statements prior to the Business Combination include:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Balance sheet includes all of our owned assets, assets assigned or contributed by Amprius Holdings, and liabilities incurred by Amprius Holdings on our behalf. </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Statement of operations reflects all activities directly attributable to us, which include an allocation of certain general and administrative expenses of Amprius Holdings. </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Certain general and administrative expenses of Amprius Holdings, such as the payroll-related expenses for two executive employees, legal, tax, insurance and accounting fees, were shared between us, Amprius Holdings and its other subsidiaries. Since those two executive employees provided us and Amprius Holdings' other subsidiaries with governance and management oversight, those shared expenses were allocated between us and Amprius Holdings' other subsidiaries. The level of effort spent by Amprius Holdings' executives was not correlated with the level of our business activity, revenue or other financial operating metrics and of Amprius Holdings' other subsidiaries. As a result, those shared expenses were allocated equally between us and Amprius Holdings' other subsidiaries. </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Prior to the distribution of Amprius Holdings' other subsidiaries in January 2022 and February 2022, the shared expenses of Amprius Holdings were allocated equally between us and Amprius Holdings' other subsidiaries. After February 2022, those expenses were fully allocated to us.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management believes that the assumptions described above, including the allocation of certain shared expenses, are reasonable and consistently applied for all periods presented prior to the Business Combination. However, the financial statements of that were presented prior to the Business Combination may not be indicative of our future performance and </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">do not necessarily reflect what the financial position, results of operations and cash flows would have been had we operated as a separate and standalone entity.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unaudited Interim Condensed Consolidated Financial Statements</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated balance sheet as of December&#160;31, 2022, which has been derived from our audited financial statements as filed in our Annual Report on Form 10-K with the Securities and Exchange Commission (&#8220;SEC&#8221;) on March 30, 2023, and the unaudited interim condensed consolidated financial statements have been prepared in accordance with U.S. GAAP and applicable rules and regulations of the SEC regarding interim financial reporting. Any reference in these notes to applicable accounting guidance is meant to refer to the authoritative U.S. GAAP included in the Accounting Standards Codification (&#8220;ASC&#8221;), and Accounting Standards Updates (&#8220;ASU&#8221;) issued by the Financial Accounting Standards Board (&#8220;FASB&#8221;). The condensed consolidated financial statements have been prepared on a basis consistent with the audited financial statements. In management&#8217;s opinion, all adjustments made were normal or recurring in nature and necessary for the fair statement of our financial position as of March&#160;31, 2023 and our results of operations and cash flows during the three months ended March&#160;31, 2023 and 2022. The financial data and other financial information disclosed in the notes to these condensed consolidated financial statements are also unaudited. The results of operations during the three months ended March&#160;31, 2023 are not necessarily indicative of the results to be expected for the full fiscal year or any other period.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain information and note disclosures normally included in annual financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to those rules and regulations, although we believe that the disclosures made are adequate to make the information not misleading.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Emerging Growth Company</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are an emerging growth company as defined in Section&#160;2(a) of the Securities Act of 1933 (as amended) (&#8220;Securities Act&#8221;), and we may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies. Further, Section&#160;102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised accounting standards until private companies are required to comply with such standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. We have elected to not opt out of such extended transition period. This means that when a standard is issued or revised and it has different application dates for public or private companies, we, as an&#160;emerging growth company, can adopt the new or revised standard at the time private companies adopt such new or revised standard unless we are no longer deemed an emerging growth company. As a result, the accompanying condensed consolidated financial statements may not be comparable to companies that comply with the new or revised accounting pronouncements as of public company effective dates.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. These estimates are based on current facts, historical experience and various other factors believed to be reasonable under the circumstances; the results of which form the basis for making judgements that are not readily apparent from other sources. Actual results could materially differ from management estimates using different assumptions or under different conditions. </span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our significant accounting estimates include useful lives of property, plant and equipment; valuation of deferred taxes; lower of cost or net realizable adjustment of inventory; carve-out of financial statements including the allocation of assets, liabilities and expenses prior to the Business Combination; incremental borrowing rate used in calculating lease obligations and right-of-use assets; and fair value of common stock prior to the Business Combination and other inputs used to value stock-based compensation awards.  </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fair Value Measurements</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had a money market fund amounting to $41.1&#160;million and $69.4&#160;million as of March&#160;31, 2023 and December&#160;31, 2022, respectively, which was measured at Level 1 fair value based on the active market price of such instrument. </span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We did not have assets or liabilities measured at fair value on a recurring basis using Level 2 or Level 3 inputs as of March&#160;31, 2023 and December&#160;31, 2022. </span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no transfers of financial instruments between Level 1, Level 2 and Level 3 during the three months ended March&#160;31, 2023 and 2022.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Restricted Cash</span></div><div style="margin-top:10pt;text-align:justify;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Restricted cash pertains to cash collateral required by our lessor to satisfy a letter of credit requirement under our lease agreement. Restricted cash, which is included in other assets in the accompanying condensed consolidated balance sheets, was $56 thousand as of March&#160;31, 2023 and December&#160;31, 2022. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Concentration of Credit Risk</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable mainly consist of amounts due from U.S. government agencies or sponsored entities and large public entities which limits our credit risk. Through March&#160;31, 2023, we have not experienced any credit losses. </span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2023, three customers represented 34%, 23% and 19% of our revenue. During the three months ended March&#160;31, 2022, three customers represented 40%, 31% and 19% of our revenue. </span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023 and December&#160;31, 2022, two and three customers represented 65% and 88%, respectively, of our total accounts receivable.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment Reporting</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have determined that the Chief Executive Officer is our Chief Operating Decision Maker (&#8220;CODM&#8221;). The CODM reviews financial information presented on an aggregate basis for the purposes of assessing our performance and making decisions on how to allocate resources. Accordingly, we have determined that we operate in a single operating and reportable segment. All of our revenues are geographically earned in the United States and our property, plant and equipment are located in the United States.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Significant Accounting Policies</span></div><div><span><br/></span></div><div style="text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no changes to our significant accounting policies described in the Annual Report on Form 10-K for the year ended December 31, 2022, other than the new accounting policy that was implemented as a result of the adoption of a new accounting standard as described below.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Adopted Accounting Standard</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2023, we adopted FASB ASU 2016-13,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Financial Instruments&#8212;Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and related amendment under ASU 2019-10, which requires that credit losses on financial assets, such as trade and other receivables, be recognized as allowance for losses. Credit losses on trade and other receivables will reflect the current estimate of the expected credit losses that generally will result in the earlier recognition of allowances for losses. The adoption of this ASU did not have a material impact on our condensed consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18726-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI https://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140066177101280">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerTextBlock', window );">Revenue</a></td>
<td class="text">Revenue<div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Disaggregation of Revenue</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from customers consists mainly of customized design services arrangements and sale of battery products. Revenue from customized design services arrangements, which may include a requirement to achieve certain agreed upon milestones, is recognized when the battery design is completed and the final prototype batteries are delivered. Revenue from sale of battery products is recognized upon shipment. We disaggregate our revenue from customers by the type of arrangement, either as customization design services or as sale of battery products, as this depicts how the nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factors. The table below shows the composition of revenue from customers, as disaggregated by type of arrangement in accordance with Topic 606, and other revenue from a government grant accounted for using the analogy from IAS 20 (in thousands). </span></div><div style="margin-top:10pt;text-indent:25.2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.939%"><tr><td style="width:1.0%"/><td style="width:71.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.803%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.933%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue from customers:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sale of battery products</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">605&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customized design services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,505&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue from customers</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,110&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenue &#8211; government grant</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,110&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue from sale of batteries includes bill-and-hold arrangements, of which there was none during the three months ended March&#160;31, 2023 and $67 thousand during the three months ended March&#160;31, 2022.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contract Balances</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The timing of revenue recognition, billings and cash collections can result in accounts receivable, contract assets recorded as unbilled receivables, and contract liabilities recorded as deferred revenue.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable represents our right to consideration that is unconditional. A right to consideration is unconditional if only the passage of time is required before payment of that consideration is due. Accounts receivable was $0.6 million, $0.7 million and $0.3 million as of March&#160;31, 2023, December&#160;31, 2022 and January 1, 2022, respectively. </span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract assets primarily relate to the rights to consideration for progress on contractual requirements performed but not billed at the reporting date. The contract assets are transferred to accounts receivable when the rights become unconditional. As of March&#160;31, 2023 and December&#160;31, 2022, we had no contract assets.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Contract liabilities consist primarily of deferred revenue, w</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">hich is the amount of progress payments received or billed in advance of revenue recognition. Deferred revenue is subsequently recognized as revenue when the performance obligation is satisfied. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred revenue was $4.0 million, $3.4 million and $2.9 million as of March&#160;31, 2023, December&#160;31, 2022 and January 1, 2022, respectively. Deferred revenue as of March&#160;31, 2023 and December&#160;31, 2022 increased compared to the deferred revenue as of December&#160;31, 2022 and January 1, 2022, respectively, primarily due to progress payments for certain customer contracts that have not been recognized as revenue as of the end of those periods.</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> During the three months ended March&#160;31, 2023 and 2022, revenue recognized from the prior year deferred revenue balance was $120 thousand and $1.4 million, respectively.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Remaining Performance Obligations</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have performance obligations associated with commitments in customer contracts for future services that have not yet been recognized as revenue. As of March&#160;31, 2023, the aggregate amount of the transaction price allocated to the remaining performance obligations related to customer contracts that were unsatisfied or partially unsatisfied, including deferred revenue, was approximately $11.0 million. Given the applicable contract terms, approximately $7.1 million is expected to be recognized as revenue within one year and approximately $3.9 million is expected to be recognized between two to five years. This amount does not include contracts to which the customer is not committed. The estimated timing of the recognition of remaining unsatisfied performance obligations is subject to change and is affected by changes to scope, changes in timing of delivery of products and services, or contract modifications.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI https://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130551-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130550-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130558-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130554-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140066180079616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventory<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureTextBlock', window );">Inventory</a></td>
<td class="text">Inventory<div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory consisted of the following (in thousands):</span></div><div style="text-indent:25.2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.636%"><tr><td style="width:1.0%"/><td style="width:70.097%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.977%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.447%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.979%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td style="background-color:#ffffff;border-bottom:2.5pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2.5pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">845&#160;</span></td><td style="background-color:#ffffff;border-bottom:2.5pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2.5pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2.5pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;border-bottom:2.5pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI https://asc.fasb.org/topic&amp;trid=2126998<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140066265593024">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant and Equipment, Net<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock', window );">Property, Plant and Equipment, Net</a></td>
<td class="text">Property, Plant and Equipment, Net<div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment, net consisted of the following (in thousands):</span></div><div style="text-indent:25.2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.636%"><tr><td style="width:1.0%"/><td style="width:70.097%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.977%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.447%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.979%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Production equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,114&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,488&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lab equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,452&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,304&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,080&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,525&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture, fixtures and other equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">602&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, at cost</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,608&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,480&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,660)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,244)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,948&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,236&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div>Depreciation and amortization expense was $0.4 million during each of the three months ended March&#160;31, 2023 and 2022.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99893-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -URI https://asc.fasb.org/topic&amp;trid=2155823<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=SL120174063-112916<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126982197&amp;loc=d3e99779-112916<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140066179938688">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued and Other Current Liabilities<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock', window );">Accrued and Other Current Liabilities</a></td>
<td class="text">Accrued and Other Current Liabilities <div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued and other current liabilities consisted of the following (in thousands):</span></div><div style="margin-top:10pt;text-indent:25.2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.333%"><tr><td style="width:1.0%"/><td style="width:70.653%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.023%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.024%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional fees</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,406&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">481&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation and benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,840&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued financing costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued and other current liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,665&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,708&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a),20,24)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140066180768624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Stockholders' Equity</a></td>
<td class="text">Stockholders&#8217; Equity<div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Common and Preferred Stock</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, we had a total of 1,000,000,000 shares of stock authorized to be issued, of which 950,000,000 shares are designated as common stock, $0.0001 par value per share, and 50,000,000 shares are designated as preferred stock, $0.0001 par value per share. Holders of common stock are entitled to one vote for each share held and entitled to receive dividends when and if declared by the board of directors. Through and as of March&#160;31, 2023, we have not declared any dividends.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Equity Incentive Plans</span></div><div style="margin-top:10pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">We adopted the 2022 Equity Incentive Plan (&#8220;2022 Plan&#8221;) effective September 14, 2022. The 2022 Plan authorizes awards in the form of stock options, stock appreciation rights, restricted stock, restricted stock units, or performance awards and may be granted to directors, employees or consultants. </span></div><div style="margin-top:10pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">As of March&#160;31, 2023, the total number of shares reserved for issuance under the 2022 Plan was 13,915,807, which includes the increase in shares reserved pursuant to the evergreen provisions contained in the 2022 Plan and the assumed awards that were cancelled, expired or otherwise terminated without having been exercised in full, were tendered to or withheld for payment of an exercise price or for tax withholding obligations, or were forfeited to or repurchased due to failure to vest. The number of shares available for issuance under the 2022 Plan may be increased annually at the beginning of the fiscal year, subject to certain limitations.</span></div><div style="margin-top:10pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Amprius Technologies, Inc. 2016 Equity Incentive Plan (&#8220;2016 Plan&#8221;), which we maintained prior to the Business Combination, was terminated concurrently with the adoption of the 2022 Plan. However, the 2016 Plan continues to govern the terms and conditions of the outstanding awards previously granted under the 2016 Plan.</span></div><div style="margin-top:10pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">The 2022 Plan and 2016 Plan are collectively referred to as the &#8220;Equity Incentive Plans.&#8221;</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%">Stock Options</span></div><div style="margin-top:10pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options granted under the Equity Incentive Plans provided an exercise price not less than 100% of the fair value at the grant date, unless the optionee is a 10% stockholder, in which case the option price will not be less than 110% of such fair market value. Options granted generally have a maximum term of 10 years from grant date or 90 days from the termination of the optionee, are exercisable upon vesting unless otherwise designated for early exercise by the Board of Directors at the time of grant, and generally vest over a period of four years. </span></div><div><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">As of March&#160;31, 2023, the total unrecognized stock-based compensation expense related to the unvested stock options was approximately $7.7 million, which we expect to recognize over a weighted-average period of 2.9 years.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%">Restricted Stock Units (&#8220;RSU&#8221;)</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of RSUs is determined based upon the market closing price of our common stock on the date of grant. RSUs generally vest over a period of approximately four years from the date of grant, subject to the continued employment or services of the grantee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="margin-top:10pt;text-indent:27pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, the total unrecognized stock-based compensation expense related to the unvested RSUs was approximately $2.4&#160;million, which we expect to recognize over a weighted-average period of 3.8 years.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Amprius Holdings 2008 Stock Plan</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The stock-based compensation costs associated with grants to certain individuals who provided services to our company under the Amprius Holdings 2008 Stock Plan were included in the accompanying condensed consolidated statements of operations, with a corresponding increase in additional paid-in capital. The remaining unrecognized compensation cost as of March&#160;31, 2023 was not material.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:107%">Employee Stock Purchase Plan (&#8220;ESPP&#8221;)</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">We adopted the 2022 Employee Stock Purchase Plan (&#8220;ESPP&#8221;) effective September&#160;14, 2022. As of March&#160;31, 2023, the total number of shares reserved for issuance was 1,836,101, which may be increased annually at the beginning of the fiscal year subject to certain limitations. The ESPP is intended to qualify under Section 423 of the Internal Revenue Code of 1986 (as amended) and will provide eligible employees an opportunity to purchase our common stock at a discount through payroll deductions. We have not established an offering under the ESPP as of March&#160;31, 2023.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%">  </span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:107%">Executive Incentive Compensation Plan</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">On September&#160;14, 2022, our board of directors approved our Executive Incentive Compensation Plan, which will allow us to grant incentive awards to certain executive employees, generally payable in cash, based upon achieving specified goals. We have the right to settle the award by granting an equity award, which may be subject to vesting conditions. All awards under the Executive Incentive Compensation Plan will be subject to reduction, cancellation, forfeiture, or recoupment in accordance with any clawback policy that we are required to adopt pursuant to applicable laws. As of March&#160;31, 2023, there were no awards granted under the Executive Incentive Compensation Plan. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Common Stock Warrants</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding stock warrants consisted of the following as of March&#160;31, 2023:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.787%"><tr><td style="width:1.0%"/><td style="width:45.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.185%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.824%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:22.003%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of <br/>Warrants</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exercise Price <br/>Per Share</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Expiration Date</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Public warrants</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,268,336&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.50&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 14, 2027</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,400,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 14, 2027</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PIPE warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,052,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 14, 2027</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total warrants</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,720,836</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Holders of the public warrants and private warrants are entitled to purchase one share our common stock at a price of $11.50 per share subject to adjustment pursuant to the Warrant Agreement, dated as of March 1, 2022. The public warrants are listed on the NYSE and are redeemable by us when the price per share of our common stock equals or </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">exceeds $18.00 </span></div><div style="margin-top:10pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">per share for at least 20 trading days during a period of 30 consecutive trading days prior to the redemption date. The private warrants are not listed on any securities exchange and not redeemable.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The warrants issued as part of units in a private placement in connection with the Business Combination (the &#8220;PIPE warrants&#8221;) are substantially identical to the public warrants, except that the exercise price of each PIPE warrant is $12.50 per share. In addition, we may only be able to redeem the PIPE warrants if the price per share of our common stock equals or exceeds $20.00 per share for at least 20 trading days during a period of 30 consecutive trading days prior to the redemption date. The PIPE warrants are also not listed on any securities exchange.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The warrants described above are classified as equity in accordance with the guidance under ASC 815-40, </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Derivatives and Hedging&#8211;Contracts in Entity&#8217;s Own Equity</span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Equity-classified contracts, such as stock warrants, are initially measured at fair value or allocated value. Any subsequent changes in fair value are not recognized as long as the contracts continue to be classified in equity. </span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Stock Purchase Agreement</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On September&#160;27, 2022, we entered into the Purchase Agreement with BRPC II, pursuant to which we, at our option, have the right to sell to BRPC II up to $200.0 million of our common stock until January 1, 2025, subject to certain contractual terms. The purchase price will be determined by reference to the volume weighted average price of our common stock (as defined in the Purchase Agreement), less a discount of 3%. We cannot issue to BRPC II more than 19.99% of the aggregate number of shares of the common stock issued and outstanding immediately prior to the execution of the Purchase Agreement, except in limited circumstances. Proceeds from the sale of our common stock to BRPC II will depend upon the frequency and the market price of our common stock on the date of sale.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2023, we issued a total of 331,351 shares of common stock to BRPC II with proceeds totaling $2.4&#160;million. The deferred stock issuance cost, which is included in other assets in the accompanying condensed consolidated balance sheets and will be charged proportionally against the proceeds from future issuance of shares to BRPC II under the Purchase Agreement, was $0.6&#160;million as of March&#160;31, 2023.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:107%">Stock-Based Compensation </span></div><div style="margin-top:10pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation from stock options and RSUs under the Equity Incentive Plans and from stock options under the Amprius Holdings 2008 Stock Plan that we recorded were included in the following lines in the accompanying condensed consolidated statements of operations during the periods presented (in thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div><span><br/></span></div><div style="text-indent:25.2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.636%"><tr><td style="width:1.0%"/><td style="width:70.097%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.977%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.447%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.979%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#ccecff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td style="background-color:#ccecff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ccecff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#ccecff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ccecff;padding:0 1pt"/><td style="background-color:#ccecff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ccecff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#ccecff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ccecff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#ccecff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">537&#160;</span></td><td style="background-color:#ccecff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ccecff;padding:0 1pt"/><td colspan="2" style="background-color:#ccecff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337&#160;</span></td><td style="background-color:#ccecff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">726&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">456&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI https://asc.fasb.org/topic&amp;trid=2208762<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (g)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496171-112644<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496189-112644<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 16<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496180-112644<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126731327&amp;loc=SL126733271-114008<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140066176890080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureTextBlock', window );">Income Taxes</a></td>
<td class="text">Income TaxesWe have no income tax expense as a result of the continued generation of net operating losses (&#8220;NOLs&#8221;)&#160;offset by a full valuation allowance recorded on such NOLs, as we determined it is not more-likely-than-not&#160;that our NOLs will be utilized.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32857-109319<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 11.C)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330215-122817<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32809-109319<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.5.Q1)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 14<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32705-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 270<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6424409&amp;loc=d3e44925-109338<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -URI https://asc.fasb.org/topic&amp;trid=2144680<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6424122&amp;loc=d3e41874-109331<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140066176853536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">LeasesWe have a non-cancelable operating lease for our corporate headquarters and facilities in Fremont, California. On January&#160;4, 2023, we entered into an amendment of such lease, which includes the lease of additional space in the same building and extending the lease term to end on June&#160;30, 2027, with an option to extend for an additional&#160;five-year term.  Our operating lease does not contain any material residual value guarantees. We had no leases that were classified as a financing lease as of March&#160;31, 2023.  <div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2023, the weighted-average remaining term of the operating lease was 9.3 years and the weighted-average discount rate used to estimate the net present value of the operating lease liabilities was 7.9%.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2023, the total amount of right-of-use assets obtained in exchange for new operating lease liabilities was $5.2 million. The total amount paid for amounts included in the measurement of operating lease liabilities was $179 thousand and $86 thousand during the three months ended March&#160;31, 2023 and 2022, respectively.  </span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Operating lease expense was $202 thousand and $140 thousand during the three months ended March&#160;31, 2023 and 2022, respectively. Variable lease expense was not material.</span></div><div style="margin-top:9pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future operating lease payments as of March&#160;31, 2023 were as follows (in thousands): </span></div><div style="margin-top:10pt;text-indent:25.2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.272%"><tr><td style="width:1.0%"/><td style="width:84.614%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.186%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ending December 31:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">822&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,193&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,241&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,278&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,729&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross lease payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,547&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less - present value adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,359)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,188&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI https://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140066176946208">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitment and Contingencies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and ContingenciesFrom time to time, we may be involved in lawsuits, claims or legal proceedings that arise in the ordinary course of business. We accrue a contingent liability when it is probable that a liability has been incurred and the amount of loss can be reasonably estimated. Management believes that there are no claims against us for which the outcome is expected to have a material effect on our financial position, results of operations or cash flows .<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI https://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 440<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6491277&amp;loc=d3e6429-115629<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI https://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123406679&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140066174654272">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Loss Per Share</a></td>
<td class="text">Net Loss Per Share<div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the calculation of basic and diluted net loss per share attributable to common stockholders </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in thousands, except share and per share amounts)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div><span><br/></span></div><div style="text-indent:25.2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.636%"><tr><td style="width:1.0%"/><td style="width:70.097%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.977%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.447%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.979%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,102)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,878)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average number of common shares outstanding</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,645,097</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,774,528</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net loss per common share</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.11)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.04)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the outstanding shares of potentially dilutive securities that were excluded from the calculation of diluted earnings per share because their inclusion would have been anti-dilutive:</span></div><div><span><br/></span></div><div style="text-indent:25.2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.939%"><tr><td style="width:1.0%"/><td style="width:41.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.445%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.932%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.445%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.932%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.445%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.934%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,720,836&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,971,079&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,351,020&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,986,915</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,351,020</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI https://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140066176892512">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Subsequent Events<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsAbstract', window );"><strong>Subsequent Events [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventsTextBlock', window );">Subsequent Event</a></td>
<td class="text">Subsequent Events<div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Brighton, Colorado Lease</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On April&#160;15, 2023, we entered into a lease agreement to lease a space for our GWh-scale manufacturing facility in Brighton, Colorado. The lease expires in May 2039, with an option to extend for two additional five-year terms. Future lease payments, which commence in December 2024 after the rent abatement period, total approximately $62.9 million. The current zoning for this site does not allow for manufacturing our batteries. As such, the property owner is in the process of applying to re-zone the site for our planned development and use. Until the re-zoning is complete, we will not be able to apply for permits required to repurpose the facility for manufacturing. If the re-zoning application is not approved, the lease agreement will automatically terminate.</span></div><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Merger with Amprius Holdings</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On May 9, 2023, we entered into an Agreement and Plan of Merger and Reorganization (the &#8220;Merger Agreement&#8221;) with, among others, Amprius Holdings. Under the Merger Agreement, through a series of transactions that are intended to qualify as a tax-free reorganization for U.S. income tax purposes, Amprius Holdings will become our wholly owned subsidiary and then be merged into another wholly owned subsidiary, with such other subsidiary surviving. Subject to the terms and conditions in the Merger Agreement, the shares of our common stock currently owned by Amprius Holdings will be cancelled, and we will issue to the stockholders of Amprius Holdings new shares of our common stock or shares of our non-voting common stock based on a negotiated and discounted exchange ratio. Furthermore, the options in Amprius Holdings, whether vested or unvested, to purchase Amprius Holdings stock shall be converted into options to purchase shares of our common stock and the warrants to purchase Amprius Holdings stock shall automatically be replaced with warrants representing the right to receive shares of our common stock on a net-exercise basis. The transactions contemplated by the Merger Agreement are conditioned on, among other items, the approval of a majority of shares held by our stockholders that are not affiliated with either Amprius Holdings or held by any of our directors or officers.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -URI https://asc.fasb.org/topic&amp;trid=2122774<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 855<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=6842918&amp;loc=SL6314017-165662<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140066180830592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">and Principles of Consolidation</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;). </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All intercompany accounts and transactions have been eliminated.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The significant accounting policies described below, together with other notes that follow, are an integral part of the condensed consolidated financial statements. </span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the closing of the Business Combination, whereby Legacy Amprius was determined as the accounting acquirer for accounting and reporting purposes, the historical financial statements of Legacy Amprius became the historical financial statements of the combined company and no goodwill or other intangible assets were recorded. As a result, the accompanying condensed consolidated financial statements reflect (i) the assets and liabilities of Legacy Amprius at their historical cost; (ii) the historical operating results of Legacy Amprius prior to the Business Combination; and (iii) Legacy Amprius&#8217; equity structure, which has been retroactively restated in the comparative period to reflect the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">number of shares of the Compa</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ny&#8217;s common stock issued to Legacy Amprius stockholders. As such, the shares, corresponding capital amounts, and net loss per share related to Legacy Amprius common stock have been retroactively restated to reflect the effect of the exchange ratio of 1.45590 (the &#8220;Exchange Ratio&#8221;) established in the Business Combination.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Business Combination, our financial statements were presented on a carve-out basis using our historical results of operations and historical basis of assets and liabilities derived from the accounting records of our majority stockholder, Amprius, Inc. (&#8220;Amprius Holdings&#8221;), adjusted as necessary to conform with U.S. GAAP.  The underlying assumptions in our presentation of our financial statements prior to the Business Combination include:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Balance sheet includes all of our owned assets, assets assigned or contributed by Amprius Holdings, and liabilities incurred by Amprius Holdings on our behalf. </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Statement of operations reflects all activities directly attributable to us, which include an allocation of certain general and administrative expenses of Amprius Holdings. </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Certain general and administrative expenses of Amprius Holdings, such as the payroll-related expenses for two executive employees, legal, tax, insurance and accounting fees, were shared between us, Amprius Holdings and its other subsidiaries. Since those two executive employees provided us and Amprius Holdings' other subsidiaries with governance and management oversight, those shared expenses were allocated between us and Amprius Holdings' other subsidiaries. The level of effort spent by Amprius Holdings' executives was not correlated with the level of our business activity, revenue or other financial operating metrics and of Amprius Holdings' other subsidiaries. As a result, those shared expenses were allocated equally between us and Amprius Holdings' other subsidiaries. </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Prior to the distribution of Amprius Holdings' other subsidiaries in January 2022 and February 2022, the shared expenses of Amprius Holdings were allocated equally between us and Amprius Holdings' other subsidiaries. After February 2022, those expenses were fully allocated to us.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management believes that the assumptions described above, including the allocation of certain shared expenses, are reasonable and consistently applied for all periods presented prior to the Business Combination. However, the financial statements of that were presented prior to the Business Combination may not be indicative of our future performance and </span></div>do not necessarily reflect what the financial position, results of operations and cash flows would have been had we operated as a separate and standalone entity.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Principles of Consolidation</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Basis of Presentation </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">and Principles of Consolidation</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#8220;U.S. GAAP&#8221;). </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All intercompany accounts and transactions have been eliminated.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The significant accounting policies described below, together with other notes that follow, are an integral part of the condensed consolidated financial statements. </span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the closing of the Business Combination, whereby Legacy Amprius was determined as the accounting acquirer for accounting and reporting purposes, the historical financial statements of Legacy Amprius became the historical financial statements of the combined company and no goodwill or other intangible assets were recorded. As a result, the accompanying condensed consolidated financial statements reflect (i) the assets and liabilities of Legacy Amprius at their historical cost; (ii) the historical operating results of Legacy Amprius prior to the Business Combination; and (iii) Legacy Amprius&#8217; equity structure, which has been retroactively restated in the comparative period to reflect the </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">number of shares of the Compa</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ny&#8217;s common stock issued to Legacy Amprius stockholders. As such, the shares, corresponding capital amounts, and net loss per share related to Legacy Amprius common stock have been retroactively restated to reflect the effect of the exchange ratio of 1.45590 (the &#8220;Exchange Ratio&#8221;) established in the Business Combination.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the Business Combination, our financial statements were presented on a carve-out basis using our historical results of operations and historical basis of assets and liabilities derived from the accounting records of our majority stockholder, Amprius, Inc. (&#8220;Amprius Holdings&#8221;), adjusted as necessary to conform with U.S. GAAP.  The underlying assumptions in our presentation of our financial statements prior to the Business Combination include:</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Balance sheet includes all of our owned assets, assets assigned or contributed by Amprius Holdings, and liabilities incurred by Amprius Holdings on our behalf. </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Statement of operations reflects all activities directly attributable to us, which include an allocation of certain general and administrative expenses of Amprius Holdings. </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Certain general and administrative expenses of Amprius Holdings, such as the payroll-related expenses for two executive employees, legal, tax, insurance and accounting fees, were shared between us, Amprius Holdings and its other subsidiaries. Since those two executive employees provided us and Amprius Holdings' other subsidiaries with governance and management oversight, those shared expenses were allocated between us and Amprius Holdings' other subsidiaries. The level of effort spent by Amprius Holdings' executives was not correlated with the level of our business activity, revenue or other financial operating metrics and of Amprius Holdings' other subsidiaries. As a result, those shared expenses were allocated equally between us and Amprius Holdings' other subsidiaries. </span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Prior to the distribution of Amprius Holdings' other subsidiaries in January 2022 and February 2022, the shared expenses of Amprius Holdings were allocated equally between us and Amprius Holdings' other subsidiaries. After February 2022, those expenses were fully allocated to us.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Management believes that the assumptions described above, including the allocation of certain shared expenses, are reasonable and consistently applied for all periods presented prior to the Business Combination. However, the financial statements of that were presented prior to the Business Combination may not be indicative of our future performance and </span></div>do not necessarily reflect what the financial position, results of operations and cash flows would have been had we operated as a separate and standalone entity.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ampx_UnauditedInterimCondensedFinancialStatementsPolicyPolicyTextBlock', window );">Unaudited Interim Condensed Consolidated Financial Statements</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Unaudited Interim Condensed Consolidated Financial Statements</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated balance sheet as of December&#160;31, 2022, which has been derived from our audited financial statements as filed in our Annual Report on Form 10-K with the Securities and Exchange Commission (&#8220;SEC&#8221;) on March 30, 2023, and the unaudited interim condensed consolidated financial statements have been prepared in accordance with U.S. GAAP and applicable rules and regulations of the SEC regarding interim financial reporting. Any reference in these notes to applicable accounting guidance is meant to refer to the authoritative U.S. GAAP included in the Accounting Standards Codification (&#8220;ASC&#8221;), and Accounting Standards Updates (&#8220;ASU&#8221;) issued by the Financial Accounting Standards Board (&#8220;FASB&#8221;). The condensed consolidated financial statements have been prepared on a basis consistent with the audited financial statements. In management&#8217;s opinion, all adjustments made were normal or recurring in nature and necessary for the fair statement of our financial position as of March&#160;31, 2023 and our results of operations and cash flows during the three months ended March&#160;31, 2023 and 2022. The financial data and other financial information disclosed in the notes to these condensed consolidated financial statements are also unaudited. The results of operations during the three months ended March&#160;31, 2023 are not necessarily indicative of the results to be expected for the full fiscal year or any other period.</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain information and note disclosures normally included in annual financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to those rules and regulations, although we believe that the disclosures made are adequate to make the information not misleading.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ampx_EmergingGrowthCompanyPolicyPolicyTextBlock', window );">Emerging Growth Company</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Emerging Growth Company</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are an emerging growth company as defined in Section&#160;2(a) of the Securities Act of 1933 (as amended) (&#8220;Securities Act&#8221;), and we may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies. Further, Section&#160;102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised accounting standards until private companies are required to comply with such standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. We have elected to not opt out of such extended transition period. This means that when a standard is issued or revised and it has different application dates for public or private companies, we, as an&#160;emerging growth company, can adopt the new or revised standard at the time private companies adopt such new or revised standard unless we are no longer deemed an emerging growth company. As a result, the accompanying condensed consolidated financial statements may not be comparable to companies that comply with the new or revised accounting pronouncements as of public company effective dates.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. These estimates are based on current facts, historical experience and various other factors believed to be reasonable under the circumstances; the results of which form the basis for making judgements that are not readily apparent from other sources. Actual results could materially differ from management estimates using different assumptions or under different conditions. </span></div>Our significant accounting estimates include useful lives of property, plant and equipment; valuation of deferred taxes; lower of cost or net realizable adjustment of inventory; carve-out of financial statements including the allocation of assets, liabilities and expenses prior to the Business Combination; incremental borrowing rate used in calculating lease obligations and right-of-use assets; and fair value of common stock prior to the Business Combination and other inputs used to value stock-based compensation awards.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy', window );">Restricted Cash</a></td>
<td class="text">Restricted CashRestricted cash pertains to cash collateral required by our lessor to satisfy a letter of credit requirement under our lease agreement.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk</a></td>
<td class="text">Concentration of Credit RiskAccounts receivable mainly consist of amounts due from U.S. government agencies or sponsored entities and large public entities which limits our credit risk. Through March&#160;31, 2023, we have not experienced any credit losses.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segment Reporting</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Segment Reporting</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have determined that the Chief Executive Officer is our Chief Operating Decision Maker (&#8220;CODM&#8221;). The CODM reviews financial information presented on an aggregate basis for the purposes of assessing our performance and making decisions on how to allocate resources. Accordingly, we have determined that we operate in a single operating and reportable segment. All of our revenues are geographically earned in the United States and our property, plant and equipment are located in the United States.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recently Adopted Accounting Standard</a></td>
<td class="text"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recently Adopted Accounting Standard</span></div><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 1, 2023, we adopted FASB ASU 2016-13,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> Financial Instruments&#8212;Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments,</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and related amendment under ASU 2019-10, which requires that credit losses on financial assets, such as trade and other receivables, be recognized as allowance for losses. Credit losses on trade and other receivables will reflect the current estimate of the expected credit losses that generally will result in the earlier recognition of allowances for losses. The adoption of this ASU did not have a material impact on our condensed consolidated financial statements.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ampx_EmergingGrowthCompanyPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Emerging Growth Company, Policy</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ampx_EmergingGrowthCompanyPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ampx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ampx_UnauditedInterimCondensedFinancialStatementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Unaudited Interim Condensed Financial Statements, Policy</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ampx_UnauditedInterimCondensedFinancialStatementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ampx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126941378&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126899994&amp;loc=d3e18823-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8864-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140066176827904">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerAbstract', window );"><strong>Revenue from Contract with Customer [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock', window );">Schedule of Composition of Revenue</a></td>
<td class="text">The table below shows the composition of revenue from customers, as disaggregated by type of arrangement in accordance with Topic 606, and other revenue from a government grant accounted for using the analogy from IAS 20 (in thousands). <table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.939%"><tr><td style="width:1.0%"/><td style="width:71.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.803%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:12.933%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue from customers:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sale of battery products</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">605&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customized design services</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,505&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue from customers</span></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,110&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other revenue &#8211; government grant</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">209</span></td><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total revenue</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">679&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,110&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140066179037840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Inventory (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of Inventory</a></td>
<td class="text"><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory consisted of the following (in thousands):</span></div><div style="text-indent:25.2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.636%"><tr><td style="width:1.0%"/><td style="width:70.097%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.977%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.447%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.979%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">164&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">180&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">218&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods&#160;</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">286&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">102&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Inventories, net</span></td><td style="background-color:#ffffff;border-bottom:2.5pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2.5pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">845&#160;</span></td><td style="background-color:#ffffff;border-bottom:2.5pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:2.5pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:2.5pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">500&#160;</span></td><td style="background-color:#ffffff;border-bottom:2.5pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140066177270320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant and Equipment, Net (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Schedule of Property and Equipment, Net</a></td>
<td class="text"><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property, plant and equipment, net consisted of the following (in thousands):</span></div><div style="text-indent:25.2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.636%"><tr><td style="width:1.0%"/><td style="width:70.097%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.977%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.447%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.979%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Production equipment</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,114&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,488&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Lab equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,452&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,304&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,080&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,525&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture, fixtures and other equipment</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">360&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">206&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in progress</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">602&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">957&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, at cost</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,608&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,480&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: accumulated depreciation and amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,660)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,244)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Property, plant and equipment, net</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,948&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,236&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140066174622736">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Accrued and Other Current Liabilities (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued and Other Current Liabilities</a></td>
<td class="text"><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued and other current liabilities consisted of the following (in thousands):</span></div><div style="margin-top:10pt;text-indent:25.2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.333%"><tr><td style="width:1.0%"/><td style="width:70.653%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.023%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.024%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued professional fees</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,406&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">481&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued compensation and benefits</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,105&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,840&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued financing costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">123&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">193&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accrued and other current liabilities</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,665&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,708&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140066176791984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">Summary of Outstanding Stock Warrants</a></td>
<td class="text"><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Outstanding stock warrants consisted of the following as of March&#160;31, 2023:</span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.787%"><tr><td style="width:1.0%"/><td style="width:45.588%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.185%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:11.824%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:22.003%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of <br/>Warrants</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exercise Price <br/>Per Share</span></td><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Expiration Date</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Public warrants</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,268,336&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.50&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 14, 2027</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Private warrants</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,400,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.50&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 14, 2027</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PIPE warrants</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,052,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12.50&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 14, 2027</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total warrants</span></td><td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,720,836</span></td><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock', window );">Summary of Stock-Based Compensation Expense</a></td>
<td class="text"><div style="margin-top:10pt;text-indent:22.5pt"><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock-based compensation from stock options and RSUs under the Equity Incentive Plans and from stock options under the Amprius Holdings 2008 Stock Plan that we recorded were included in the following lines in the accompanying condensed consolidated statements of operations during the periods presented (in thousands)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div><span><br/></span></div><div style="text-indent:25.2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.636%"><tr><td style="width:1.0%"/><td style="width:70.097%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.977%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.447%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.979%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31, 2023</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#ccecff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td style="background-color:#ccecff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ccecff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">169&#160;</span></td><td style="background-color:#ccecff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ccecff;padding:0 1pt"/><td style="background-color:#ccecff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ccecff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">113&#160;</span></td><td style="background-color:#ccecff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ccecff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Selling, general and administrative</span></td><td colspan="2" style="background-color:#ccecff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">537&#160;</span></td><td style="background-color:#ccecff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ccecff;padding:0 1pt"/><td colspan="2" style="background-color:#ccecff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">337&#160;</span></td><td style="background-color:#ccecff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total stock-based compensation expense</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">726&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">456&#160;</span></td><td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 50<br> -Section S99<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6784392&amp;loc=d3e188667-122775<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140066176862944">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Schedule of Future Maturing Operating Lease Payments</a></td>
<td class="text"><div style="margin-top:9pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Future operating lease payments as of March&#160;31, 2023 were as follows (in thousands): </span></div><div style="margin-top:10pt;text-indent:25.2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.272%"><tr><td style="width:1.0%"/><td style="width:84.614%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.186%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year ending December 31:</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Amount</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remainder of 2023</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">822&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,126&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,158&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2026</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,193&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2027</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,241&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2028</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,278&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,729&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross lease payments</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,547&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less - present value adjustments</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,359)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,188&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140066176875360">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2023</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Calculation of Basic and Diluted Net Loss Per Share</a></td>
<td class="text"><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the calculation of basic and diluted net loss per share attributable to common stockholders </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(in thousands, except share and per share amounts)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div><span><br/></span></div><div style="text-indent:25.2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.636%"><tr><td style="width:1.0%"/><td style="width:70.097%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.977%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.447%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.979%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Numerator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,102)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,878)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Denominator:</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average number of common shares outstanding</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">84,645,097</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,774,528</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted net loss per common share</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.11)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.04)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Potentially Dilutive Securities</a></td>
<td class="text"><div style="margin-top:10pt;text-indent:25.2pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the outstanding shares of potentially dilutive securities that were excluded from the calculation of diluted earnings per share because their inclusion would have been anti-dilutive:</span></div><div><span><br/></span></div><div style="text-indent:25.2pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.939%"><tr><td style="width:1.0%"/><td style="width:41.964%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.803%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.445%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.932%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.445%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.932%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.445%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.934%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three months ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock warrants</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47,720,836&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Stock options</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,971,079&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,351,020&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RSUs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">295,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">61,986,915</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,351,020</span></td></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140066176194224">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Nature of Operations and Organization - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Oct. 19, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems', window );"><strong>Business Acquisition, Equity Interests Issued or Issuable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="nump">$ 9,102,000<span></span>
</td>
<td class="nump">$ 2,878,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="nump">101,989,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 92,887,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsAtCarryingValue', window );">Cash and cash equivalents</a></td>
<td class="nump">64,187,000<span></span>
</td>
<td class="nump">$ 8,616,000<span></span>
</td>
<td class="nump">$ 69,696,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ampx_CommittedEquityFinancing', window );">Committed equity financing balance</a></td>
<td class="nump">197,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ampx_GovernmentAssistanceGrantNotYetReceived', window );">Grant not yet received</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 50,000,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsidiarySaleOfStockAxis=ampx_PurchaseAgreementMember', window );">Common Stock Purchase Agreement | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems', window );"><strong>Business Acquisition, Equity Interests Issued or Issuable [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction', window );">Consideration received</a></td>
<td class="nump">$ 200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ampx_CommittedEquityFinancing">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Committed Equity Financing</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ampx_CommittedEquityFinancing</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ampx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ampx_GovernmentAssistanceGrantNotYetReceived">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Government Assistance, Grant Not Yet Received</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ampx_GovernmentAssistanceGrantNotYetReceived</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ampx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3044-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=124431353&amp;loc=SL124452729-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22499-107794<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669619-108580<br><br>Reference 25: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126968391&amp;loc=SL7669625-108580<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 34: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI https://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=124501264&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cash received on stock transaction after deduction of issuance costs.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=ampx_PurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=ampx_PurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140066175048480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Narrative (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>executiveEmployee</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Sep. 14, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ampx_RecapitalizationExchangeRatio', window );">Recapitalization exchange ratio</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.45590<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ampx_NumberOfExecutiveEmployeesOfParentSharingFacilitiesCosts', window );">Number of executive employees of parent sharing facilities costs (in executive employees) | executiveEmployee</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RestrictedCash', window );">Restricted cash included in other assets</a></td>
<td class="nump">$ 56<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 56<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member', window );">Level 1 | Money Market Funds</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure', window );">Cash equivalents</a></td>
<td class="nump">$ 41,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 69,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue benchmark | Customer concentration risk | Customer One</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">34.00%<span></span>
</td>
<td class="nump">40.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue benchmark | Customer concentration risk | Customer Two</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">23.00%<span></span>
</td>
<td class="nump">31.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue benchmark | Customer concentration risk | Customer Three</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">19.00%<span></span>
</td>
<td class="nump">19.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Accounts receivable | Customer concentration risk | Three customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="nump">65.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember', window );">Accounts receivable | Customer concentration risk | Five customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems', window );"><strong>New Accounting Pronouncements or Change in Accounting Principle [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk percentage</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">88.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ampx_NumberOfExecutiveEmployeesOfParentSharingFacilitiesCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number Of Executive Employees Of Parent Sharing Facilities Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ampx_NumberOfExecutiveEmployeesOfParentSharingFacilitiesCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ampx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ampx_RecapitalizationExchangeRatio">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Recapitalization Exchange Ratio</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ampx_RecapitalizationExchangeRatio</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ampx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:pureItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsFairValueDisclosure">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsFairValueDisclosure</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123594938&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI https://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RestrictedCash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=126999549&amp;loc=SL98516268-108586<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(1)(a))<br> -URI https://asc.fasb.org/extlink&amp;oid=126897435&amp;loc=d3e534808-122878<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RestrictedCash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsAxis=us-gaap_MoneyMarketFundsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ampx_CustomerOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ampx_CustomerOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ampx_CustomerTwoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ampx_CustomerTwoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ampx_CustomerThreeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ampx_CustomerThreeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_AccountsReceivableMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ampx_ThreeCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ampx_ThreeCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=ampx_FiveCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=ampx_FiveCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140066165266784">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Schedule of Composition of Revenue (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">$ 679<span></span>
</td>
<td class="nump">$ 2,110<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ampx_TotalRevenueFromCustomersMember', window );">Total revenue from customers</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">470<span></span>
</td>
<td class="nump">2,110<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ampx_SaleOfBatteryMember', window );">Sale of battery products</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">470<span></span>
</td>
<td class="nump">605<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ampx_CustomizedDesignServicesMember', window );">Customized design services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">1,505<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_ProductOrServiceAxis=ampx_OtherRevenueGovernmentGrantMember', window );">Other revenue &#8211; government grant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">$ 209<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ampx_TotalRevenueFromCustomersMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ampx_TotalRevenueFromCustomersMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ampx_SaleOfBatteryMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ampx_SaleOfBatteryMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ampx_CustomizedDesignServicesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ampx_CustomizedDesignServicesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=ampx_OtherRevenueGovernmentGrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=ampx_OtherRevenueGovernmentGrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140066175021616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Revenue - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Jan. 01, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">$ 679,000<span></span>
</td>
<td class="nump">$ 2,110,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable</a></td>
<td class="nump">555,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 686,000<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetNet', window );">Contract asset</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiability', window );">Contract liability</a></td>
<td class="nump">4,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3,400,000<span></span>
</td>
<td class="nump">$ 2,900,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized', window );">Revenue recognized</a></td>
<td class="nump">120,000<span></span>
</td>
<td class="nump">1,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredAtPointInTimeMember', window );">Bill-and-hold</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_Revenues', window );">Revenue</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 67,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124259787&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130533-203044<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126919976&amp;loc=SL49130532-203044<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityRevenueRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityRevenueRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Revenues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=123596393&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9031-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9038-108599<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e9054-108599<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442552-122756<br><br>Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -URI https://asc.fasb.org/extlink&amp;oid=126975872&amp;loc=SL124442526-122756<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Revenues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredAtPointInTimeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TimingOfTransferOfGoodOrServiceAxis=us-gaap_TransferredAtPointInTimeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140066176215472">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Revenue - Performance Obligation (Details)<br> $ in Millions</strong></div></th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, remaining performance obligation, amount</a></td>
<td class="nump">$ 11.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-04-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-04-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, remaining performance obligation, amount</a></td>
<td class="nump">$ 7.1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue, remaining performance obligation, period</a></td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2024-04-01', window );">Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-04-01</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems', window );"><strong>Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligation', window );">Revenue, remaining performance obligation, amount</a></td>
<td class="nump">$ 3.9<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1', window );">Revenue, remaining performance obligation, period</a></td>
<td class="text">4 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of transaction price allocated to performance obligation that has not been recognized as revenue.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126920106&amp;loc=SL49130556-203045<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-04-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2023-04-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2024-04-01">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis=2024-04-01</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140066175188288">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Inventory - Schedule of Inventory (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryDisclosureAbstract', window );"><strong>Inventory Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">$ 164,000<span></span>
</td>
<td class="nump">$ 180,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work in process</a></td>
<td class="nump">395,000<span></span>
</td>
<td class="nump">218,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods&#160;</a></td>
<td class="nump">286,000<span></span>
</td>
<td class="nump">102,000<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventories, net</a></td>
<td class="nump">$ 845,000<span></span>
</td>
<td class="nump">$ 500,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124098289&amp;loc=d3e6676-107765<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI https://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140066165305072">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Property, Plant and Equipment, Net - Schedule of Property and Equipment (Details) - USD ($)<br></strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, at cost</a></td>
<td class="nump">$ 12,608,000<span></span>
</td>
<td class="nump">$ 11,480,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: accumulated depreciation and amortization</a></td>
<td class="num">(7,660,000)<span></span>
</td>
<td class="num">(7,244,000)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">4,948,000<span></span>
</td>
<td class="nump">4,236,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=ampx_ProductionEquipmentMember', window );">Production equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, at cost</a></td>
<td class="nump">5,114,000<span></span>
</td>
<td class="nump">4,488,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=ampx_LaboratoryEquipmentMember', window );">Lab equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, at cost</a></td>
<td class="nump">2,452,000<span></span>
</td>
<td class="nump">2,304,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, at cost</a></td>
<td class="nump">4,080,000<span></span>
</td>
<td class="nump">3,525,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture, fixtures and other equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, at cost</a></td>
<td class="nump">360,000<span></span>
</td>
<td class="nump">206,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in progress</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, at cost</a></td>
<td class="nump">$ 602,000<span></span>
</td>
<td class="nump">$ 957,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI https://asc.fasb.org/extlink&amp;oid=126734703&amp;loc=d3e572229-122910<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -URI https://asc.fasb.org/extlink&amp;oid=124429447&amp;loc=SL124453093-239630<br><br>Reference 4: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 852<br> -SubTopic 10<br> -Section 55<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=84165509&amp;loc=d3e56426-112766<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=ampx_ProductionEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=ampx_ProductionEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=ampx_LaboratoryEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=ampx_LaboratoryEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140066176845536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Property, Plant and Equipment, Net - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentAbstract', window );"><strong>Property, Plant and Equipment [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_DepreciationDepletionAndAmortization', window );">Depreciation and amortization</a></td>
<td class="nump">$ 416<span></span>
</td>
<td class="nump">$ 358<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DepreciationDepletionAndAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (e)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DepreciationDepletionAndAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140066168244288">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Accrued and Other Current Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PayablesAndAccrualsAbstract', window );"><strong>Payables and Accruals [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Accrued professional fees</a></td>
<td class="nump">$ 2,406<span></span>
</td>
<td class="nump">$ 481<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeRelatedLiabilitiesCurrent', window );">Accrued compensation and benefits</a></td>
<td class="nump">1,105<span></span>
</td>
<td class="nump">1,840<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ampx_AccruedOfferingCostsCurrent', window );">Accrued financing costs</a></td>
<td class="nump">31<span></span>
</td>
<td class="nump">194<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">123<span></span>
</td>
<td class="nump">193<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued and other current liabilities</a></td>
<td class="nump">$ 3,665<span></span>
</td>
<td class="nump">$ 2,708<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ampx_AccruedOfferingCostsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Accrued Offering Costs, Current</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ampx_AccruedOfferingCostsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ampx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeRelatedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeRelatedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PayablesAndAccrualsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PayablesAndAccrualsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140066168448720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Sep. 27, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Sep. 14, 2022 </div>
<div>day </div>
<div>$ / shares</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2022 </div>
<div>$ / shares </div>
<div>shares</div>
</th>
<th class="th">
<div>Mar. 01, 2022 </div>
<div>$ / shares</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ampx_SharesAuthorized', window );">Shares authorized (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,000,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common stock, authorized (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">950,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">950,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockParOrStatedValuePerShare', window );">Common stock, par value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockSharesAuthorized', window );">Preferred stock, shares authorized (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">50,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PreferredStockParOrStatedValuePerShare', window );">Preferred stock, par value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0.0001<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized', window );">Unrecognized compensation expense | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Issuance of common stock in connection with a stock purchase agreement | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,389,000<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_srt_CounterpartyNameAxis=ampx_BRPCIIMember', window );">BRPC II | Common Stock Purchase Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ampx_SaleOfStockPotentialMaximumConsiderationReceivedOnTransaction', window );">Common stock, purchase agreement, potential maximum consideration | $</a></td>
<td class="nump">$ 200,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ampx_SaleOfStockDiscount', window );">Discount on sale of stock (percentage)</a></td>
<td class="nump">3.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ampx_SaleOfStockMaximumSharesAvailableForSalePercentageOfSharesIssuedAndOutstandingPriorToTransaction', window );">Maximum shares available for sale as a percentage of aggregate shares issued and outstanding (percentage)</a></td>
<td class="nump">19.99%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction', window );">Number of shares issued in transaction (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">331,351<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Issuance of common stock in connection with a stock purchase agreement | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ampx_DeferredStockIssuanceCosts', window );">Deferred stock issuance costs | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=ampx_PublicWarrantsMember', window );">Public warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ampx_SaleOfStockAveragePricePerShareRedemption', window );">Average price per share of redeemable warrants (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 18.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ampx_WarrantsRedemptionThresholdTradingDays', window );">Warrants, redeem, threshold trading days | day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ampx_WarrantsRedemptionThresholdConsecutiveTradingDays', window );">Warrants, redeem, threshold consecutive trading days | day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=ampx_PrivateWarrantsMember', window );">Private warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=ampx_PIPEWarrantsMember', window );">PIPE warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ampx_SaleOfStockAveragePricePerShareRedemption', window );">Average price per share of redeemable warrants (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 20.00<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ampx_WarrantsRedemptionThresholdTradingDays', window );">Warrants, redeem, threshold trading days | day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ampx_WarrantsRedemptionThresholdConsecutiveTradingDays', window );">Warrants, redeem, threshold consecutive trading days | day</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">30<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted average period to be recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">3 years 9 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Unrecognized compensation cost | $</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Weighted average period to be recognized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 10 months 24 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ampx_TwentyTwentyTwoEquityIncentivePlanMember', window );">2022 Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares available for future issuance (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">13,915,807<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ampx_EquityIncentivePlansMember', window );">Equity Incentive Plans</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ampx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfFairValue', window );">Exercise price as a percentage of fair value</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">100.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ampx_StockholderPercentageOfOptioneeForOptionPrice', window );">Stockholder Percentage Of Optionee For Option Price</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ampx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfFairValueSignificantStockholder', window );">Exercise price as a percentage of fair value, ten percent stockholders</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">110.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod', window );">Award expiration period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ampx_EquityIncentivePlansMember', window );">Equity Incentive Plans | Employee stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Award vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ampx_TwentyTwentyTwoEmployeeStockPurchasePlanMember', window );">Employee Stock Purchase Plan | Employee stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ampx_ShareBasedCompensationArrangementByShareBasedPaymentAwardReservedForIssuance', window );">Reserved for issuance (Shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,836,101<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_PlanNameAxis=ampx_ExecutiveIncentiveCompensationPlanMember', window );">Executive Incentive Compensation Plan</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ampx_DeferredStockIssuanceCosts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Deferred Stock Issuance Costs</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ampx_DeferredStockIssuanceCosts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ampx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ampx_SaleOfStockAveragePricePerShareRedemption">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Average Price Per Share, Redemption</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ampx_SaleOfStockAveragePricePerShareRedemption</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ampx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ampx_SaleOfStockDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Discount</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ampx_SaleOfStockDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ampx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ampx_SaleOfStockMaximumSharesAvailableForSalePercentageOfSharesIssuedAndOutstandingPriorToTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Maximum Shares Available For Sale, Percentage Of Shares Issued And Outstanding Prior To Transaction</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ampx_SaleOfStockMaximumSharesAvailableForSalePercentageOfSharesIssuedAndOutstandingPriorToTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ampx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ampx_SaleOfStockPotentialMaximumConsiderationReceivedOnTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Sale Of Stock, Potential Maximum Consideration Received On Transaction</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ampx_SaleOfStockPotentialMaximumConsiderationReceivedOnTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ampx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ampx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share Based Compensation Arrangement By Share Based Payment Award, Exercise Price As A Percentage Of Fair Value</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ampx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ampx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ampx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfFairValueSignificantStockholder">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share Based Compensation Arrangement By Share Based Payment Award, Exercise Price As A Percentage Of Fair Value, Significant Stockholder</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ampx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfFairValueSignificantStockholder</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ampx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ampx_ShareBasedCompensationArrangementByShareBasedPaymentAwardReservedForIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Share-Based Compensation Arrangement by Share-Based Payment Award, Reserved For Issuance</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ampx_ShareBasedCompensationArrangementByShareBasedPaymentAwardReservedForIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ampx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ampx_SharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Shares, Authorized</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ampx_SharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ampx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ampx_StockholderPercentageOfOptioneeForOptionPrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Stockholder Percentage Of Optionee For Option Price</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ampx_StockholderPercentageOfOptioneeForOptionPrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ampx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ampx_WarrantsRedemptionThresholdConsecutiveTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants, Redemption, Threshold Consecutive Trading Days</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ampx_WarrantsRedemptionThresholdConsecutiveTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ampx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ampx_WarrantsRedemptionThresholdTradingDays">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Warrants, Redemption, Threshold Trading Days</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ampx_WarrantsRedemptionThresholdTradingDays</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ampx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of common stock.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost not yet recognized for nonvested award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockParOrStatedValuePerShare">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=SL123496158-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockParOrStatedValuePerShare</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PreferredStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI https://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PreferredStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126954810&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(01)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_CounterpartyNameAxis=ampx_BRPCIIMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_CounterpartyNameAxis=ampx_BRPCIIMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsidiarySaleOfStockAxis=ampx_PurchaseAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsidiarySaleOfStockAxis=ampx_PurchaseAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=ampx_PublicWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=ampx_PublicWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=ampx_PrivateWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=ampx_PrivateWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=ampx_PIPEWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=ampx_PIPEWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=ampx_TwentyTwentyTwoEquityIncentivePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=ampx_TwentyTwentyTwoEquityIncentivePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=ampx_EquityIncentivePlansMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=ampx_EquityIncentivePlansMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=ampx_TwentyTwentyTwoEmployeeStockPurchasePlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=ampx_TwentyTwentyTwoEmployeeStockPurchasePlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=ampx_ExecutiveIncentiveCompensationPlanMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=ampx_ExecutiveIncentiveCompensationPlanMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140066168264000">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Stockholders' Equity - Stock Warrant (Details) - $ / shares<br></strong></div></th>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 01, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding (in shares)</a></td>
<td class="nump">47,720,836<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.50<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=ampx_PublicWarrantsMember', window );">Public warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding (in shares)</a></td>
<td class="nump">29,268,336<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in dollars per share)</a></td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=ampx_PrivateWarrantsMember', window );">Private warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding (in shares)</a></td>
<td class="nump">16,400,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in dollars per share)</a></td>
<td class="nump">$ 11.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=ampx_PIPEWarrantsMember', window );">PIPE warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding (in shares)</a></td>
<td class="nump">2,052,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price (in dollars per share)</a></td>
<td class="nump">$ 12.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=126973232&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=ampx_PublicWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=ampx_PublicWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=ampx_PrivateWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=ampx_PrivateWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=ampx_PIPEWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=ampx_PIPEWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140066170226000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Stockholders' Equity - Stock-Based Compensation Expense (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation</a></td>
<td class="nump">$ 726<span></span>
</td>
<td class="nump">$ 456<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember', window );">Cost of revenue</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation</a></td>
<td class="nump">169<span></span>
</td>
<td class="nump">113<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Selling, general and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems', window );"><strong>Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Total stock-based compensation</a></td>
<td class="nump">$ 537<span></span>
</td>
<td class="nump">$ 337<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI https://asc.fasb.org/extlink&amp;oid=128089324&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_CostOfSalesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140066179037840">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Income Taxes (Details)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxDisclosureAbstract', window );"><strong>Income Tax Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Income tax expense</a></td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI https://asc.fasb.org/extlink&amp;oid=122134291&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=121826272&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI https://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=123586238&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140066180942256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Narrative (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($) </div>
<div>lease</div>
</th>
<th class="th">
<div>Mar. 31, 2022 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Lease renewal term (in years)</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ampx_LesseeFinanceLeaseNumberOfLeases', window );">Number of finance leases (in leases) | lease</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Weighted-average remaining term (in years)</a></td>
<td class="text">9 years 3 months 18 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Net present value of operating lease liabilities</a></td>
<td class="nump">7.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Right-of-use asset obtained in exchange for operating lease liability</a></td>
<td class="nump">$ 5,200<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating lease payments</a></td>
<td class="nump">179<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease expense</a></td>
<td class="nump">202<span></span>
</td>
<td class="nump">$ 140<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LegalEntityAxis=ampx_AmpriusHoldingsMember', window );">Amprius Holdings</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating lease payments</a></td>
<td class="nump">$ 86<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ampx_LesseeFinanceLeaseNumberOfLeases">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Finance Lease, Number Of Leases</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ampx_LesseeFinanceLeaseNumberOfLeases</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ampx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI https://asc.fasb.org/extlink&amp;oid=123414884&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LegalEntityAxis=ampx_AmpriusHoldingsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LegalEntityAxis=ampx_AmpriusHoldingsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140066175203872">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Schedule of Future Maturing Operating Lease Payments (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear', window );">Remainder of 2023</a></td>
<td class="nump">$ 822<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2024</a></td>
<td class="nump">1,126<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2025</a></td>
<td class="nump">1,158<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2026</a></td>
<td class="nump">1,193<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2027</a></td>
<td class="nump">1,241<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2028</a></td>
<td class="nump">1,278<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">4,729<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Gross lease payments</a></td>
<td class="nump">11,547<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less - present value adjustments</a></td>
<td class="num">(3,359)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Total operating lease liabilities</a></td>
<td class="nump">$ 8,188<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=123391704&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140066168407136">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share - Schedule of Calculation of Basic and Diluted Net Loss Per Share (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareReconciliationAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic', window );">Net loss</a></td>
<td class="num">$ (9,102)<span></span>
</td>
<td class="num">$ (2,878)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted', window );">Net loss</a></td>
<td class="num">$ (9,102)<span></span>
</td>
<td class="num">$ (2,878)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic', window );">Weighted-average common shares outstanding, basic (in shares)</a></td>
<td class="nump">84,645,097<span></span>
</td>
<td class="nump">65,774,528<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding', window );">Weighted-average common shares outstanding, diluted (in shares)</a></td>
<td class="nump">84,645,097<span></span>
</td>
<td class="nump">65,774,528<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasic', window );">Net loss per common shares, basic (in dollars per share)</a></td>
<td class="num">$ (0.11)<span></span>
</td>
<td class="num">$ (0.04)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_EarningsPerShareDiluted', window );">Net loss per common shares, diluted (in dollars per share)</a></td>
<td class="num">$ (0.11)<span></span>
</td>
<td class="num">$ (0.04)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 52<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e4984-109258<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22644-107794<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 55<br> -Paragraph 15<br> -URI https://asc.fasb.org/extlink&amp;oid=128363288&amp;loc=d3e3842-109258<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1252-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (d)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(27))<br> -URI https://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(23))<br> -URI https://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1337-109256<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 40<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (e)(4)<br> -URI https://asc.fasb.org/extlink&amp;oid=126732423&amp;loc=SL123482106-238011<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(25))<br> -URI https://asc.fasb.org/extlink&amp;oid=126953954&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareReconciliationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareReconciliationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22595-107794<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1377-109256<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8736-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22694-107794<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8924-108599<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8906-108599<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI https://asc.fasb.org/extlink&amp;oid=124431687&amp;loc=d3e22583-107794<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126901519&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(2)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=SL5780133-109256<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (b)(1)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 40<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1930-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 16<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1505-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfSharesOutstandingBasic">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 10<br> -URI https://asc.fasb.org/extlink&amp;oid=126958026&amp;loc=d3e1448-109256<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfSharesOutstandingBasic</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140066180359424">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share - Potentially Dilutive Securities (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2023</div></th>
<th class="th"><div>Mar. 31, 2022</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive securities excluded from the computation of net loss per share (in shares)</a></td>
<td class="nump">61,986,915<span></span>
</td>
<td class="nump">10,351,020<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Stock warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive securities excluded from the computation of net loss per share (in shares)</a></td>
<td class="nump">47,720,836<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember', window );">Stock options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive securities excluded from the computation of net loss per share (in shares)</a></td>
<td class="nump">13,971,079<span></span>
</td>
<td class="nump">10,351,020<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">RSUs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Potentially dilutive securities excluded from the computation of net loss per share (in shares)</a></td>
<td class="nump">295,000<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI https://asc.fasb.org/extlink&amp;oid=124432515&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140066180830528">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Subsequent Events - Narrative (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Apr. 15, 2023 </div>
<div>USD ($) </div>
<div>term</div>
</th>
<th class="th">
<div>Mar. 31, 2023 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Lease renewal term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Future lease payments</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11,547<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember', window );">Subsequent Events | Brighton, Colorado</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_SubsequentEventLineItems', window );"><strong>Subsequent Event [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ampx_LesseeOperatingLeaseOptionToExtendNumber', window );">Number of extension terms | term</a></td>
<td class="nump">2<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseRenewalTerm', window );">Lease renewal term</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Future lease payments</a></td>
<td class="nump">$ 62,900<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ampx_LesseeOperatingLeaseOptionToExtendNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Lessee, Operating Lease, Option to Extend, Number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ampx_LesseeOperatingLeaseOptionToExtendNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ampx_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseRenewalTerm">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI https://asc.fasb.org/extlink&amp;oid=128292326&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseRenewalTerm</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ampx_NameOfFacilityAxis=ampx_BrightonColoradoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ampx_NameOfFacilityAxis=ampx_BrightonColoradoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>ampx-20230331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:ampx="http://www.amprius.com/20230331"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2022"
  xmlns:us-gaap="http://fasb.org/us-gaap/2022"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="ampx-20230331.xsd" xlink:type="simple"/>
    <context id="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i5f69aaee1e4f40698eb541763e1fdba8_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i0f2107c9841f453a82a0c7c211510fd3_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">ampx:RedeemableWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ib58f786ebe7b4b848751f6ae32c45cf4_I20230504">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
        </entity>
        <period>
            <instant>2023-05-04</instant>
        </period>
    </context>
    <context id="i6023c648ad62464a83503c70b103bde2_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i988b24a7822c4dd0a13444855095dca6_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i8f5097542ed94e019e553cb2481ed488_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i2afb5bfd349b44c8b991e6359c2ea6ac_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6db38870876b40778cbddcf2716d2e8c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="id53f479a40704e0db1e45d90b74f3ab2_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iee3994aee9fd4eec960461ddc9dede6e_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ibf9077943bf2498e945a5b5cffea4ede_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="icbda858436fb409e928a18346f855b84_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i38d004c355644a42b820f2b35e0874a5_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i55afdc11794d46c3844a5877adc375f6_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ife934d56970b49fdbc5f246e8c61d0f5_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i720988f66ee2413488964d010217db49_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0266250627e24a9d98564b0fca01e7dc_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i11415fde3f7d40df98aa03c58126edec_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:ScenarioPreviouslyReportedMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="idd6d5ba96ae14bb0b84986d93719cf0c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i6449e443d30c455184fed3bff4010086_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RestatementAxis">srt:RestatementAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i3a1b0acc07434411a2695d9dbe33e259_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i1a1fa4a0e8fb49cc8d3c759e2e0c17e7_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0cad88c1b2cb4985ad2e0e7a12c33ca0_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="ifce6518367b34d3ab4c10e9de84e7829_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i4378b9360776445ba70d80981bf38d62_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i7f7477a44afb4479b9c1eee284f3005c_I20211231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CumulativeEffectPeriodOfAdoptionAxis">srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-12-31</instant>
        </period>
    </context>
    <context id="i0f1b454495df444b9b332af549b60b6a_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i50f6cb59fed6438795bb51a3698b7cef_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i269ea436a3b44ee9800781cda13e9ced_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i7025e13610834dba9e2d509086735e0f_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="id94df322b86f4f07b19482d29fdb864b_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i74bb0e27b0d34b379dd2c30509852fed_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i4b2c45cb6722425d93cf25d37d538c75_I20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
        </entity>
        <period>
            <instant>2022-03-31</instant>
        </period>
    </context>
    <context id="i10455920b55e4d9b921af5961e20e70c_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ampx:PurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i5204fd658af644a69b260e135d17b875_I20221019">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
        </entity>
        <period>
            <instant>2022-10-19</instant>
        </period>
    </context>
    <context id="i1e90ee49c2a54d3a851c9f496677d786_I20220914">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
        </entity>
        <period>
            <instant>2022-09-14</instant>
        </period>
    </context>
    <context id="i249e71b6552c4c1eb0877da134e2de5a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i57089d02123243da8af388b3d544181d_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:CashAndCashEquivalentsAxis">us-gaap:MoneyMarketFundsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i5371cedb4ff54ccd8164da48c07a4e65_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ampx:CustomerOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i2491a8cf26ae441db19f29da6405e4f3_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ampx:CustomerTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ia0ca1db60f404e5e8963bf33fc47c360_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ampx:CustomerThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i97a5618b45474da28680c8670a3e72f1_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ampx:CustomerOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="id9df38d6aecc41ac937ddb4c6110b735_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ampx:CustomerTwoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="iade7297fa7ee4e99b67dd741d1ffe066_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ampx:CustomerThreeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i851c46bd9c414d139116e6b9fb6058fa_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ampx:ThreeCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ifa2cb13888a54b6c8e0df0d3d5d53aee_D20220101-20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">ampx:FiveCustomersMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:AccountsReceivableMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="i43cd424ce72a4a40ac5fe4088c873948_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ampx:SaleOfBatteryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="iee19788a62c34779b7e8c93581517ccc_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ampx:SaleOfBatteryMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ic144432f29d243b0b1d00f76340bc40e_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ampx:CustomizedDesignServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i42b2afc255654cec93289ac97a7463f7_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ampx:CustomizedDesignServicesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i3ef781aff42644a5b81b5015320dace1_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ampx:TotalRevenueFromCustomersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i6cf8fcfb69a74fd9aa89d6dc6e5f7b7f_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ampx:TotalRevenueFromCustomersMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0e692c0e7a0a484c82160d4323ca8b64_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ampx:OtherRevenueGovernmentGrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i8593a7e0ef1947cc8d2ea977da1fe0b0_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">ampx:OtherRevenueGovernmentGrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0ae713297f034937abe6ba4c9366e66b_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i076e74831991483a8e8261e35d5fdc5d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:TimingOfTransferOfGoodOrServiceAxis">us-gaap:TransferredAtPointInTimeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i35c52756179342cb89a7e4fbbc177710_I20220101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
        </entity>
        <period>
            <instant>2022-01-01</instant>
        </period>
    </context>
    <context id="i904eec3b78d5419aa0f9501d2ea7f78e_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2023-04-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i9f2425ecaf1e4131b7a7a5b98fa6ec56_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:typedMember dimension="us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis">
                    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>2024-04-01</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i903b361bf85148a5aa5dbeb03ba0ea1d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ampx:ProductionEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i5977eefa4b7f4aa09e7fdb5aea5dd806_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ampx:ProductionEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ia6d7ea55505e405b8d49c84e5c00e216_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ampx:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i0cdadfcb55ef4456992d4eac608c568c_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">ampx:LaboratoryEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i6305afd21797431abefaa882fdec1d44_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ie7d6fdab3f1b47a985e1326bf5737eca_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ib5ac7197a264438baf93759ed1193030_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i3e9ea2df75d5435493c2296c08d770cc_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="i255153329caf42fbad158d721b25384a_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i670d9fe2f1524ac7bd4b7736aac57795_I20221231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-12-31</instant>
        </period>
    </context>
    <context id="ic33e1539b78a40bda4ef216dea1bd960_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ampx:TwentyTwentyTwoEquityIncentivePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="if8307ba91dca43aa98a87dbc1eace892_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ampx:EquityIncentivePlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i998fc01b463d4ba5a09b1286fdb9c50a_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ampx:EquityIncentivePlansMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i50e98b1619b14d3aad7cc2e81158f8fd_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ibe21b3a289994d4a97c4c69f932acff6_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i3aff53d2317b441595d7b67e66f87d6d_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i296bde8d08c2448f98f54612571ba0c2_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ampx:TwentyTwentyTwoEmployeeStockPurchasePlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i88342beb5da647d28102477fd33b6c49_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">ampx:ExecutiveIncentiveCompensationPlanMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i1083d46db3cb4333bd42aa18cd72741b_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ampx:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i89b26f35c8c743ec898b2e7cbd65d2da_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ampx:PrivateWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="ia369e97ca86a4015bacdfaf2d5b614d2_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ampx:PIPEWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i65f6ecb200ca4a2ea079f7914b85be3e_I20220301">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
        </entity>
        <period>
            <instant>2022-03-01</instant>
        </period>
    </context>
    <context id="i8b54249c302d4bbd84bcc1b8b3beb2fc_D20220914-20220914">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ampx:PublicWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-14</startDate>
            <endDate>2022-09-14</endDate>
        </period>
    </context>
    <context id="i31467a3e9fbe4b59983ccf8194ea8070_D20220914-20220914">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">ampx:PIPEWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-14</startDate>
            <endDate>2022-09-14</endDate>
        </period>
    </context>
    <context id="i421fa02da0234be3b23eab9845b639a4_D20220927-20220927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ampx:BRPCIIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ampx:PurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-09-27</startDate>
            <endDate>2022-09-27</endDate>
        </period>
    </context>
    <context id="i6f0bf828381846a8b705dd517c0690c7_I20220927">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ampx:BRPCIIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ampx:PurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2022-09-27</instant>
        </period>
    </context>
    <context id="i09c21ae7eb0c4550b4f44db99a8f9cfa_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ampx:BRPCIIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ampx:PurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i6240ae66e6554cf88516b271e123fbbe_I20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:CounterpartyNameAxis">ampx:BRPCIIMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:SubsidiarySaleOfStockAxis">ampx:PurchaseAgreementMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-03-31</instant>
        </period>
    </context>
    <context id="i7b9b12b7e31d4c76a8d6a376c2b7d713_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ide8e49695f9d47238f505b8412513868_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:CostOfSalesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i1d86f0bf8ca54c31a23e7d6b7920910e_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i755fa2560d3b49c389b0764776734331_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i118c22344d0e445ab1d3ec905d1a450d_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i95e94b4180df453fa35e812c22acf32d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie8eddb8a90d3462cb31d18d8295be70a_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:LegalEntityAxis">ampx:AmpriusHoldingsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i5f45d6b4a1b249b19e2aff7a526d83be_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="i571e7f29efd349649731d4a3cf40f70d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="i0650b7f12c5745f1b9f3e5dd848c75eb_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ie7e13065ea5344339868b25a9ccb583d_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ib6658dea46b142f48028a62a75c5d390_D20230101-20230331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-03-31</endDate>
        </period>
    </context>
    <context id="ia19169091dae45ab9040ca0a01a98e92_D20220101-20220331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-03-31</endDate>
        </period>
    </context>
    <context id="ie3036f0dcbac452caf4e05d02eb07b89_D20230415-20230415">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ampx:NameOfFacilityAxis">ampx:BrightonColoradoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-04-15</startDate>
            <endDate>2023-04-15</endDate>
        </period>
    </context>
    <context id="i054651541ac248b38a3b2a7e6475566b_I20230415">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001899287</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:SubsequentEventTypeAxis">us-gaap:SubsequentEventMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ampx:NameOfFacilityAxis">ampx:BrightonColoradoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2023-04-15</instant>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="executiveemployee">
        <measure>ampx:executiveEmployee</measure>
    </unit>
    <unit id="day">
        <measure>ampx:day</measure>
    </unit>
    <unit id="lease">
        <measure>ampx:lease</measure>
    </unit>
    <unit id="term">
        <measure>ampx:term</measure>
    </unit>
    <dei:EntityCentralIndexKey
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV83L2ZyYWc6ZmY4OTM4M2JjZTA2NDU5ZjhhMGU3NDAyMDk2MmRiZDkvdGFibGU6Mzc1MWExYWUxYTQxNDM0YThkOWM4NTc3NzlhNmRiYzQvdGFibGVyYW5nZTozNzUxYTFhZTFhNDE0MzRhOGQ5Yzg1Nzc3OWE2ZGJjNF8yLTEtMS0xLTYxOTkw_486805dc-d176-4a1a-96af-d95c98b3e6bc">0001899287</dei:EntityCentralIndexKey>
    <dei:CurrentFiscalYearEndDate
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV83L2ZyYWc6ZmY4OTM4M2JjZTA2NDU5ZjhhMGU3NDAyMDk2MmRiZDkvdGFibGU6Mzc1MWExYWUxYTQxNDM0YThkOWM4NTc3NzlhNmRiYzQvdGFibGVyYW5nZTozNzUxYTFhZTFhNDE0MzRhOGQ5Yzg1Nzc3OWE2ZGJjNF8zLTEtMS0xLTYxOTkw_211e80f0-cceb-4d7e-978c-2ff864d74df6">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:DocumentFiscalYearFocus
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV83L2ZyYWc6ZmY4OTM4M2JjZTA2NDU5ZjhhMGU3NDAyMDk2MmRiZDkvdGFibGU6Mzc1MWExYWUxYTQxNDM0YThkOWM4NTc3NzlhNmRiYzQvdGFibGVyYW5nZTozNzUxYTFhZTFhNDE0MzRhOGQ5Yzg1Nzc3OWE2ZGJjNF80LTEtMS0xLTYxOTkw_85abab34-4068-4a88-9918-8eb21c20729d">2023</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV83L2ZyYWc6ZmY4OTM4M2JjZTA2NDU5ZjhhMGU3NDAyMDk2MmRiZDkvdGFibGU6Mzc1MWExYWUxYTQxNDM0YThkOWM4NTc3NzlhNmRiYzQvdGFibGVyYW5nZTozNzUxYTFhZTFhNDE0MzRhOGQ5Yzg1Nzc3OWE2ZGJjNF81LTEtMS0xLTYxOTkw_6708a397-9312-477e-9018-5b190cf769d3">Q1</dei:DocumentFiscalPeriodFocus>
    <dei:AmendmentFlag
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV83L2ZyYWc6ZmY4OTM4M2JjZTA2NDU5ZjhhMGU3NDAyMDk2MmRiZDkvdGFibGU6Mzc1MWExYWUxYTQxNDM0YThkOWM4NTc3NzlhNmRiYzQvdGFibGVyYW5nZTozNzUxYTFhZTFhNDE0MzRhOGQ5Yzg1Nzc3OWE2ZGJjNF82LTEtMS0xLTYxOTkw_14782df6-a0a3-42bd-86e6-9082a9d96538">false</dei:AmendmentFlag>
    <us-gaap:AccountingStandardsUpdateExtensibleList
      contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOjFjNDZmODgyMWIzNjRjYmM4NTllMzRhMjE5M2I3ZjAzL3RhYmxlcmFuZ2U6MWM0NmY4ODIxYjM2NGNiYzg1OWUzNGEyMTkzYjdmMDNfNy0wLTEtMS02MTk5MA_553a4f00-e978-4e3b-ac10-ef28c58a3c8b">http://fasb.org/us-gaap/2022#AccountingStandardsUpdate201602Member</us-gaap:AccountingStandardsUpdateExtensibleList>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i9f2425ecaf1e4131b7a7a5b98fa6ec56_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80OS9mcmFnOmU5ZjM4NDljODljMTQ5YmFhYTA5MmM5OWJkYWMyYzQ0L3RleHRyZWdpb246ZTlmMzg0OWM4OWMxNDliYWFhMDkyYzk5YmRhYzJjNDRfMTky_a7f1b717-5185-4cf6-a180-906ce440400f">P4Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <dei:DocumentType
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80L2ZyYWc6ZjY1ZWY5YzkzN2U2NGMyZWIwN2RlZTk1ZWEzOTIxMzYvdGV4dHJlZ2lvbjpmNjVlZjljOTM3ZTY0YzJlYjA3ZGVlOTVlYTM5MjEzNl8yMTQz_30b4697e-8689-420f-bbd2-d255fb5f072c">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80L2ZyYWc6ZjY1ZWY5YzkzN2U2NGMyZWIwN2RlZTk1ZWEzOTIxMzYvdGFibGU6Yjk0NzdkOTY3MGQ4NDYzZDliZmQwZTdmY2YwM2I4NzMvdGFibGVyYW5nZTpiOTQ3N2Q5NjcwZDg0NjNkOWJmZDBlN2ZjZjAzYjg3M18wLTAtMS0xLTYxOTkw_ccb0a9a4-1279-4913-895c-7a5034a5723f">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80L2ZyYWc6ZjY1ZWY5YzkzN2U2NGMyZWIwN2RlZTk1ZWEzOTIxMzYvdGV4dHJlZ2lvbjpmNjVlZjljOTM3ZTY0YzJlYjA3ZGVlOTVlYTM5MjEzNl8xODE_1a032017-1c15-4620-b32c-7bb1ab6eaef4">2023-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80L2ZyYWc6ZjY1ZWY5YzkzN2U2NGMyZWIwN2RlZTk1ZWEzOTIxMzYvdGFibGU6Y2UyZjZjMThhZmYwNDEyMWI1YjI1NGFjY2FjNWVmYTEvdGFibGVyYW5nZTpjZTJmNmMxOGFmZjA0MTIxYjViMjU0YWNjYWM1ZWZhMV8wLTAtMS0xLTYxOTkw_71174b77-f30b-485c-b766-c55366249b52">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80L2ZyYWc6ZjY1ZWY5YzkzN2U2NGMyZWIwN2RlZTk1ZWEzOTIxMzYvdGV4dHJlZ2lvbjpmNjVlZjljOTM3ZTY0YzJlYjA3ZGVlOTVlYTM5MjEzNl8yMTQ0_e23a3468-6878-4b8b-a168-1e71f60dd56f">001-04321</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80L2ZyYWc6ZjY1ZWY5YzkzN2U2NGMyZWIwN2RlZTk1ZWEzOTIxMzYvdGV4dHJlZ2lvbjpmNjVlZjljOTM3ZTY0YzJlYjA3ZGVlOTVlYTM5MjEzNl8yMTQ3_e89004e0-776c-470c-bc7b-a030b4fc87b9">AMPRIUS TECHNOLOGIES, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80L2ZyYWc6ZjY1ZWY5YzkzN2U2NGMyZWIwN2RlZTk1ZWEzOTIxMzYvdGFibGU6NmJkZWU2MGY5ZDc5NDBlNGFiNDM2ZTkzNGUzYjQ2YmYvdGFibGVyYW5nZTo2YmRlZTYwZjlkNzk0MGU0YWI0MzZlOTM0ZTNiNDZiZl8wLTAtMS0xLTYxOTkw_94d7d184-ac42-4075-8c5e-a21be096c40e">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityTaxIdentificationNumber
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80L2ZyYWc6ZjY1ZWY5YzkzN2U2NGMyZWIwN2RlZTk1ZWEzOTIxMzYvdGFibGU6NmJkZWU2MGY5ZDc5NDBlNGFiNDM2ZTkzNGUzYjQ2YmYvdGFibGVyYW5nZTo2YmRlZTYwZjlkNzk0MGU0YWI0MzZlOTM0ZTNiNDZiZl8wLTItMS0xLTYxOTkw_1b3c53dd-5a74-43e7-9aa5-c45601e4d0fe">98-1591811</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80L2ZyYWc6ZjY1ZWY5YzkzN2U2NGMyZWIwN2RlZTk1ZWEzOTIxMzYvdGFibGU6NmJkZWU2MGY5ZDc5NDBlNGFiNDM2ZTkzNGUzYjQ2YmYvdGFibGVyYW5nZTo2YmRlZTYwZjlkNzk0MGU0YWI0MzZlOTM0ZTNiNDZiZl8zLTAtMS0xLTYxOTkwL3RleHRyZWdpb246ZjUxMmU0MWVkMGYwNDM4MTk0NjJlNzNhYTFhY2EzZDlfNQ_572a632c-fcc2-4fd4-89a7-f7c22aeb8134">1180 Page Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80L2ZyYWc6ZjY1ZWY5YzkzN2U2NGMyZWIwN2RlZTk1ZWEzOTIxMzYvdGFibGU6NmJkZWU2MGY5ZDc5NDBlNGFiNDM2ZTkzNGUzYjQ2YmYvdGFibGVyYW5nZTo2YmRlZTYwZjlkNzk0MGU0YWI0MzZlOTM0ZTNiNDZiZl8zLTAtMS0xLTYxOTkwL3RleHRyZWdpb246ZjUxMmU0MWVkMGYwNDM4MTk0NjJlNzNhYTFhY2EzZDlfOQ_ff7c175b-2263-491b-bc61-30ce8ceca7c5">Fremont</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80L2ZyYWc6ZjY1ZWY5YzkzN2U2NGMyZWIwN2RlZTk1ZWEzOTIxMzYvdGFibGU6NmJkZWU2MGY5ZDc5NDBlNGFiNDM2ZTkzNGUzYjQ2YmYvdGFibGVyYW5nZTo2YmRlZTYwZjlkNzk0MGU0YWI0MzZlOTM0ZTNiNDZiZl8zLTAtMS0xLTYxOTkwL3RleHRyZWdpb246ZjUxMmU0MWVkMGYwNDM4MTk0NjJlNzNhYTFhY2EzZDlfMTM_8f1c0165-428b-4623-9a27-8124f2f283ec">CA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80L2ZyYWc6ZjY1ZWY5YzkzN2U2NGMyZWIwN2RlZTk1ZWEzOTIxMzYvdGFibGU6NmJkZWU2MGY5ZDc5NDBlNGFiNDM2ZTkzNGUzYjQ2YmYvdGFibGVyYW5nZTo2YmRlZTYwZjlkNzk0MGU0YWI0MzZlOTM0ZTNiNDZiZl8zLTItMS0xLTYxOTkw_b5eced0c-c017-4a17-a3b4-5a55585792ae">94538</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80L2ZyYWc6ZjY1ZWY5YzkzN2U2NGMyZWIwN2RlZTk1ZWEzOTIxMzYvdGV4dHJlZ2lvbjpmNjVlZjljOTM3ZTY0YzJlYjA3ZGVlOTVlYTM5MjEzNl80MDg_6ee99f14-3f3b-4bfb-b63a-41941bb89c70">800</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80L2ZyYWc6ZjY1ZWY5YzkzN2U2NGMyZWIwN2RlZTk1ZWEzOTIxMzYvdGV4dHJlZ2lvbjpmNjVlZjljOTM3ZTY0YzJlYjA3ZGVlOTVlYTM5MjEzNl8yMTQ4_4f4a2590-4b28-4a74-bb40-5292445c085a">425-8803</dei:LocalPhoneNumber>
    <dei:Security12bTitle
      contextRef="i5f69aaee1e4f40698eb541763e1fdba8_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80L2ZyYWc6ZjY1ZWY5YzkzN2U2NGMyZWIwN2RlZTk1ZWEzOTIxMzYvdGFibGU6NjQ3MzI0NWMzMzU4NDdjMTlhMzE0NDZjMmE5ZTczYmQvdGFibGVyYW5nZTo2NDczMjQ1YzMzNTg0N2MxOWEzMTQ0NmMyYTllNzNiZF8xLTAtMS0xLTYxOTkw_8733d363-1208-443d-ac87-ec05e9cf8b01">Common stock, $0.0001 par value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i5f69aaee1e4f40698eb541763e1fdba8_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80L2ZyYWc6ZjY1ZWY5YzkzN2U2NGMyZWIwN2RlZTk1ZWEzOTIxMzYvdGFibGU6NjQ3MzI0NWMzMzU4NDdjMTlhMzE0NDZjMmE5ZTczYmQvdGFibGVyYW5nZTo2NDczMjQ1YzMzNTg0N2MxOWEzMTQ0NmMyYTllNzNiZF8xLTEtMS0xLTYxOTkw_f787153f-882f-44d8-ac11-63761fe3a9b3">AMPX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i5f69aaee1e4f40698eb541763e1fdba8_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80L2ZyYWc6ZjY1ZWY5YzkzN2U2NGMyZWIwN2RlZTk1ZWEzOTIxMzYvdGFibGU6NjQ3MzI0NWMzMzU4NDdjMTlhMzE0NDZjMmE5ZTczYmQvdGFibGVyYW5nZTo2NDczMjQ1YzMzNTg0N2MxOWEzMTQ0NmMyYTllNzNiZF8xLTItMS0xLTYxOTkw_0f8f252c-ae25-4b25-a8e8-f809671dbef2">NYSE</dei:SecurityExchangeName>
    <dei:Security12bTitle
      contextRef="i0f2107c9841f453a82a0c7c211510fd3_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80L2ZyYWc6ZjY1ZWY5YzkzN2U2NGMyZWIwN2RlZTk1ZWEzOTIxMzYvdGFibGU6NjQ3MzI0NWMzMzU4NDdjMTlhMzE0NDZjMmE5ZTczYmQvdGFibGVyYW5nZTo2NDczMjQ1YzMzNTg0N2MxOWEzMTQ0NmMyYTllNzNiZF8yLTAtMS0xLTYxOTkw_9c30b8ec-0ef8-45e1-b202-98dda0bc5c78">Redeemable warrants, each exercisable for one share of common stock at an exercise price of $11.50</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i0f2107c9841f453a82a0c7c211510fd3_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80L2ZyYWc6ZjY1ZWY5YzkzN2U2NGMyZWIwN2RlZTk1ZWEzOTIxMzYvdGFibGU6NjQ3MzI0NWMzMzU4NDdjMTlhMzE0NDZjMmE5ZTczYmQvdGFibGVyYW5nZTo2NDczMjQ1YzMzNTg0N2MxOWEzMTQ0NmMyYTllNzNiZF8yLTEtMS0xLTYxOTkw_e1ac103d-997f-44ac-bdec-60e0109fdd8e">AMPX.W</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i0f2107c9841f453a82a0c7c211510fd3_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80L2ZyYWc6ZjY1ZWY5YzkzN2U2NGMyZWIwN2RlZTk1ZWEzOTIxMzYvdGFibGU6NjQ3MzI0NWMzMzU4NDdjMTlhMzE0NDZjMmE5ZTczYmQvdGFibGVyYW5nZTo2NDczMjQ1YzMzNTg0N2MxOWEzMTQ0NmMyYTllNzNiZF8yLTItMS0xLTYxOTkw_18583187-a3ae-4e16-940a-cce43a7ce519">NYSE</dei:SecurityExchangeName>
    <dei:EntityCurrentReportingStatus
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80L2ZyYWc6ZjY1ZWY5YzkzN2U2NGMyZWIwN2RlZTk1ZWEzOTIxMzYvdGV4dHJlZ2lvbjpmNjVlZjljOTM3ZTY0YzJlYjA3ZGVlOTVlYTM5MjEzNl8yMTQ1_8fbb8c04-5227-4a97-b799-de91064461d9">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80L2ZyYWc6ZjY1ZWY5YzkzN2U2NGMyZWIwN2RlZTk1ZWEzOTIxMzYvdGV4dHJlZ2lvbjpmNjVlZjljOTM3ZTY0YzJlYjA3ZGVlOTVlYTM5MjEzNl8yMTQ2_0b95bf9f-455d-4636-be3d-407f3bd8f8f9">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80L2ZyYWc6ZjY1ZWY5YzkzN2U2NGMyZWIwN2RlZTk1ZWEzOTIxMzYvdGFibGU6YjJjMjAyZjFjMDM2NDY1YWI2NjAxZmEzN2JjMzBlMTYvdGFibGVyYW5nZTpiMmMyMDJmMWMwMzY0NjVhYjY2MDFmYTM3YmMzMGUxNl8xLTAtMS0xLTYxOTkw_4e574cf6-f8da-4685-af01-59af2fc409fb">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80L2ZyYWc6ZjY1ZWY5YzkzN2U2NGMyZWIwN2RlZTk1ZWEzOTIxMzYvdGFibGU6YjJjMjAyZjFjMDM2NDY1YWI2NjAxZmEzN2JjMzBlMTYvdGFibGVyYW5nZTpiMmMyMDJmMWMwMzY0NjVhYjY2MDFmYTM3YmMzMGUxNl8xLTQtMS0xLTYxOTkw_2f7c5b31-97a7-48b8-9f00-b701461efb11">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80L2ZyYWc6ZjY1ZWY5YzkzN2U2NGMyZWIwN2RlZTk1ZWEzOTIxMzYvdGFibGU6YjJjMjAyZjFjMDM2NDY1YWI2NjAxZmEzN2JjMzBlMTYvdGFibGVyYW5nZTpiMmMyMDJmMWMwMzY0NjVhYjY2MDFmYTM3YmMzMGUxNl8yLTQtMS0xLTYxOTkw_6997d08c-35d0-4081-b476-7bdd3d541e39">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80L2ZyYWc6ZjY1ZWY5YzkzN2U2NGMyZWIwN2RlZTk1ZWEzOTIxMzYvdGV4dHJlZ2lvbjpmNjVlZjljOTM3ZTY0YzJlYjA3ZGVlOTVlYTM5MjEzNl8yMTQx_1d6499dc-7110-4ff8-92f9-1bbc16ec3cd1">false</dei:EntityExTransitionPeriod>
    <dei:EntityShellCompany
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80L2ZyYWc6ZjY1ZWY5YzkzN2U2NGMyZWIwN2RlZTk1ZWEzOTIxMzYvdGV4dHJlZ2lvbjpmNjVlZjljOTM3ZTY0YzJlYjA3ZGVlOTVlYTM5MjEzNl8xMDk5NTExNjI5OTI5_d5eee307-787d-4551-bcea-be952d216189">false</dei:EntityShellCompany>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="ib58f786ebe7b4b848751f6ae32c45cf4_I20230504"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80L2ZyYWc6ZjY1ZWY5YzkzN2U2NGMyZWIwN2RlZTk1ZWEzOTIxMzYvdGV4dHJlZ2lvbjpmNjVlZjljOTM3ZTY0YzJlYjA3ZGVlOTVlYTM5MjEzNl8yMDgy_4ce6c04b-6c53-403f-951d-05d52ded61df"
      unitRef="shares">84971565</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMy0xLTEtMS02MTk5MA_18ff5f3e-9353-4494-8b8b-a4b7247b6bbb"
      unitRef="usd">64187000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMy0zLTEtMS02MTk5MA_9aae5909-f526-448f-a53c-7d5ffa446e76"
      unitRef="usd">69696000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfNC0xLTEtMS02MTk5MA_e1a46df5-89c1-43ea-9f85-5b93997acd3b"
      unitRef="usd">555000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfNC0zLTEtMS02MTk5MA_9d9e1fc2-9958-4c3b-a5e0-5451ef58cc93"
      unitRef="usd">686000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfNS0xLTEtMS02MTk5MA_9aef43dd-7d8c-4417-990b-810d4cd3f680"
      unitRef="usd">845000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfNS0zLTEtMS02MTk5MA_0df53bf8-3a08-4658-b27e-8bcd8e94b0d4"
      unitRef="usd">500000</us-gaap:InventoryNet>
    <us-gaap:DeferredCostsCurrent
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfNi0xLTEtMS02MTk5MA_1920aa51-afb4-493a-aee5-a6ca2e9a6028"
      unitRef="usd">2475000</us-gaap:DeferredCostsCurrent>
    <us-gaap:DeferredCostsCurrent
      contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfNi0zLTEtMS02MTk5MA_1c9dde1c-5a86-43af-a250-b5c9cb416b01"
      unitRef="usd">1897000</us-gaap:DeferredCostsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfNy0xLTEtMS02MTk5MA_4c2eb257-984d-41f4-b16a-dae7458b8572"
      unitRef="usd">1841000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfNy0zLTEtMS02MTk5MA_a7455079-5183-4a47-b9a8-2852730be303"
      unitRef="usd">2394000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfOC0xLTEtMS02MTk5MA_8fbdb7f7-9da2-4b2f-87da-d8fdf0d43e92"
      unitRef="usd">69903000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfOC0zLTEtMS02MTk5MA_95be1c49-d104-489e-adc7-d67fdb244e28"
      unitRef="usd">75173000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMTAtMS0xLTEtNjE5OTA_75efc4e6-da2d-4e86-ae00-906c2bdf26f8"
      unitRef="usd">4948000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMTAtMy0xLTEtNjE5OTA_1452bfd9-69ca-40ea-adb8-c7b1ecde844c"
      unitRef="usd">4236000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMTEtMS0xLTEtNjE5OTA_ca02f758-084a-4f87-b127-56884b63d119"
      unitRef="usd">7894000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMTEtMy0xLTEtNjE5OTA_99ad7eda-3c07-4661-a052-923d65a78229"
      unitRef="usd">2751000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:DeferredCosts
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMTItMS0xLTEtNjE5OTA_0f5040b4-a17b-45b8-b26d-2688e9fed372"
      unitRef="usd">519000</us-gaap:DeferredCosts>
    <us-gaap:DeferredCosts
      contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMTItMy0xLTEtNjE5OTA_ae68c2e4-33e5-4eb5-bfa4-afd68324cd70"
      unitRef="usd">367000</us-gaap:DeferredCosts>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMTMtMS0xLTEtNjE5OTA_e5ff9cb5-9a61-4077-b387-0deda1499246"
      unitRef="usd">684000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMTMtMy0xLTEtNjE5OTA_31f441c7-920f-49b7-a3a4-96e9efa603a9"
      unitRef="usd">644000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMTQtMS0xLTEtNjE5OTA_3f6d01a2-7ffc-4bd8-848a-a73121221e9c"
      unitRef="usd">83948000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMTQtMy0xLTEtNjE5OTA_2ecb732e-3c51-4022-ba7d-4de8ae0afcc3"
      unitRef="usd">83171000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMTctMS0xLTEtNjE5OTA_a1408131-ab8b-4ddc-b4b5-c029f240f924"
      unitRef="usd">1023000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMTctMy0xLTEtNjE5OTA_10e6a791-3ff3-4776-88c5-cdf7ec04678d"
      unitRef="usd">1028000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMTgtMS0xLTEtNjE5OTA_f58a62c7-e50a-4170-b8d9-c61b90942fbe"
      unitRef="usd">3665000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent
      contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMTgtMy0xLTEtNjE5OTA_c3091626-bfec-4d97-a65b-fb83f57918e5"
      unitRef="usd">2708000</us-gaap:AccountsPayableAndOtherAccruedLiabilitiesCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMTktMS0xLTEtNjE5OTA_b362a79a-b109-4e39-b4d4-a77a0ef5c81d"
      unitRef="usd">3135000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMTktMy0xLTEtNjE5OTA_88eb04b5-7f3f-46e2-94a2-09b132b329e8"
      unitRef="usd">2660000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMjAtMS0xLTEtNjE5OTA_1e0fde44-b31c-42ad-b087-6dc38bcd0aaa"
      unitRef="usd">1061000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMjAtMy0xLTEtNjE5OTA_e2b679e0-c842-4bc7-8914-7676cb99fe3e"
      unitRef="usd">521000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMjEtMS0xLTEtNjE5OTA_e9e6ce83-8f24-49bb-ab3e-2289d1ee8b33"
      unitRef="usd">8884000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMjEtMy0xLTEtNjE5OTA_35b5cdc5-1af3-4485-a24f-1cf2932b0e62"
      unitRef="usd">6917000</us-gaap:LiabilitiesCurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMjMtMS0xLTEtNjE5OTA_9f28a020-5e26-49e2-909d-132512fa0cbd"
      unitRef="usd">902000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMjMtMy0xLTEtNjE5OTA_1f090afd-bf63-4945-ad29-93231cda8e66"
      unitRef="usd">720000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMjQtMS0xLTEtNjE5OTA_d61231e1-15e5-429d-8edf-2f7bcddae942"
      unitRef="usd">7127000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMjQtMy0xLTEtNjE5OTA_73fc146a-ac87-46a9-acd7-2bc28209979c"
      unitRef="usd">2501000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:Liabilities
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMjUtMS0xLTEtNjE5OTA_42e2350c-4caa-475e-bf4b-13ed7bdecad1"
      unitRef="usd">16913000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMjUtMy0xLTEtNjE5OTA_1c8b5ce1-8782-4b4c-8bfc-c6fb01d16a45"
      unitRef="usd">10138000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMjYtMS0xLTEtNjE5OTA_736390aa-4368-4331-a43a-00d77efdfdac"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMjYtMy0xLTEtNjE5OTA_28b8a596-b267-4ca1-b70c-29891739217a"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMjktMC0xLTEtNjI4MjMvdGV4dHJlZ2lvbjo3NTBkYjljNDkwNGQ0MmU2OWY5ZTU4NzFhNmYwYTgwYV81NDk3NTU4MTM5OTg_8f5f3e34-dc68-4e6e-a12a-206b05c520ae"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMjktMC0xLTEtNjI4MjMvdGV4dHJlZ2lvbjo3NTBkYjljNDkwNGQ0MmU2OWY5ZTU4NzFhNmYwYTgwYV81NDk3NTU4MTM5OTg_f25fa216-fc5c-495d-8535-4ed406a0c676"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMjktMC0xLTEtNjI4MjMvdGV4dHJlZ2lvbjo3NTBkYjljNDkwNGQ0MmU2OWY5ZTU4NzFhNmYwYTgwYV81NDk3NTU4MTQwMTE_6771fe5b-71a6-4c83-879d-8cdd2d8d06e9"
      unitRef="shares">50000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMjktMC0xLTEtNjI4MjMvdGV4dHJlZ2lvbjo3NTBkYjljNDkwNGQ0MmU2OWY5ZTU4NzFhNmYwYTgwYV81NDk3NTU4MTQwMTE_fd14377b-783d-4aa2-a966-05c81da37c5d"
      unitRef="shares">50000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMjktMC0xLTEtNjI4MjMvdGV4dHJlZ2lvbjo3NTBkYjljNDkwNGQ0MmU2OWY5ZTU4NzFhNmYwYTgwYV81NDk3NTU4MTQwMTY_1bedffce-4f18-436c-8544-06cd162fea0e"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMjktMC0xLTEtNjI4MjMvdGV4dHJlZ2lvbjo3NTBkYjljNDkwNGQ0MmU2OWY5ZTU4NzFhNmYwYTgwYV81NDk3NTU4MTQwMTY_31556111-7a58-4fcb-a547-680dc802974a"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesIssued
      contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMjktMC0xLTEtNjI4MjMvdGV4dHJlZ2lvbjo3NTBkYjljNDkwNGQ0MmU2OWY5ZTU4NzFhNmYwYTgwYV81NDk3NTU4MTQwMTY_da8903a6-2fec-431e-9a1f-d3e9dd7224d9"
      unitRef="shares">0</us-gaap:PreferredStockSharesIssued>
    <us-gaap:PreferredStockSharesOutstanding
      contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMjktMC0xLTEtNjI4MjMvdGV4dHJlZ2lvbjo3NTBkYjljNDkwNGQ0MmU2OWY5ZTU4NzFhNmYwYTgwYV81NDk3NTU4MTQwMTY_ebb1ba9b-cc60-44cb-a7eb-67dd2bda0d90"
      unitRef="shares">0</us-gaap:PreferredStockSharesOutstanding>
    <us-gaap:PreferredStockValueOutstanding
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMjktMS0xLTEtNjI3ODk_91f9ea54-54cd-40d6-8442-ff5a806d010b"
      unitRef="usd">0</us-gaap:PreferredStockValueOutstanding>
    <us-gaap:PreferredStockValueOutstanding
      contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMjktMy0xLTEtNjI3ODk_a50537e0-c732-4bf5-88bf-ac889dbceec6"
      unitRef="usd">0</us-gaap:PreferredStockValueOutstanding>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMjgtMC0xLTEtNjE5OTAvdGV4dHJlZ2lvbjo5ZTI4NmY4ZmU1MzI0NDg2ODdjYjBkNzY3ZDY0NzIyZl81NDk3NTU4MTQwNjI_9c7801c2-3051-465a-baaa-57160c737954"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMjgtMC0xLTEtNjE5OTAvdGV4dHJlZ2lvbjo5ZTI4NmY4ZmU1MzI0NDg2ODdjYjBkNzY3ZDY0NzIyZl81NDk3NTU4MTQwNjI_c6d6a3f2-6090-4e25-9940-d00b7ef1c08c"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMjgtMC0xLTEtNjE5OTAvdGV4dHJlZ2lvbjo5ZTI4NmY4ZmU1MzI0NDg2ODdjYjBkNzY3ZDY0NzIyZl81NDk3NTU4MTQwNzY_4f94db58-83a3-4410-a687-a6f99d84f44e"
      unitRef="shares">950000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMjgtMC0xLTEtNjE5OTAvdGV4dHJlZ2lvbjo5ZTI4NmY4ZmU1MzI0NDg2ODdjYjBkNzY3ZDY0NzIyZl81NDk3NTU4MTQwNzY_d44737fc-445e-4bcc-b194-8bb8e50579da"
      unitRef="shares">950000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesIssued
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMjgtMC0xLTEtNjE5OTAvdGV4dHJlZ2lvbjo5ZTI4NmY4ZmU1MzI0NDg2ODdjYjBkNzY3ZDY0NzIyZl81NDk3NTU4MTQxMjY_98a79a0f-4ecd-402e-b0cd-b3870805986a"
      unitRef="shares">84971465</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMjgtMC0xLTEtNjE5OTAvdGV4dHJlZ2lvbjo5ZTI4NmY4ZmU1MzI0NDg2ODdjYjBkNzY3ZDY0NzIyZl81NDk3NTU4MTQxMjY_f8a798a1-588c-4f34-af33-510064aba6f5"
      unitRef="shares">84971465</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMjgtMC0xLTEtNjE5OTAvdGV4dHJlZ2lvbjo5ZTI4NmY4ZmU1MzI0NDg2ODdjYjBkNzY3ZDY0NzIyZl81NDk3NTU4MTQxMzk_b153b0d8-05b9-42c8-80db-b14c8ed44e5f"
      unitRef="shares">84610114</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMjgtMC0xLTEtNjE5OTAvdGV4dHJlZ2lvbjo5ZTI4NmY4ZmU1MzI0NDg2ODdjYjBkNzY3ZDY0NzIyZl81NDk3NTU4MTQxMzk_e5576488-af73-451c-a99d-5778d5f9bf02"
      unitRef="shares">84610114</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValueOutstanding
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMjgtMS0xLTEtNjE5OTA_486b5ed7-5c24-44b8-a337-340ab7ad6673"
      unitRef="usd">8000</us-gaap:CommonStockValueOutstanding>
    <us-gaap:CommonStockValueOutstanding
      contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMjgtMy0xLTEtNjE5OTA_33ae3147-466a-421c-a75e-99d5dbb067fb"
      unitRef="usd">8000</us-gaap:CommonStockValueOutstanding>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMjktMS0xLTEtNjE5OTA_16d3a821-cc01-4895-9eae-f8ec0a463d4e"
      unitRef="usd">169016000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMjktMy0xLTEtNjE5OTA_98e9b103-3c02-4d1d-8d15-302df82fec60"
      unitRef="usd">165912000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMzAtMS0xLTEtNjE5OTA_4a637076-4f2f-42bf-bd19-f89ec2cac497"
      unitRef="usd">-101989000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMzAtMy0xLTEtNjE5OTA_7b29d12c-b033-4c83-aeea-f6deac3d4ce8"
      unitRef="usd">-92887000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:StockholdersEquity
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMzEtMS0xLTEtNjE5OTA_82201bbb-68c4-4be1-b219-fc8d4be7c5c1"
      unitRef="usd">67035000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMzEtMy0xLTEtNjE5OTA_2df1967f-6593-4192-809b-b39ac566a85e"
      unitRef="usd">73033000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMzItMS0xLTEtNjE5OTA_10ce8265-d623-4d06-ac97-49ba7741d624"
      unitRef="usd">83948000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yMi9mcmFnOjY3MmQzZjU0MWE1MjRlOGU5MzBkNGQ0Y2ZhMzZmNTVhL3RhYmxlOjU5ZmFkNTc4OGNkYzQzZTU5NzY2NTZhZjAyYWM5Y2VmL3RhYmxlcmFuZ2U6NTlmYWQ1Nzg4Y2RjNDNlNTk3NjY1NmFmMDJhYzljZWZfMzItMy0xLTEtNjE5OTA_ec39a10d-49a3-4c89-8485-ce8cfc271244"
      unitRef="usd">83171000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:Revenues
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yNS9mcmFnOjhkMjg1MGRkOWMxYjQ4YTU4YjEwNWVkZGQ2M2RkYTFlL3RhYmxlOjA2NzIxOWFjMzI0ODQ3Zjg5NDA2YmUxYjE2NjMzMDMyL3RhYmxlcmFuZ2U6MDY3MjE5YWMzMjQ4NDdmODk0MDZiZTFiMTY2MzMwMzJfMi0xLTEtMS02MTk5MA_c25ba343-8bdf-40d5-b693-fccf7f18561d"
      unitRef="usd">679000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yNS9mcmFnOjhkMjg1MGRkOWMxYjQ4YTU4YjEwNWVkZGQ2M2RkYTFlL3RhYmxlOjA2NzIxOWFjMzI0ODQ3Zjg5NDA2YmUxYjE2NjMzMDMyL3RhYmxlcmFuZ2U6MDY3MjE5YWMzMjQ4NDdmODk0MDZiZTFiMTY2MzMwMzJfMi0zLTEtMS02MTk5MA_7360c104-dc3d-4f2b-a61d-83b36ad2f49e"
      unitRef="usd">2110000</us-gaap:Revenues>
    <us-gaap:CostOfRevenue
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yNS9mcmFnOjhkMjg1MGRkOWMxYjQ4YTU4YjEwNWVkZGQ2M2RkYTFlL3RhYmxlOjA2NzIxOWFjMzI0ODQ3Zjg5NDA2YmUxYjE2NjMzMDMyL3RhYmxlcmFuZ2U6MDY3MjE5YWMzMjQ4NDdmODk0MDZiZTFiMTY2MzMwMzJfMy0xLTEtMS02MTk5MA_a7a0160d-3bb2-4f4f-97b9-f12be9005d71"
      unitRef="usd">4104000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yNS9mcmFnOjhkMjg1MGRkOWMxYjQ4YTU4YjEwNWVkZGQ2M2RkYTFlL3RhYmxlOjA2NzIxOWFjMzI0ODQ3Zjg5NDA2YmUxYjE2NjMzMDMyL3RhYmxlcmFuZ2U6MDY3MjE5YWMzMjQ4NDdmODk0MDZiZTFiMTY2MzMwMzJfMy0zLTEtMS02MTk5MA_a32bb4fc-c7cb-432c-8763-00be713a14fb"
      unitRef="usd">3149000</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yNS9mcmFnOjhkMjg1MGRkOWMxYjQ4YTU4YjEwNWVkZGQ2M2RkYTFlL3RhYmxlOjA2NzIxOWFjMzI0ODQ3Zjg5NDA2YmUxYjE2NjMzMDMyL3RhYmxlcmFuZ2U6MDY3MjE5YWMzMjQ4NDdmODk0MDZiZTFiMTY2MzMwMzJfNC0xLTEtMS02MTk5MA_00b22de6-c887-4504-86a1-010effd8673e"
      unitRef="usd">-3425000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yNS9mcmFnOjhkMjg1MGRkOWMxYjQ4YTU4YjEwNWVkZGQ2M2RkYTFlL3RhYmxlOjA2NzIxOWFjMzI0ODQ3Zjg5NDA2YmUxYjE2NjMzMDMyL3RhYmxlcmFuZ2U6MDY3MjE5YWMzMjQ4NDdmODk0MDZiZTFiMTY2MzMwMzJfNC0zLTEtMS02MTk5MA_c97ed165-572d-428f-87f1-1c7a718a1d44"
      unitRef="usd">-1039000</us-gaap:GrossProfit>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yNS9mcmFnOjhkMjg1MGRkOWMxYjQ4YTU4YjEwNWVkZGQ2M2RkYTFlL3RhYmxlOjA2NzIxOWFjMzI0ODQ3Zjg5NDA2YmUxYjE2NjMzMDMyL3RhYmxlcmFuZ2U6MDY3MjE5YWMzMjQ4NDdmODk0MDZiZTFiMTY2MzMwMzJfNi0xLTEtMS02MTk5MA_6484cd85-d1cb-42fe-b78a-5198d8fa1860"
      unitRef="usd">800000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yNS9mcmFnOjhkMjg1MGRkOWMxYjQ4YTU4YjEwNWVkZGQ2M2RkYTFlL3RhYmxlOjA2NzIxOWFjMzI0ODQ3Zjg5NDA2YmUxYjE2NjMzMDMyL3RhYmxlcmFuZ2U6MDY3MjE5YWMzMjQ4NDdmODk0MDZiZTFiMTY2MzMwMzJfNi0zLTEtMS02MTk5MA_62d76aca-02a7-4772-a6ff-8efdbd8b6d7c"
      unitRef="usd">369000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yNS9mcmFnOjhkMjg1MGRkOWMxYjQ4YTU4YjEwNWVkZGQ2M2RkYTFlL3RhYmxlOjA2NzIxOWFjMzI0ODQ3Zjg5NDA2YmUxYjE2NjMzMDMyL3RhYmxlcmFuZ2U6MDY3MjE5YWMzMjQ4NDdmODk0MDZiZTFiMTY2MzMwMzJfNy0xLTEtMS02MTk5MA_45489fa0-7e2b-4b39-b47a-360989582e4b"
      unitRef="usd">5526000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yNS9mcmFnOjhkMjg1MGRkOWMxYjQ4YTU4YjEwNWVkZGQ2M2RkYTFlL3RhYmxlOjA2NzIxOWFjMzI0ODQ3Zjg5NDA2YmUxYjE2NjMzMDMyL3RhYmxlcmFuZ2U6MDY3MjE5YWMzMjQ4NDdmODk0MDZiZTFiMTY2MzMwMzJfNy0zLTEtMS02MTk5MA_23b38f51-e0b5-493c-9fd5-a47e00341a79"
      unitRef="usd">1502000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:OperatingExpenses
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yNS9mcmFnOjhkMjg1MGRkOWMxYjQ4YTU4YjEwNWVkZGQ2M2RkYTFlL3RhYmxlOjA2NzIxOWFjMzI0ODQ3Zjg5NDA2YmUxYjE2NjMzMDMyL3RhYmxlcmFuZ2U6MDY3MjE5YWMzMjQ4NDdmODk0MDZiZTFiMTY2MzMwMzJfOC0xLTEtMS02MTk5MA_eea2a142-6c28-495f-aeeb-e0f8a66551e0"
      unitRef="usd">6326000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yNS9mcmFnOjhkMjg1MGRkOWMxYjQ4YTU4YjEwNWVkZGQ2M2RkYTFlL3RhYmxlOjA2NzIxOWFjMzI0ODQ3Zjg5NDA2YmUxYjE2NjMzMDMyL3RhYmxlcmFuZ2U6MDY3MjE5YWMzMjQ4NDdmODk0MDZiZTFiMTY2MzMwMzJfOC0zLTEtMS02MTk5MA_0c3b432f-02af-43da-9139-95b1af36627e"
      unitRef="usd">1871000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yNS9mcmFnOjhkMjg1MGRkOWMxYjQ4YTU4YjEwNWVkZGQ2M2RkYTFlL3RhYmxlOjA2NzIxOWFjMzI0ODQ3Zjg5NDA2YmUxYjE2NjMzMDMyL3RhYmxlcmFuZ2U6MDY3MjE5YWMzMjQ4NDdmODk0MDZiZTFiMTY2MzMwMzJfOS0xLTEtMS02MTk5MA_ea913c90-c884-4f66-b13b-b36109084d55"
      unitRef="usd">-9751000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yNS9mcmFnOjhkMjg1MGRkOWMxYjQ4YTU4YjEwNWVkZGQ2M2RkYTFlL3RhYmxlOjA2NzIxOWFjMzI0ODQ3Zjg5NDA2YmUxYjE2NjMzMDMyL3RhYmxlcmFuZ2U6MDY3MjE5YWMzMjQ4NDdmODk0MDZiZTFiMTY2MzMwMzJfOS0zLTEtMS02MTk5MA_096b7875-5087-4381-8c6e-4e747461a9ec"
      unitRef="usd">-2910000</us-gaap:OperatingIncomeLoss>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yNS9mcmFnOjhkMjg1MGRkOWMxYjQ4YTU4YjEwNWVkZGQ2M2RkYTFlL3RhYmxlOjA2NzIxOWFjMzI0ODQ3Zjg5NDA2YmUxYjE2NjMzMDMyL3RhYmxlcmFuZ2U6MDY3MjE5YWMzMjQ4NDdmODk0MDZiZTFiMTY2MzMwMzJfMTMtMS0xLTEtNjE5OTA_e5bb5b88-fc3a-4f5a-9da2-723989d010a2"
      unitRef="usd">649000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NonoperatingIncomeExpense
      contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yNS9mcmFnOjhkMjg1MGRkOWMxYjQ4YTU4YjEwNWVkZGQ2M2RkYTFlL3RhYmxlOjA2NzIxOWFjMzI0ODQ3Zjg5NDA2YmUxYjE2NjMzMDMyL3RhYmxlcmFuZ2U6MDY3MjE5YWMzMjQ4NDdmODk0MDZiZTFiMTY2MzMwMzJfMTMtMy0xLTEtNjE5OTA_0dcf12ef-7fa2-42ad-b8f2-61b146725b35"
      unitRef="usd">32000</us-gaap:NonoperatingIncomeExpense>
    <us-gaap:NetIncomeLoss
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yNS9mcmFnOjhkMjg1MGRkOWMxYjQ4YTU4YjEwNWVkZGQ2M2RkYTFlL3RhYmxlOjA2NzIxOWFjMzI0ODQ3Zjg5NDA2YmUxYjE2NjMzMDMyL3RhYmxlcmFuZ2U6MDY3MjE5YWMzMjQ4NDdmODk0MDZiZTFiMTY2MzMwMzJfMTQtMS0xLTEtNjE5OTA_d77ed056-a9de-44c1-a32b-47e9c74ed7b2"
      unitRef="usd">-9102000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yNS9mcmFnOjhkMjg1MGRkOWMxYjQ4YTU4YjEwNWVkZGQ2M2RkYTFlL3RhYmxlOjA2NzIxOWFjMzI0ODQ3Zjg5NDA2YmUxYjE2NjMzMDMyL3RhYmxlcmFuZ2U6MDY3MjE5YWMzMjQ4NDdmODk0MDZiZTFiMTY2MzMwMzJfMTQtMy0xLTEtNjE5OTA_fea9bee6-a962-48c6-ac3d-c9430c46955e"
      unitRef="usd">-2878000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yNS9mcmFnOjhkMjg1MGRkOWMxYjQ4YTU4YjEwNWVkZGQ2M2RkYTFlL3RhYmxlOjA2NzIxOWFjMzI0ODQ3Zjg5NDA2YmUxYjE2NjMzMDMyL3RhYmxlcmFuZ2U6MDY3MjE5YWMzMjQ4NDdmODk0MDZiZTFiMTY2MzMwMzJfMTctMS0xLTEtNjE5OTA_33debc42-506e-4185-9240-1ba771f2f8ff"
      unitRef="shares">84645097</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yNS9mcmFnOjhkMjg1MGRkOWMxYjQ4YTU4YjEwNWVkZGQ2M2RkYTFlL3RhYmxlOjA2NzIxOWFjMzI0ODQ3Zjg5NDA2YmUxYjE2NjMzMDMyL3RhYmxlcmFuZ2U6MDY3MjE5YWMzMjQ4NDdmODk0MDZiZTFiMTY2MzMwMzJfMTctMS0xLTEtNjE5OTA_abae1b03-8d4b-4a20-9d0b-c14abeaafd1a"
      unitRef="shares">84645097</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yNS9mcmFnOjhkMjg1MGRkOWMxYjQ4YTU4YjEwNWVkZGQ2M2RkYTFlL3RhYmxlOjA2NzIxOWFjMzI0ODQ3Zjg5NDA2YmUxYjE2NjMzMDMyL3RhYmxlcmFuZ2U6MDY3MjE5YWMzMjQ4NDdmODk0MDZiZTFiMTY2MzMwMzJfMTctMy0xLTEtNjE5OTA_9e573f62-de79-4a12-bff0-e965588ce71c"
      unitRef="shares">65774528</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yNS9mcmFnOjhkMjg1MGRkOWMxYjQ4YTU4YjEwNWVkZGQ2M2RkYTFlL3RhYmxlOjA2NzIxOWFjMzI0ODQ3Zjg5NDA2YmUxYjE2NjMzMDMyL3RhYmxlcmFuZ2U6MDY3MjE5YWMzMjQ4NDdmODk0MDZiZTFiMTY2MzMwMzJfMTctMy0xLTEtNjE5OTA_f019863a-5d61-4975-a186-98eafedcfb4e"
      unitRef="shares">65774528</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:EarningsPerShareBasic
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yNS9mcmFnOjhkMjg1MGRkOWMxYjQ4YTU4YjEwNWVkZGQ2M2RkYTFlL3RhYmxlOjA2NzIxOWFjMzI0ODQ3Zjg5NDA2YmUxYjE2NjMzMDMyL3RhYmxlcmFuZ2U6MDY3MjE5YWMzMjQ4NDdmODk0MDZiZTFiMTY2MzMwMzJfMTktMS0xLTEtNjE5OTA_620a2cdc-adfb-4468-8630-c4fa7d86cb89"
      unitRef="usdPerShare">-0.11</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yNS9mcmFnOjhkMjg1MGRkOWMxYjQ4YTU4YjEwNWVkZGQ2M2RkYTFlL3RhYmxlOjA2NzIxOWFjMzI0ODQ3Zjg5NDA2YmUxYjE2NjMzMDMyL3RhYmxlcmFuZ2U6MDY3MjE5YWMzMjQ4NDdmODk0MDZiZTFiMTY2MzMwMzJfMTktMS0xLTEtNjE5OTA_e5387956-33f3-4196-ab58-8765e99859e1"
      unitRef="usdPerShare">-0.11</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareDiluted
      contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yNS9mcmFnOjhkMjg1MGRkOWMxYjQ4YTU4YjEwNWVkZGQ2M2RkYTFlL3RhYmxlOjA2NzIxOWFjMzI0ODQ3Zjg5NDA2YmUxYjE2NjMzMDMyL3RhYmxlcmFuZ2U6MDY3MjE5YWMzMjQ4NDdmODk0MDZiZTFiMTY2MzMwMzJfMTktMy0xLTEtNjE5OTA_0c2371d4-782b-410d-af82-76910b0da6d4"
      unitRef="usdPerShare">-0.04</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yNS9mcmFnOjhkMjg1MGRkOWMxYjQ4YTU4YjEwNWVkZGQ2M2RkYTFlL3RhYmxlOjA2NzIxOWFjMzI0ODQ3Zjg5NDA2YmUxYjE2NjMzMDMyL3RhYmxlcmFuZ2U6MDY3MjE5YWMzMjQ4NDdmODk0MDZiZTFiMTY2MzMwMzJfMTktMy0xLTEtNjE5OTA_ba5ad63c-84ac-480f-be5a-ba166d8053b1"
      unitRef="usdPerShare">-0.04</us-gaap:EarningsPerShareBasic>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i8f5097542ed94e019e553cb2481ed488_I20221231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOmZjYzFjYWI4YmE4MjRiZWViYjY0MWQ5NjAwZDk2ZWIxL3RhYmxlcmFuZ2U6ZmNjMWNhYjhiYTgyNGJlZWJiNjQxZDk2MDBkOTZlYjFfMy0xLTEtMS02MTk5MA_c492165a-b7e7-4839-92b7-9efdcf75c9e3"
      unitRef="shares">84610114</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i8f5097542ed94e019e553cb2481ed488_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOmZjYzFjYWI4YmE4MjRiZWViYjY0MWQ5NjAwZDk2ZWIxL3RhYmxlcmFuZ2U6ZmNjMWNhYjhiYTgyNGJlZWJiNjQxZDk2MDBkOTZlYjFfMy0zLTEtMS02MTk5MA_ddd7630f-417b-432f-b380-430773b67517"
      unitRef="usd">8000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i2afb5bfd349b44c8b991e6359c2ea6ac_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOmZjYzFjYWI4YmE4MjRiZWViYjY0MWQ5NjAwZDk2ZWIxL3RhYmxlcmFuZ2U6ZmNjMWNhYjhiYTgyNGJlZWJiNjQxZDk2MDBkOTZlYjFfMy01LTEtMS02MTk5MA_269a533a-4b55-4e39-a126-56999cd0d6ee"
      unitRef="usd">165912000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6db38870876b40778cbddcf2716d2e8c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOmZjYzFjYWI4YmE4MjRiZWViYjY0MWQ5NjAwZDk2ZWIxL3RhYmxlcmFuZ2U6ZmNjMWNhYjhiYTgyNGJlZWJiNjQxZDk2MDBkOTZlYjFfMy03LTEtMS02MTk5MA_42a011b7-5ded-4f77-9869-40cb14228006"
      unitRef="usd">-92887000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOmZjYzFjYWI4YmE4MjRiZWViYjY0MWQ5NjAwZDk2ZWIxL3RhYmxlcmFuZ2U6ZmNjMWNhYjhiYTgyNGJlZWJiNjQxZDk2MDBkOTZlYjFfMy05LTEtMS02MTk5MA_4b5b2cdd-b547-447b-8d38-3eea80d2877b"
      unitRef="usd">73033000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="id53f479a40704e0db1e45d90b74f3ab2_D20230101-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOmZjYzFjYWI4YmE4MjRiZWViYjY0MWQ5NjAwZDk2ZWIxL3RhYmxlcmFuZ2U6ZmNjMWNhYjhiYTgyNGJlZWJiNjQxZDk2MDBkOTZlYjFfNC0xLTEtMS03MDAwMA_40af28e1-6a0c-4dcf-80b7-55d81a8df382"
      unitRef="shares">331351</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="iee3994aee9fd4eec960461ddc9dede6e_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOmZjYzFjYWI4YmE4MjRiZWViYjY0MWQ5NjAwZDk2ZWIxL3RhYmxlcmFuZ2U6ZmNjMWNhYjhiYTgyNGJlZWJiNjQxZDk2MDBkOTZlYjFfNC01LTEtMS03MDAwMA_1ac82d83-f148-4dd4-87ea-9760574e5902"
      unitRef="usd">2376000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOmZjYzFjYWI4YmE4MjRiZWViYjY0MWQ5NjAwZDk2ZWIxL3RhYmxlcmFuZ2U6ZmNjMWNhYjhiYTgyNGJlZWJiNjQxZDk2MDBkOTZlYjFfNC05LTEtMS03MDAwMA_be70d0c7-47ec-4829-9d7d-0a7c6becb44a"
      unitRef="usd">2376000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="id53f479a40704e0db1e45d90b74f3ab2_D20230101-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOmZjYzFjYWI4YmE4MjRiZWViYjY0MWQ5NjAwZDk2ZWIxL3RhYmxlcmFuZ2U6ZmNjMWNhYjhiYTgyNGJlZWJiNjQxZDk2MDBkOTZlYjFfNi0xLTEtMS02MTk5MA_48b21d64-9743-4549-8e97-03b156d57dd0"
      unitRef="shares">30000</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="iee3994aee9fd4eec960461ddc9dede6e_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOmZjYzFjYWI4YmE4MjRiZWViYjY0MWQ5NjAwZDk2ZWIxL3RhYmxlcmFuZ2U6ZmNjMWNhYjhiYTgyNGJlZWJiNjQxZDk2MDBkOTZlYjFfNi01LTEtMS02MTk5MA_85e83500-25bd-4015-af37-e57c827ae8dc"
      unitRef="usd">2000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOmZjYzFjYWI4YmE4MjRiZWViYjY0MWQ5NjAwZDk2ZWIxL3RhYmxlcmFuZ2U6ZmNjMWNhYjhiYTgyNGJlZWJiNjQxZDk2MDBkOTZlYjFfNi05LTEtMS02MTk5MA_79bb1d42-c04a-45a4-b85e-10081b9dc911"
      unitRef="usd">2000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="iee3994aee9fd4eec960461ddc9dede6e_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOmZjYzFjYWI4YmE4MjRiZWViYjY0MWQ5NjAwZDk2ZWIxL3RhYmxlcmFuZ2U6ZmNjMWNhYjhiYTgyNGJlZWJiNjQxZDk2MDBkOTZlYjFfOC01LTEtMS02MTk5MA_14b28642-7fc3-41d5-a74b-f1c494f54e41"
      unitRef="usd">723000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOmZjYzFjYWI4YmE4MjRiZWViYjY0MWQ5NjAwZDk2ZWIxL3RhYmxlcmFuZ2U6ZmNjMWNhYjhiYTgyNGJlZWJiNjQxZDk2MDBkOTZlYjFfOC05LTEtMS02MTk5MA_e537f685-58ac-46a7-860e-8f3c4f625b0b"
      unitRef="usd">723000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <ampx:AdjustmentsToAdditionalPaidInCapitalContributionFromParentRelatedToStockBasedCompensation
      contextRef="iee3994aee9fd4eec960461ddc9dede6e_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOmZjYzFjYWI4YmE4MjRiZWViYjY0MWQ5NjAwZDk2ZWIxL3RhYmxlcmFuZ2U6ZmNjMWNhYjhiYTgyNGJlZWJiNjQxZDk2MDBkOTZlYjFfOS01LTEtMS02MTk5MA_d3334ab8-239d-4dc6-ae19-efaa7e6dcbde"
      unitRef="usd">3000</ampx:AdjustmentsToAdditionalPaidInCapitalContributionFromParentRelatedToStockBasedCompensation>
    <ampx:AdjustmentsToAdditionalPaidInCapitalContributionFromParentRelatedToStockBasedCompensation
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOmZjYzFjYWI4YmE4MjRiZWViYjY0MWQ5NjAwZDk2ZWIxL3RhYmxlcmFuZ2U6ZmNjMWNhYjhiYTgyNGJlZWJiNjQxZDk2MDBkOTZlYjFfOS05LTEtMS02MTk5MA_0b86baff-346b-481f-8c92-1f642ebfe62e"
      unitRef="usd">3000</ampx:AdjustmentsToAdditionalPaidInCapitalContributionFromParentRelatedToStockBasedCompensation>
    <us-gaap:NetIncomeLoss
      contextRef="ibf9077943bf2498e945a5b5cffea4ede_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOmZjYzFjYWI4YmE4MjRiZWViYjY0MWQ5NjAwZDk2ZWIxL3RhYmxlcmFuZ2U6ZmNjMWNhYjhiYTgyNGJlZWJiNjQxZDk2MDBkOTZlYjFfMTAtNy0xLTEtNjE5OTA_123581fe-3fbe-4394-913d-129a9079129f"
      unitRef="usd">-9102000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOmZjYzFjYWI4YmE4MjRiZWViYjY0MWQ5NjAwZDk2ZWIxL3RhYmxlcmFuZ2U6ZmNjMWNhYjhiYTgyNGJlZWJiNjQxZDk2MDBkOTZlYjFfMTAtOS0xLTEtNjE5OTA_b8769b76-73d4-4984-899d-bb1ff6fb2c80"
      unitRef="usd">-9102000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="icbda858436fb409e928a18346f855b84_I20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOmZjYzFjYWI4YmE4MjRiZWViYjY0MWQ5NjAwZDk2ZWIxL3RhYmxlcmFuZ2U6ZmNjMWNhYjhiYTgyNGJlZWJiNjQxZDk2MDBkOTZlYjFfMTEtMS0xLTEtNjE5OTA_9ed27d18-a70b-4033-9a13-9c150c8dfab0"
      unitRef="shares">84971465</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="icbda858436fb409e928a18346f855b84_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOmZjYzFjYWI4YmE4MjRiZWViYjY0MWQ5NjAwZDk2ZWIxL3RhYmxlcmFuZ2U6ZmNjMWNhYjhiYTgyNGJlZWJiNjQxZDk2MDBkOTZlYjFfMTEtMy0xLTEtNjE5OTA_2cc72b90-14ff-4ded-b01b-dfb9e0b1e624"
      unitRef="usd">8000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i38d004c355644a42b820f2b35e0874a5_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOmZjYzFjYWI4YmE4MjRiZWViYjY0MWQ5NjAwZDk2ZWIxL3RhYmxlcmFuZ2U6ZmNjMWNhYjhiYTgyNGJlZWJiNjQxZDk2MDBkOTZlYjFfMTEtNS0xLTEtNjE5OTA_3596915b-2ee5-4aa0-b45f-60c50f5ec134"
      unitRef="usd">169016000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i55afdc11794d46c3844a5877adc375f6_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOmZjYzFjYWI4YmE4MjRiZWViYjY0MWQ5NjAwZDk2ZWIxL3RhYmxlcmFuZ2U6ZmNjMWNhYjhiYTgyNGJlZWJiNjQxZDk2MDBkOTZlYjFfMTEtNy0xLTEtNjE5OTA_83f07ae1-f154-4f2a-b6ff-072ae1afb42f"
      unitRef="usd">-101989000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOmZjYzFjYWI4YmE4MjRiZWViYjY0MWQ5NjAwZDk2ZWIxL3RhYmxlcmFuZ2U6ZmNjMWNhYjhiYTgyNGJlZWJiNjQxZDk2MDBkOTZlYjFfMTEtOS0xLTEtNjE5OTA_c5e7b749-6349-4ffd-ab2d-0e5c5414141f"
      unitRef="usd">67035000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ife934d56970b49fdbc5f246e8c61d0f5_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOjFjNDZmODgyMWIzNjRjYmM4NTllMzRhMjE5M2I3ZjAzL3RhYmxlcmFuZ2U6MWM0NmY4ODIxYjM2NGNiYzg1OWUzNGEyMTkzYjdmMDNfNS0xLTEtMS02MTk5MA_e767619a-5700-4993-aa41-ad88fdc4bc95"
      unitRef="shares">45176145</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="ife934d56970b49fdbc5f246e8c61d0f5_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOjFjNDZmODgyMWIzNjRjYmM4NTllMzRhMjE5M2I3ZjAzL3RhYmxlcmFuZ2U6MWM0NmY4ODIxYjM2NGNiYzg1OWUzNGEyMTkzYjdmMDNfNS0zLTEtMS02MTk5MA_4f28e086-d0e0-4d01-b091-925370e14331"
      unitRef="usd">1000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i720988f66ee2413488964d010217db49_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOjFjNDZmODgyMWIzNjRjYmM4NTllMzRhMjE5M2I3ZjAzL3RhYmxlcmFuZ2U6MWM0NmY4ODIxYjM2NGNiYzg1OWUzNGEyMTkzYjdmMDNfNS01LTEtMS02MTk5MA_b3394c72-e101-4220-b2af-bfa6045072ba"
      unitRef="usd">89258000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0266250627e24a9d98564b0fca01e7dc_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOjFjNDZmODgyMWIzNjRjYmM4NTllMzRhMjE5M2I3ZjAzL3RhYmxlcmFuZ2U6MWM0NmY4ODIxYjM2NGNiYzg1OWUzNGEyMTkzYjdmMDNfNS03LTEtMS02MTk5MA_7bd0cf78-a6d4-48ed-9501-ddfe22f2da11"
      unitRef="usd">-75401000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i11415fde3f7d40df98aa03c58126edec_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOjFjNDZmODgyMWIzNjRjYmM4NTllMzRhMjE5M2I3ZjAzL3RhYmxlcmFuZ2U6MWM0NmY4ODIxYjM2NGNiYzg1OWUzNGEyMTkzYjdmMDNfNS05LTEtMS02MTk5MA_f109c80b-eb4e-4110-bca9-05f12428c2f8"
      unitRef="usd">13858000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="idd6d5ba96ae14bb0b84986d93719cf0c_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOjFjNDZmODgyMWIzNjRjYmM4NTllMzRhMjE5M2I3ZjAzL3RhYmxlcmFuZ2U6MWM0NmY4ODIxYjM2NGNiYzg1OWUzNGEyMTkzYjdmMDNfNC0xLTEtMS02MzMyOA_6671168d-b1a3-41d4-903c-3210508258bf"
      unitRef="shares">20595856</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="idd6d5ba96ae14bb0b84986d93719cf0c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOjFjNDZmODgyMWIzNjRjYmM4NTllMzRhMjE5M2I3ZjAzL3RhYmxlcmFuZ2U6MWM0NmY4ODIxYjM2NGNiYzg1OWUzNGEyMTkzYjdmMDNfNC0zLTEtMS02MzMyOA_b910d4c6-363e-47cb-a45d-db89b8dcc22e"
      unitRef="usd">6000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i6449e443d30c455184fed3bff4010086_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOjFjNDZmODgyMWIzNjRjYmM4NTllMzRhMjE5M2I3ZjAzL3RhYmxlcmFuZ2U6MWM0NmY4ODIxYjM2NGNiYzg1OWUzNGEyMTkzYjdmMDNfNC01LTEtMS02MzMyOA_81020192-b1e1-480e-abef-7a4729c02832"
      unitRef="usd">-6000</us-gaap:StockholdersEquity>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i3a1b0acc07434411a2695d9dbe33e259_I20211231"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOjFjNDZmODgyMWIzNjRjYmM4NTllMzRhMjE5M2I3ZjAzL3RhYmxlcmFuZ2U6MWM0NmY4ODIxYjM2NGNiYzg1OWUzNGEyMTkzYjdmMDNfNi0xLTEtMS02MTk5MA_9745897d-6c60-4d60-9d56-6f5b7bbff4bb"
      unitRef="shares">65772001</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i3a1b0acc07434411a2695d9dbe33e259_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOjFjNDZmODgyMWIzNjRjYmM4NTllMzRhMjE5M2I3ZjAzL3RhYmxlcmFuZ2U6MWM0NmY4ODIxYjM2NGNiYzg1OWUzNGEyMTkzYjdmMDNfNi0zLTEtMS02MTk5MA_608cf046-25b7-4a8d-8e08-ff48c477a117"
      unitRef="usd">7000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1a1fa4a0e8fb49cc8d3c759e2e0c17e7_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOjFjNDZmODgyMWIzNjRjYmM4NTllMzRhMjE5M2I3ZjAzL3RhYmxlcmFuZ2U6MWM0NmY4ODIxYjM2NGNiYzg1OWUzNGEyMTkzYjdmMDNfNi01LTEtMS02MTk5MA_afcf0236-f3ae-4a47-b2c5-0d9d2285f868"
      unitRef="usd">89252000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i0cad88c1b2cb4985ad2e0e7a12c33ca0_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOjFjNDZmODgyMWIzNjRjYmM4NTllMzRhMjE5M2I3ZjAzL3RhYmxlcmFuZ2U6MWM0NmY4ODIxYjM2NGNiYzg1OWUzNGEyMTkzYjdmMDNfNi03LTEtMS02MTk5MA_3b9f0fa0-cc93-4e7a-a18c-454794bfe918"
      unitRef="usd">-75401000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ifce6518367b34d3ab4c10e9de84e7829_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOjFjNDZmODgyMWIzNjRjYmM4NTllMzRhMjE5M2I3ZjAzL3RhYmxlcmFuZ2U6MWM0NmY4ODIxYjM2NGNiYzg1OWUzNGEyMTkzYjdmMDNfNi05LTEtMS02MTk5MA_c62b1e13-f4ee-4d4f-b1a2-e518bc967f13"
      unitRef="usd">13858000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4378b9360776445ba70d80981bf38d62_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOjFjNDZmODgyMWIzNjRjYmM4NTllMzRhMjE5M2I3ZjAzL3RhYmxlcmFuZ2U6MWM0NmY4ODIxYjM2NGNiYzg1OWUzNGEyMTkzYjdmMDNfNy03LTEtMS02MTk5MA_3eb70384-d4f6-402b-8ecd-1a18fc6ec25c"
      unitRef="usd">-154000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7f7477a44afb4479b9c1eee284f3005c_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOjFjNDZmODgyMWIzNjRjYmM4NTllMzRhMjE5M2I3ZjAzL3RhYmxlcmFuZ2U6MWM0NmY4ODIxYjM2NGNiYzg1OWUzNGEyMTkzYjdmMDNfNy05LTEtMS02MTk5MA_0d3c7130-db61-460c-95a0-f3ca9a0d8496"
      unitRef="usd">-154000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i0f1b454495df444b9b332af549b60b6a_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOjFjNDZmODgyMWIzNjRjYmM4NTllMzRhMjE5M2I3ZjAzL3RhYmxlcmFuZ2U6MWM0NmY4ODIxYjM2NGNiYzg1OWUzNGEyMTkzYjdmMDNfOC0xLTEtMS02MTk5MA_f9faf29d-caf4-4e58-a9bc-ed9692ad05d7"
      unitRef="shares">4549</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i50f6cb59fed6438795bb51a3698b7cef_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOjFjNDZmODgyMWIzNjRjYmM4NTllMzRhMjE5M2I3ZjAzL3RhYmxlcmFuZ2U6MWM0NmY4ODIxYjM2NGNiYzg1OWUzNGEyMTkzYjdmMDNfOC01LTEtMS02MTk5MA_e8a6cbfb-d2aa-4914-96e5-36936eeb6bf2"
      unitRef="usd">8000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOjFjNDZmODgyMWIzNjRjYmM4NTllMzRhMjE5M2I3ZjAzL3RhYmxlcmFuZ2U6MWM0NmY4ODIxYjM2NGNiYzg1OWUzNGEyMTkzYjdmMDNfOC05LTEtMS02MTk5MA_8af7409f-5cc6-4dab-bc09-d62cb0f63b17"
      unitRef="usd">8000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <ampx:AdjustmentsToAdditionalPaidInCapitalCapitalContributionsFromParent
      contextRef="i50f6cb59fed6438795bb51a3698b7cef_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOjFjNDZmODgyMWIzNjRjYmM4NTllMzRhMjE5M2I3ZjAzL3RhYmxlcmFuZ2U6MWM0NmY4ODIxYjM2NGNiYzg1OWUzNGEyMTkzYjdmMDNfOS01LTEtMS02MTk5MA_fc187c30-77c3-402b-a8f1-0fe446681076"
      unitRef="usd">247000</ampx:AdjustmentsToAdditionalPaidInCapitalCapitalContributionsFromParent>
    <ampx:AdjustmentsToAdditionalPaidInCapitalCapitalContributionsFromParent
      contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOjFjNDZmODgyMWIzNjRjYmM4NTllMzRhMjE5M2I3ZjAzL3RhYmxlcmFuZ2U6MWM0NmY4ODIxYjM2NGNiYzg1OWUzNGEyMTkzYjdmMDNfOS05LTEtMS02MTk5MA_74f0b651-50a2-4821-b143-929c402b5b6c"
      unitRef="usd">247000</ampx:AdjustmentsToAdditionalPaidInCapitalCapitalContributionsFromParent>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="i50f6cb59fed6438795bb51a3698b7cef_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOjFjNDZmODgyMWIzNjRjYmM4NTllMzRhMjE5M2I3ZjAzL3RhYmxlcmFuZ2U6MWM0NmY4ODIxYjM2NGNiYzg1OWUzNGEyMTkzYjdmMDNfMTAtNS0xLTEtNjE5OTA_8fe4902e-7cb8-44c2-ab5a-1b2ed9fde9a6"
      unitRef="usd">350000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
      contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOjFjNDZmODgyMWIzNjRjYmM4NTllMzRhMjE5M2I3ZjAzL3RhYmxlcmFuZ2U6MWM0NmY4ODIxYjM2NGNiYzg1OWUzNGEyMTkzYjdmMDNfMTAtOS0xLTEtNjE5OTA_9b4b2548-31d0-434d-b500-3bdf122cf917"
      unitRef="usd">350000</us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue>
    <ampx:AdjustmentsToAdditionalPaidInCapitalContributionFromParentRelatedToStockBasedCompensation
      contextRef="i50f6cb59fed6438795bb51a3698b7cef_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOjFjNDZmODgyMWIzNjRjYmM4NTllMzRhMjE5M2I3ZjAzL3RhYmxlcmFuZ2U6MWM0NmY4ODIxYjM2NGNiYzg1OWUzNGEyMTkzYjdmMDNfMTAtNS0xLTEtNjQ1Mzc_edef3695-91e1-406a-8384-3646e1ff7539"
      unitRef="usd">106000</ampx:AdjustmentsToAdditionalPaidInCapitalContributionFromParentRelatedToStockBasedCompensation>
    <ampx:AdjustmentsToAdditionalPaidInCapitalContributionFromParentRelatedToStockBasedCompensation
      contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOjFjNDZmODgyMWIzNjRjYmM4NTllMzRhMjE5M2I3ZjAzL3RhYmxlcmFuZ2U6MWM0NmY4ODIxYjM2NGNiYzg1OWUzNGEyMTkzYjdmMDNfMTAtOS0xLTEtNjQ1Mzc_83bf65ae-1d34-4572-b1ce-3fe6382e857c"
      unitRef="usd">106000</ampx:AdjustmentsToAdditionalPaidInCapitalContributionFromParentRelatedToStockBasedCompensation>
    <us-gaap:NetIncomeLoss
      contextRef="i269ea436a3b44ee9800781cda13e9ced_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOjFjNDZmODgyMWIzNjRjYmM4NTllMzRhMjE5M2I3ZjAzL3RhYmxlcmFuZ2U6MWM0NmY4ODIxYjM2NGNiYzg1OWUzNGEyMTkzYjdmMDNfMTEtNy0xLTEtNjg3MTY_1b8892df-4070-4e7b-b1da-16c4788bdbdc"
      unitRef="usd">-2878000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOjFjNDZmODgyMWIzNjRjYmM4NTllMzRhMjE5M2I3ZjAzL3RhYmxlcmFuZ2U6MWM0NmY4ODIxYjM2NGNiYzg1OWUzNGEyMTkzYjdmMDNfMTEtOS0xLTEtNjg3MTY_45c89ca1-3491-4aff-a986-1dbbbc0421f2"
      unitRef="usd">-2878000</us-gaap:NetIncomeLoss>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i7025e13610834dba9e2d509086735e0f_I20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOjFjNDZmODgyMWIzNjRjYmM4NTllMzRhMjE5M2I3ZjAzL3RhYmxlcmFuZ2U6MWM0NmY4ODIxYjM2NGNiYzg1OWUzNGEyMTkzYjdmMDNfMTItMS0xLTEtNjg3MTY_a8e2b284-ed9a-4b48-a635-f6fc8c2f9823"
      unitRef="shares">65776550</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:StockholdersEquity
      contextRef="i7025e13610834dba9e2d509086735e0f_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOjFjNDZmODgyMWIzNjRjYmM4NTllMzRhMjE5M2I3ZjAzL3RhYmxlcmFuZ2U6MWM0NmY4ODIxYjM2NGNiYzg1OWUzNGEyMTkzYjdmMDNfMTItMy0xLTEtNjg3MTY_006ee9d7-aeb2-42d6-a9d7-ff4f27a325ec"
      unitRef="usd">7000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id94df322b86f4f07b19482d29fdb864b_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOjFjNDZmODgyMWIzNjRjYmM4NTllMzRhMjE5M2I3ZjAzL3RhYmxlcmFuZ2U6MWM0NmY4ODIxYjM2NGNiYzg1OWUzNGEyMTkzYjdmMDNfMTItNS0xLTEtNjg3MTY_56888e5c-2836-4bf9-9597-38216d9bdc4d"
      unitRef="usd">89963000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i74bb0e27b0d34b379dd2c30509852fed_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOjFjNDZmODgyMWIzNjRjYmM4NTllMzRhMjE5M2I3ZjAzL3RhYmxlcmFuZ2U6MWM0NmY4ODIxYjM2NGNiYzg1OWUzNGEyMTkzYjdmMDNfMTItNy0xLTEtNjg3MTY_4ed21718-a31e-4a76-bbd2-f0fa0bfd7bdc"
      unitRef="usd">-78433000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i4b2c45cb6722425d93cf25d37d538c75_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8yOC9mcmFnOjEyY2M4MGQ4NDc4YjRlYmJhZDAwYzU4MjBkNWY0MGEzL3RhYmxlOjFjNDZmODgyMWIzNjRjYmM4NTllMzRhMjE5M2I3ZjAzL3RhYmxlcmFuZ2U6MWM0NmY4ODIxYjM2NGNiYzg1OWUzNGEyMTkzYjdmMDNfMTItOS0xLTEtNjg3MTY_1564d74f-bd68-4d6d-8153-70e8e86d9836"
      unitRef="usd">11537000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMy0xLTEtMS02MTk5MA_76404d8f-5276-44d1-9370-a6c05e82dba0"
      unitRef="usd">-9102000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMy0zLTEtMS02MTk5MA_e199291a-e30c-44ca-b06f-95aeb5dc2adf"
      unitRef="usd">-2878000</us-gaap:NetIncomeLoss>
    <us-gaap:ShareBasedCompensation
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfNS0xLTEtMS02MTk5MA_11f6af1c-2248-41c4-a0d3-d53b581b6c1e"
      unitRef="usd">726000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfNS0zLTEtMS02MTk5MA_2f140fa6-45a6-42af-abca-f2af91b25335"
      unitRef="usd">456000</us-gaap:ShareBasedCompensation>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfNi0xLTEtMS02MTk5MA_a7a3acd5-021a-4fe0-af1b-6ff76ae9ef3c"
      unitRef="usd">416000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfNi0zLTEtMS02MTk5MA_20751b76-276c-4ab6-805c-034709733153"
      unitRef="usd">358000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:OtherAmortizationOfDeferredCharges
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfNy0xLTEtMS02MTk5MA_2bd73ece-6a0b-43e9-837a-e30b64301228"
      unitRef="usd">134000</us-gaap:OtherAmortizationOfDeferredCharges>
    <us-gaap:OtherAmortizationOfDeferredCharges
      contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfNy0zLTEtMS02MTk5MA_fbdd0dc1-db3b-486a-84c3-8447bac2798a"
      unitRef="usd">1252000</us-gaap:OtherAmortizationOfDeferredCharges>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfOC0xLTEtMS02MTk5MA_c0ce9400-bff4-4fdd-bc8b-c9942a19a043"
      unitRef="usd">202000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfOC0zLTEtMS02MTk5MA_e51cfc0e-7822-48a9-b294-db97208a739f"
      unitRef="usd">140000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMTAtMS0xLTEtNjE5OTA_3c74648e-0340-4849-979e-27730af7e6b7"
      unitRef="usd">-131000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMTAtMy0xLTEtNjE5OTA_9a03c5b9-c3dd-474a-bbb0-cfa96e529d1c"
      unitRef="usd">209000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMTEtMS0xLTEtNjE5OTA_62e51a1e-b3ff-4ae9-b599-a978fd68a63d"
      unitRef="usd">345000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMTEtMy0xLTEtNjE5OTA_daaba134-6e86-4ac4-8f26-e139702fe6c0"
      unitRef="usd">-161000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInDeferredCharges
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMTItMS0xLTEtNjE5OTA_6a235f07-ae1e-4686-86f4-7b9f783fb96f"
      unitRef="usd">864000</us-gaap:IncreaseDecreaseInDeferredCharges>
    <us-gaap:IncreaseDecreaseInDeferredCharges
      contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMTItMy0xLTEtNjE5OTA_6c1c7e3b-3674-4e74-af85-ddf2c5a0a3f2"
      unitRef="usd">595000</us-gaap:IncreaseDecreaseInDeferredCharges>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMTMtMS0xLTEtNjE5OTA_bbdac6db-8318-4eed-b06f-5d40c7c83075"
      unitRef="usd">-553000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMTMtMy0xLTEtNjE5OTA_14fb87d1-67f2-480f-9b5a-239cdfb50b5e"
      unitRef="usd">-41000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMTQtMS0xLTEtNjE5OTA_3aa44316-a519-408f-9b8b-b244d867e56f"
      unitRef="usd">59000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMTQtMy0xLTEtNjE5OTA_799b3abc-093a-47c6-991c-72cab0b8e113"
      unitRef="usd">-51000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMTUtMS0xLTEtNjE5OTA_55ab6cf5-baea-4d6d-99fa-08447774ae47"
      unitRef="usd">1120000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
      contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMTUtMy0xLTEtNjE5OTA_9c19bab9-c270-4abc-809a-95c78c6a8cb3"
      unitRef="usd">-332000</us-gaap:IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMTYtMS0xLTEtNjE5OTA_d7dae4ac-37cb-4ce6-bdf2-fa0d7b17ffb2"
      unitRef="usd">657000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInDeferredRevenue
      contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMTYtMy0xLTEtNjE5OTA_9d1b13d9-42fb-4028-88ec-5f9293732dbe"
      unitRef="usd">-1300000</us-gaap:IncreaseDecreaseInDeferredRevenue>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMTctMS0xLTEtNjE5OTA_60892ea1-88d8-4302-8989-68014de218a0"
      unitRef="usd">-179000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:IncreaseDecreaseInOperatingLeaseLiability
      contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMTctMy0xLTEtNjE5OTA_8f22669f-83d4-4241-9efe-fed1f3900e04"
      unitRef="usd">-86000</us-gaap:IncreaseDecreaseInOperatingLeaseLiability>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMTgtMS0xLTEtNjE5OTA_99126a1a-096f-4402-94bc-bd6f2fc62979"
      unitRef="usd">-6492000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMTgtMy0xLTEtNjE5OTA_d570a0af-0d7f-4bdd-a29e-1009bb77bd6a"
      unitRef="usd">-3043000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMjAtMS0xLTEtNjE5OTA_a702eb8d-e3b4-400f-9d2f-38aead18927e"
      unitRef="usd">1140000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMjAtMy0xLTEtNjE5OTA_40054632-0e82-4aac-8e6d-f6a9c01a9445"
      unitRef="usd">34000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMjEtMS0xLTEtNjE5OTA_6e593857-04b4-484d-a358-e81b9669d4f8"
      unitRef="usd">-1140000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMjEtMy0xLTEtNjE5OTA_2df2f45a-ff32-44ff-81de-406d0e67bb38"
      unitRef="usd">-34000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMjQtMS0xLTEtNjg3OTM_65c6d103-f1d0-4e3f-9e9c-b37e70c48cb4"
      unitRef="usd">2389000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMjQtMy0xLTEtNjg3OTM_7c78ad8d-a0d1-4b47-86e3-114b6a24fc8e"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMjQtMS0xLTEtNzA4MTc_2957c3a8-01c9-4735-8c4e-cb88635c8d43"
      unitRef="usd">268000</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:PaymentsOfStockIssuanceCosts
      contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMjUtMy0xLTEtNzAwMzc_37b2aeaf-cc4d-4ae9-9428-6897b5b4634a"
      unitRef="usd">0</us-gaap:PaymentsOfStockIssuanceCosts>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMjMtMS0xLTEtNjE5OTA_ba627d24-3285-45ca-be8d-980c0aff6560"
      unitRef="usd">2000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMjMtMy0xLTEtNjE5OTA_b3bfdb14-05d8-4e11-b5fe-a5cd2df1df3a"
      unitRef="usd">8000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromContributionsFromParent
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMjUtMS0xLTEtNjE5OTA_e581bb96-d817-4826-8748-9d051578a10e"
      unitRef="usd">0</us-gaap:ProceedsFromContributionsFromParent>
    <us-gaap:ProceedsFromContributionsFromParent
      contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMjUtMy0xLTEtNjE5OTA_52a87992-b64d-4017-a1ef-3db4788f66d3"
      unitRef="usd">247000</us-gaap:ProceedsFromContributionsFromParent>
    <ampx:PaymentOfTransactionAndIssuanceCostsInConnectionWithBusinessCombinationAndPIPEInvestment
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMjYtMS0xLTEtNjE5OTA_1065a008-bc47-4c9d-a92e-2013e542525f"
      unitRef="usd">0</ampx:PaymentOfTransactionAndIssuanceCostsInConnectionWithBusinessCombinationAndPIPEInvestment>
    <ampx:PaymentOfTransactionAndIssuanceCostsInConnectionWithBusinessCombinationAndPIPEInvestment
      contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMjYtMy0xLTEtNjE5OTA_2c137553-26f1-4372-9d69-19637c45de01"
      unitRef="usd">51000</ampx:PaymentOfTransactionAndIssuanceCostsInConnectionWithBusinessCombinationAndPIPEInvestment>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMjctMS0xLTEtNjE5OTA_23d62f52-e1bd-4809-ba39-b596ac676f0f"
      unitRef="usd">2123000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMjctMy0xLTEtNjE5OTA_b58d4b7b-f659-499a-b840-ad8c191ede58"
      unitRef="usd">204000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMjgtMS0xLTEtNjE5OTA_07c59dfd-1e76-4862-bfd1-31e905eb3fab"
      unitRef="usd">-5509000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMjgtMy0xLTEtNjE5OTA_f7577f8e-8962-4e71-b0f9-efeecc83f90b"
      unitRef="usd">-2873000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMjktMS0xLTEtNjE5OTA_6ab98a79-7b3e-423c-9999-f0771c243cca"
      unitRef="usd">69752000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ifce6518367b34d3ab4c10e9de84e7829_I20211231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMjktMy0xLTEtNjE5OTA_38e88a8a-4654-4600-bb23-f1b95de36f97"
      unitRef="usd">11489000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMzAtMS0xLTEtNjE5OTA_ce4c3192-c0b7-4871-85f0-a46df1ed9cf8"
      unitRef="usd">64243000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i4b2c45cb6722425d93cf25d37d538c75_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMzAtMy0xLTEtNjE5OTA_f29bba33-905c-4adb-a4ac-aad4754c28ed"
      unitRef="usd">8616000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMzMtMS0xLTEtNjE5OTA_699e05f0-af43-42ba-a89c-3ee1bff4fb7b"
      unitRef="usd">64187000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i4b2c45cb6722425d93cf25d37d538c75_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMzMtMy0xLTEtNjE5OTA_f97f8f83-bf07-45bf-aba0-4900254681a6"
      unitRef="usd">8616000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:RestrictedCash
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMzQtMS0xLTEtNjE5OTA_d3cce74c-25e4-44a1-877e-25b789f37936"
      unitRef="usd">56000</us-gaap:RestrictedCash>
    <us-gaap:RestrictedCash
      contextRef="i4b2c45cb6722425d93cf25d37d538c75_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMzQtMy0xLTEtNjE5OTA_2cb4f468-5650-4cac-81a2-64d3c6e4e11f"
      unitRef="usd">0</us-gaap:RestrictedCash>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMzUtMS0xLTEtNjE5OTA_7da061f7-93f9-4fc0-9f7f-6814342f8fb8"
      unitRef="usd">64243000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i4b2c45cb6722425d93cf25d37d538c75_I20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zMS9mcmFnOjlkZGIzMzcyODA0YTQxZGNhMTBhNjEwYjlkNGYzMjM5L3RhYmxlOmNiZWM1OGZlMmZhZTQwODQ5ZjRmNGMzYWMyNWE2YjdlL3RhYmxlcmFuZ2U6Y2JlYzU4ZmUyZmFlNDA4NDlmNGY0YzNhYzI1YTZiN2VfMzUtMy0xLTEtNjE5OTA_62f49148-e93f-46c1-bd92-90a880222e1f"
      unitRef="usd">8616000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zNy9mcmFnOmVjNzk0OThkMjM3YTRlOWFhN2FiMGIyYWRkOTc0ODkyL3RleHRyZWdpb246ZWM3OTQ5OGQyMzdhNGU5YWE3YWIwYjJhZGQ5NzQ4OTJfODg2OQ_b1dcf0e8-01fd-4e2b-9e53-4452cf9e1b8d">Nature of Operations and Organization &lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Nature of Operations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Amprius Technologies, Inc. (hereafter referred to as the &#x201c;Company,&#x201d; &#x201c;we,&#x201d; &#x201c;us,&#x201d; or &#x201c;our&#x201d;) has developed, and since 2018, been in commercial production of lithium-ion batteries for mobility applications leveraging a disruptive silicon anode. Our silicon anode technology is intended to enable batteries with higher energy density, higher power density and fast charging capabilities over a wide range of operating temperatures. Our headquarters is located in Fremont, California.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Business Combination&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During fiscal year 2022, on September 14, 2022 (the &#x201c;Closing Date&#x201d;), we completed a business combination pursuant to the Business Combination Agreement, dated May 11, 2022 (the &#x201c;Business Combination Agreement&#x201d;), by and among the Company, Amprius Technologies Operating, Inc. (formerly known as Amprius Technologies, Inc. or "Legacy Amprius"), Kensington Capital Acquisition Corp. IV, and Kensington Capital Merger Sub Corp. (&#x201c;Merger Sub&#x201d;). Pursuant to the terms of the Business Combination Agreement, Kensington Capital Acquisition Corp. IV changed its jurisdiction of incorporation by domesticating as a corporation incorporated under the laws of the State of Delaware (the &#x201c;Domestication&#x201d;), upon which it changed its name to &#x201c;Amprius Technologies, Inc.,&#x201d; and a business combination between  Kensington Capital Acquisition Corp. IV and Legacy Amprius was effected through the merger of Merger Sub with and into Legacy Amprius, with Legacy Amprius surviving as a wholly owned subsidiary of the Company (together with the Domestication and the other transactions contemplated by the Business Combination Agreement, the &#x201c;Business Combination&#x201d;).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Unless the context otherwise provides, the &#x201c;Company&#x201d; refers (i) prior to the Closing Date, to Legacy Amprius and (ii) on and after the Closing Date, to Amprius Technologies, Inc. and its subsidiaries, including Legacy Amprius. Prior to the Business Combination, Kensington Capital Acquisition Corp. IV is referred to herein as &#x201c;Kensington.&#x201d; &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Business Combination was treated as a reverse recapitalization. Legacy Amprius was determined as the accounting acquirer and Kensington as the accounting acquiree for financial reporting purposes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Liquidity and Capital Resources&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Since our inception, we have incurred recurring losses and negative cash flows from operations. During the three months ended March&#160;31, 2023, our net loss was $9.1 million and at March&#160;31, 2023, our accumulated deficit was $102.0 million. We expect to incur additional losses in the future as we scale our business and increase our operating expenditures, such as increasing our research and development spend and headcount. Additionally, we expect to increase our capital expenditures as we plan to build a &lt;/span&gt;&lt;span style="color:#231f20;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;GWh-scale manufacturing facility &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;in the future. We may need to raise funds in order to meet our future operating and capital expenditure requirements. We may be unable to raise additional funds or enter into such other agreements when needed on favorable terms or at all. If sufficient funding is not raised, we may need to reduce our spending activities, which may negatively affect our ability to achieve our operating goals. To the extent that we raise additional funds by issuing equity securities, our stockholders may experience additional dilution.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We had cash and cash equivalents of $64.2 million as of March&#160;31, 2023. We believe that our cash and cash equivalents will be sufficient to fund our operating and capital expenditure requirements over twelve months from the date these financial statements are issued. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September&#160;27, 2022, we entered into a Common Stock Purchase Agreement (&#x201c;Purchase Agreement&#x201d;) with B. Riley Principal Capital II, LLC (&#x201c;BRPC II&#x201d;), pursuant to which BRPC II committed to purchase up to $200.0 million of our common stock until January 1, 2025, subject to certain contractual terms (the &#x201c;Committed Equity Financing&#x201d;). As of March&#160;31, 2023, $197.6 million remained available under the Committed Equity Financing. There can be no assurance that we will be able to raise such amount over the remaining period as the Committed Equity Financing contains certain limitations and conditions. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On October&#160;19, 2022, the U.S. Department of Energy (&#x201c;DOE&#x201d;) under the Bipartisan Infrastructure Law awarded us a cost-sharing grant of $50.0 million. The grant is dependent upon the successful negotiation of a final contract. There can be no assurance that such negotiation will be successful.   &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Other Risk and Uncertainties&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We face risks related to the COVID-19&#160;pandemic, which has created significant volatility in the global economy, led to business disruptions, reduced economic activities, and imposition of travel restrictions. Although the COVID-19 pandemic did not have an adverse impact to us to-date, its future development is highly uncertain and cannot be predicted. Even after the COVID-19 pandemic has subsided, our company and our customers may continue to experience its negative effect, which may adversely affect our future financial condition, results of operations and cash flows.&lt;/span&gt;&lt;/div&gt;We also face risks related to the war between Russia and Ukraine, which has also led to significant volatility in the global economy resulting in higher inflation, volatility in the credit and capital markets, and interruption in the supply chain. Although this war did not have an adverse impact to us to-date, its future outcome is highly unpredictable and uncertain, which may also adversely affect our future financial condition, results of operations and cash flows.</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zNy9mcmFnOmVjNzk0OThkMjM3YTRlOWFhN2FiMGIyYWRkOTc0ODkyL3RleHRyZWdpb246ZWM3OTQ5OGQyMzdhNGU5YWE3YWIwYjJhZGQ5NzQ4OTJfNTQ5NzU1ODQ5MzE3_d53a187c-2bb6-45e4-a12c-ece46e6f9a1e"
      unitRef="usd">-9100000</us-gaap:NetIncomeLoss>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zNy9mcmFnOmVjNzk0OThkMjM3YTRlOWFhN2FiMGIyYWRkOTc0ODkyL3RleHRyZWdpb246ZWM3OTQ5OGQyMzdhNGU5YWE3YWIwYjJhZGQ5NzQ4OTJfNTQ5NzU1ODQ5MzUz_009c0355-42a9-4503-9095-1cccf4232af0"
      unitRef="usd">-102000000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:CashAndCashEquivalentsAtCarryingValue
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zNy9mcmFnOmVjNzk0OThkMjM3YTRlOWFhN2FiMGIyYWRkOTc0ODkyL3RleHRyZWdpb246ZWM3OTQ5OGQyMzdhNGU5YWE3YWIwYjJhZGQ5NzQ4OTJfNTQ5NzU1ODQ5NTE5_ac3cb2f1-9414-4881-a2b5-696c1a0806cb"
      unitRef="usd">64200000</us-gaap:CashAndCashEquivalentsAtCarryingValue>
    <us-gaap:SaleOfStockConsiderationReceivedOnTransaction
      contextRef="i10455920b55e4d9b921af5961e20e70c_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zNy9mcmFnOmVjNzk0OThkMjM3YTRlOWFhN2FiMGIyYWRkOTc0ODkyL3RleHRyZWdpb246ZWM3OTQ5OGQyMzdhNGU5YWE3YWIwYjJhZGQ5NzQ4OTJfNTQ5NzU1ODQ5NDI4_71e1e8fa-3af8-48c0-b6aa-a3ea71f27eab"
      unitRef="usd">200000000</us-gaap:SaleOfStockConsiderationReceivedOnTransaction>
    <ampx:CommittedEquityFinancing
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zNy9mcmFnOmVjNzk0OThkMjM3YTRlOWFhN2FiMGIyYWRkOTc0ODkyL3RleHRyZWdpb246ZWM3OTQ5OGQyMzdhNGU5YWE3YWIwYjJhZGQ5NzQ4OTJfNTQ5NzU1ODUzNjI5_c969bc11-7480-439d-912c-1f2a0e26a977"
      unitRef="usd">197600000</ampx:CommittedEquityFinancing>
    <ampx:GovernmentAssistanceGrantNotYetReceived
      contextRef="i5204fd658af644a69b260e135d17b875_I20221019"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV8zNy9mcmFnOmVjNzk0OThkMjM3YTRlOWFhN2FiMGIyYWRkOTc0ODkyL3RleHRyZWdpb246ZWM3OTQ5OGQyMzdhNGU5YWE3YWIwYjJhZGQ5NzQ4OTJfNTQ5NzU1ODQ5NDgz_8101b2f8-84a0-48c4-9a50-4cb0592b8b35"
      unitRef="usd">50000000</ampx:GovernmentAssistanceGrantNotYetReceived>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80MC9mcmFnOjdhMTk2Y2ZkMGIwYjRjY2M5YjM1NjU5M2M4MWIzMzIxL3RleHRyZWdpb246N2ExOTZjZmQwYjBiNGNjYzliMzU2NTkzYzgxYjMzMjFfMjk5MDA_95899616-eedd-4a60-b76f-f194807c412a">Summary of Significant Accounting Policies&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Basis of Presentation &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;and Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;U.S. GAAP&#x201d;). &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All intercompany accounts and transactions have been eliminated.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The significant accounting policies described below, together with other notes that follow, are an integral part of the condensed consolidated financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the closing of the Business Combination, whereby Legacy Amprius was determined as the accounting acquirer for accounting and reporting purposes, the historical financial statements of Legacy Amprius became the historical financial statements of the combined company and no goodwill or other intangible assets were recorded. As a result, the accompanying condensed consolidated financial statements reflect (i) the assets and liabilities of Legacy Amprius at their historical cost; (ii) the historical operating results of Legacy Amprius prior to the Business Combination; and (iii) Legacy Amprius&#x2019; equity structure, which has been retroactively restated in the comparative period to reflect the &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;number of shares of the Compa&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ny&#x2019;s common stock issued to Legacy Amprius stockholders. As such, the shares, corresponding capital amounts, and net loss per share related to Legacy Amprius common stock have been retroactively restated to reflect the effect of the exchange ratio of 1.45590 (the &#x201c;Exchange Ratio&#x201d;) established in the Business Combination.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to the Business Combination, our financial statements were presented on a carve-out basis using our historical results of operations and historical basis of assets and liabilities derived from the accounting records of our majority stockholder, Amprius, Inc. (&#x201c;Amprius Holdings&#x201d;), adjusted as necessary to conform with U.S. GAAP.  The underlying assumptions in our presentation of our financial statements prior to the Business Combination include:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Balance sheet includes all of our owned assets, assets assigned or contributed by Amprius Holdings, and liabilities incurred by Amprius Holdings on our behalf. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Statement of operations reflects all activities directly attributable to us, which include an allocation of certain general and administrative expenses of Amprius Holdings. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Certain general and administrative expenses of Amprius Holdings, such as the payroll-related expenses for two executive employees, legal, tax, insurance and accounting fees, were shared between us, Amprius Holdings and its other subsidiaries. Since those two executive employees provided us and Amprius Holdings' other subsidiaries with governance and management oversight, those shared expenses were allocated between us and Amprius Holdings' other subsidiaries. The level of effort spent by Amprius Holdings' executives was not correlated with the level of our business activity, revenue or other financial operating metrics and of Amprius Holdings' other subsidiaries. As a result, those shared expenses were allocated equally between us and Amprius Holdings' other subsidiaries. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Prior to the distribution of Amprius Holdings' other subsidiaries in January 2022 and February 2022, the shared expenses of Amprius Holdings were allocated equally between us and Amprius Holdings' other subsidiaries. After February 2022, those expenses were fully allocated to us.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Management believes that the assumptions described above, including the allocation of certain shared expenses, are reasonable and consistently applied for all periods presented prior to the Business Combination. However, the financial statements of that were presented prior to the Business Combination may not be indicative of our future performance and &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;do not necessarily reflect what the financial position, results of operations and cash flows would have been had we operated as a separate and standalone entity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Unaudited Interim Condensed Consolidated Financial Statements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated balance sheet as of December&#160;31, 2022, which has been derived from our audited financial statements as filed in our Annual Report on Form 10-K with the Securities and Exchange Commission (&#x201c;SEC&#x201d;) on March 30, 2023, and the unaudited interim condensed consolidated financial statements have been prepared in accordance with U.S. GAAP and applicable rules and regulations of the SEC regarding interim financial reporting. Any reference in these notes to applicable accounting guidance is meant to refer to the authoritative U.S. GAAP included in the Accounting Standards Codification (&#x201c;ASC&#x201d;), and Accounting Standards Updates (&#x201c;ASU&#x201d;) issued by the Financial Accounting Standards Board (&#x201c;FASB&#x201d;). The condensed consolidated financial statements have been prepared on a basis consistent with the audited financial statements. In management&#x2019;s opinion, all adjustments made were normal or recurring in nature and necessary for the fair statement of our financial position as of March&#160;31, 2023 and our results of operations and cash flows during the three months ended March&#160;31, 2023 and 2022. The financial data and other financial information disclosed in the notes to these condensed consolidated financial statements are also unaudited. The results of operations during the three months ended March&#160;31, 2023 are not necessarily indicative of the results to be expected for the full fiscal year or any other period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain information and note disclosures normally included in annual financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to those rules and regulations, although we believe that the disclosures made are adequate to make the information not misleading.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Emerging Growth Company&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are an emerging growth company as defined in Section&#160;2(a) of the Securities Act of 1933 (as amended) (&#x201c;Securities Act&#x201d;), and we may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies. Further, Section&#160;102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised accounting standards until private companies are required to comply with such standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. We have elected to not opt out of such extended transition period. This means that when a standard is issued or revised and it has different application dates for public or private companies, we, as an&#160;emerging growth company, can adopt the new or revised standard at the time private companies adopt such new or revised standard unless we are no longer deemed an emerging growth company. As a result, the accompanying condensed consolidated financial statements may not be comparable to companies that comply with the new or revised accounting pronouncements as of public company effective dates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. These estimates are based on current facts, historical experience and various other factors believed to be reasonable under the circumstances; the results of which form the basis for making judgements that are not readily apparent from other sources. Actual results could materially differ from management estimates using different assumptions or under different conditions. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Our significant accounting estimates include useful lives of property, plant and equipment; valuation of deferred taxes; lower of cost or net realizable adjustment of inventory; carve-out of financial statements including the allocation of assets, liabilities and expenses prior to the Business Combination; incremental borrowing rate used in calculating lease obligations and right-of-use assets; and fair value of common stock prior to the Business Combination and other inputs used to value stock-based compensation awards.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Fair Value Measurements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We had a money market fund amounting to $41.1&#160;million and $69.4&#160;million as of March&#160;31, 2023 and December&#160;31, 2022, respectively, which was measured at Level 1 fair value based on the active market price of such instrument. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We did not have assets or liabilities measured at fair value on a recurring basis using Level 2 or Level 3 inputs as of March&#160;31, 2023 and December&#160;31, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no transfers of financial instruments between Level 1, Level 2 and Level 3 during the three months ended March&#160;31, 2023 and 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Restricted Cash&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-align:justify;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;Restricted cash pertains to cash collateral required by our lessor to satisfy a letter of credit requirement under our lease agreement. Restricted cash, which is included in other assets in the accompanying condensed consolidated balance sheets, was $56 thousand as of March&#160;31, 2023 and December&#160;31, 2022. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Concentration of Credit Risk&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable mainly consist of amounts due from U.S. government agencies or sponsored entities and large public entities which limits our credit risk. Through March&#160;31, 2023, we have not experienced any credit losses. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended March&#160;31, 2023, three customers represented 34%, 23% and 19% of our revenue. During the three months ended March&#160;31, 2022, three customers represented 40%, 31% and 19% of our revenue. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2023 and December&#160;31, 2022, two and three customers represented 65% and 88%, respectively, of our total accounts receivable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Segment Reporting&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have determined that the Chief Executive Officer is our Chief Operating Decision Maker (&#x201c;CODM&#x201d;). The CODM reviews financial information presented on an aggregate basis for the purposes of assessing our performance and making decisions on how to allocate resources. Accordingly, we have determined that we operate in a single operating and reportable segment. All of our revenues are geographically earned in the United States and our property, plant and equipment are located in the United States.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Significant Accounting Policies&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There have been no changes to our significant accounting policies described in the Annual Report on Form 10-K for the year ended December 31, 2022, other than the new accounting policy that was implemented as a result of the adoption of a new accounting standard as described below.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Standard&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 1, 2023, we adopted FASB ASU 2016-13,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Financial Instruments&#x2014;Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and related amendment under ASU 2019-10, which requires that credit losses on financial assets, such as trade and other receivables, be recognized as allowance for losses. Credit losses on trade and other receivables will reflect the current estimate of the expected credit losses that generally will result in the earlier recognition of allowances for losses. The adoption of this ASU did not have a material impact on our condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80MC9mcmFnOjdhMTk2Y2ZkMGIwYjRjY2M5YjM1NjU5M2M4MWIzMzIxL3RleHRyZWdpb246N2ExOTZjZmQwYjBiNGNjYzliMzU2NTkzYzgxYjMzMjFfMjk5MDg_cf03e9e2-8397-4683-b632-d47941fdee53">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Basis of Presentation &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;and Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;U.S. GAAP&#x201d;). &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All intercompany accounts and transactions have been eliminated.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The significant accounting policies described below, together with other notes that follow, are an integral part of the condensed consolidated financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the closing of the Business Combination, whereby Legacy Amprius was determined as the accounting acquirer for accounting and reporting purposes, the historical financial statements of Legacy Amprius became the historical financial statements of the combined company and no goodwill or other intangible assets were recorded. As a result, the accompanying condensed consolidated financial statements reflect (i) the assets and liabilities of Legacy Amprius at their historical cost; (ii) the historical operating results of Legacy Amprius prior to the Business Combination; and (iii) Legacy Amprius&#x2019; equity structure, which has been retroactively restated in the comparative period to reflect the &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;number of shares of the Compa&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ny&#x2019;s common stock issued to Legacy Amprius stockholders. As such, the shares, corresponding capital amounts, and net loss per share related to Legacy Amprius common stock have been retroactively restated to reflect the effect of the exchange ratio of 1.45590 (the &#x201c;Exchange Ratio&#x201d;) established in the Business Combination.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to the Business Combination, our financial statements were presented on a carve-out basis using our historical results of operations and historical basis of assets and liabilities derived from the accounting records of our majority stockholder, Amprius, Inc. (&#x201c;Amprius Holdings&#x201d;), adjusted as necessary to conform with U.S. GAAP.  The underlying assumptions in our presentation of our financial statements prior to the Business Combination include:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Balance sheet includes all of our owned assets, assets assigned or contributed by Amprius Holdings, and liabilities incurred by Amprius Holdings on our behalf. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Statement of operations reflects all activities directly attributable to us, which include an allocation of certain general and administrative expenses of Amprius Holdings. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Certain general and administrative expenses of Amprius Holdings, such as the payroll-related expenses for two executive employees, legal, tax, insurance and accounting fees, were shared between us, Amprius Holdings and its other subsidiaries. Since those two executive employees provided us and Amprius Holdings' other subsidiaries with governance and management oversight, those shared expenses were allocated between us and Amprius Holdings' other subsidiaries. The level of effort spent by Amprius Holdings' executives was not correlated with the level of our business activity, revenue or other financial operating metrics and of Amprius Holdings' other subsidiaries. As a result, those shared expenses were allocated equally between us and Amprius Holdings' other subsidiaries. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Prior to the distribution of Amprius Holdings' other subsidiaries in January 2022 and February 2022, the shared expenses of Amprius Holdings were allocated equally between us and Amprius Holdings' other subsidiaries. After February 2022, those expenses were fully allocated to us.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Management believes that the assumptions described above, including the allocation of certain shared expenses, are reasonable and consistently applied for all periods presented prior to the Business Combination. However, the financial statements of that were presented prior to the Business Combination may not be indicative of our future performance and &lt;/span&gt;&lt;/div&gt;do not necessarily reflect what the financial position, results of operations and cash flows would have been had we operated as a separate and standalone entity.</us-gaap:ConsolidationPolicyTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80MC9mcmFnOjdhMTk2Y2ZkMGIwYjRjY2M5YjM1NjU5M2M4MWIzMzIxL3RleHRyZWdpb246N2ExOTZjZmQwYjBiNGNjYzliMzU2NTkzYzgxYjMzMjFfMjk5MDg_f7d2f93a-6d93-4c4c-8603-575b5db187c2">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Basis of Presentation &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;and Principles of Consolidation&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (&#x201c;U.S. GAAP&#x201d;). &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All intercompany accounts and transactions have been eliminated.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The significant accounting policies described below, together with other notes that follow, are an integral part of the condensed consolidated financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the closing of the Business Combination, whereby Legacy Amprius was determined as the accounting acquirer for accounting and reporting purposes, the historical financial statements of Legacy Amprius became the historical financial statements of the combined company and no goodwill or other intangible assets were recorded. As a result, the accompanying condensed consolidated financial statements reflect (i) the assets and liabilities of Legacy Amprius at their historical cost; (ii) the historical operating results of Legacy Amprius prior to the Business Combination; and (iii) Legacy Amprius&#x2019; equity structure, which has been retroactively restated in the comparative period to reflect the &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;number of shares of the Compa&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ny&#x2019;s common stock issued to Legacy Amprius stockholders. As such, the shares, corresponding capital amounts, and net loss per share related to Legacy Amprius common stock have been retroactively restated to reflect the effect of the exchange ratio of 1.45590 (the &#x201c;Exchange Ratio&#x201d;) established in the Business Combination.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to the Business Combination, our financial statements were presented on a carve-out basis using our historical results of operations and historical basis of assets and liabilities derived from the accounting records of our majority stockholder, Amprius, Inc. (&#x201c;Amprius Holdings&#x201d;), adjusted as necessary to conform with U.S. GAAP.  The underlying assumptions in our presentation of our financial statements prior to the Business Combination include:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Balance sheet includes all of our owned assets, assets assigned or contributed by Amprius Holdings, and liabilities incurred by Amprius Holdings on our behalf. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Statement of operations reflects all activities directly attributable to us, which include an allocation of certain general and administrative expenses of Amprius Holdings. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Certain general and administrative expenses of Amprius Holdings, such as the payroll-related expenses for two executive employees, legal, tax, insurance and accounting fees, were shared between us, Amprius Holdings and its other subsidiaries. Since those two executive employees provided us and Amprius Holdings' other subsidiaries with governance and management oversight, those shared expenses were allocated between us and Amprius Holdings' other subsidiaries. The level of effort spent by Amprius Holdings' executives was not correlated with the level of our business activity, revenue or other financial operating metrics and of Amprius Holdings' other subsidiaries. As a result, those shared expenses were allocated equally between us and Amprius Holdings' other subsidiaries. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Prior to the distribution of Amprius Holdings' other subsidiaries in January 2022 and February 2022, the shared expenses of Amprius Holdings were allocated equally between us and Amprius Holdings' other subsidiaries. After February 2022, those expenses were fully allocated to us.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Management believes that the assumptions described above, including the allocation of certain shared expenses, are reasonable and consistently applied for all periods presented prior to the Business Combination. However, the financial statements of that were presented prior to the Business Combination may not be indicative of our future performance and &lt;/span&gt;&lt;/div&gt;do not necessarily reflect what the financial position, results of operations and cash flows would have been had we operated as a separate and standalone entity.</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <ampx:RecapitalizationExchangeRatio
      contextRef="i1e90ee49c2a54d3a851c9f496677d786_I20220914"
      decimals="5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80MC9mcmFnOjdhMTk2Y2ZkMGIwYjRjY2M5YjM1NjU5M2M4MWIzMzIxL3RleHRyZWdpb246N2ExOTZjZmQwYjBiNGNjYzliMzU2NTkzYzgxYjMzMjFfNTQ5NzU1ODc0OTE1_4dc80335-45ab-429a-b112-ee5ba937a262"
      unitRef="number">1.45590</ampx:RecapitalizationExchangeRatio>
    <ampx:NumberOfExecutiveEmployeesOfParentSharingFacilitiesCosts
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80MC9mcmFnOjdhMTk2Y2ZkMGIwYjRjY2M5YjM1NjU5M2M4MWIzMzIxL3RleHRyZWdpb246N2ExOTZjZmQwYjBiNGNjYzliMzU2NTkzYzgxYjMzMjFfNTQ5NzU1ODc1MDAw_8cd753c2-6e79-4dfb-9d22-c10ab87fe679"
      unitRef="executiveemployee">2</ampx:NumberOfExecutiveEmployeesOfParentSharingFacilitiesCosts>
    <ampx:NumberOfExecutiveEmployeesOfParentSharingFacilitiesCosts
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80MC9mcmFnOjdhMTk2Y2ZkMGIwYjRjY2M5YjM1NjU5M2M4MWIzMzIxL3RleHRyZWdpb246N2ExOTZjZmQwYjBiNGNjYzliMzU2NTkzYzgxYjMzMjFfNTQ5NzU1ODc1MDA3_8cd753c2-6e79-4dfb-9d22-c10ab87fe679"
      unitRef="executiveemployee">2</ampx:NumberOfExecutiveEmployeesOfParentSharingFacilitiesCosts>
    <ampx:UnauditedInterimCondensedFinancialStatementsPolicyPolicyTextBlock
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80MC9mcmFnOjdhMTk2Y2ZkMGIwYjRjY2M5YjM1NjU5M2M4MWIzMzIxL3RleHRyZWdpb246N2ExOTZjZmQwYjBiNGNjYzliMzU2NTkzYzgxYjMzMjFfMjk5MDQ_8374ea3d-7b73-47a8-bc77-bcc232ab532d">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Unaudited Interim Condensed Consolidated Financial Statements&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated balance sheet as of December&#160;31, 2022, which has been derived from our audited financial statements as filed in our Annual Report on Form 10-K with the Securities and Exchange Commission (&#x201c;SEC&#x201d;) on March 30, 2023, and the unaudited interim condensed consolidated financial statements have been prepared in accordance with U.S. GAAP and applicable rules and regulations of the SEC regarding interim financial reporting. Any reference in these notes to applicable accounting guidance is meant to refer to the authoritative U.S. GAAP included in the Accounting Standards Codification (&#x201c;ASC&#x201d;), and Accounting Standards Updates (&#x201c;ASU&#x201d;) issued by the Financial Accounting Standards Board (&#x201c;FASB&#x201d;). The condensed consolidated financial statements have been prepared on a basis consistent with the audited financial statements. In management&#x2019;s opinion, all adjustments made were normal or recurring in nature and necessary for the fair statement of our financial position as of March&#160;31, 2023 and our results of operations and cash flows during the three months ended March&#160;31, 2023 and 2022. The financial data and other financial information disclosed in the notes to these condensed consolidated financial statements are also unaudited. The results of operations during the three months ended March&#160;31, 2023 are not necessarily indicative of the results to be expected for the full fiscal year or any other period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain information and note disclosures normally included in annual financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to those rules and regulations, although we believe that the disclosures made are adequate to make the information not misleading.&lt;/span&gt;&lt;/div&gt;</ampx:UnauditedInterimCondensedFinancialStatementsPolicyPolicyTextBlock>
    <ampx:EmergingGrowthCompanyPolicyPolicyTextBlock
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80MC9mcmFnOjdhMTk2Y2ZkMGIwYjRjY2M5YjM1NjU5M2M4MWIzMzIxL3RleHRyZWdpb246N2ExOTZjZmQwYjBiNGNjYzliMzU2NTkzYzgxYjMzMjFfMjk5MDE_b8d0611e-b09a-49d4-87fb-921eba57bf1c">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Emerging Growth Company&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We are an emerging growth company as defined in Section&#160;2(a) of the Securities Act of 1933 (as amended) (&#x201c;Securities Act&#x201d;), and we may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies. Further, Section&#160;102(b)(1) of the JOBS Act exempts emerging growth companies from being required to comply with new or revised accounting standards until private companies are required to comply with such standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such election to opt out is irrevocable. We have elected to not opt out of such extended transition period. This means that when a standard is issued or revised and it has different application dates for public or private companies, we, as an&#160;emerging growth company, can adopt the new or revised standard at the time private companies adopt such new or revised standard unless we are no longer deemed an emerging growth company. As a result, the accompanying condensed consolidated financial statements may not be comparable to companies that comply with the new or revised accounting pronouncements as of public company effective dates.&lt;/span&gt;&lt;/div&gt;</ampx:EmergingGrowthCompanyPolicyPolicyTextBlock>
    <us-gaap:UseOfEstimates
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80MC9mcmFnOjdhMTk2Y2ZkMGIwYjRjY2M5YjM1NjU5M2M4MWIzMzIxL3RleHRyZWdpb246N2ExOTZjZmQwYjBiNGNjYzliMzU2NTkzYzgxYjMzMjFfMjk5MDU_ee0a0109-a13e-4058-8ced-c3211b980f78">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. These estimates are based on current facts, historical experience and various other factors believed to be reasonable under the circumstances; the results of which form the basis for making judgements that are not readily apparent from other sources. Actual results could materially differ from management estimates using different assumptions or under different conditions. &lt;/span&gt;&lt;/div&gt;Our significant accounting estimates include useful lives of property, plant and equipment; valuation of deferred taxes; lower of cost or net realizable adjustment of inventory; carve-out of financial statements including the allocation of assets, liabilities and expenses prior to the Business Combination; incremental borrowing rate used in calculating lease obligations and right-of-use assets; and fair value of common stock prior to the Business Combination and other inputs used to value stock-based compensation awards.</us-gaap:UseOfEstimates>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i249e71b6552c4c1eb0877da134e2de5a_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80MC9mcmFnOjdhMTk2Y2ZkMGIwYjRjY2M5YjM1NjU5M2M4MWIzMzIxL3RleHRyZWdpb246N2ExOTZjZmQwYjBiNGNjYzliMzU2NTkzYzgxYjMzMjFfNTQ5NzU1ODg1MTMy_f046d17c-34b4-4b03-9d45-1dccbb452d3a"
      unitRef="usd">41100000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsFairValueDisclosure
      contextRef="i57089d02123243da8af388b3d544181d_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80MC9mcmFnOjdhMTk2Y2ZkMGIwYjRjY2M5YjM1NjU5M2M4MWIzMzIxL3RleHRyZWdpb246N2ExOTZjZmQwYjBiNGNjYzliMzU2NTkzYzgxYjMzMjFfNTQ5NzU1ODg1MTM5_7792ef90-c5ca-48a3-9c31-749b620094d5"
      unitRef="usd">69400000</us-gaap:CashAndCashEquivalentsFairValueDisclosure>
    <us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80MC9mcmFnOjdhMTk2Y2ZkMGIwYjRjY2M5YjM1NjU5M2M4MWIzMzIxL3RleHRyZWdpb246N2ExOTZjZmQwYjBiNGNjYzliMzU2NTkzYzgxYjMzMjFfMTY0OTI2NzU0NDY1OQ_4c06d999-55ec-4079-9534-f29a93f090ff">Restricted CashRestricted cash pertains to cash collateral required by our lessor to satisfy a letter of credit requirement under our lease agreement.</us-gaap:CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:RestrictedCash
      contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80MC9mcmFnOjdhMTk2Y2ZkMGIwYjRjY2M5YjM1NjU5M2M4MWIzMzIxL3RleHRyZWdpb246N2ExOTZjZmQwYjBiNGNjYzliMzU2NTkzYzgxYjMzMjFfNTQ5NzU1OTE0NTY2_1e21df38-e38b-4412-a7c3-460cb0fe3525"
      unitRef="usd">56000</us-gaap:RestrictedCash>
    <us-gaap:RestrictedCash
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80MC9mcmFnOjdhMTk2Y2ZkMGIwYjRjY2M5YjM1NjU5M2M4MWIzMzIxL3RleHRyZWdpb246N2ExOTZjZmQwYjBiNGNjYzliMzU2NTkzYzgxYjMzMjFfNTQ5NzU1OTE0NTY2_d133ec9e-4c00-4e3e-8bd5-522eda95a158"
      unitRef="usd">56000</us-gaap:RestrictedCash>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80MC9mcmFnOjdhMTk2Y2ZkMGIwYjRjY2M5YjM1NjU5M2M4MWIzMzIxL3RleHRyZWdpb246N2ExOTZjZmQwYjBiNGNjYzliMzU2NTkzYzgxYjMzMjFfMjk5MTM_7fbd9a2f-9996-4293-a468-19324966e452">Concentration of Credit RiskAccounts receivable mainly consist of amounts due from U.S. government agencies or sponsored entities and large public entities which limits our credit risk. Through March&#160;31, 2023, we have not experienced any credit losses.</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i5371cedb4ff54ccd8164da48c07a4e65_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80MC9mcmFnOjdhMTk2Y2ZkMGIwYjRjY2M5YjM1NjU5M2M4MWIzMzIxL3RleHRyZWdpb246N2ExOTZjZmQwYjBiNGNjYzliMzU2NTkzYzgxYjMzMjFfNTQ5NzU1ODg3MzU1_c83ebc4e-0631-4ec4-9bcb-feeb59051be6"
      unitRef="number">0.34</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i2491a8cf26ae441db19f29da6405e4f3_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80MC9mcmFnOjdhMTk2Y2ZkMGIwYjRjY2M5YjM1NjU5M2M4MWIzMzIxL3RleHRyZWdpb246N2ExOTZjZmQwYjBiNGNjYzliMzU2NTkzYzgxYjMzMjFfNTQ5NzU1ODg3MzYw_fc964c20-38b9-43af-9950-1de6305f9190"
      unitRef="number">0.23</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ia0ca1db60f404e5e8963bf33fc47c360_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80MC9mcmFnOjdhMTk2Y2ZkMGIwYjRjY2M5YjM1NjU5M2M4MWIzMzIxL3RleHRyZWdpb246N2ExOTZjZmQwYjBiNGNjYzliMzU2NTkzYzgxYjMzMjFfNTQ5NzU1ODg3MzY1_3488febe-f2a9-4ef6-bdaa-99728527badb"
      unitRef="number">0.19</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i97a5618b45474da28680c8670a3e72f1_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80MC9mcmFnOjdhMTk2Y2ZkMGIwYjRjY2M5YjM1NjU5M2M4MWIzMzIxL3RleHRyZWdpb246N2ExOTZjZmQwYjBiNGNjYzliMzU2NTkzYzgxYjMzMjFfNTQ5NzU1ODg3NDMw_510690b8-4fce-4e22-8abf-0704a241fa0e"
      unitRef="number">0.40</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="id9df38d6aecc41ac937ddb4c6110b735_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80MC9mcmFnOjdhMTk2Y2ZkMGIwYjRjY2M5YjM1NjU5M2M4MWIzMzIxL3RleHRyZWdpb246N2ExOTZjZmQwYjBiNGNjYzliMzU2NTkzYzgxYjMzMjFfNTQ5NzU1ODg3NDM0_7cbf4ecd-9c7b-48c6-85df-820f9f0dbd4d"
      unitRef="number">0.31</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="iade7297fa7ee4e99b67dd741d1ffe066_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80MC9mcmFnOjdhMTk2Y2ZkMGIwYjRjY2M5YjM1NjU5M2M4MWIzMzIxL3RleHRyZWdpb246N2ExOTZjZmQwYjBiNGNjYzliMzU2NTkzYzgxYjMzMjFfNTQ5NzU1OTE3NTM3_7362794f-570b-4e3a-ae22-6faabfa8692d"
      unitRef="number">0.19</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i851c46bd9c414d139116e6b9fb6058fa_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80MC9mcmFnOjdhMTk2Y2ZkMGIwYjRjY2M5YjM1NjU5M2M4MWIzMzIxL3RleHRyZWdpb246N2ExOTZjZmQwYjBiNGNjYzliMzU2NTkzYzgxYjMzMjFfNTQ5NzU1ODg3NDYx_293e8f50-4bc6-4d2f-bfbe-238755c6349c"
      unitRef="number">0.65</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ifa2cb13888a54b6c8e0df0d3d5d53aee_D20220101-20221231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80MC9mcmFnOjdhMTk2Y2ZkMGIwYjRjY2M5YjM1NjU5M2M4MWIzMzIxL3RleHRyZWdpb246N2ExOTZjZmQwYjBiNGNjYzliMzU2NTkzYzgxYjMzMjFfNTQ5NzU1ODg3NDY1_dc0770eb-6516-46e6-bb1d-fb2babe5dd39"
      unitRef="number">0.88</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80MC9mcmFnOjdhMTk2Y2ZkMGIwYjRjY2M5YjM1NjU5M2M4MWIzMzIxL3RleHRyZWdpb246N2ExOTZjZmQwYjBiNGNjYzliMzU2NTkzYzgxYjMzMjFfMjk5MTE_cc43e17f-e288-42ae-ba6a-04d490c27a82">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Segment Reporting&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have determined that the Chief Executive Officer is our Chief Operating Decision Maker (&#x201c;CODM&#x201d;). The CODM reviews financial information presented on an aggregate basis for the purposes of assessing our performance and making decisions on how to allocate resources. Accordingly, we have determined that we operate in a single operating and reportable segment. All of our revenues are geographically earned in the United States and our property, plant and equipment are located in the United States.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80MC9mcmFnOjdhMTk2Y2ZkMGIwYjRjY2M5YjM1NjU5M2M4MWIzMzIxL3RleHRyZWdpb246N2ExOTZjZmQwYjBiNGNjYzliMzU2NTkzYzgxYjMzMjFfMjk5MDc_9cbdff93-0db4-43e0-836d-c527a43d08bc">&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Recently Adopted Accounting Standard&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On January 1, 2023, we adopted FASB ASU 2016-13,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt; Financial Instruments&#x2014;Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments,&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and related amendment under ASU 2019-10, which requires that credit losses on financial assets, such as trade and other receivables, be recognized as allowance for losses. Credit losses on trade and other receivables will reflect the current estimate of the expected credit losses that generally will result in the earlier recognition of allowances for losses. The adoption of this ASU did not have a material impact on our condensed consolidated financial statements.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerTextBlock
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80Ni9mcmFnOjNhZjQxMTFjMjA4ZjQwZmNhMzlkYjY5YWViMmYzYzIwL3RleHRyZWdpb246M2FmNDExMWMyMDhmNDBmY2EzOWRiNjlhZWIyZjNjMjBfMzEyOA_0ddeda06-9d91-4034-a58c-06c097df7d0c">Revenue&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Disaggregation of Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue from customers consists mainly of customized design services arrangements and sale of battery products. Revenue from customized design services arrangements, which may include a requirement to achieve certain agreed upon milestones, is recognized when the battery design is completed and the final prototype batteries are delivered. Revenue from sale of battery products is recognized upon shipment. We disaggregate our revenue from customers by the type of arrangement, either as customization design services or as sale of battery products, as this depicts how the nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factors. The table below shows the composition of revenue from customers, as disaggregated by type of arrangement in accordance with Topic 606, and other revenue from a government grant accounted for using the analogy from IAS 20 (in thousands). &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.939%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.933%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue from customers:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sale of battery products&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customized design services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue from customers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;470&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other revenue &#x2013; government grant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue from sale of batteries includes bill-and-hold arrangements, of which there was none during the three months ended March&#160;31, 2023 and $67 thousand during the three months ended March&#160;31, 2022.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Contract Balances&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The timing of revenue recognition, billings and cash collections can result in accounts receivable, contract assets recorded as unbilled receivables, and contract liabilities recorded as deferred revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable represents our right to consideration that is unconditional. A right to consideration is unconditional if only the passage of time is required before payment of that consideration is due. Accounts receivable was $0.6 million, $0.7 million and $0.3 million as of March&#160;31, 2023, December&#160;31, 2022 and January 1, 2022, respectively. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contract assets primarily relate to the rights to consideration for progress on contractual requirements performed but not billed at the reporting date. The contract assets are transferred to accounts receivable when the rights become unconditional. As of March&#160;31, 2023 and December&#160;31, 2022, we had no contract assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Contract liabilities consist primarily of deferred revenue, w&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;hich is the amount of progress payments received or billed in advance of revenue recognition. Deferred revenue is subsequently recognized as revenue when the performance obligation is satisfied. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred revenue was $4.0 million, $3.4 million and $2.9 million as of March&#160;31, 2023, December&#160;31, 2022 and January 1, 2022, respectively. Deferred revenue as of March&#160;31, 2023 and December&#160;31, 2022 increased compared to the deferred revenue as of December&#160;31, 2022 and January 1, 2022, respectively, primarily due to progress payments for certain customer contracts that have not been recognized as revenue as of the end of those periods.&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; During the three months ended March&#160;31, 2023 and 2022, revenue recognized from the prior year deferred revenue balance was $120 thousand and $1.4 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Remaining Performance Obligations&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;We have performance obligations associated with commitments in customer contracts for future services that have not yet been recognized as revenue. As of March&#160;31, 2023, the aggregate amount of the transaction price allocated to the remaining performance obligations related to customer contracts that were unsatisfied or partially unsatisfied, including deferred revenue, was approximately $11.0 million. Given the applicable contract terms, approximately $7.1 million is expected to be recognized as revenue within one year and approximately $3.9 million is expected to be recognized between two to five years. This amount does not include contracts to which the customer is not committed. The estimated timing of the recognition of remaining unsatisfied performance obligations is subject to change and is affected by changes to scope, changes in timing of delivery of products and services, or contract modifications.&lt;/span&gt;&lt;/div&gt;</us-gaap:RevenueFromContractWithCustomerTextBlock>
    <us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80Ni9mcmFnOjNhZjQxMTFjMjA4ZjQwZmNhMzlkYjY5YWViMmYzYzIwL3RleHRyZWdpb246M2FmNDExMWMyMDhmNDBmY2EzOWRiNjlhZWIyZjNjMjBfMTY0OTI2NzQ0ODEzNw_8e6f6e64-a65c-4d28-b3c5-db21924e64c3">The table below shows the composition of revenue from customers, as disaggregated by type of arrangement in accordance with Topic 606, and other revenue from a government grant accounted for using the analogy from IAS 20 (in thousands). &lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.939%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.933%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Revenue from customers:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sale of battery products&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;470&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customized design services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,505&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue from customers&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;470&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other revenue &#x2013; government grant&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;209&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;679&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,110&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock>
    <us-gaap:Revenues
      contextRef="i43cd424ce72a4a40ac5fe4088c873948_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80Ni9mcmFnOjNhZjQxMTFjMjA4ZjQwZmNhMzlkYjY5YWViMmYzYzIwL3RhYmxlOmQ0MmU4MzU2ZjFmZDQ2YzFiOTgwMDBiMzhhNWU1OTZhL3RhYmxlcmFuZ2U6ZDQyZTgzNTZmMWZkNDZjMWI5ODAwMGIzOGE1ZTU5NmFfMy0xLTEtMS02NjUxMg_2d8d9532-c6b4-4fdb-9d0c-226d4081df51"
      unitRef="usd">470000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iee19788a62c34779b7e8c93581517ccc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80Ni9mcmFnOjNhZjQxMTFjMjA4ZjQwZmNhMzlkYjY5YWViMmYzYzIwL3RhYmxlOmQ0MmU4MzU2ZjFmZDQ2YzFiOTgwMDBiMzhhNWU1OTZhL3RhYmxlcmFuZ2U6ZDQyZTgzNTZmMWZkNDZjMWI5ODAwMGIzOGE1ZTU5NmFfMy0zLTEtMS02NjUxMg_58e7393b-2d9f-4145-bd04-2611af542c97"
      unitRef="usd">605000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ic144432f29d243b0b1d00f76340bc40e_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80Ni9mcmFnOjNhZjQxMTFjMjA4ZjQwZmNhMzlkYjY5YWViMmYzYzIwL3RhYmxlOmQ0MmU4MzU2ZjFmZDQ2YzFiOTgwMDBiMzhhNWU1OTZhL3RhYmxlcmFuZ2U6ZDQyZTgzNTZmMWZkNDZjMWI5ODAwMGIzOGE1ZTU5NmFfNC0xLTEtMS02NjUxMg_17d3645f-f56b-42cf-a31c-65f120b95f0a"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i42b2afc255654cec93289ac97a7463f7_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80Ni9mcmFnOjNhZjQxMTFjMjA4ZjQwZmNhMzlkYjY5YWViMmYzYzIwL3RhYmxlOmQ0MmU4MzU2ZjFmZDQ2YzFiOTgwMDBiMzhhNWU1OTZhL3RhYmxlcmFuZ2U6ZDQyZTgzNTZmMWZkNDZjMWI5ODAwMGIzOGE1ZTU5NmFfNC0zLTEtMS02NjUxMg_0642f417-ca83-446d-9176-d460c9d99a5e"
      unitRef="usd">1505000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i3ef781aff42644a5b81b5015320dace1_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80Ni9mcmFnOjNhZjQxMTFjMjA4ZjQwZmNhMzlkYjY5YWViMmYzYzIwL3RhYmxlOmQ0MmU4MzU2ZjFmZDQ2YzFiOTgwMDBiMzhhNWU1OTZhL3RhYmxlcmFuZ2U6ZDQyZTgzNTZmMWZkNDZjMWI5ODAwMGIzOGE1ZTU5NmFfNS0xLTEtMS02NjUxMg_03fca890-dcf4-48c8-9975-254311fb944f"
      unitRef="usd">470000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i6cf8fcfb69a74fd9aa89d6dc6e5f7b7f_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80Ni9mcmFnOjNhZjQxMTFjMjA4ZjQwZmNhMzlkYjY5YWViMmYzYzIwL3RhYmxlOmQ0MmU4MzU2ZjFmZDQ2YzFiOTgwMDBiMzhhNWU1OTZhL3RhYmxlcmFuZ2U6ZDQyZTgzNTZmMWZkNDZjMWI5ODAwMGIzOGE1ZTU5NmFfNS0zLTEtMS02NjUxMg_b1538df0-c7a8-427e-be4e-176976fbceb9"
      unitRef="usd">2110000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0e692c0e7a0a484c82160d4323ca8b64_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80Ni9mcmFnOjNhZjQxMTFjMjA4ZjQwZmNhMzlkYjY5YWViMmYzYzIwL3RhYmxlOmQ0MmU4MzU2ZjFmZDQ2YzFiOTgwMDBiMzhhNWU1OTZhL3RhYmxlcmFuZ2U6ZDQyZTgzNTZmMWZkNDZjMWI5ODAwMGIzOGE1ZTU5NmFfNi0xLTEtMS02NjUxMg_d7dbe2e1-8eff-499a-99d0-256b206c9344"
      unitRef="usd">209000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i8593a7e0ef1947cc8d2ea977da1fe0b0_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80Ni9mcmFnOjNhZjQxMTFjMjA4ZjQwZmNhMzlkYjY5YWViMmYzYzIwL3RhYmxlOmQ0MmU4MzU2ZjFmZDQ2YzFiOTgwMDBiMzhhNWU1OTZhL3RhYmxlcmFuZ2U6ZDQyZTgzNTZmMWZkNDZjMWI5ODAwMGIzOGE1ZTU5NmFfNi0zLTEtMS02NjUxMg_02c0a112-0a80-4f4c-8bd1-58404e296498"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80Ni9mcmFnOjNhZjQxMTFjMjA4ZjQwZmNhMzlkYjY5YWViMmYzYzIwL3RhYmxlOmQ0MmU4MzU2ZjFmZDQ2YzFiOTgwMDBiMzhhNWU1OTZhL3RhYmxlcmFuZ2U6ZDQyZTgzNTZmMWZkNDZjMWI5ODAwMGIzOGE1ZTU5NmFfNy0xLTEtMS02NjUxMg_7590fb26-cac8-48bd-9f0c-20bdb68bfc42"
      unitRef="usd">679000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80Ni9mcmFnOjNhZjQxMTFjMjA4ZjQwZmNhMzlkYjY5YWViMmYzYzIwL3RhYmxlOmQ0MmU4MzU2ZjFmZDQ2YzFiOTgwMDBiMzhhNWU1OTZhL3RhYmxlcmFuZ2U6ZDQyZTgzNTZmMWZkNDZjMWI5ODAwMGIzOGE1ZTU5NmFfNy0zLTEtMS02NjUxMg_226806ce-f132-45e2-83f0-722dc2b515cb"
      unitRef="usd">2110000</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i0ae713297f034937abe6ba4c9366e66b_D20230101-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80Ni9mcmFnOjNhZjQxMTFjMjA4ZjQwZmNhMzlkYjY5YWViMmYzYzIwL3RleHRyZWdpb246M2FmNDExMWMyMDhmNDBmY2EzOWRiNjlhZWIyZjNjMjBfNTQ5NzU1ODM1Mjkz_6daa8bb3-e2ae-4523-ae23-8ae28dcc1f4a"
      unitRef="usd">0</us-gaap:Revenues>
    <us-gaap:Revenues
      contextRef="i076e74831991483a8e8261e35d5fdc5d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80Ni9mcmFnOjNhZjQxMTFjMjA4ZjQwZmNhMzlkYjY5YWViMmYzYzIwL3RleHRyZWdpb246M2FmNDExMWMyMDhmNDBmY2EzOWRiNjlhZWIyZjNjMjBfNTQ5NzU1ODI1MTk0_8a0756a3-096c-4adf-b36d-79c221bd8e00"
      unitRef="usd">67000</us-gaap:Revenues>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80Ni9mcmFnOjNhZjQxMTFjMjA4ZjQwZmNhMzlkYjY5YWViMmYzYzIwL3RleHRyZWdpb246M2FmNDExMWMyMDhmNDBmY2EzOWRiNjlhZWIyZjNjMjBfNjU5NzA2OTc4ODg5Nw_abe1c848-7ba8-4e2d-bdac-74b320102955"
      unitRef="usd">600000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80Ni9mcmFnOjNhZjQxMTFjMjA4ZjQwZmNhMzlkYjY5YWViMmYzYzIwL3RleHRyZWdpb246M2FmNDExMWMyMDhmNDBmY2EzOWRiNjlhZWIyZjNjMjBfNjU5NzA2OTc4ODkwMQ_4c6f5741-bf99-4c03-a821-15ff8640945d"
      unitRef="usd">700000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i35c52756179342cb89a7e4fbbc177710_I20220101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80Ni9mcmFnOjNhZjQxMTFjMjA4ZjQwZmNhMzlkYjY5YWViMmYzYzIwL3RleHRyZWdpb246M2FmNDExMWMyMDhmNDBmY2EzOWRiNjlhZWIyZjNjMjBfNjU5NzA2OTc4ODkwNQ_6d5138dd-40ce-4b3f-8edd-ef5271140809"
      unitRef="usd">300000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i4b2c45cb6722425d93cf25d37d538c75_I20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80Ni9mcmFnOjNhZjQxMTFjMjA4ZjQwZmNhMzlkYjY5YWViMmYzYzIwL3RleHRyZWdpb246M2FmNDExMWMyMDhmNDBmY2EzOWRiNjlhZWIyZjNjMjBfODc5NjA5MzAzOTU1OQ_62789a6a-a372-40e2-87a4-a17906b50d0f"
      unitRef="usd">0</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerAssetNet
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80Ni9mcmFnOjNhZjQxMTFjMjA4ZjQwZmNhMzlkYjY5YWViMmYzYzIwL3RleHRyZWdpb246M2FmNDExMWMyMDhmNDBmY2EzOWRiNjlhZWIyZjNjMjBfODc5NjA5MzAzOTU1OQ_dd8f5283-c3f2-4b74-bde0-d0f0733926dd"
      unitRef="usd">0</us-gaap:ContractWithCustomerAssetNet>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80Ni9mcmFnOjNhZjQxMTFjMjA4ZjQwZmNhMzlkYjY5YWViMmYzYzIwL3RleHRyZWdpb246M2FmNDExMWMyMDhmNDBmY2EzOWRiNjlhZWIyZjNjMjBfNjU5NzA2OTc4OTE4NQ_44e12c74-6ebf-4bd5-ae7d-9195ae93db4b"
      unitRef="usd">4000000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80Ni9mcmFnOjNhZjQxMTFjMjA4ZjQwZmNhMzlkYjY5YWViMmYzYzIwL3RleHRyZWdpb246M2FmNDExMWMyMDhmNDBmY2EzOWRiNjlhZWIyZjNjMjBfNjU5NzA2OTc4OTE4OQ_abb2f42b-bbbe-4d98-92a0-02598210ac0c"
      unitRef="usd">3400000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiability
      contextRef="i35c52756179342cb89a7e4fbbc177710_I20220101"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80Ni9mcmFnOjNhZjQxMTFjMjA4ZjQwZmNhMzlkYjY5YWViMmYzYzIwL3RleHRyZWdpb246M2FmNDExMWMyMDhmNDBmY2EzOWRiNjlhZWIyZjNjMjBfNjU5NzA2OTc4OTE5Mw_7e7dd88e-f2b3-4b16-b75f-912994f74f88"
      unitRef="usd">2900000</us-gaap:ContractWithCustomerLiability>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80Ni9mcmFnOjNhZjQxMTFjMjA4ZjQwZmNhMzlkYjY5YWViMmYzYzIwL3RleHRyZWdpb246M2FmNDExMWMyMDhmNDBmY2EzOWRiNjlhZWIyZjNjMjBfODc5NjA5MzAzNzcxNA_dc81254b-dac2-4f0d-b81d-9acc19d5d5b2"
      unitRef="usd">120000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:ContractWithCustomerLiabilityRevenueRecognized
      contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80Ni9mcmFnOjNhZjQxMTFjMjA4ZjQwZmNhMzlkYjY5YWViMmYzYzIwL3RleHRyZWdpb246M2FmNDExMWMyMDhmNDBmY2EzOWRiNjlhZWIyZjNjMjBfODc5NjA5MzAzNzcxOA_454325b6-1728-4576-bb52-0f6d7b1cf75d"
      unitRef="usd">1400000</us-gaap:ContractWithCustomerLiabilityRevenueRecognized>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80Ni9mcmFnOjNhZjQxMTFjMjA4ZjQwZmNhMzlkYjY5YWViMmYzYzIwL3RleHRyZWdpb246M2FmNDExMWMyMDhmNDBmY2EzOWRiNjlhZWIyZjNjMjBfNTQ5NzU1ODIxMzYy_55d1c73b-c556-49db-9c37-795d4860f5cc"
      unitRef="usd">11000000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i904eec3b78d5419aa0f9501d2ea7f78e_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80Ni9mcmFnOjNhZjQxMTFjMjA4ZjQwZmNhMzlkYjY5YWViMmYzYzIwL3RleHRyZWdpb246M2FmNDExMWMyMDhmNDBmY2EzOWRiNjlhZWIyZjNjMjBfNTQ5NzU1ODIxMzY2_2dcdbc4b-5205-4a56-8bbc-956402272971"
      unitRef="usd">7100000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1
      contextRef="i904eec3b78d5419aa0f9501d2ea7f78e_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80Ni9mcmFnOjNhZjQxMTFjMjA4ZjQwZmNhMzlkYjY5YWViMmYzYzIwL3RleHRyZWdpb246M2FmNDExMWMyMDhmNDBmY2EzOWRiNjlhZWIyZjNjMjBfNTQ5NzU1ODIxMzUx_11d5156f-8b13-46c4-8e80-eea6069b02e4">P1Y</us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1>
    <us-gaap:RevenueRemainingPerformanceObligation
      contextRef="i9f2425ecaf1e4131b7a7a5b98fa6ec56_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV80Ni9mcmFnOjNhZjQxMTFjMjA4ZjQwZmNhMzlkYjY5YWViMmYzYzIwL3RleHRyZWdpb246M2FmNDExMWMyMDhmNDBmY2EzOWRiNjlhZWIyZjNjMjBfNTQ5NzU1ODIxMzcw_6de19d28-2754-4c5f-aeb5-f698b2f1ad09"
      unitRef="usd">3900000</us-gaap:RevenueRemainingPerformanceObligation>
    <us-gaap:InventoryDisclosureTextBlock
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81Mi9mcmFnOjUzOTA4ZjM5MTdmMzQwNDFhMDE2YzYwNmI1ODY5YzY4L3RleHRyZWdpb246NTM5MDhmMzkxN2YzNDA0MWEwMTZjNjA2YjU4NjljNjhfNjM_cee3eb62-ccef-452a-b4ee-7d287f7476b5">Inventory&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:25.2pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.636%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.097%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.977%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.447%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.979%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2.5pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2.5pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2.5pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2.5pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2.5pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2.5pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:InventoryDisclosureTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81Mi9mcmFnOjUzOTA4ZjM5MTdmMzQwNDFhMDE2YzYwNmI1ODY5YzY4L3RleHRyZWdpb246NTM5MDhmMzkxN2YzNDA0MWEwMTZjNjA2YjU4NjljNjhfMTY0OTI2NzQ0MTc2OA_fcf00d88-b3f9-4ffa-a2b0-bdb8b924ea92">&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:25.2pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.636%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.097%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.977%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.447%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.979%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;164&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;180&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;218&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;286&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;102&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Inventories, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2.5pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2.5pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;845&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2.5pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:2.5pt double #000000;border-top:0.5pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2.5pt double #000000;border-top:0.5pt solid #000000;padding:2px 0;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:2.5pt double #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81Mi9mcmFnOjUzOTA4ZjM5MTdmMzQwNDFhMDE2YzYwNmI1ODY5YzY4L3RhYmxlOmI3ZTgxNWY5OGQ5MTQ5MTI5N2JjNjllN2U5MjFhYWM3L3RhYmxlcmFuZ2U6YjdlODE1Zjk4ZDkxNDkxMjk3YmM2OWU3ZTkyMWFhYzdfMi0xLTEtMS02MTk5MA_ba276059-bac5-47eb-a73f-9198b53841ef"
      unitRef="usd">164000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81Mi9mcmFnOjUzOTA4ZjM5MTdmMzQwNDFhMDE2YzYwNmI1ODY5YzY4L3RhYmxlOmI3ZTgxNWY5OGQ5MTQ5MTI5N2JjNjllN2U5MjFhYWM3L3RhYmxlcmFuZ2U6YjdlODE1Zjk4ZDkxNDkxMjk3YmM2OWU3ZTkyMWFhYzdfMi0zLTEtMS02MTk5MA_475175ff-07ab-4fd9-95a3-0f160468631f"
      unitRef="usd">180000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81Mi9mcmFnOjUzOTA4ZjM5MTdmMzQwNDFhMDE2YzYwNmI1ODY5YzY4L3RhYmxlOmI3ZTgxNWY5OGQ5MTQ5MTI5N2JjNjllN2U5MjFhYWM3L3RhYmxlcmFuZ2U6YjdlODE1Zjk4ZDkxNDkxMjk3YmM2OWU3ZTkyMWFhYzdfMy0xLTEtMS02MTk5MA_d415358a-94ea-4fa9-b56e-5aa6373e9aca"
      unitRef="usd">395000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81Mi9mcmFnOjUzOTA4ZjM5MTdmMzQwNDFhMDE2YzYwNmI1ODY5YzY4L3RhYmxlOmI3ZTgxNWY5OGQ5MTQ5MTI5N2JjNjllN2U5MjFhYWM3L3RhYmxlcmFuZ2U6YjdlODE1Zjk4ZDkxNDkxMjk3YmM2OWU3ZTkyMWFhYzdfMy0zLTEtMS02MTk5MA_db6e0932-be0a-48be-97f3-f7e66b56a815"
      unitRef="usd">218000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81Mi9mcmFnOjUzOTA4ZjM5MTdmMzQwNDFhMDE2YzYwNmI1ODY5YzY4L3RhYmxlOmI3ZTgxNWY5OGQ5MTQ5MTI5N2JjNjllN2U5MjFhYWM3L3RhYmxlcmFuZ2U6YjdlODE1Zjk4ZDkxNDkxMjk3YmM2OWU3ZTkyMWFhYzdfNC0xLTEtMS02MTk5MA_ec73ad35-1dea-4360-b2c4-916257e133e0"
      unitRef="usd">286000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81Mi9mcmFnOjUzOTA4ZjM5MTdmMzQwNDFhMDE2YzYwNmI1ODY5YzY4L3RhYmxlOmI3ZTgxNWY5OGQ5MTQ5MTI5N2JjNjllN2U5MjFhYWM3L3RhYmxlcmFuZ2U6YjdlODE1Zjk4ZDkxNDkxMjk3YmM2OWU3ZTkyMWFhYzdfNC0zLTEtMS02MTk5MA_dbefdd84-f962-4f64-9ab4-578a628cdce9"
      unitRef="usd">102000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81Mi9mcmFnOjUzOTA4ZjM5MTdmMzQwNDFhMDE2YzYwNmI1ODY5YzY4L3RhYmxlOmI3ZTgxNWY5OGQ5MTQ5MTI5N2JjNjllN2U5MjFhYWM3L3RhYmxlcmFuZ2U6YjdlODE1Zjk4ZDkxNDkxMjk3YmM2OWU3ZTkyMWFhYzdfNS0xLTEtMS02MTk5MA_ebba04b5-9d19-4f6b-8b1e-4f81713858c3"
      unitRef="usd">845000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81Mi9mcmFnOjUzOTA4ZjM5MTdmMzQwNDFhMDE2YzYwNmI1ODY5YzY4L3RhYmxlOmI3ZTgxNWY5OGQ5MTQ5MTI5N2JjNjllN2U5MjFhYWM3L3RhYmxlcmFuZ2U6YjdlODE1Zjk4ZDkxNDkxMjk3YmM2OWU3ZTkyMWFhYzdfNS0zLTEtMS02MTk5MA_70040b63-8a54-482d-897a-0f362fab1d0e"
      unitRef="usd">500000</us-gaap:InventoryNet>
    <us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81NS9mcmFnOjdiOTViYWNhNzdlNDRjMTRiMDdhYjQyOWU2ZjkzZDdiL3RleHRyZWdpb246N2I5NWJhY2E3N2U0NGMxNGIwN2FiNDI5ZTZmOTNkN2JfMzY4_eea1d147-544f-4530-868c-cf746d90d5df">Property, Plant and Equipment, Net&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment, net consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:25.2pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.636%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.097%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.977%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.447%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.979%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Production equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lab equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture, fixtures and other equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, at cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,660)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,244)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;Depreciation and amortization expense was $0.4 million during each of the three months ended March&#160;31, 2023 and 2022.</us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81NS9mcmFnOjdiOTViYWNhNzdlNDRjMTRiMDdhYjQyOWU2ZjkzZDdiL3RleHRyZWdpb246N2I5NWJhY2E3N2U0NGMxNGIwN2FiNDI5ZTZmOTNkN2JfMzY5_1bff2d5d-3c1d-4494-8bec-85ecf9b98abc">&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property, plant and equipment, net consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:25.2pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.636%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.097%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.977%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.447%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.979%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Production equipment&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,114&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,488&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Lab equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,452&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,304&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,080&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,525&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture, fixtures and other equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;360&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;206&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in progress&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;602&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;957&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, at cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,608&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,480&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,660)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(7,244)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Property, plant and equipment, net&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,948&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i903b361bf85148a5aa5dbeb03ba0ea1d_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81NS9mcmFnOjdiOTViYWNhNzdlNDRjMTRiMDdhYjQyOWU2ZjkzZDdiL3RhYmxlOjM5MThmMzgxMTA3ZjQzY2I4NDI2ZDI2NGZlZjgxNzM4L3RhYmxlcmFuZ2U6MzkxOGYzODExMDdmNDNjYjg0MjZkMjY0ZmVmODE3MzhfMi0xLTEtMS02MTk5MA_82cf7cad-3db6-499f-9f13-163ee6b772cf"
      unitRef="usd">5114000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i5977eefa4b7f4aa09e7fdb5aea5dd806_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81NS9mcmFnOjdiOTViYWNhNzdlNDRjMTRiMDdhYjQyOWU2ZjkzZDdiL3RhYmxlOjM5MThmMzgxMTA3ZjQzY2I4NDI2ZDI2NGZlZjgxNzM4L3RhYmxlcmFuZ2U6MzkxOGYzODExMDdmNDNjYjg0MjZkMjY0ZmVmODE3MzhfMi0zLTEtMS02MTk5MA_d46ca015-9c5f-4fa0-a146-3ad9aceb8229"
      unitRef="usd">4488000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ia6d7ea55505e405b8d49c84e5c00e216_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81NS9mcmFnOjdiOTViYWNhNzdlNDRjMTRiMDdhYjQyOWU2ZjkzZDdiL3RhYmxlOjM5MThmMzgxMTA3ZjQzY2I4NDI2ZDI2NGZlZjgxNzM4L3RhYmxlcmFuZ2U6MzkxOGYzODExMDdmNDNjYjg0MjZkMjY0ZmVmODE3MzhfMy0xLTEtMS02MTk5MA_e43cefc7-2bb2-48b8-80d6-7418519a045e"
      unitRef="usd">2452000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i0cdadfcb55ef4456992d4eac608c568c_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81NS9mcmFnOjdiOTViYWNhNzdlNDRjMTRiMDdhYjQyOWU2ZjkzZDdiL3RhYmxlOjM5MThmMzgxMTA3ZjQzY2I4NDI2ZDI2NGZlZjgxNzM4L3RhYmxlcmFuZ2U6MzkxOGYzODExMDdmNDNjYjg0MjZkMjY0ZmVmODE3MzhfMy0zLTEtMS02MTk5MA_90a4e7eb-94af-4c3e-867a-46ee6df9d563"
      unitRef="usd">2304000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i6305afd21797431abefaa882fdec1d44_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81NS9mcmFnOjdiOTViYWNhNzdlNDRjMTRiMDdhYjQyOWU2ZjkzZDdiL3RhYmxlOjM5MThmMzgxMTA3ZjQzY2I4NDI2ZDI2NGZlZjgxNzM4L3RhYmxlcmFuZ2U6MzkxOGYzODExMDdmNDNjYjg0MjZkMjY0ZmVmODE3MzhfNC0xLTEtMS02MTk5MA_6c8d8496-1a8d-4783-94b5-a47c26c9b8ff"
      unitRef="usd">4080000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ie7d6fdab3f1b47a985e1326bf5737eca_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81NS9mcmFnOjdiOTViYWNhNzdlNDRjMTRiMDdhYjQyOWU2ZjkzZDdiL3RhYmxlOjM5MThmMzgxMTA3ZjQzY2I4NDI2ZDI2NGZlZjgxNzM4L3RhYmxlcmFuZ2U6MzkxOGYzODExMDdmNDNjYjg0MjZkMjY0ZmVmODE3MzhfNC0zLTEtMS02MTk5MA_162fb22d-8605-4306-a61c-53b2dbbda456"
      unitRef="usd">3525000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ib5ac7197a264438baf93759ed1193030_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81NS9mcmFnOjdiOTViYWNhNzdlNDRjMTRiMDdhYjQyOWU2ZjkzZDdiL3RhYmxlOjM5MThmMzgxMTA3ZjQzY2I4NDI2ZDI2NGZlZjgxNzM4L3RhYmxlcmFuZ2U6MzkxOGYzODExMDdmNDNjYjg0MjZkMjY0ZmVmODE3MzhfNS0xLTEtMS02MTk5MA_ee2c0d0e-d85b-4aaf-8757-10c78a1af690"
      unitRef="usd">360000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i3e9ea2df75d5435493c2296c08d770cc_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81NS9mcmFnOjdiOTViYWNhNzdlNDRjMTRiMDdhYjQyOWU2ZjkzZDdiL3RhYmxlOjM5MThmMzgxMTA3ZjQzY2I4NDI2ZDI2NGZlZjgxNzM4L3RhYmxlcmFuZ2U6MzkxOGYzODExMDdmNDNjYjg0MjZkMjY0ZmVmODE3MzhfNS0zLTEtMS02MTk5MA_e4a047fa-9691-4b78-b219-1338c9644655"
      unitRef="usd">206000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i255153329caf42fbad158d721b25384a_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81NS9mcmFnOjdiOTViYWNhNzdlNDRjMTRiMDdhYjQyOWU2ZjkzZDdiL3RhYmxlOjM5MThmMzgxMTA3ZjQzY2I4NDI2ZDI2NGZlZjgxNzM4L3RhYmxlcmFuZ2U6MzkxOGYzODExMDdmNDNjYjg0MjZkMjY0ZmVmODE3MzhfNi0xLTEtMS02OTc2MQ_c4b6ad1f-1486-4ecf-b58c-6550a63f6acb"
      unitRef="usd">602000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i670d9fe2f1524ac7bd4b7736aac57795_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81NS9mcmFnOjdiOTViYWNhNzdlNDRjMTRiMDdhYjQyOWU2ZjkzZDdiL3RhYmxlOjM5MThmMzgxMTA3ZjQzY2I4NDI2ZDI2NGZlZjgxNzM4L3RhYmxlcmFuZ2U6MzkxOGYzODExMDdmNDNjYjg0MjZkMjY0ZmVmODE3MzhfNi0zLTEtMS02OTc2MQ_00b667f3-ff4d-44f2-afac-2018293bfdfa"
      unitRef="usd">957000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81NS9mcmFnOjdiOTViYWNhNzdlNDRjMTRiMDdhYjQyOWU2ZjkzZDdiL3RhYmxlOjM5MThmMzgxMTA3ZjQzY2I4NDI2ZDI2NGZlZjgxNzM4L3RhYmxlcmFuZ2U6MzkxOGYzODExMDdmNDNjYjg0MjZkMjY0ZmVmODE3MzhfNi0xLTEtMS02MTk5MA_19bdac53-c81d-4f9e-9865-1a24a0b8c7a1"
      unitRef="usd">12608000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81NS9mcmFnOjdiOTViYWNhNzdlNDRjMTRiMDdhYjQyOWU2ZjkzZDdiL3RhYmxlOjM5MThmMzgxMTA3ZjQzY2I4NDI2ZDI2NGZlZjgxNzM4L3RhYmxlcmFuZ2U6MzkxOGYzODExMDdmNDNjYjg0MjZkMjY0ZmVmODE3MzhfNi0zLTEtMS02MTk5MA_d5928502-7342-424c-902b-b29f21e95dca"
      unitRef="usd">11480000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81NS9mcmFnOjdiOTViYWNhNzdlNDRjMTRiMDdhYjQyOWU2ZjkzZDdiL3RhYmxlOjM5MThmMzgxMTA3ZjQzY2I4NDI2ZDI2NGZlZjgxNzM4L3RhYmxlcmFuZ2U6MzkxOGYzODExMDdmNDNjYjg0MjZkMjY0ZmVmODE3MzhfNy0xLTEtMS02MTk5MA_63c479f6-bf1e-4333-80b5-89387dba276e"
      unitRef="usd">7660000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81NS9mcmFnOjdiOTViYWNhNzdlNDRjMTRiMDdhYjQyOWU2ZjkzZDdiL3RhYmxlOjM5MThmMzgxMTA3ZjQzY2I4NDI2ZDI2NGZlZjgxNzM4L3RhYmxlcmFuZ2U6MzkxOGYzODExMDdmNDNjYjg0MjZkMjY0ZmVmODE3MzhfNy0zLTEtMS02MTk5MA_4ffb61cb-9005-4f21-adb9-0385853cde1b"
      unitRef="usd">7244000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81NS9mcmFnOjdiOTViYWNhNzdlNDRjMTRiMDdhYjQyOWU2ZjkzZDdiL3RhYmxlOjM5MThmMzgxMTA3ZjQzY2I4NDI2ZDI2NGZlZjgxNzM4L3RhYmxlcmFuZ2U6MzkxOGYzODExMDdmNDNjYjg0MjZkMjY0ZmVmODE3MzhfOC0xLTEtMS02MTk5MA_b3a94cc8-b6b3-4495-b85a-062a43536d88"
      unitRef="usd">4948000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81NS9mcmFnOjdiOTViYWNhNzdlNDRjMTRiMDdhYjQyOWU2ZjkzZDdiL3RhYmxlOjM5MThmMzgxMTA3ZjQzY2I4NDI2ZDI2NGZlZjgxNzM4L3RhYmxlcmFuZ2U6MzkxOGYzODExMDdmNDNjYjg0MjZkMjY0ZmVmODE3MzhfOC0zLTEtMS02MTk5MA_b923d933-27cd-49b8-ad10-8562f56048c7"
      unitRef="usd">4236000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81NS9mcmFnOjdiOTViYWNhNzdlNDRjMTRiMDdhYjQyOWU2ZjkzZDdiL3RleHRyZWdpb246N2I5NWJhY2E3N2U0NGMxNGIwN2FiNDI5ZTZmOTNkN2JfNTQ5NzU1ODE0NDQ5_50de8e06-e7d9-4dec-ba5e-751f8fbcdb30"
      unitRef="usd">400000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:DepreciationDepletionAndAmortization
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81NS9mcmFnOjdiOTViYWNhNzdlNDRjMTRiMDdhYjQyOWU2ZjkzZDdiL3RleHRyZWdpb246N2I5NWJhY2E3N2U0NGMxNGIwN2FiNDI5ZTZmOTNkN2JfNTQ5NzU1ODE0NDQ5_87dc6087-c8b4-45ad-80d5-01b98f9ef3c1"
      unitRef="usd">400000</us-gaap:DepreciationDepletionAndAmortization>
    <us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81OC9mcmFnOjg2OWFiOTY5ZDMwNDQ3NmRhNzBlYzM3MjlmYzIwMGI0L3RleHRyZWdpb246ODY5YWI5NjlkMzA0NDc2ZGE3MGVjMzcyOWZjMjAwYjRfMTE4_23d3cf35-f2db-414d-bb18-c3bb9a343d43">Accrued and Other Current Liabilities &lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued and other current liabilities consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.333%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.653%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.023%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.024%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued professional fees&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued compensation and benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,708&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock>
    <us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81OC9mcmFnOjg2OWFiOTY5ZDMwNDQ3NmRhNzBlYzM3MjlmYzIwMGI0L3RleHRyZWdpb246ODY5YWI5NjlkMzA0NDc2ZGE3MGVjMzcyOWZjMjAwYjRfMTE5_e672ad84-7cd0-434a-b1b6-61addd60eed0">&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued and other current liabilities consisted of the following (in thousands):&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.333%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.653%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.023%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.024%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued professional fees&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued compensation and benefits&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,840&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued financing costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;194&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;123&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Accrued and other current liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,665&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,708&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81OC9mcmFnOjg2OWFiOTY5ZDMwNDQ3NmRhNzBlYzM3MjlmYzIwMGI0L3RhYmxlOmNjYjMyYTYyZDNiNTQ2ZTE5ZDk1NjNiZjY1Y2M4MzIzL3RhYmxlcmFuZ2U6Y2NiMzJhNjJkM2I1NDZlMTlkOTU2M2JmNjVjYzgzMjNfMi0xLTEtMS02MTk5MA_70225752-5a3d-45bb-aefa-de879e48f50e"
      unitRef="usd">2406000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81OC9mcmFnOjg2OWFiOTY5ZDMwNDQ3NmRhNzBlYzM3MjlmYzIwMGI0L3RhYmxlOmNjYjMyYTYyZDNiNTQ2ZTE5ZDk1NjNiZjY1Y2M4MzIzL3RhYmxlcmFuZ2U6Y2NiMzJhNjJkM2I1NDZlMTlkOTU2M2JmNjVjYzgzMjNfMi0zLTEtMS02MTk5MA_dd70ac2c-3bc8-4201-9526-246040b6f226"
      unitRef="usd">481000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81OC9mcmFnOjg2OWFiOTY5ZDMwNDQ3NmRhNzBlYzM3MjlmYzIwMGI0L3RhYmxlOmNjYjMyYTYyZDNiNTQ2ZTE5ZDk1NjNiZjY1Y2M4MzIzL3RhYmxlcmFuZ2U6Y2NiMzJhNjJkM2I1NDZlMTlkOTU2M2JmNjVjYzgzMjNfMy0xLTEtMS02MTk5MA_5c5cdafe-4184-4346-ac51-6255e4b73fe1"
      unitRef="usd">1105000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <us-gaap:EmployeeRelatedLiabilitiesCurrent
      contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81OC9mcmFnOjg2OWFiOTY5ZDMwNDQ3NmRhNzBlYzM3MjlmYzIwMGI0L3RhYmxlOmNjYjMyYTYyZDNiNTQ2ZTE5ZDk1NjNiZjY1Y2M4MzIzL3RhYmxlcmFuZ2U6Y2NiMzJhNjJkM2I1NDZlMTlkOTU2M2JmNjVjYzgzMjNfMy0zLTEtMS02MTk5MA_93860509-572d-4a8a-a79c-6905a717b857"
      unitRef="usd">1840000</us-gaap:EmployeeRelatedLiabilitiesCurrent>
    <ampx:AccruedOfferingCostsCurrent
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81OC9mcmFnOjg2OWFiOTY5ZDMwNDQ3NmRhNzBlYzM3MjlmYzIwMGI0L3RhYmxlOmNjYjMyYTYyZDNiNTQ2ZTE5ZDk1NjNiZjY1Y2M4MzIzL3RhYmxlcmFuZ2U6Y2NiMzJhNjJkM2I1NDZlMTlkOTU2M2JmNjVjYzgzMjNfNC0xLTEtMS02MTk5MA_e82e908f-25f7-4946-80aa-fe02a21c1c1a"
      unitRef="usd">31000</ampx:AccruedOfferingCostsCurrent>
    <ampx:AccruedOfferingCostsCurrent
      contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81OC9mcmFnOjg2OWFiOTY5ZDMwNDQ3NmRhNzBlYzM3MjlmYzIwMGI0L3RhYmxlOmNjYjMyYTYyZDNiNTQ2ZTE5ZDk1NjNiZjY1Y2M4MzIzL3RhYmxlcmFuZ2U6Y2NiMzJhNjJkM2I1NDZlMTlkOTU2M2JmNjVjYzgzMjNfNC0zLTEtMS02MTk5MA_913b342c-c676-40d2-b6fd-0b0ab99f4598"
      unitRef="usd">194000</ampx:AccruedOfferingCostsCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81OC9mcmFnOjg2OWFiOTY5ZDMwNDQ3NmRhNzBlYzM3MjlmYzIwMGI0L3RhYmxlOmNjYjMyYTYyZDNiNTQ2ZTE5ZDk1NjNiZjY1Y2M4MzIzL3RhYmxlcmFuZ2U6Y2NiMzJhNjJkM2I1NDZlMTlkOTU2M2JmNjVjYzgzMjNfOC0xLTEtMS02MTk5MA_c98b86ce-0004-4ed6-af9b-9763e761e5e5"
      unitRef="usd">123000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81OC9mcmFnOjg2OWFiOTY5ZDMwNDQ3NmRhNzBlYzM3MjlmYzIwMGI0L3RhYmxlOmNjYjMyYTYyZDNiNTQ2ZTE5ZDk1NjNiZjY1Y2M4MzIzL3RhYmxlcmFuZ2U6Y2NiMzJhNjJkM2I1NDZlMTlkOTU2M2JmNjVjYzgzMjNfOC0zLTEtMS02MTk5MA_f9de69fd-674e-4488-a742-fed415bac221"
      unitRef="usd">193000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81OC9mcmFnOjg2OWFiOTY5ZDMwNDQ3NmRhNzBlYzM3MjlmYzIwMGI0L3RhYmxlOmNjYjMyYTYyZDNiNTQ2ZTE5ZDk1NjNiZjY1Y2M4MzIzL3RhYmxlcmFuZ2U6Y2NiMzJhNjJkM2I1NDZlMTlkOTU2M2JmNjVjYzgzMjNfNy0xLTEtMS03NDIyOA_528a1904-e42e-4724-a406-605fb9c72e09"
      unitRef="usd">3665000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i988b24a7822c4dd0a13444855095dca6_I20221231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV81OC9mcmFnOjg2OWFiOTY5ZDMwNDQ3NmRhNzBlYzM3MjlmYzIwMGI0L3RhYmxlOmNjYjMyYTYyZDNiNTQ2ZTE5ZDk1NjNiZjY1Y2M4MzIzL3RhYmxlcmFuZ2U6Y2NiMzJhNjJkM2I1NDZlMTlkOTU2M2JmNjVjYzgzMjNfNy0zLTEtMS03NDIyOA_804d6130-ccce-4c3d-bc12-c4927f874d77"
      unitRef="usd">2708000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RleHRyZWdpb246ZWQ1NzgzMjFhMWEzNDExM2I5NGU3Mzc4YmRjN2E2MTdfOTE5NA_efbc7573-5740-49e2-8476-e1a0b9c4970e">Stockholders&#x2019; Equity&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Common and Preferred Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2023, we had a total of 1,000,000,000 shares of stock authorized to be issued, of which 950,000,000 shares are designated as common stock, $0.0001 par value per share, and 50,000,000 shares are designated as preferred stock, $0.0001 par value per share. Holders of common stock are entitled to one vote for each share held and entitled to receive dividends when and if declared by the board of directors. Through and as of March&#160;31, 2023, we have not declared any dividends.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Equity Incentive Plans&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;We adopted the 2022 Equity Incentive Plan (&#x201c;2022 Plan&#x201d;) effective September 14, 2022. The 2022 Plan authorizes awards in the form of stock options, stock appreciation rights, restricted stock, restricted stock units, or performance awards and may be granted to directors, employees or consultants. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;As of March&#160;31, 2023, the total number of shares reserved for issuance under the 2022 Plan was 13,915,807, which includes the increase in shares reserved pursuant to the evergreen provisions contained in the 2022 Plan and the assumed awards that were cancelled, expired or otherwise terminated without having been exercised in full, were tendered to or withheld for payment of an exercise price or for tax withholding obligations, or were forfeited to or repurchased due to failure to vest. The number of shares available for issuance under the 2022 Plan may be increased annually at the beginning of the fiscal year, subject to certain limitations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Amprius Technologies, Inc. 2016 Equity Incentive Plan (&#x201c;2016 Plan&#x201d;), which we maintained prior to the Business Combination, was terminated concurrently with the adoption of the 2022 Plan. However, the 2016 Plan continues to govern the terms and conditions of the outstanding awards previously granted under the 2016 Plan.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;The 2022 Plan and 2016 Plan are collectively referred to as the &#x201c;Equity Incentive Plans.&#x201d;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock options granted under the Equity Incentive Plans provided an exercise price not less than 100% of the fair value at the grant date, unless the optionee is a 10% stockholder, in which case the option price will not be less than 110% of such fair market value. Options granted generally have a maximum term of 10 years from grant date or 90 days from the termination of the optionee, are exercisable upon vesting unless otherwise designated for early exercise by the Board of Directors at the time of grant, and generally vest over a period of four years. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;As of March&#160;31, 2023, the total unrecognized stock-based compensation expense related to the unvested stock options was approximately $7.7 million, which we expect to recognize over a weighted-average period of 2.9 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:115%"&gt;Restricted Stock Units (&#x201c;RSU&#x201d;)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of RSUs is determined based upon the market closing price of our common stock on the date of grant. RSUs generally vest over a period of approximately four years from the date of grant, subject to the continued employment or services of the grantee&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:27pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2023, the total unrecognized stock-based compensation expense related to the unvested RSUs was approximately $2.4&#160;million, which we expect to recognize over a weighted-average period of 3.8 years.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%"&gt;Amprius Holdings 2008 Stock Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The stock-based compensation costs associated with grants to certain individuals who provided services to our company under the Amprius Holdings 2008 Stock Plan were included in the accompanying condensed consolidated statements of operations, with a corresponding increase in additional paid-in capital. The remaining unrecognized compensation cost as of March&#160;31, 2023 was not material.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:107%"&gt;Employee Stock Purchase Plan (&#x201c;ESPP&#x201d;)&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;We adopted the 2022 Employee Stock Purchase Plan (&#x201c;ESPP&#x201d;) effective September&#160;14, 2022. As of March&#160;31, 2023, the total number of shares reserved for issuance was 1,836,101, which may be increased annually at the beginning of the fiscal year subject to certain limitations. The ESPP is intended to qualify under Section 423 of the Internal Revenue Code of 1986 (as amended) and will provide eligible employees an opportunity to purchase our common stock at a discount through payroll deductions. We have not established an offering under the ESPP as of March&#160;31, 2023.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:107%"&gt;  &lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:107%"&gt;Executive Incentive Compensation Plan&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"&gt;On September&#160;14, 2022, our board of directors approved our Executive Incentive Compensation Plan, which will allow us to grant incentive awards to certain executive employees, generally payable in cash, based upon achieving specified goals. We have the right to settle the award by granting an equity award, which may be subject to vesting conditions. All awards under the Executive Incentive Compensation Plan will be subject to reduction, cancellation, forfeiture, or recoupment in accordance with any clawback policy that we are required to adopt pursuant to applicable laws. As of March&#160;31, 2023, there were no awards granted under the Executive Incentive Compensation Plan. &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Common Stock Warrants&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Outstanding stock warrants consisted of the following as of March&#160;31, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.787%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.185%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.003%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of &lt;br/&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Exercise Price &lt;br/&gt;Per Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Expiration Date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Public warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,268,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 14, 2027&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Private warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,400,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 14, 2027&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;PIPE warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,052,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 14, 2027&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,720,836&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Holders of the public warrants and private warrants are entitled to purchase one share our common stock at a price of $11.50 per share subject to adjustment pursuant to the Warrant Agreement, dated as of March 1, 2022. The public warrants are listed on the NYSE and are redeemable by us when the price per share of our common stock equals or &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;exceeds $18.00 &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;per share for at least 20 trading days during a period of 30 consecutive trading days prior to the redemption date. The private warrants are not listed on any securities exchange and not redeemable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The warrants issued as part of units in a private placement in connection with the Business Combination (the &#x201c;PIPE warrants&#x201d;) are substantially identical to the public warrants, except that the exercise price of each PIPE warrant is $12.50 per share. In addition, we may only be able to redeem the PIPE warrants if the price per share of our common stock equals or exceeds $20.00 per share for at least 20 trading days during a period of 30 consecutive trading days prior to the redemption date. The PIPE warrants are also not listed on any securities exchange.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The warrants described above are classified as equity in accordance with the guidance under ASC 815-40, &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Derivatives and Hedging&#x2013;Contracts in Entity&#x2019;s Own Equity&lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Equity-classified contracts, such as stock warrants, are initially measured at fair value or allocated value. Any subsequent changes in fair value are not recognized as long as the contracts continue to be classified in equity. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Stock Purchase Agreement&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On September&#160;27, 2022, we entered into the Purchase Agreement with BRPC II, pursuant to which we, at our option, have the right to sell to BRPC II up to $200.0 million of our common stock until January 1, 2025, subject to certain contractual terms. The purchase price will be determined by reference to the volume weighted average price of our common stock (as defined in the Purchase Agreement), less a discount of 3%. We cannot issue to BRPC II more than 19.99% of the aggregate number of shares of the common stock issued and outstanding immediately prior to the execution of the Purchase Agreement, except in limited circumstances. Proceeds from the sale of our common stock to BRPC II will depend upon the frequency and the market price of our common stock on the date of sale.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended March&#160;31, 2023, we issued a total of 331,351 shares of common stock to BRPC II with proceeds totaling $2.4&#160;million. The deferred stock issuance cost, which is included in other assets in the accompanying condensed consolidated balance sheets and will be charged proportionally against the proceeds from future issuance of shares to BRPC II under the Purchase Agreement, was $0.6&#160;million as of March&#160;31, 2023.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:107%"&gt;Stock-Based Compensation &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock-based compensation from stock options and RSUs under the Equity Incentive Plans and from stock options under the Amprius Holdings 2008 Stock Plan that we recorded were included in the following lines in the accompanying condensed consolidated statements of operations during the periods presented (in thousands)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:25.2pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.636%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.097%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.977%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.447%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.979%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ccecff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ccecff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ccecff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ccecff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ccecff;padding:0 1pt"/&gt;&lt;td style="background-color:#ccecff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ccecff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ccecff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ccecff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ccecff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ccecff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ccecff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ccecff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ccecff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <ampx:SharesAuthorized
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RleHRyZWdpb246ZWQ1NzgzMjFhMWEzNDExM2I5NGU3Mzc4YmRjN2E2MTdfNDk0NzgwMjM1Njc5NQ_7515e431-a911-49cc-a560-8dfe042a708b"
      unitRef="shares">1000000000</ampx:SharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RleHRyZWdpb246ZWQ1NzgzMjFhMWEzNDExM2I5NGU3Mzc4YmRjN2E2MTdfNDk0NzgwMjM1Njc5OQ_57ff5758-82d0-4df5-b770-bf3dbf858e32"
      unitRef="shares">950000000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:CommonStockParOrStatedValuePerShare
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RleHRyZWdpb246ZWQ1NzgzMjFhMWEzNDExM2I5NGU3Mzc4YmRjN2E2MTdfNDk0NzgwMjM1NjgwMw_c9f620b9-9df9-47ac-9b24-45eaf98b9bbe"
      unitRef="usdPerShare">0.0001</us-gaap:CommonStockParOrStatedValuePerShare>
    <us-gaap:PreferredStockSharesAuthorized
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RleHRyZWdpb246ZWQ1NzgzMjFhMWEzNDExM2I5NGU3Mzc4YmRjN2E2MTdfNDk0NzgwMjM1NjgwNw_9e33a615-81df-4c72-8021-271dd2b1f9e9"
      unitRef="shares">50000000</us-gaap:PreferredStockSharesAuthorized>
    <us-gaap:PreferredStockParOrStatedValuePerShare
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RleHRyZWdpb246ZWQ1NzgzMjFhMWEzNDExM2I5NGU3Mzc4YmRjN2E2MTdfNDk0NzgwMjM1NjgxMQ_1434549f-48fc-468c-8b7e-3cd318a7329a"
      unitRef="usdPerShare">0.0001</us-gaap:PreferredStockParOrStatedValuePerShare>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="ic33e1539b78a40bda4ef216dea1bd960_I20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RleHRyZWdpb246ZWQ1NzgzMjFhMWEzNDExM2I5NGU3Mzc4YmRjN2E2MTdfNTQ5NzU1ODU0Njg1_bdbb5ba2-10cf-4143-8c2e-8f74524faea7"
      unitRef="shares">13915807</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <ampx:ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfFairValue
      contextRef="if8307ba91dca43aa98a87dbc1eace892_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RleHRyZWdpb246ZWQ1NzgzMjFhMWEzNDExM2I5NGU3Mzc4YmRjN2E2MTdfMzg0NA_490acde8-85b2-41b1-bdcb-b74a649c0e50"
      unitRef="number">1</ampx:ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfFairValue>
    <ampx:StockholderPercentageOfOptioneeForOptionPrice
      contextRef="if8307ba91dca43aa98a87dbc1eace892_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RleHRyZWdpb246ZWQ1NzgzMjFhMWEzNDExM2I5NGU3Mzc4YmRjN2E2MTdfMzkwOQ_4b4b05f8-8617-4f56-8daf-09710f73fc02"
      unitRef="number">0.10</ampx:StockholderPercentageOfOptioneeForOptionPrice>
    <ampx:ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfFairValueSignificantStockholder
      contextRef="if8307ba91dca43aa98a87dbc1eace892_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RleHRyZWdpb246ZWQ1NzgzMjFhMWEzNDExM2I5NGU3Mzc4YmRjN2E2MTdfMzk3OA_6f14d2d7-32c7-475d-925f-1be650c8836e"
      unitRef="number">1.10</ampx:ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfFairValueSignificantStockholder>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
      contextRef="if8307ba91dca43aa98a87dbc1eace892_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RleHRyZWdpb246ZWQ1NzgzMjFhMWEzNDExM2I5NGU3Mzc4YmRjN2E2MTdfNDA1Nw_1c477f31-fcb9-4c9a-9a98-a81f73f88e4e">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i998fc01b463d4ba5a09b1286fdb9c50a_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RleHRyZWdpb246ZWQ1NzgzMjFhMWEzNDExM2I5NGU3Mzc4YmRjN2E2MTdfNTQ5NzU1ODcwMzE1_98d1f1a1-7694-4cfc-8752-9b227eaa0bd5">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RleHRyZWdpb246ZWQ1NzgzMjFhMWEzNDExM2I5NGU3Mzc4YmRjN2E2MTdfNDk0NzgwMjM1MDM0MA_ca997b5b-fd8d-4e0c-a2ed-7959fbdbf588"
      unitRef="usd">7700000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i50e98b1619b14d3aad7cc2e81158f8fd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RleHRyZWdpb246ZWQ1NzgzMjFhMWEzNDExM2I5NGU3Mzc4YmRjN2E2MTdfNjU5NzA2OTgyMzc5MA_53d2a581-1a18-4d85-8186-dc445d01a66b">P2Y10M24D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ibe21b3a289994d4a97c4c69f932acff6_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RleHRyZWdpb246ZWQ1NzgzMjFhMWEzNDExM2I5NGU3Mzc4YmRjN2E2MTdfNTQ5NzU1ODcwMzIw_5e8e7c91-b900-4835-a760-4cf98d2e342e">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="i3aff53d2317b441595d7b67e66f87d6d_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RleHRyZWdpb246ZWQ1NzgzMjFhMWEzNDExM2I5NGU3Mzc4YmRjN2E2MTdfNDk0NzgwMjM0MTUzMg_b4a57369-1b51-4b55-b894-929cbebd2f81"
      unitRef="usd">2400000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="ibe21b3a289994d4a97c4c69f932acff6_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RleHRyZWdpb246ZWQ1NzgzMjFhMWEzNDExM2I5NGU3Mzc4YmRjN2E2MTdfNjU5NzA2OTgyMzc5OA_37fb704e-8b58-414f-8e76-882d5631731d">P3Y9M18D</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <ampx:ShareBasedCompensationArrangementByShareBasedPaymentAwardReservedForIssuance
      contextRef="i296bde8d08c2448f98f54612571ba0c2_I20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RleHRyZWdpb246ZWQ1NzgzMjFhMWEzNDExM2I5NGU3Mzc4YmRjN2E2MTdfNTQ5NzU1ODU0MTUz_b54034e5-d81f-49e8-99e4-eca7790f27ac"
      unitRef="shares">1836101</ampx:ShareBasedCompensationArrangementByShareBasedPaymentAwardReservedForIssuance>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i88342beb5da647d28102477fd33b6c49_D20230101-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RleHRyZWdpb246ZWQ1NzgzMjFhMWEzNDExM2I5NGU3Mzc4YmRjN2E2MTdfNTQ5NzU1ODcwMzI5_50fad636-50c7-4a41-8dd3-377f8a13f03e"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RleHRyZWdpb246ZWQ1NzgzMjFhMWEzNDExM2I5NGU3Mzc4YmRjN2E2MTdfMTY0OTI2NzQ3NTMwOQ_9200fd7b-3a7d-4443-95a4-6094e4d5fbb4">&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Outstanding stock warrants consisted of the following as of March&#160;31, 2023:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.787%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:45.588%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.185%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.824%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:22.003%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of &lt;br/&gt;Warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Exercise Price &lt;br/&gt;Per Share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Expiration Date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Public warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29,268,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 14, 2027&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Private warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,400,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 14, 2027&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;PIPE warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,052,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12.50&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 14, 2027&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,720,836&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="i1083d46db3cb4333bd42aa18cd72741b_I20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RhYmxlOmI3OWJiN2M2ZTNjMDQwMTM4MDlmYzJmN2Q1Zjk3YzBmL3RhYmxlcmFuZ2U6Yjc5YmI3YzZlM2MwNDAxMzgwOWZjMmY3ZDVmOTdjMGZfMS0xLTEtMS02NDk5Nw_90fede9a-0aed-4640-90a2-4c5a6856f5a0"
      unitRef="shares">29268336</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="i1083d46db3cb4333bd42aa18cd72741b_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RhYmxlOmI3OWJiN2M2ZTNjMDQwMTM4MDlmYzJmN2Q1Zjk3YzBmL3RhYmxlcmFuZ2U6Yjc5YmI3YzZlM2MwNDAxMzgwOWZjMmY3ZDVmOTdjMGZfMS0zLTEtMS02NDk5Nw_727b7ca3-c868-45d2-9112-8c4878e70be3"
      unitRef="usdPerShare">11.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="i89b26f35c8c743ec898b2e7cbd65d2da_I20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RhYmxlOmI3OWJiN2M2ZTNjMDQwMTM4MDlmYzJmN2Q1Zjk3YzBmL3RhYmxlcmFuZ2U6Yjc5YmI3YzZlM2MwNDAxMzgwOWZjMmY3ZDVmOTdjMGZfMi0xLTEtMS02NDk5Nw_d6f602f8-4c48-46cf-b644-52711e22ad1d"
      unitRef="shares">16400000</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="i89b26f35c8c743ec898b2e7cbd65d2da_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RhYmxlOmI3OWJiN2M2ZTNjMDQwMTM4MDlmYzJmN2Q1Zjk3YzBmL3RhYmxlcmFuZ2U6Yjc5YmI3YzZlM2MwNDAxMzgwOWZjMmY3ZDVmOTdjMGZfMi0zLTEtMS02NDk5Nw_b468b348-3c45-45af-96d7-9e403b11fed8"
      unitRef="usdPerShare">11.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="ia369e97ca86a4015bacdfaf2d5b614d2_I20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RhYmxlOmI3OWJiN2M2ZTNjMDQwMTM4MDlmYzJmN2Q1Zjk3YzBmL3RhYmxlcmFuZ2U6Yjc5YmI3YzZlM2MwNDAxMzgwOWZjMmY3ZDVmOTdjMGZfMy0xLTEtMS02NDk5Nw_02a0b328-8013-4073-824a-c199ced73f92"
      unitRef="shares">2052500</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="ia369e97ca86a4015bacdfaf2d5b614d2_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RhYmxlOmI3OWJiN2M2ZTNjMDQwMTM4MDlmYzJmN2Q1Zjk3YzBmL3RhYmxlcmFuZ2U6Yjc5YmI3YzZlM2MwNDAxMzgwOWZjMmY3ZDVmOTdjMGZfMy0zLTEtMS02NDk5Nw_d7ffbc1f-2105-4b28-8be8-25883f0b4e24"
      unitRef="usdPerShare">12.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RhYmxlOmI3OWJiN2M2ZTNjMDQwMTM4MDlmYzJmN2Q1Zjk3YzBmL3RhYmxlcmFuZ2U6Yjc5YmI3YzZlM2MwNDAxMzgwOWZjMmY3ZDVmOTdjMGZfNC0xLTEtMS02NDk5Nw_c7436c5d-c3e4-4c05-a0aa-275c5ee48948"
      unitRef="shares">47720836</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="i65f6ecb200ca4a2ea079f7914b85be3e_I20220301"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RleHRyZWdpb246ZWQ1NzgzMjFhMWEzNDExM2I5NGU3Mzc4YmRjN2E2MTdfNTQ5NzU1ODcwMzM1_54148bab-abe2-44e8-a9c7-1fbfbf3b612a"
      unitRef="usdPerShare">11.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <ampx:SaleOfStockAveragePricePerShareRedemption
      contextRef="i8b54249c302d4bbd84bcc1b8b3beb2fc_D20220914-20220914"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RleHRyZWdpb246ZWQ1NzgzMjFhMWEzNDExM2I5NGU3Mzc4YmRjN2E2MTdfNTQ5NzU1ODcwMzM5_e183117c-fa23-4a00-a1b9-b76ffefcb41c"
      unitRef="usdPerShare">18.00</ampx:SaleOfStockAveragePricePerShareRedemption>
    <ampx:WarrantsRedemptionThresholdTradingDays
      contextRef="i8b54249c302d4bbd84bcc1b8b3beb2fc_D20220914-20220914"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RleHRyZWdpb246ZWQ1NzgzMjFhMWEzNDExM2I5NGU3Mzc4YmRjN2E2MTdfNTQ5NzU1ODcwMzQ3_d13ee84a-49cf-4afb-8632-d30b08e58615"
      unitRef="day">20</ampx:WarrantsRedemptionThresholdTradingDays>
    <ampx:WarrantsRedemptionThresholdConsecutiveTradingDays
      contextRef="i8b54249c302d4bbd84bcc1b8b3beb2fc_D20220914-20220914"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RleHRyZWdpb246ZWQ1NzgzMjFhMWEzNDExM2I5NGU3Mzc4YmRjN2E2MTdfNTQ5NzU1ODcwMzUx_20e561f8-d83e-421c-8a83-cd998c3f4fe3"
      unitRef="day">30</ampx:WarrantsRedemptionThresholdConsecutiveTradingDays>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="ia369e97ca86a4015bacdfaf2d5b614d2_I20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RleHRyZWdpb246ZWQ1NzgzMjFhMWEzNDExM2I5NGU3Mzc4YmRjN2E2MTdfNDk0NzgwMjM1MzI4MA_8fecc9bd-eda0-43fd-b6a7-69c891f6cbac"
      unitRef="usdPerShare">12.50</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <ampx:SaleOfStockAveragePricePerShareRedemption
      contextRef="i31467a3e9fbe4b59983ccf8194ea8070_D20220914-20220914"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RleHRyZWdpb246ZWQ1NzgzMjFhMWEzNDExM2I5NGU3Mzc4YmRjN2E2MTdfNDk0NzgwMjM1MzQzNg_ea0c7392-b203-485f-8e86-ed87ed1190f7"
      unitRef="usdPerShare">20.00</ampx:SaleOfStockAveragePricePerShareRedemption>
    <ampx:WarrantsRedemptionThresholdTradingDays
      contextRef="i31467a3e9fbe4b59983ccf8194ea8070_D20220914-20220914"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RleHRyZWdpb246ZWQ1NzgzMjFhMWEzNDExM2I5NGU3Mzc4YmRjN2E2MTdfNTQ5NzU1ODcwMzU1_435c0d39-ca4c-4b21-86b6-9ca1369c85ef"
      unitRef="day">20</ampx:WarrantsRedemptionThresholdTradingDays>
    <ampx:WarrantsRedemptionThresholdConsecutiveTradingDays
      contextRef="i31467a3e9fbe4b59983ccf8194ea8070_D20220914-20220914"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RleHRyZWdpb246ZWQ1NzgzMjFhMWEzNDExM2I5NGU3Mzc4YmRjN2E2MTdfNTQ5NzU1ODcwMzU5_c6622ec9-a7f4-4f1a-b441-82fb27135905"
      unitRef="day">30</ampx:WarrantsRedemptionThresholdConsecutiveTradingDays>
    <ampx:SaleOfStockPotentialMaximumConsiderationReceivedOnTransaction
      contextRef="i421fa02da0234be3b23eab9845b639a4_D20220927-20220927"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RleHRyZWdpb246ZWQ1NzgzMjFhMWEzNDExM2I5NGU3Mzc4YmRjN2E2MTdfNzg4Mw_107eeb18-2879-4d1f-930a-ab0446e1ea9c"
      unitRef="usd">200000000</ampx:SaleOfStockPotentialMaximumConsiderationReceivedOnTransaction>
    <ampx:SaleOfStockDiscount
      contextRef="i6f0bf828381846a8b705dd517c0690c7_I20220927"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RleHRyZWdpb246ZWQ1NzgzMjFhMWEzNDExM2I5NGU3Mzc4YmRjN2E2MTdfODI1Mg_20b8dd82-04f6-4ff5-ade7-77b928b0c8ad"
      unitRef="number">0.03</ampx:SaleOfStockDiscount>
    <ampx:SaleOfStockMaximumSharesAvailableForSalePercentageOfSharesIssuedAndOutstandingPriorToTransaction
      contextRef="i421fa02da0234be3b23eab9845b639a4_D20220927-20220927"
      decimals="4"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RleHRyZWdpb246ZWQ1NzgzMjFhMWEzNDExM2I5NGU3Mzc4YmRjN2E2MTdfODMwMg_66c45f49-fc49-4c0e-b35a-7a690c13bfc4"
      unitRef="number">0.1999</ampx:SaleOfStockMaximumSharesAvailableForSalePercentageOfSharesIssuedAndOutstandingPriorToTransaction>
    <us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction
      contextRef="i09c21ae7eb0c4550b4f44db99a8f9cfa_D20230101-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RleHRyZWdpb246ZWQ1NzgzMjFhMWEzNDExM2I5NGU3Mzc4YmRjN2E2MTdfNTQ5NzU1ODU2NTQ3_ad46a244-c673-44a0-a21c-da8662785658"
      unitRef="shares">331351</us-gaap:SaleOfStockNumberOfSharesIssuedInTransaction>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i09c21ae7eb0c4550b4f44db99a8f9cfa_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RleHRyZWdpb246ZWQ1NzgzMjFhMWEzNDExM2I5NGU3Mzc4YmRjN2E2MTdfNTQ5NzU1ODU2NjEw_48d52cce-2a71-4696-8fe7-c6327566ea9a"
      unitRef="usd">2400000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <ampx:DeferredStockIssuanceCosts
      contextRef="i6240ae66e6554cf88516b271e123fbbe_I20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RleHRyZWdpb246ZWQ1NzgzMjFhMWEzNDExM2I5NGU3Mzc4YmRjN2E2MTdfNDk0NzgwMjM2MDA3OA_c5aad065-e9f9-4479-bb19-27b4c8aa7c2d"
      unitRef="usd">600000</ampx:DeferredStockIssuanceCosts>
    <us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RleHRyZWdpb246ZWQ1NzgzMjFhMWEzNDExM2I5NGU3Mzc4YmRjN2E2MTdfMTY0OTI2NzQ3NTMwOA_3b118cc0-0604-4b64-9e11-1f3dc016dc29">&lt;div style="margin-top:10pt;text-indent:22.5pt"&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Stock-based compensation from stock options and RSUs under the Equity Incentive Plans and from stock options under the Amprius Holdings 2008 Stock Plan that we recorded were included in the following lines in the accompanying condensed consolidated statements of operations during the periods presented (in thousands)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:25.2pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.636%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.097%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.977%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.447%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.979%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended March 31, 2023&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ccecff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cost of revenue&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ccecff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ccecff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;169&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ccecff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ccecff;padding:0 1pt"/&gt;&lt;td style="background-color:#ccecff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ccecff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;113&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ccecff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ccecff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Selling, general and administrative&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ccecff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;537&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ccecff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ccecff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ccecff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;337&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ccecff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total stock-based compensation expense&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;726&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i7b9b12b7e31d4c76a8d6a376c2b7d713_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RhYmxlOjI4NTBlODJlZmNhNDRmZTI4MzViZWQxM2VlNjY4NmExL3RhYmxlcmFuZ2U6Mjg1MGU4MmVmY2E0NGZlMjgzNWJlZDEzZWU2Njg2YTFfMi0xLTEtMS02NDE2Mw_771ddc37-3680-4163-a5c5-e0e3e1042e5c"
      unitRef="usd">169000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ide8e49695f9d47238f505b8412513868_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RhYmxlOjI4NTBlODJlZmNhNDRmZTI4MzViZWQxM2VlNjY4NmExL3RhYmxlcmFuZ2U6Mjg1MGU4MmVmY2E0NGZlMjgzNWJlZDEzZWU2Njg2YTFfMi0zLTEtMS02NDE2Mw_3997473c-542a-4e55-ab79-5e5d6464c1d9"
      unitRef="usd">113000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i1d86f0bf8ca54c31a23e7d6b7920910e_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RhYmxlOjI4NTBlODJlZmNhNDRmZTI4MzViZWQxM2VlNjY4NmExL3RhYmxlcmFuZ2U6Mjg1MGU4MmVmY2E0NGZlMjgzNWJlZDEzZWU2Njg2YTFfMy0xLTEtMS02NDE2Mw_a796f687-0e82-4edf-8d47-88b45486b63f"
      unitRef="usd">20000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i755fa2560d3b49c389b0764776734331_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RhYmxlOjI4NTBlODJlZmNhNDRmZTI4MzViZWQxM2VlNjY4NmExL3RhYmxlcmFuZ2U6Mjg1MGU4MmVmY2E0NGZlMjgzNWJlZDEzZWU2Njg2YTFfMy0zLTEtMS02NDE2Mw_80520dab-5f6d-4421-b2ca-197de5cdf5d5"
      unitRef="usd">6000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i118c22344d0e445ab1d3ec905d1a450d_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RhYmxlOjI4NTBlODJlZmNhNDRmZTI4MzViZWQxM2VlNjY4NmExL3RhYmxlcmFuZ2U6Mjg1MGU4MmVmY2E0NGZlMjgzNWJlZDEzZWU2Njg2YTFfNC0xLTEtMS02NDE2Mw_77a5c09b-842d-4804-a629-b751c4ad14ba"
      unitRef="usd">537000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i95e94b4180df453fa35e812c22acf32d_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RhYmxlOjI4NTBlODJlZmNhNDRmZTI4MzViZWQxM2VlNjY4NmExL3RhYmxlcmFuZ2U6Mjg1MGU4MmVmY2E0NGZlMjgzNWJlZDEzZWU2Njg2YTFfNC0zLTEtMS02NDE2Mw_ea8801cb-0851-4c28-ac41-106867cc1cec"
      unitRef="usd">337000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RhYmxlOjI4NTBlODJlZmNhNDRmZTI4MzViZWQxM2VlNjY4NmExL3RhYmxlcmFuZ2U6Mjg1MGU4MmVmY2E0NGZlMjgzNWJlZDEzZWU2Njg2YTFfNS0xLTEtMS02NDE2Mw_01048bb9-3245-41ac-a6e9-a7fba29b2df2"
      unitRef="usd">726000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82MS9mcmFnOmVkNTc4MzIxYTFhMzQxMTNiOTRlNzM3OGJkYzdhNjE3L3RhYmxlOjI4NTBlODJlZmNhNDRmZTI4MzViZWQxM2VlNjY4NmExL3RhYmxlcmFuZ2U6Mjg1MGU4MmVmY2E0NGZlMjgzNWJlZDEzZWU2Njg2YTFfNS0zLTEtMS02NDE2Mw_f698b35d-1897-4436-87a9-4901c2e42b0d"
      unitRef="usd">456000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:IncomeTaxDisclosureTextBlock
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82NC9mcmFnOjg2NDA2ZTdhMjhmODQzNWVhMjQ2YTA2MTdlMTY4YjVjL3RleHRyZWdpb246ODY0MDZlN2EyOGY4NDM1ZWEyNDZhMDYxN2UxNjhiNWNfMjg2_ac6dbc04-f2b1-4a2e-85e3-e336db9332a8">Income TaxesWe have no income tax expense as a result of the continued generation of net operating losses (&#x201c;NOLs&#x201d;)&#160;offset by a full valuation allowance recorded on such NOLs, as we determined it is not more-likely-than-not&#160;that our NOLs will be utilized.</us-gaap:IncomeTaxDisclosureTextBlock>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82NC9mcmFnOjg2NDA2ZTdhMjhmODQzNWVhMjQ2YTA2MTdlMTY4YjVjL3RleHRyZWdpb246ODY0MDZlN2EyOGY4NDM1ZWEyNDZhMDYxN2UxNjhiNWNfNDM_626000ec-9d7e-4fc2-9344-d4422a6b9542"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82NC9mcmFnOjg2NDA2ZTdhMjhmODQzNWVhMjQ2YTA2MTdlMTY4YjVjL3RleHRyZWdpb246ODY0MDZlN2EyOGY4NDM1ZWEyNDZhMDYxN2UxNjhiNWNfNDM_93ea5984-6394-4d7b-8b49-add2df90d921"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82NC9mcmFnOjg2NDA2ZTdhMjhmODQzNWVhMjQ2YTA2MTdlMTY4YjVjL3RleHRyZWdpb246ODY0MDZlN2EyOGY4NDM1ZWEyNDZhMDYxN2UxNjhiNWNfNDM_9bdd9251-3659-43b4-9a73-3e5b33a8ccfb"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82NC9mcmFnOjg2NDA2ZTdhMjhmODQzNWVhMjQ2YTA2MTdlMTY4YjVjL3RleHRyZWdpb246ODY0MDZlN2EyOGY4NDM1ZWEyNDZhMDYxN2UxNjhiNWNfNDM_a1fac311-4641-48fa-9397-24a4330fb3ff"
      unitRef="usd">0</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV83MC9mcmFnOjdhZDljNTRlMGNhODQ4ZGViNjk0MmZmZjhkNWExNjQ2L3RleHRyZWdpb246N2FkOWM1NGUwY2E4NDhkZWI2OTQyZmZmOGQ1YTE2NDZfMTI5Ng_1abcc2da-8fae-423e-af14-6c5c6a6128e6">LeasesWe have a non-cancelable operating lease for our corporate headquarters and facilities in Fremont, California. On January&#160;4, 2023, we entered into an amendment of such lease, which includes the lease of additional space in the same building and extending the lease term to end on June&#160;30, 2027, with an option to extend for an additional&#160;five-year term.  Our operating lease does not contain any material residual value guarantees. We had no leases that were classified as a financing lease as of March&#160;31, 2023.  &lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2023, the weighted-average remaining term of the operating lease was 9.3 years and the weighted-average discount rate used to estimate the net present value of the operating lease liabilities was 7.9%.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended March&#160;31, 2023, the total amount of right-of-use assets obtained in exchange for new operating lease liabilities was $5.2 million. The total amount paid for amounts included in the measurement of operating lease liabilities was $179 thousand and $86 thousand during the three months ended March&#160;31, 2023 and 2022, respectively.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Operating lease expense was $202 thousand and $140 thousand during the three months ended March&#160;31, 2023 and 2022, respectively. Variable lease expense was not material.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:9pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future operating lease payments as of March&#160;31, 2023 were as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.272%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ending December 31:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less - present value adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,359)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV83MC9mcmFnOjdhZDljNTRlMGNhODQ4ZGViNjk0MmZmZjhkNWExNjQ2L3RleHRyZWdpb246N2FkOWM1NGUwY2E4NDhkZWI2OTQyZmZmOGQ1YTE2NDZfMTA5OTUxMTY0NjkxMw_42a4532e-a83f-48a8-ac7b-0133407dac93">P5Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <ampx:LesseeFinanceLeaseNumberOfLeases
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV83MC9mcmFnOjdhZDljNTRlMGNhODQ4ZGViNjk0MmZmZjhkNWExNjQ2L3RleHRyZWdpb246N2FkOWM1NGUwY2E4NDhkZWI2OTQyZmZmOGQ1YTE2NDZfNTQ5NzU1ODI2MjMx_e6a27ae9-05b7-40fe-ac49-d42cde6af41b"
      unitRef="lease">0</ampx:LesseeFinanceLeaseNumberOfLeases>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV83MC9mcmFnOjdhZDljNTRlMGNhODQ4ZGViNjk0MmZmZjhkNWExNjQ2L3RleHRyZWdpb246N2FkOWM1NGUwY2E4NDhkZWI2OTQyZmZmOGQ1YTE2NDZfNTQ5NzU1ODE2MjAz_79f2d899-b2e8-433a-a76b-aca6915e4a42">P9Y3M18D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV83MC9mcmFnOjdhZDljNTRlMGNhODQ4ZGViNjk0MmZmZjhkNWExNjQ2L3RleHRyZWdpb246N2FkOWM1NGUwY2E4NDhkZWI2OTQyZmZmOGQ1YTE2NDZfNTQ5NzU1ODE2MjEw_9864b5f9-a64e-41e8-868a-57c45c08c45e"
      unitRef="number">0.079</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV83MC9mcmFnOjdhZDljNTRlMGNhODQ4ZGViNjk0MmZmZjhkNWExNjQ2L3RleHRyZWdpb246N2FkOWM1NGUwY2E4NDhkZWI2OTQyZmZmOGQ1YTE2NDZfODc5NjA5MzAzNTc2MQ_281785e1-f821-412f-a488-a265b53355fc"
      unitRef="usd">5200000</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:OperatingLeasePayments
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV83MC9mcmFnOjdhZDljNTRlMGNhODQ4ZGViNjk0MmZmZjhkNWExNjQ2L3RleHRyZWdpb246N2FkOWM1NGUwY2E4NDhkZWI2OTQyZmZmOGQ1YTE2NDZfNTQ5NzU1ODIwMjg2_aff76456-569f-4b96-a9d9-c17f75a3aa35"
      unitRef="usd">179000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="ie8eddb8a90d3462cb31d18d8295be70a_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV83MC9mcmFnOjdhZDljNTRlMGNhODQ4ZGViNjk0MmZmZjhkNWExNjQ2L3RleHRyZWdpb246N2FkOWM1NGUwY2E4NDhkZWI2OTQyZmZmOGQ1YTE2NDZfNjU5NzA2OTc4MzgxMQ_9b9f79d1-9cba-4302-86f0-06d746277e01"
      unitRef="usd">86000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeaseCost
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV83MC9mcmFnOjdhZDljNTRlMGNhODQ4ZGViNjk0MmZmZjhkNWExNjQ2L3RleHRyZWdpb246N2FkOWM1NGUwY2E4NDhkZWI2OTQyZmZmOGQ1YTE2NDZfNTQ5NzU1ODIwMzM3_83e35fc3-f8ca-492d-abb4-0f50c08cf7b7"
      unitRef="usd">202000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV83MC9mcmFnOjdhZDljNTRlMGNhODQ4ZGViNjk0MmZmZjhkNWExNjQ2L3RleHRyZWdpb246N2FkOWM1NGUwY2E4NDhkZWI2OTQyZmZmOGQ1YTE2NDZfNjU5NzA2OTc4Mzc4MQ_42e9765e-ede8-4b67-b71d-24745fd1f038"
      unitRef="usd">140000</us-gaap:OperatingLeaseCost>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV83MC9mcmFnOjdhZDljNTRlMGNhODQ4ZGViNjk0MmZmZjhkNWExNjQ2L3RleHRyZWdpb246N2FkOWM1NGUwY2E4NDhkZWI2OTQyZmZmOGQ1YTE2NDZfMTI5Nw_f5a7ca60-188a-4fdf-9475-493ff6a3b952">&lt;div style="margin-top:9pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Future operating lease payments as of March&#160;31, 2023 were as follows (in thousands): &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.272%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:84.614%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.186%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year ending December 31:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Amount&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remainder of 2023&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;822&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,158&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2026&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,193&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2027&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,241&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2028&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,729&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Gross lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11,547&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less - present value adjustments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,359)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 37pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV83MC9mcmFnOjdhZDljNTRlMGNhODQ4ZGViNjk0MmZmZjhkNWExNjQ2L3RhYmxlOjJlYjNjNjYxMjkxMDRmYjY4MjMzMTcwMGRkYWQyNTRmL3RhYmxlcmFuZ2U6MmViM2M2NjEyOTEwNGZiNjgyMzMxNzAwZGRhZDI1NGZfMS0xLTEtMS02MTk5MA_b19321fc-ad8c-4a4c-9fb9-f1cabd5dd3f8"
      unitRef="usd">822000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV83MC9mcmFnOjdhZDljNTRlMGNhODQ4ZGViNjk0MmZmZjhkNWExNjQ2L3RhYmxlOjJlYjNjNjYxMjkxMDRmYjY4MjMzMTcwMGRkYWQyNTRmL3RhYmxlcmFuZ2U6MmViM2M2NjEyOTEwNGZiNjgyMzMxNzAwZGRhZDI1NGZfMi0xLTEtMS02MTk5MA_c02b7476-57d7-4514-b1a1-2b62a29ad4a7"
      unitRef="usd">1126000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV83MC9mcmFnOjdhZDljNTRlMGNhODQ4ZGViNjk0MmZmZjhkNWExNjQ2L3RhYmxlOjJlYjNjNjYxMjkxMDRmYjY4MjMzMTcwMGRkYWQyNTRmL3RhYmxlcmFuZ2U6MmViM2M2NjEyOTEwNGZiNjgyMzMxNzAwZGRhZDI1NGZfMy0xLTEtMS02MTk5MA_7391f8ff-5bed-42e6-bd46-c000baef1f85"
      unitRef="usd">1158000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV83MC9mcmFnOjdhZDljNTRlMGNhODQ4ZGViNjk0MmZmZjhkNWExNjQ2L3RhYmxlOjJlYjNjNjYxMjkxMDRmYjY4MjMzMTcwMGRkYWQyNTRmL3RhYmxlcmFuZ2U6MmViM2M2NjEyOTEwNGZiNjgyMzMxNzAwZGRhZDI1NGZfNC0xLTEtMS02MTk5MA_7a317108-0d9d-488f-bd0b-7a9240a13954"
      unitRef="usd">1193000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV83MC9mcmFnOjdhZDljNTRlMGNhODQ4ZGViNjk0MmZmZjhkNWExNjQ2L3RhYmxlOjJlYjNjNjYxMjkxMDRmYjY4MjMzMTcwMGRkYWQyNTRmL3RhYmxlcmFuZ2U6MmViM2M2NjEyOTEwNGZiNjgyMzMxNzAwZGRhZDI1NGZfNS0xLTEtMS02MTk5MA_65d1c3b3-aedc-46b4-bc48-ee182bfe0856"
      unitRef="usd">1241000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV83MC9mcmFnOjdhZDljNTRlMGNhODQ4ZGViNjk0MmZmZjhkNWExNjQ2L3RhYmxlOjJlYjNjNjYxMjkxMDRmYjY4MjMzMTcwMGRkYWQyNTRmL3RhYmxlcmFuZ2U6MmViM2M2NjEyOTEwNGZiNjgyMzMxNzAwZGRhZDI1NGZfNi0xLTEtMS02MTk5MA_32eea2bf-1f4c-464f-b5b8-e9cc8329e6c7"
      unitRef="usd">1278000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV83MC9mcmFnOjdhZDljNTRlMGNhODQ4ZGViNjk0MmZmZjhkNWExNjQ2L3RhYmxlOjJlYjNjNjYxMjkxMDRmYjY4MjMzMTcwMGRkYWQyNTRmL3RhYmxlcmFuZ2U6MmViM2M2NjEyOTEwNGZiNjgyMzMxNzAwZGRhZDI1NGZfNy0xLTEtMS02MTk5MA_750ef889-79fd-4f1f-9ab7-379e225c371c"
      unitRef="usd">4729000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV83MC9mcmFnOjdhZDljNTRlMGNhODQ4ZGViNjk0MmZmZjhkNWExNjQ2L3RhYmxlOjJlYjNjNjYxMjkxMDRmYjY4MjMzMTcwMGRkYWQyNTRmL3RhYmxlcmFuZ2U6MmViM2M2NjEyOTEwNGZiNjgyMzMxNzAwZGRhZDI1NGZfOC0xLTEtMS02MTk5MA_87c7b6da-297f-4739-a068-deab6a6484f6"
      unitRef="usd">11547000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV83MC9mcmFnOjdhZDljNTRlMGNhODQ4ZGViNjk0MmZmZjhkNWExNjQ2L3RhYmxlOjJlYjNjNjYxMjkxMDRmYjY4MjMzMTcwMGRkYWQyNTRmL3RhYmxlcmFuZ2U6MmViM2M2NjEyOTEwNGZiNjgyMzMxNzAwZGRhZDI1NGZfOS0xLTEtMS02MTk5MA_bdea0c04-0d25-4570-a336-7baa2c24570d"
      unitRef="usd">3359000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="i6023c648ad62464a83503c70b103bde2_I20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV83MC9mcmFnOjdhZDljNTRlMGNhODQ4ZGViNjk0MmZmZjhkNWExNjQ2L3RhYmxlOjJlYjNjNjYxMjkxMDRmYjY4MjMzMTcwMGRkYWQyNTRmL3RhYmxlcmFuZ2U6MmViM2M2NjEyOTEwNGZiNjgyMzMxNzAwZGRhZDI1NGZfMTAtMS0xLTEtNjE5OTA_a52560fe-045c-4113-9468-8f769c5e02d6"
      unitRef="usd">8188000</us-gaap:OperatingLeaseLiability>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV83My9mcmFnOmRmNWY2OTJlYjIxYzQ5MDdiMDBhMjIwYjQyNWJjMDVjL3RleHRyZWdpb246ZGY1ZjY5MmViMjFjNDkwN2IwMGEyMjBiNDI1YmMwNWNfNTMy_ca3895f0-0674-48be-9668-b97b5be01cfa">Commitments and ContingenciesFrom time to time, we may be involved in lawsuits, claims or legal proceedings that arise in the ordinary course of business. We accrue a contingent liability when it is probable that a liability has been incurred and the amount of loss can be reasonably estimated. Management believes that there are no claims against us for which the outcome is expected to have a material effect on our financial position, results of operations or cash flows .</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82Ny9mcmFnOjYwMjFhMjYxYjc1YTQ3MzJhMjgyY2UxM2VmMWEwMzE4L3RleHRyZWdpb246NjAyMWEyNjFiNzVhNDczMmEyODJjZTEzZWYxYTAzMThfNDM3_edcdd541-5c5f-4272-99b0-721a76a1c1eb">Net Loss Per Share&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the calculation of basic and diluted net loss per share attributable to common stockholders &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(in thousands, except share and per share amounts)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:25.2pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.636%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.097%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.977%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.447%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.979%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,102)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,878)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average number of common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,645,097&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,774,528&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic and diluted net loss per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.04)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the outstanding shares of potentially dilutive securities that were excluded from the calculation of diluted earnings per share because their inclusion would have been anti-dilutive:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:25.2pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.939%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.445%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.932%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.445%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.932%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.445%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.934%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,720,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,971,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,351,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,986,915&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,351,020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82Ny9mcmFnOjYwMjFhMjYxYjc1YTQ3MzJhMjgyY2UxM2VmMWEwMzE4L3RleHRyZWdpb246NjAyMWEyNjFiNzVhNDczMmEyODJjZTEzZWYxYTAzMThfNDM1_34794ad8-55d9-47eb-8cba-995eac521392">&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table presents the calculation of basic and diluted net loss per share attributable to common stockholders &lt;/span&gt;&lt;span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;(in thousands, except share and per share amounts)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:25.2pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.636%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:70.097%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.977%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.447%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.979%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,102)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,878)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average number of common shares outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;84,645,097&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,774,528&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic and diluted net loss per common share&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.11)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.04)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82Ny9mcmFnOjYwMjFhMjYxYjc1YTQ3MzJhMjgyY2UxM2VmMWEwMzE4L3RhYmxlOmQ2ZDMyYTEyZWIyZjRhZTc5NzA2NmI3MjMxMDNjNDNhL3RhYmxlcmFuZ2U6ZDZkMzJhMTJlYjJmNGFlNzk3MDY2YjcyMzEwM2M0M2FfMy0xLTEtMS02MTk5MA_7f910901-649a-41fc-8ec7-46616b16039f"
      unitRef="usd">-9102000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82Ny9mcmFnOjYwMjFhMjYxYjc1YTQ3MzJhMjgyY2UxM2VmMWEwMzE4L3RhYmxlOmQ2ZDMyYTEyZWIyZjRhZTc5NzA2NmI3MjMxMDNjNDNhL3RhYmxlcmFuZ2U6ZDZkMzJhMTJlYjJmNGFlNzk3MDY2YjcyMzEwM2M0M2FfMy0xLTEtMS02MTk5MA_84cb233d-46d3-49b2-9e81-fcd116556274"
      unitRef="usd">-9102000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
      contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82Ny9mcmFnOjYwMjFhMjYxYjc1YTQ3MzJhMjgyY2UxM2VmMWEwMzE4L3RhYmxlOmQ2ZDMyYTEyZWIyZjRhZTc5NzA2NmI3MjMxMDNjNDNhL3RhYmxlcmFuZ2U6ZDZkMzJhMTJlYjJmNGFlNzk3MDY2YjcyMzEwM2M0M2FfMy0zLTEtMS02MTk5MA_0e448888-1499-481b-a5fc-75c65a02e22e"
      unitRef="usd">-2878000</us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic>
    <us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted
      contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82Ny9mcmFnOjYwMjFhMjYxYjc1YTQ3MzJhMjgyY2UxM2VmMWEwMzE4L3RhYmxlOmQ2ZDMyYTEyZWIyZjRhZTc5NzA2NmI3MjMxMDNjNDNhL3RhYmxlcmFuZ2U6ZDZkMzJhMTJlYjJmNGFlNzk3MDY2YjcyMzEwM2M0M2FfMy0zLTEtMS02MTk5MA_f83d9925-d0a0-419f-b897-2bb2af1737e9"
      unitRef="usd">-2878000</us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82Ny9mcmFnOjYwMjFhMjYxYjc1YTQ3MzJhMjgyY2UxM2VmMWEwMzE4L3RhYmxlOmQ2ZDMyYTEyZWIyZjRhZTc5NzA2NmI3MjMxMDNjNDNhL3RhYmxlcmFuZ2U6ZDZkMzJhMTJlYjJmNGFlNzk3MDY2YjcyMzEwM2M0M2FfNS0xLTEtMS02MTk5MA_6c314a32-41fe-42c6-ba9f-7d417a373acc"
      unitRef="shares">84645097</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82Ny9mcmFnOjYwMjFhMjYxYjc1YTQ3MzJhMjgyY2UxM2VmMWEwMzE4L3RhYmxlOmQ2ZDMyYTEyZWIyZjRhZTc5NzA2NmI3MjMxMDNjNDNhL3RhYmxlcmFuZ2U6ZDZkMzJhMTJlYjJmNGFlNzk3MDY2YjcyMzEwM2M0M2FfNS0xLTEtMS02MTk5MA_7aba954a-74a9-40de-aacc-429761ba9a78"
      unitRef="shares">84645097</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:WeightedAverageNumberOfSharesOutstandingBasic
      contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82Ny9mcmFnOjYwMjFhMjYxYjc1YTQ3MzJhMjgyY2UxM2VmMWEwMzE4L3RhYmxlOmQ2ZDMyYTEyZWIyZjRhZTc5NzA2NmI3MjMxMDNjNDNhL3RhYmxlcmFuZ2U6ZDZkMzJhMTJlYjJmNGFlNzk3MDY2YjcyMzEwM2M0M2FfNS0zLTEtMS02MTk5MA_8846c8e7-7e0c-4e95-94be-c5b880509093"
      unitRef="shares">65774528</us-gaap:WeightedAverageNumberOfSharesOutstandingBasic>
    <us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
      contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82Ny9mcmFnOjYwMjFhMjYxYjc1YTQ3MzJhMjgyY2UxM2VmMWEwMzE4L3RhYmxlOmQ2ZDMyYTEyZWIyZjRhZTc5NzA2NmI3MjMxMDNjNDNhL3RhYmxlcmFuZ2U6ZDZkMzJhMTJlYjJmNGFlNzk3MDY2YjcyMzEwM2M0M2FfNS0zLTEtMS02MTk5MA_e71de950-5b2d-476f-86e8-451da6592c19"
      unitRef="shares">65774528</us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding>
    <us-gaap:EarningsPerShareBasic
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82Ny9mcmFnOjYwMjFhMjYxYjc1YTQ3MzJhMjgyY2UxM2VmMWEwMzE4L3RhYmxlOmQ2ZDMyYTEyZWIyZjRhZTc5NzA2NmI3MjMxMDNjNDNhL3RhYmxlcmFuZ2U6ZDZkMzJhMTJlYjJmNGFlNzk3MDY2YjcyMzEwM2M0M2FfNi0xLTEtMS02MTk5MA_41ee40d8-7811-4166-a40b-606fb19e976c"
      unitRef="usdPerShare">-0.11</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82Ny9mcmFnOjYwMjFhMjYxYjc1YTQ3MzJhMjgyY2UxM2VmMWEwMzE4L3RhYmxlOmQ2ZDMyYTEyZWIyZjRhZTc5NzA2NmI3MjMxMDNjNDNhL3RhYmxlcmFuZ2U6ZDZkMzJhMTJlYjJmNGFlNzk3MDY2YjcyMzEwM2M0M2FfNi0xLTEtMS02MTk5MA_938eed96-66f8-4037-98fd-2b4d15baaa7f"
      unitRef="usdPerShare">-0.11</us-gaap:EarningsPerShareDiluted>
    <us-gaap:EarningsPerShareBasic
      contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82Ny9mcmFnOjYwMjFhMjYxYjc1YTQ3MzJhMjgyY2UxM2VmMWEwMzE4L3RhYmxlOmQ2ZDMyYTEyZWIyZjRhZTc5NzA2NmI3MjMxMDNjNDNhL3RhYmxlcmFuZ2U6ZDZkMzJhMTJlYjJmNGFlNzk3MDY2YjcyMzEwM2M0M2FfNi0zLTEtMS02MTk5MA_4e65d75b-934a-4f4d-b995-924bfb3970ea"
      unitRef="usdPerShare">-0.04</us-gaap:EarningsPerShareBasic>
    <us-gaap:EarningsPerShareDiluted
      contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82Ny9mcmFnOjYwMjFhMjYxYjc1YTQ3MzJhMjgyY2UxM2VmMWEwMzE4L3RhYmxlOmQ2ZDMyYTEyZWIyZjRhZTc5NzA2NmI3MjMxMDNjNDNhL3RhYmxlcmFuZ2U6ZDZkMzJhMTJlYjJmNGFlNzk3MDY2YjcyMzEwM2M0M2FfNi0zLTEtMS02MTk5MA_813e573c-4a66-49c9-93f4-f02e9178e488"
      unitRef="usdPerShare">-0.04</us-gaap:EarningsPerShareDiluted>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82Ny9mcmFnOjYwMjFhMjYxYjc1YTQ3MzJhMjgyY2UxM2VmMWEwMzE4L3RleHRyZWdpb246NjAyMWEyNjFiNzVhNDczMmEyODJjZTEzZWYxYTAzMThfNDM2_5af9d156-24fa-430d-a7d1-1284417c0d29">&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the outstanding shares of potentially dilutive securities that were excluded from the calculation of diluted earnings per share because their inclusion would have been anti-dilutive:&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-indent:25.2pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.939%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:41.964%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.803%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.445%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.932%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.445%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.932%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.445%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.934%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three months ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock warrants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47,720,836&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Stock options&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13,971,079&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,351,020&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;RSUs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;295,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:top"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:top"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;61,986,915&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,351,020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i5f45d6b4a1b249b19e2aff7a526d83be_D20230101-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82Ny9mcmFnOjYwMjFhMjYxYjc1YTQ3MzJhMjgyY2UxM2VmMWEwMzE4L3RhYmxlOmJhYzZmMGNiMjZjMTRiZDJiZTFiYWZlNGNkYzExM2QwL3RhYmxlcmFuZ2U6YmFjNmYwY2IyNmMxNGJkMmJlMWJhZmU0Y2RjMTEzZDBfMi01LTEtMS02MTk5MA_ca0155d4-27c3-4f17-b020-abd1d6cdf3f6"
      unitRef="shares">47720836</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i571e7f29efd349649731d4a3cf40f70d_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82Ny9mcmFnOjYwMjFhMjYxYjc1YTQ3MzJhMjgyY2UxM2VmMWEwMzE4L3RhYmxlOmJhYzZmMGNiMjZjMTRiZDJiZTFiYWZlNGNkYzExM2QwL3RhYmxlcmFuZ2U6YmFjNmYwY2IyNmMxNGJkMmJlMWJhZmU0Y2RjMTEzZDBfMi03LTEtMS02MTk5MA_fe87e239-7232-4918-a56f-e18f834b1c5f"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i0650b7f12c5745f1b9f3e5dd848c75eb_D20230101-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82Ny9mcmFnOjYwMjFhMjYxYjc1YTQ3MzJhMjgyY2UxM2VmMWEwMzE4L3RhYmxlOmJhYzZmMGNiMjZjMTRiZDJiZTFiYWZlNGNkYzExM2QwL3RhYmxlcmFuZ2U6YmFjNmYwY2IyNmMxNGJkMmJlMWJhZmU0Y2RjMTEzZDBfMy01LTEtMS02MTk5MA_a3399826-f5e8-48fc-933f-3be2f7b8aea8"
      unitRef="shares">13971079</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ie7e13065ea5344339868b25a9ccb583d_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82Ny9mcmFnOjYwMjFhMjYxYjc1YTQ3MzJhMjgyY2UxM2VmMWEwMzE4L3RhYmxlOmJhYzZmMGNiMjZjMTRiZDJiZTFiYWZlNGNkYzExM2QwL3RhYmxlcmFuZ2U6YmFjNmYwY2IyNmMxNGJkMmJlMWJhZmU0Y2RjMTEzZDBfMy03LTEtMS02MTk5MA_1d5cc634-3c4e-423e-80a7-26b586dc1790"
      unitRef="shares">10351020</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ib6658dea46b142f48028a62a75c5d390_D20230101-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82Ny9mcmFnOjYwMjFhMjYxYjc1YTQ3MzJhMjgyY2UxM2VmMWEwMzE4L3RhYmxlOmJhYzZmMGNiMjZjMTRiZDJiZTFiYWZlNGNkYzExM2QwL3RhYmxlcmFuZ2U6YmFjNmYwY2IyNmMxNGJkMmJlMWJhZmU0Y2RjMTEzZDBfNC01LTEtMS02MTk5MA_574d764e-be2c-460f-8ac6-5cfe17474bd2"
      unitRef="shares">295000</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ia19169091dae45ab9040ca0a01a98e92_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82Ny9mcmFnOjYwMjFhMjYxYjc1YTQ3MzJhMjgyY2UxM2VmMWEwMzE4L3RhYmxlOmJhYzZmMGNiMjZjMTRiZDJiZTFiYWZlNGNkYzExM2QwL3RhYmxlcmFuZ2U6YmFjNmYwY2IyNmMxNGJkMmJlMWJhZmU0Y2RjMTEzZDBfNC03LTEtMS02MTk5MA_a9fa4c5c-79f5-41d2-8322-5968d46cb7bb"
      unitRef="shares">0</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82Ny9mcmFnOjYwMjFhMjYxYjc1YTQ3MzJhMjgyY2UxM2VmMWEwMzE4L3RhYmxlOmJhYzZmMGNiMjZjMTRiZDJiZTFiYWZlNGNkYzExM2QwL3RhYmxlcmFuZ2U6YmFjNmYwY2IyNmMxNGJkMmJlMWJhZmU0Y2RjMTEzZDBfNS01LTEtMS02NDgxOQ_8972e6bb-1471-4e0f-ab4b-fca4d24470bb"
      unitRef="shares">61986915</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="iaea77284eb404d738f37e47d7f1227fc_D20220101-20220331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV82Ny9mcmFnOjYwMjFhMjYxYjc1YTQ3MzJhMjgyY2UxM2VmMWEwMzE4L3RhYmxlOmJhYzZmMGNiMjZjMTRiZDJiZTFiYWZlNGNkYzExM2QwL3RhYmxlcmFuZ2U6YmFjNmYwY2IyNmMxNGJkMmJlMWJhZmU0Y2RjMTEzZDBfNS03LTEtMS02NDgxOQ_451be7c7-5b2a-452c-9a45-06a42389235b"
      unitRef="shares">10351020</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:SubsequentEventsTextBlock
      contextRef="ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV83OS9mcmFnOmI5NWQ5OTJiNDNkMTQwNjk4ZThiY2MxODE2N2MwNTNkL3RleHRyZWdpb246Yjk1ZDk5MmI0M2QxNDA2OThlOGJjYzE4MTY3YzA1M2RfMTI1NA_825d7b85-1921-48ba-a7ac-63a73ba47992">Subsequent Events&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Brighton, Colorado Lease&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On April&#160;15, 2023, we entered into a lease agreement to lease a space for our GWh-scale manufacturing facility in Brighton, Colorado. The lease expires in May 2039, with an option to extend for two additional five-year terms. Future lease payments, which commence in December 2024 after the rent abatement period, total approximately $62.9 million. The current zoning for this site does not allow for manufacturing our batteries. As such, the property owner is in the process of applying to re-zone the site for our planned development and use. Until the re-zoning is complete, we will not be able to apply for permits required to repurpose the facility for manufacturing. If the re-zoning application is not approved, the lease agreement will automatically terminate.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"&gt;Merger with Amprius Holdings&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:10pt;text-indent:25.2pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On May 9, 2023, we entered into an Agreement and Plan of Merger and Reorganization (the &#x201c;Merger Agreement&#x201d;) with, among others, Amprius Holdings. Under the Merger Agreement, through a series of transactions that are intended to qualify as a tax-free reorganization for U.S. income tax purposes, Amprius Holdings will become our wholly owned subsidiary and then be merged into another wholly owned subsidiary, with such other subsidiary surviving. Subject to the terms and conditions in the Merger Agreement, the shares of our common stock currently owned by Amprius Holdings will be cancelled, and we will issue to the stockholders of Amprius Holdings new shares of our common stock or shares of our non-voting common stock based on a negotiated and discounted exchange ratio. Furthermore, the options in Amprius Holdings, whether vested or unvested, to purchase Amprius Holdings stock shall be converted into options to purchase shares of our common stock and the warrants to purchase Amprius Holdings stock shall automatically be replaced with warrants representing the right to receive shares of our common stock on a net-exercise basis. The transactions contemplated by the Merger Agreement are conditioned on, among other items, the approval of a majority of shares held by our stockholders that are not affiliated with either Amprius Holdings or held by any of our directors or officers.&lt;/span&gt;&lt;/div&gt;</us-gaap:SubsequentEventsTextBlock>
    <ampx:LesseeOperatingLeaseOptionToExtendNumber
      contextRef="ie3036f0dcbac452caf4e05d02eb07b89_D20230415-20230415"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV83OS9mcmFnOmI5NWQ5OTJiNDNkMTQwNjk4ZThiY2MxODE2N2MwNTNkL3RleHRyZWdpb246Yjk1ZDk5MmI0M2QxNDA2OThlOGJjYzE4MTY3YzA1M2RfNTQ5NzU1ODE4Njg0_71d2e84c-95eb-4d0e-be31-15d7246609e7"
      unitRef="term">2</ampx:LesseeOperatingLeaseOptionToExtendNumber>
    <us-gaap:LesseeOperatingLeaseRenewalTerm
      contextRef="i054651541ac248b38a3b2a7e6475566b_I20230415"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV83OS9mcmFnOmI5NWQ5OTJiNDNkMTQwNjk4ZThiY2MxODE2N2MwNTNkL3RleHRyZWdpb246Yjk1ZDk5MmI0M2QxNDA2OThlOGJjYzE4MTY3YzA1M2RfMTA5OTUxMTY1NTA1Ng_f0d0aab7-3fde-4aad-9503-8211ee8437a5">P5Y</us-gaap:LesseeOperatingLeaseRenewalTerm>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i054651541ac248b38a3b2a7e6475566b_I20230415"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjA2NmZkYWJiMWQwODQ4ZDViMDM5MTkzMWY4N2MzYzBlL3NlYzowNjZmZGFiYjFkMDg0OGQ1YjAzOTE5MzFmODdjM2MwZV83OS9mcmFnOmI5NWQ5OTJiNDNkMTQwNjk4ZThiY2MxODE2N2MwNTNkL3RleHRyZWdpb246Yjk1ZDk5MmI0M2QxNDA2OThlOGJjYzE4MTY3YzA1M2RfNTQ5NzU1ODE4Njc3_7e30c7ee-6152-4fb6-8496-04eea9da5fa8"
      unitRef="usd">62900000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>56
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M,#0>F@06;*:9-AK"%K78(B>V!5LS*&^8;2[M4QP9SR5!;,%GVN$DC0<!QBW
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MMRBET8/5I+K#RF H^[9S1&"453$YGSZ:/WXTR?KXV_OK6]:$\.N/4Q,QYGK
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MYF'BF(G#C4_V@+:4ZJ*#+.!N<>/*3)]DAIRN\@DBV;?(EGRS\L@+M$J.^\5
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M('*"0 "SCH'B] A7((0C0AF_>\Y@<.D,#]=[]D\^=HPEIP:NE/C!"ULM@FE
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M$O(Q ;%29<&L#1=;E2N$)%'H&UVHNG!0B0K6T NPFY>2^)MOA%\I,3?2%L1
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MO ^1E!OA%22!@OFM?F@S=[Q:3)KK7P?/\'QV-!FH^WY)X#U-4@(3H,.'\Z*
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M@'?H&? )$A*\.3PX2]/DXO.73Q26_8NW[2&8LB1&3-><H&R4@H5034LF%(\
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MR;B]MWNN,""K!NE-E O25IE6R >RO%.6NN U<P5(H=@H'+-@)"5CQ@C##LR
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MF_SZ;)1JUM]$U\BA>>$B+""7)7[SD.<%>%\X%_L;#C#\BCK_%U!+ P04
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M4I9LZ8<5U4'4+H#V2Z7L;N(.&"IK]A=02P,$%     @ =H"K5NGP:+#Z @
MIP8  !D   !X;"]W;W)K<VAE971S+W-H965T,C(N>&ULG57;3MM $/V5D5M5
M(%GX&A/2)!(!JE:"*H)>'JH^;.Q)O&*]:W;7!/KUG;43DTHA2'WQ7L^9,S,[
MX_%:Z7M3(EIXJH0T$Z^TMAX%@<E+K)@Y435*.EDJ73%+2[T*3*V1%2VH$D$<
MAEE0,2Z]Z;C=F^OI6#56<(ES#::I*J:?9RC4>N)%WG;CEJ]*ZS:"Z;AF*[Q#
M^[V>:UH%/4O!*Y2&*PD:EQ/O/!K-4G>_O?"#X]KLS,%YLE#JWBV^%!,O=()0
M8&X= Z/A$2]0"$=$,AXVG%YOT@%WYUOV3ZWOY,N"&;Q0XB<O;#GQAAX4N&2-
ML+=J_1DW_@P<7ZZ$:;^P[NZFJ0=Y8ZRJ-F!24''9C>QI$X<=P#!\!1!O '&K
MNS/4JKQDEDW'6JU!N]O$YB:MJRV:Q''IDG)G-9URPMGI7%-^M7WV82Z8M,!D
M 5</#:\I\-:'K_0LCKZQA4!S/ XL&72P(-^0SSKR^!7R!&Z4M*6!*UE@\2\^
M(*&]VGBK=A8?)+QA^@22R(<XC),#?$GO?=+R)?_C/?PZ7QBKZ=W\WN=ZQYSN
M9W:U-#(URW'B4;$8U(_H33^\B[+PXP'=::\[/<0^O:/:+!J!H):P]6%/ZO;)
M/DB\7_9+E.H^2OAB2-(;R165J;%8.$6V1%@J0?7.Y0J.N*0=U1B"F>,14 [S
MLDWB)>98+5#W&76?V#E4-%W-]E;@/0S\*$II3/UT.(1KMM@YC?UT$-,W"5.X
M1BK24HD">%5K]8CNAB%8. PA\0?Q #XU6G+;:/1AR9_<Q+1.*5*N=VB3+"1)
M&5R0=U9O-)$[1+LBC($LC.%L< IO1(BY !D+4>QGX1"BB%P(2:@Q(VI+>5,U
M@KG8%4A!SSGK^A5QL$IIR_]T&T>G?I:%QVZ,T_3X+:,N+2Y:9^FP'>,D@WU/
M+]AI'A7J5=LB#0ENI.WZ2+_;=^'SKOF\7.]:.*5VQ:4!@4N"AB>G P]TUQ:[
MA55UVXH6RE)C:Z<E_4E0NPMTOE3*;A?.0/]OFOX%4$L#!!0    ( ': JU;;
MVK*:K0(   T&   9    >&PO=V]R:W-H965T<R]S:&5E=#(S+GAM;(U5VV[;
M, S]%<(KA@X(ZEN2IEEB(&DW;,"*!>TN#\,>9)N.A<I2)LE-^_>CY,3+@#3H
MBR1*Y.$A:=*SK=(/ID:T\-0(:>9!;>UF&H:FJ+%AYD)M4-)+I73#+(EZ'9J-
M1E9ZHT:$212-PX9Q&60S?[?2V4RU5G")*PVF;1JFGY<HU'8>Q,'^XHZO:^LN
MPFRV86N\1_M]L](DA3U*R1N4ABL)&JMYL(BGRZ'3]PH_.&[-P1E<)+E2#T[X
M7,Z#R!%"@85U"(RV1[Q&(1P0T?BSPPQZE\[P\+Q'_^ACIUAR9O!:B9^\M/4\
MF 108L5:8>_4]A/NXADYO$()XU?8=KJC*("B-58U.V-BT'#9[>QIEX<#@\E+
M!LG.(/&\.T>>Y0VS+)MIM07MM G-'7RHWIK(<>F*<F\UO7*RL]FB*'2+)3!9
MPE=;HX;K5FN4%KYPEG/!+4<#Y]]8+M"\FX66?#K+L-CA+SO\Y 7\%&Z5M+6!
M#[+$\G_[D+CVA),]X65R$O"6Z0M(XP$D49*>P$O[!*0>+WT!;\6>?6P^ SX;
M3!CXM<B-U?3)_#X6<H<X/([HVFAJ-JS >4!]8E _8I"]?1./H_<G^ Y[OL-3
MZ-D]M679"@15P:N*=RR DRZ.!W#H2WE?Q<Z7./A0"D7M:BSI$3W2@DH)ZGLN
MUW#.)=VHUA"">3<%*F11^TK>8(%-3HC[LKHEZ:/;:%6A<5. ":B0O)Q!,AA&
M8]J'D[C7*U1#H\JPKMN)9HX2*VX-Q(,X&M$Z&4:]=L4EDX4C5BA#.FD,\=5P
ME\:8.,17*;PNZ#-(!^/QR-.ZC"9PK,KA08LVJ-=^$+E\M=)VW=K?]K-NT;7X
M/_5N4%+BUEP:$%B1:71Q.0I =\.G$ZS:^(;/E:7QX8\US6O43H'>*Z7L7G .
M^C] ]A=02P,$%     @ =H"K5G%U-^6V P  B0@  !D   !X;"]W;W)K<VAE
M971S+W-H965T,C0N>&ULC5;;;MM&$/V5 5NT":"8%*F+XTH";-=%_)!6L)SF
MH>C#BAR)"R]WF=VE9?]]9Y84K0:2D!=I+W/.7'>&LYVQ3ZY$]/!2*>WF4>E]
M?17'+B^Q$N["U*CI9F-L)3QM[39VM451!%"EXC1))G$EI(X6LW"VM(N9:;R2
M&I<67%-5PK[>H#*[>32,]@</<EMZ/H@7LUIL<87^2[VTM(M[ED)6J)TT&BQN
MYM'U\.IFS/)!X&^).W>P!O9D;<P3;^Z+>92P0:@P]\P@Z.\9;U$I)B(SOG6<
M4:^2@8?K/?L?P7?R92T<WAKU51:^G$>7$12X$8WR#V;W"3M_@H&Y42[\PJZ5
M'8TBR!OG3=6!R8)*ZO9?O'1Q. !<)B< :0=(@]VMHF#E[\*+Q<R:'5B6)C9>
M!%<#FHR3FI.R\I9N)>'\8N5-_E0:5:!UO\+=MT;Z5WCW*-8*W?M9[$D%"\9Y
M1W?3TJ4GZ#+X;+0O'=SI HO_XV,RK;<OW=MWDYXE_"SL!63# :1)FIWARWI_
ML\"7G>#K//SG>NV\I9+X]YB/+<7H. 4_DRM7BQSG$;T#A_89H\4O/PTGR6]G
M#!SU!H[.L2]6[>L LX&_&N^\T(746PAY@J_"6J&].V;T>=I#+A>X=AT7Y(:>
MF/-8L$Y?(FR,HK?*DL+Q&>4@+_LD7,&?3;5&RS=W+VASZ1"65N9(VUI:$5X;
M%2.=-FLE\S=-Z<=!.KD<9-D$?H;A\&*<P IKCX%N. K\4^9Z9G0/&TX&HR09
M)$ER%G:_O#M0-4C&Z6#<0M(3D$?CA7K#C*:#:9H,+K/)F3R.^SR.?S2/(7<?
M;JAW%'!K*NJGK@T2Q8O6>"R;9\F/EV"K9AW4Y(=J-M947=)-S2<.J!+@8?7%
M04/OU(:L=R_C7N>HN5/"4HE.\@C!&^ZZJJUL''RB)D(U0Z%/DLNN7IF"A(2'
M'5(+SXVEKD!KBR!UKAK>2?U=T;&S;G\L<G9%Z%>^H4HM.&!%J%FC9"&X;*FP
M*;/(*:1HT[QJ:]!!T5B&,0\=2E,X".'2C'H7-)C&D8?N/5S!8VD1H6K[%W+_
M^J[R^Y^4TN@\*[/XC+I!+K+)QU"=&3R0AH#CT!4DH$S-UA$2)E2&BAS<#F"+
MF@Q504H4U-HE=Z00^7$VA2S;UZ<[E5=LRX?43E-^4:/Q!(Y5;GPP'BJTVS $
M^=TWVK>3HC_MY^QU.U[>Q-LA30'92HJLP@U!DXLIU:EM!U^[\:8.PV9M/(VN
ML"SI6P$M"]#]QAB_W[""_NMC\1]02P,$%     @ =H"K5M0XI)?$ @  ^P4
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MR^(VXAM-<3F"N>"&81:<P!HIG;,Q;MVRN&\H*EKL\H3Z7FA,S_/B%BC&U'3
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MR[6.#0\DVTC=8,\F6YS!(\@/VWNN[NS:)24Y%(*P G%83ZT[]W;I&H&)^(?
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MWT^27=<%QQO=POH2ZW:^BWQ.?,(M%P]R!:#0+J5,CIV54MG(=66\@A3+-L^
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M3OE$\<SV*W.N=/=CARO=;X(P!_3^@G/U-#$M4-G!1K\ 4$L#!!0    ( ':
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MZ)$KQ=/R\$!)3(4)T/=WG*OG$[/OU.PSKO\!4$L#!!0    ( ': JU;\QYI
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M=<<WGZ#S,S)\.:?2?M&FC4U"!^6-5+SJP%I!15C[QT]='G8 ?O0"(.@ P:F
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MY67/ZY&'K"RS>?5P)L5$YOH#ZOW'+"O73W2 YRS_7E7[ZO]02P,$%     @
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M01#: )\O.5>[C;Z@&B^#OU!+ P04    " !V@*M6@$B#)!D"  ".!   &0
M 'AL+W=O<FMS:&5E=',O<VAE970S.2YX;6R%E%UOVC 4AO^*Y4U3*TTX))1.
M+(D$9=-Z40F5=;N8=F&2 ['JC\QV"/WWLYV048FR&^)CG_?Q>\@Y25NEGTT%
M8-%!<&DR7%E;SP@Q106"FI&J0;J3K=*"6A?J'3&U!EH&D> DCJ(I$91)G*=A
M;Z7S5#66,PDKC4PC!-4O"^"JS? 8'S<>V:ZR?H/D:4UWL ;[5*^TB\A *9D
M:9B22,,VP_/Q;#'Q^2'A!X/6G*R1KV2CU+,/[LL,1]X0<"BL)U#WV,,=<.Y!
MSL:?GHF'*[WP='VD?PVUNUHVU,"=XC]9::L,?\*HA"UMN'U4[3?HZ[GQO$)Q
M$WY1V^4F"49%8ZP2O=@Y$$QV3WKH_X<301R_(8A[01Q\=Q<%ETMJ:9YJU2+M
MLQW-+T*I0>W,,>E?RMIJ=\J<SN;WLE "T'=Z (.NEF IX^8Z)=:Q?08I>LZB
MX\1O<!+TH*2M#/HB2RA?ZXGS-!B+C\86\47@ ]4CE(P_HCB*$_2T7J*K]]<7
MN,E0<!*XR7\+1DMF"JY,HP']FF^,U:Y%?I\KO2-.SA/]V,Q,30O(L)L+ WH/
M./_P;CR-/E_P.QG\3B[1CWZM\PL'-XH&SCGL&-/ \'.XSZ.4[$^O)2<](D#O
MPB085*A&VJY=AMUAV.9=C_U+[R;5O9H=DP9QV#II-+J]P4AWW=\%5M6AXS;*
MNOX-R\I],$#[!'>^5<H> W_!\ G*_P)02P,$%     @ =H"K5M$7!4VU P
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MQ^,GRX=&V=$BM[7Z3&BL_&USB8\SD&8"?I\+H;<=LT#]W)O\!U!+ P04
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MO))H@VD#".>_50D^K,7?TW(2AM&A7+S6+'^PXF3W3&**6%]UVZQ0@A>$$DG
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M#,Y[>%144005'2.7KHYXD :K$M=,L7 $90UP?BZEV73L E4I.OH/4$L#!!0
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MS$8E2C(@/*$$,5B.C7/[;#I2\_6$GPF4?*.-%,F<TD?5N8[&AJ4V!"DLA%+
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M)SY' P  U!0   T   !X;"]S='EL97,N>&ULW5A1;]HP$/XKD;M.K30U0-I
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M?K X?I_$7/Y,DR2*XABKZ&3B53#!ZA;'\.-GP[2!!Q8'(OU=K?'=QCOD^3[
M]O2Y#L$RQ3L1RQ2O-2#^NH%'DOAW&XL#'M@N8+T#\?UQH*?\/E$$NXIIPYY@
M'$D2#(%>]/=H'"/5B>'CWQ_L*8FB)/$C@/D51!&&P-.((Y@"T( A463?@WOO
MHW#SG@JW_\<<_P%02P,$%     @ =H"K5I>*NQS     $P(   L   !?<F5L
M<R\N<F5L<YV2N6[#, Q ?\70GC 'T"&(,V7Q%@3Y 5:B#]@2!8I%G;^OVJ5Q
MD L9>3T\$MP>:4#M.*2VBZD8_1!2:5K5N %(MB6/:<Z10J[4+!XUA]) 1-MC
M0[!:+#Y +AEFM[UD%J=SI%>(7->=I3W;+T]!;X"O.DQQ0FE(2S,.\,W2?S+W
M\PPU1>5*(Y5;&GC3Y?YVX$G1H2)8%II%R=.B':5_'<?VD-/IKV,BM'I;Z/EQ
M:%0*CMQC)8QQ8K3^-8+)#^Q^ %!+ P04    " !V@*M6.URTFND#  !<'0
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MDN,>) <?HP1!(2I'02I'82I'@2I'H2I'P2I'X2I' 2M'(:M (:M (:M (:M
M(:M (:M (:M (:M (:M (:M (:M$(:M$(:M$(:M$(:M$(:M$(:M$(:M$(:M$
M(:M$(6N"0M8$A:P)"ED3%+(F_TG6=ZU7?_UWI5WC6I7-T9]UO[#FGU!+ 0(4
M Q0    ( '6 JU8'04UB@0   +$    0              "  0    !D;V-0
M<F]P<R]A<' N>&UL4$L! A0#%     @ =8"K5I\5+;7N    *P(  !$
M         ( !KP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ =8"K
M5IE<G",0!@  G"<  !,              ( !S $  'AL+W1H96UE+W1H96UE
M,2YX;6Q02P$"% ,4    " !U@*M6K@DIT9P&  "/)@  &
M@($-"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ =8"K
M5LQ# =P<!@  #AL  !@              ("!WPX  'AL+W=O<FMS:&5E=',O
M<VAE970R+GAM;%!+ 0(4 Q0    ( '6 JU9;'4N4"@,  % *   8
M      " @3$5  !X;"]W;W)K<VAE971S+W-H965T,RYX;6Q02P$"% ,4
M" !U@*M6/<F^\&\$   -$0  &               @(%Q&   >&PO=V]R:W-H
M965T<R]S:&5E=#0N>&UL4$L! A0#%     @ =8"K5H44ZDQ]"0  .V8  !@
M             ("!%AT  'AL+W=O<FMS:&5E=',O<VAE970U+GAM;%!+ 0(4
M Q0    ( '6 JU:)%1CQ&@<  #(?   8              " @<DF  !X;"]W
M;W)K<VAE971S+W-H965T-BYX;6Q02P$"% ,4    " !U@*M64C J1R@*  "8
M&0  &               @($9+@  >&PO=V]R:W-H965T<R]S:&5E=#<N>&UL
M4$L! A0#%     @ =8"K5N=.!:.I$   S#$  !@              ("!=S@
M 'AL+W=O<FMS:&5E=',O<VAE970X+GAM;%!+ 0(4 Q0    ( '6 JU:I#;T[
M>P<  *04   8              " @59)  !X;"]W;W)K<VAE971S+W-H965T
M.2YX;6Q02P$"% ,4    " !U@*M6F[]:X6L"  !:!0  &0
M@($'40  >&PO=V]R:W-H965T<R]S:&5E=#$P+GAM;%!+ 0(4 Q0    ( '6
MJU8_#10UY0(  +P&   9              " @:E3  !X;"]W;W)K<VAE971S
M+W-H965T,3$N>&UL4$L! A0#%     @ =H"K5GC&Q:"< @  '@8  !D
M         ("!Q58  'AL+W=O<FMS:&5E=',O<VAE970Q,BYX;6Q02P$"% ,4
M    " !V@*M6XIXR@Y$-  ";)@  &0              @(&860  >&PO=V]R
M:W-H965T<R]S:&5E=#$S+GAM;%!+ 0(4 Q0    ( ': JU;$E<ABFP(  )H%
M   9              " @6!G  !X;"]W;W)K<VAE971S+W-H965T,30N>&UL
M4$L! A0#%     @ =H"K5B"-&AZ,!   M H  !D              ("!,FH
M 'AL+W=O<FMS:&5E=',O<VAE970Q-2YX;6Q02P$"% ,4    " !V@*M68E)$
M1@@#  "5!@  &0              @('U;@  >&PO=V]R:W-H965T<R]S:&5E
M=#$V+GAM;%!+ 0(4 Q0    ( ': JU8#F.#(= ,  *@'   9
M  " @31R  !X;"]W;W)K<VAE971S+W-H965T,3<N>&UL4$L! A0#%     @
M=H"K5HX5S_*B!0  40T  !D              ("!WW4  'AL+W=O<FMS:&5E
M=',O<VAE970Q."YX;6Q02P$"% ,4    " !V@*M6\ 7/[T4/  !"/0  &0
M            @(&X>P  >&PO=V]R:W-H965T<R]S:&5E=#$Y+GAM;%!+ 0(4
M Q0    ( ': JU;T$I%: 0,  +,&   9              " @32+  !X;"]W
M;W)K<VAE971S+W-H965T,C N>&UL4$L! A0#%     @ =H"K5GT#[49Y @
M904  !D              ("!;(X  'AL+W=O<FMS:&5E=',O<VAE970R,2YX
M;6Q02P$"% ,4    " !V@*M6Z?!HL/H"  "G!@  &0              @($<
MD0  >&PO=V]R:W-H965T<R]S:&5E=#(R+GAM;%!+ 0(4 Q0    ( ': JU;;
MVK*:K0(   T&   9              " @4V4  !X;"]W;W)K<VAE971S+W-H
M965T,C,N>&UL4$L! A0#%     @ =H"K5G%U-^6V P  B0@  !D
M     ("!,9<  'AL+W=O<FMS:&5E=',O<VAE970R-"YX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( ': JU:;"L;!@P,   T0   9              "
M@0"L  !X;"]W;W)K<VAE971S+W-H965T,CDN>&UL4$L! A0#%     @ =H"K
M5M$=)I:# P  H1   !D              ("!NJ\  'AL+W=O<FMS:&5E=',O
M<VAE970S,"YX;6Q02P$"% ,4    " !V@*M68?XV%K\"  #-"@  &0
M        @(%TLP  >&PO=V]R:W-H965T<R]S:&5E=#,Q+GAM;%!+ 0(4 Q0
M   ( ': JU9>2>H'@ (  /<&   9              " @6JV  !X;"]W;W)K
M<VAE971S+W-H965T,S(N>&UL4$L! A0#%     @ =H"K5M[C1B+G P  <Q0
M !D              ("!(;D  'AL+W=O<FMS:&5E=',O<VAE970S,RYX;6Q0
M2P$"% ,4    " !V@*M6_,>:0&<"  #/!0  &0              @($_O0
M>&PO=V]R:W-H965T<R]S:&5E=#,T+GAM;%!+ 0(4 Q0    ( ': JU;GY;?)
MO0(  *@'   9              " @=V_  !X;"]W;W)K<VAE971S+W-H965T
M,S4N>&UL4$L! A0#%     @ =H"K5AZB@-'3"P  ,84  !D
M ("!T<(  'AL+W=O<FMS:&5E=',O<VAE970S-BYX;6Q02P$"% ,4    " !V
M@*M63RC6\'$#  "_$0  &0              @(';S@  >&PO=V]R:W-H965T
M<R]S:&5E=#,W+GAM;%!+ 0(4 Q0    ( ': JU;+47)J< ,  &H.   9
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M970T,BYX;6Q02P$"% ,4    " !V@*M60A[.IF$#  !C#P  &0
M    @('IX@  >&PO=V]R:W-H965T<R]S:&5E=#0S+GAM;%!+ 0(4 Q0    (
M ': JU:HZD;HU0(  (T*   9              " @8'F  !X;"]W;W)K<VAE
M971S+W-H965T-#0N>&UL4$L! A0#%     @ =H"K5F32)SY' P  U!0   T
M             ( !C>D  'AL+W-T>6QE<RYX;6Q02P$"% ,4    " !V@*M6
MEXJ[',     3 @  "P              @ '_[   7W)E;',O+G)E;'-02P$"
M% ,4    " !V@*M6.URTFND#  !<'0  #P              @ 'H[0  >&PO
M=V]R:V)O;VLN>&UL4$L! A0#%     @ =H"K5D<<8+FD 0  FQH  !H
M         ( !_O$  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS4$L! A0#
M%     @ =H"K5B[2^,"N 0  RAH  !,              ( !VO,  %M#;VYT
D96YT7U1Y<&5S72YX;6Q02P4&     #0 -  C#@  N?4

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>104</ContextCount>
  <ElementCount>206</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>51</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>8</UnitCount>
  <MyReports>
    <Report instance="ampx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amprius.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="ampx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>0000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="ampx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical</Role>
      <ShortName>CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="ampx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>0000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="ampx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>0000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS??? EQUITY</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS??? EQUITY</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="ampx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS</Role>
      <ShortName>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="ampx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>0000007 - Disclosure - Nature of Operations and Organization</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amprius.com/role/NatureofOperationsandOrganization</Role>
      <ShortName>Nature of Operations and Organization</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="ampx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>0000008 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amprius.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="ampx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>0000009 - Disclosure - Revenue</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amprius.com/role/Revenue</Role>
      <ShortName>Revenue</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="ampx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>0000010 - Disclosure - Inventory</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amprius.com/role/Inventory</Role>
      <ShortName>Inventory</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="ampx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>0000011 - Disclosure - Property, Plant and Equipment, Net</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amprius.com/role/PropertyPlantandEquipmentNet</Role>
      <ShortName>Property, Plant and Equipment, Net</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="ampx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>0000012 - Disclosure - Accrued and Other Current Liabilities</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amprius.com/role/AccruedandOtherCurrentLiabilities</Role>
      <ShortName>Accrued and Other Current Liabilities</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="ampx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>0000013 - Disclosure - Stockholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amprius.com/role/StockholdersEquity</Role>
      <ShortName>Stockholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="ampx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>0000014 - Disclosure - Income Taxes</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amprius.com/role/IncomeTaxes</Role>
      <ShortName>Income Taxes</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="ampx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>0000015 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amprius.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="ampx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>0000016 - Disclosure - Commitment and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amprius.com/role/CommitmentandContingencies</Role>
      <ShortName>Commitment and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="ampx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>0000017 - Disclosure - Net Loss Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amprius.com/role/NetLossPerShare</Role>
      <ShortName>Net Loss Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="ampx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>0000018 - Disclosure - Subsequent Events</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amprius.com/role/SubsequentEvents</Role>
      <ShortName>Subsequent Events</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="ampx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>0000019 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amprius.com/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://www.amprius.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>19</Position>
    </Report>
    <Report instance="ampx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>0000020 - Disclosure - Revenue (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amprius.com/role/RevenueTables</Role>
      <ShortName>Revenue (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.amprius.com/role/Revenue</ParentRole>
      <Position>20</Position>
    </Report>
    <Report instance="ampx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>0000021 - Disclosure - Inventory (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amprius.com/role/InventoryTables</Role>
      <ShortName>Inventory (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.amprius.com/role/Inventory</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="ampx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>0000022 - Disclosure - Property, Plant and Equipment, Net (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amprius.com/role/PropertyPlantandEquipmentNetTables</Role>
      <ShortName>Property, Plant and Equipment, Net (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.amprius.com/role/PropertyPlantandEquipmentNet</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="ampx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>0000023 - Disclosure - Accrued and Other Current Liabilities (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amprius.com/role/AccruedandOtherCurrentLiabilitiesTables</Role>
      <ShortName>Accrued and Other Current Liabilities (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.amprius.com/role/AccruedandOtherCurrentLiabilities</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="ampx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>0000024 - Disclosure - Stockholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amprius.com/role/StockholdersEquityTables</Role>
      <ShortName>Stockholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.amprius.com/role/StockholdersEquity</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="ampx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>0000025 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amprius.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.amprius.com/role/Leases</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="ampx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>0000026 - Disclosure - Net Loss Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amprius.com/role/NetLossPerShareTables</Role>
      <ShortName>Net Loss Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://www.amprius.com/role/NetLossPerShare</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="ampx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>0000027 - Disclosure - Nature of Operations and Organization - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amprius.com/role/NatureofOperationsandOrganizationNarrativeDetails</Role>
      <ShortName>Nature of Operations and Organization - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>27</Position>
    </Report>
    <Report instance="ampx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>0000028 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amprius.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>28</Position>
    </Report>
    <Report instance="ampx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>0000029 - Disclosure - Revenue - Schedule of Composition of Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amprius.com/role/RevenueScheduleofCompositionofRevenueDetails</Role>
      <ShortName>Revenue - Schedule of Composition of Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>29</Position>
    </Report>
    <Report instance="ampx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>0000030 - Disclosure - Revenue - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amprius.com/role/RevenueNarrativeDetails</Role>
      <ShortName>Revenue - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>30</Position>
    </Report>
    <Report instance="ampx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>0000031 - Disclosure - Revenue - Performance Obligation (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amprius.com/role/RevenuePerformanceObligationDetails</Role>
      <ShortName>Revenue - Performance Obligation (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>31</Position>
    </Report>
    <Report instance="ampx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>0000032 - Disclosure - Inventory - Schedule of Inventory (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amprius.com/role/InventoryScheduleofInventoryDetails</Role>
      <ShortName>Inventory - Schedule of Inventory (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>32</Position>
    </Report>
    <Report instance="ampx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>0000033 - Disclosure - Property, Plant and Equipment, Net - Schedule of Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amprius.com/role/PropertyPlantandEquipmentNetScheduleofPropertyandEquipmentDetails</Role>
      <ShortName>Property, Plant and Equipment, Net - Schedule of Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="ampx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>0000034 - Disclosure - Property, Plant and Equipment, Net - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amprius.com/role/PropertyPlantandEquipmentNetNarrativeDetails</Role>
      <ShortName>Property, Plant and Equipment, Net - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="ampx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>0000035 - Disclosure - Accrued and Other Current Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amprius.com/role/AccruedandOtherCurrentLiabilitiesDetails</Role>
      <ShortName>Accrued and Other Current Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.amprius.com/role/AccruedandOtherCurrentLiabilitiesTables</ParentRole>
      <Position>35</Position>
    </Report>
    <Report instance="ampx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>0000036 - Disclosure - Stockholders' Equity - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amprius.com/role/StockholdersEquityNarrativeDetails</Role>
      <ShortName>Stockholders' Equity - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="ampx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>0000037 - Disclosure - Stockholders' Equity - Stock Warrant (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amprius.com/role/StockholdersEquityStockWarrantDetails</Role>
      <ShortName>Stockholders' Equity - Stock Warrant (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="ampx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>0000038 - Disclosure - Stockholders' Equity - Stock-Based Compensation Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amprius.com/role/StockholdersEquityStockBasedCompensationExpenseDetails</Role>
      <ShortName>Stockholders' Equity - Stock-Based Compensation Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="ampx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>0000039 - Disclosure - Income Taxes (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amprius.com/role/IncomeTaxesDetails</Role>
      <ShortName>Income Taxes (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://www.amprius.com/role/IncomeTaxes</ParentRole>
      <Position>39</Position>
    </Report>
    <Report instance="ampx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>0000040 - Disclosure - Leases - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amprius.com/role/LeasesNarrativeDetails</Role>
      <ShortName>Leases - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="ampx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>0000041 - Disclosure - Leases - Schedule of Future Maturing Operating Lease Payments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amprius.com/role/LeasesScheduleofFutureMaturingOperatingLeasePaymentsDetails</Role>
      <ShortName>Leases - Schedule of Future Maturing Operating Lease Payments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="ampx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>0000042 - Disclosure - Net Loss Per Share - Schedule of Calculation of Basic and Diluted Net Loss Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amprius.com/role/NetLossPerShareScheduleofCalculationofBasicandDilutedNetLossPerShareDetails</Role>
      <ShortName>Net Loss Per Share - Schedule of Calculation of Basic and Diluted Net Loss Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="ampx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>0000043 - Disclosure - Net Loss Per Share - Potentially Dilutive Securities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amprius.com/role/NetLossPerSharePotentiallyDilutiveSecuritiesDetails</Role>
      <ShortName>Net Loss Per Share - Potentially Dilutive Securities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="ampx-20230331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>0000044 - Disclosure - Subsequent Events - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.amprius.com/role/SubsequentEventsNarrativeDetails</Role>
      <ShortName>Subsequent Events - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <Logs>
    <Log type="Warning">[ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: us-gaap:RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1 -  ampx-20230331.htm 4</Log>
  </Logs>
  <InputFiles>
    <File doctype="10-Q" original="ampx-20230331.htm">ampx-20230331.htm</File>
    <File>ampx-20230331.xsd</File>
    <File>ampx-20230331_cal.xml</File>
    <File>ampx-20230331_def.xml</File>
    <File>ampx-20230331_lab.xml</File>
    <File>ampx-20230331_pre.xml</File>
    <File>ampx-20230331xexhibit311.htm</File>
    <File>ampx-20230331xexhibit312.htm</File>
    <File>ampx-20230331xexhibit321.htm</File>
    <File>ampx-20230331xexhibit322.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="377">http://fasb.org/us-gaap/2022</BaseTaxonomy>
    <BaseTaxonomy items="33">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>62
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "ampx-20230331.htm": {
   "axisCustom": 1,
   "axisStandard": 23,
   "baseTaxonomies": {
    "http://fasb.org/us-gaap/2022": 377,
    "http://xbrl.sec.gov/dei/2022": 33
   },
   "contextCount": 104,
   "dts": {
    "calculationLink": {
     "local": [
      "ampx-20230331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "ampx-20230331_def.xml"
     ]
    },
    "inline": {
     "local": [
      "ampx-20230331.htm"
     ]
    },
    "labelLink": {
     "local": [
      "ampx-20230331_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ampx-20230331_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "ampx-20230331.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd",
      "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd",
      "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd",
      "https://xbrl.sec.gov/country/2022/country-2022.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 358,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2022": 2,
    "http://xbrl.sec.gov/dei/2022": 5,
    "total": 7
   },
   "keyCustom": 24,
   "keyStandard": 182,
   "memberCustom": 23,
   "memberStandard": 25,
   "nsprefix": "ampx",
   "nsuri": "http://www.amprius.com/20230331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - Cover",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.amprius.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000010 - Disclosure - Inventory",
     "menuCat": "Notes",
     "order": "10",
     "role": "http://www.amprius.com/role/Inventory",
     "shortName": "Inventory",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000011 - Disclosure - Property, Plant and Equipment, Net",
     "menuCat": "Notes",
     "order": "11",
     "role": "http://www.amprius.com/role/PropertyPlantandEquipmentNet",
     "shortName": "Property, Plant and Equipment, Net",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000012 - Disclosure - Accrued and Other Current Liabilities",
     "menuCat": "Notes",
     "order": "12",
     "role": "http://www.amprius.com/role/AccruedandOtherCurrentLiabilities",
     "shortName": "Accrued and Other Current Liabilities",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000013 - Disclosure - Stockholders' Equity",
     "menuCat": "Notes",
     "order": "13",
     "role": "http://www.amprius.com/role/StockholdersEquity",
     "shortName": "Stockholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000014 - Disclosure - Income Taxes",
     "menuCat": "Notes",
     "order": "14",
     "role": "http://www.amprius.com/role/IncomeTaxes",
     "shortName": "Income Taxes",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000015 - Disclosure - Leases",
     "menuCat": "Notes",
     "order": "15",
     "role": "http://www.amprius.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000016 - Disclosure - Commitment and Contingencies",
     "menuCat": "Notes",
     "order": "16",
     "role": "http://www.amprius.com/role/CommitmentandContingencies",
     "shortName": "Commitment and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000017 - Disclosure - Net Loss Per Share",
     "menuCat": "Notes",
     "order": "17",
     "role": "http://www.amprius.com/role/NetLossPerShare",
     "shortName": "Net Loss Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000018 - Disclosure - Subsequent Events",
     "menuCat": "Notes",
     "order": "18",
     "role": "http://www.amprius.com/role/SubsequentEvents",
     "shortName": "Subsequent Events",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SubsequentEventsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ConsolidationPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000019 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "menuCat": "Policies",
     "order": "19",
     "role": "http://www.amprius.com/role/SummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:ConsolidationPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "i6023c648ad62464a83503c70b103bde2_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashAndCashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000002 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS",
     "menuCat": "Statements",
     "order": "2",
     "role": "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "i6023c648ad62464a83503c70b103bde2_I20230331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:DeferredCostsCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000020 - Disclosure - Revenue (Tables)",
     "menuCat": "Tables",
     "order": "20",
     "role": "http://www.amprius.com/role/RevenueTables",
     "shortName": "Revenue (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000021 - Disclosure - Inventory (Tables)",
     "menuCat": "Tables",
     "order": "21",
     "role": "http://www.amprius.com/role/InventoryTables",
     "shortName": "Inventory (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000022 - Disclosure - Property, Plant and Equipment, Net (Tables)",
     "menuCat": "Tables",
     "order": "22",
     "role": "http://www.amprius.com/role/PropertyPlantandEquipmentNetTables",
     "shortName": "Property, Plant and Equipment, Net (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000023 - Disclosure - Accrued and Other Current Liabilities (Tables)",
     "menuCat": "Tables",
     "order": "23",
     "role": "http://www.amprius.com/role/AccruedandOtherCurrentLiabilitiesTables",
     "shortName": "Accrued and Other Current Liabilities (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000024 - Disclosure - Stockholders' Equity (Tables)",
     "menuCat": "Tables",
     "order": "24",
     "role": "http://www.amprius.com/role/StockholdersEquityTables",
     "shortName": "Stockholders' Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000025 - Disclosure - Leases (Tables)",
     "menuCat": "Tables",
     "order": "25",
     "role": "http://www.amprius.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000026 - Disclosure - Net Loss Per Share (Tables)",
     "menuCat": "Tables",
     "order": "26",
     "role": "http://www.amprius.com/role/NetLossPerShareTables",
     "shortName": "Net Loss Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000027 - Disclosure - Nature of Operations and Organization - Narrative (Details)",
     "menuCat": "Details",
     "order": "27",
     "role": "http://www.amprius.com/role/NatureofOperationsandOrganizationNarrativeDetails",
     "shortName": "Nature of Operations and Organization - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "i6023c648ad62464a83503c70b103bde2_I20230331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "ampx:CommittedEquityFinancing",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
       "us-gaap:ConsolidationPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "i1e90ee49c2a54d3a851c9f496677d786_I20220914",
      "decimals": "5",
      "first": true,
      "lang": "en-US",
      "name": "ampx:RecapitalizationExchangeRatio",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000028 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)",
     "menuCat": "Details",
     "order": "28",
     "role": "http://www.amprius.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
     "shortName": "Summary of Significant Accounting Policies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
       "us-gaap:ConsolidationPolicyTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "i1e90ee49c2a54d3a851c9f496677d786_I20220914",
      "decimals": "5",
      "first": true,
      "lang": "en-US",
      "name": "ampx:RecapitalizationExchangeRatio",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000029 - Disclosure - Revenue - Schedule of Composition of Revenue (Details)",
     "menuCat": "Details",
     "order": "29",
     "role": "http://www.amprius.com/role/RevenueScheduleofCompositionofRevenueDetails",
     "shortName": "Revenue - Schedule of Composition of Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "i3ef781aff42644a5b81b5015320dace1_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockParOrStatedValuePerShare",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "i6023c648ad62464a83503c70b103bde2_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PreferredStockParOrStatedValuePerShare",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000003 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "menuCat": "Statements",
     "order": "3",
     "role": "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical",
     "shortName": "CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:PreferredStockSharesOutstanding",
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "i6023c648ad62464a83503c70b103bde2_I20230331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:PreferredStockSharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000030 - Disclosure - Revenue - Narrative (Details)",
     "menuCat": "Details",
     "order": "30",
     "role": "http://www.amprius.com/role/RevenueNarrativeDetails",
     "shortName": "Revenue - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "i35c52756179342cb89a7e4fbbc177710_I20220101",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:AccountsReceivableNetCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "i6023c648ad62464a83503c70b103bde2_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000031 - Disclosure - Revenue - Performance Obligation (Details)",
     "menuCat": "Details",
     "order": "31",
     "role": "http://www.amprius.com/role/RevenuePerformanceObligationDetails",
     "shortName": "Revenue - Performance Obligation (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "i6023c648ad62464a83503c70b103bde2_I20230331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueRemainingPerformanceObligation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "i6023c648ad62464a83503c70b103bde2_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000032 - Disclosure - Inventory - Schedule of Inventory (Details)",
     "menuCat": "Details",
     "order": "32",
     "role": "http://www.amprius.com/role/InventoryScheduleofInventoryDetails",
     "shortName": "Inventory - Schedule of Inventory (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "i6023c648ad62464a83503c70b103bde2_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "i6023c648ad62464a83503c70b103bde2_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000033 - Disclosure - Property, Plant and Equipment, Net - Schedule of Property and Equipment (Details)",
     "menuCat": "Details",
     "order": "33",
     "role": "http://www.amprius.com/role/PropertyPlantandEquipmentNetScheduleofPropertyandEquipmentDetails",
     "shortName": "Property, Plant and Equipment, Net - Schedule of Property and Equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "i6023c648ad62464a83503c70b103bde2_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DepreciationDepletionAndAmortization",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000034 - Disclosure - Property, Plant and Equipment, Net - Narrative (Details)",
     "menuCat": "Details",
     "order": "34",
     "role": "http://www.amprius.com/role/PropertyPlantandEquipmentNetNarrativeDetails",
     "shortName": "Property, Plant and Equipment, Net - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "i6023c648ad62464a83503c70b103bde2_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccruedProfessionalFeesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000035 - Disclosure - Accrued and Other Current Liabilities (Details)",
     "menuCat": "Details",
     "order": "35",
     "role": "http://www.amprius.com/role/AccruedandOtherCurrentLiabilitiesDetails",
     "shortName": "Accrued and Other Current Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "i6023c648ad62464a83503c70b103bde2_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccruedProfessionalFeesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "i6023c648ad62464a83503c70b103bde2_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "ampx:SharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000036 - Disclosure - Stockholders' Equity - Narrative (Details)",
     "menuCat": "Details",
     "order": "36",
     "role": "http://www.amprius.com/role/StockholdersEquityNarrativeDetails",
     "shortName": "Stockholders' Equity - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "i6023c648ad62464a83503c70b103bde2_I20230331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "ampx:SharesAuthorized",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "i6023c648ad62464a83503c70b103bde2_I20230331",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000037 - Disclosure - Stockholders' Equity - Stock Warrant (Details)",
     "menuCat": "Details",
     "order": "37",
     "role": "http://www.amprius.com/role/StockholdersEquityStockWarrantDetails",
     "shortName": "Stockholders' Equity - Stock Warrant (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "i6023c648ad62464a83503c70b103bde2_I20230331",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000038 - Disclosure - Stockholders' Equity - Stock-Based Compensation Expense (Details)",
     "menuCat": "Details",
     "order": "38",
     "role": "http://www.amprius.com/role/StockholdersEquityStockBasedCompensationExpenseDetails",
     "shortName": "Stockholders' Equity - Stock-Based Compensation Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000039 - Disclosure - Income Taxes (Details)",
     "menuCat": "Details",
     "order": "39",
     "role": "http://www.amprius.com/role/IncomeTaxesDetails",
     "shortName": "Income Taxes (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:IncomeTaxExpenseBenefit",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Revenues",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000004 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "menuCat": "Statements",
     "order": "4",
     "role": "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CostOfRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "i6023c648ad62464a83503c70b103bde2_I20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseRenewalTerm",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000040 - Disclosure - Leases - Narrative (Details)",
     "menuCat": "Details",
     "order": "40",
     "role": "http://www.amprius.com/role/LeasesNarrativeDetails",
     "shortName": "Leases - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "i6023c648ad62464a83503c70b103bde2_I20230331",
      "decimals": "0",
      "lang": "en-US",
      "name": "ampx:LesseeFinanceLeaseNumberOfLeases",
      "reportCount": 1,
      "unique": true,
      "unitRef": "lease",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "i6023c648ad62464a83503c70b103bde2_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000041 - Disclosure - Leases - Schedule of Future Maturing Operating Lease Payments (Details)",
     "menuCat": "Details",
     "order": "41",
     "role": "http://www.amprius.com/role/LeasesScheduleofFutureMaturingOperatingLeasePaymentsDetails",
     "shortName": "Leases - Schedule of Future Maturing Operating Lease Payments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "i6023c648ad62464a83503c70b103bde2_I20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted",
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000042 - Disclosure - Net Loss Per Share - Schedule of Calculation of Basic and Diluted Net Loss Per Share (Details)",
     "menuCat": "Details",
     "order": "42",
     "role": "http://www.amprius.com/role/NetLossPerShareScheduleofCalculationofBasicandDilutedNetLossPerShareDetails",
     "shortName": "Net Loss Per Share - Schedule of Calculation of Basic and Diluted Net Loss Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted",
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000043 - Disclosure - Net Loss Per Share - Potentially Dilutive Securities (Details)",
     "menuCat": "Details",
     "order": "43",
     "role": "http://www.amprius.com/role/NetLossPerSharePotentiallyDilutiveSecuritiesDetails",
     "shortName": "Net Loss Per Share - Potentially Dilutive Securities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "i6023c648ad62464a83503c70b103bde2_I20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseRenewalTerm",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000044 - Disclosure - Subsequent Events - Narrative (Details)",
     "menuCat": "Details",
     "order": "44",
     "role": "http://www.amprius.com/role/SubsequentEventsNarrativeDetails",
     "shortName": "Subsequent Events - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "ie3036f0dcbac452caf4e05d02eb07b89_D20230415-20230415",
      "decimals": "0",
      "lang": "en-US",
      "name": "ampx:LesseeOperatingLeaseOptionToExtendNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "term",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "i3a1b0acc07434411a2695d9dbe33e259_I20211231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000005 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS\u2019 EQUITY",
     "menuCat": "Statements",
     "order": "5",
     "role": "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS\u2019 EQUITY",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "i3a1b0acc07434411a2695d9dbe33e259_I20211231",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesOutstanding",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "0000006 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "menuCat": "Statements",
     "order": "6",
     "role": "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
     "shortName": "CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensation",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000007 - Disclosure - Nature of Operations and Organization",
     "menuCat": "Notes",
     "order": "7",
     "role": "http://www.amprius.com/role/NatureofOperationsandOrganization",
     "shortName": "Nature of Operations and Organization",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000008 - Disclosure - Summary of Significant Accounting Policies",
     "menuCat": "Notes",
     "order": "8",
     "role": "http://www.amprius.com/role/SummaryofSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "0000009 - Disclosure - Revenue",
     "menuCat": "Notes",
     "order": "9",
     "role": "http://www.amprius.com/role/Revenue",
     "shortName": "Revenue",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ampx-20230331.htm",
      "contextRef": "ib77a2a9d039d465d9db5473005eaecfd_D20230101-20230331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 51,
   "tag": {
    "ampx_AccruedOfferingCostsCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.amprius.com/role/AccruedandOtherCurrentLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Offering Costs, Current",
        "label": "Accrued Offering Costs, Current",
        "terseLabel": "Accrued financing costs"
       }
      }
     },
     "localname": "AccruedOfferingCostsCurrent",
     "nsuri": "http://www.amprius.com/20230331",
     "presentation": [
      "http://www.amprius.com/role/AccruedandOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ampx_AdjustmentsToAdditionalPaidInCapitalCapitalContributionsFromParent": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments To Additional Paid In Capital, Capital Contributions From Parent",
        "label": "Adjustments To Additional Paid In Capital, Capital Contributions From Parent",
        "terseLabel": "Capital contributions from Amprius Holdings"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalCapitalContributionsFromParent",
     "nsuri": "http://www.amprius.com/20230331",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ampx_AdjustmentsToAdditionalPaidInCapitalContributionFromParentRelatedToStockBasedCompensation": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Adjustments To Additional Paid In Capital, Contribution From Parent Related To Stock-Based Compensation",
        "label": "Adjustments To Additional Paid In Capital, Contribution From Parent Related To Stock-Based Compensation",
        "terseLabel": "Contribution from Amprius Holdings related to stock-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalContributionFromParentRelatedToStockBasedCompensation",
     "nsuri": "http://www.amprius.com/20230331",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ampx_AmpriusHoldingsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amprius Holdings",
        "label": "Amprius Holdings [Member]",
        "terseLabel": "Amprius Holdings"
       }
      }
     },
     "localname": "AmpriusHoldingsMember",
     "nsuri": "http://www.amprius.com/20230331",
     "presentation": [
      "http://www.amprius.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ampx_BRPCIIMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "BRPC II",
        "label": "BRPC II [Member]",
        "terseLabel": "BRPC II"
       }
      }
     },
     "localname": "BRPCIIMember",
     "nsuri": "http://www.amprius.com/20230331",
     "presentation": [
      "http://www.amprius.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ampx_BrightonColoradoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Brighton, Colorado",
        "label": "Brighton, Colorado [Member]",
        "terseLabel": "Brighton, Colorado"
       }
      }
     },
     "localname": "BrightonColoradoMember",
     "nsuri": "http://www.amprius.com/20230331",
     "presentation": [
      "http://www.amprius.com/role/SubsequentEventsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ampx_CommittedEquityFinancing": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Committed Equity Financing",
        "label": "Committed Equity Financing",
        "terseLabel": "Committed equity financing balance"
       }
      }
     },
     "localname": "CommittedEquityFinancing",
     "nsuri": "http://www.amprius.com/20230331",
     "presentation": [
      "http://www.amprius.com/role/NatureofOperationsandOrganizationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ampx_CustomerOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer One",
        "label": "Customer One [Member]",
        "terseLabel": "Customer One"
       }
      }
     },
     "localname": "CustomerOneMember",
     "nsuri": "http://www.amprius.com/20230331",
     "presentation": [
      "http://www.amprius.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ampx_CustomerThreeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer Three",
        "label": "Customer Three [Member]",
        "terseLabel": "Customer Three"
       }
      }
     },
     "localname": "CustomerThreeMember",
     "nsuri": "http://www.amprius.com/20230331",
     "presentation": [
      "http://www.amprius.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ampx_CustomerTwoMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer Two",
        "label": "Customer Two [Member]",
        "terseLabel": "Customer Two"
       }
      }
     },
     "localname": "CustomerTwoMember",
     "nsuri": "http://www.amprius.com/20230331",
     "presentation": [
      "http://www.amprius.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ampx_CustomizedDesignServicesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customized Design Services",
        "label": "Customized Design Services [Member]",
        "terseLabel": "Customized design services"
       }
      }
     },
     "localname": "CustomizedDesignServicesMember",
     "nsuri": "http://www.amprius.com/20230331",
     "presentation": [
      "http://www.amprius.com/role/RevenueScheduleofCompositionofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ampx_DeferredStockIssuanceCosts": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Deferred Stock Issuance Costs",
        "label": "Deferred Stock Issuance Costs",
        "terseLabel": "Deferred stock issuance costs"
       }
      }
     },
     "localname": "DeferredStockIssuanceCosts",
     "nsuri": "http://www.amprius.com/20230331",
     "presentation": [
      "http://www.amprius.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ampx_EmergingGrowthCompanyPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Emerging Growth Company, Policy",
        "label": "Emerging Growth Company, Policy [Policy Text Block]",
        "terseLabel": "Emerging Growth Company"
       }
      }
     },
     "localname": "EmergingGrowthCompanyPolicyPolicyTextBlock",
     "nsuri": "http://www.amprius.com/20230331",
     "presentation": [
      "http://www.amprius.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ampx_EquityIncentivePlansMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Incentive Plans",
        "label": "Equity Incentive Plans [Member]",
        "terseLabel": "Equity Incentive Plans"
       }
      }
     },
     "localname": "EquityIncentivePlansMember",
     "nsuri": "http://www.amprius.com/20230331",
     "presentation": [
      "http://www.amprius.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ampx_ExecutiveIncentiveCompensationPlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Executive Incentive Compensation Plan",
        "label": "Executive Incentive Compensation Plan [Member]",
        "terseLabel": "Executive Incentive Compensation Plan"
       }
      }
     },
     "localname": "ExecutiveIncentiveCompensationPlanMember",
     "nsuri": "http://www.amprius.com/20230331",
     "presentation": [
      "http://www.amprius.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ampx_FiveCustomersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Five Customers",
        "label": "Five Customers [Member]",
        "terseLabel": "Five customers"
       }
      }
     },
     "localname": "FiveCustomersMember",
     "nsuri": "http://www.amprius.com/20230331",
     "presentation": [
      "http://www.amprius.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ampx_GovernmentAssistanceGrantNotYetReceived": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Government Assistance, Grant Not Yet Received",
        "label": "Government Assistance, Grant Not Yet Received",
        "terseLabel": "Grant not yet received"
       }
      }
     },
     "localname": "GovernmentAssistanceGrantNotYetReceived",
     "nsuri": "http://www.amprius.com/20230331",
     "presentation": [
      "http://www.amprius.com/role/NatureofOperationsandOrganizationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ampx_LaboratoryEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Laboratory Equipment",
        "label": "Laboratory Equipment [Member]",
        "terseLabel": "Lab equipment"
       }
      }
     },
     "localname": "LaboratoryEquipmentMember",
     "nsuri": "http://www.amprius.com/20230331",
     "presentation": [
      "http://www.amprius.com/role/PropertyPlantandEquipmentNetScheduleofPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ampx_LesseeFinanceLeaseNumberOfLeases": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Finance Lease, Number Of Leases",
        "label": "Lessee, Finance Lease, Number Of Leases",
        "terseLabel": "Number of finance leases (in leases)"
       }
      }
     },
     "localname": "LesseeFinanceLeaseNumberOfLeases",
     "nsuri": "http://www.amprius.com/20230331",
     "presentation": [
      "http://www.amprius.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "ampx_LesseeOperatingLeaseOptionToExtendNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Lessee, Operating Lease, Option to Extend, Number",
        "label": "Lessee, Operating Lease, Option to Extend, Number",
        "terseLabel": "Number of extension terms"
       }
      }
     },
     "localname": "LesseeOperatingLeaseOptionToExtendNumber",
     "nsuri": "http://www.amprius.com/20230331",
     "presentation": [
      "http://www.amprius.com/role/SubsequentEventsNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "ampx_NameOfFacilityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of Facility",
        "label": "Name of Facility [Axis]",
        "terseLabel": "Name of Facility [Axis]"
       }
      }
     },
     "localname": "NameOfFacilityAxis",
     "nsuri": "http://www.amprius.com/20230331",
     "presentation": [
      "http://www.amprius.com/role/SubsequentEventsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "ampx_NameOfFacilityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of Facility [Domain]",
        "label": "Name of Facility [Domain]",
        "terseLabel": "Name of Facility [Domain]"
       }
      }
     },
     "localname": "NameOfFacilityDomain",
     "nsuri": "http://www.amprius.com/20230331",
     "presentation": [
      "http://www.amprius.com/role/SubsequentEventsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ampx_NumberOfExecutiveEmployeesOfParentSharingFacilitiesCosts": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Executive Employees Of Parent Sharing Facilities Costs",
        "label": "Number Of Executive Employees Of Parent Sharing Facilities Costs",
        "terseLabel": "Number of executive employees of parent sharing facilities costs (in executive employees)"
       }
      }
     },
     "localname": "NumberOfExecutiveEmployeesOfParentSharingFacilitiesCosts",
     "nsuri": "http://www.amprius.com/20230331",
     "presentation": [
      "http://www.amprius.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "ampx_OtherRevenueGovernmentGrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Revenue - Government Grant",
        "label": "Other Revenue - Government Grant [Member]",
        "terseLabel": "Other revenue \u2013 government grant"
       }
      }
     },
     "localname": "OtherRevenueGovernmentGrantMember",
     "nsuri": "http://www.amprius.com/20230331",
     "presentation": [
      "http://www.amprius.com/role/RevenueScheduleofCompositionofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ampx_PIPEWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "PIPE Warrants",
        "label": "PIPE Warrants [Member]",
        "terseLabel": "PIPE warrants"
       }
      }
     },
     "localname": "PIPEWarrantsMember",
     "nsuri": "http://www.amprius.com/20230331",
     "presentation": [
      "http://www.amprius.com/role/StockholdersEquityNarrativeDetails",
      "http://www.amprius.com/role/StockholdersEquityStockWarrantDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ampx_PaymentOfTransactionAndIssuanceCostsInConnectionWithBusinessCombinationAndPIPEInvestment": {
     "auth_ref": [],
     "calculation": {
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payment of transaction and issuance costs in connection with Business Combination and PIPE investment",
        "label": "Payment of transaction and issuance costs in connection with Business Combination and PIPE investment",
        "negatedTerseLabel": "Payment of transaction and issuance costs in connection with Business Combination and PIPE investment"
       }
      }
     },
     "localname": "PaymentOfTransactionAndIssuanceCostsInConnectionWithBusinessCombinationAndPIPEInvestment",
     "nsuri": "http://www.amprius.com/20230331",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ampx_PrivateWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Private Warrants",
        "label": "Private Warrants [Member]",
        "terseLabel": "Private warrants"
       }
      }
     },
     "localname": "PrivateWarrantsMember",
     "nsuri": "http://www.amprius.com/20230331",
     "presentation": [
      "http://www.amprius.com/role/StockholdersEquityNarrativeDetails",
      "http://www.amprius.com/role/StockholdersEquityStockWarrantDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ampx_ProductionEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Production Equipment",
        "label": "Production Equipment [Member]",
        "terseLabel": "Production equipment"
       }
      }
     },
     "localname": "ProductionEquipmentMember",
     "nsuri": "http://www.amprius.com/20230331",
     "presentation": [
      "http://www.amprius.com/role/PropertyPlantandEquipmentNetScheduleofPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ampx_PublicWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Public Warrants",
        "label": "Public Warrants [Member]",
        "terseLabel": "Public warrants"
       }
      }
     },
     "localname": "PublicWarrantsMember",
     "nsuri": "http://www.amprius.com/20230331",
     "presentation": [
      "http://www.amprius.com/role/StockholdersEquityNarrativeDetails",
      "http://www.amprius.com/role/StockholdersEquityStockWarrantDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ampx_PurchaseAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Purchase Agreement",
        "label": "Purchase Agreement [Member]",
        "terseLabel": "Common Stock Purchase Agreement"
       }
      }
     },
     "localname": "PurchaseAgreementMember",
     "nsuri": "http://www.amprius.com/20230331",
     "presentation": [
      "http://www.amprius.com/role/NatureofOperationsandOrganizationNarrativeDetails",
      "http://www.amprius.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ampx_RecapitalizationExchangeRatio": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Recapitalization Exchange Ratio",
        "label": "Recapitalization Exchange Ratio",
        "terseLabel": "Recapitalization exchange ratio"
       }
      }
     },
     "localname": "RecapitalizationExchangeRatio",
     "nsuri": "http://www.amprius.com/20230331",
     "presentation": [
      "http://www.amprius.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "pureItemType"
    },
    "ampx_RedeemableWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Redeemable Warrants",
        "label": "Redeemable Warrants [Member]",
        "terseLabel": "Redeemable warrants"
       }
      }
     },
     "localname": "RedeemableWarrantsMember",
     "nsuri": "http://www.amprius.com/20230331",
     "presentation": [
      "http://www.amprius.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "ampx_SaleOfBatteryMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale Of Battery",
        "label": "Sale Of Battery [Member]",
        "terseLabel": "Sale of battery products"
       }
      }
     },
     "localname": "SaleOfBatteryMember",
     "nsuri": "http://www.amprius.com/20230331",
     "presentation": [
      "http://www.amprius.com/role/RevenueScheduleofCompositionofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ampx_SaleOfStockAveragePricePerShareRedemption": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale Of Stock, Average Price Per Share, Redemption",
        "label": "Sale Of Stock, Average Price Per Share, Redemption",
        "terseLabel": "Average price per share of redeemable warrants (in dollars per share)"
       }
      }
     },
     "localname": "SaleOfStockAveragePricePerShareRedemption",
     "nsuri": "http://www.amprius.com/20230331",
     "presentation": [
      "http://www.amprius.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "ampx_SaleOfStockDiscount": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale Of Stock, Discount",
        "label": "Sale Of Stock, Discount",
        "terseLabel": "Discount on sale of stock (percentage)"
       }
      }
     },
     "localname": "SaleOfStockDiscount",
     "nsuri": "http://www.amprius.com/20230331",
     "presentation": [
      "http://www.amprius.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ampx_SaleOfStockMaximumSharesAvailableForSalePercentageOfSharesIssuedAndOutstandingPriorToTransaction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale Of Stock, Maximum Shares Available For Sale, Percentage Of Shares Issued And Outstanding Prior To Transaction",
        "label": "Sale Of Stock, Maximum Shares Available For Sale, Percentage Of Shares Issued And Outstanding Prior To Transaction",
        "terseLabel": "Maximum shares available for sale as a percentage of aggregate shares issued and outstanding (percentage)"
       }
      }
     },
     "localname": "SaleOfStockMaximumSharesAvailableForSalePercentageOfSharesIssuedAndOutstandingPriorToTransaction",
     "nsuri": "http://www.amprius.com/20230331",
     "presentation": [
      "http://www.amprius.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ampx_SaleOfStockPotentialMaximumConsiderationReceivedOnTransaction": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale Of Stock, Potential Maximum Consideration Received On Transaction",
        "label": "Sale Of Stock, Potential Maximum Consideration Received On Transaction",
        "terseLabel": "Common stock, purchase agreement, potential maximum consideration"
       }
      }
     },
     "localname": "SaleOfStockPotentialMaximumConsiderationReceivedOnTransaction",
     "nsuri": "http://www.amprius.com/20230331",
     "presentation": [
      "http://www.amprius.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "ampx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfFairValue": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Based Compensation Arrangement By Share Based Payment Award, Exercise Price As A Percentage Of Fair Value",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award, Exercise Price As A Percentage Of Fair Value",
        "terseLabel": "Exercise price as a percentage of fair value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfFairValue",
     "nsuri": "http://www.amprius.com/20230331",
     "presentation": [
      "http://www.amprius.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ampx_ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfFairValueSignificantStockholder": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share Based Compensation Arrangement By Share Based Payment Award, Exercise Price As A Percentage Of Fair Value, Significant Stockholder",
        "label": "Share Based Compensation Arrangement By Share Based Payment Award, Exercise Price As A Percentage Of Fair Value, Significant Stockholder",
        "terseLabel": "Exercise price as a percentage of fair value, ten percent stockholders"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardExercisePriceAsAPercentageOfFairValueSignificantStockholder",
     "nsuri": "http://www.amprius.com/20230331",
     "presentation": [
      "http://www.amprius.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ampx_ShareBasedCompensationArrangementByShareBasedPaymentAwardReservedForIssuance": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-Based Compensation Arrangement by Share-Based Payment Award, Reserved For Issuance",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Reserved For Issuance",
        "terseLabel": "Reserved for issuance (Shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardReservedForIssuance",
     "nsuri": "http://www.amprius.com/20230331",
     "presentation": [
      "http://www.amprius.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "ampx_SharesAuthorized": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares, Authorized",
        "label": "Shares, Authorized",
        "terseLabel": "Shares authorized (in shares)"
       }
      }
     },
     "localname": "SharesAuthorized",
     "nsuri": "http://www.amprius.com/20230331",
     "presentation": [
      "http://www.amprius.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "ampx_StockholderPercentageOfOptioneeForOptionPrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stockholder Percentage Of Optionee For Option Price",
        "label": "Stockholder Percentage Of Optionee For Option Price",
        "terseLabel": "Stockholder Percentage Of Optionee For Option Price"
       }
      }
     },
     "localname": "StockholderPercentageOfOptioneeForOptionPrice",
     "nsuri": "http://www.amprius.com/20230331",
     "presentation": [
      "http://www.amprius.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "ampx_ThreeCustomersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Three Customers",
        "label": "Three Customers [Member]",
        "terseLabel": "Three customers"
       }
      }
     },
     "localname": "ThreeCustomersMember",
     "nsuri": "http://www.amprius.com/20230331",
     "presentation": [
      "http://www.amprius.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ampx_TotalRevenueFromCustomersMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total Revenue From Customers",
        "label": "Total Revenue From Customers [Member]",
        "terseLabel": "Total revenue from customers"
       }
      }
     },
     "localname": "TotalRevenueFromCustomersMember",
     "nsuri": "http://www.amprius.com/20230331",
     "presentation": [
      "http://www.amprius.com/role/RevenueScheduleofCompositionofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ampx_TwentyTwentyTwoEmployeeStockPurchasePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Twenty Twenty Two Employee Stock Purchase Plan",
        "label": "Twenty Twenty Two Employee Stock Purchase Plan [Member]",
        "terseLabel": "Employee Stock Purchase Plan"
       }
      }
     },
     "localname": "TwentyTwentyTwoEmployeeStockPurchasePlanMember",
     "nsuri": "http://www.amprius.com/20230331",
     "presentation": [
      "http://www.amprius.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ampx_TwentyTwentyTwoEquityIncentivePlanMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Twenty Twenty Two Equity Incentive Plan",
        "label": "Twenty Twenty Two Equity Incentive Plan [Member]",
        "terseLabel": "2022 Plan"
       }
      }
     },
     "localname": "TwentyTwentyTwoEquityIncentivePlanMember",
     "nsuri": "http://www.amprius.com/20230331",
     "presentation": [
      "http://www.amprius.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "ampx_UnauditedInterimCondensedFinancialStatementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unaudited Interim Condensed Financial Statements, Policy",
        "label": "Unaudited Interim Condensed Financial Statements, Policy [Policy Text Block]",
        "terseLabel": "Unaudited Interim Condensed Consolidated Financial Statements"
       }
      }
     },
     "localname": "UnauditedInterimCondensedFinancialStatementsPolicyPolicyTextBlock",
     "nsuri": "http://www.amprius.com/20230331",
     "presentation": [
      "http://www.amprius.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "ampx_WarrantsRedemptionThresholdConsecutiveTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants, Redemption, Threshold Consecutive Trading Days",
        "label": "Warrants, Redemption, Threshold Consecutive Trading Days",
        "terseLabel": "Warrants, redeem, threshold consecutive trading days"
       }
      }
     },
     "localname": "WarrantsRedemptionThresholdConsecutiveTradingDays",
     "nsuri": "http://www.amprius.com/20230331",
     "presentation": [
      "http://www.amprius.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "ampx_WarrantsRedemptionThresholdTradingDays": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Warrants, Redemption, Threshold Trading Days",
        "label": "Warrants, Redemption, Threshold Trading Days",
        "terseLabel": "Warrants, redeem, threshold trading days"
       }
      }
     },
     "localname": "WarrantsRedemptionThresholdTradingDays",
     "nsuri": "http://www.amprius.com/20230331",
     "presentation": [
      "http://www.amprius.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amprius.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amprius.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amprius.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amprius.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amprius.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Document Information [Line Items]",
        "terseLabel": "Document Information [Line Items]"
       }
      }
     },
     "localname": "DocumentInformationLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amprius.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentInformationTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package.",
        "label": "Document Information [Table]",
        "terseLabel": "Document Information [Table]"
       }
      }
     },
     "localname": "DocumentInformationTable",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amprius.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amprius.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r446"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amprius.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r447"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amprius.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amprius.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amprius.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amprius.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amprius.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amprius.com/role/Cover"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r444"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amprius.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amprius.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amprius.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains.",
        "label": "Entity [Domain]",
        "terseLabel": "Entity [Domain]"
       }
      }
     },
     "localname": "EntityDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amprius.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r444"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amprius.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r449"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amprius.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amprius.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r444"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amprius.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amprius.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r448"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amprius.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r444"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amprius.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r444"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amprius.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r444"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amprius.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r444"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amprius.com/role/Cover"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LegalEntityAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The set of legal entities associated with a report.",
        "label": "Legal Entity [Axis]",
        "terseLabel": "Legal Entity [Axis]"
       }
      }
     },
     "localname": "LegalEntityAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amprius.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amprius.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r443"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amprius.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r445"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amprius.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.amprius.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "srt_CounterpartyNameAxis": {
     "auth_ref": [
      "r118",
      "r119",
      "r217",
      "r221",
      "r415",
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Axis]",
        "terseLabel": "Counterparty Name [Axis]"
       }
      }
     },
     "localname": "CounterpartyNameAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.amprius.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAdjustmentMember": {
     "auth_ref": [
      "r89",
      "r123",
      "r131",
      "r138",
      "r196",
      "r293",
      "r294",
      "r295",
      "r302",
      "r303",
      "r322",
      "r325",
      "r327",
      "r328",
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption, Adjustment [Member]",
        "terseLabel": "Adjustment"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionAxis": {
     "auth_ref": [
      "r89",
      "r123",
      "r131",
      "r138",
      "r196",
      "r293",
      "r294",
      "r295",
      "r302",
      "r303",
      "r322",
      "r325",
      "r327",
      "r328",
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Axis]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Axis]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_CumulativeEffectPeriodOfAdoptionDomain": {
     "auth_ref": [
      "r89",
      "r123",
      "r131",
      "r138",
      "r196",
      "r293",
      "r294",
      "r295",
      "r302",
      "r303",
      "r322",
      "r325",
      "r327",
      "r328",
      "r368"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cumulative Effect, Period of Adoption [Domain]",
        "terseLabel": "Cumulative Effect, Period of Adoption [Domain]"
       }
      }
     },
     "localname": "CumulativeEffectPeriodOfAdoptionDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r187",
      "r428",
      "r487",
      "r536"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]",
        "terseLabel": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.amprius.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r204",
      "r205",
      "r206",
      "r207",
      "r261",
      "r378",
      "r388",
      "r407",
      "r408",
      "r425",
      "r436",
      "r442",
      "r486",
      "r526",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.amprius.com/role/NatureofOperationsandOrganizationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r187",
      "r428",
      "r487",
      "r536"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.amprius.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r185",
      "r379",
      "r426",
      "r441",
      "r481",
      "r482",
      "r487",
      "r535"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.amprius.com/role/RevenueScheduleofCompositionofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r185",
      "r379",
      "r426",
      "r441",
      "r481",
      "r482",
      "r487",
      "r535"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.amprius.com/role/RevenueScheduleofCompositionofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r204",
      "r205",
      "r206",
      "r207",
      "r254",
      "r261",
      "r287",
      "r288",
      "r289",
      "r377",
      "r378",
      "r388",
      "r407",
      "r408",
      "r425",
      "r436",
      "r442",
      "r480",
      "r486",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.amprius.com/role/NatureofOperationsandOrganizationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r204",
      "r205",
      "r206",
      "r207",
      "r254",
      "r261",
      "r287",
      "r288",
      "r289",
      "r377",
      "r378",
      "r388",
      "r407",
      "r408",
      "r425",
      "r436",
      "r442",
      "r480",
      "r486",
      "r527",
      "r528",
      "r529",
      "r530",
      "r531"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.amprius.com/role/NatureofOperationsandOrganizationNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RepurchaseAgreementCounterpartyNameDomain": {
     "auth_ref": [
      "r118",
      "r119",
      "r217",
      "r221",
      "r416",
      "r417"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Counterparty Name [Domain]",
        "terseLabel": "Counterparty Name [Domain]"
       }
      }
     },
     "localname": "RepurchaseAgreementCounterpartyNameDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.amprius.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RestatementAdjustmentMember": {
     "auth_ref": [
      "r120",
      "r121",
      "r122",
      "r133",
      "r134",
      "r156",
      "r327",
      "r328",
      "r463",
      "r464",
      "r466",
      "r467",
      "r469",
      "r472",
      "r473"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period, Adjustment [Member]",
        "terseLabel": "Revision of Prior Period, Adjustment"
       }
      }
     },
     "localname": "RestatementAdjustmentMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RestatementAxis": {
     "auth_ref": [
      "r90",
      "r120",
      "r121",
      "r122",
      "r124",
      "r125",
      "r128",
      "r129",
      "r130",
      "r131",
      "r133",
      "r134",
      "r135",
      "r136",
      "r137",
      "r138",
      "r156",
      "r197",
      "r198",
      "r303",
      "r323",
      "r327",
      "r328",
      "r329",
      "r353",
      "r369",
      "r370",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Axis]",
        "terseLabel": "Revision of Prior Period [Axis]"
       }
      }
     },
     "localname": "RestatementAxis",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RestatementDomain": {
     "auth_ref": [
      "r90",
      "r120",
      "r121",
      "r122",
      "r124",
      "r125",
      "r128",
      "r129",
      "r130",
      "r131",
      "r133",
      "r134",
      "r135",
      "r136",
      "r137",
      "r138",
      "r156",
      "r197",
      "r198",
      "r303",
      "r323",
      "r327",
      "r328",
      "r329",
      "r353",
      "r369",
      "r370",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revision of Prior Period [Domain]",
        "terseLabel": "Revision of Prior Period [Domain]"
       }
      }
     },
     "localname": "RestatementDomain",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ScenarioPreviouslyReportedMember": {
     "auth_ref": [
      "r90",
      "r120",
      "r122",
      "r124",
      "r125",
      "r128",
      "r129",
      "r137",
      "r156",
      "r303",
      "r323",
      "r327",
      "r328",
      "r353",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r478",
      "r479",
      "r517",
      "r522",
      "r523"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Previously Reported [Member]",
        "terseLabel": "Previously Reported"
       }
      }
     },
     "localname": "ScenarioPreviouslyReportedMember",
     "nsuri": "http://fasb.org/srt/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingStandardsUpdateExtensibleList": {
     "auth_ref": [
      "r87",
      "r88",
      "r89",
      "r90",
      "r91",
      "r124",
      "r125",
      "r126",
      "r190",
      "r191",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r293",
      "r294",
      "r295",
      "r302",
      "r303",
      "r311",
      "r312",
      "r313",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400",
      "r465"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates amendment to accounting standards.",
        "label": "Accounting Standards Update [Extensible Enumeration]",
        "terseLabel": "Accounting Standards Update [Extensible Enumeration]"
       }
      }
     },
     "localname": "AccountingStandardsUpdateExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "enumerationSetItemType"
    },
    "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": {
     "auth_ref": [
      "r13"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.",
        "label": "Accounts Payable and Accrued Liabilities Disclosure [Text Block]",
        "terseLabel": "Accrued and Other Current Liabilities"
       }
      }
     },
     "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/AccruedandOtherCurrentLiabilities"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_AccountsPayableAndOtherAccruedLiabilitiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities incurred to vendors for goods and services received, and accrued liabilities classified as other, payable within one year or the normal operating cycle, if longer.",
        "label": "Accounts Payable and Other Accrued Liabilities, Current",
        "terseLabel": "Accrued and other current liabilities"
       }
      }
     },
     "localname": "AccountsPayableAndOtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r12",
      "r440"
     ],
     "calculation": {
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableMember": {
     "auth_ref": [
      "r402"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Due from customers or clients for goods or services that have been delivered or sold.",
        "label": "Accounts Receivable [Member]",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r188",
      "r189"
     ],
     "calculation": {
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.amprius.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r15"
     ],
     "calculation": {
      "http://www.amprius.com/role/AccruedandOtherCurrentLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "totalLabel": "Accrued and other current liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/AccruedandOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "auth_ref": [
      "r15"
     ],
     "calculation": {
      "http://www.amprius.com/role/AccruedandOtherCurrentLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Professional Fees, Current",
        "terseLabel": "Accrued professional fees"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/AccruedandOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r51",
      "r97"
     ],
     "calculation": {
      "http://www.amprius.com/role/PropertyPlantandEquipmentNetScheduleofPropertyandEquipmentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedTerseLabel": "Less: accumulated depreciation and amortization"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/PropertyPlantandEquipmentNetScheduleofPropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r4",
      "r440"
     ],
     "calculation": {
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in\u00a0capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r293",
      "r294",
      "r295",
      "r460",
      "r461",
      "r462",
      "r516"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-in Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": {
     "auth_ref": [
      "r63",
      "r64",
      "r263"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.",
        "label": "APIC, Share-Based Payment Arrangement, Increase for Cost Recognition",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "verboseLabel": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r291"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-Based Payment Arrangement, Expense",
        "terseLabel": "Total stock-based compensation"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/StockholdersEquityStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Potentially dilutive securities excluded from the computation of net loss per share (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/NetLossPerSharePotentiallyDilutiveSecuritiesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r40"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/NetLossPerSharePotentiallyDilutiveSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/NetLossPerSharePotentiallyDilutiveSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r40"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/NetLossPerSharePotentiallyDilutiveSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r74",
      "r80",
      "r99",
      "r115",
      "r170",
      "r179",
      "r183",
      "r192",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r314",
      "r316",
      "r332",
      "r440",
      "r484",
      "r485",
      "r524"
     ],
     "calculation": {
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets [Abstract]"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r93",
      "r104",
      "r115",
      "r192",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r314",
      "r316",
      "r332",
      "r440",
      "r484",
      "r485",
      "r524"
     ],
     "calculation": {
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Assets, Current [Abstract]"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Noncurrent [Abstract]",
        "terseLabel": "Non-current assets:"
       }
      }
     },
     "localname": "AssetsNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Business Acquisition, Equity Interests Issued or Issuable [Line Items]",
        "terseLabel": "Business Acquisition, Equity Interests Issued or Issuable [Line Items]"
       }
      }
     },
     "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/NatureofOperationsandOrganizationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r35",
      "r95",
      "r410"
     ],
     "calculation": {
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 5.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash and Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash and cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.amprius.com/role/NatureofOperationsandOrganizationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsAxis": {
     "auth_ref": [
      "r95"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of cash and cash equivalent balance.",
        "label": "Cash and Cash Equivalents [Axis]",
        "terseLabel": "Cash and Cash Equivalents [Axis]"
       }
      }
     },
     "localname": "CashAndCashEquivalentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashAndCashEquivalentsFairValueDisclosure": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value portion of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents, Fair Value Disclosure",
        "terseLabel": "Cash equivalents"
       }
      }
     },
     "localname": "CashAndCashEquivalentsFairValueDisclosure",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy": {
     "auth_ref": [
      "r36",
      "r72"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Entity's cash and cash equivalents accounting policy with respect to restricted balances. Restrictions may include legally restricted deposits held as compensating balances against short-term borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits.",
        "label": "Cash and Cash Equivalents, Restricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Restricted Cash"
       }
      }
     },
     "localname": "CashAndCashEquivalentsRestrictedCashAndCashEquivalentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r30",
      "r35",
      "r37"
     ],
     "calculation": {
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents",
        "periodEndLabel": "Cash, cash equivalents and restricted cash, end of period",
        "periodStartLabel": "Cash, cash equivalents and restricted cash, beginning of period",
        "totalLabel": "Total cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents [Abstract]",
        "terseLabel": "Reconciliation of cash, cash equivalents and restricted cash shown on the condensed consolidated balance sheets:"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r30",
      "r71"
     ],
     "calculation": {
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net decrease in cash, cash equivalents and restricted cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r100",
      "r101",
      "r102",
      "r115",
      "r142",
      "r143",
      "r150",
      "r152",
      "r159",
      "r160",
      "r192",
      "r208",
      "r210",
      "r211",
      "r212",
      "r215",
      "r216",
      "r219",
      "r220",
      "r223",
      "r227",
      "r233",
      "r332",
      "r409",
      "r450",
      "r458",
      "r474"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "auth_ref": [
      "r57",
      "r59"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of warrant or right issued.",
        "label": "Class of Warrant or Right [Axis]",
        "terseLabel": "Class of Warrant or Right [Axis]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/StockholdersEquityNarrativeDetails",
      "http://www.amprius.com/role/StockholdersEquityStockWarrantDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.",
        "label": "Class of Warrant or Right [Domain]",
        "terseLabel": "Class of Warrant or Right [Domain]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/StockholdersEquityNarrativeDetails",
      "http://www.amprius.com/role/StockholdersEquityStockWarrantDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "auth_ref": [
      "r234"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "terseLabel": "Exercise price (in dollars per share)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/StockholdersEquityNarrativeDetails",
      "http://www.amprius.com/role/StockholdersEquityStockWarrantDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Outstanding",
        "terseLabel": "Warrants outstanding (in shares)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/StockholdersEquityStockWarrantDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r17",
      "r76",
      "r84"
     ],
     "calculation": {
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies (Note 10)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r54",
      "r202",
      "r203",
      "r403",
      "r483"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CommitmentandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r18"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "terseLabel": "Shares available for future issuance (in shares)"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r460",
      "r461",
      "r516"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Stock"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.amprius.com/role/Cover"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of common stock.",
        "label": "Common Stock, Par or Stated Value Per Share",
        "terseLabel": "Common stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "CommonStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.amprius.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common stock, authorized (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.amprius.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r3",
      "r55"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "periodEndLabel": "Ending Balance (in shares)",
        "periodStartLabel": "Beginning Balance (in shares)",
        "terseLabel": "Common stock, outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValueOutstanding": {
     "auth_ref": [
      "r3"
     ],
     "calculation": {
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of all classes of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares exclude common shares repurchased by the entity and held as treasury shares.",
        "label": "Common Stock, Value, Outstanding",
        "terseLabel": "Common stock; $0.0001 par value; 950,000,000 shares authorized; 84,971,465 and 84,610,114 shares issued and outstanding at March\u00a031, 2023 and December\u00a031, 2022, respectively"
       }
      }
     },
     "localname": "CommonStockValueOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r42",
      "r43",
      "r69",
      "r70",
      "r187",
      "r402"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r42",
      "r43",
      "r69",
      "r70",
      "r187",
      "r401",
      "r402"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r42",
      "r43",
      "r69",
      "r70",
      "r187",
      "r402",
      "r537"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r78",
      "r163"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentration of Credit Risk"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r42",
      "r43",
      "r69",
      "r70",
      "r187"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Concentration risk percentage"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r42",
      "r43",
      "r69",
      "r70",
      "r187",
      "r402"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r67",
      "r419"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Principles of Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConstructionInProgressMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress [Member]",
        "terseLabel": "Construction in progress"
       }
      }
     },
     "localname": "ConstructionInProgressMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/PropertyPlantandEquipmentNetScheduleofPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerAssetNet": {
     "auth_ref": [
      "r236",
      "r238",
      "r250"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "Contract with Customer, Asset, after Allowance for Credit Loss",
        "terseLabel": "Contract asset"
       }
      }
     },
     "localname": "ContractWithCustomerAssetNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiability": {
     "auth_ref": [
      "r236",
      "r237",
      "r250"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.",
        "label": "Contract with Customer, Liability",
        "terseLabel": "Contract liability"
       }
      }
     },
     "localname": "ContractWithCustomerLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r236",
      "r237",
      "r250"
     ],
     "calculation": {
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityNoncurrent": {
     "auth_ref": [
      "r236",
      "r237",
      "r250"
     ],
     "calculation": {
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.",
        "label": "Contract with Customer, Liability, Noncurrent",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityRevenueRecognized": {
     "auth_ref": [
      "r251"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized that was previously included in balance of obligation to transfer good or service to customer for which consideration from customer has been received or is due.",
        "label": "Contract with Customer, Liability, Revenue Recognized",
        "terseLabel": "Revenue recognized"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityRevenueRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfRevenue": {
     "auth_ref": [
      "r22",
      "r115",
      "r192",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r332",
      "r484"
     ],
     "calculation": {
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.",
        "label": "Cost of Revenue",
        "terseLabel": "Cost of revenue"
       }
      }
     },
     "localname": "CostOfRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfSalesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing cost of sales.",
        "label": "Cost of Sales [Member]",
        "terseLabel": "Cost of revenue"
       }
      }
     },
     "localname": "CostOfSalesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/StockholdersEquityStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r41",
      "r187"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer concentration risk"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DeferredCosts": {
     "auth_ref": [
      "r73",
      "r79",
      "r452"
     ],
     "calculation": {
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of deferred cost, excluding capitalized cost related to contract with customer; classified as noncurrent.",
        "label": "Deferred Costs, Noncurrent",
        "terseLabel": "Deferred costs"
       }
      }
     },
     "localname": "DeferredCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DeferredCostsCurrent": {
     "auth_ref": [
      "r453"
     ],
     "calculation": {
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of deferred costs capitalized at the end of the reporting period that are expected to be charged against earnings within one year or the normal operating cycle, if longer.",
        "label": "Deferred Costs, Current",
        "terseLabel": "Deferred costs"
       }
      }
     },
     "localname": "DeferredCostsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DepreciationDepletionAndAmortization": {
     "auth_ref": [
      "r33",
      "r168"
     ],
     "calculation": {
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.",
        "label": "Depreciation, Depletion and Amortization",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationDepletionAndAmortization",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.amprius.com/role/PropertyPlantandEquipmentNetNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/RevenueNarrativeDetails",
      "http://www.amprius.com/role/RevenueScheduleofCompositionofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r249",
      "r426",
      "r427",
      "r428",
      "r429",
      "r430",
      "r431",
      "r432"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/RevenueNarrativeDetails",
      "http://www.amprius.com/role/RevenueScheduleofCompositionofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Net loss per share of common stock:"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasic": {
     "auth_ref": [
      "r111",
      "r128",
      "r129",
      "r131",
      "r132",
      "r133",
      "r139",
      "r142",
      "r150",
      "r151",
      "r152",
      "r156",
      "r328",
      "r329",
      "r383",
      "r386",
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic",
        "terseLabel": "Net loss per share of common stock, basic (in dollars per share)",
        "verboseLabel": "Net loss per common shares, basic (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.amprius.com/role/NetLossPerShareScheduleofCalculationofBasicandDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareDiluted": {
     "auth_ref": [
      "r111",
      "r128",
      "r129",
      "r131",
      "r132",
      "r133",
      "r142",
      "r150",
      "r151",
      "r152",
      "r156",
      "r328",
      "r329",
      "r383",
      "r386",
      "r420"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Diluted",
        "terseLabel": "Net loss per share of common stock, diluted (in dollars per share)",
        "verboseLabel": "Net loss per common shares, diluted (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.amprius.com/role/NetLossPerShareScheduleofCalculationofBasicandDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareReconciliationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share Reconciliation [Abstract]",
        "terseLabel": "Numerator:"
       }
      }
     },
     "localname": "EarningsPerShareReconciliationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/NetLossPerShareScheduleofCalculationofBasicandDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r153",
      "r154",
      "r155",
      "r157"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Net Loss Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/NetLossPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EmployeeRelatedLiabilitiesCurrent": {
     "auth_ref": [
      "r15"
     ],
     "calculation": {
      "http://www.amprius.com/role/AccruedandOtherCurrentLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Employee-related Liabilities, Current",
        "terseLabel": "Accrued compensation and benefits"
       }
      }
     },
     "localname": "EmployeeRelatedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/AccruedandOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]",
        "terseLabel": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/StockholdersEquityStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized": {
     "auth_ref": [
      "r292"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost not yet recognized for nonvested award under share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized compensation expense"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r292"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Weighted average period to be recognized"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": {
     "auth_ref": [
      "r515"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized compensation cost"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.",
        "label": "Employee Stock [Member]",
        "terseLabel": "Employee stock"
       }
      }
     },
     "localname": "EmployeeStockMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-Based Payment Arrangement, Option [Member]",
        "terseLabel": "Stock options"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/NetLossPerSharePotentiallyDilutiveSecuritiesDetails",
      "http://www.amprius.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r55",
      "r89",
      "r107",
      "r108",
      "r109",
      "r120",
      "r121",
      "r122",
      "r125",
      "r134",
      "r137",
      "r158",
      "r196",
      "r235",
      "r293",
      "r294",
      "r295",
      "r302",
      "r303",
      "r327",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r370",
      "r391",
      "r392",
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r218",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r331",
      "r374",
      "r375",
      "r376",
      "r423",
      "r424",
      "r433",
      "r434",
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r218",
      "r255",
      "r260",
      "r331",
      "r374",
      "r433",
      "r434",
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level 1"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r218",
      "r255",
      "r256",
      "r257",
      "r258",
      "r259",
      "r260",
      "r374",
      "r375",
      "r376",
      "r423",
      "r424",
      "r433",
      "r434",
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Furniture, fixtures and other equipment"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/PropertyPlantandEquipmentNetScheduleofPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r21",
      "r115",
      "r170",
      "r178",
      "r182",
      "r184",
      "r192",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r332",
      "r422",
      "r484"
     ],
     "calculation": {
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross loss"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r200",
      "r201"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/StockholdersEquityStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [
      "r201"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/StockholdersEquityStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Tax Disclosure [Abstract]"
       }
      }
     },
     "localname": "IncomeTaxDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeTaxDisclosureTextBlock": {
     "auth_ref": [
      "r116",
      "r297",
      "r298",
      "r299",
      "r304",
      "r306",
      "r308",
      "r309",
      "r310"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.",
        "label": "Income Tax Disclosure [Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/IncomeTaxes"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r117",
      "r136",
      "r137",
      "r169",
      "r296",
      "r305",
      "r307",
      "r387"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "terseLabel": "Income tax expense"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/IncomeTaxesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r32"
     ],
     "calculation": {
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r32"
     ],
     "calculation": {
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedTerseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities": {
     "auth_ref": [
      "r455"
     ],
     "calculation": {
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in accrued expenses, and obligations classified as other.",
        "label": "Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities",
        "terseLabel": "Accrued and other current liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredCharges": {
     "auth_ref": [
      "r32"
     ],
     "calculation": {
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the value of expenditures made during the current reporting period for benefits that will be received over a period of years. Deferred charges differ from prepaid expenses in that they usually extend over a long period of time and may or may not be regularly recurring costs of operation.",
        "label": "Increase (Decrease) in Deferred Charges",
        "negatedTerseLabel": "Deferred costs"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInDeferredRevenue": {
     "auth_ref": [
      "r418"
     ],
     "calculation": {
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.",
        "label": "Increase (Decrease) in Deferred Revenue",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "IncreaseDecreaseInDeferredRevenue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r32"
     ],
     "calculation": {
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedTerseLabel": "Inventories"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Operating Capital [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingCapitalAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOperatingLeaseLiability": {
     "auth_ref": [
      "r455",
      "r520"
     ],
     "calculation": {
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in obligation for operating lease.",
        "label": "Increase (Decrease) in Operating Lease Liability",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r32"
     ],
     "calculation": {
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Inventory Disclosure [Abstract]"
       }
      }
     },
     "localname": "InventoryDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_InventoryDisclosureTextBlock": {
     "auth_ref": [
      "r199"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for inventory. Includes, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the classes of inventory, and the nature of the cost elements included in inventory.",
        "label": "Inventory Disclosure [Text Block]",
        "terseLabel": "Inventory"
       }
      }
     },
     "localname": "InventoryDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/Inventory"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r49",
      "r412"
     ],
     "calculation": {
      "http://www.amprius.com/role/InventoryScheduleofInventoryDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/InventoryScheduleofInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r103",
      "r411",
      "r440"
     ],
     "calculation": {
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      },
      "http://www.amprius.com/role/InventoryScheduleofInventoryDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventories",
        "totalLabel": "Inventories, net"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.amprius.com/role/InventoryScheduleofInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r49",
      "r414"
     ],
     "calculation": {
      "http://www.amprius.com/role/InventoryScheduleofInventoryDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/InventoryScheduleofInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r49",
      "r413"
     ],
     "calculation": {
      "http://www.amprius.com/role/InventoryScheduleofInventoryDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work in process"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/InventoryScheduleofInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r50"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/PropertyPlantandEquipmentNetScheduleofPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r357"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r521"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "verboseLabel": "Schedule of Future Maturing Operating Lease Payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r363"
     ],
     "calculation": {
      "http://www.amprius.com/role/LeasesScheduleofFutureMaturingOperatingLeasePaymentsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://www.amprius.com/role/LeasesScheduleofFutureMaturingOperatingLeasePaymentsDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "terseLabel": "Future lease payments",
        "totalLabel": "Gross lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/LeasesScheduleofFutureMaturingOperatingLeasePaymentsDetails",
      "http://www.amprius.com/role/SubsequentEventsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r363"
     ],
     "calculation": {
      "http://www.amprius.com/role/LeasesScheduleofFutureMaturingOperatingLeasePaymentsDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/LeasesScheduleofFutureMaturingOperatingLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r363"
     ],
     "calculation": {
      "http://www.amprius.com/role/LeasesScheduleofFutureMaturingOperatingLeasePaymentsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/LeasesScheduleofFutureMaturingOperatingLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r363"
     ],
     "calculation": {
      "http://www.amprius.com/role/LeasesScheduleofFutureMaturingOperatingLeasePaymentsDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2028"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/LeasesScheduleofFutureMaturingOperatingLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r363"
     ],
     "calculation": {
      "http://www.amprius.com/role/LeasesScheduleofFutureMaturingOperatingLeasePaymentsDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2027"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/LeasesScheduleofFutureMaturingOperatingLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r363"
     ],
     "calculation": {
      "http://www.amprius.com/role/LeasesScheduleofFutureMaturingOperatingLeasePaymentsDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2026"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/LeasesScheduleofFutureMaturingOperatingLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r363"
     ],
     "calculation": {
      "http://www.amprius.com/role/LeasesScheduleofFutureMaturingOperatingLeasePaymentsDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/LeasesScheduleofFutureMaturingOperatingLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear": {
     "auth_ref": [
      "r521"
     ],
     "calculation": {
      "http://www.amprius.com/role/LeasesScheduleofFutureMaturingOperatingLeasePaymentsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease having initial or remaining lease term in excess of one year to be paid in remainder of current fiscal year.",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year",
        "terseLabel": "Remainder of 2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/LeasesScheduleofFutureMaturingOperatingLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r363"
     ],
     "calculation": {
      "http://www.amprius.com/role/LeasesScheduleofFutureMaturingOperatingLeasePaymentsDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less - present value adjustments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/LeasesScheduleofFutureMaturingOperatingLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseRenewalTerm": {
     "auth_ref": [
      "r519"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease renewal, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Renewal Term",
        "terseLabel": "Lease renewal term",
        "verboseLabel": "Lease renewal term (in years)"
       }
      }
     },
     "localname": "LesseeOperatingLeaseRenewalTerm",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/LeasesNarrativeDetails",
      "http://www.amprius.com/role/SubsequentEventsNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r364"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r14",
      "r115",
      "r192",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r315",
      "r316",
      "r317",
      "r332",
      "r421",
      "r484",
      "r524",
      "r525"
     ],
     "calculation": {
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r8",
      "r75",
      "r82",
      "r440",
      "r459",
      "r477",
      "r518"
     ],
     "calculation": {
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and stockholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "LIABILITIES AND STOCKHOLDERS\u2019 EQUITY"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r16",
      "r94",
      "r115",
      "r192",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r315",
      "r316",
      "r317",
      "r332",
      "r440",
      "r484",
      "r524",
      "r525"
     ],
     "calculation": {
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Noncurrent [Abstract]",
        "terseLabel": "Non-current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MoneyMarketFundsMember": {
     "auth_ref": [
      "r488"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fund that invests in short-term money-market instruments, for example, but not limited to, commercial paper, banker's acceptances, repurchase agreements, government securities, certificates of deposit, and other highly liquid securities.",
        "label": "Money Market Funds [Member]",
        "terseLabel": "Money Market Funds"
       }
      }
     },
     "localname": "MoneyMarketFundsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r112"
     ],
     "calculation": {
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r112"
     ],
     "calculation": {
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "verboseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r30",
      "r31",
      "r34"
     ],
     "calculation": {
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r20",
      "r34",
      "r77",
      "r85",
      "r92",
      "r105",
      "r106",
      "r109",
      "r115",
      "r124",
      "r128",
      "r129",
      "r131",
      "r132",
      "r136",
      "r137",
      "r148",
      "r170",
      "r178",
      "r182",
      "r184",
      "r192",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r329",
      "r332",
      "r422",
      "r484"
     ],
     "calculation": {
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "negatedLabel": "Net loss",
        "terseLabel": "Net loss",
        "totalLabel": "Net loss",
        "verboseLabel": "Net loss"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY",
      "http://www.amprius.com/role/NatureofOperationsandOrganizationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic": {
     "auth_ref": [
      "r128",
      "r129",
      "r131",
      "r132",
      "r139",
      "r140",
      "r149",
      "r152",
      "r170",
      "r178",
      "r182",
      "r184",
      "r422"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Basic",
        "terseLabel": "Net loss"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/NetLossPerShareScheduleofCalculationofBasicandDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetIncomeLossAvailableToCommonStockholdersDiluted": {
     "auth_ref": [
      "r141",
      "r144",
      "r145",
      "r146",
      "r147",
      "r149",
      "r152"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after deduction of tax, noncontrolling interests, dividends on preferred stock and participating securities, and addition from assumption of issuance of common shares for dilutive potential common shares; of income (loss) available to common shareholders.",
        "label": "Net Income (Loss) Available to Common Stockholders, Diluted",
        "terseLabel": "Net loss"
       }
      }
     },
     "localname": "NetIncomeLossAvailableToCommonStockholdersDiluted",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/NetLossPerShareScheduleofCalculationofBasicandDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]",
        "terseLabel": "New Accounting Pronouncements or Change in Accounting Principle [Line Items]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsOrChangeInAccountingPrincipleTable": {
     "auth_ref": [
      "r39",
      "r87",
      "r88",
      "r89",
      "r90",
      "r91",
      "r123",
      "r124",
      "r125",
      "r126",
      "r127",
      "r131",
      "r138",
      "r156",
      "r190",
      "r191",
      "r193",
      "r194",
      "r195",
      "r196",
      "r197",
      "r198",
      "r293",
      "r294",
      "r295",
      "r300",
      "r301",
      "r302",
      "r303",
      "r311",
      "r312",
      "r313",
      "r319",
      "r320",
      "r321",
      "r322",
      "r323",
      "r324",
      "r325",
      "r326",
      "r327",
      "r328",
      "r329",
      "r330",
      "r333",
      "r334",
      "r335",
      "r336",
      "r337",
      "r338",
      "r339",
      "r340",
      "r348",
      "r349",
      "r350",
      "r351",
      "r352",
      "r353",
      "r365",
      "r366",
      "r367",
      "r368",
      "r369",
      "r370",
      "r380",
      "r381",
      "r382",
      "r389",
      "r390",
      "r391",
      "r392",
      "r393",
      "r394",
      "r395",
      "r396",
      "r397",
      "r398",
      "r399",
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summarization of the changes in an accounting principle or a new accounting pronouncement, including the line items affected by the change and the financial effects of the change on those particular line items.",
        "label": "Accounting Standards Update and Change in Accounting Principle [Table]",
        "terseLabel": "Accounting Standards Update and Change in Accounting Principle [Table]"
       }
      }
     },
     "localname": "NewAccountingPronouncementsOrChangeInAccountingPrincipleTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recently Adopted Accounting Standard"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonoperatingIncomeExpense": {
     "auth_ref": [
      "r25"
     ],
     "calculation": {
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).",
        "label": "Nonoperating Income (Expense)",
        "terseLabel": "Other income, net"
       }
      }
     },
     "localname": "NonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingCostsAndExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Costs and Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingCostsAndExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r170",
      "r178",
      "r182",
      "r184",
      "r422"
     ],
     "calculation": {
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Loss from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r358",
      "r439"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating lease expense"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r355"
     ],
     "calculation": {
      "http://www.amprius.com/role/LeasesScheduleofFutureMaturingOperatingLeasePaymentsDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Total operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/LeasesScheduleofFutureMaturingOperatingLeasePaymentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r355"
     ],
     "calculation": {
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r355"
     ],
     "calculation": {
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r356",
      "r359"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating lease payments"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r354"
     ],
     "calculation": {
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Operating lease right-of-use assets, net"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "auth_ref": [
      "r456"
     ],
     "calculation": {
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense for right-of-use asset from operating lease.",
        "label": "Operating Lease, Right-of-Use Asset, Amortization Expense",
        "verboseLabel": "Non-cash operating lease expense"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r362",
      "r439"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Net present value of operating lease liabilities"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r361",
      "r439"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Weighted-average remaining term (in years)"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r0",
      "r68"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "Nature of Operations and Organization"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/NatureofOperationsandOrganization"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r15"
     ],
     "calculation": {
      "http://www.amprius.com/role/AccruedandOtherCurrentLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/AccruedandOtherCurrentLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAmortizationOfDeferredCharges": {
     "auth_ref": [
      "r23",
      "r33"
     ],
     "calculation": {
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization of other deferred costs recognized in the income statement.",
        "label": "Amortization of Other Deferred Charges",
        "terseLabel": "Amortization of deferred costs"
       }
      }
     },
     "localname": "OtherAmortizationOfDeferredCharges",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PayablesAndAccrualsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Payables and Accruals [Abstract]"
       }
      }
     },
     "localname": "PayablesAndAccrualsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PaymentsOfStockIssuanceCosts": {
     "auth_ref": [
      "r29"
     ],
     "calculation": {
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow for cost incurred directly with the issuance of an equity security.",
        "label": "Payments of Stock Issuance Costs",
        "negatedTerseLabel": "Payment of financing costs in connection with a stock purchase agreement"
       }
      }
     },
     "localname": "PaymentsOfStockIssuanceCosts",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r26"
     ],
     "calculation": {
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedLabel": "Purchase of property, plant and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [
      "r489",
      "r490",
      "r491",
      "r492",
      "r493",
      "r494",
      "r495",
      "r496",
      "r497",
      "r498",
      "r499",
      "r500",
      "r501",
      "r502",
      "r503",
      "r504",
      "r505",
      "r506",
      "r507",
      "r508",
      "r509",
      "r510",
      "r511",
      "r512",
      "r513",
      "r514"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PreferredStockParOrStatedValuePerShare": {
     "auth_ref": [
      "r2",
      "r219"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.",
        "label": "Preferred Stock, Par or Stated Value Per Share",
        "terseLabel": "Preferred stock, par value (in dollars per share)"
       }
      }
     },
     "localname": "PreferredStockParOrStatedValuePerShare",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.amprius.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_PreferredStockSharesAuthorized": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.",
        "label": "Preferred Stock, Shares Authorized",
        "terseLabel": "Preferred stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical",
      "http://www.amprius.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesIssued": {
     "auth_ref": [
      "r2",
      "r219"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.",
        "label": "Preferred Stock, Shares Issued",
        "terseLabel": "Preferred stock, shares issued (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockSharesOutstanding": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.",
        "label": "Preferred Stock, Shares Outstanding",
        "terseLabel": "Preferred stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "PreferredStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETSParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_PreferredStockValueOutstanding": {
     "auth_ref": [
      "r2"
     ],
     "calculation": {
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by shareholders, which is net of related treasury stock. May be all or a portion of the number of preferred shares authorized. These shares represent the ownership interest of the preferred shareholders.",
        "label": "Preferred Stock, Value, Outstanding",
        "terseLabel": "Preferred stock; $0.0001 par value; 50,000,000 shares authorized; no shares issued and outstanding."
       }
      }
     },
     "localname": "PreferredStockValueOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r454"
     ],
     "calculation": {
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromContributionsFromParent": {
     "auth_ref": [
      "r28"
     ],
     "calculation": {
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from parent as a source of financing that is recorded as additional paid in capital.",
        "label": "Proceeds from Contributions from Parent",
        "terseLabel": "Capital contributions from Amprius Holdings"
       }
      }
     },
     "localname": "ProceedsFromContributionsFromParent",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r27"
     ],
     "calculation": {
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Issuance of common stock in connection with a stock purchase agreement"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.amprius.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r27",
      "r61"
     ],
     "calculation": {
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "verboseLabel": "Proceeds from exercise of stock options"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Property, Plant and Equipment [Abstract]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r52"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Long-Lived Tangible Asset [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/PropertyPlantandEquipmentNetScheduleofPropertyandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": {
     "auth_ref": [
      "r53",
      "r404",
      "r405",
      "r406"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment Disclosure [Text Block]",
        "terseLabel": "Property, Plant and Equipment, Net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/PropertyPlantandEquipmentNet"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r50",
      "r96"
     ],
     "calculation": {
      "http://www.amprius.com/role/PropertyPlantandEquipmentNetScheduleofPropertyandEquipmentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Property, plant and equipment, at cost"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/PropertyPlantandEquipmentNetScheduleofPropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/PropertyPlantandEquipmentNetScheduleofPropertyandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r52",
      "r83",
      "r385",
      "r440"
     ],
     "calculation": {
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://www.amprius.com/role/PropertyPlantandEquipmentNetScheduleofPropertyandEquipmentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property, plant and equipment, net",
        "totalLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.amprius.com/role/PropertyPlantandEquipmentNetScheduleofPropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r52"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Schedule of Property and Equipment, Net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/PropertyPlantandEquipmentNetTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r50"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Long-Lived Tangible Asset [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/PropertyPlantandEquipmentNetScheduleofPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r65",
      "r86",
      "r532"
     ],
     "calculation": {
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/StockholdersEquityStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedCash": {
     "auth_ref": [
      "r451",
      "r457",
      "r533",
      "r534"
     ],
     "calculation": {
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash restricted as to withdrawal or usage. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits.",
        "label": "Restricted Cash",
        "terseLabel": "Restricted cash included in other assets"
       }
      }
     },
     "localname": "RestrictedCash",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS",
      "http://www.amprius.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": {
     "auth_ref": [
      "r95"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash and Cash Equivalents [Domain]",
        "terseLabel": "Cash and Cash Equivalents [Domain]"
       }
      }
     },
     "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "RSUs"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/NetLossPerSharePotentiallyDilutiveSecuritiesDetails",
      "http://www.amprius.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r5",
      "r56",
      "r81",
      "r395",
      "r400",
      "r440"
     ],
     "calculation": {
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "negatedLabel": "Accumulated deficit",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.amprius.com/role/NatureofOperationsandOrganizationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r89",
      "r120",
      "r121",
      "r122",
      "r125",
      "r134",
      "r137",
      "r196",
      "r293",
      "r294",
      "r295",
      "r302",
      "r303",
      "r327",
      "r391",
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Revenue from Contract with Customer [Abstract]"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerTextBlock": {
     "auth_ref": [
      "r239",
      "r240",
      "r241",
      "r242",
      "r243",
      "r244",
      "r247",
      "r248",
      "r252",
      "r253"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.",
        "label": "Revenue from Contract with Customer [Text Block]",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/Revenue"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligation": {
     "auth_ref": [
      "r245"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of transaction price allocated to performance obligation that has not been recognized as revenue.",
        "label": "Revenue, Remaining Performance Obligation, Amount",
        "terseLabel": "Revenue, remaining performance obligation, amount"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/RevenuePerformanceObligationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/RevenuePerformanceObligationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1": {
     "auth_ref": [
      "r246"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period in which remaining performance obligation is expected to be recognized as revenue, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Period",
        "terseLabel": "Revenue, remaining performance obligation, period"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/RevenuePerformanceObligationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis": {
     "auth_ref": [
      "r246"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Start date of time band for expected timing of satisfaction of remaining performance obligation, in YYYY-MM-DD format.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionStartDateAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/RevenuePerformanceObligationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about expected timing for satisfying remaining performance obligation.",
        "label": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]",
        "terseLabel": "Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Table]"
       }
      }
     },
     "localname": "RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/RevenuePerformanceObligationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_Revenues": {
     "auth_ref": [
      "r110",
      "r115",
      "r166",
      "r167",
      "r177",
      "r180",
      "r181",
      "r185",
      "r186",
      "r187",
      "r192",
      "r208",
      "r209",
      "r210",
      "r211",
      "r212",
      "r213",
      "r214",
      "r215",
      "r216",
      "r332",
      "r384",
      "r484"
     ],
     "calculation": {
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).",
        "label": "Revenues",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "Revenues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.amprius.com/role/RevenueNarrativeDetails",
      "http://www.amprius.com/role/RevenueScheduleofCompositionofRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r360",
      "r439"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Right-of-use asset obtained in exchange for operating lease liability"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash received on stock transaction after deduction of issuance costs.",
        "label": "Sale of Stock, Consideration Received on Transaction",
        "terseLabel": "Consideration received"
       }
      }
     },
     "localname": "SaleOfStockConsiderationReceivedOnTransaction",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/NatureofOperationsandOrganizationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SaleOfStockNameOfTransactionDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sale of the entity's stock, including, but not limited to, initial public offering (IPO) and private placement.",
        "label": "Sale of Stock [Domain]",
        "terseLabel": "Sale of Stock [Domain]"
       }
      }
     },
     "localname": "SaleOfStockNameOfTransactionDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/NatureofOperationsandOrganizationNarrativeDetails",
      "http://www.amprius.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.",
        "label": "Sale of Stock, Number of Shares Issued in Transaction",
        "terseLabel": "Number of shares issued in transaction (in shares)"
       }
      }
     },
     "localname": "SaleOfStockNumberOfSharesIssuedInTransaction",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SalesRevenueNetMember": {
     "auth_ref": [
      "r187",
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue Benchmark [Member]",
        "terseLabel": "Revenue benchmark"
       }
      }
     },
     "localname": "SalesRevenueNetMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.",
        "label": "Schedule of Accounts Payable and Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Accrued and Other Current Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/AccruedandOtherCurrentLiabilitiesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r40"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/NetLossPerSharePotentiallyDilutiveSecuritiesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r40"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Schedule of Potentially Dilutive Securities"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/NetLossPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTable": {
     "auth_ref": [
      "r66"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of the equity interest (such as common shares, preferred shares, or partnership interest) issued or issuable to acquire an entity in a business combination.",
        "label": "Schedule of Business Acquisitions by Acquisition, Equity Interest Issued or Issuable [Table]",
        "terseLabel": "Schedule of Business Acquisitions by Acquisition, Equity Interest Issued or Issuable [Table]"
       }
      }
     },
     "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionEquityInterestIssuedOrIssuableTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/NatureofOperationsandOrganizationNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r475"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Calculation of Basic and Diluted Net Loss Per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/NetLossPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable": {
     "auth_ref": [
      "r60",
      "r62"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about amount recognized for award under share-based payment arrangement. Includes, but is not limited to, amount expensed in statement of income or comprehensive income, amount capitalized in statement of financial position, and corresponding reporting line item in financial statements.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]",
        "terseLabel": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table]"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/StockholdersEquityStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock": {
     "auth_ref": [
      "r60"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of allocation of amount expensed and capitalized for award under share-based payment arrangement to statement of income or comprehensive income and statement of financial position. Includes, but is not limited to, corresponding line item in financial statement.",
        "label": "Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Table Text Block]",
        "terseLabel": "Summary of Stock-Based Compensation Expense"
       }
      }
     },
     "localname": "ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/StockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock": {
     "auth_ref": [
      "r47"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.",
        "label": "Revenue from External Customers by Products and Services [Table Text Block]",
        "terseLabel": "Schedule of Composition of Revenue"
       }
      }
     },
     "localname": "ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/RevenueTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r1",
      "r9",
      "r10",
      "r11"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Schedule of Inventory"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/InventoryTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r52"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/PropertyPlantandEquipmentNetScheduleofPropertyandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r262",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]",
        "terseLabel": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/StockholdersEquityNarrativeDetails",
      "http://www.amprius.com/role/StockholdersEquityStockWarrantDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": {
     "auth_ref": [
      "r57",
      "r59"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.",
        "label": "Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]",
        "terseLabel": "Summary of Outstanding Stock Warrants"
       }
      }
     },
     "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/StockholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r171",
      "r172",
      "r173",
      "r174",
      "r175",
      "r176",
      "r186"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "terseLabel": "Segment Reporting"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r24"
     ],
     "calculation": {
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.",
        "label": "Selling, General and Administrative Expenses [Member]",
        "terseLabel": "Selling, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/StockholdersEquityStockBasedCompensationExpenseDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r32"
     ],
     "calculation": {
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-Based Payment Arrangement, Noncash Expense",
        "terseLabel": "Stock-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFCASHFLOWS"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period",
        "terseLabel": "Award vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r279"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]",
        "terseLabel": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/StockholdersEquityNarrativeDetails",
      "http://www.amprius.com/role/StockholdersEquityStockWarrantDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270",
      "r271",
      "r272",
      "r273",
      "r274",
      "r275",
      "r276",
      "r277",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r286",
      "r287",
      "r288",
      "r289",
      "r290"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod": {
     "auth_ref": [
      "r438"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period from grant date that an equity-based award expires, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Expiration Period",
        "terseLabel": "Award expiration period"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r38",
      "r113"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r100",
      "r101",
      "r102",
      "r115",
      "r142",
      "r143",
      "r150",
      "r152",
      "r159",
      "r160",
      "r192",
      "r208",
      "r210",
      "r211",
      "r212",
      "r215",
      "r216",
      "r219",
      "r220",
      "r223",
      "r227",
      "r233",
      "r332",
      "r409",
      "r450",
      "r458",
      "r474"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/Cover"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r19",
      "r55",
      "r89",
      "r107",
      "r108",
      "r109",
      "r120",
      "r121",
      "r122",
      "r125",
      "r134",
      "r137",
      "r158",
      "r196",
      "r235",
      "r293",
      "r294",
      "r295",
      "r302",
      "r303",
      "r327",
      "r341",
      "r342",
      "r343",
      "r344",
      "r345",
      "r346",
      "r370",
      "r391",
      "r392",
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r120",
      "r121",
      "r122",
      "r158",
      "r379"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r2",
      "r3",
      "r55",
      "r56"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "verboseLabel": "Issuance of common stock in connection with a stock purchase agreement, net of issuance cost (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r2",
      "r3",
      "r55",
      "r56",
      "r273"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period",
        "verboseLabel": "Exercise of stock options (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r2",
      "r3",
      "r55",
      "r56"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "terseLabel": "Issuance of common stock in connection with a stock purchase agreement, net of issuance cost"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r19",
      "r55",
      "r56"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Exercise of stock options"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r3",
      "r6",
      "r7",
      "r48",
      "r440",
      "r459",
      "r477",
      "r518"
     ],
     "calculation": {
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance",
        "totalLabel": "Total stockholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS",
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFSTOCKHOLDERSEQUITY"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Stockholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDBALANCESHEETS"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r58",
      "r114",
      "r220",
      "r222",
      "r223",
      "r224",
      "r225",
      "r226",
      "r227",
      "r228",
      "r229",
      "r230",
      "r231",
      "r232",
      "r235",
      "r318"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Stockholders' Equity"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/StockholdersEquity"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsequentEventLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.",
        "label": "Subsequent Event [Line Items]",
        "terseLabel": "Subsequent Event [Line Items]"
       }
      }
     },
     "localname": "SubsequentEventLineItems",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/SubsequentEventsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventMember": {
     "auth_ref": [
      "r347",
      "r372"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event [Member]",
        "terseLabel": "Subsequent Events"
       }
      }
     },
     "localname": "SubsequentEventMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/SubsequentEventsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventTable": {
     "auth_ref": [
      "r347",
      "r372"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.",
        "label": "Subsequent Event [Table]",
        "terseLabel": "Subsequent Event [Table]"
       }
      }
     },
     "localname": "SubsequentEventTable",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/SubsequentEventsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeAxis": {
     "auth_ref": [
      "r347",
      "r372"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Axis]",
        "terseLabel": "Subsequent Event Type [Axis]"
       }
      }
     },
     "localname": "SubsequentEventTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/SubsequentEventsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventTypeDomain": {
     "auth_ref": [
      "r347",
      "r372"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued.",
        "label": "Subsequent Event Type [Domain]",
        "terseLabel": "Subsequent Event Type [Domain]"
       }
      }
     },
     "localname": "SubsequentEventTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/SubsequentEventsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SubsequentEventsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Subsequent Events [Abstract]"
       }
      }
     },
     "localname": "SubsequentEventsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "xbrltype": "stringItemType"
    },
    "us-gaap_SubsequentEventsTextBlock": {
     "auth_ref": [
      "r371",
      "r373"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.",
        "label": "Subsequent Events [Text Block]",
        "terseLabel": "Subsequent Event"
       }
      }
     },
     "localname": "SubsequentEventsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/SubsequentEvents"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SubsidiarySaleOfStockAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of sale of the entity's stock.",
        "label": "Sale of Stock [Axis]",
        "terseLabel": "Sale of Stock [Axis]"
       }
      }
     },
     "localname": "SubsidiarySaleOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/NatureofOperationsandOrganizationNarrativeDetails",
      "http://www.amprius.com/role/StockholdersEquityNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TimingOfTransferOfGoodOrServiceAxis": {
     "auth_ref": [
      "r431",
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by timing of transfer of good or service to customer.",
        "label": "Timing of Transfer of Good or Service [Axis]",
        "terseLabel": "Timing of Transfer of Good or Service [Axis]"
       }
      }
     },
     "localname": "TimingOfTransferOfGoodOrServiceAxis",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_TimingOfTransferOfGoodOrServiceDomain": {
     "auth_ref": [
      "r431",
      "r487"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Timing of transfer of good or service to customer. Includes, but is not limited to, at point in time or over time.",
        "label": "Timing of Transfer of Good or Service [Domain]",
        "terseLabel": "Timing of Transfer of Good or Service [Domain]"
       }
      }
     },
     "localname": "TimingOfTransferOfGoodOrServiceDomain",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransferredAtPointInTimeMember": {
     "auth_ref": [
      "r431"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Contract with customer in which good or service is transferred at point in time.",
        "label": "Transferred at Point in Time [Member]",
        "terseLabel": "Bill-and-hold"
       }
      }
     },
     "localname": "TransferredAtPointInTimeMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/RevenueNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r44",
      "r45",
      "r46",
      "r161",
      "r162",
      "r164",
      "r165"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_WarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
        "label": "Warrant [Member]",
        "verboseLabel": "Stock warrants"
       }
      }
     },
     "localname": "WarrantMember",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/NetLossPerSharePotentiallyDilutiveSecuritiesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfDilutedSharesOutstanding": {
     "auth_ref": [
      "r141",
      "r152"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.",
        "label": "Weighted Average Number of Shares Outstanding, Diluted",
        "terseLabel": "Weighted-average common shares outstanding, diluted (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfDilutedSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.amprius.com/role/NetLossPerShareScheduleofCalculationofBasicandDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Weighted Average Number of Shares Outstanding, Diluted [Abstract]",
        "terseLabel": "Denominator:",
        "verboseLabel": "Weighted-average common shares outstanding:"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingAbstract",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.amprius.com/role/NetLossPerShareScheduleofCalculationofBasicandDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": {
     "auth_ref": [
      "r139",
      "r152"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.",
        "label": "Weighted Average Number of Shares Outstanding, Basic",
        "terseLabel": "Weighted-average common shares outstanding, basic (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfSharesOutstandingBasic",
     "nsuri": "http://fasb.org/us-gaap/2022",
     "presentation": [
      "http://www.amprius.com/role/CONDENSEDCONSOLIDATEDSTATEMENTSOFOPERATIONS",
      "http://www.amprius.com/role/NetLossPerShareScheduleofCalculationofBasicandDilutedNetLossPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 8
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "https://asc.fasb.org/topic&trid=2122149",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27)(b))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(1))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(25))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18726-107790",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h)(2))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(1)(iii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(m)(2)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21728-107793",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(4)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a),20,24)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=SL124452830-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.M.Q2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1377-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1505-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1930-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "https://asc.fasb.org/topic&trid=2144383",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=126986314&loc=SL124402458-218513",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "https://asc.fasb.org/topic&trid=2126998",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "420",
   "URI": "https://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q4)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.3)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130533-203044",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(1)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7)",
   "Topic": "220",
   "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "https://asc.fasb.org/topic&trid=49130388",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.5.Q1)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.C)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "270",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "740",
   "URI": "https://asc.fasb.org/topic&trid=2144680",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=128092918&loc=SL128093175-196984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(1)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(2)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(4)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL126732908-238011",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL120254526-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL121967933-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=126983955&loc=SL122642865-165497",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "832",
   "URI": "https://asc.fasb.org/extlink&oid=128342835&loc=SL128342857-244232",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128293352&loc=SL126838806-209984",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918643-209977",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/subtopic&trid=77888251",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL122150809-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "855",
   "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "855",
   "URI": "https://asc.fasb.org/topic&trid=2122774",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "https://asc.fasb.org/topic&trid=2122369",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "926",
   "URI": "https://asc.fasb.org/extlink&oid=120154821&loc=SL120154904-197079",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(27))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(23))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iii)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(iv)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(1)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "440",
   "Subparagraph": "(a)",
   "Topic": "954",
   "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(c)",
   "Topic": "976",
   "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "310",
   "Subparagraph": "(b)",
   "Topic": "978",
   "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r409": {
   "Name": "Regulation S-K (SK)",
   "Number": "229",
   "Paragraph": "(a)",
   "Publisher": "SEC",
   "Section": "1402",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226024-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226049-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=99393222&loc=SL20226052-175313",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "52",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69B",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "69C",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441",
   "role": "http://www.xbrl.org/2003/role/exampleRef"
  },
  "r443": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r444": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r445": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r446": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r447": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r448": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r449": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054",
   "role": "http://www.xbrl.org/2003/role/recommendedDisclosureRef"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(9))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=SL124452830-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(3)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)(4)",
   "Topic": "326",
   "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "410",
   "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "20",
   "Subparagraph": "(SAB Topic 5.Y.Q2)",
   "Topic": "450",
   "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "https://asc.fasb.org/topic&trid=2127136",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii))",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)",
   "Topic": "470",
   "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "https://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(v)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)(3)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)",
   "Topic": "815",
   "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(01)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)(3)(iii)(03)",
   "Topic": "848",
   "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "852",
   "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "360",
   "URI": "https://asc.fasb.org/topic&trid=2155823",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "730",
   "Topic": "912",
   "URI": "https://asc.fasb.org/extlink&oid=6472174&loc=d3e58812-109433",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(2))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195",
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "https://asc.fasb.org/topic&trid=2144648",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "50",
   "Topic": "505",
   "URI": "https://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "https://asc.fasb.org/topic&trid=2208762",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=SL79508275-113901",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "718",
   "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "https://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)(4)",
   "Topic": "805",
   "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "https://asc.fasb.org/topic&trid=2197479",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "https://asc.fasb.org/extlink&oid=123444420&loc=d3e33268-110906",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(1)(a))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(10))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "105",
   "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(1))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(17))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(18))",
   "Topic": "210",
   "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682",
   "role": "http://www.xbrl.org/2003/role/disclosureRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>63
<FILENAME>0001899287-23-000076-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001899287-23-000076-xbrl.zip
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MWR/ ,+LU5(^,MKIQUH#1U#_4\TCPS=TO%_4/:^?QW1J'KE5;K8?Z.3H=$I[
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M8G$IA':6"AZR-T.F5T69XZ-/\(HRQS,ED&$ 3(SE8, RP/\ 35 8B!%^ U[
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MD_H@)-8A,!)SC;B1V'"$.27(:>OQ[,OF3J>GFT/O<[WHM-XT=L]LD,&"UZE
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M42?C3[[8/M"%_^O\_AO<U!O#L/V;9 6!O0A$^0"BK#*F1'2K-;6!H2#0+)F
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M2]>BBDN.207E=U=.%$%:<YSJ8%C*%-6I]IZG.K.:>*6!LG)NB<PS4<4(WK
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M\BMS-*;4_YWE:(I*&%H_7..;.\O?!/?!,I^E $%=RKS,4NT12A7*+#$ND"R
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M0*1&!*7<DPR 9HRN(^523 G')&ADC9M;4HA,46R]6BV;"K!82>WK2>WMI."
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M*4)."!]<<-I&";NE R:VD/H2[/D4\U6QY\NRY^V*C=)(S546>_2("%!Q:@1
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M06.4>PI*AF$*&9YKQ#*LI!*2>FXVML6FH'5+\%]8M%>N9M2B_>2B/:F,4&:
MCH(@CXU 7#&+5' ":9Y[C!DG.E?1O27PK]HF_(6TN>I,>;7JD-QZ*"A#?V.)
M5W5*XLH ZW@Z'.<]4(]PBC)+)0"6"+&[L '\"E)GF1#$XXWM;),]7!>I8W*_
MHORO7(NIY?\QY7]28<&6&<YHB-Z3@#AS&BD"!HD2ANC LHSF<4#1IEQU?Z$Z
M*/<0 ?TK)A*%;N>B4F0Z[?LI, O'O%X0>JU'0M$0QP[:MG/A(\5J)%L9DIU,
M:S(:@,LJ'!.+..(ARY A+/8?S@A66'(GQ,:VVLS%-)(MGEFPE+R\(%?+JP6
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MQK\ZK?@4O3GI>ZG),9@#_4X1S5F5=5#[=FI_6+UGZV,=Z(O+'PN=KN-(\A:
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M6F-DN @HPU;@(+PEC,?FP&H3DP<W :@!M ;05P6@R_CSA-#!64)RQ1W/+).
MHT+FN7:6Y2)D\Q&T;CO\/% ZH85*%G"N/4&!"(YXH!J9#/11G%-X58/50 -
M*2:;2JJ5-1ZN4;1&T5\<19?IW0X0:3,NM0.3+^,ZENHSFX,-B)EQGM9JZ'I@
MYV0<Q J?FYPKE#'X 5:\0]I0A[ 75G 2_PO8F>6;F$T[#U^D%IH"*?],D^OA
M7]?\OOV_\*-:]=1<R%+TME.!P?!1%_E:NL5P-XIG@IUHZ<N>?U/]\KMK]BY;
M^OI-LYWD+WWI]PO=/6NVJRT2EU./E.Y7O/U[,>Y;J2VLDM"60:+RQG?/$>=D
M*R>+S1%?<CRY>J19ZO?[YFV+E5LXYR]DK7'N>W:_<?+U8N]>;+;09>\(Q]Z=
M1I$O,O-X_4;3GIYWO6]<P.?.>PW?=M[=C-/>'(7Z@ G0<W=._6JSM8OH:2-I
M/O6(\OL/31[FSZ>C.B;1HV8[_5ZFTM>;>__-M79P,4@U!VE']WQHVN9"\P[J
M'9T-I)U^R:GC)D_*Q,U_3Z\7YL\B>$H7P--G-<.'6Y(N^"8*8],NL$F_';0;
M_?/. "[J>IL-_\/Z2/*88])PNJ^G?#?+,."+8YDBMV95C[Q(=OLOLW4[%V"(
M+@)72^S.0S]ZWXR^>P'@VKG<;N;Z[7GK+XSO5FHD64&ZWW(;](*\;S-3^8)7
MC#N1J1P;KH(S5@3*,R]M1AP.11R83$X6JU/Y;GKBOK[]>K3W&:YW=GWX\>#G
MT=?W7S]='/*CTU;K\.?[\\.O<#]ZP#[#O2<]<8<?#_'1Q2=^O'?PXQ.LYNC/
MH^:GGV?D^..'GT=_[E_'9_OTU5T<[AV%*A@\WGHDS_*,*(T$(!CB2C&D-2=(
M.RF#L]Q8)3:VN=@D>;9)^%IE\KWJ&,"K<?'?#V%>3Q[>TV''S\DN[7$4%Y89
M<M@#=CA,D,&*($4%R[$G/(9=MJ?'<*WC9,(:N6KD6C5RY10K.$6SS'O*">-2
MJBQ*"<!5[@#+'H)<OWQP\NE@;;)MC&%,<9M3Y&,M':<4(T-U0";H#'.!<VKT
MQK94FU2L.,6XQK9UD?+7B6W+I*]AFF54X(SF &Y:.25%Q@T.5F/B<V?G@UN=
MOO8<*,<F>\D;AVW()=)9K$25WB$E .^<"Y[20)V.O>1SL<GQM 9WW^2U&N#6
M1=1?)\ M@6^$<"*"\RSDCF,7E-0:,RLDH9D'#*J5M[6 M<D66H%@924VR!ON
M$2<$E#>K%<(B$,JIM#1(L$G9IGPARMMKZ+#UWO>[G4B#[W&>?1N6UHO2V0FQ
M8VY,4IC39K>8E.@&/C;:_6/0@POW>HW=SH5IME_7"(XEIR>ZS FC5:8]X<9@
M([F2F5,L)\H&/ ?;:J?]\X#<[IC3_N?A]?'.ERS+"<FD0X;H-.R (P5G$V*4
M8($EV*4F;&Q3O"F4 *![XFG3OV:KGB54A_N)5^VQ7KW@_)P0'*,(=MQFB&4,
MM(/<&J2Y<,@9J8QTUM+88'.=AA_7PKEJQT7&N?*<,\>PY4(0R8-WS(0 AB[&
M,EN)XZ(6TV7$E$R(J2288J(HG&^>("ZQ1]KX@'+-<ZHLII+166):=[I;6PDM
M>WW60%J3J>XW=WL.VF9\0Z<>[=X]2D+:+YZ3QC0Q6%N+<\XX)T333*5^F9XQ
M3\6<N&MMWC[/\=^<RDE3.1=2Y0YE-HMY)?!#.9&A+ B3FZBI&0/'O]C,<[J)
M9X0GGGL8Q<*"]T).A67Z MU+]FK;=_52-9FME6%I ^99'&2?(ZZE0S%["X$X
M2<OS7!.2;VSGC^T47[.87RW6BT7#- F::^QE,%Q9*QVSN5">>FQ)[O,Z&K86
M,C^9RJ0#B#QE&0I,>Y!YGB-#K4 8$)E2*8+,9)G*M*JI\;7@K[_@+Y7G8V,I
M@"7 -R#Y4F@',N_AM*"6,:MQG>>S7A PF>?#C HX:(RL50QQH!S21%K$!<\5
M-\$K(I\@SZ>6_K61_F5J+ZS/!)$LRPWCCFG#+<%>.2^!D22M,YC70^8GDV!L
M1J/GG*' /1S[CH<8*:;( RV-55D>"'NJ))@Z#V8)R1R_*5S$HN8/=-YTSK??
MU#)PFPQ<XZL)&1"":1XP1E[E$LX]9I &\$(^4&F%U,Q*L[&]6[27B(E'P,7>
M]DO':QR.64S\GI-ZU#_W\-'.9;],5-HYV6U(/FI#\TKRCNH1;B\VTE*3J2;3
M+T.F92Q:SG)I%,MPGF><"Z-S["16DIC I,MHG0#RY(?WE-'J38Z9Y A4UPQQ
M3 V2WCI$P'0--O.6"@L*K.!U"LBO*:-YR&-(@O/81IOGRBA+O/=4\A G'JZF
MNJR6T65D=&I8>0P!$(:1,QE!/,,6*:$Q"LQJI0%2N<K62$9?0V+)_@_?M<V>
MCP9)41M1&"CW&UU^]P:L'\8LERB" S%<<*Z$"YQSHPQC5 ?!E<FPR70:J4JK
MD:KTSH&$"60.>KV!=WN#+FS:.WB*CBNR1]*;QP4]*D*Y.H]D50AUO#N51Q)4
MT($J8&@=..)>2*25L<@[E2FJ'18NW]CFFT#OM4LA>8'G^_U,I=DH\U)B R^0
M3,N,J,$ALT:HX%W&F<R5,$80S3(E36Y]N ,?Y\0!I@'R/[HU\'/PL5;2EH'
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MW&BUM_-%D&F](TUC$#;R<KXO\.FTD]Q"?TP>^_6!?F]SZV]R^--^\<X'(*I
M*G6OQ9E&,M8RL8QGGH20"Z8VM@FNVTR_-&&O,?E%D&F](U U)C^ID55@LF0F
M9$)[1!SCB(L\]A:W'K'@,R:IER*WZX;)KR$R=>3[C5:G]WH*U.I(5.WKK,E4
MD^FYR;1,,3[-E-><99H9SKU7$N-<$NLT85Y9[Q90DN94Y0/\'[1MY\+_!6=
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MD0U:95Y0Y4@<((35+S5VY&7H$ ?M[[[=[W1!*WQE<:XGKDJ["W?&"%$#SE*
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M@6:9H81:QU40FG"EI,V)5)(&HC8:'LS[RRB$W0'HBT>Z#QL=%:_C2U_H<$5
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MZ-9TH_NRV\#CU@*=C'A\9YC4]*[3BH[OWII4^.##W:K7A#N'Z]%/]/,W,)_
M#'K_]1,]%)^^'I*CKQ\$?)X??HR]* Y^3)I31W3_Q_'I9[CKW_"]/YI'?QY]
M_?2SU3S\^8$>P1H__3S[ =?Y>?CU;9RS)@[W=KXH(97*2(:\=PZ!)H61R;.
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MY$.===RD<^RR,)N*5'@-,MS][E%GT&^89%@-AD498P?(?*_KV(=,99C-.<4
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M'DN&6M<-K[OM>?/_JEXJMU9XI(M6_4=G7>:.2LOT8O$!T_WG=&3CF<3NKFG
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MW^Z=%/[)/KSJ\Z]W!K3RM4PT6=%7CL.SS(X%OSCJ]N%5(3J;XM<'-&;]03N
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M>H3<$.>OU#Z!):QVJ4 X6DU?CD:&6YRYMVM.9WFPW!C,8_3,*1T$)\9:G(S
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M)G%A-#A],ZO&>(L-A+NI6$E.6FP2//4F09GFR?2HA7&YOW&94O_EC79:^HA
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M-'1%I*Z<3>=/AT<%_9R?ZLR^4^M6/F5XU%F%Y7&@SB^QA?[0Y",UC_4TL\;
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MGM7@7*6![&^16.&Q<4AS"@9'8XZLI)E^2A#/;2#<V:55P=2,(HDYV@A9Z.Y
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M4#,W4%/VF 2.26N#E$D0S"62D+%.(:9,I%1XIHA?6N7+BLZB6^4\PB8JYMQ
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M&*XQ, M]!9D62*:B^&"WMLIZY<QDA,)ZSR63AA$3X8EQ<1,.0KI*QM'BRSO
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M/Q!(UC2Y-*3F$+BRU3'/_M[Z:C&$C)_]W8V-SB[95,U:Y\ %W6!X=@7A/@@
M97F9%27?"/[=/#LWLR59$Z@HWTZ39\M+R.GGZ"Z371XYBBYE 83W'J@E-TS-
MC*S=!.*S ;DJLV)IMX=!JLKO&,YC"H!U/)'!J1,4J82IPI!%4Y/E,A-*8FM<
M6)F@=74#I3_![>( %$<&V-3=SNOI8@TCZ0:YL5BO<#115L:,O#:-,N=2)"E9
M*<V8!%/A=(G+<HQ>F%9+3-<D4"0<,T:C:)0,^^N@C$$D)S(2_PE4%0<N7@2%
M?AY'S3ML'Q#P-8J+ZK0R5F#"T15$CAT9D6:!) *W&27FF/LAT^XR[8\.F?;/
M/I2O)=/.^8,Y*WFNC:;S/C7JUUA-C!R6@P':[V8"F\87+2LJ$[5*F0#P<[6:
M(_[61+GTWVT&-H M*;)GHBR)X8V2%RTY :1<,M7-DS GTQC.TDD)[Y4J2'^C
M[)^I_[LHQ^0G;[OMGY$?X#\#]UAL7<9C5!I7BK"8&Y;[VENT\UI*6SC(HU;>
M".&XIWM3O$<0Q8%S<#-\Y+6)[',;D!(1YXO,#M.Y >KAEXC=)ES:@VX,^&J;
M81!DX!7'YCC%0+NZ6Z],^YV?;V%S6FJ/6#-VX/[$ =^9R;E P2>1(V (!PIY
MTENC$/6PZ<(;LY;<\O<[R]L*-GDU/RK-K/O^_,%  H].3XX??3819$/ZP2=B
M"AL[RO'J/#P^QU(\9SO-^P1KMM6^_YQ0<K%3O<0[#\%Z VR2ML/(KDI](ZZ9
M=L/>B#DK?$$P"SB^6[WJN"2&;66&]&Y0"K-*8%]>^!>7*^2?^(0$+JQU%EVY
M)KE#9-?.)6.,O)S@IS; 0Q(@C:BS<^#@I=6,)M7=>P('W9O>/$04:E2@H:!1
M@*K-E5H):B&B[Z>;BCZD%2/M.&U=0#7.WNZ>K3X<R]L>2^V;&,>A.:40[L#G
M/:9Z#$PUS^;:;J>:UY"H")Z-8(DZJNQPE7#C?*;" O\"C)T_=YFV<A2">/DF
MXYAF\?IHX46$+1@>_8.X?CQQ_37CDE@T*XV<^^\_:TT2 E9!+-)8Y1GTCAG&
M:VUR(;A4$,Q;KQ3V.JC[.3J]_V0AQ4)+^IQ'1\\LFFE#AI]-:EF<SS -&85<
MO&57RF(&ZSB(UW$["G-M1#B*!NZ?N3[H929!:PE!MY*C9/.[:$47E!R0&D<V
M;J:* FL^!(@*>?-\@>BW7H::I!%P6A2]W3\W[J5'BOZ*DNQIMC+[)QBO30A$
M!5C >BDV5!^P8G"T-TS@F.K2=D,1HK"^=. M;UT)2D<Z^'(G:@X\(D]3S=E1
M@5>%Q(@]WYK'2\%D@*J[O&@9F%_/4G\N4UNH).<;K F]QO 7V5_DG]5]&UZ"
MFD<(I@/2$(4,N(&C:S7#G4(+OLUFQJ*Z!R9MX+4M#$";R2#^J;\=?9?X=GC3
MR(@WF!2V+G;$)D4B1;8Q8O^.LXU;_0DK#LQXI(35&\:VQQ F&:* J1!OZ033
MB\B76+7.,(YV.WSV5!MJ6AZ= -KKD: *R'@^P[[,LJ+4<!2P@L)%$;8XTACT
MV"*F8UTAQTCF95BCX%N/<, : BZCS0  H<=S063?.1;G:<-D0J6D#_ IG4#E
MIIFL/81<"!EDW0+:>99RG5$ -Q>2DE81R0K&33<QRDMRM'I-B(G/X1!A]A&*
M9HL614,%7P( [)>RGM#J@Q]A#]FV8$0]??'WYS\=G3Y.8,? S^6<'_>KZJM5
M8_)B*BDQ:4NZ0K8W%VB*X#+6D4/OSUJ8'JLLWAX_F<N:D?ZM:KS/=M=C7LCK
ML1A6C"1AJ=!Y5YS?C4['CJY5_SD;/"L=:Y^;NB*>Z\[QH-Y%#U*8" ]K #2!
M&9?,*&!EP@6[6&O@[\&A$K:Z'-TBNCU YIN[>':X#5#69%,*NL>NI9V]PC']
MF8PM,AA7PSV27T;N&^Y?^W'#Y50,3;69;V;/::17*D87L>G(2NVC\1I51DAJ
M&Y=7P\L_(Z71.;#W2W25S7B7_WR# B)7$3(Q<S9ODI_-I+'D%6<IKQO(13>W
M3 .HT;:(%>"%UR<Z;,%&M,MXN(@:C<URQ.GS+54B.._4S]^8EQH88D=5M6TL
M4C?!B4AMY;1^J0MXBYTUP3"_5)<G37XT9#3U_""W3 6;>WS[M85>-GH^PJ(9
M=_*#T@ZYAQMENAG&$=-!85(4]TY= 8E;%4O4L0! AIL8,$^E0;V*8A^1!L7W
MO YRD@"Y']$XD?9B-Z5O')M9)%.61=!?ZEX9!1 BKT%MRGTF)@F> 2:A5J"0
M%D'[(>YJ5FFC.R0])YR-8_?]W5FRSL[VBB7KJ0+?E9 A;&;_W#<;WS_=]\(7
M"6R1B$@=.<MU:TW 2#U MA$<V-)*Z16W!=[V>3(MZS9@.*(O\V5D^^EN9 NE
MSJMO7!O>T:(C6Q(+A+1--V\RKO3=;9* [E >$"D.D?+X@$CY[$/Y6A I UC
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MH09V6)N[NC ;=C@OS+?O(TX?1);V:[W^=2]UZ;Y\\P:=O]F':#HU9C:[3H1
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M;#U'K(AYQ7@(]AH/6,;'7X>]$$$H+'7_8&&VR!BS-5R%QX0<'C!.\ )+8]Y
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M,721O=<*-[&8XN?HU56C ,QP=H/;PP= -P4O\6BNX(HH-'@6#T<:83&1.1F
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M@GVP:!>L=O5[[71!KD]I CU,?YF^*8MV -$M /.'<O!ND>I..$2,V^=R&HT
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M+&!\8PHD+N#XT0#U:DM!,\L'S")BX1MILJ[[I%TP['1*HB\N'Q-"6EB,E(!
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MZ4N^^&^6T@X0PJRP]78,28%5R5X]O1+\ <R^M$&!)YR]ENE$N>X.DO I[O
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MY(H2*-85="]PM<N<] +S;HQM:U'-D$G3.BE-^/KK:2+DK$= =O5+1]2EY2_
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M(XI06:>D]!^I2:WW-V^1RFIAO=LDF%D+M/?M"GDT[IE3CM]YNY51/CRYPQU
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M?"=D"U +'NAQ\C,<O+<94%JIM'SQ+2(F$%U7)4BS&4<+8B#S6F("#.*F<1^
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MC60!@9 -=^ E:PC9#A,VQX(QR=$>=GV*^F3KA9('"@#N?JH+D28_TMW8"&9
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ML^/, EW?G+4Y/?-JF/':*I?GF!0=K9Z\ZIP%S'L]9@ :3)]%'OXN!O >4&2
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M7?"H>J1(+_95#G6'M?E/,12^'GHR'-U(9QK,OB[W*+".L.(%G-,MJH;UZTG
MI2V"$QH6U155"YJV+G-N\4JD(T=/N%:D(-SL'NQ3<21IV>2"6L'Z#-.IW;PV
MAM)*P$>=]TCB(>>$1])4Z@@@#AJ*^">#?\L>S:SK,!D^JJO5-JHL)CJR%W=
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M8@E^?L\DP*8C[R)$D<N2MZ0<_6'WQ^>P:4CV/I_Z=AHHIN2.OY:63!@.)CS
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M[V4Y'(1EH)M/3DS*D(4X?K?G<!8*P-RG*40B^NK\7=AR)4O:@^4Y2;)R$K@
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M9;HLHEB#XV%DSD7>"FN8:(H_P]V"\6I+P*BJ/GDB$B1P>DHXY^I.\'1R7%L
MEJ]<"=(I=R_#[=>:=F$,UU1/XPS/0%1JG282:+N]&H1PDM].G$.K&[_C[)OU
M6=B0!".1DDS[@J>.:5B[S2EW?D0G5]92S@-Y7'[@Q7^(Y4HF)I3L1)*_R#4^
MJ$17,:51C![J=BA1H0I+.[(<,GM FX8N(Y-(N[UH(Q(0IDS L&PCK+@U<EKG
MKFZO)!G"Z[ E04<>U?Y&K!].A0--7#HS'L4I/74I$D&)?"+,Z S7NINL::"Z
M"N]-OMG,0">,+LQ\'B>&,,[U=4-PJ"WED]3I4OA>\)'6RMK9M"EPV38&Q:*)
MJ17J@LPV',?:$^48R?,ZW*S?>&H^PXG?"O%!F]_&(TLS0G'R+1F=#I +(9BV
MOJ1%).R+J5E0\JMW.\CP0,K6ABP3/Q3>;?1D,W%9\2$1WZ/S3C*SZIP>\4'I
M[%GFXAA5E.$;=HSE;MY2'Z$-1)1(H8.D!\HW&:ERW)A@;,UH*]W2$*MK;X^N
M;CO=+*.3/[RX ,/CPYIOSG5Q>DN[71CC(F_)_DK1QH[Z=+E$%M3+X(%2Q0A!
M7CH'R8H6>^X]46/N BRGJ:H!XZ#3PS+:A"#EZGB^8NL@B5. ^/@;P68&2U\N
M&0T"="3$:L/%$H+&B12 (GGYYG3/.)3L_@'XS0L$Z1BW?$ WPIW'LL]AMR:K
MT#S6U*.?%\((#BPQMX:]J^#%Z'$E,&XY5=* 8$0!&KD\&1C*/W%'Q\QS7=YC
M#2+6X,M[K,$G?Y3?"M8@*24KX.A(NH9M1L'^8DF.756^*8R.W@Z'4<9%+!1)
M&SH)%7: R3A;T8?N^'?2%(5T%Z<P5RKK,KZHZ1>&D:)X,F.6MDS.2LR&\'&Q
M_-/,1<[0N6/V5,I>C VNA3(Q[3;*KD1HR'PP<[<CS.6-$, R B!?5_@'/12S
MK%-29,5IL[JIHVL598[1J\:'Q^!R&_YP.?JVPD20'"$C 4HZ@42L@4719MKP
MDK/1^[N\6NIU);SWDS6]XTYIY[4>+[-,61'HV1S= ;@8&81QX$S02*0:6,.I
MK^+HXA'I:-[ZY),+]CZ9E+EL7+(VN,P_D5Q&GX>^+V+-X1Q#IM=C.9=#,Z2L
M]EY;VGLYU7B7S=I.;KM;<&.KZ,&.?H9J4/@-A>IE%TGXZ5*03$7UF?@L* P*
M'A4A-Z#4PACY^<2L(_0KM<AN2:"XQ<D<@U6F(/(,RY/(-D_OFKS8J -51TO;
M&2="H/.]798H..9,DF>:^O66&%8R\K&D\QPH:''<>DK"&3$!A2.)+,_1?;$0
M2?)8+67I'(+>@3?)]K-HOJ0[:#T8 ?OIS7WWC8V)39]W9'VU0VN(8' C=$^K
MP#-I_#$_A&:V8V<NNE@GQB(S8>::E4C)](_-/10BTK3_701_?P:TV.+K=^]A
M'HVH71PWQ'@3N/:C$>J-&DJBS6W:42 6H]U"S4O4+$T@,3P]&OZ?I<&==KNW
MQ4T9+N\8M3D/(%E3QHBNPP00R&A2VF5[S;G72<Z/=AFVAGI)%Q-YJKE)Q\&M
M7O&(9UQ*1=9.Y)0C$J_"TXO&-0.X[%%B<_&Q*"MON"SSG/E*BJ"JH+F1>@O'
MD2%9,C++1-V+/U%Z466:6Q;2@<+(%?B542!:5SN]R=#6WCD,5K]8Z[J?Z#C%
MDD.R_[E:="0WBPB"*F[@6=Z&-0#G/JEE[&B1N80%@85#7$+MGY#8]*W6]L)G
MB18]"6(Y6F_G265R8)3'+$9"0G"^CQ$%Q0]#(;V?P-?/ .C]]=BXOT+D[1@D
MPH=4>@J0I8G=S&%W(LEY&[Y%L<%?\B7E*8*!R8)96EW2=D$+-!VJ< ># WL1
M3.)%./(V)77T"?=64\ON6:O)H8XA<2.LHW(C#0,^(C""=#@&NF;H^%]3]=A5
M%.6C./^CMT'C7<1CTLT3R"G #S#F::T,R6>LHB/JJE"4+PI%.\ASX*0E#A-'
M%\SK.$5 D,^_*PI.]HY@J>;X<'J7;%J\+X$(4M(2DX!,]H_CV*,=RSR#DW$6
M:A!KW3M57>LGTGL6AX<%D=^"?'WC_3&((O5:B*[/LJJ51-!:XXAS&9'33OT=
M0?15%6*ZQ5=A/,+)"U#3MFG6P?=&2<%,7XB5&D4-$-9:_QXN\R#,?UZVI%B=
MD])]"5DR:D&AC.O#C!L^ 3S!4O+"*%9ASA;QO\:V8+X(EV%'&AR(0Q/3$*WR
M$L3JM"+$@?B;-B#*]ES\\+?%TS]>/J4PL'1_1K<BKXPX@/Z%M8-#->V:VUJ(
M%*A.P%8D%Z'J2[U+;#S(U\U>=!"BIV#0GX([)GU1A%M1'-\YND]W.:@E25+:
M>U08E6U%!2^Q)2(*/SFF&"V58J#F3SC98VD^)Q86Q8FQ>-#!?,[/=?AF_AQ7
M2^\0G1%=8N#.N6,^HLUF2I-&*'N4/^:?UP$00B"@%N6PG3T7YM0@$*=+_OM8
M:CMZN0-<,*H?JI;ML4+QF+)@Y$6BJ\3T#RP)]1,6Q3RT$^E5OJCVX"=Z1')I
M=[-1IG8;7DV/?"D\X&30!$D6<9Z#%M(G-N!(*?TH=G/J4?-"I;15O6T8/,9:
MG.]TEL?8"W:.I#:LGEC\64S,&T!P[!=(+F;5EN225 M!R'H7K1:G*K',(PZ"
MR*F+5!P'#"TES3<'$O^;I(UQ& 1W<C]P?*'% $;&IBG\=1.VPY%[C--! BNU
M@4VG909Y/D%M,CE%"MM,"]_@,W><9YJ)S.9C4!5N!;8IMF>LG)2VB5./H NU
ML&KS5*SR/1EL3NS=N +&?1G<RN!_O"^#?_)'^:V4P5T[M<1*EKB.2#/%+Y,C
MV+046=JA9;IGC+9.^FNB!-V,D+N4 &+= 0+MF9@8%MU+D=B2?J?2:CC9UIFI
MD[7J'R#\XY*G&*0<Q.L3<-?9^:Z2]E+=NQ%9:C"\%V$-M\/>^A+QMR6!M-I#
M_ -5:NF\P#I7ZZSM_K&CR /L]=AAYDUMY!C#%H.=*9&=1/_>JKPI!76I9S)'
MZD*:I,T A& @_X/K%H8AS[03I2*"APX\/H@9D7*.)U52-%G=10YHUL&>+9^(
MRZ/BP&?HA$\SI;37OKGZ]CF'U$ 06E%!EPJ(Q/HBW3R/_XAO7UTN_O?_>OS%
ME\\63QX]=A?YOLUOBFKQ?-6/FS<8<C^[%-UZ-1=S?HVJ%.JL>'T"*1=D=,8Q
MNZM-B6Z8?.K1E,_?M7=P]YAD,6FW?+L-JZGC BSTL\EI6!R*7$)^%NN(P'50
M=W S._OM%4N(79?+,B%";:C;!^V ZY+<3U0;G,&=D1[=,L \K%<NX6(?*JV;
M,?ORXV!G1242>7>:K0TS_:%RN"N9I$/UYY0D#(0F^(0?#BTZE(S5?^7U ;$.
M"^56@Q!$KLI]J110L/F<5\4E^=SI\*KGN=% BT!$G9QV\:5N<!L?T9[1#CJ#
M\\=L %8+@9"S7W9-6.F"[^,GE[^J12>F@]QP?4G0#!;)AKF/& L\RDJB!&0
M+Y@<C_*V&V(P1_14J)Q[7J]=G'1=5-P[6T56:%FS3FVFDG*D[>Q8#72C=&1,
MYH:O:4^-DB,;%PD=(K,A $%E.?I_" &YMS;'X39REOVB<PU7@AX&,KIY-*@I
M.3A3O*'?.K_EW*Q97"6>#0?ZCD41,5_A*?;A6B6(_IYW)BD4VX[<3'$D2P4
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MJY+G:*:N*'U8 M_$1#[I1"8;&73P9KFB"0(%F.>QO^$UCS)Z2NX5XH)%/5!
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M71(HX<AZ.#;/\D1-PH;+S/NUX:SLBK?7C30-TVX<NE.+8;064MZQN!J:B)2
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M'A$Z:YT<'[=;OWR^&RO11B3K8O_[AO1R2MU8_K0E'T\A0[$X]!;+#7%Q@^*
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M?P> UOSOM\V?@*FQ?0.N1J2(E<8=86R$Z'@.J>GB?EM+:_YL7(S$#"H@@,
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M8;6;MUS1*C!U\S#J#@:[*[\I4X5:CRBQ Q6SKM_ATT0[Q0I5:$_T0MO0$7U
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M=/J]=7/]/[2UZD5M9LV1!S^^^2]02P,$%     @ =H"K5D;OHI;E%   8,,
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MQ@Q>60HYA<Z"Y52\:IVVN@G/'?ML/&I5U5P^+=<QKQKX6<1Z;N#<.2U%K-W
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M,(B<:688VI!10#G4P<TEH$EI@N<,5!# UT1C#Z5Z9?2'QG<7X:Z)GW0*D]T
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MQ28Q!VBPB<'^PW4+ZRY+^C^+\P1:'&$>UYSUZT -G,RO+IRUY6\_RUE9IDN
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M-1&L'/L) 25RF8@1$!037'MY5X_,G0]3EP,^8C/B<,%7SKF>@5@HX2XP:N9
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M9%3F0DAG=SO7N7.8XWL-QU64E;9"M01>NU'4V\LBM+/\\BO$R]E5#US5FF\
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M--$6B":+<-<NH"HF]6T$<ORDONX<W2:\DH"/QK[AWJH<//')"B*CL6A&!TJ
ME<J4:*NQ7*/TYI%9OR.M[TBD[R/7VBE&'YNI'RU6L5<X^=6#>Z<$YX8RHH27
MN .")B%220*N9NC1:ZJ5W.:-[#+0<;,>*G'1]"3(VBF \ZK?O_CI%-IOR_JD
M43B;/7K"L;3RXZJT2 J62,DU3PI-&[M;^Z$U#S\>F?5%WU246S_Y@,/_+0T9
M)\/S\5)WES%8+Q@XX0D-N629EF)UM#@<5,JD%0,K[!ZI@9O&>2CL5I1F[;S!
ML^DG:!=SOFIH-6MCM4 7I0C))=Q[7%FG:.F*#2X2 8:Y&&VT;K?7=^M0O_N5
MN:XP-[[3/<0':Y11WO2H:E&_O0HA,^,=REI)ZKW,KJ14.,UH*&*FC.7!IH?V
M',M3G.)[C2K%E2I]#@(C7J/?KZV/)B9GO*I]]'.T6!Y--(/%-4PKJ] MM:C=
MI5H<,I$"%30+5K]TZ+V-Y>W#],98WCXB/4HMD+<P?7[9EFJV Y,"UTXX7!U3
MJ7@A2C5 A]@2$X&+6 J15Z;[+CP/3 6JB;Z?V_O3UL?IWX?33TLKZ=ED E.$
M.(BX]+( EH#%C4[ZR$C15%(.QL"@,9MH#]?W-^)Y8&I13?3]U/VXA>W-T(=2
M[?K;@ 5NG J:2.4,FKDJ$L\%)T[JS*5U*O91VW SH$>@&(<)OY^ROYO!+<2
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M"(-<2,8SR?(46]6;L9IM:F3P+.H"S+=1%Z[I7WT0VQD'WH +S JG,3M?T69
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MHEI,O\[_'AP\>OF/S3*Z.[]'U6-^^[[+7VB;6I7*F!&)XJQ(D-ZB(J091$+
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M4(2M>BTU6%\_L%/5 ROE?S_HP=\^ZO]\U:-4;S_.,,D@8Z!0"060:C*@LD!
M9%F!<0)YKJSZ+I^99VJ$L!,SJN2,C*!.]L4Y8.UV:A[@"LP$@Y!R[_;4CX.O
MEDXG9AFW;U._J@?-F<Y</HP.ZD@,TY"VZOCUP2R09INZ$>TL3RC!><8!+G)C
M)IAZ\FFA-R=%C%.<TR*33F6O>F>;&C4T$4%;::-67,>NQ790V]&$-P #D\4%
MV#E3AA4FGHBC?ZY1Z<-*[><D8G?3);%8^UTQMC[SIG5@^>9!7BO]]/Y%TO4[
MO?6993"F3-,(P$G* 2R2&&#%""#0-.HQ@:O2RN%QD113HYZOW^1:[\#T5$/B
MM%R7P(YZ@@,;F)+:V*Z#[CR=@[C-*F(R^D3GXBJJX(^,(I'1Q'?@UT @O8:$
MN<KP L%B V$Z'D8V=+!A?&C*3V^>C$]YM=3#-^_Y0DK*,Y8"*#()H,0*T")7
M !$&TX+00A"GJ-2CLTR-SVHAHZV4 RVHXXC:T=?%. 6F)W>(G(FG%P)/Q')\
MCE&)HU?-Y\30?[&[U_5:,XDP;/)N06]GE,4*%2P&25H@ !75#SM.&"@22'-&
MBD))JX?]8.2I/>!;X2(CG;T3=1^N\U[3P2"$/IBVT]_))WI4UT%.T/V11O-Z
M'E6@Z^8\?L'@W$K3\^'3>O4X%U*\>OJUE.+]\OWR49;FE7_--_/'ZL17/Y4H
MEI D($=,Z:=2/Y"$Q*:T&Y6$%;!@##HF7EI.[?38CI256?6\>3#MW>=+_;]&
MYHANA7;."[-=![L7=QAT _.! ;9J2].*';&GZ*=?:Y1_CK;"1]?G81Z27.:(
MF+_,,]N)QTY+<P3D2,Z:ZPC>CF<:,Q?%J,@9DD#1A.O=@X@!*10'),Z4A )3
M@9T<)2=GFIIM<>+@8= .XC2\@X]I)K>3&(B7CZ.:(%N*T_.\]'%-_];B_ T^
M^J&_7I6;&4V8S#.8@TPD&8"9R@'.:082*C,""1$D<SJG.9QB:J2P\^+5[<OE
M#],CQC$IX0B2=C1P&3Z!G_\#!Z>1+U1O\:[N0;J'5Q.\8'_PKH+]'<#WKASH
M,GP6<_I9&IGGBWEU2K/M-,&4(HQ+!0H8(P"+7)L"-,L!P4(;"'F>,FK5:,YM
MVJE1P,>'.P/_:NW8PL,29$NWHG?H0OL9#Y,Q]V4.TN?##29?ODB[2<=U3CH!
M<>"M=+O;WSENN6O!)6A&BU0I .,8 X@0!PRE'$B2Y$HAS"7"EQ[8EI-M?5:+
M=_FI;.G:T\P?3"]SSEH&ZEEFATO 8]/RA7J2V2EN<Q!ZY"Z?U7@^;*.BDQAE
MB!0IP G2_)%C"E@,,Q S::INX4QO52ZOR/-AJL'G?=5E/@RM:7$.<Q=V\8+D
M2/0R%$1/=7H.H E:J^?#RY2 L%3=KF;/X6T#.SCHK\-'_06I@JN3.&4H(YI"
ME-[_0 X1P 1E0!0XQPQ+)I43HW0'GQI]5)V>C7"#PM/W8+,CA:%@!&8 :QS<
MNR<<4=A7HX3NT./V1#BBU$'[@V/7#*ZGHG<A#U7-W/?+3^O5K5[[LNDEGJ80
M$L2I?DC3#$"F#0"24@7BG%(L"Y3JI]BQCLK)R:;V^'9E-4>M]XVTSG543L-K
M]UC[ BWP8_X<KU;0\\WNAY1+.8N(OS(IIZ<:NSS*6:6/E$4Y?X][T-3;Y697
M5N6SO%^MS=[$1*D_E+-,*AF+S+0U@$1S!M'LD2@"%&:<*9JQA%N5USLWT=3X
MHI9UVWUW*VU4BVL?8]6+;C]E^,0LM%]S(%Q.(5DV6 R*T.H=>+2 +1OUNO%;
M5M?[*\MVK;<5FX]R,XL9%40__X 0@0 D>6'"*C4EL)QR*"DBQ*GB9M]D4Z.%
M;3DQ:@2\O C;%E1KX\$+5.&-AZ-%URI1V]R.Z\5B];WJ(*)6Z^CU6HJY253K
M,<F\%&)[#E?  FS;J5Z\\-ISI6T*KAW<,S!>8O.M&:O\J!5H:@T2P4224P&R
M! L BX(!6B0")+!0/!-IE@JGSFM'9YD:>51"ULSAN.\X#J(=9UP,36"RJ%&I
M!;R*=B)ZC)GH0\!7V,31.<:-G.A3\R!XHO?B88_Z&WF_EKP^#=4_+V1U++H4
MUW?&-/E;]?E,Q:E,BB(!><(* "$RR::Y H7$B%'*4 ZYRY-O,^G4B* K<T27
M(J(=8=V8P0IS.Z+PC61@WNB*:TXB&H$K/*]M\'3F$1> /-&*U92CLHP+",])
MQ^G>@1PT+^GM[5K>-G4$F\YC=;.,E!<LIHB!'"EA6EC%@,(, LYAD25Y3DCJ
M5*ZU;[+)<<Z>K*8&72/ML)XDO3A;\HTG]$+SS&#@W G& A%?Q-(WU;B$8J'T
M 9'8W.-&(/3N_L?LL^3T?KZABX:,WO[@W_1W07XVO\TD5S@C9I>280R@V;Y@
MCA 0"BI6)&E"8ZOSD_-338T\G@MK:C97TD8FD&5E1QT6"/<3AU_< M/& 62M
MH-%GKY")IEA=;>F- ]W>G-.#T)IW[5&I6==<;Z@TB[,LJ>C48H11R-1>DY9*
M'>X8&$U_=[]8/4GY1:X?YUQ6$;.O:"F%2?>7R[*:4.\]30Z?%-??Z5J47TW6
M;??O)JK_XVKS%[DQP;:WR_G?I-B-5-]4;66_:KEOJDB7<H9H2C"&&#"5:)ZF
M+ /$I!DG4"J8D)1QY>2@?C%-IO8:^'6YWLI>%>EOE=._]"2Y3.SK86>=_ETL
M>N!W6"4JJ&2-FC(]T?5Z;1C"_%QYZVK]HTJ7JZ85@#GXJ[6ITY_T=9OH26ZB
M'0K^FP"\^(+YRIMX,3W&3<5XZ>4ZR.YX<8$NB\AL,JDIQTCQA (BS>DLDSG
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M3L+8SP@^P F^;W#$Q?K1/Z=\W_.N[^T\Z_JWW7-^<MA1'NYS2K5/]-GK+@S
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M6=F3%TDQ-6ZI]3"&@FPUB62KBOGXOE*F:E=A-FIJJT[$JXXQ/\V7QV[]V>%
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M\4)I^@/A.IV&/W3 P1XB+LW>K4KVGY=_?267_)OFA;\VX?&%H$B@.#&Y3QC
M0@E L"! (1'+/"$TSUQ]0KT33HTE]^2-C,#15N*!^0EG,;=V!7E#,KSSYP(0
MASA[K)#QY][IGVYLAXZ5\D=<.';W75#/XX#6WLQ+OEB9;(9.Y$I>9%#_3V^_
MD#;8\D*;;I)E  FAJ+;DXAQ9M3YUGGEJU'/,.AA0C\,*=$O[*P24H>VM4S96
MM)-;FU9!C"I7N'S6Y[":=_P:'2YP'*W3X32 CV9QE<%UHWXM917"=WVW6F_F
M?ZMHLJGE.RMDCDB>"9 135100;W'Q*:I4I(F22KR/$V56XU/5Q%<'KAQ*GQ6
M'99,F/FNXO:B*@W1U-V^I$V<Q9+8$5I(F /SVD&;N$IZL%) RQ]5"EQ%717:
MXMZA.L79HQ>D4YS%]"_8*<X>G/Y.<0[CN'$?O;O_,?OZ75N 3^U_5S7'OJ_L
MPOFC-(&$S5E0QH3@.4J Y"8AR;3(I#'E "M*M?T6,Q&G-C::TZQ3L\_,%[(*
MB+6C,C>$^_DK&&ZA#]TJ8:/M/ZO6(-N*70%Z_OSM F1%$U]3/33C([PW_8LC
M??G+8!!0]1O W&IH/8NS+*FHW6VP4?A\D'XMB0^[>9C5NI^O.F,TH2I-!,@)
M@@#R FJ*)@G(4R03FC$N<>ZRC=X??FI<W,GJKHS.^9(O'D15Y+RI!C<DJ>L9
MI'8VY7"@ I.O;>T!9SOPN,:>K+QG@X]JPQU7[+F%=N*JH4]Q$RS5M #^)-=5
M,5XM[PU;S&^WIIZ9[^O\3E]RH[[H3TM%JSJO=>W*9"9XG E3*UU)*?6>5%MG
M+&<Q$$HASF6>R<(JJ,&W8--CCDJOJTY#\_N=:M%JJ]N5^5QKX$HAGM;3EGS&
M7Z7@M-4LT*[M>4>KZ*:S0*UB4:U9=<3:T>VJ*<CKD_G\PNV-,SV)-3+;^@7S
MD*<]CS_P)&1^NYRK.3=9>9RO'I9F<U\5$YEW^R) 3G"B<@X@,L<@"B- 5<9!
MP3)*,BHYIF['(%;33HV=.T$J'06BG091JX+CR8C=(E@>BWB'-O292#^4H8Y#
MG&#R=19B-^FX!R%.0!R<@KC=[=Y>\$A7AR8P(88DSQ()0<%);#+V<D 10B 3
M7,6<4IFD5GO*WEFF1D&-H-V6*XZ!'_V@]G.,-Z@"4\H@E)SZ%9Y%X8+>A:?'
M'JV/X5GUNCT-SU\\S#9Y>W>_6#U)V0QZO+OYQU7524R*JI%Y6=7.Z?[]]:K<
M?%QM_B(WG?2V5,DT3>,"()E+$V.? 990!0H%8YSE&>>P<#%G@DDZ-?KY=;E+
M0#3M7;;"#SM(#;?"=K;2)-8MM'EEE *55M$G^E2E/U^;^,W;IM/.5K^H4O J
M,@J9H)3H26XZ^8_5 >Z#SPI,P>'W9+:%DW-42R\XW,^-P_ 3#DZY^B87U2QT
M^31+,ZG26&]NA=#6))1* BI@#&2.&!,<RMR^],/A\%.C\#:[R(@8-3(ZYUMU
MX>NGVLM!"<R/3G@,2;8ZHO8EN5;=X<9.M3JBRI%,JV-7#8C_:%.WOVJTVK3?
MG,4*(\B @H4VW%!! 4," YI**+71EN+$JA?*J0FF]K"V(D:5C X!",? ZW]0
M?4 2^%'=1V-(7,8Q6!Q","Z$9Z1H"\LOC5M018_JO?$3Q^X;+U2B1^J]J(B^
MZSQ7Q3P6\)XFBL5QP0 ML-*T1A) H"A 2@JA$DX(0D['HRZ33XWR>LL[^BR2
M.3SS(!2\X;UB/84S@R<@#$$M=!W-%T]#& **=6U-_\D(AYWRWC2%^9KSS!F'
M6$&HJ4PP85QK6%,9QSF0 C.F"I%"3B_K#/ILQJGQ5RM>M![2VOX\P'84Y16V
MP+QTHD_G%LC/9X#TT(3S!#C!NFP^G^^%VVB>4/]\G\Q3-P[8[C6G"";JH>6O
M=M,7YPJSQ"1\,Z;_@QA@F4J!RO*L2!F.J1VE]$\S-1[9"5JU%ZDD==CIG(;3
M8AOH!:1QSOBJ7*)=]6_W+>%IH!PVAEX &VE[> PX3YO$LS#T;A5/WSW>AO&L
M!GO;QO-7#S.S/LBRE'(_V6I;P; YQ"G?F'[P/S9?O\O%H_SS:KGY5LXP3$1*
M<@I22&, 4X@!XR@'&1<,8RCB'#K%:0T59&IDJK]LT,T0&[P$=O;9&, &)N!:
MA:OH(/>S4T5ULXJ8C#[1N;B*_B+I.KI9>K3C+@71DWDW6(Q1K;Y+P7IN#%X\
MGN]N,WJ\MDQ01CCDG (DBP3 +$X YE1H4A0BIP3GB#CM02WFG!KA?5@M;\&'
M^:,)/]>?STVMKBI)=V"9(!O8+W2>#0,S-,D-Q]%C>YD#9(+WE]G-. UWV"$$
M]AUF#F_UY?QJ0E[+SY++^:,IB#=3:<X3D]I(4*$ A,CT4]<[5I@7A,2"L2*6
MLZ6\I2:L_Q(WV.'<5H\-J1^; PG"/4*MH*9V?2/II3ZQ([@/=8L-A/%%/6-;
M1#^?1]2#<^PT1,'\8T>F?&$7V6D0SGO)>NYU#V#Z(OG#6IM82<J^SC?ZFY]+
M44B90D#RPL3!QPR0F*<@)X6B2&_[,+=JKG=L\*F9-950)O\F27]B/T>MN/;Q
M2P?H]?/&I9@$Y@=7.)S"ET[I/2AXZ6"PT4*73JG1#5PZ><W DEWK6[IL"N&\
M7BW+U6(NJE^T6?))KW_KX[M1[^9+NN1SNOBB/Y'UENG(L33"5'"JC0J6YA!H
MFP("*F(.\JR@5&*F!'%JN>U;P*G1Q$>Z,>?8IIATO3_5.E;'W5W%'6M^^5Y3
M.X/E)5<J,'EU53-!YQWEJK7JJF>6<JM@M-,P?-1"J 7P57;,MWCCEB4+!.Y!
MV;)0\PQ,NGY@I?SO!SWXV\?=<1.*(6=08L!QIO>+(E-Z#YFD@!*4<I&E*:%.
M;4J/SC(UIMX)&552NF9.'T72CEHOQB<P/SZ')D ?H%X(?.4\'YUCW!3G/C4/
M,II[+Q[XP-.%+)L8B8^R_9I"BG"LD.F%GA)MU<42D"PM &5(TA1+*)%5W<+>
M6:;VP+=]]5A;T-OQ@3^*I.4#?RD^@1_X%II.-7K_3WP?!KZ>^*-SC/O$]ZEY
M\,3W7GQIBZ"VY] U_^^'>3FO]B*OGCJ_M27X]-,GRTW=U?AF;?XUGJ*JS<HL
MR;,4B30%,B$40(XPP"E'0,*TB"53B-F5. TCWM0XIMO5IM4OZBH8L:?N[U>[
M<I2UEDV+;]/NIE6T:7CC>&SF^6M@R7,OMKBA+:*76-<+NA?YA-][2R,OPKU0
MGR.?P)YN?N1U%G='?]MZNR[T]78IWN@=Z8SEI$!YAH#>#1)3]88"BA0#7'\&
M99[%F7N?^KT9ID;FVY[MM921%C,R<KKWKM\'\KSC_V)X M.A,S*#&ML?U?ZB
M#O?[(X[>ZOZH0L=ZWA^_<&#8$GTR=&!JY%QSOGZ@B_*:E56;:MNXF=,C3.@[
MV4I9>7!;.:/?6TE]1LN<Q\-7E$S/3.-&QYQ7^2 JQN(6+T[,#_I5^7XC[\H9
MR64B49&"3!#]ADHE!)@( 2@L<DPQ+ AS.JPZ-='47E2'_CHC:E3)ZKIM.(7M
M(,_F(,1&=V[:@'6I@_, B3 ^SMTT+^GF/%#VC*?S\/H!65Q5C9_R^F'S;;6N
M"G'!M$ <%A D!:HJ?V- $,E!FE"B*$LX8HEU\M;ST2=' 95\$=T*&/TT7T9E
M]>G/#CE)!RCV/_<78Q/Z8:]$NXIVPEV"A4-:UB68C)2-Y8"-6R[6*=U[4[ .
M;AHO\^J4O'L)5R<O\M%;;YN],,L$PJQ(,$@Y-YML"@%+)0<<IBHF":$T=4H@
M.#'/U.BKJKUVT")OT8CK7-;Z%+IV1HP'S +3VNG$IU!=[0Y0"-*\;C?+"_:H
M.U"UOQ7=X>7#&*'*[2AG2)J61%D.D##G+5F: \PA 0)**!(N18S$;&,>%SL"
MJ(=U>MZW@X=^WH?T(FI@LGN2W94/_.!>]VOL_)#N*^CIF6P&'?41W%?D^1/W
M[*\#=@<?]:+<J'>45X]JDS:6Q"E*5%* #.K'#!8T!OKA*T#!8\5B2&0FK#S:
M)V>8VFO6R%@%-#92.J;DG4;28I=P*3Z!G\Q@T#AL&BZ%:*2-@SM4;ON'/AAZ
M]Q!';QQO']$G]]Y>HO?"@3Y1N=!_O?T/N=2VR<+X7,7=?#DW_E;37;%IBELV
M44L*,:I03$'.,020$ $P% Q0Q E+42QIZA;PZ3+[U$BQ$?XJNJW%KPX0Z)X"
MCCY4I[6P=*R&0CBT Z8%]S\ZX.[+WC;D+D,$G0V!S9=KUFGN<?VU0V Y<.(.
M&F1@0PZZ-JW*RD]R73EBMB>8F9)YQA((8H(X@)S' +.$ L[20O^;(607E'!N
MHJF1UD>YB1:KLC3-&&LWKWDC\]7=W6H9E9L5_^N?'!MBG$+8CI]\X!:8BEH1
M3=!"5 D9Y'3X'!*^.D.<FF;<Q@YGE#WHRW#N^L'U$59W<ILX\\$LDLFQ^3$O
M9PE*$*0H!830#,"8"D!2_1,MD@)I.RA1;K'N/7--C21J47=):U$KK/[B:W$=
MCX;[0+8C"4_0!>:)P:@-*7AP#@]_=0Y.SC1V>8-S*A^I:G#V%O?N?E^X7-+U
M?/5I+1_GJX=R\?19WJ_6&RG:'!F8JI0Q;4\DI  PI1+0!.HM4Y9D%*<$I\JJ
MH)W-9%,CCIV<42NH?8N_L\CVDX5OO *SQ1&H/.YC7,"XH._?V2E&:_]GJVRW
M"Z#U/0,/9I:;N9@O'LRFIBG7,)?EVQ]\\2"D>*?%-RUG'MH\WN<FSJNGXP-4
M[TU,5,%9G -.$KU]B0D&-*809'H3DZ:<\D1A%^,DH*Q3XZBNI-%.U$&F3<@E
MMCRIFL;"A3[^&K9F[L=BX='T==864-)Q#_#"0WYP*CC"E .K*.\"5TQK6N..
M^;9:Z/O+.G%GZUR)N:)YRE. 49(;_D_TYK2 0#*9QWE"&5*94]5DRXFG1N8?
MWE^_>O_A_=?W;[]$UQ_?1%^^WKS^G_]Y\^'-V\]?_ND?<9H4_Q*]_;]^??_U
M+XZUE&T7PHZE0\ ;F'([(F_;[I@CNP">+U=T?!5!MIUVW*+'CF <%#EVO7^@
M<6M2,Z3HS/;Z8;W6V^R99'$6<\( %L:S+K("X$SF0'$B4FVHIAC%3H%(IV::
M6FQ2(VCUM*PVW^0ZXK6@P^,13Z-L:1WZP"ZT;=? UA'R*FK$]&C9G4/"EUUV
M<IYQK:ISZA[81&=ON+2J1%M2M,GO:M.[]N:L$I!W!>=BF,>,YPH0HB2 /(:
M<96 1*028::R@@RL(>$NS-0LGVYE@2[SW%3,TRQ>]Z$:6@9BP+I9AB:,M!JA
M(Q7V%Z(N<]QHLLLIW2>XIH1#%*3^GP]<O==N&"#*"U5J& [:Z;H,%XP9MAV/
MZ7#R3N]B9UADB"N3Y9:;I#>L."!09H F*DT%1%G.G:C658"IT:O^*N,P[7>V
MD%MN'0,"&7H+.:3=SKN^L+E@_7:>HS=RGYWM])/LK_,<G*%]=0[&&1"/W[9O
MK#:V5=T:K>KK5;DI9ZF0"<MB;2V*% (HJ0(X%Z;L3,I9GO$B5O9-%T_/,S6F
MVC8=K:*WHGDC:\2-L Y!Z#W(]C.51[P"$](6JDK*J!4S>NT/*H>H?3^0C12[
M/PPZM_C]\X#T1O'WW#Y>+/]Y'?8B^BTN'V8 ?I2;U[3\]FF]>IP+*5X]_5I*
M\7[9%(M>WE[SS?RQLCMG3!8%+G@.<A:G !9Y"EA1(,!3*E%.L%2F^HF]P\Y^
MZJEY\$QP+->B1_>-[*8ZGVKECNA6<#?+T&$M[&S", @')E\#KI$Z^M0!]R<C
M>31?_AQMA8^NS\/L; >Z(^;) G28>%3;SQV0YU;?@!$&'S68S;,>\M-J,>?F
M8,/M].WT !-Z/'9"1JV400[;SH/ASQ-^:J*Q7>%G%#[B"S]WQ[!O\F]R?OMM
M(\7UH]XJW<J/#R;*[$;5)4)N'C;EABZ%>73:[[=^+Q<92@DHB,0 YC0'5&8$
M4)6GC&+.!6$S/1A;V?IE7$5P>4*Z@H1[4%H- *U5V":OU)6,5CL='#-9G%<'
MPDS 1&8 82H!C',&J$"F;)R$D,0)CY53#E'(M1EG)[I<W6GZUP04&GH[X@\)
M:.#702MZU,@>U<*;0X:F9%='_JOHC8E&,A'$ =X80U'T]!YQGG[4M\M0<)Z_
M<P:/,[R]AQ[=[#I-=R%MP-4]Q^I^CU+<++^NZ;(T.Y[5<I9GA"=829!3<PZ;
M$0AP2A40^MVD4BYC*9R*2SG-/C66VY.XZ1!KF^8P#'[+X]10H(8^/Z7UV6DE
M>=U5;0=O*WRD?^Z([[>[B#-J'KN.V,\]>C<29UB.=2EQ'V1H)J<I"+I:/^EM
MZ:PH*"XXYP!G- 4P30A@F20 8BFPRGC,"71+W=P-/C4Z:F5S]DH]0PPJ*0@&
MF90Q@-(P/&<9D(P5:8%)01!S\0$.1FP$+U\'L:MH*4\'F9V'S8Z9AX(1F'BW
M8EU%'WM0&)"=>JBNMW34SM CYY\>*G68<'KDFH%U*^[N%ZLG*3_+A6EZ?R0
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M%8+),B1XSH#47-EP+ BHQB7@(BMSP0N*D'L!A?-RID99YWQ?;I*MYD&>04<
M]W-:1-@&)C<7Q"*FG'4$)HX/T5'KK^%-=,[$,WY%9Q^_+@_A)_9B T%O%_*"
M:ZQ6&<N$%H!DF@,DJ !4I;8&B]0L)01EF1-QA"HP-4;I3N&VM6W;XEWA->N\
M^\3Y8',PI(<_ZFPR';:ZUVB/Z=4<BEWDO(?.XE\E%Z(O..?R(WJW$YI5^YM:
M/*O/RCJ7V"@PM=++U:/-FGG''^;W]:+XW?<G9:L%=%&KO]I21+HI&_[KFJW6
M;PTOU_'5LM"I*' *<H$90%098J10 %C:HE2,,B*\#FOBJC<UVFRMLY5(6ON2
M'0.3K84W26=CLHWVWC7S)JD-3:RE0<'SD;\#-S)^O=X=?KWX"AT;D!M["/RC
MY=&.JMS(.;>' /8X/_<@4@(. 7]:?E.K1;TRKZJY6:8;%7Y:L<7ZE^7Z/]6Z
MR?6KY$P4*$WK<BZ2F@VWG1DH507 JJ2%63DCP9SR\?H(G1KIURHFB^4Z>5'K
M-L&WDAXG9:Y@.QPH#@#AP,RZU3C9JGR3-* :K1.C=O)Y.% ]#B4' '>DH\HX
M(/N=97JBU7O"Z=K6>.>>GM;MG8;ZOAOH&;Y<;/R8/RS$\E'9F6-1J1DNLDS)
M3 &M2@X0UAK0@F<@9XK"'$*N1>[E 'Y.TM28NME;SVL5;Y*%\BSP<AY1M]5Q
M%)P&IN-='9-&R>2'5LV(15PN0A'+S_JLG''=J2^9>^0U??&%*[VLS+IQO11_
MMX6]S,!K$JIZ>ADXM36A3WOK0F2W9#L:_W/2YOD=PB_!"Z78OD:],E_'_<@%
MAK,>24XOAXV,MTJKU<IFFJS6FR/H0BN><;.I88((@ K% 4^+ LB2<"S,#D?D
MW&>F/"5D:I-DIV,BK))^,^1)$-W8Y%IH!B:/#2JU?@.<Q??9'XD63HH8E07Z
MC#P<]+W/AHWQ]VR^^AM[>%8_OFQ^_/>YF697XNO+1_7-V&[/.E,H&<%4@DP)
M,^HS(0&74 '(8%EBR AAS&?4NXF=&@]859-:UV2C;'U#]<OMWX).I!W1=Z.+
M^)@.3"#7P.E-)G[H1*(71Z&C$HX?$(<4Y/EVX)+\F5=S.6>KEU]9G?3:KG#J
MD< PH2E+,T H40#EA3(\9+;M.$\YS HL$/8JBG16TM2HQZJW6:2'%2DY"ZKC
MWB8&5$/O9WQ0\M^W7$(@UE[EK)QQ]R>7S#W:DUQ\(33-\X/YU_N?U,+PS,/M
M0M[*Q_EB7M7Y%[]M3IP*20J5FC4*I+@ B&,%"$(E8 H**'%6YMPKB8.;V,D1
M1:/U37+?Z%U/J&Q/<]_4ST[H.Y)(=$R'9I0.SI]VX-Q7.FFUCIGZV0>E:+F?
MG82.G/S9!XCC[,]>;P?<"=>GY^T5]?8*H[ZX:+V#L5*L*&D!H.0VLTQ6 &YK
M/3-;RQ&5A53:*?F\F[BID5%SN[!J-$[^_">2I>E?D_OMU=N]U=WC"O,RX XW
MPE%A')A_&@1;91.0[%Q;-E>5 6$HET'TN &."N9(=[^70(UTW>L,3>]%[^56
MQKOB=;9H[W+7_:T "OYMP9[E?&T3Z!A&FS^^62ZDI77Y?KY@"S%G#YNC\NIT
MU8H4(<XU(8 44)L])>. 9@4$:9FG&9$4<K?J=''4F1J%;PQ*6HN2C4GVI\IH
M+YG]YXV!R=9"#U*ZOA\=F'_4WAEX9NCKF%-]$50_8(A^\IA<1NVOD2:?T'Z+
M-"E%@[1WTKI>RGB36C1$]B:]>*U&S8+92C^9;5%+09 J!) :Y@#IK 1$*0B$
M)!EC&88Y\G."\E9A:I/?819,W:D>/0MF7[^X':T,B_; D]F%+)@;(UXI"Z8#
MB,-FP>Q38 I9,!T <LR"Z=)28&F=SGOLHV*5^CR__[J^TT9HG2=DEA6F+U"N
M02D+LPO0F@&:*P4RC#%1M"BA7U17K[2I\=PVR^R#U399677!4H-G\S^LSJ,2
MX!S:#[@;JT6#<>ASF@V"M:(WR><.0J-L4FL;L?2."RBQ*N_TRAJW\(Z+V4=U
M=YQ>"CAX^,5\#7?Z/1,V5O6E\9(I<HP+@0%2TBR@(#4<PC0'(M>(Y6DN4>K$
M(6?:GQIK6 WM;6NGH]>U]#D,'7;QUR$S]$IF"% \MLS7@3/2'O@0I$A[V_.V
M]VY63[PVWN[SO,Y[V\F>QP(OU4\6DI^E&19*9Q#P DNS#,HQH-RLA1@L-*-"
MY#3W6@:=%C,U)JL]%0"W:B9B1T_/F_+3D#K>C%\-U- WX59!4&MHLW,TD7.K
ME7FD/L2X27XQ7[O=PL6_#N^%)M;U]VDAXUYW]QIZ=+W=_W1@->,'L]R_T__!
M;,^N[U;-@NEY;4/RI%E%S3+"<0:5  IC"% N4\!% 8$BABLXHB@MO+QL+@F<
M&E6TBE;)<JMC\L-\D52V.ZKS 6%A<+N11TP0!Z:16E4[][?*FJ^SV2O=)#L*
M1RQH[ A-K*K&E\2-6]K8T?BC^L:N[P7LFSY]^/2N&T2MNX$-KY549(!PP@#"
M- ,\UPI0I;@BJ(!(*.=]TW'[4Z,0JV'R1ZNBQ\;@!'(.NZ7K\!B8#6HH-I0:
MX,MR A./S=)UV(RT6=K#*-).Z;SAO3NE$Z^-MU,ZK_/>3JGGL?#:K%],<]6\
MKO:NGI:K]0Q*263*.4B9-)25<0:X+@70(H52YWDFD-,RJ$_(U'AK4WUTJVC2
M:.I?G?4(T'XFBP73P'06@%!0?=9S$%Q5H/6HT=$KM)XSZU2)UK//^@_RCP;S
MAT]?EPOURW.S'I&L+%6)0"ES"5!*4T#*G .%\D)J*@3,4]?!?=CXU 9UK5]2
M*Y@T&KH/YB/@+@_B:^ 8>/!Z(.$U:,^9'#18CQH;;9">,V-W<)Y])NPPHCUF
MJKXL;\4_GN<K]6EE4X"L7SZ9CEO?+J1-=_#T6*<E2%%*4*I B4H-$,]+>VXI
M0"8S*4BND<S1;*'NK:NBV\&$NW"G;Y@VW_"N"@,N&4U#7^U%KMEG/[5JWR1/
M5O$Z@$5UJON=5GCTA]NY162,1]JSM$HGZV72JIU\VH!<:WY3H_SN(LK>IQG^
M@$4ZU_ 0/.H)AS\@AV<= 2U<Z7_29"_ZN*RJ&<T(H25+@2 Z-]L(LX/@3*>
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M?,Q9"7B>D50*(@GURM5^)&%J9&D5M*N?-M^I9R38$7YN9'85*@-35 =(K=T
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M8/E,GQUE'PMW04(N+%:Z#0D#%3B3!-,.D]&B"3CJVP;EE>ZINWL \6A!#@0
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MXNR"JXL&*J.84F9<9[ 4P( 2R"'DHL PG@NM+6MX\YF8.]#5KSO?$>":*V0
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M-0P44-?S<3IK)C@YK4*[5#L#*V*'"9!*B,"C1LV> E6/38EVF'SH 5K[*F0
M^+J6Z]VXP6N'3-;NTQ01US&-&2%:ER$CCS86X81N?82S UE]9RDZQEEKQ0P+
M:W?V>6=50AUCO<E3ZXQRO2<4+>B@N2E*)=OEL<Y>/E=G:8NGQ-9!BA@BIM;;
M/!>QV&0<"&\X*)_KS;!,7"E$$PT7QK?.A6T@92<L-1]7TQ^6]E# $'%T?4]W
M1F59E #.+59>2#09%>3"?4 ;6;3MZ[0.'*?6?+A-?XC:5Q7/:8;%I\_T];?7
M[S]_.GIS].'UQQ>?W])OFR52-SR^LR3J+NPT2J"^G1 I>(G*JYR^CRB]$)"C
MJ$T\M"9'W$4H":TA:$J'K7> #:0<?@S]#2=G]1JKHS44T4,4WM=K/ :"\1PH
MI&"<%EG@KG4]S<6[^TUUMM#QW?/D/:0ZB)UJ3J9W3?V(C)\O]8P[BT2&EM&7
M0*81@LBQF&*BUJTA<8. ?K.37>!B?_D. !S_F$WG\P^S:1DO1H)E(PUGH'6M
M3$PE0"S(@%ONA'$&36IM *^]OM\,8Q? V%>V [@Z<%E)LVR*5_MQKEI'7W7-
MPF"]CR8"%SS5$9.NC@6+8&,R/MO@N&I]\>1!HOK-)'8!H;9Z&("]^4@Z(0+J
M\)579#%/ILLFKVNN1M(D29$ "<ABH2B &XA)1_HNNBB4<4RT/DO;2E"_3DQC
MY=]Q9UII8@"P^H0G]*OC?^"$1'9"++W(I^/)N(II,?Z&%URI8% 8$0"=%[04
M:9OV*#D@JP.656#$6>MK$3M1UJ]7U"W0.M#- !!W*;,+68U4C)S%B&"S(0:B
M5^!J(U CC-5*R*2;SPJ\0T2_3E2W.#I,XD-RJE:>PCOR#D<^:&65=^0<L#H:
M2B@(K-9("!D$9HNQNY8[5V3T>S36J>.TIZP' )?WT\GT)A>7F[.4EJC5$(JB
M8"(J!.]%@1"TL0%3HB75&#0;B>GWY*L+Z+21^P"VJ/>XN(;^5)+A]=8=NF)!
M:7+KR!!K2,IR:9GC-K0^,+U!0+_'6IT 96_Y#L"Z_(%U+ +F%]\(ZL?X_NPT
MXNRHW#E N924M"8Z+0UH9X@_J2VX0M\Q25*SGEN>6B<.'TMCO^=<74"L4RWM
MC4(B)DX;&:E=.?PUS,>)PE+/4%D'1NI4KPXOPU(%TA6'PA>-L?7MM4<1V&_"
MH%NT[ G-QRMN %OG!N9>C4_.Z*=W3YF3UEXFF<&:PD$A!O Y.7(MM46N72GR
MB7"YB<1^,PQ#0&83Y0T FQ?UK!>W^BYE9JUGLL0(*!)M-%H+\(4B'>XH&F;2
MZ*1:G]]LHF4GM/GGM!,WD?H T;,RS]SX&$+@4(2EY9:LAZBLI'7 "PJNZ^"U
MCJ$S@/VSC8X? ,[C!3Y U*QMZ2B%HI.(#C0CXE7&3&8Z1=!H8U0>O9*M,Q$;
M2.EW?WL2Y.PC].=ZI>W3YZ.7__,_CMZ]>OWQT^O_]?O;S__5R=6V>U[S)%?<
M'F*O?:WPEF)V;2-G61GRS>O(#L,3^*@9>,)H2<4:9UKWZ]Z)L,/;9:Q?\KE.
MC!C9I#'53MO)YMIXVR=P*CM(*0O+R#$(I3,VEQ0,IOJW$1;N=LS86]X#V.(N
MJ5])Y.7T].MTLFSB^'T\'VF3,3C:KWVHE3-*2G(=HP;4P:DDDG&I]3G-5H(&
M@J4]-+T)- >+?0 8NL7#J^EI&$]&7"LT 8EJ7L7C* !Q& 6Y!#J6Y I3S:]<
MWDO(0#!SN*)O^TD'2WT T+E6Q/ ;UH3%2*=L)".1,*,XJ&!%G5C,ZVR9)%ER
M,D37&#9WB.@Y'CM<L9M+1?:0\@!@LJ%1WIJ9:)G-S'N0.07:O0OMWDX'<!%)
M.LE%8K0Q9+82U'-0UAP^[:0_ "C=[H^WYH)B4NVYMB"Q-CFS4H%GH0!7W(JH
M2PFR]1VY^RGI]RY3>_ TD'>/J)G/%J.7J_Z)]=)>*9@6'W VGN:C\B)/OR[U
M4G?R%$D*(0C@.<FZDPOBAWS#+.J8HX2&[79.3"^\AAWZUQ5N=J5E()UP]G>2
M.Q'ZP$&T7FD&+1,LD_7,68'2(D%4.H,L6H3BI':[C>@Y$$9]>L[=:/\1T-I#
M%0,'UXO\?\[FR]D,:^O+4V$A10,F%]JS@Z$(Q!"K+)$E=UH''9\"9K?I&B[@
M]L'$8ZS9(0KJ&7P?<7YYY%B7I76.)<X$"$E>H(K&0]#D.P0A@TM&E51:[(2W
M7CN03EV';7J'B'(X*%BOE>1$EI(@3"S4%@3&0'0J0HBT5D@:KN!.W2!VQT'?
MN]9!ZKL?!GO(LF<@?$HX"63=/LSPVWAZ-C\Y_XA?I[,%YHMX41;#(K,@"K=U
M&!D#)UP!GQ)MV#+YY':*UA_ Q4-T# (F^ZAWVI&LAV- [NR&WF6F&5.06'"U
M69P#KRTM).-LD8([5EJX*UM(Z">F:HN65A(>0!+G<K]]-Y[@6_IV/N*1O"2-
M$8RK'I,CKRRH0+MOR"9)95"YSLXY+ZD82%/'AN=3^PEX !!Y.TFS.@_S%:[^
M^W9R]_SWX_3DY,UT]E>8Y5%,6HAB"Y129]HS8\$'[2$;:XLPB%*V+L)^)(D#
M.<C:$Q'3IU// -"WM3D7>HNNSDW(,B901BL(F5C3W-C"C2[6V,90.[A/6I<]
MB[H#PF-:ICU&*WLC[.LR\*>U-%LTV@COS-%0//'L9(:<F &5#0=G'(4>HF@1
MF8C^"494]M[OZ,DP=: &AH6D55/*5V<S6A"K'-5JG;S'OY:_FH]80O(=L@5=
M<AV1J!)$GS5HE3$%3?ZG%%V@ZT'*>F^D]+2(:ZNI0=3$;>!KV<OYBJUL<O%*
M<>#%4?0CO*-UQ04D%Q5JBFN-:#_C90?">N_"U#?^#M#3 !RVK8MJ^<NC9:9^
M_OH[SM)XCGEDM=!&H@?A:H]5G@($G@P4PY/W/HK80<3Y6"I[[W'1-RQ;:7#P
M)O)^%E-,490@(";&2:*Q#H;1=3",*:+>,$RZ]76Z1Q/9>S.-OC':2'\]FM%:
MA#*ZRBK./T\W7!J[^,]TLIB-X]F2VS>DD]4$N1'+R0NE)1B.@MBM]\@2+5!)
MK I$[K*[U:[C;OE+(UIZ[]S1.2K[4-H MOI=.%[N&I'DGNM=.)S,EXK_B"3W
M^7B!GW#V;9QPM7H_8IH>3Y9/62[D$8_>,QLXT-82ZK:2P;&"H$D4:#UBT*U=
MU*YYZKW'R).9Z$&AXUE8]&M6X<HH?,3ER.G/TZ6F?KTMJY$0$EU($5!;VM>4
MB>!54%!4+-$JI"TOMS/T^Y#8>S'_@.Q_YRH>P+9PLZ\5M]KHDCE8DTF>R2AP
MKE[W$J5PQU#XYGV?'M\WC+/G#+_#!3\ U&P]4HA!8F QTPJ(M62=^UH:82'(
M**1RT1O;.D-P^$'/CW_2\QBU')B??SW)79WSF&RU"(;B0:VK>4V<O&Z6(&>-
M/L5H?6A]BKCG.0__40]Z'J."@0#I14K3LTEM\OFI+@<2ROSWKYGV\=>U]\)\
M'$_PW7B^&'&3O)9&@T]<@2K)06WU"2Q%+VUARNK6?3-W)&T@Y2UMKD%TH8[G
MVOSDY8M/__'FW=$?W8SSNGKZD[0ZV<!,^PXG+\/\RYN3Z5]7W<:U,I(0X8![
M<J-4]*S68CK(S*:D-?.Q^?BK;?0T\,OK,S_,IM_&)+E?SW^G0./MY++5]8NT
M&'^CJ.5:O_5ZFQ%YD637Z\VWXB($NSR%B@5%Y,+RUH,('T_E0*YS'8J@>[SY
M+M4U )?_9KRB...6+#VX6A>DF,W@9!$0BF$^H<Y)MVX_N$>@V!6,NM;VUE#Q
M,:(?Q/'=C5Q+30Q.TO@$;S#U>?I8>2I;,'N;@-=R-,54[;7F22C*6\S"A"!:
MG_!UP4>_;MT3X[AW( QB.5PTAKR5-W0Z&LYD@,CK[J-H]PDH*&:SJ6@OF-&R
M^;V*>RGIU[3VCY'; ?#AZAK [OT*Z<UIO*2=OC_!I3XG^<7I=+88_W/%4U2T
MLW@;0%A1;W!RA, 5Q75"2(VTK5C6>E/?A:Y^;>3@ -E<E0. Y]'B"\ZN,W!4
M7JTI>4GK[QCG(XV.62VJ8\Z)(QX0(D-#;$EN"D\QA.;#DQZDJM_KMX.#9F,U
M#@&8%Y)Z5Q.M'VNO^:-"0GPQG^/B.J=78X,X\\P%*#$64"DX""EH,"KGK+Q4
M.K6^*?Y8&ON]LSL\T':IXD%XG'?/"ZZ&]ZV.NB\%:4*N99()K*Y.O8^^=N"0
MH)TV11KNC6V=0]J=NGYO]0X.N!VI=0!6]RYGZQ.#.<D=Q]^6A;XF!56DEF"E
ME[6K/DD-LX9DF T)+3K1NO_A+G0-K:ZP#28>A-Z!"GH\Z/P*=!,\7E['Z1![
M;R??2/+3V;C6=V14VG ))@E'?G4HX*+7$'3FI203O6P]"7TK04.K.'PBM.VK
MDB'#[+:G7"_ TQ; :-&4""I( UZR BDS5:O86':M*UH?)&IHY89/!+=#5#-D
MR'V8X=<PSA?LK1W<%Y.\"N2J SP?H:USE\D[<9@4*"1Y1NT%I"2U=CE8YUK?
MN-F/TJ'5(CX1.)LK\5#$=NP"?@CG2_=""F>2+PETE!2&98_@,G+PFMO$A?4)
MG\[_6Q,UM+K#)W;^]E'-4,.-V1G1,0YQ?+**V-;KZ2I;</6[D2TNYTC+R7I'
M+H@T"7RH1[+>(3J>B.CN3>3C:!Y:]>'3(;4KQ0X2R!>[PD<DA_D,1R'6 0@N
MD@QKOB'7T:SD((.U00<>L@C-AP8\2-302@Z?V*G<1S6#Q-K-1.K%,CH?21\S
M"TI#,9%\C^1-O2FJ(:8Z9HH;[U7KE/C.Q VMPN^)L-="50/ X.[W5T8YJ(B%
M+'F1:*O\"@1#7T0NQOC$"H5SO5V.[#>L?OK;;%TH;7\X3FF==0G'FJR:;Q"D
M42:C-;28A<TD2,7(4[8*2(:R(#<A^=9)GL=3.9#:@R>ZL]M*78,X^J.([*+(
M-?WWV7B&Q"TMM,7YAY,P69#O6VMZOM:/C&HY=K),@(^">*NM=IVV%HJ.BM-O
M>-"MH;@[=8.\[]L,*=,G4=H@\CJ[BW*D4'I.#@=@\K2UL)IO58:^>&ZM$N0@
MA]8-)7:G;I 7=[L"9$=*&^Z6_68\"9-TOR#K)?N2!(*4RP$\NAYK1@W2<2S6
M15?4$VW96Z@<R&"0)]JR6ZEK "$-L980\[+14&V917PA2?&JL'M40O;2F S"
M:T=.<6+@?>!0ZG&G4)S)W<8"/&:??HBH06[/S5!Q>WMNJJ(A8&[M;ZR'A5_P
M]'(Z7\Q'4@A;6^=#X4F#<HYX(;\"0@G*>U\KRUN71&^C9Y#[;F=(:Z68X1Q"
M7U\\&]I32IV%*9QV!5L7#[/D/&1=RRM4S@4M5ZW=O@>)&F2"YBGLV^$J&D88
M?(VE3?W\M,UDM2F XM&0YQJ*@1"M 9L3*PRCLKIU =8.9/5[J:%'Y+504]^-
MY-;V^ZA\GH7)G*2SJM2Y8<??3HC3"2Y_]\=X\>77L_EX@O,Y^1.1Q+S^DP]O
M/[Q>A5O+L-\')XMT$1RM1/*A-=E^<JI)'#Z7;"+)^E;UZX8^<EU1V.]%B">"
M[7!T/)S]?7?1CUCF)-4ZNC9("@11%P@Y&R"F/7-1<E)';X%TO_<CGMCN=J2T
M >1W*EOU?S5C^BV<X/*&.DELG CU]1>T[F[^X-HG5ZU,[YZ>II.SVE'M]??T
M)4R.\6-M7+0<<#M*+(F8HX(2R"=2A;YS"6GADD]4I TDO-:YH:?E<""CWEKG
ME08,D^>^B$8\:),8;6&990'*<D\A:A(0#,M&UM)DVSJ!<!#!_;HNPX3XHY0X
MF.%.A[%LI"@^2A(V\\2R1@N1,TY?M/26%2YBZX+S[G';F<<R4-P^1HD#Z55Y
M$,.7(L\VTJK4M0$$#[1@@X6@A8><DT>T6F3>NAU>$\+[O0PZ3!3OI=0!G"NL
M^;K-#<4:L]DY>4:KR0".IU@RR5&(.D?#V]KN4Z=E,54HAG//6Y]G[418OV=:
M/0#F'LBVU=X ('E39",47/ B/7A5-$6S+-0SE PJ"9%K D:4UO':30KZ/<[J
M'V0'Z&, :#K,-XG*DM@4!\1(+')GP2$B",4%1IUY^X/\[AW,S@[!^L?JTVF[
M6<S?MI?U^[ XF^&TK*]J3R?S,,E'L^,PN>C4=H/^W5I8/_S0%IVK'TEZHX;5
MUU_PDMXY/1GGRVS_-5:.RCK5&DXN/=!KF)5)<*4M6,,2*"$U1!<E>&M=;;"!
M&EO;B2:$']Q[ZQ B7HWGZ60Z)Z5_)F7^>E*OY>@<BPC<@Z:-!%1F&9Q'!=F3
M[RZ3SX6U+GYKS4._3NG3X_E.LZX^,3'0$0.?SDY/P^Q\6CZ-CR?C,D[UDOCE
MA(4/)*)4#[3VL,T[/KF%@=Z'B496^NYK+J&:<E*N%L!E8\@?K?>E8\H&0K B
M*]31-<]=;Z;FX,;#VR1[;44PFZ6+%M 7!TKE %&&#!IEX#J1*\YC8YYWHZSG
MQL1M4'*GO7![I0S43%U4>^]AAVX4BA]H:.XEHY$E63_[\OH2@:->]WAY-E],
M3W%V"9@8H['."$#G3+W003N@S0YH*Y0I^% <:VU6=B3M\/S*UM=< =IR;I/*
M";1"6:\0)@K$H@*9L\_(N9?-&ZGM2EN_=J8+#-W-NG2@I8&:G8M6<>?[&)ZK
M/VYA>C:0TLCX7#[]RLV]:C,:9!!><+"2,]*C2."%,) E_<*&HI)N'4)N(>?P
MUA-W'GT%66Y,=,YE2"K4=9$CT+]D[3+MN&*H/&]]?7P;/7VW VV#B;L=)1II
M8*!&XT;!;;A6</L>%_O8D:W/:V%:=B>XD;796))\B:^0M;<L,; A$@PB>:N!
M4YB?K9>!(*9-:9UM>9"H!G4$][_@OG60DD\)"P?F7>U>@;$>9I@ZW5<X[A-Y
M\JTOD#R&OGXM4UO\W%-(T(V>!FJOUFW-PKJ7V<NS6=7!]79O>QBMAQ_:PG(]
MDO16YFO5J;!V?UL2$$ZN-;>QIG@K:E\;32@0UM+&2.YU<CES$U@RJ8.*QTWD
M-!I]>]&;\>(--WK@W;<J@F".%\E 2@R@T'O:P"T#(U-R/JKD1&OKM2>I/1NR
M1DC:,".W4[T-U)K=,W![G^3UAK'=AR:J'R"ND8%:/?H2244Z8[6*P+2(M!G:
MVM]<9MJMC!&E>,6:VZ2;%+0?Y?Y^NL![MV-)P8.0",G6,4&)&8B<%HUBO&A6
M1P2IUJSN3%R_IN8 3#P\UKV%.@9J3U8#6CZ'[_OY0=?_O$T:: ,YS1)!Z^??
M$_2G(LB1M@ZR]XZV)28@*%4@21Z,E]9%V7I7WT).@QZDMQ]]+7>II52U,EAS
M76\FUHFY,2&$$NN$QH))M[X!O8V>OA-!;3!Q3VO1-AH8J.E8]D?=RVJL_[*%
MP;B/B$:V8O7H:PYKE,H74E8=%JFTX^!*1L <A>3.ZJA:G\K<I.!0B_ .YW/$
MF^UMKQVC9B^50Z[!L'H)3^8,GID /!%OWJ>:6&C.WS:*^K4*!VC_MB%H*/B!
MFH+:X&F\+,T/DUR/S8A-G.Q[M6;+TUJ8C%V);61&KEY7X^ ;[[MGPY%6!Q.S
M(HD@N93%%/!92PC!*"PQZH2MK<RC"#SX6O@N+[L6L<L0#0I+&VYB%+$+"9$D
M TRJI+ECBO;*/L0Q$"/5';;N7/#N3F\#M6GO<5'G5G[ V7+,^5[WMV\]HLEM
M[6UDM4JPA-F$U'OYDDL$(8],B:PAN^)!V>3 U^NI+GFED-1:;&J=:ME RZ&&
MZ/9SKYW1:IUH ]80=:CSH&BM.$E?)&I3K'4LL=9QX$9B>DZJM,#!;4O21O #
M-1J?SN(<__N,GO3ZV[(N:)_D[.UGM+E#O(VP1G;C]DNNTG%:51>97%Q31ZQE
M<G:]JE,T>%9*!&^L:7W'9A,M!R=K;SWW"KZ,<9%Y[><L8@3%8H$8I(2$Y."'
MS*,*K7LV;22F7[O1! =WTK)-!#]8N['+%?_NZQ5ZJ%OHJWY!<F8%A>\4=HL:
MUL<$+K( ,G$?8ZP'!:WOX'17O_!KF(_G1^76"\Y77Z]62O0^^.C$^JJ\M 4"
M]P6R*L(%%T1LWD]@-\H&6[_P&)3<ME@=*&4(A=W72\MN\V*%HL@O%- JY]H"
M#R$DZ<"FF!/#K(1IG[[83$^_+00Z@E4S!?3= O;W23C+XT5MITA/'-?[]KG.
MY\WWU"?>OW22\EY;6P]03"!_0AAPF5B.7F5G<D[E=B>?#;U>#R:EWP8 C9'6
M@W;ZQN+K4YP=D_S^,9O^M?CR<GKZ-4S.[V=+,ZX2QP!9UJ, DXBMH#SXPG/D
M,C.OTDZ@V_V=_;:6[ )='<E[ /OC[W,\*J_GB_$IK8[YB,>0#0H$='4*54$$
MC[).)LC2&LU83*TSV#<IZ+=G8T=[X %"'@!$[F\?=:=ARNU>JLMU,8J9I&9B
M[>]>+S%&6V=;B @:36 JHT'3NHCG$'K[;;W8E0OV5 H< EBGDX2U$++J[.-X
M_N=+HF&\J-^-<G1,L4);>F2U#[O/X*6KS8-B,"X$%+%YFZ;-Y/3;'[$[;[^)
M^ > I$]X7+W%C_AU.ML2#CL?N!,!#-:2$Y0"O+(.A!92T\;/-&]]QK038?V.
MP^X(7>U5,@"<O<>_KHEK-IW0MVEKH,*U5XI7YY(7J,,@(5A%%EDP[HS#$'/[
ML86/HW$G]/EGAKY.%3703/^ZO\#G96',/HG\FP]HV/;C/I*>N/D'LU$9E11(
M+1T9FCJ2-:4 0<B43,FB-#]Z?Z+F'Y_2%\QG)S5J(;0OSO\89WP[*=/9Z6IC
MOZ+B-8E\-@DG%Q3,?SVGI9'/TO+FS2><?1NGZ]<'A<N29*. )Z9!">,@%)LA
M(WD'B<)EV?Q.1F?,/(_V(H]!Z9T-=Q X&*AMO&R=L+]UO/V(IKU).K20V[I1
M1.&8UJ$0WFK3"*T2:9;4*XW5.4O+D;O&*[S##B57*^#R)>O"YJ5XKY^+":F2
ME^1K.@:JU"8<]::12!QMDJ6H]L5N.]+6=\%*&ZQLMDT--3-04[.M*<C^UF>'
MIW;=T:1#&_5P7PKK3*R=_>KL&UO;ES)PC+XD&WP1P@OGGZRM1^=]3:X=NDH9
M0G*\5HEQ4$IP<#S2>G \Z8*QE-S:!7N8JJ'W,'D,5G;N8;*?3@9JHQYL_[&_
MH=KUT4_2Q:1+D[6E T4TPFA6:Q2\JI>8:PFF4QRX+%Q*9J)N7@3;82^3J\U[
ME^X8MS9TXC=$(50M9"^@6,D0M:15&2PM&EL8=\W[VAY [W"[FCP&4YO=KXXU
M.%!S=[?OPO[V;>.SNFESTJ$%N]78HI[J\$2;F<SDY"NK:V="DT$R9S1YXT[S
MUA?L&C<[N43Y_7TV_@BS&6WJ\Z/9Q_'QEQO7O%4)+!9%44>J\^HDN0Y8Y_E&
ME8,WV3+7^L+NWL0.JAG*8S"SV2AUJ:X!'!I=2\R1@9F>(ZY3;,LBI5_#''.]
MI823^4J-)\M'+L<I?,0T/9Z,_XEY->YV.=?\VJ%%5BB9\*"%C^2)HH&@!(+1
M/B11"R2Q]>E29\ST>Z&V$USWJ>Z![L3K#@5[[[XW_KY=EX\.=]E;W1Y0N\1B
M9L"TJ3Z4TA 8(Z 9GU,VZ!VV#@VZ[_5QX3R>_U8'/EUX+5? ]091B-KAAAE#
MP)41@L[DNWII+1.LB.8#/?8@<U!=01Z#DUVZ@K14T=ZVY1O.XO3I"NOW-S/W
M/ZB#(OLNW?M-)=929>N0+UMCFEH@&2$ZAB"255(X+Q*WK1W]CDKMK^VUM]Y0
M*Z02A;>OQB=G"\RWT!Z4M]+7(#9*59NE(SC# E T2[1'&;7JSN%_%*D#+=-_
M#(:V.$B=*6U0;O^+R6*<*TOC;^0+IFI^QSA__3V=G-$R7UT*./UZ=C%#;4L;
M VM2M.3QI9K35EZ5>CKF:]D+A4.:Z=Q\=FE[+GIV]+M%="^J'JBO_^#TS_<U
MPJ^2>H6+,#[9;Z=^]$N>9+#I=M8&->C4<4S+H@&M@@254H;@$8%++EDVMMC<
M^@[(( :=7BW:7\_FXPGYS"_2?Y^-Y^.E/G\]O_:O579@6:V(\\7;^?P,2=OU
MO\L=JGX999T8T]&#<,NA3;7V0F &J8+++!H>.LS%M.#@1QAR^A@L;S;B3XZ'
M(7@K9W%..U>8G7\*ESG9%]_'\U&43@1>!%AD]>!). B6&;"!NZQ$0,6:WP+=
M1$S/S6=Z1,@]+6L.5]<0<'=%_OMP2M]^G@7:35,5XJOI:1A/1LE$25Y0!&U+
M@EJP"\ZZ "*'$&263,GFM_4>I*K_-D@-U'\;5&UUT7?A_8>S6?H2YOCB>(;+
M?>(W/(TX&_D8E,ZTVE#6OOW)F5HE::!PYFO#%"G\;E7V&U[0,S0:*W':6*(]
MHF(^6XP^ALDQ+E=*$)$X+P8D#[4YCD3PF<BW$J/F4IB@=KJ90D^]9E+H7U?F
MY,8+^XU[![!W[2_^(6!F#76)(D=O%"!S$53Q:3EAD?#.+691K-<[]3+?!35]
MFI,#E'5;W7M(KF>%_Q:^CT_/3M>$9]3"8[T_FA.92Z4"Q(@6T&3$8$S,::?(
M[@&5WWAISTK?1V73%O(;@$=ZCWV\:1'GMTWB._K\6PI%YR,TWI/0:O=K54"%
MF(#"3TWQ9Y":EZ)D:=U!XP!R^^TL-8 =Z:E5/@!TO\?%:GI,/84<><:*2:HV
M0E9U:7H%P>D$67HA5$"N=MO-'E6>?HV ?EWE)U/[G>+T?77P> #Y%8 F>!P6
MZ\\>"J&/-:4]P7QQ>/$BI;/3LY/Z_%=8QFF\&&4>,]>> Q.Y2H?B4?(7..T
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M ->&DIJZ(+,W(625("T79 X)8J'04:&@H#$Y'V+KPL[-U/1;#=#C:68;_0P
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M%M/1URK:-2,B%"5D$D!!$0<5HP+/N8!2G'<A!*YMZQ.>C<3T&ZL.#H%ME#8
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MFVYH%Y\V?+VG4.J/L/J E[\MA.#11QG R)#K>1X+Y&@)"":9%#,OAK?.K+U
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ME9 5R4,Y8<$E;>C#.U&<-ERT+EBVY:"OK-\HQ#T_I>OD*N[ :SN2Y^__W/^
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M_GY_A9;.[28SO!E(2"#-#"7TEMENDB5TNOOICFS+6!/;\DHRA/WU]QS)YB5
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M&DJ,-B^<[C%X]WS3N\_WX&N-1&-W)-Y3!?X'3\=S<I^(6<3\"2O;@$@;!E^
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M8FLW8_0>&8&EFX83&*)LCG*+\[)G MUNP^R!RI9,2GWHJ=@BD>Y<%3F_ABX
M;:#!9<M+%) 2E<4Q["7_8L::O(!M/5I<<(X?AG(<WIX/F44@(:DA-IC)PP O
M<SZ?X[!L"S-/IB*:,JS."9WD/S/(/'6S.(W$G$'K+!0V7],UE ,J7X2Z;-;E
M;X/*Y84VF\B\LPL09K("@8AHJEBG^-*%JI-&=-[AB7&GZ=0%>$]X4G&%UB+N
M@!N[4RQ=0';R7W -W&QS?KF@=5(];S?P?H$&;;1?3)Q?/:B:JP<U[6^V0<]V
MH[VSN5YU=K8].6SUO-5X^5%/J_7F[JZKP]:,(ZPSP-TJI<F[4K/T*)R=1OI
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M$  1              "  0    !A;7!X+3(P,C,P,S,Q+FAT;5!+ 0(4 Q0
M   ( ': JU:;R'X[-PT  *^%   1              "  7\! @!A;7!X+3(P
M,C,P,S,Q+GAS9%!+ 0(4 Q0    ( ': JU9&[Z*6Y10  &##   5
M      "  >4. @!A;7!X+3(P,C,P,S,Q7V-A;"YX;6Q02P$"% ,4    " !V
M@*M6S>%E/;DX  #73 ( %0              @ '](P( 86UP>"TR,#(S,#,S
M,5]D968N>&UL4$L! A0#%     @ =H"K5J( 5VP'G@  N98& !4
M     ( !Z5P" &%M<'@M,C R,S S,S%?;&%B+GAM;%!+ 0(4 Q0    ( ':
MJU:9Z1A!A5T  .$)!  5              "  2/[ @!A;7!X+3(P,C,P,S,Q
M7W!R92YX;6Q02P$"% ,4    " !V@*M6CK3YM+D(  ":*P  '
M    @ ';6 , 86UP>"TR,#(S,#,S,7AE>&AI8FET,S$Q+FAT;5!+ 0(4 Q0
M   ( ': JU;#I]"5M @  *$K   <              "  <YA P!A;7!X+3(P
M,C,P,S,Q>&5X:&EB:70S,3(N:'1M4$L! A0#%     @ =H"K5H5]<30(!0
MM10  !P              ( !O&H# &%M<'@M,C R,S S,S%X97AH:6)I=#,R
M,2YH=&U02P$"% ,4    " !V@*M6D>_]MQ<%  #@%0  '
M@ '^;P, 86UP>"TR,#(S,#,S,7AE>&AI8FET,S(R+FAT;5!+!08     "@ *
+ +("  !/=0,    !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
